{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "from Bio.Entrez import efetch\n",
    "# must install biopython package\n",
    "# pip install biopython\n",
    "\n",
    "import xml.etree.cElementTree as ET\n",
    "import codecs\n",
    "\n",
    "import os\n",
    "import codecs\n",
    "import sys  \n",
    "import string\n",
    "import unicodedata\n",
    "import xml.etree.cElementTree as ET\n",
    "import codecs\n",
    "import nltk\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem.snowball import SnowballStemmer\n",
    "from nltk.tokenize import sent_tokenize, word_tokenize\n",
    "from Bio import Entrez\n",
    "from Bio.Entrez import efetch\n",
    "\n",
    "\n",
    "#from AutoQuery import GetQuery\n",
    "#from GetAbstract import ProccessQuery\n",
    "#from FeatureExtraction import TokenStemmer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# returns a list of citation IDs in ['IdList] using esearch utility\n",
    "def search(query):\n",
    "    Entrez.email = 'your.email@example.com'\n",
    "    handle = Entrez.esearch(db='pubmed', \n",
    "                            sort='relevance', \n",
    "                            retmax='1000', # current limit is 200, could download more if done in blocks\n",
    "                            retmode='xml', \n",
    "                            term=query)\n",
    "    results = Entrez.read(handle)\n",
    "    handle.close()\n",
    "    return results\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# uses the id_list to query pubmed using efetch utility\n",
    "def fetch_abstract(id_list):\n",
    "    ids = ','.join(id_list)\n",
    "    handle = efetch(db='pubmed', id=ids, retmode='xml') ### this step returns xml object\n",
    "    #results = Entrez.read(handle) #this step read xml to string\n",
    "    #return results\n",
    "    return handle"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def GetQuery(term):\n",
    "    #arbitrary search term for now (incorporate into front end?)\n",
    "    results = search(term)\n",
    "    id_list = results['IdList']\n",
    "    papers = fetch_abstract(id_list)\n",
    "\n",
    "    return papers ##returns a xml object, which is taken by the parser as input\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "##read file to the tree\n",
    "def get_root(fname):\n",
    "    tree = ET.parse(fname)\n",
    "    return tree.getroot()\n",
    "\n",
    "##extract ArticleTitle, Abstract,Author information into a list of dictionary\n",
    "def get_abstracts(root):\n",
    "    collection = []\n",
    "    for article in root.findall(\"./PubmedArticle/MedlineCitation/Article\"):\n",
    "        data = {\n",
    "                \"ArticleTitle\": None,\n",
    "                \"Abstract\": None, \n",
    "                \"Author\":None,\n",
    "        } \n",
    "        \n",
    "        \n",
    "        ##check the exsitence of those tags for each item, pass if it's None\n",
    "        check= article.find('./ArticleTitle')==None or article.findall('./Abstract/AbstractText')==None or article.find('./AuthorList/Author/LastName')==None or article.find('./AuthorList/Author/ForeName')==None            \n",
    "        if check==True:\n",
    "            pass\n",
    "        else:\n",
    "            \n",
    "            \n",
    "            ##extract title and author as string\n",
    "            data[\"ArticleTitle\"] = article.find('./ArticleTitle').text\n",
    "            data[\"Author\"] = article.find('./AuthorList/Author/LastName').text +' '+ article.find('./AuthorList/Author/ForeName').text\n",
    "                      \n",
    "            \n",
    "            ##deal with multiple segments of AbstractText\n",
    "            abstract=''\n",
    "            abtext=article.findall('./Abstract/AbstractText')\n",
    "            \n",
    "            \n",
    "            \n",
    "            for text in abtext:\n",
    "                if text.text:\n",
    "                    abstract=abstract+' '+text.text\n",
    "            data[\"Abstract\"]=abstract\n",
    "            \n",
    "            #add the current entry to collection\n",
    "            collection.append(data)\n",
    "    \n",
    "    return collection\n",
    "\n",
    "    \n",
    "\n",
    "##call the helper function, returns data as list of dictionary\n",
    "def ProccessQuery(filename):\n",
    "    root = get_root(filename)\n",
    "    data = get_abstracts(root)\n",
    "    return data\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "##create two stopword lists\n",
    "def swansonStoplist():\n",
    "    with codecs.open('test-query-to-feature/stopwords_swanson.txt','r', encoding='utf-8') as f:\n",
    "        swanson = f.readlines()\n",
    "    swanson = [x.strip() for x in swanson] \n",
    "    return swanson\n",
    "\n",
    "def pubmedStoplist():    \n",
    "    with codecs.open('test-query-to-feature/stopwords_pubmed.txt','r', encoding='utf-8') as f:\n",
    "        pubmed = f.readlines()\n",
    "    pubmed = [x.strip() for x in pubmed]     \n",
    "    return pubmed\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "##tokenize and stem unicode string, returns a clean unicode string\n",
    "def TokenStemmer(f):\n",
    "                \n",
    "    new_content=word_tokenize(f)\n",
    "    \n",
    "    #stemmer and stopwords\n",
    "    stemmer = SnowballStemmer(\"english\",ignore_stopwords=False)    \n",
    "    swansonstopWords=stopwords.words('english')+swansonStoplist()\n",
    "    pubmedstopWords=stopwords.words('english')+pubmedStoplist()\n",
    "        \n",
    "\n",
    "    ##iterate through content word list, skip pubmed stop words and do stemming  \n",
    "    words=''\n",
    "    for i in new_content:\n",
    "        if i not in pubmedstopWords:\n",
    "            new=stemmer.stem(i)\n",
    "            words=words+' '+new\n",
    "    return words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def fileparser(term):\n",
    "    \n",
    "    xml_object = GetQuery(term)\n",
    "    sample=ProccessQuery(xml_object)\n",
    "\n",
    "    feature_list=[]     \n",
    "    for i in sample:\n",
    "        if i['Abstract']!=None: #make sure not include missing/bad data point\n",
    "            content=i['Abstract']\n",
    "            #translate to string type for punctuation removal\n",
    "            text_string = content.encode('utf-8').translate(None, string.punctuation)\n",
    "            #back to unicode\n",
    "            Utext_string=unicode(text_string, \"utf-8\")\n",
    "            #call the TokenStemmer() from FeatureExtraction.py\n",
    "            text = TokenStemmer(Utext_string)\n",
    "            #change again back to ascii string type and split into word list\n",
    "            #text=unicodedata.normalize('NFKD', text).encode('ascii','ignore')\n",
    "            #change again back to ascii string type and split into word list\n",
    "            features=text.encode('ascii','ignore')\n",
    "            \n",
    "            ##update value of 'Abstract' to the feature list\n",
    "            i['Abstract']=features\n",
    "            feature_list.append(i)\n",
    "    return feature_list \n",
    "            \n",
    "            \n",
    "if __name__ == '__main__':\n",
    "    sample_query1='((tumor) AND \"Cell\"[Journal])'\n",
    "    sample_query2='immunotherapy'\n",
    "    sample_query3='(HDAC) AND immunotherapy' \n",
    "    ablist=fileparser(sample_query1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'Abstract': ' intratumor heterogen foster tumor evolut key challeng cancer medicin here review data technolog reveal intratumor heterogen cancer type dynam constraint conting inher tumor evolut we emphas macroevolutionari leap involv largescal chromosom alter drive tumor evolut metastasi consid role tumor microenviron engend heterogen drug resist we suggest bold approach drug develop har adapt properti immunemicroenviron limit tumor combin advanc clinic trialdesign improv patient outcom',\n",
       "  'ArticleTitle': 'Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.',\n",
       "  'Author': 'McGranahan Nicholas'},\n",
       " {'Abstract': ' failur t cell protect cancer thought result lack antigen recognit chronic activ andor suppress cell use mous sarcoma model glucos consumpt tumor metabol restrict t cell lead dampen mtor activ glycolyt capac ifn product allow tumor progress we enhanc glycolysi antigen regressor tumor suffici overrid protect abil t cell control tumor growth we checkpoint blockad antibodi ctla4 pd1 pdl1 clinic restor glucos tumor microenviron permit t cell glycolysi ifn product furthermor block pdl1 direct tumor dampen glycolysi inhibit mtor activ decreas express glycolysi enzym reflect role pdl1 tumor glucos util our result establish tumorimpos metabol restrict mediat t cell hyporespons cancer',\n",
       "  'ArticleTitle': 'Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.',\n",
       "  'Author': 'Chang Chih-Hao'},\n",
       " {'Abstract': ' primit neuroectoderm tumor central nervous system cnspnet high aggress poor differenti embryon tumor occur young children affect adolesc adult herein demonstr signific proport institut diagnos cnspnet display molecular profil indistinguish welldefin cns tumor entiti facilit diagnosi appropri therapi patient tumor from remain fraction cnspnet identifi four new cns tumor entiti associ recurr genet alter distinct histopatholog clinic featur these new molecular entiti design cns neuroblastoma foxr2 activ cns nbfoxr2 cns ewe sarcoma famili tumor cic alter cns eftcic cns highgrad neuroepitheli tumor mn1 alter cns hgnetmn1 cns highgrad neuroepitheli tumor bcor alter cns hgnetbcor enabl meaning clinic trial develop therapeut strategi patient affect poor differenti cns tumor',\n",
       "  'ArticleTitle': 'New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.',\n",
       "  'Author': 'Sturm Dominik'},\n",
       " {'Abstract': ' passiv administ antitumor monoclon antibodi mab rapid kill tumor target fcrmediat cytotox adcc shortterm process howev antitumor mab treatment induc vaccin effect mabmedi tumor death induc longterm antitumor cellular immun respons to determin respons generat util murin model antitumor vaccin effect model neoantigen we demonstr fcr express cd11c antigenpres cell requir generat antitumor t cell respons adccmedi tumor clearanc use fcrhuman mice demonstr antitumor human higg1 engag hfcriiia macrophag mediat adcc engag hfcriia sole hfcr express human dendrit cell dcs generat potent vaccin effect thus nextgener antitumor antibodi enhanc bind hfcriiia clinic ideal antitumor antibodi optim cytotox effect well hfcriia engag dcs stimul longterm antitumor cellular immun',\n",
       "  'ArticleTitle': 'Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect.',\n",
       "  'Author': 'DiLillo David J'},\n",
       " {'Abstract': ' regulatori t cell t',\n",
       "  'ArticleTitle': u'Interferon-\\u03b3 Drives T',\n",
       "  'Author': 'Overacre-Delgoffe Abigail E'},\n",
       " {'Abstract': ' the mechan melanoma cancer cell evad antitumor immun remain incomplet understood here growth tumor form mutant brafv600 mous melanoma cell immunocompet host requir product prostaglandin e2 suppress immun fuel tumorpromot inflamm genet ablat cyclooxygenas cox prostaglandin e synthas brafv600 mous melanoma cell well nrasg12d melanoma breast colorect cancer cell render suscept immun control provok shift tumor inflammatori profil classic anticanc immun pathway this mous coxdepend inflammatori signatur remark conserv human cutan melanoma biopsi argu cox activ driver immun suppress speci preclin data demonstr inhibit cox synerg antipd1 blockad induc erad tumor impli cox inhibitor use adjuv immunebas therapi cancer patient',\n",
       "  'ArticleTitle': 'Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.',\n",
       "  'Author': 'Zelenay Santiago'},\n",
       " {'Abstract': ' there grow evid stresscop mechan repres tumor cell vulner function therapeut benefici target recent work delin integr stress adapt mechan character format cytoplasm mrna protein foci term stress granul sgs here demonstr sgs mark elev mutant kras cell follow exposur stressinduc stimuli the upregul sgs mutant kras depend product signal lipid molecul 15deoxydelta 1214 prostaglandin j2 15dpgj2 confer cytoprotect stress stimuli chemotherapeut agent the secret 15dpgj2 mutant kras cell suffici enhanc sg format stress resist cancer cell wildtyp kras our find identifi mutant krasdepend cell nonautonom mechan afford establish stressresist nich encompass differ tumor subclon these result inform design strategi erad tumor cell communiti',\n",
       "  'ArticleTitle': 'Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.',\n",
       "  'Author': 'Grabocka Elda'},\n",
       " {'Abstract': ' the hvem tnfrsf14 receptor gene frequent mutat gene germin center lymphoma we report loss hvem lead cellautonom activ b cell prolifer drive develop gc lymphoma vivo hvemdefici lymphoma b cell induc tumorsupport microenviron mark exacerb lymphoid stroma activ increas recruit t follicular helper t',\n",
       "  'ArticleTitle': 'Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.',\n",
       "  'Author': 'Boice Michael'},\n",
       " {'Abstract': ' homeostat program balanc immun protect selftoler such mechan like impact autoimmun tumor format respect how homeostasi maintain impact tumor surveil unknown here differ immun mononuclear phagocyt share conserv steadyst program differenti entri healthi tissu ifn necessari suffici induc program reveal key instruct role remark homeostat ifndepend program enrich primari human tumor includ melanoma stratifi surviv singlecel rna sequenc rnaseq reveal enrich homeostat modul monocyt dcs human metastat melanoma suppressorofcytokine2 socs2 protein conserv program transcript express mononuclear phagocyt infiltr primari melanoma induc ifn socs2 limit adapt antitumor immun dcbase prime t cell vivo indic critic regulatori role these find link immun homeostasi key determin antitumor immun escap reveal coopt tissuespecif immun develop tumor microenviron',\n",
       "  'ArticleTitle': u'IFN\\u03b3-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.',\n",
       "  'Author': 'Nirschl Christopher J'},\n",
       " {'Abstract': ' genet unstabl tetraploid cell promot tumorigenesi recent estim suggest 37 human tumor undergon genomedoubl event develop this potenti oncogen effect tetraploidi counter p53depend barrier prolifer howev cellular defect correspond signal pathway trigger growth suppress tetraploid cell known here combin rnai screen vitro evolut approach demonstr cytokinesi failur activ hippo tumor suppressor pathway cultur cell well natur occur tetraploid cell vivo induct hippo pathway trigger part extra centrosom alter small g protein signal activ lats2 kinas lats2 turn stabil p53 inhibit transcript regul yap taz these find defin tumor suppress mechan uncov adapt mechan potenti avail nascent tumor cell bypass inhibitori regul',\n",
       "  'ArticleTitle': 'Cytokinesis failure triggers hippo tumor suppressor pathway activation.',\n",
       "  'Author': 'Ganem Neil J'},\n",
       " {'Abstract': ' the inter intratumor heterogen breast cancer need adequ captur preclin model we creat larg collect breast cancer patientderiv tumor xenograft pdtxs morpholog molecular characterist origin tumor preserv passag mous an integr platform combin vivo mainten pdtxs shortterm cultur pdtxderiv tumor cell pdtcs optim remark intratumor genom clonal architectur origin breast cancer preserv serial passag xenograft shortterm cultur pdtcs we assess drug respons pdtcs highthroughput platform valid ex vivo respons vivo the biobank repres power resourc preclin breast cancer pharmacogenom studi httpcaldaslabcrukcamacukbcap includ identif biomark respons resist',\n",
       "  'ArticleTitle': 'A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.',\n",
       "  'Author': 'Bruna Alejandra'},\n",
       " {'Abstract': ' reciproc interact tumor cell microenviron drive cancer progress therapi resist in issu nabet al demonstr dynam feedback tumor stroma subvert normal inflammatori respons trigger releas exosom contain unshield rnas activ pattern recognit receptor promot tumor growth metastasi',\n",
       "  'ArticleTitle': 'Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis.',\n",
       "  'Author': 'Matei Irina'},\n",
       " {'Abstract': ' it thought cancer cell engag warburg metabol meet intrins biosynthet requir cell growth prolifer paper chang al ho al warburg metabol enabl tumor cell restrict glucos avail t cell suppress antitumor immun',\n",
       "  'ArticleTitle': 'Nutrient Competition: A New Axis of Tumor Immunosuppression.',\n",
       "  'Author': 'Sukumar Madhusudhanan'},\n",
       " {'Abstract': ' protein kinas c pkc isozym remain elus cancer target despit unambigu tumor promot function potent ligand phorbol ester preval mutat we analyz 8 pkc mutat identifi human cancer surpris loss function none activ lossoffunct mutat occur pkc subgroup imped secondmesseng bind phosphoryl catalysi correct lossoffunct pkc mutat crisprmedi genom edit patientderiv colon cancer cell line suppress anchorageindepend growth reduc tumor growth xenograft model hemizyg delet promot anchorageindepend growth reveal pkc haploinsuffici tumor suppress sever mutat domin negat suppress global pkc signal output bioinformat analysi suggest pkc mutat cooper cooccur mutat cancer driver these data establish pkc isozym general function tumor suppressor indic therapi focus restor inhibit pkc activ',\n",
       "  'ArticleTitle': \"Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.\",\n",
       "  'Author': 'Antal Corina E'},\n",
       " {'Abstract': ' signal rasmap kinas pathway central biolog erk long perceiv substrat mek here report hsf1 master regul proteotox stress respons new mek substrat beyond mediat cellenviron interact mekhsf1 regul impact malign in tumor cell mek blockad inactiv hsf1 provok proteom chao present protein destabil aggreg strike amyloidogenesi unlik nontransform counterpart tumor cell suscept proteom perturb amyloid induct amyloidogenesi tumor suppress reduc vivo melanoma growth contribut potent antineoplast effect proteotox stressor our find unveil key biolog function oncogen rasmek signal guard proteostasi suppress amyloidogenesi thus proteom instabl intrins featur malign state disrupt fragil tumor proteostasi promot amyloidogenesi feasibl therapeut strategi',\n",
       "  'ArticleTitle': 'MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1.',\n",
       "  'Author': 'Tang Zijian'},\n",
       " {'Abstract': ' t cell redirect kill cancer cell chimer antigen receptor car t cell receptor tcrs this approach constrain rariti tumorspecif singl antigen target antigen bystand tissu caus lifethreaten advers effect a power way enhanc ontarget activ therapeut t cell engin requir combinatori antigen here engin combinatori activ t cell circuit synthet notch receptor one antigen induc express car second antigen these dualreceptor andgat t cell arm activ presenc dual antigen tumor cell these t cell precis therapeut discrimin vivospar singl antigen bystand tumor effici clear combinatori antigen diseas tumor this precis dualreceptor circuit open door immun recognit wider rang tumor video abstract',\n",
       "  'ArticleTitle': 'Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.',\n",
       "  'Author': 'Roybal Kole T'},\n",
       " {'Abstract': ' dendrit cell dcs requir initi sustain t celldepend anticanc immun howev tumor evad immun control crippl normal dc function the endoplasm reticulum er stress respons factor xbp1 promot intrins tumor growth direct regul host antitumor immun respons known here constitut activ xbp1 tumorassoci dcs tdcs drive ovarian cancer ovca progress blunt antitumor immun xbp1 activ fuel lipid peroxid byproduct induc triglycerid biosynthet program tdcs lead abnorm lipid accumul subsequ inhibit tdc capac support antitumor t cell accord dcspecif xbp1 delet select nanoparticlemedi xbp1 silenc tdcs restor immunostimulatori activ situ extend surviv evok protect 1 antitumor respons target er stress respons concomit inhibit tumor growth enhanc anticanc immun offer uniqu approach cancer immunotherapi',\n",
       "  'ArticleTitle': 'ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.',\n",
       "  'Author': 'Cubillos-Ruiz Juan R'},\n",
       " {'Abstract': ' the pyruv kinas m2 isoform pkm2 express cancer play role regul anabol metabol to determin pkm2 requir tumor format growth generat mice condit allel abolish pkm2 express disrupt pkm1 express pkm2 delet acceler mammari tumor format brca1lossdriven model breast cancer pkm2 null tumor display heterogen pkm1 express pkm1 nonprolifer tumor cell detect pyruv kinas express prolifer cell this suggest pkm2 necessari tumor cell prolifer impli inact state pkm2 associ prolifer cell popul tumor nonprolifer tumor cell requir activ pyruv kinas consist find variabl pkm2 express heterozyg pkm2 mutat human tumor these data suggest regul pkm2 activ support differ metabol requir prolifer nonprolifer tumor cell',\n",
       "  'ArticleTitle': 'PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.',\n",
       "  'Author': 'Israelsen William J'},\n",
       " {'Abstract': ' oncogen mutat regul signal tumor cell adjac stromal cell here oncogen kras krasg12d regul tumor cell signal stromal cell by combin cellspecif proteom label multivari phosphoproteom analyz heterocellular krasg12d signal pancreat ductal adenocarcinoma pda cell tumor cell krasg12d engag heterotyp fibroblast subsequ instig reciproc signal tumor cell reciproc signal employ addit kinas doubl number regul signal node cellautonom krasg12d consequ reciproc krasg12d produc tumor cell phosphoproteom total proteom distinct cellautonom krasg12d reciproc signal regul tumor cell prolifer apoptosi increas mitochondri capac igf1raxlakt axi these result demonstr oncogen signal view heterocellular process exist cellautonom perspect underrepres extent oncogen signal cancer video abstract',\n",
       "  'ArticleTitle': 'Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.',\n",
       "  'Author': 'Tape Christopher J'},\n",
       " {'Abstract': ' circul tumor cell blood patient signal flare exist tumor harbing metastasi with recent technolog develop cell isol analyz provid insight biolog cancer spread respons therapi offer new avenu blood biomark develop',\n",
       "  'ArticleTitle': 'SnapShot: Circulating Tumor Cells.',\n",
       "  'Author': 'Dive Caroline'},\n",
       " {'Abstract': ' curat therapi success cancer diagnos treat earli stage we advoc technolog advanc nextgener sequenc circul tumorderiv nucleic acid hold promis address challeng develop safe effect cancer screen test',\n",
       "  'ArticleTitle': 'Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.',\n",
       "  'Author': 'Aravanis Alexander M'},\n",
       " {'Abstract': ' reprogram cellular metabol key event tumorigenesi despit known decad warburg effect molecular mechan regul switch remain unexplor here identifi sirt6 tumor suppressor regul aerob glycolysi cancer cell import loss sirt6 lead tumor format activ known oncogen transform sirt6defici cell display increas glycolysi tumor growth suggest sirt6 play role establish mainten cancer by condit sirt6 allel sirt6 delet vivo increas number size aggress tumor sirt6 function regul ribosom metabol corepress myc transcript activ last sirt6 select downregul human cancer express level sirt6 predict prognosi tumorfre surviv rate highlight sirt6 critic modul cancer metabol our studi reveal sirt6 potent tumor suppressor act suppress cancer metabol',\n",
       "  'ArticleTitle': 'The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.',\n",
       "  'Author': u'Sebasti\\xe1n Carlos'},\n",
       " {'Abstract': ' we except case patient highgrad serous ovarian cancer treat multipl chemotherapi regimen exhibit regress metastat lesion concomit progress lesion treatmentfre period use immunogenom approach progress metastas character immun cell exclus regress stabl metastas infiltr cd8',\n",
       "  'ArticleTitle': 'Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.',\n",
       "  'Author': u'Jim\\xe9nez-S\\xe1nchez Alejandro'},\n",
       " {'Abstract': ' the mechan immun checkpoint blockad modul tumor evolut therapi unclear we assess genom chang tumor 68 patient advanc melanoma progress ipilimumab ipilimumabna nivolumab initi ca209038 studi tumor analyz wholeexom transcriptom andor t cell receptor tcr sequenc in respond patient mutat neoantigen load reduc baselin analysi intratumor heterogen therapi demonstr differenti clonal evolut tumor putat select neoantigen mutat ontherapi transcriptom analys nivolumab therapi reveal increas distinct immun cell subset activ specif transcript network upregul immun checkpoint gene pronounc patient respons tempor chang intratumor tcr repertoir reveal expans t cell clone set neoantigen loss comprehens genom profil data studi provid insight nivolumab mechan action',\n",
       "  'ArticleTitle': 'Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.',\n",
       "  'Author': 'Riaz Nadeem'},\n",
       " {'Abstract': ' circul tumor cell cluster ctc cluster blood patient cancer contribut metastasi well defin use mous model tag mammari tumor demonstr ctc cluster oligoclon tumor cell group intravascular aggreg event although rare circul compar singl ctcs ctc cluster 23 50fold increas metastat potenti in patient breast cancer singlecel resolut rna sequenc ctc cluster singl ctcs match individu blood sampl identifi cell junction compon plakoglobin high differenti express in mous model knockdown plakoglobin abrog ctc cluster format suppress lung metastas in breast cancer patient abund ctc cluster high tumor plakoglobin level denot advers outcom thus ctc cluster deriv multicellular group primari tumor cell held plakoglobindepend intercellular adhes rare great contribut metastat spread cancer',\n",
       "  'ArticleTitle': 'Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.',\n",
       "  'Author': 'Aceto Nicola'},\n",
       " {'Abstract': ' mous model cancer reveal novel cancerpromot role autophagi autophagi promot tumor growth suppress p53 respons maintain mitochondri function sustain metabol homeostasi surviv stress prevent divers tumor progress benign oncocytoma',\n",
       "  'ArticleTitle': 'Autophagy-mediated tumor promotion.',\n",
       "  'Author': 'Guo Jessie Yanxiang'},\n",
       " {'Abstract': ' nfb key transcript regul involv inflamm cell prolifer surviv transform sever key step activ mediat ubiquitin ub system one uncharacter step limit proteasom process nfb1 precursor p105 p50 activ subunit here identifi kpc1 ub ligas e3 bind ankyrin repeat domain p105 ubiquitin mediat process basal condit follow signal overexpress kpc1 inhibit tumor growth like mediat excess generat p50 also overabund p50 downregul p65 suggest p50p50 homodim modul transcript place tumorigen p50p65 transcript analysi reveal increas express gene associ tumorsuppress signal overal kpc1 regul nfb1 process appear constitut balanc step stimulatori inhibitori activ transcript factor cell growth control',\n",
       "  'ArticleTitle': u'KPC1-mediated ubiquitination and proteasomal processing of NF-\\u03baB1 p105 to p50 restricts tumor growth.',\n",
       "  'Author': 'Kravtsova-Ivantsiv Yelena'},\n",
       " {'Abstract': ' antibodi blockad inhibitori ctla4 pathway led clinic benefit subset patient metastat melanoma antictla4 enhanc t cell respons includ product ifn critic cytokin host immun respons howev role ifn signal tumor cell set antictla4 therapi remain unknown here demonstr patient identifi nonrespond antictla4 ipilimumab tumor genom defect ifn pathway gene furthermor mice bear melanoma tumor knockdown ifn receptor 1 ifngr1 impair tumor reject antictla4 therapi these data highlight loss ifn signal pathway associ primari resist antictla4 therapi our find demonstr tumor genom data ifn relat gene prognost inform patient select receiv treatment immun checkpoint therapi',\n",
       "  'ArticleTitle': u'Loss of IFN-\\u03b3 Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.',\n",
       "  'Author': 'Gao Jianjun'},\n",
       " {'Abstract': ' focal adhes kinas fak promot antitumor immun evas specif kinas activ nucleartarget fak squamous cell carcinoma scc cell drive exhaust cd8 t cell recruit regulatori t cell treg tumor microenviron regul chemokinecytokin ligandreceptor network includ transcript ccl5 crucial these chang inhibit antigenprim cytotox cd8 t cell activ permit growth fakexpress tumor mechanist nuclear fak associ chromatin exist complex transcript factor upstream regul control ccl5 express furthermor fak immunomodulatori nuclear activ specif cancer squamous epitheli cell normal keratinocyt nuclear fak final smallmolecul fak kinas inhibitor vs4718 current clinic develop drive deplet treg promot cd8 t cellmedi antitumor respons therefor fak inhibitor trigger immunemedi tumor regress provid unrecogn therapeut opportun',\n",
       "  'ArticleTitle': 'Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity.',\n",
       "  'Author': 'Serrels Alan'},\n",
       " {'Abstract': ' cellcycl arrest apoptosi senesc wide accept major mechan p53 inhibit tumor format nevertheless remain unclear ratelimit step tumor suppress here generat mice bear lysin arginin mutat one p53k117r three p533kr k117rk161rk162r p53 acetyl site although p53k117rk117r cell compet p53mediat cellcycl arrest senesc apoptosi three process ablat p533kr3kr cell surpris unlik p53 null mice rapid succumb spontan thymic lymphoma earlyonset tumor format occur p53k117rk117r p533kr3kr anim notabl p533kr retain abil regul energi metabol reactiv oxygen speci product these find underscor crucial role acetyl differenti modul p53 respons suggest unconvent activ p53 metabol regul antioxid function critic suppress earlyonset spontan tumorigenesi',\n",
       "  'ArticleTitle': 'Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.',\n",
       "  'Author': 'Li Tongyuan'},\n",
       " {'Abstract': ' the divers malign stromal immun cell tumor affect growth metastasi respons therapi we profil transcriptom 6000 singl cell 18 head neck squamous cell carcinoma hnscc patient includ five match pair primari tumor lymph node metastas stromal immun cell consist express program patient convers malign cell vari tumor express signatur relat cell cycl stress hypoxia epitheli differenti partial epithelialtomesenchym transit pemt cell express pemt program spatial local lead edg primari tumor by integr singlecel transcriptom bulk express profil hundr tumor refin hnscc subtyp malign stromal composit establish pemt independ predictor nodal metastasi grade advers patholog featur our result provid insight hnscc ecosystem defin stromal interact pemt program associ metastasi',\n",
       "  'ArticleTitle': 'Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.',\n",
       "  'Author': 'Puram Sidharth V'},\n",
       " {'Abstract': ' chromatin regul attract target cancer therapi unclear inhibit ubiquit regul genespecif effect tumor cell here inhibit wide express transcript coactiv brd4 lead select inhibit myc oncogen multipl myeloma mm brd4 mediat cooccupi thousand enhanc associ activ gene they cooccupi small set except larg superenhanc associ gene featur promin mm biolog includ myc oncogen treatment mm tumor cell betbromodomain inhibitor jq1 led preferenti loss brd4 superenhanc consequ transcript elong defect preferenti impact gene superenhanc includ myc superenhanc key oncogen driver tumor cell these observ implic discoveri cancer therapeut direct compon superenhanc divers tumor type',\n",
       "  'ArticleTitle': 'Selective inhibition of tumor oncogenes by disruption of super-enhancers.',\n",
       "  'Author': u'Lov\\xe9n Jakob'},\n",
       " {'Abstract': ' elev express cmyc transcript factor occur frequent human cancer associ tumor aggress poor clinic outcom the effect high level cmyc global gene regul poor understood wide thought involv newli activ repress myc target gene we report tumor cell express high level cmyc transcript factor accumul promot region activ gene caus transcript amplif produc increas level transcript cell gene express program thus bind regul new set gene cmyc amplifi output exist gene express program these result provid explan divers effect oncogen cmyc gene express differ tumor cell suggest transcript amplif reduc ratelimit constraint tumor cell growth prolifer',\n",
       "  'ArticleTitle': 'Transcriptional amplification in tumor cells with elevated c-Myc.',\n",
       "  'Author': 'Lin Charles Y'},\n",
       " {'Abstract': ' cancer cell leav primari tumor seed metastas distant organ thought unidirect process here circul tumor cell ctcs colon tumor origin process call tumor selfseed selfseed breast cancer colon cancer melanoma tumor mice preferenti mediat aggress ctcs includ bone lung brainmetastat tropism we tumorderiv cytokin il6 il8 act ctc attract mmp1collagenase1 actin cytoskeleton compon fascin1 mediat ctc infiltr mammari tumor we selfseed acceler tumor growth angiogenesi stromal recruit seedderiv factor includ chemokin cxcl1 tumor selfseed explain relationship anaplasia tumor size vascular prognosi local recurr seed dissemin cell follow ostens complet tumor excis',\n",
       "  'ArticleTitle': 'Tumor self-seeding by circulating cancer cells.',\n",
       "  'Author': 'Kim Mi-Young'},\n",
       " {'Abstract': ' immun respons involv coordin cell type tissu howev studi cancer immunotherapi focus heavili local immun respons tumor microenviron to immun activ broad perform organismwid studi genet engin cancer model mass cytometri we analyz immun respons tissu immunotherapi develop intuit model visual singlecel data statist infer immun activ evid tumor system short effect therapi administ howev tumor reject peripher immun cell sustain prolifer this system respons coordin tissu requir tumor erad immunotherapi model an emerg popul peripher cd4 t cell confer protect new tumor expand patient respond immunotherapi these studi demonstr critic impact system immun respons drive tumor reject',\n",
       "  'ArticleTitle': 'Systemic Immunity Is Required for Effective Cancer Immunotherapy.',\n",
       "  'Author': 'Spitzer Matthew H'},\n",
       " {'Abstract': ' cancer immunotherapi substanti clinic activ subset patient epitheli cancer still technolog platform studi cancer tcell interact individu patient understand determin respons lack here establish valid platform induc tumorspecif t cell respons epitheli cancer person manner we demonstr cocultur autolog tumor organoid peripher blood lymphocyt enrich tumorreact t cell peripher blood patient mismatch repairdefici colorect cancer nonsmallcel lung cancer furthermor demonstr t cell assess effici kill match tumor organoid this platform provid unbias strategi isol tumorreact t cell provid mean assess sensit tumor cell t cellmedi attack level individu patient',\n",
       "  'ArticleTitle': 'Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.',\n",
       "  'Author': 'Dijkstra Krijn K'},\n",
       " {'Abstract': ' knowledg immun cell phenotyp tumor microenviron essenti understand mechan cancer progress immunotherapi respons we profil 45000 immun cell eight breast carcinoma well match normal breast tissu blood lymph node singlecel rnaseq we develop preprocess pipelin seqc bayesian cluster normal method biscuit address comput challeng inher singlecel data despit signific similar normal tumor tissueresid immun cell observ continu phenotyp expans specif tumor microenviron analysi pair singlecel rna t cell receptor tcr sequenc data 27000 addit t cell reveal combinatori impact tcr util phenotyp divers our result support model continu activ t cell comport macrophag polar model cancer our result implic character tumorinfiltr immun cell',\n",
       "  'ArticleTitle': 'Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.',\n",
       "  'Author': 'Azizi Elham'},\n",
       " {'Abstract': ' activ t cell engag aerob glycolysi anabol metabol growth prolifer effector function we propos glucosepoor tumor microenviron limit aerob glycolysi tumorinfiltr t cell suppress tumoricid effector function we discov new role glycolyt metabolit phosphoenolpyruv pep sustain t cell receptormedi ca2nfat signal effector function repress sarcoer ca2atpas serca activ tumorspecif cd4 cd8 t cell metabol reprogram increas pep product overexpress phosphoenolpyruv carboxykinas 1 pck1 bolster effector function moreov pck1overexpress t cell restrict tumor growth prolong surviv melanomabear mice this studi uncov new metabol checkpoint t cell activ demonstr metabol reprogram tumorreact t cell enhanc antitumor t cell respons illumin new form immunotherapi',\n",
       "  'ArticleTitle': 'Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.',\n",
       "  'Author': 'Ho Ping-Chih'},\n",
       " {'Abstract': ' revers dysfunct t cell state aris cancer chronic viral infect focus therapeut intervent current therapi effect patient tumor type to gain deeper molecular understand dysfunct t cell state analyz popul singlecel rna profil cd8 tumorinfiltr lymphocyt til genet perturb identifi distinct gene modul t cell dysfunct uncoupl t cell activ this distinct dysfunct modul downstream intracellular metallothionein regul zinc metabol identifi singlecel resolut we identifi gata3 zincfing transcript factor dysfunct modul regul dysfunct crisprcas9 genom edit drive dysfunct phenotyp cd8 til our result open novel avenu target dysfunct t cell state leav activ program intact',\n",
       "  'ArticleTitle': 'A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.',\n",
       "  'Author': 'Singer Meromit'},\n",
       " {'Abstract': ' the molecular basi p53mediat tumor suppress remain unclear here elucid mechan p53 tumor suppress knockin mice express allel seri p53 transcript activ mutant microarray analysi reveal one mutant p532526 sever compromis transactiv p53 target gene p532526 induc g1arrest apoptosi respons acut dna damag surpris p532526 retain robust activ senesc tumor suppress indic effici transactiv major known p53 target dispens pathway in contrast transactivationdead p5325265354 mutant induc senesc inhibit tumorigenesi p53 nullizygos thus p53 transactiv essenti tumor suppress intrigu associ small set novel p53 target gene togeth studi distinguish p53 transcript program involv acut dnadamag respons tumor suppressiona critic goal design therapeut block p53depend side effect chemotherapi compromis p53 tumor suppress',\n",
       "  'ArticleTitle': 'Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.',\n",
       "  'Author': 'Brady Colleen A'},\n",
       " {'Abstract': ' identifi tumorinduc leukocyt subset deriv circul factor instrument understand cancer system diseas nevertheless primari tumorinduc nonleukocyt popul distal organ contribut system spread remain poor defin here report one popul tumorinduc erythroblastlik cell tercel deriv megakaryocyteerythroid progenitor cell uniqu ter119',\n",
       "  'ArticleTitle': 'Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.',\n",
       "  'Author': 'Han Yanmei'},\n",
       " {'Abstract': ' chromatin regul play broad role regul gene express awri lead cancer here demonstr ablat histon demethylas lsd1 cancer cell increas repetit element express includ endogen retrovir element erv decreas express rnainduc silenc complex risc compon signific lead doublestrand rna dsrna stress activ 1 interferon stimul antitumor t cell immun restrain tumor growth furthermor lsd1 deplet enhanc tumor immunogen t cell infiltr poor immunogen tumor elicit signific respons checkpoint blockaderefractori mous melanoma antipd1 therapi consist tcga data analysi invers correl lsd1 express cd8',\n",
       "  'ArticleTitle': 'LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.',\n",
       "  'Author': 'Sheng Wanqiang'},\n",
       " {'Abstract': ' the p53 tumor suppressor restrict malign transform trigger cellautonom program cellcycl arrest apoptosi p53 promot cellular senesc tumorsuppress program involv stabl cellcycl arrest secret factor modifi tissu microenviron in presenc chronic liver damag ablat p53depend senesc program hepat stellat cell increas liver fibrosi cirrhosi associ reduc surviv enhanc transform adjac epitheli cell hepatocellular carcinoma p53express senesc stellat cell releas factor skew macrophag polar tumorinhibit m1state capabl attack senesc cell cultur prolifer p53defici stellat cell secret factor stimul polar macrophag tumorpromot m2state enhanc prolifer premalign cell henc p53 act noncel autonom suppress tumorigenesi promot antitumor microenviron part secret factor modul macrophag function',\n",
       "  'ArticleTitle': 'Non-cell-autonomous tumor suppression by p53.',\n",
       "  'Author': 'Lujambio Amaia'},\n",
       " {'Abstract': ' the cytokin tweak cognat receptor fn14 member tnftnfr superfamili upregul tumor we fn14 express tumor caus cachexia antibodi fn14 dramat extend lifespan inhibit tumorinduc weight loss moder inhibitori effect tumor growth antifn14 antibodi prevent tumorinduc inflamm loss fat muscl mass fn14 signal tumor host respons induc cachexia tumor fn14 tweakdefici host develop cachexia compar wildtyp mice these result extend role fn14 wound repair muscl develop involv etiolog cachexia indic fn14 antibodi promis approach treat cachexia extend lifespan improv qualiti life cancer patient',\n",
       "  'ArticleTitle': 'Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival.',\n",
       "  'Author': 'Johnston Amelia J'},\n",
       " {'Abstract': ' cell surfac growth factor receptor coupl environment cue regul cytoplasm homeostat process includ autophagi aberr activ receptor common featur human malign here defin molecular basi epiderm growth factor receptor egfr tyrosin kinas regul autophagi activ egfr bind autophagi protein beclin 1 lead multisit tyrosin phosphoryl enhanc bind inhibitor decreas beclin 1associ vps34 kinas activ egfr tyrosin kinas inhibitor tki therapi disrupt beclin 1 tyrosin phosphoryl bind inhibitor restor autophagi nonsmallcel lung carcinoma nsclc cell tkisensit egfr mutat in nsclc tumor xenograft express tyrosin phosphomimet beclin 1 mutant lead reduc autophagi enhanc tumor growth tumor dedifferenti resist tki therapi thus oncogen receptor tyrosin kinas direct regul core autophagi machineri contribut tumor progress chemoresist',\n",
       "  'ArticleTitle': 'EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.',\n",
       "  'Author': 'Wei Yongjie'},\n",
       " {'Abstract': ' glutam receptor nmethyldaspart receptor nmdar associ cancer function fulli understood herein implic glutamatedriven nmdar signal mous model pancreat neuroendocrin tumorigenesi pnet select human cancer nmdar upregul peripheri pnet tumor invas front moreov elev coexpress nmdar glutam export correl poor prognosi cancer patient treatment tumorderiv cell line nmdar antagonist impair cancer cell prolifer invas flow condit mimick interstiti fluid pressur induc autolog glutam secret activ nmdar downstream mekmapk camk effector promot invas congruent pharmacolog inhibit nmdar mice pnet reduc tumor growth invas therefor tradit role neuron nmdar activ human tumor fluid flow consequ higher interstiti pressur induc autocrin glutam signal circuit result stimul malign',\n",
       "  'ArticleTitle': 'Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion.',\n",
       "  'Author': 'Li Leanne'},\n",
       " {'Abstract': ' therapeut antibodi target program cell death 1 pd1 activ tumorspecif immun remark efficaci treatment melanoma yet littl known tumor cellintrins pd1 pathway effect here murin human melanoma contain pd1express cancer subpopul demonstr melanoma cellintrins pd1 promot tumorigenesi even mice lack adapt immun pd1 inhibit melanoma cell rnai block antibodi mutagenesi melanomapd1 signal motif suppress tumor growth immunocompet immunocompromis pd1defici tumor graft recipi mice convers melanomaspecif pd1 overexpress enhanc tumorigen engag melanomapd1 ligand pdl1 melanomapdl1 inhibit knockout hostpdl1 attenu growth pd1posit melanoma mechanist melanomapd1 receptor modul downstream effector mtor signal our result identifi melanoma cellintrins function pd1pdl1 axi tumor growth suggest block melanomapd1 contribut strike clinic efficaci antipd1 therapi',\n",
       "  'ArticleTitle': 'Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.',\n",
       "  'Author': 'Kleffel Sonja'},\n",
       " {'Abstract': ' the p53 tumor suppressor coordin seri antiprolif respons restrict expans malign cell consequ p53 lost mutat major human cancer here p53 restrict express stem progenitorcellassoci protein nestin sp13 transcriptionfactordepend manner nestin requir tumor initi vivo moreov loss p53 facilit dedifferenti matur hepatocyt nestinposit progenitorlik cell pois differenti hepatocellular carcinoma hccs cholangiocarcinoma ccs respons lineagespecif mutat target wnt notch signal respect mani human hccs ccs elev nestin express correl p53 loss function associ decreas patient surviv therefor transcript repress nestin p53 restrict cellular plastic tumorigenesi liver cancer',\n",
       "  'ArticleTitle': 'p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.',\n",
       "  'Author': 'Tschaharganeh Darjus F'},\n",
       " {'Abstract': ' convent 1 dendrit cell cdc1 critic antitumor immun abund tumor associ immunemedi reject success immunotherapi here cdc1 accumul mous tumor depend natur killer nk cell produc cdc1 chemoattract ccl5 xcl1 similar human cancer intratumor ccl5 xcl1 xcl2 transcript close correl gene signatur nk cell cdc1 associ increas patient surviv notabl tumor product prostaglandin e2 pge',\n",
       "  'ArticleTitle': 'NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.',\n",
       "  'Author': u'B\\xf6ttcher Jan P'},\n",
       " {'Abstract': ' genet screen power tool identifi gene respons divers phenotyp here describ genomewid crisprcas9medi lossoffunct screen tumor growth metastasi we mutagen nonmetastat mous cancer cell line genomescal librari 67405 singleguid rnas sgrnas the mutant cell pool rapid generat metastas transplant immunocompromis mice enrich sgrnas lung metastas latestag primari tumor target small set gene suggest specif lossoffunct mutat drive tumor growth metastasi individu sgrnas small pool 624 sgrnas target topscor gene primari screen dramat acceler metastasi in experi effect mutat primari tumor growth posit correl develop metastas our studi demonstr cas9bas screen robust method systemat assay gene phenotyp cancer evolut vivo',\n",
       "  'ArticleTitle': 'Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.',\n",
       "  'Author': 'Chen Sidi'},\n",
       " {'Abstract': ' tgf signal protumorigen tumor suppress we investig dualiti pancreat ductal adenocarcinoma pda gastrointestin cancer exhibit frequent inactiv tgf mediat smad4 we tgf induc epithelialmesenchym transit emt general consid protumorigen event howev tgfsensit pda cell emt lethal convert tgfinduc sox4 enforc tumorigenesi promot apoptosi this result emtlink remodel cellular transcript factor landscap includ repress gastrointestin lineagemast regul klf5 klf5 cooper sox4 oncogenesi prevent sox4induc apoptosi smad4 requir emt dispens sox4 induct tgf tgfinduc sox4 gear bolster progenitor ident simultan smad4depend emt strip sox4 essenti partner oncogenesi our work demonstr tgf tumor suppress function emtmedi disrupt lineagespecif transcript network',\n",
       "  'ArticleTitle': u'TGF-\\u03b2 Tumor Suppression through a Lethal EMT.',\n",
       "  'Author': 'David Charles J'},\n",
       " {'Abstract': ' metabol activ intim link t cell fate function use highresolut mass spectrometri generat dynam metabolom proteom profil human primari naiv t cell follow activ we discov critic chang arginin metabol led drop intracellular larginin concentr elev larginin level induc global metabol chang includ shift glycolysi oxid phosphoryl activ t cell promot generat central memorylik cell endow higher surviv capac mous model antitumor activ proteomewid probe structur alter valid analysi knockout t cell clone identifi three transcript regul baz1b psip1 tsn sens larginin level promot t cell surviv thus intracellular larginin concentr direct impact metabol fit surviv capac t cell crucial antitumor respons',\n",
       "  'ArticleTitle': 'L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.',\n",
       "  'Author': 'Geiger Roger'},\n",
       " {'Abstract': ' development fate decis dictat master transcript factor tfs interact cisregulatori element direct transcript program certain malign tumor cellular hierarchi reminisc normal develop superimpos under genet aberr in glioblastoma gbm subset stemlik tumorpropag cell tpcs appear drive tumor progress underli therapeut resist remain poor understood here identifi core set neurodevelopment tfs pou3f2 sox2 sall2 olig2 essenti gbm propag these tfs coordin bind activ tpcspecif regulatori element suffici fulli reprogram differenti gbm cell induc tpcs recapitul epigenet landscap phenotyp nativ tpcs we reconstruct network model highlight critic interact identifi candid therapeut target elimin tpcs our studi establish epigenet basi development hierarchi gbm provid detail insight under gene regulatori program suggest attend therapeut strategi paperclip',\n",
       "  'ArticleTitle': 'Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.',\n",
       "  'Author': u'Suv\\xe0 Mario L'},\n",
       " {'Abstract': ' bladder cancer fifth preval cancer us understudi laboratori model exist reflect biolog human diseas here describ biobank patientderiv organoid line recapitul histopatholog molecular divers human bladder cancer organoid line establish effici patient biopsi acquir diseas recurr interconvert orthotop xenograft notabl organoid line retain parent tumor heterogen exhibit spectrum genom chang consist tumor evolut cultur analys drug respons bladder tumor organoid partial correl mutat profil well chang associ treatment resist specif respons valid xenograft vivo our studi indic patientderiv bladder tumor organoid repres faith model system studi tumor evolut treatment respons context precis cancer medicin',\n",
       "  'ArticleTitle': 'Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.',\n",
       "  'Author': 'Lee Suk Hyung'},\n",
       " {'Abstract': ' how organspecif metastat trait primari tumor remain unknown here role breast tumor stroma select cancer cell prime metastasi bone cancerassoci fibroblast caf tripleneg tn breast tumor skew heterogen cancer cell popul predomin clone thrive cafderiv factor cxcl12 igf1 limit concentr factor select cancer cell high src activ known clinic predictor bone relaps enhanc pi3kakt pathway activ cxcl12 igf1 carcinoma clone select manner prime metastasi cxcl12rich microenviron bone marrow the evid suggest stromal signal resembl distant organ select cancer cell prime metastasi organ illumin evolut metastat trait primari tumor distant metastas',\n",
       "  'ArticleTitle': 'Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.',\n",
       "  'Author': 'Zhang Xiang H-F'},\n",
       " {'Abstract': ' mani tumor produc plateletderiv growth factor pdgfdd promot cellular prolifer epithelialmesenchym transit stromal reaction angiogenesi autocrin paracrin pdgfr signal by screen secretom librari human immunoreceptor nkp44 encod ncr2 express natur killer nk cell innat lymphoid cell recogn pdgfdd pdgfdd engag nkp44 trigger nk cell secret interferon gamma ifn tumor necrosi factor alpha tnf induc tumor cell growth arrest a distinct transcript signatur pdgfddinduc cytokin downregul tumor cellcycl gene correl ncr2 express greater surviv glioblastoma nkp44 express mous nk cell control dissemin tumor express pdgfdd effect control mice effect enhanc blockad inhibitori receptor cd96 cpgoligonucleotid treatment thus cancer cell product pdgfdd support tumor growth stromal reaction concomit activ innat immun respons tumor expans',\n",
       "  'ArticleTitle': 'Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.',\n",
       "  'Author': 'Barrow Alexander D'},\n",
       " {'Abstract': ' poor immunogen tumor cell evad host immun grow even presenc intact immun system complex mechan regul tumor immunogen elucid here discov unexpect role hippo pathway suppress antitumor immun we demonstr three differ murin syngen tumor model b16 scc7 4t1 loss hippo pathway kinas lats12 larg tumor suppressor 1 2 tumor cell inhibit tumor growth tumor regress lats12 delet requir adapt immun respons lats12 defici enhanc tumor vaccin efficaci mechanist lats12nul tumor cell secret nucleicacidrich extracellular vesicl induc i interferon respons tolllik receptorsmyd88trif pathway lats12 delet tumor improv tumor immunogen lead tumor destruct enhanc antitumor immun respons our observ uncov key role hippo pathway modul tumor immunogen demonstr proof concept target lats12 cancer immunotherapi',\n",
       "  'ArticleTitle': 'The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.',\n",
       "  'Author': 'Moroishi Toshiro'},\n",
       " {'Abstract': ' cancer cell express oncogen allel ras typic requir sustain express mutant allel surviv molecular basi oncogen depend remain incomplet understood to identifi gene function substitut oncogen ras systemat express 15294 open read frame human krasdepend colon cancer cell line engin express induc krasspecif shrna we 147 gene promot surviv kras suppress in particular transcript coactiv yap1 rescu cell viabil krasdepend cell suppress kras requir krasinduc cell transform acquir resist kras suppress krasdriven murin lung cancer model involv increas yap1 signal kras yap1 converg transcript factor fos activ transcript program involv regul epithelialmesenchym transit emt togeth find implic transcript regul emt yap1 signific compon oncogen ras signal',\n",
       "  'ArticleTitle': 'KRAS and YAP1 converge to regulate EMT and tumor survival.',\n",
       "  'Author': 'Shao Diane D'},\n",
       " {'Abstract': ' therapeut block pd1 pathway result signific tumor respons resist common we demonstr prolong interferon signal orchestr pdl1depend pdl1independ resist immun checkpoint blockad icb combin radiat plus antictla4 persist ii interferon signal allow tumor acquir stat1rel epigenom chang augment express interferonstimul gene ligand multipl t cell inhibitori receptor both i ii interferon maintain resist program crippl program genet pharmacolog interfer multipl inhibitori pathway expand distinct t cell popul improv function despit express marker sever exhaust consequ tumor resist multiag icb render respons icb monotherapi final observ biomark interferondriven resist associ clinic progress antipd1 therapi thus durat tumor interferon signal augment adapt resist inhibit interferon respons bypass requir combinatori icb therapi',\n",
       "  'ArticleTitle': 'Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.',\n",
       "  'Author': 'Benci Joseph L'},\n",
       " {'Abstract': ' pancreat cancer dead malign lack effect therapeut we report oncogen kras induc redox master regul nfe2l2nrf2 stimul pancreat lung cancer initi here nrf2 necessari maintain pancreat cancer prolifer regul mrna translat specif loss nrf2 led defect autocrin epiderm growth factor receptor egfr signal oxid specif translat regulatori protein result impair capdepend capindepend mrna translat pancreat cancer cell combin target egfr effector akt glutathion antioxid pathway mimick nrf2 ablat potent inhibit pancreat cancer ex vivo vivo repres promis synthet lethal strategi treat diseas',\n",
       "  'ArticleTitle': 'NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.',\n",
       "  'Author': 'Chio Iok In Christine'},\n",
       " {'Abstract': ' it report treatment antiplacenta growth factor plgf antibodi inhibit metastasi primari tumor growth here antiplgf treatment inhibit wound heal extravas b16f10 cell growth tumor engin overexpress plgf receptor vegfr1 neutral plgf four novel block antibodi signific effect tumor angiogenesi 15 model also genet ablat tyrosin kinas domain vegfr1 host result growth inhibit antivegfa sensit resist tumor test furthermor combin antiplgf antivegfa antibodi result greater antitumor efficaci antivegfa monotherapi in conclus data argu role plgf primari tumor growth model suggest clinic evalu antiplgf antibodi challeng',\n",
       "  'ArticleTitle': 'PlGF blockade does not inhibit angiogenesis during primary tumor growth.',\n",
       "  'Author': 'Bais Carlos'},\n",
       " {'Abstract': ' clear cell renal cell carcinoma ccrcc common kidney cancer mutat share differ patient to better understand intratumor genet under mutat ccrcc carri singlecel exom sequenc ccrcc tumor adjac kidney tissu our data indic tumor unlik result mutat vhl pbrm1 quantit popul genet analysi indic tumor contain signific clonal subpopul mutat differ allel frequenc popul differ mutat spectrum analys data allow delin detail intratumor genet landscap singlecel level our pilot studi demonstr ccrcc genet complex thought provid inform lead new way individu tumor aim develop effect cellular target therapi',\n",
       "  'ArticleTitle': 'Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.',\n",
       "  'Author': 'Xu Xun'},\n",
       " {'Abstract': ' identif factor critic tumoriniti cell tic state open new avenu cancer therapi here metabol enzym glycin decarboxylas gldc critic tic nonsmal cell lung cancer nsclc tic primari nsclc tumor express high level oncogen stem cell factor lin28b gldc requir tic growth tumorigenesi overexpress gldc glycineserin enzym catalyt inact gldc promot cellular transform tumorigenesi we gldc induc dramat chang glycolysi glycineserin metabol lead chang pyrimidin metabol regul cancer cell prolifer in clinic aberr activ gldc correl poorer surviv lung cancer patient aberr gldc express observ multipl cancer type this link glycin metabol tumorigenesi provid novel target advanc anticanc therapi',\n",
       "  'ArticleTitle': 'Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.',\n",
       "  'Author': 'Zhang Wen Cai'},\n",
       " {'Abstract': ' there persuas clinic experiment evid macrophag promot cancer initi malign progress dure tumor initi creat inflammatori environ mutagen promot growth as tumor progress malign macrophag stimul angiogenesi enhanc tumor cell migrat invas suppress antitumor immun at metastat site macrophag prepar target tissu arriv tumor cell differ subpopul macrophag promot tumor cell extravas surviv subsequ growth special subpopul macrophag repres new therapeut target',\n",
       "  'ArticleTitle': 'Macrophage diversity enhances tumor progression and metastasis.',\n",
       "  'Author': 'Qian Bin-Zhi'},\n",
       " {'Abstract': ' stromal cell tumor microenviron essenti tumor progress metastasi surpris littl known factor drive transcript reprogram stromal cell tumor we report transcript regul heat shock factor 1 hsf1 frequent activ cancerassoci fibroblast caf potent enabl malign hsf1 drive transcript program caf complement complet differ program drive adjac cancer cell this caf program uniqu structur support malign noncellautonom way two central stromal signal moleculestgf sdf1play critic role in earlystag breast lung cancer high stromal hsf1 activ associ poor patient outcom thus tumor coopt ancient surviv function hsf1 orchestr malign cellautonom noncellautonom way farreach therapeut implic',\n",
       "  'ArticleTitle': 'The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.',\n",
       "  'Author': 'Scherz-Shouval Ruth'},\n",
       " {'Abstract': ' metastas repres end product multistep cellbiolog process term invasionmetastasi cascad involv dissemin cancer cell anatom distant organ site subsequ adapt foreign tissu microenviron each event driven acquisit genet andor epigenet alter tumor cell cooption nonneoplast stromal cell endow incipi metastat cell trait need generat macroscop metastas recent advanc provid provoc insight cellbiolog molecular chang implic step invasionmetastasi cascad appear amen therapeut target',\n",
       "  'ArticleTitle': 'Tumor metastasis: molecular insights and evolving paradigms.',\n",
       "  'Author': 'Valastyan Scott'},\n",
       " {'Abstract': ' the evolutionari featur clearcel renal cell carcinoma ccrcc systemat date we analyz 1206 primari tumor region 101 patient recruit multicent prospect studi tracerx renal we observ 30 driver event tumor subclon diversif associ known prognost paramet by resolv pattern driver event order cooccurr mutual exclus clone level determinist natur clonal evolut ccrcc group seven evolutionari subtyp rang tumor character earli fixat multipl mutat copi number driver rapid metastas high branch tumor 10 subclon driver extens parallel evolut associ attenu progress we identifi genet divers chromosom complex determin patient outcom our insight reconcil variabl clinic behavior ccrcc suggest evolutionari potenti biomark intervent surveil',\n",
       "  'ArticleTitle': 'Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.',\n",
       "  'Author': 'Turajlic Samra'},\n",
       " {'Abstract': ' circul tumor cell respons seed metastat growth distant site kim al 2009 circul tumor cell reinfiltr tumor primari organ promot tumor progress',\n",
       "  'ArticleTitle': 'Tumor self-seeding: bidirectional flow of tumor cells.',\n",
       "  'Author': 'Leung Cheuk T'},\n",
       " {'Abstract': ' glioblastoma gbms high vascular lethal brain tumor display cellular hierarchi contain selfrenew tumorigen glioma stem cell gscs becaus gscs resid perivascular nich undergo mesenchym differenti interrog gsc potenti generat vascular pericyt here gscs rise pericyt support vessel function tumor growth in vivo cell lineag trace constitut lineagespecif fluoresc report demonstr gscs generat major vascular pericyt select elimin gscderiv pericyt disrupt neovasculatur potent inhibit tumor growth analysi human gbm specimen pericyt deriv neoplast cell gscs recruit endotheli cell sdf1cxcr4 axi induc pericyt transform growth factor  thus gscs contribut vascular pericyt activ remodel perivascular nich therapeut target gscderiv pericyt effect block tumor progress improv antiangiogen therapi',\n",
       "  'ArticleTitle': 'Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.',\n",
       "  'Author': 'Cheng Lin'},\n",
       " {'Abstract': ' malign cell util divers strategi enabl thrive advers condit simultan inhibit develop antitumor immun respons hostil microenvironment condit tumor mass nutrient depriv oxygen limit high metabol demand oxid stress disturb proteinfold capac endoplasm reticulum er provok cellular state er stress sustain activ er stress sensor endow malign cell greater tumorigen metastat drugresist capac addit recent studi uncov er stress respons imped develop protect anticanc immun manipul function myeloid cell tumor microenviron here discuss tumorigen immunoregulatori effect er stress cancer explor concept target er stress respons enhanc efficaci standard chemotherapi evolv cancer immunotherapi clinic',\n",
       "  'ArticleTitle': 'Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.',\n",
       "  'Author': 'Cubillos-Ruiz Juan R'},\n",
       " {'Abstract': ' therapyresist microenviron repres major barrier effect elimin dissemin malign here select microenviron underli resist antibodybas therapi use human model treatment refractori b cell leukemia infiltr leukemia cell bone marrow rewir tumor microenviron inhibit engulf antibodytarget tumor cell resist macrophagemedi kill overcom combin regimen involv therapeut antibodi chemotherapi specif nitrogen mustard cyclophosphamid induc acut secretori activ phenotyp asap releas ccl4 il8 vegf tnf treat tumor cell these factor induc macrophag infiltr phagocyt activ bone marrow thus acut induct stressrel cytokin effect target cancer cell remov innat immun system this synergist chemoimmunotherapeut regimen repres potent strategi convent anticanc agent alter tumor microenviron promot efficaci target therapeut',\n",
       "  'ArticleTitle': 'Sensitizing protective tumor microenvironments to antibody-mediated therapy.',\n",
       "  'Author': 'Pallasch Christian P'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Tumor angiogenesis.',\n",
       "  'Author': 'Jain Rakesh K'},\n",
       " {'Abstract': ' mechanotransduct key determin tissu homeostasi tumor progress it driven intercellular adhes cell contractil forc generat microenviron depend extracellular matrix composit organ complianc we caveolin1 cav1 favor cell elong threedimension cultur promot rho forcedepend contract matrix align microenviron stiffen regul p190rhogap in turn microenviron remodel cav1 fibroblast forc cell elong cav1defici mice disorgan stromal tissu architectur stroma associ human carcinoma melanoma metastas enrich cav1express carcinomaassoci fibroblast caf cav1 express breast caf correl low surviv cav1 deplet caf decreas caf contractil consist fibroblast express cav1 p190rhogap regul favor direct migrat invas carcinoma cell vitro in vivo stromal cav1 remodel peri intratumor microenviron facilit tumor invas correl increas metastat potenc thus cav1 modul tissu respons forcedepend architectur regul microenviron',\n",
       "  'ArticleTitle': 'Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.',\n",
       "  'Author': 'Goetz Jacky G'},\n",
       " {'Abstract': ' it establish tumor cellderiv vegf act endotheli cell promot angiogenesi tumor growth here demonstr k5sosdepend mous skin tumor autocrin vegf requir tumor cell prolifer cellautonom angiogenesisindepend manner vegf upregul sosexpress tumor delet epiderm cell delay tumorigenesi suppress angiogenesi tumor cell prolifer epidermisspecif flt1 delet impair tumorigenesi prolifer surpris complet tumor inhibit occur absenc vegf egfr mutant mice demonstr vegfr egfr synerg neoplast cell promot tumor growth mechanist k5sos upregul vegf flt1 neuropilin1 erkdepend manner activ autocrin prolifer loop egfr prevent tumor cell apoptosi moreov flt1 upregul human scc inhibit scc cell impair prolifer thus addit regul angiogenesi vegf consid potent growth factor epiderm tumor',\n",
       "  'ArticleTitle': 'Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.',\n",
       "  'Author': 'Lichtenberger Beate M'},\n",
       " {'Abstract': ' we extens assess mutat burden sequenc analysi 81000 tumor pediatr adult patient includ tumor hypermut caus chemotherapi carcinogen germlin alter hypermut detect tumor type associ high mutat burden replic repair defici major contribut factor we uncov new driver mutat replicationrepairassoci dna polymeras distinct impact microsatellit instabl replic repair defici scale mutat load unbias cluster base mutat context reveal clinic relev subgroup regardless tumor tissu origin highlight similar evolutionari dynam lead hypermut mutagen uv light implic unexpect cancer includ sarcoma lung tumor the order mutat signatur identifi previous treatment germlin replic repair defici improv manag patient famili these data inform tumor classif genet test clinic trial design',\n",
       "  'ArticleTitle': 'Comprehensive Analysis of Hypermutation in Human Cancer.',\n",
       "  'Author': 'Campbell Brittany B'},\n",
       " {'Abstract': ' autophagi cellular wast dispos process wellestablish tumorsuppress properti new studi indic addit cellautonom antitumorigen function autophagi inhibit cancer develop orchestr inflamm immun while attenu tumorpromot inflamm autophagi enhanc process present tumor antigen stimul antitumor immun although cancer cell escap immunosurveil tune autophagi certain chemotherapeut agent immunogen properti enhanc antitumor immun induc autophag cell death understand intric complex relationship troika affect autophagi enhanc drug improv efficaci cancer immunotherapi',\n",
       "  'ArticleTitle': 'Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment.',\n",
       "  'Author': 'Zhong Zhenyu'},\n",
       " {'Abstract': ' pten frequent mutat tumor suppressor gene oppos pi3kakt pathway dephosphoryl phosphoinositide345triphosph recent nuclear compartment pten key compon tumorsuppress activ nuclear function remain poor defin here nuclear pten interact apcc promot apcc associ cdh1 enhanc tumorsuppress activ apccdh1 complex we nuclear exclus phosphatas inactiv pten impair apccdh1 this nuclear function pten provid straightforward mechanist explan failsaf cellular senesc respons elicit acut pten loss tumorsuppress activ catalyt inact pten import demonstr pten mutant pten null state synonym differenti sensit pharmacolog inhibit apccdh1 target plk1 aurora kinas this find identifi strategi cancer patient stratif optim target therapi paperclip',\n",
       "  'ArticleTitle': 'Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.',\n",
       "  'Author': 'Song Min Sup'},\n",
       " {'Abstract': ' noncod mutat cancer genom frequent challeng interpret pvt1 encod oncogen lncrna recurr transloc delet human cancer suggest altern mechan here pvt1 promot tumorsuppressor function independ pvt1 lncrna crispr interfer pvt1 promot enhanc breast cancer cell competit growth vivo the promot pvt1 myc oncogen locat 55 kb apart chromosom 8q24 compet engag four intragen enhanc pvt1 locus allow pvt1 promot regul paus releas myc transcript pvt1 undergo development regul monoallel express pvt1 promot inhibit myc express chromosom promot competit cancer genom sequenc identifi recurr mutat encompass human pvt1 promot genom edit verifi pvt1 promot mutat promot cancer cell growth these result highlight regulatori sequenc lncrna gene potenti diseaseassoci dna element',\n",
       "  'ArticleTitle': 'Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.',\n",
       "  'Author': 'Cho Seung Woo'},\n",
       " {'Abstract': ' the prevail approach address secondari drug resist cancer focus treat resist mechan relaps howev dynam natur clonal evolut potenti fit cost cost compens exploit vulnerabilitiesa notion term tempor collater sensit use combin pharmacolog screen drug resist select approach murin model ph acut lymphoblast leukemia tempor andor persist collater sensit nonclass bcrabl1 drug aris emerg tumor subpopul evolut resist initi treatment bcrabl1target inhibitor we determin sensit mechan genotyp phenotyp signal bind measur combin comput model demonstr signific surviv extens mice addit stochast mathemat model smallmolecul screen extend insight indic valu focus evolutionari trajectori pharmacolog profil identifi new strategi treat dynam tumor vulner',\n",
       "  'ArticleTitle': 'Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution.',\n",
       "  'Author': 'Zhao Boyang'},\n",
       " {'Abstract': ' extracellular proteolysi mediat tissu homeostasi in cancer alter proteolysi lead unregul tumor growth tissu remodel inflamm tissu invas metastasi the matrix metalloproteinas mmps repres promin famili proteinas associ tumorigenesi recent technolog develop mark advanc understand mmps modul tumor microenviron in addit role extracellular matrix turnov cancer cell migrat mmps regul signal pathway control cell growth inflamm angiogenesi even work nonproteolyt manner these aspect mmp function reorient approach cancer therapi',\n",
       "  'ArticleTitle': 'Matrix metalloproteinases: regulators of the tumor microenvironment.',\n",
       "  'Author': 'Kessenbrock Kai'},\n",
       " {'Abstract': ' combin cancer therapi aim improv probabl magnitud therapeut respons reduc likelihood acquir resist individu patient howev drug test clinic trial genet divers patient popul we patienttopati variabl independ drug action suffici explain superior fdaapprov drug combin absenc drug synergi addit this true combin test patientderiv tumor xenograft in combin exhibit independ drug action patient benefit sole drug tumor sensit ad benefit drug even drug combin exhibit addit synergi preclin model patienttopati variabl low crossresist independ action domin mechan clinic popul this insight repres differ way interpret trial data differ way design combin therapi',\n",
       "  'ArticleTitle': 'Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy.',\n",
       "  'Author': 'Palmer Adam C'},\n",
       " {'Abstract': ' tp53 frequent mutat gene human cancer function p53 activ host stress stimuli turn govern exquisit complex antiprolif transcript program touch bewild array biolog respons despit unveil facet p53 network clear appreci context p53 exert divers effect remain unclear how interpret p53s dispar activ consequ dysfunct understand cell mutat profil epigenet cell state dictat outcom restor tumorsuppress activ cancer',\n",
       "  'ArticleTitle': 'Putting p53 in Context.',\n",
       "  'Author': 'Kastenhuber Edward R'},\n",
       " {'Abstract': ' cancer develop result somat mutat clonal select quantit measur select cancer evolut lack we adapt method molecular evolut appli 7664 tumor 29 cancer type unlik speci evolut posit select outweigh negat select cancer develop on averag 1 code base substitutiontumor lost negat select purifi select absent outsid homozyg loss essenti gene this allow exomewid enumer driver code mutat includ outsid known cancer gene on averag tumor carri 4 code substitut posit select rang 1tumor thyroid testicular cancer 10tumor endometri colorect cancer half driver substitut occur yettobediscov cancer gene with increas mutat burden number driver mutat increas linear we systemat catalog cancer gene gene vari extens proport mutat driver versus passeng',\n",
       "  'ArticleTitle': 'Universal Patterns of Selection in Cancer and Somatic Tissues.',\n",
       "  'Author': u'Martincorena I\\xf1igo'},\n",
       " {'Abstract': ' tumor blood vessel deliv oxygen poor contribut tumor hypoxia upregul proangiogen cytokin escal feedback loop mazzon al 2009 reduc amount protein involv endotheli oxygen sens lead chang endotheli cell shape interrupt feedback loop reduc tumor metastasi',\n",
       "  'ArticleTitle': 'Endothelial cells form a phalanx to block tumor metastasis.',\n",
       "  'Author': 'Bautch Victoria L'},\n",
       " {'Abstract': ' a key function blood vessel suppli oxygen impair tumor abnorm endotheli line phd protein serv oxygen sensor regul oxygen deliveri we role endotheli phd2 vessel shape implant tumor phd2 mice haplodefici phd2 affect tumor vessel densiti lumen size normal endotheli line vessel matur this result improv tumor perfus oxygen inhibit tumor cell invas intravas metastasi haplodefici phd2 redirect specif endotheli tip cell quiescent cell lack filopodia array phalanx format this transit reli hifdriven upregul solubl vegfr1 vecadherin thus decreas activ oxygen sensor hypox condit prompt endotheli cell readjust shape phenotyp restor oxygen suppli inhibit phd2 offer altern therapeut opportun anticanc therapi',\n",
       "  'ArticleTitle': 'Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.',\n",
       "  'Author': 'Mazzone Massimiliano'},\n",
       " {'Abstract': ' the immun system mount t cell respons tumor antigen specif tumorinfiltr lymphocyt til well understood we yeastdisplay librari peptidehuman leukocyt antigen phla screen antigen orphan t cell receptor tcrs express til human colorect adenocarcinoma four tilderiv tcrs exhibit strong select peptid present high divers phlaa',\n",
       "  'ArticleTitle': 'Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.',\n",
       "  'Author': 'Gee Marvin H'},\n",
       " {'Abstract': ' r2hydroxyglutar r2hg produc high level mutant isocitr dehydrogenas 12 idh12 enzym report oncometabolit we r2hg exert broad antileukem activ vitro vivo inhibit leukemia cell proliferationvi promot cellcycl arrest apoptosi mechanist r2hg inhibit fat mass obesityassoci protein fto activ increas global n',\n",
       "  'ArticleTitle': 'R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m',\n",
       "  'Author': 'Su Rui'},\n",
       " {'Abstract': ' to guid design immunotherapi strategi patient earli stage lung tumor develop multiscal immun profil strategi map immun landscap earli lung adenocarcinoma lesion search tumordriven immun chang util barcod method allow simultan singlecel analysi tumor noninvolv lung blood cell provid detail immun cell atlas earli lung tumor we stage i lung adenocarcinoma lesion harbor alter t cell nk cell compart moreov identifi chang tumorinfiltr myeloid cell tim subset like compromis antitumor t cell immun pair singlecel analys offer valuabl knowledg tumordriven immun chang provid power tool ration design immun therapi video abstract',\n",
       "  'ArticleTitle': 'Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.',\n",
       "  'Author': 'Lavin Yonit'},\n",
       " {'Abstract': ' in issu cell two articl tumorspecif chang hlamedi antigen present affect tumor immunogen play role shape cancer cell surviv',\n",
       "  'ArticleTitle': 'Tumor Evolution: A Problem of Histocompatibility.',\n",
       "  'Author': 'Vokes Natalie I'},\n",
       " {'Abstract': ' synthet lethal occur inhibit two gene lethal inhibit singl gene it har select treat cancer identifi inact gene given cancer target synthet lethal sl partner we datadriven comput pipelin genomewid identif sl interact cancer analyz larg volum cancer genom data first approach success captur known sl partner tumor suppressor oncogen we valid sl predict tumor suppressor vhl next construct genomewid network sl interact cancer demonstr valu predict gene essenti clinic prognosi final identifi synthet lethal aris gene overactiv predict drug efficaci these result form comput basi exploit synthet lethal uncov cancerspecif suscept',\n",
       "  'ArticleTitle': 'Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.',\n",
       "  'Author': 'Jerby-Arnon Livnat'},\n",
       " {'Abstract': ' insight cancer genet lead therapeut opportun by crossreferenc chromosom chang unbias genet screen identifi ephrin receptor a7 epha7 tumor suppressor follicular lymphoma fl epha7 target 6q delet inactiv 72 fls knockdown epha7 drive lymphoma develop murin fl model in analog physiolog function brain develop solubl splice variant epha7 epha7tr interfer ephreceptor block oncogen signal lymphoma cell consist druglik activ administr purifi epha7tr protein produc antitumor effect xenograft human lymphoma further fuse epha7tr anticd20 antibodi rituximab direct target tumor suppressor lymphoma vivo our studi attest power combin descript tumor genom function screen reveal epha7tr tumor suppressor immedi therapeut potenti',\n",
       "  'ArticleTitle': 'The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.',\n",
       "  'Author': 'Oricchio Elisa'},\n",
       " {'Abstract': ' a deep understand immun landscap human cancer essenti guid develop immunotherapi benefit patient longlast efficaci now two studi lavin al chevrier al employ mass cytometri studi immun infiltr lung adenocarcinoma clear cell renal cell carcinoma respect',\n",
       "  'ArticleTitle': 'Heavy Metal Enlightens Tumor Immunity.',\n",
       "  'Author': 'Chen Jonathan H'},\n",
       " {'Abstract': ' cancer cell origin difficult identifi analyz cell termin stage tumor ident conceal acquir plastic thus ideal approach identifi cell origin prolif abnorm distinct lineag prior malign here mosaic analysi doubl marker madm mice model gliomagenesi initi concurr p53nf1 mutat sporad neural stem cell nscs surpris madmbas lineag trace reveal signific aberr growth prior malign oligodendrocyt precursor cell opc nscderiv lineag nscs upon tumor format phenotyp transcriptom analys tumor cell reveal salient opc featur final introduc p53nf1 mutat direct opc consist led gliomagenesi our find suggest opc cell origin model even initi mutat occur nscs highlight analyz premalign stage identifi cancer cell origin',\n",
       "  'ArticleTitle': 'Mosaic analysis with double markers reveals tumor cell of origin in glioma.',\n",
       "  'Author': 'Liu Chong'},\n",
       " {'Abstract': ' the two oncogen kras myc cooper drive tumorigenesi mechan under remain unclear in mous lung model kras',\n",
       "  'ArticleTitle': 'Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.',\n",
       "  'Author': 'Kortlever Roderik M'},\n",
       " {'Abstract': ' the role noncod genom cancer biolog continu expand cho al reveal new unexpect mechan regul myc express mediat promot sequenc neighbor gene pvt1 this dna element act promoterenhanc competitor candid tumor suppressor',\n",
       "  'ArticleTitle': 'A \"Counter-Enhancer\" in Tumor Suppression.',\n",
       "  'Author': 'Marchese Francesco P'},\n",
       " {'Abstract': ' stemlik cell integr develop mainten human cancer direct proof lack poor understand biolog differ normal cancer stem cell scs use erbb2 transgen model breast cancer selfrenew divis cancer scs frequent normal counterpart unlimit symmetr contribut increas number scs tumor tissu scs target mutat tumor suppressor p53 possess selfrenew properti cancer scs number increas progress p53 null premalign mammari gland pharmacolog reactiv p53 correl restor asymmetr divis cancer scs tumor growth reduct signific effect addit cancer cell these data demonstr p53 regul polar cell divis mammari scs suggest loss p53 favor symmetr divis cancer scs contribut tumor growth',\n",
       "  'ArticleTitle': 'The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.',\n",
       "  'Author': 'Cicalese Angelo'},\n",
       " {'Abstract': ' how genom landscap tumor shape shape antitumor immun systemat explor use largescal genom data set solid tissu tumor biopsi quantifi cytolyt activ local immun infiltr identifi associ properti 18 tumor type the number predict mhc class iassoci neoantigen correl cytolyt activ lower expect colorect tumor suggest immunemedi elimin we identifi recurr mutat gene posit associ cytolyt activ includ beta2microglobulin b2m hlaa b c caspas 8 casp8 highlight loss antigen present blockad extrins apoptosi key strategi resist cytolyt activ genet amplif associ high cytolyt activ includ immunosuppress factor pdl12 alox12b15b our genet find provid evid immunoedit tumor uncov mechan tumorintrins resist cytolyt activ',\n",
       "  'ArticleTitle': 'Molecular and genetic properties of tumors associated with local immune cytolytic activity.',\n",
       "  'Author': 'Rooney Michael S'},\n",
       " {'Abstract': ' elucid mutat landscap human cancer progress rapid accompani develop therapeut target mutant oncogen howev comprehens map cancer depend lag behind discoveri therapeut target counteract tumor suppressor gene loss need to identifi vulner relev specif cancer subtyp conduct largescal rnai screen viabil effect mrna knockdown assess 7837 gene averag 20 shrnas gene 398 cancer cell line we describ find screen outlin class cancer depend gene relationship genet express lineag featur in addit describ robust geneinteract network recapitul protein complex function cooper complex pathway this dataset web portal provid communiti assist discoveri translat new therapeut approach cancer',\n",
       "  'ArticleTitle': 'Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.',\n",
       "  'Author': 'McDonald E Robert'},\n",
       " {'Abstract': ' tumor cell undergo metabol shift specif bioenerget glycolysi anabol protein lipid synthesi process promot rapid growth nomura al 2010 demonstr increas monoacylglycerol lipas magl drive tumorigenesi lipolyt releas remodel free fatti acid',\n",
       "  'ArticleTitle': 'Chewing the fat on tumor cell metabolism.',\n",
       "  'Author': 'Yecies Jessica L'},\n",
       " {'Abstract': ' combin dnademethyl agent dna methyltransferas inhibitor dnmtis histon deacetylas inhibitor hdaci hold promis enhanc cancer immun therapi herein pharmacolog isoform specif hdaci investig guid addit dnmti devis new lowdos sequenti regimen impart robust antitumor effect nonsmallcel lung cancer nsclc use invitrotr nsclc cell line elucid interferon base transcript program accompani upregul antigen present machineri mediat part doublestrand rna dsrna induct this accompani suppress myc signal increas t cell chemoattract ccl5 use combin treatment schema mous model nsclc revers tumor immun evas modul t cell exhaust state memori effector t cell phenotyp key correl scienc metric emerg upcom clinic trial test enhanc immun checkpoint therapi nsclc',\n",
       "  'ArticleTitle': 'Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.',\n",
       "  'Author': 'Topper Michael J'},\n",
       " {'Abstract': ' like apoptosi oncogeneinduc senesc barrier tumor develop howev relat littl known signal pathway mediat senesc respons p38regulatedactiv protein kinas prak p38 mapk substrat physiolog function poor understood here describ role prak tumor suppress demonstr prak mediat senesc activ p38 respons oncogen ras prak defici mice enhanc dmbainduc skin carcinogenesi coincid compromis senesc induct in primari cell inactiv prak prevent senesc promot oncogen transform furthermor prak activ p53 direct phosphoryl we propos phosphoryl p53 prak follow activ p38 mapk ras play role rasinduc senesc tumor suppress',\n",
       "  'ArticleTitle': 'PRAK is essential for ras-induced senescence and tumor suppression.',\n",
       "  'Author': 'Sun Peiqing'},\n",
       " {'Abstract': ' cancer heterogen hallmark enabl clonal surviv therapi resist shape activ immun respons antigenspecif t cell control cancer reveal clinic immunotherapeut adopt tcell transfer checkpoint blockad the host immun system power tool better har enhanc efficaci cytotox therapi improv outcom cancer suffer to realiz vision number research frontier tackl these includ develop strategi neutral tumorpromot inflamm broaden tcell repertoir vaccin elucid mechan immun cell organ tumor microenviron regul tcell activ such effort pave way identifi new target combin therapi overcom resist current treatment promot longterm cancer control',\n",
       "  'ArticleTitle': 'The Basis of Oncoimmunology.',\n",
       "  'Author': 'Palucka A Karolina'},\n",
       " {'Abstract': ' t cell dysfunct cancer come form two new varieti report issu daley al t cell express  t cell receptor tcr promot pancreat tumor growth inhibit activ t cell convent tcrs singer al character dysfunct tumor infiltr lymphocyt reveal role zinc homeostasi antitumor immun',\n",
       "  'ArticleTitle': u'Probing the Diversity of T\\xa0Cell Dysfunction in Cancer.',\n",
       "  'Author': 'Sowell Ryan T'},\n",
       " {'Abstract': ' mhci molecul expos intracellular protein content cell surfac allow t cell detect foreign mutat peptid the combin six mhci allel individu carri defin subpeptidom effect present we appli concept human cancer hypothes oncogen mutat gap person mhci present to valid hypothesi develop appli residuecentr patient present score 9176 cancer patient 1018 recurr oncogen mutat we patient mhci genotypebas score predict mutat like emerg tumor accord poor present mutat patient correl higher frequenc tumor these result support mhci genotyperestrict immunoedit tumor format shape landscap oncogen mutat observ clinic diagnos tumor pave way predict person cancer suscept knowledg mhci genotyp',\n",
       "  'ArticleTitle': 'MHC-I Genotype Restricts the Oncogenic Mutational Landscape.',\n",
       "  'Author': 'Marty Rachel'},\n",
       " {'Abstract': ' anticanc immun respons consid desir form autoimmun profound shape microbiom here discuss evid microbiom influenc antitumor immunosurveil includ indirect act distanc put forward hypothes mechan effect implement these involv crossreact microbi tumor antigen shape t cell repertoir andor microbi product stimul pattern recognit receptor influenc intens immun respons understand microbiom impact natur cancer immunosurveil well treatmentinduc immun respons pave way effect therapi prophylact',\n",
       "  'ArticleTitle': 'Microbiome and Anticancer Immunosurveillance.',\n",
       "  'Author': 'Zitvogel Laurence'},\n",
       " {'Abstract': ' immun infiltr correl surviv patient colorect cancer in issu ziegler al reveal complex unexpect connect loss stat3 mitophagi induct adapt immun respons limit growth colorect carcinoma',\n",
       "  'ArticleTitle': 'The Walrus and the Carpenter: Complex Regulation of Tumor Immunity in Colorectal Cancer.',\n",
       "  'Author': 'Dewson Grant'},\n",
       " {'Abstract': ' immunecheckpoint blockad abl achiev durabl respons subset patient lack satisfi comprehens under mechan antictla4 antipd1induc tumor reject to address issu util mass cytometri comprehens profil effect checkpoint blockad tumor immun infiltr human melanoma murin tumor model these analys reveal spectrum tumorinfiltr t cell popul high similar tumor model indic checkpoint blockad target specif subset tumorinfiltr t cell popul antipd1 induc expans specif tumorinfiltr exhaustedlik cd8 t cell subset in contrast antictla4 induc expans ico',\n",
       "  'ArticleTitle': 'Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.',\n",
       "  'Author': 'Wei Spencer C'},\n",
       " {'Abstract': ' adaptor protein particip select autophagi critic cellular detoxif stress relief howev new evid support autophagyindepend key role adaptor p62 encod gene sqstm1 signal function central tumor initi epithelium suppress tumor progress stroma',\n",
       "  'ArticleTitle': 'p62 in Cancer: Signaling Adaptor Beyond Autophagy.',\n",
       "  'Author': 'Moscat Jorge'},\n",
       " {'Abstract': ' acetylcoa repres central node carbon metabol play key role bioenerget cell prolifer regul gene express high glycolyt hypox tumor produc suffici quantiti metabolit support cell growth surviv nutrientlimit condit here nucleocytosol acetylcoa synthetas enzym acss2 suppli key sourc acetylcoa tumor captur acet carbon sourc despit exhibit gross deficit growth develop adult mice lack acss2 exhibit signific reduct tumor burden two differ model hepatocellular carcinoma acss2 express larg proport human tumor activ respons major cellular acet uptak lipid histon these observ qualifi acss2 target metabol vulner wide spectrum tumor',\n",
       "  'ArticleTitle': 'Acetate dependence of tumors.',\n",
       "  'Author': 'Comerford Sarah A'},\n",
       " {'Abstract': ' lineag map identifi prolif quiescent intestin stem cell molecular circuitri control stem cell quiescenc incomplet understood by lineag map lrig1 panerbb inhibitor mark predomin noncycl longliv stem cell locat crypt base injuri prolifer divid replenish damag crypt transcriptom profil lrig1 colon stem cell differ mark profil high prolif lgr5 colon stem cell gene upregul lrig1 popul includ involv cell cycl repress respons oxid damag loss apc lrig1 cell lead intestin adenoma genet ablat lrig1 result heighten erbb13 express duoden adenoma these result shed light relationship prolif quiescent intestin stem cell support model intestin stem cell quiescenc maintain calibr erbb signal loss negat regul predispos neoplasia',\n",
       "  'ArticleTitle': 'The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor.',\n",
       "  'Author': 'Powell Anne E'},\n",
       " {'Abstract': ' subset longliv tumoriniti stem cell escap cancer therapi howev sourc mechan generat tumor heterogen drugresist cell popul unfold here devis function report system lineag trace andor genet ablat signal tgfactiv squamous cell carcinoma stem cell sccscs dissect tgfs impact malign progress demonstr tgf concentr near tumorvasculatur generat heterogen tgf signal tumorstroma interfac bestow slowercycl properti neighbor sccscs while nonrespond progeni prolifer faster acceler tumor growth tgfrespond progeni invad aberr differenti affect gene express intrigu tgfrespond sccscs increas protect anticanc drug slowercycl confer surviv rather tgf transcript activ p21 stabil nrf2 mark enhanc glutathion metabol diminish effect anticanc therapeut togeth find establish surpris nongenet paradigm tgf signal fuel heterogen sccscs tumor characterist drug resist',\n",
       "  'ArticleTitle': u'TGF-\\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma.',\n",
       "  'Author': 'Oshimori Naoki'},\n",
       " {'Abstract': ' evolut minim dna tumor virus genom select small viral oncoprotein hijack critic cellular protein interact network the structur basi multipl domin function adenovirus oncoprotein remain elus e4orf3 form nuclear polym simultan inactiv p53 pml trim24 mre11rad50nbs1 mrn tumor suppressor we identifi oligomer mutant solv crystal structur e4orf3 e4orf3 form dimer central  core structur unrel known polym oncogen e4orf3 dimer unit coassembl reciproc nonreciproc exchang ctermin tail this result linear branch oligom chain assembl variabl arrang form polym network partit nuclear volum e4orf3 assembl creat aviditydriven interact pml emerg mrn bind interfac this reveal eleg structur solut small protein form multival matrix trap dispar tumor suppressor',\n",
       "  'ArticleTitle': 'A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.',\n",
       "  'Author': 'Ou Horng D'},\n",
       " {'Abstract': ' systemat interrog tumorinfiltr lymphocyt key develop immunotherapi predict clinic respons cancer here perform deep singlecel rna sequenc 5063 singl t cell isol peripher blood tumor adjac normal tissu six hepatocellular carcinoma patient the transcript profil individu cell coupl assembl t cell receptor tcr sequenc enabl identifi 11 t cell subset base molecular function properti delin development trajectori specif subset exhaust cd8',\n",
       "  'ArticleTitle': 'Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.',\n",
       "  'Author': 'Zheng Chunhong'},\n",
       " {'Abstract': ' the pml tumor suppressor control key pathway growth suppress induct apoptosi cellular senesc pml loss occur frequent human tumor unknown posttransl mechan casein kinas 2 ck2 oncogen frequent upregul human tumor here ck2 regul pml protein level promot ubiquitinmedi degrad depend direct phosphoryl ser517 consequ pml mutant resist ck2 phosphoryl display increas tumorsuppress function in faith mous model lung cancer demonstr pml inactiv lead increas tumorigenesi furthermor ck2 pharmacolog inhibit enhanc pml tumorsuppress properti vivo import invers correl ck2 kinas activ pml protein level human lung cancerderiv cell line primari specimen these data identifi key posttransl mechan control pml protein level provid therapeut mean pml restor ck2 inhibit',\n",
       "  'ArticleTitle': 'A CK2-dependent mechanism for degradation of the PML tumor suppressor.',\n",
       "  'Author': 'Scaglioni Pier Paolo'},\n",
       " {'Abstract': ' most human epitheli tumor harbor numer alter make difficult predict gene requir tumor surviv to systemat identifi cancer depend analyz 501 genomescal lossoffunct screen perform divers human cancer cell line we develop demet analyt framework segreg offtarget effect rnai 769 gene differenti requir subset cell line threshold six sds mean we predict model 426 depend 55 nonlinear regress model consid 66646 molecular featur mani depend fall limit number class unexpect 82 model top biomark express base we demonstr basi behind one predict model link hypermethyl ubb ubiquitin gene depend ubc togeth observ provid foundat cancer depend map facilit priorit therapeut target',\n",
       "  'ArticleTitle': 'Defining a Cancer Dependency Map.',\n",
       "  'Author': 'Tsherniak Aviad'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.',\n",
       "  'Author': 'Singer Meromit'},\n",
       " {'Abstract': ' mani process caus nucleotid chang genom make identif mechan caus mutat difficult challeng here cluster mutat provid precis fingerprint mutagen process of nine cluster mutat signatur identifi 1000 tumor genom three variabl apobec activ three associ tobacco smoke an addit signatur match spectrum transles dna polymeras eta polh in lymphoid cell mutat target promot consist aidiniti somat hypermut in solid tumor associ uv exposur alcohol consumpt target h3k36me3 chromatin activ gene mismatch repair mmrdepend manner these region low mutat rate errorfre mmr target h3k36me3 chromatin carcinogen errorpron repair redistribut mutat region genom contribut substanti mutat load tumor includ driver mutat',\n",
       "  'ArticleTitle': 'Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes.',\n",
       "  'Author': 'Supek Fran'},\n",
       " {'Abstract': ' metastasi lead caus cancerassoci death difficult studi involv seri rare stochast event to captur event develop sensit method tag track pancreat epitheli cell mous model pancreat cancer tag cell invad enter bloodstream unexpect earli frank malign detect rigor histolog analysi behavior wide associ epithelialtomesenchym transit emt circul pancreat cell maintain mesenchym phenotyp exhibit stem cell properti seed liver emt invas abund inflammatori foci induct pancreat increas number circul pancreat cell convers treatment immunosuppress agent dexamethason abolish dissemin these result provid insight earliest event cellular invas situ suggest inflamm enhanc cancer progress part facilit emt entri circul',\n",
       "  'ArticleTitle': 'EMT and dissemination precede pancreatic tumor formation.',\n",
       "  'Author': 'Rhim Andrew D'},\n",
       " {'Abstract': ' appropri cell number organ size multicellular organ determin coordin cell growth prolifer apoptosi disrupt process caus cancer recent studi identifi larg tumor suppressor latswart wts protein kinas key compon pathway control coordin cell prolifer apoptosi here describ growth inhibitori function mob superfamili protein term mat mob tumor suppressor drosophila loss mat function result increas cell prolifer defect apoptosi induct tissu overgrowth we mat wts function common pathway mat physic associ wts stimul catalyt activ wts kinas a human mat ortholog mats1 rescu lethal associ loss mat function drosophila as mats1 mutat human tumor matsmedi growth inhibit tumor suppress like conserv human',\n",
       "  'ArticleTitle': 'Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.',\n",
       "  'Author': 'Lai Zhi-Chun'},\n",
       " {'Abstract': ' cancer gene discoveri reli extens analyz tumor gain loss reveal locat oncogen tumor suppressor gene respect delet 1p36 extrem common genet lesion human cancer occur malign epitheli neural hematopoiet origin although suggest 1p36 harbor gene drive tumorigenesi inactiv ident tumor suppressor remain elus here chromosom engin generat mous model gain loss region correspond human 1p36 this approach function identifi chromodomain helicas dna bind domain 5 chd5 tumor suppressor control prolifer apoptosi senesc p19arfp53 pathway we demonstr chd5 function tumor suppressor vivo implic delet chd5 human cancer identif tumor suppressor provid new avenu explor innov clinic intervent cancer',\n",
       "  'ArticleTitle': 'CHD5 is a tumor suppressor at human 1p36.',\n",
       "  'Author': 'Bagchi Anindya'},\n",
       " {'Abstract': ' cancer cell evad immun respons distant site establish metastas the lung frequent site metastasi we hypothes lungspecif immunoregulatori mechan creat immunolog permiss environ tumor colon we tcellintrins express oxygensens prolylhydroxylas phd protein requir maintain local toler innocu antigen lung power licens colon circul tumor cell phd protein limit pulmonari helper th1 respons promot cd4regulatori t treg cell induct restrain cd8 t cell effector function tumor colon accompani phdproteindepend induct pulmonari treg cell suppress ifndepend tumor clearanc tcellintrins delet pharmacolog inhibit phd protein limit tumor colon lung improv efficaci adopt cell transfer immunotherapi collect phd protein function t cell coordin distinct immunoregulatori program lung permiss cancer metastasi paperclip',\n",
       "  'ArticleTitle': 'Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.',\n",
       "  'Author': 'Clever David'},\n",
       " {'Abstract': ' earli success identifi target individu oncogen driver increas feasibl sequenc tumor genom brought forth promis genomedriven oncolog care as expand breadth depth genom analys biolog clinic complex implement unparallel challeng includ target credenti valid implement drug combin clinic trial design target tumor heterogen deploy technolog dna sequenc we review contemporari approach tackl challeng ultim serv engin biolog discoveri increas insight cancer treatment',\n",
       "  'ArticleTitle': 'Implementing Genome-Driven Oncology.',\n",
       "  'Author': 'Hyman David M'},\n",
       " {'Abstract': ' transform cell adapt metabol support tumor initi progress specif metabol activ particip direct process transform support biolog process enabl tumor growth exploit cancer metabol clinic benefit requir defin pathway limit cancer progress understand context specif metabol prefer liabil malign cell progress answer question provid new insight cancer biolog guid effect target metabol help patient',\n",
       "  'ArticleTitle': 'Understanding the Intersections between Metabolism and Cancer Biology.',\n",
       "  'Author': 'Vander Heiden Matthew G'},\n",
       " {'Abstract': ' redirect t cell attack cancer engin chimer receptor provid power new therapeut capabl howev effect therapeut t cell constrain endogen t cell respons certain facet natur respons program toxic respons abil overcom tumor immunosuppress absent thus efficaci safeti therapeut cell improv custom sculpt immun cell respons synthet notch synnotch receptor induc transcript activ respons recognit userspecifi antigen we synnotch receptor sculpt custom respons program primari t cell drive la cart cytokin secret profil bias t cell differenti local deliveri nonnat therapeut payload antibodi respons antigen synnotch t cell general platform recogn remodel local microenviron associ divers diseas',\n",
       "  'ArticleTitle': 'Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.',\n",
       "  'Author': 'Roybal Kole T'},\n",
       " {'Abstract': ' molecular genet studi famili cancer syndrom identifi defin recess natur tumor suppressor gene resolv paradox tumor aris famili exhibit autosom domin pattern inherit subsequ character tumor suppressor protein reveal widespread involv sporad cancer pinpoint key mechan protect anim tumor develop we recogn tumor suppressor gene regul divers cellular activ includ cell cycl checkpoint respons detect repair dna damag protein ubiquitin degrad mitogen signal cell specif differenti migrat tumor angiogenesi their studi centerpiec contemporari cancer research',\n",
       "  'ArticleTitle': 'Principles of tumor suppression.',\n",
       "  'Author': 'Sherr Charles J'},\n",
       " {'Abstract': ' sinc discoveri elus tumor suppressor gene frequent mutat 10q23 locus pten identifi lost mutat sporad herit tumor type a decad work establish pten nonredund phosphatas essenti regul high oncogen prosurviv pi3kakt signal pathway this review discuss emerg mode pten function regul specul manipul pten function cancer therapi',\n",
       "  'ArticleTitle': 'Tenets of PTEN tumor suppression.',\n",
       "  'Author': 'Salmena Leonardo'},\n",
       " {'Abstract': ' immun cell tumor microenviron modul cancer progress attract therapeut target macrophag t cell key compon microenviron phenotyp relationship ecosystem clinic outcom ill defin we mass cytometri extens antibodi panel perform indepth immun profil sampl 73 clear cell renal cell carcinoma ccrcc patient five healthi control in 35 million measur cell identifi 17 tumorassoci macrophag phenotyp 22 t cell phenotyp distinct immun composit correl progressionfre surviv present indepth human atlas immun tumor microenviron diseas this studi reveal potenti biomark target immunotherapi develop valid tool immun profil tumor type',\n",
       "  'ArticleTitle': 'An Immune Atlas of Clear Cell Renal Cell Carcinoma.',\n",
       "  'Author': u'Chevrier St\\xe9phane'},\n",
       " {'Abstract': ' absenc cyld encod deubiquitin enzym caus inherit diseas character benign skin tumor in issu cell massoumi al 2006 cyld deubiquitin coactiv bcl3 prevent transloc nucleus interact nfkappab activ transcript prolifer gene respons growth signal',\n",
       "  'ArticleTitle': 'CYLD in ubiquitin signaling and tumor pathogenesis.',\n",
       "  'Author': 'Ikeda Fumiyo'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Circulating Tumor Cells.',\n",
       "  'Author': 'Dive Caroline'},\n",
       " {'Abstract': ' the tumor suppressor p53 gene mutat minim half cancer it reason natur occur polymorph genet variant p53 stress respons pathway determin individu suscept cancer a central node p53 pathway mdm2 protein direct negat regul p53 in report singl nucleotid polymorph snp309 mdm2 promot increas affin transcript activ sp1 result higher level mdm2 rna protein subsequ attenu p53 pathway in human snp309 associ acceler tumor format hereditari sporad cancer a model propos snp309 serv ratelimit event carcinogenesi',\n",
       "  'ArticleTitle': 'A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.',\n",
       "  'Author': 'Bond Gareth L'},\n",
       " {'Abstract': ' the effect primari tumor host system environ result contribut host tumor growth poor understood here human breast carcinoma instig growth otherwiseindol tumor cell micrometastas human tumor surgic specimen locat distant anatom site this system instig accompani incorpor bonemarrow cell bmcs stroma distant onceindol tumor we bmcs host bear instig tumor function activ prior mobil coinject indol cell activ bmcs mimic system effect impart instig tumor secret osteopontin instig tumor necessari bmc activ subsequ outgrowth distant otherwiseindol tumor these result reveal outgrowth indol tumor govern system level endocrin factor releas certain instig tumor hold experiment therapeut implic',\n",
       "  'ArticleTitle': 'Systemic endocrine instigation of indolent tumor growth requires osteopontin.',\n",
       "  'Author': 'McAllister Sandra S'},\n",
       " {'Abstract': ' tumor develop darwinian evolutionari process involv interplay cancer subclon local immun microenviron these complex interact highlight issu cell result jimnezsnchez al deep analysi one patient advanc serous carcinoma ovari',\n",
       "  'ArticleTitle': 'Cancer Evolution Constrained by the Immune Microenvironment.',\n",
       "  'Author': 'McGranahan Nicholas'},\n",
       " {'Abstract': ' cancer high heterogen contain passeng driver mutat to function identifi tumor suppressor gene relev human cancer compil pool short hairpin rnas shrnas target mous ortholog gene recurr delet seri human hepatocellular carcinoma test abil promot tumorigenesi mosaic mous model in contrast random select shrna pool deletionspecif pool acceler hepatocarcinogenesi mice through analysi identifi valid 13 tumor suppressor gene 12 link cancer one gene xpo4 encod nuclear export protein substrat eif5a2 amplifi human tumor requir prolifer xpo4defici tumor cell promot hepatocellular carcinoma mice our result establish feasibl vivo rnai screen illustr combin cancer genom rna interfer mosaic mous model facilit function annot cancer genom',\n",
       "  'ArticleTitle': 'An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.',\n",
       "  'Author': 'Zender Lars'},\n",
       " {'Abstract': ' the microenviron tumor known influenc tumor progress spread distant site metastasi padua al 2008 transient exposur breast cancer cell signal molecul transform growth factor beta tgfbeta promot extravas blood vessel entri lung upregul adipokin angiopoietinlik 4 angptl4 their work later stage metastasi influenc transient signal produc primari tumor microenviron',\n",
       "  'ArticleTitle': 'TGFbeta primes breast tumor cells for metastasis.',\n",
       "  'Author': 'Welm Alana L'},\n",
       " {'Abstract': ' metastasi frequent develop year remov primari tumor minor dissemin cancer cell surviv latent entiti unknown mechan we isol latenc compet cancer lcc cell earli stage human lung breast carcinoma cell line defin mechan suppress outgrowth support longterm surviv maintain tumoriniti potenti cell latent metastasi stage lcc cell stemcelllik characterist express sox2 sox9 transcript factor essenti surviv host organ immun surveil metastat outgrowth permiss condit through express wnt inhibitor dkk1 lcc cell selfimpos slowcycl state broad downregul ulbp ligand nk cell evas nkcellmedi clearanc by express soxdepend stemlik state activ silenc wnt signal lcc cell enter quiescenc evad innat immun remain latent extend period',\n",
       "  'ArticleTitle': 'Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.',\n",
       "  'Author': 'Malladi Srinivas'},\n",
       " {'Abstract': ' macrophag tumor microenviron facilit angiogenesi extracellularmatrix breakdown remodel promot tumor cell motil recent studi reveal direct communic macrophag tumor cell lead invas egress tumor cell blood vessel intravas thus macrophag center invas microenviron drug target cancer therapi',\n",
       "  'ArticleTitle': 'Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.',\n",
       "  'Author': 'Condeelis John'},\n",
       " {'Abstract': ' chimer antigen receptor car t cell proven engin immun cell serv power new class cancer therapeut clinic experi help defin major challeng met engin t cell reliabl safe effect platform deploy broad rang tumor the emerg synthet biolog approach cellular engin provid broad expand set tool program immun cell we discuss tool design generat smart t cell precis therapeut',\n",
       "  'ArticleTitle': 'The Principles of Engineering Immune Cells to Treat Cancer.',\n",
       "  'Author': 'Lim Wendell A'},\n",
       " {'Abstract': ' rapid evolv genom technolog enabl extens molecular analysi limit tumor biopsi materi facilit broader implement person cancer medicin howev genomicsbas patient stratif divers tumor type unlik supplant tissueoforigin consider address clinic need includ develop applic novel ration target cancer therapi',\n",
       "  'ArticleTitle': \"From cancer genomics to precision oncology--tissue's still an issue.\",\n",
       "  'Author': 'Cohen Robert L'},\n",
       " {'Abstract': ' improv efficaci immun checkpoint blockad cancer facilit combin agent andor convent target therapi interferon innat immun signal pathway immun tumor cell emerg intrigu determin respons resist complex seem paradox way',\n",
       "  'ArticleTitle': 'Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling.',\n",
       "  'Author': 'Minn Andy J'},\n",
       " {'Abstract': ' emerg invas behavior cancer lifethreaten illdefin multifactori natur we multiscal mathemat model cancer invas consid cellular microenvironment factor simultan interact unexpect model simul predict harsh tumor microenviron condit hypoxia heterogen extracellular matrix exert dramat select forc tumor grow invas mass finger margin domin clone aggress trait in contrast mild microenviron condit normoxia homogen matrix allow clone similar aggress trait coexist less aggress phenotyp heterogen tumor mass smooth noninvas margin thus genet makeup cancer cell realiz invas potenti clonal evolut process driven defin microenvironment select forc our mathemat model provid theoreticalexperiment framework quantit character select pressur invas test way elimin',\n",
       "  'ArticleTitle': 'Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment.',\n",
       "  'Author': 'Anderson Alexander R A'},\n",
       " {'Abstract': ' in multicellular organ distant cell exchang inform send signal compos singl molecul increas exemplifi literatur complex packet stuf select protein lipid nucleic acid call extracellular vesicl ev known exosom microvesicl name this review cover strike function describ ev secret present limit knowledg physiolog role while initi indic evmedi pathway oper vivo actual natur ev involv effect need clarifi here focus context tumor cell microenviron similar result challeng pathophysiolog system evmedi communic propos place',\n",
       "  'ArticleTitle': 'Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.',\n",
       "  'Author': 'Tkach Mercedes'},\n",
       " {'Abstract': ' although evid suggest serinethreonin protein phosphatas 2a pp2a tumor suppressor protein difficult pin role tumor suppress act wide varieti signal pathway recent find includ work issu junttila al 2007 provid convinc evid suppress pp2a activ cooper oncogen chang caus transform multipl cell type',\n",
       "  'ArticleTitle': 'PP2A: unveiling a reluctant tumor suppressor.',\n",
       "  'Author': 'Mumby Marc'},\n",
       " {'Abstract': ' melanoma high heterogen tumor biolog signific differ subpopul clear use h3k4 demethylas jarid1b kdm5bplu1rbp2h1 biomark character small subpopul slowcycl melanoma cell cycl doubl time 4 week rapid prolifer main popul isol jarid1bposit melanoma cell rise high prolif progeni knockdown jarid1b lead initi acceler tumor growth follow exhaust suggest jarid1bposit subpopul essenti continu tumor growth express jarid1b dynam regul follow hierarch cancer stem cell model jarid1bneg cell posit even singl melanoma cell irrespect select tumorigen these result suggest new understand melanoma heterogen tumor mainten dynam process mediat temporarili distinct subpopul',\n",
       "  'ArticleTitle': 'A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.',\n",
       "  'Author': 'Roesch Alexander'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.',\n",
       "  'Author': 'Tape Christopher J'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer.',\n",
       "  'Author': 'Tschaharganeh Darjus F'},\n",
       " {'Abstract': ' mani cellular stress activ senesc persist hyporepl state character part express p16',\n",
       "  'ArticleTitle': 'Senescence in Health and Disease.',\n",
       "  'Author': 'He Shenghui'},\n",
       " {'Abstract': ' despit success clinic trial cancer immunotherapi remain limit rariti target tumorspecif antigen tumormedi immun suppress toxic trigger system deliveri potent immunomodul here proofofconcept immunomodulatori gene circuit platform enabl tumorspecif express immunostimul potenti overcom limit our design compris novo synthet cancerspecif promot enhanc specif rnabas and gate generat combinatori immunomodulatori output promot mutual activ these output includ immunogen cellsurfac protein cytokin chemokin checkpoint inhibitor antibodi the circuit trigger select t cellmedi kill cancer cell normal cell vitro in vivo efficaci assay lentivir circuit deliveri mediat signific tumor reduct prolong mous surviv our design adapt drive addit immunomodul sens cancer potenti treat diseas requir precis immunolog program',\n",
       "  'ArticleTitle': 'Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.',\n",
       "  'Author': 'Nissim Lior'},\n",
       " {'Abstract': ' cell migrat critic process divers pathophysiolog phenomena intrigu cell migrat physic confin space persist even typic hallmark 2d planar migrat actin polymer myosin iimedi contractil inhibit here integr experiment theoret approach osmot engin model demonstr direct water permeat major mechan cell migrat confin microenviron use microfluid imag techniqu mathemat model tumor cell confin narrow channel establish polar distribut nah pump aquaporin cell membran creat net inflow water ion cell lead edg net outflow water ion trail edg lead net cell displac collect studi present altern mechan cell migrat confin depend cellvolum regul water permeat',\n",
       "  'ArticleTitle': 'Water permeation drives tumor cell migration in confined microenvironments.',\n",
       "  'Author': 'Stroka Kimberly M'},\n",
       " {'Abstract': ' certain cell type function factori secret larg quantiti one protein central physiolog respect organ exampl includ surfact protein lung alveoli albumin liver parenchyma lipas stomach line wholegenom sequenc analysi lung adenocarcinoma reveal noncod somat mutat hotspot near vmp1mir21 indel hotspot surfact protein gene sftpa1 sftpb sftpc extrapol solid cancer demonstr high recurr tumortypespecif indel hotspot target noncod region high express gene defin certain secretori cellular lineag albumin alb liver carcinoma gastric lipas lipf stomach carcinoma thyroglobulin tg thyroid carcinoma the sequenc context indel target lineagedefin gene enrich aataatd dna motif specif chromatin context includ h3k27ac h3k36me3 our find illumin preval hitherto unrecogn mutat process link cellular lineag cancer',\n",
       "  'ArticleTitle': 'Insertions and Deletions Target Lineage-Defining Genes in Human Cancers.',\n",
       "  'Author': 'Imielinski Marcin'},\n",
       " {'Abstract': ' merg tumor target moleculargenet imag integr platform limit lack strategi enabl system liganddirect deliveri imag specif transgen mani eukaryot virus serv transgen deliveri requir elimin nativ tropism mammalian cell contrast prokaryot virus adapt bind mammalian receptor poor vehicl here introduc system contain cisel adenoassoci virus aav singlestrand bacteriophag our aavphag aavp prototyp target integrin we aavp provid superior tumor transduct phage incorpor invert termin repeat associ improv fate deliv transgen moreov tempor dynam spatial heterogen gene express mediat target aavp monitor positron emiss tomographi this new class target hybrid viral particl enabl wide rang applic biolog medicin',\n",
       "  'ArticleTitle': 'A hybrid vector for ligand-directed tumor targeting and molecular imaging.',\n",
       "  'Author': 'Hajitou Amin'},\n",
       " {'Abstract': ' the adenomat polyposi coli apc tumor suppressor mutat vast major human colorect cancer crc lead deregul wnt signal to determin apc disrupt requir tumor mainten develop mous model crc apc condit suppress doxycyclineregul shrna apc suppress produc adenoma small intestin colon presenc kras p53 mutat progress invas carcinoma in establish tumor apc restor drive rapid widespread tumorcel differenti sustain regress relaps tumor regress accompani reestablish normal cryptvillus homeostasi aberr prolifer cell reacquir selfrenew multilineag differenti capabl our studi reveal crc cell revert function normal cell given appropri signal provid compel vivo valid wnt pathway therapeut target treatment crc',\n",
       "  'ArticleTitle': 'Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.',\n",
       "  'Author': 'Dow Lukas E'},\n",
       " {'Abstract': ' immun evas hallmark cancer lose abil neoantigen human leukocyt antigen hla loss facilit immun evas howev polymorph natur locus preclud accur hla copynumb analysi here loss heterozygos human leukocyt antigen lohhla comput tool determin hla allelespecif copi number sequenc data use lohhla hla loh occur 40 nonsmallcel lung cancer nsclcs associ high subclon neoantigen burden apobecmedi mutagenesi upregul cytolyt activ pdl1 posit the focal natur hla loh alter subclon frequenc enrich metastat site occurr parallel event suggest hla loh immun escap mechan subject strong microenvironment select pressur later tumor evolut character hla loh lohhla refin neoantigen predict implic understand resist mechan immunotherapeut approach target neoantigen video abstract',\n",
       "  'ArticleTitle': 'Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.',\n",
       "  'Author': 'McGranahan Nicholas'},\n",
       " {'Abstract': ' prolifer mammalian cell glutamin sourc nitrogen key anaplerot sourc provid metabolit tricarboxyl acid cycl tca biosynthesi recent mammalian target rapamycin complex 1 mtorc1 activ correl increas nutrient uptak metabol molecular connect glutaminolysi report here mtorc1 promot glutamin anaplerosi activ glutam dehydrogenas gdh this regul requir transcript repress sirt4 mitochondrialloc sirtuin inhibit gdh mechanist mtorc1 repress sirt4 promot proteasomemedi destabil camprespons element bind 2 creb2 thus relationship mtorc1 sirt4 cancer suggest find inde sirt4 express reduc human cancer overexpress reduc cell prolifer transform tumor develop final data indic target nutrient metabol energyaddict cancer high mtorc1 signal effect therapeut approach',\n",
       "  'ArticleTitle': 'The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.',\n",
       "  'Author': 'Csibi Alfred'},\n",
       " {'Abstract': ' autophagi cellautonom catabol process play contextdepend role tumor growth progress wei al report egfr signal promot tumor growth phosphoryl function inactiv beclin 1 consequ suppress autophagi',\n",
       "  'ArticleTitle': 'Self-eating limits EGFR-dependent tumor growth.',\n",
       "  'Author': 'Fantin Valeria R'},\n",
       " {'Abstract': ' cancer immunogenom origin frame research support hypothesi cancer mutat generat novel peptid nonself immun system the search neoantigen facilit combin new sequenc technolog special comput analys hla bind predict evalu somat alter cancer genom interpret abil produc immunestimulatori peptid the result inform character tumor neoantigen load cadr infiltr immun cell type t b cell receptor repertoir direct design person therapeut',\n",
       "  'ArticleTitle': 'Applications of Immunogenomics to Cancer.',\n",
       "  'Author': 'Liu X Shirley'},\n",
       " {'Abstract': ' aneuploidi recogn hallmark cancer 100 year general theori explain recur pattern aneuploidi cancer emerg here develop tumor suppressor oncogen tuson explor comput method analyz pattern mutat signatur tumor predict likelihood individu gene function tumor suppressor tsg oncogen og by analyz 8200 tumornorm pair provid statist evid suggest gene possess cancer driver properti anticip form continuum oncogen potenti integr driver predict inform somat copi number alter distribut potenc tsgs stop gene og essenti gene go gene chromosom predict complex pattern aneuploidi copi number variat characterist cancer genom we propos cancer genom shape process cumul haploinsuffici triplosensit',\n",
       "  'ArticleTitle': 'Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.',\n",
       "  'Author': 'Davoli Teresa'},\n",
       " {'Abstract': ' chromosom transloc encod oncogen fusion protein proven causal involv tumorigenesi our understand genom alter affect noncod rnas limit impact circular rnas circrna explor here wellestablish cancerassoci chromosom transloc rise fusion circrna fcircrna produc transcrib exon distinct gene affect transloc fcircrna contribut cellular transform promot cell viabil resist therapi tumorpromot properti vivo model our work expand current knowledg molecular mechan involv cancer onset progress potenti diagnost therapeut implic',\n",
       "  'ArticleTitle': 'Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.',\n",
       "  'Author': 'Guarnerio Jlenia'},\n",
       " {'Abstract': ' research two front enabl develop therapi provid signific benefit cancer patient one area stem detail knowledg mutat activ inactiv signal pathway drive cancer develop this work trigger develop target therapi lead clinic respons major patient bear target mutat respons limit durat in second front advanc molecular immunolog unveil complex mechan regul cellular immun respons these develop led success target immun checkpoint unleash antitumor t cell respons result durabl longlast respons fraction patient in review discuss evolut research two area propos intercross increas fund guid research combin agent repres path forward develop curat therapi major cancer patient',\n",
       "  'ArticleTitle': 'Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.',\n",
       "  'Author': 'Sharma Padmanee'},\n",
       " {'Abstract': ' lartruvo olaratumab monoclon antibodi extracellular domain pdgfra olaratumab block ligand bind inhibit activ pdgfra kinas activ preclin antibodi inhibit pdgfradepend tumor growth in random phase ii studi ad olaratumab doxorubicin chemotherapi improv surviv lead fda approv',\n",
       "  'ArticleTitle': 'PDGFRA Antibody for Soft Tissue Sarcoma.',\n",
       "  'Author': 'Klug Lillian R'},\n",
       " {'Abstract': ' interact stromal fibroblast cancer cell generat signal cancer progress therapi resist inflammatori respons although endogen rnas act damageassoci molecular pattern damp pattern recognit receptor prrs repres one signal rnas remain unrecogn nonpatholog condit we trigger stromal notchmyc breast cancer cell result pol3driven increas rn7sl1 endogen rna shield rna bind protein srp914 this increas rn7sl1 alter stoichiometri srp914 generat unshield rn7sl1 stromal exosom after exosom transfer immun cell unshield rn7sl1 drive inflammatori respons upon transfer breast cancer cell unshield rn7sl1 activ prr rigi enhanc tumor growth metastasi therapi resist corrobor evid patient tumor blood result demonstr regul rna unshield coupl stromal activ deploy rna damp promot aggress featur cancer video abstract',\n",
       "  'ArticleTitle': 'Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.',\n",
       "  'Author': 'Nabet Barzin Y'},\n",
       " {'Abstract': ' metastas account great major cancerassoci death complex process remain least understood aspect cancer biolog as bodi research concern metastasi continu grow rapid rate biolog program underli dissemin metastat outgrowth cancer cell begin view in review summar cellular molecular mechan involv metastasi focus carcinoma known highlight general principl metastasi begun emerg',\n",
       "  'ArticleTitle': 'Emerging Biological Principles of Metastasis.',\n",
       "  'Author': 'Lambert Arthur W'},\n",
       " {'Abstract': ' chromatin remodel protein frequent dysregul human cancer littl known control tumorigenesi here uncov epigenet program mediat naddepend histon deacetylas sirtuin 6 sirt6 critic suppress pancreat ductal adenocarcinoma pdac one lethal malign sirt6 inactiv acceler pdac progress metastasi upregul lin28b negat regul let7 microrna sirt6 loss result histon hyperacetyl lin28b promot myc recruit pronounc induct lin28b downstream let7 target gene hmga2 igf2bp1 igf2bp3 this epigenet program defin distinct subset poor prognosi repres 3040 human pdac character reduc sirt6 express exquisit depend lin28b tumor growth thus identifi sirt6 pdac tumor suppressor uncov lin28b pathway potenti therapeut target molecular defin pdac subset paperclip',\n",
       "  'ArticleTitle': 'SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.',\n",
       "  'Author': 'Kugel Sita'},\n",
       " {'Abstract': ' the pten tumor suppressor frequent affect cancer cell inherit pten mutat caus cancersuscept condit cowden syndrom pten act plasmamembran lipidphosphatas antagon phosphoinositid 3kinaseakt cell surviv pathway howev pten cell nuclei mechan function relev nuclear local remain unclear we nuclear pten essenti tumor suppress pten nuclear import mediat monoubiquitin a lysin mutant pten k289e associ cowden syndrom retain catalyt activ fail accumul nuclei patient tissu import defect we identifi lysin residu major monoubiquitin site essenti pten import while nuclear pten stabl polyubiquitin lead degrad cytoplasm thus identifi cancerassoci mutat pten target posttransl modif demonstr discret molecular mechan dictat tumor progress differenti degrad protect pten',\n",
       "  'ArticleTitle': 'Ubiquitination regulates PTEN nuclear import and tumor suppression.',\n",
       "  'Author': 'Trotman Lloyd C'},\n",
       " {'Abstract': ' tumor character extracellular matrix ecm remodel stiffen the ecm remodel cancer appreci relev stiffen less clear we breast tumorigenesi accompani collagen crosslink ecm stiffen increas focal adhes induct collagen crosslink stiffen ecm promot focal adhes enhanc pi3 kinas pi3k activ induc invas oncogeneiniti epithelium inhibit integrin signal repress invas premalign epithelium stiffen crosslink ecm forc integrin cluster promot focal adhes enhanc pi3k signal induc invas premalign epithelium consist reduct lysyl oxidasemedi collagen crosslink prevent mmtvneuinduc fibrosi decreas focal adhes pi3k activ imped malign lower tumor incid these data collagen crosslink modul tissu fibrosi stiff forc focal adhes growth factor signal breast malign',\n",
       "  'ArticleTitle': 'Matrix crosslinking forces tumor progression by enhancing integrin signaling.',\n",
       "  'Author': 'Levental Kandice R'},\n",
       " {'Abstract': ' identifi molecular biomark predict cancer drug efficaci crucial advanc precis medicin in issu cell iorio al nomin hundr potenti genet epigenet biomark highthroughput drug screen 1000 molecular annot cancer cell line',\n",
       "  'ArticleTitle': 'A Biomarker Harvest from One Thousand Cancer Cell Lines.',\n",
       "  'Author': 'Huang Yu-Han'},\n",
       " {'Abstract': ' the myc oncoprotein form binari activ complex partner protein max ternari repress complex addit max contain zinc finger protein miz1 here e3 ubiquitin ligas hecth9 ubiquitin myc vivo vitro form lysin 63link polyubiquitin chain miz1 inhibit ubiquitin hecth9medi ubiquitin myc requir transactiv multipl target gene recruit coactiv p300 induct cell prolifer myc hecth9 overexpress multipl human tumor essenti prolifer subset tumor cell our result suggest sitespecif ubiquitin regul switch activ repress state myc protein suggest strategi interfer myc function vivo',\n",
       "  'ArticleTitle': 'The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.',\n",
       "  'Author': 'Adhikary Sovana'},\n",
       " {'Abstract': ' design small molecul disrupt proteinprotein interact includ interact ras protein effector provid chemic probe therapeut agent we describ synthesi test potenti smallmolecul panra ligand design interact adjac site surfac oncogen kras one compound term 3144 bind ras protein microscal thermophoresi nuclear magnet reson spectroscopi isotherm titrat calorimetri exhibit lethal cell partial depend express ras protein this compound metabol stabl liver microsom display antitumor activ xenograft mous cancer model these find suggest panra inhibit effect therapeut strategi cancer structurebas design small molecul target multipl adjac site creat multival inhibitor effect protein',\n",
       "  'ArticleTitle': 'Multivalent Small-Molecule Pan-RAS Inhibitors.',\n",
       "  'Author': 'Welsch Matthew E'},\n",
       " {'Abstract': ' in studi evolutionarili conserv chromosom loop anchor bound ccctcbind factor ctcf cohesin vulner dna doubl strand break dsbs mediat topoisomeras 2b top2b polymorph genom redistribut ctcfcohesin occup rewir dna cleavag site novel loop anchor while transcript replicationcoupl genom rearrang well document demonstr dsbs form loop anchor larg transcript replic celltypeindepend dsbs continu form interphas enrich side strong topolog domain border frequent occur breakpoint cluster common transloc cancer thus loop anchor serv fragil site generat dsbs chromosom rearrang video abstract',\n",
       "  'ArticleTitle': 'Genome Organization Drives Chromosome Fragility.',\n",
       "  'Author': 'Canela Andres'},\n",
       " {'Abstract': ' the p53 tumor suppressor key mediat cellular respons stress here condit basal physiolog cellcultur stress p53 inhibit express cd44 cellsurfac molecul bind noncanon p53bind sequenc cd44 promot this interact enabl untransform cell respond stressinduc p53depend cytostat apoptot signal block action cd44 in absenc p53 function result derepress cd44 express essenti growth tumoriniti abil high tumorigen mammari epitheli cell in tumorigen nontumorigen cell cd44s express posit regul p63 paralogu p53 our data indic cd44 key tumorpromot agent transform tumor cell lack p53 function they suggest derepress cd44 result inactiv p53 potenti aid surviv immort premalign cell',\n",
       "  'ArticleTitle': 'Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.',\n",
       "  'Author': 'Godar Samuel'},\n",
       " {'Abstract': ' mutat cyld gene caus tumor hairfollicl keratinocyt the cyld gene encod deubiquitinas remov lysin 63link ubiquitin chain traf2 inhibit p65p50 nfkappab activ here mice lack cyld high suscept chemic induc skin tumor cyld tumor keratinocyt treat 12otetradecanoylphorbol13 acet tpa uv light hyperprolif elev cyclin d1 level the cyclin d1 elev caus increas p65p50 action increas nuclear activ bcl3associ nfkappab p50 p52 in cyld keratinocyt tpa uv light trigger transloc cyld cytoplasm perinuclear region cyld bind deubiquitin bcl3 prevent nuclear accumul bcl3 p50bcl3 p52bcl3depend prolifer these data indic depend extern signal cyld negat regul differ nfkappab pathway inactiv traf2 control surviv inflamm inhibit bcl3 control prolifer tumor growth',\n",
       "  'ArticleTitle': 'Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.',\n",
       "  'Author': 'Massoumi Ramin'},\n",
       " {'Abstract': ' systemat studi cancer genom provid unpreced insight molecular natur cancer use inform guid develop applic therapi clinic challeng here report cancerdriven alter identifi 11289 tumor 29 tissu integr somat mutat copi number alter dna methyl gene express map 1001 molecular annot human cancer cell line correl sensit 265 drug we cell line faith recapitul oncogen alter identifi tumor associ drug sensitivityresist highlight tissu lineag mediat drug respons logicbas model uncov combin alter sensit drug machin learn demonstr relat differ data type predict drug respons our analysi dataset rich resourc link genotyp cellular phenotyp identifi therapeut option select cancer subpopul',\n",
       "  'ArticleTitle': 'A Landscape of Pharmacogenomic Interactions in Cancer.',\n",
       "  'Author': 'Iorio Francesco'},\n",
       " {'Abstract': ' cancer cell abl prolifer acceler rate confin threedimension 3d extracellular matrix ecm rich i collagen the mechan tumor cell circumv endogen antigrowth signal clear defin we matrix metalloproteinas mt1mmp confer tumor cell distinct 3d growth advantag vitro vivo the replic advantag confer mt1mmp requir pericellular proteolysi ecm prolifer fulli suppress tumor cell suspend 3d gel proteaseresist collagen in absenc proteolysi tumor cell embed physiolog relev ecm matric trap compact spheric configur unabl undergo chang cell shape cytoskelet reorgan requir 3d growth these observ identifi mt1mmp tumorderiv growth factor regul prolifer control cell geometri confin 3d ecm',\n",
       "  'ArticleTitle': 'Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.',\n",
       "  'Author': 'Hotary Kevin B'},\n",
       " {'Abstract': ' hypermethyl cancer 1 hic1 epigenet regul transcript repressor function cooper p53 suppress agedepend develop cancer mice here mechan loss hic1 function promot tumorigenesi activ stresscontrol protein sirt1 attenu p53 function hic1 form transcript repress complex sirt1 deacetylas complex direct bind sirt1 promot repress transcript inactiv hic1 result upregul sirt1 express normal cancer cell deacetyl inactiv p53 allow cell bypass apoptosi surviv dna damag inhibit sirt1 function cell hic1 abolish resist apoptosi sinc age increas promot hypermethyl epigenet silenc hic1 specul result upregul sirt1 doubleedg sword promot surviv age cell increas cancer risk mammal',\n",
       "  'ArticleTitle': 'Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.',\n",
       "  'Author': 'Chen Wen Yong'},\n",
       " {'Abstract': ' we propos competit endogen rnas cerna sequest microrna regul mrna transcript contain common microrna recognit element mres howev function role cerna cancer remain unknown loss pten tumor suppressor regul cerna activ frequent occur melanoma here report discoveri signific enrich putat pten cerna gene loss acceler tumorigenesi follow sleep beauti insert mutagenesi mous model melanoma we valid putat pten cerna character one zeb2 transcript we zeb2 modul pten protein level micrornadepend protein codingindepend manner attenu zeb2 express activ pi3kakt pathway enhanc cell transform common occur human melanoma cancer express low pten level our studi genet identifi multipl putat microrna decoy pten valid zeb2 mrna bona fide pten cerna demonstr abrog zeb2 express cooper brafv600 promot melanomagenesi',\n",
       "  'ArticleTitle': 'In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.',\n",
       "  'Author': 'Karreth Florian A'},\n",
       " {'Abstract': ' metastasi multistep process cancer cell dissemin site primari tumor establish secondari tumor distant organ in search key regul metastasi murin breast tumor model transcript factor twist master regul embryon morphogenesi play essenti role metastasi suppress twist express high metastat mammari carcinoma cell inhibit abil metastas mammari gland lung ectop express twist result loss ecadherinmedi cellcel adhes activ mesenchym marker induct cell motil suggest twist contribut metastasi promot epithelialmesenchym transit emt in human breast cancer high level twist express correl invas lobular carcinoma high infiltr tumor associ loss ecadherin express these result establish mechanist link twist emt tumor metastasi',\n",
       "  'ArticleTitle': 'Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.',\n",
       "  'Author': 'Yang Jing'},\n",
       " {'Abstract': ' to determin role telomer dysfunct telomeras reactiv generat prooncogen genom event carcinoma progress induc telomeras revers transcriptas mtert allel cross prostat cancerpron mous model null pten p53 tumor suppressor constitut telomeras defici associ telomer dysfunct constrain cancer progress in contrast telomeras reactiv set telomer dysfunct allevi intratumor dnadamag signal generat aggress cancer rearrang genom new tumor biolog properti bone metastas compar oncogenom analysi reveal numer recurr amplif delet relev human prostat cancer murin tumor enrich tgfsmad4 network genet valid studi confirm cooper role pten p53 smad4 defici prostat cancer progress includ skelet metastas thus telomeras reactiv tumor cell experienc telomer dysfunct enabl full malign progress provid mechan acquisit cancerrelev genom event endow new tumor biolog capabl',\n",
       "  'ArticleTitle': 'Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.',\n",
       "  'Author': 'Ding Zhihu'},\n",
       " {'Abstract': ' recent genom analys patholog defin tumor type identifi withinatissu diseas subtyp howev extent genom signatur share tissu unclear we perform integr analysi five genomewid platform one proteom platform 3527 specimen 12 cancer type reveal unifi classif 11 major subtyp five subtyp ident tissueoforigin counterpart distinct cancer type converg common subtyp lung squamous head neck subset bladder cancer coalesc one subtyp typifi tp53 alter tp63 amplif high express immun prolifer pathway gene of note bladder cancer split three pancanc subtyp the multiplatform classif correl tissueoforigin provid independ inform predict clinic outcom all data set avail datamin unifi resourc support biolog discoveri insight novel therapeut strategi',\n",
       "  'ArticleTitle': 'Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.',\n",
       "  'Author': 'Hoadley Katherine A'},\n",
       " {'Abstract': ' the signific parallel cell plastic embryon develop carcinoma progress help understand epithelialmesenchym transit emt human diseas our expand knowledg emt led clarif emt program set multipl dynam transit state epitheli mesenchym phenotyp oppos process involv singl binari decis emt intermedi state identifi crucial driver organ fibrosi tumor progress need caution interpret contribut metastat colon here discuss current stateoftheart latest find concept cellular plastic heterogen emt we rais question pend identifi challeng face fastmov field',\n",
       "  'ArticleTitle': 'EMT: 2016.',\n",
       "  'Author': 'Nieto M Angela'},\n",
       " {'Abstract': ' metabol adapt essenti cell surviv nutrient depriv we report eukaryot elong factor 2 kinas eef2k activ ampkinas ampk confer cell surviv acut nutrient deplet block translat elong tumor cell exploit pathway adapt nutrient depriv reactiv ampkeef2k axi adapt transform cell nutrient withdraw sever compromis cell lack eef2k moreov eef2k knockdown restor sensit acut nutrient depriv high resist human tumor cell line in vivo overexpress eef2k render murin tumor remark resist calor restrict express eef2k correl surviv human medulloblastoma glioblastoma multiform final c elegan strain defici efk1 eef2k ortholog sever compromis respons nutrient deplet our data highlight conserv role eef2k protect cell nutrient depriv confer tumor cell adapt metabol stress paperclip',\n",
       "  'ArticleTitle': 'The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.',\n",
       "  'Author': 'Leprivier Gabriel'},\n",
       " {'Abstract': ' malign glioma aggress brain tumor limit therapeut option improv treatment requir deeper molecular understand diseas as cancer recent studi identifi high tumorigen subpopul malign glioma known general cancer stem cell here demonstr glioma stem cell gscs produc nitric oxid elev nitric oxid synthase2 nos2 express gscs nos2 activ growth tumorigen distinguish nongsc normal neural progenitor gene express profil identifi nos2regul gene includ cellcycl inhibitor cell divis autoantigen1 cda1 further high nos2 express correl decreas surviv human glioma patient nos2 inhibit slow glioma growth murin intracrani model these data provid insight gscs mechanist distinct less tumorigen counterpart suggest nos2 inhibit efficaci approach treat devast diseas',\n",
       "  'ArticleTitle': 'Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.',\n",
       "  'Author': 'Eyler Christine E'},\n",
       " {'Abstract': ' although merlinnf2 discov two decad ago tumor suppressor under neurofibromatosi ii precis molecular mechan remain poor understood recent studi drosophila reveal potenti link merlin hippo pathway place merlin genet upstream kinas hpomst in contrast common depict linear model merlin function hpomst drosophila mammal merlin promot downstream hippo signal activ intrins kinas activ hpomst instead merlin direct bind recruit effector kinas wtslat plasma membran membran recruit turn promot wts phosphoryl hposav kinas complex we disrupt actin cytoskeleton promot merlinwt interact implic merlin actinmedi regul hippo signal our find elucid molecular function merlin highlight plasma membran critic subcellular compart hippo signal transduct',\n",
       "  'ArticleTitle': 'Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.',\n",
       "  'Author': 'Yin Feng'},\n",
       " {'Abstract': ' the transcript factor cjun mediat cellular process includ prolifer surviv upregul carcinoma liverspecif inactiv cjun differ stage tumor develop studi role chemic induc hepatocellular carcinoma hccs mice the requir cjun restrict earli stage tumor develop number size hepat tumor dramat reduc cjun inactiv tumor initi the impair tumor develop correl increas level p53 target gene noxa result induct apoptosi affect cell prolifer primari hepatocyt lack cjun increas sensit tnfalphainduc apoptosi abrog absenc p53 these data indic cjun prevent apoptosi antagon p53 activ illustr mechan contribut earli stage human hcc develop',\n",
       "  'ArticleTitle': 'Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53.',\n",
       "  'Author': 'Eferl Robert'},\n",
       " {'Abstract': ' how stem cell generat differenti selfrenew daughter cell unclear here drosophila larval neuroblastsstem celllik precursor adult brainregul prolifer segreg growth inhibitor brat transcript factor prospero one daughter cell like prospero brat bind cosegreg adaptor protein miranda in larval neuroblast brat prospero requir inhibit selfrenew one two daughter cell while prospero regul cellcycl gene transcript brat act posttranscript inhibitor dmyc in brat prospero mutant daughter cell grow behav neuroblast lead format larval brain tumor similar defect lethal giant larva lgl mutant brat prospero asymmetr we identifi molecular mechan control selfrenew prevent tumor format stem cell well',\n",
       "  'ArticleTitle': 'Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells.',\n",
       "  'Author': 'Betschinger Joerg'},\n",
       " {'Abstract': ' ptx3 essenti compon humor arm innat immun play nonredund role resist select microb regul inflamm ptx3 activ regul complement cascad interact c1q factor h ptx3 defici associ increas suscept mesenchym epitheli carcinogenesi increas suscept ptx3 mice associ enhanc macrophag infiltr cytokin product angiogenesi trp53 mutat correl evid genetarget mice pharmacolog block experi indic ptx3 defici result amplif complement activ ccl2 product tumorpromot macrophag recruit ptx3 express epigenet regul select human tumor leiomyosarcoma colorect cancer methyl promot region putat enhanc thus ptx3 effector molecul belong humor arm innat immun act extrins oncosuppressor gene mous man regul complementdepend macrophagesustain tumorpromot inflamm',\n",
       "  'ArticleTitle': 'PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.',\n",
       "  'Author': 'Bonavita Eduardo'},\n",
       " {'Abstract': ' retino acid ra induc differenti neuroblastoma cell vitro variabl success treat aggress form diseas this variabl clinic respons ra enigmat mutat compon ra signal cascad use largescal rnai genet screen identifi crosstalk tumor suppressor nf1 retino acidinduc differenti neuroblastoma loss nf1 activ rasmek signal turn repress znf423 critic transcript coactiv retino acid receptor neuroblastoma low level nf1 znf423 extrem poor outcom we nf1 mutat neuroblastoma cell line primari tumor inhibit mek signal downstream nf1 restor respons ra suggest therapeut strategi overcom ra resist nf1defici neuroblastoma',\n",
       "  'ArticleTitle': 'NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.',\n",
       "  'Author': u'H\\xf6lzel Michael'},\n",
       " {'Abstract': ' the poor clinic outcom pancreat ductal adenocarcinoma pda attribut intrins chemoresist growthpermiss tumor microenviron convers quiescent activ pancreat stellat cell pscs drive sever stromal reaction character pda here reveal vitamin d receptor vdr express stroma human pancreat tumor treatment vdr ligand calcipotriol mark reduc marker inflamm fibrosi pancreat human tumor stroma we vdr act master transcript regul pscs repris quiescent state result induc stromal remodel increas intratumor gemcitabin reduc tumor volum 57 increas surviv compar chemotherapi this work describ molecular strategi transcript reprogram tumor stroma enabl chemotherapeut respons suggest vitamin d prime adjunct pda therapi paperflick',\n",
       "  'ArticleTitle': 'Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.',\n",
       "  'Author': 'Sherman Mara H'},\n",
       " {'Abstract': ' immunecheckpointblockad icbmedi rejuven exhaust t cell emerg promis approach treat cancer chronic infect howev t cell fulli exhaust prolong antigen exposur remain refractori icbmedi rejuven we report block novo dna methyl activ cd8 t cell allow retain effector function despit chronic stimul persist viral infect wholegenom bisulfit sequenc antigenspecif murin cd8 t cell effector exhaust stage immun respons identifi progress acquir herit novo methyl program restrict t cell expans clonal divers pd1 blockad treatment moreov exhaustionassoci dnamethyl program acquir tumorinfiltr pd1hi cd8 t cell approach revers program improv t cell respons tumor control icb these data establish novo dnamethyl program regul t cell exhaust barrier icbmedi t cell rejuven',\n",
       "  'ArticleTitle': 'De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.',\n",
       "  'Author': 'Ghoneim Hazem E'},\n",
       " {'Abstract': ' tumor cell exhibit two differ mode individu cell movement mesenchymaltyp movement character elong cellular morpholog requir extracellular proteolysi in amoeboid movement cell round morpholog less depend proteas requir high rhokinas signal drive elev level actomyosin contractil these two mode cell movement interconvert we mesenchymaltyp movement melanoma cell driven activ gtpase rac complex contain nedd9 identifi melanoma metastasi gene dock3 rac guanin nucleotid exchang factor rac signal wave2 direct mesenchym movement suppress amoeboid movement decreas actomyosin contractil convers amoeboid movement rhokinas signal activ rac gap arhgap22 suppress mesenchym movement inactiv rac we demonstr tight interplay rho rac determin differ mode tumor cell movement reveal tumor cell switch differ mode movement',\n",
       "  'ArticleTitle': 'Rac activation and inactivation control plasticity of tumor cell movement.',\n",
       "  'Author': 'Sanz-Moreno Victoria'},\n",
       " {'Abstract': ' nonsmal cell lung cancer nsclc heterogen genet environment paramet influenc cell metabol cultur here assess impact factor human nsclc metabol vivo intraop 13cglucos infus nine nsclc patient metabol tumor benign lung while enhanc glycolysi glucos oxid common tumor observ evid oxid multipl nutrient includ lactat potenti carbon sourc moreov metabol heterogen region identifi tumor surpris data suggest potenti contribut nonglucos nutrient wellperfus tumor area our find demonstr heterogen tumor metabol vivo highlight strong influenc microenviron featur',\n",
       "  'ArticleTitle': 'Metabolic Heterogeneity in Human Lung Tumors.',\n",
       "  'Author': 'Hensley Christopher T'},\n",
       " {'Abstract': ' the clinic benefit confer vascular endotheli growth factor vegftarget therapi variabl tumor treat patient eventu reiniti growth here identifi glycosylationdepend pathway compens absenc cognat ligand preserv angiogenesi respons vegf blockad remodel endotheli cell ec surfac glycom select regul bind galectin1 gal1 recognit complex nglycan vegfr2 activ vegflik signal vessel antivegfsensit tumor exhibit high level 26link sialic acid prevent gal1 bind in contrast antivegf refractori tumor secret increas gal1 associ vasculatur display glycosyl pattern facilit gal1ec interact interrupt 16glcnac branch ec silenc tumorderiv gal1 convert refractori antivegfsensit tumor elimin 26link sialic acid confer resist antivegf disrupt gal1nglycan axi promot vascular remodel immun cell influx tumor growth inhibit thus target glycosylationdepend lectinreceptor interact increas efficaci antivegf treatment',\n",
       "  'ArticleTitle': 'Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.',\n",
       "  'Author': 'Croci Diego O'},\n",
       " {'Abstract': ' p53 key tumor suppressor protein numer function it primari mode action general ascrib induct cellcycl arrest apoptosi senesc stress li al challeng dogma evid three program dispens p53s tumor suppress role',\n",
       "  'ArticleTitle': 'Tumor suppression by p53: fall of the triumvirate?',\n",
       "  'Author': 'Hock Andreas K'},\n",
       " {'Abstract': ' we pilot concept connect map cmap gene drug diseas state connect virtu common geneexpress signatur here report 1000fold scaleup cmap part nih linc consortium possibl new lowcost highthroughput reduc represent express profil method term l1000 we l1000 high reproduc compar rna sequenc suitabl comput infer express level 81 nonmeasur transcript we expand cmap mechan action small molecul function annot genet variant diseas gene inform clinic trial the 13 million l1000 profil describ well tool analysi avail httpsclueio',\n",
       "  'ArticleTitle': 'A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.',\n",
       "  'Author': 'Subramanian Aravind'},\n",
       " {'Abstract': ' decrement loss pten result cancer suscept tumor progress pten elev attract option cancer prevent therapi we generat transgen mous line pten express elev vari level take advantag bacteri artifici chromosom bacmedi transgenesi the superpten mutant viabl reduc bodi size decreas cell number effect cell size unexpect pten elev organ level result healthi metabol character increas energi expenditur reduc bodi fat accumul cell deriv mice reduc glucos glutamin uptak increas mitochondri oxid phosphoryl resist oncogen transform mechanist pten elev orchestr metabol switch regul pi3kdepend independ pathway negat impact two pronounc metabol featur tumor cell glutaminolysi warburg effect',\n",
       "  'ArticleTitle': 'Systemic elevation of PTEN induces a tumor-suppressive metabolic state.',\n",
       "  'Author': 'Garcia-Cao Isabel'},\n",
       " {'Abstract': ' cancer cell consum glucos secret lactat cultur it unknown lactat contribut energi metabol live tumor we report human nonsmallcel lung cancer nsclcs oxid glucos tricarboxyl acid tca cycl here lactat tca cycl carbon sourc nsclc in human nsclc evid lactat util appar tumor high',\n",
       "  'ArticleTitle': 'Lactate Metabolism in Human Lung Tumors.',\n",
       "  'Author': 'Faubert Brandon'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Bone Metastasis.',\n",
       "  'Author': 'Ell Brian'},\n",
       " {'Abstract': ' we describ mechan tumorigenesi mediat kinasedead braf presenc oncogen ras we drug select inhibit braf drive rasdepend braf bind craf craf activ mekerk signal this occur oncogen braf inhibit demonstr braf inhibit se drive pathway activ occur braf inhibit presenc oncogen ras kinasedead braf mimic effect brafselect drug kinasedead braf oncogen ras cooper induc melanoma mice our data reveal paradigm brafmedi signal promot tumor progress they highlight understand pathway signal clinic practic genotyp tumor prior administ brafselect drug identifi patient like respond identifi patient experi advers effect',\n",
       "  'ArticleTitle': 'Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.',\n",
       "  'Author': 'Heidorn Sonja J'},\n",
       " {'Abstract': ' tnfalpha emerg regul link inflamm cancer pathogenesi detail cellular molecular mechan under link remain elucid the tuber sclerosi 1 tsc1tsc2 tumor suppressor complex serv repressor mtor pathway disrupt tsc1tsc2 complex function contribut tumorigenesi here ikkbeta major downstream kinas tnfalpha signal pathway physic interact phosphoryl tsc1 ser487 ser511 result suppress tsc1 the ikkbetamedi tsc1 suppress activ mtor pathway enhanc angiogenesi result tumor develop we express activ ikkbeta associ tsc1 ser511 phosphoryl vegf product multipl tumor type correl poor clinic outcom breast cancer patient our find identifi pathway critic inflammationmedi tumor angiogenesi provid target clinic intervent human cancer',\n",
       "  'ArticleTitle': 'IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.',\n",
       "  'Author': 'Lee Dung-Fang'},\n",
       " {'Abstract': ' adopt immunotherapi receptor engin achiev specif tumor target t cell hold promis advanc cancer therapi here two studi boic al roybal al provid distinct potenti complimentari approach improv efficaci curb potenti toxic approach',\n",
       "  'ArticleTitle': 'Customizing Functionality and Payload Delivery for Receptor-Engineered T Cells.',\n",
       "  'Author': 'Klebanoff Christopher A'},\n",
       " {'Abstract': ' due genom instabl cancer exhibit loss region contain tumor suppressor gene collater loss gene to identifi cancerspecif vulner result copi number loss perform integr analys genomewid copi number rnai profil identifi 56 gene gene suppress inhibit prolifer cell harbor partial copi number loss gene these cyclop copi number alter yield cancer liabil partial loss gene enrich spliceosom proteasom ribosom compon one cyclop gene psmc2 encod essenti member 19s proteasom normal cell express excess psmc2 resid complex psmc1 psmd2 psmd5 act reservoir protect cell psmc2 suppress cell harbor partial psmc2 copi number loss lack complex die psmc2 suppress these observ defin distinct class cancerspecif liabil result genom instabl',\n",
       "  'ArticleTitle': 'Cancer vulnerabilities unveiled by genomic loss.',\n",
       "  'Author': 'Nijhawan Deepak'},\n",
       " {'Abstract': ' cancer distribut uneven bodi cell intrins factor stem cell function determin organ cancer risk unknown therefor crerecombin condit lineag trace oncogen tumor suppressor allel defin popul stem nonstem cell mous organ test lifelong suscept tumorigenesi we tumor incid determin lifelong generat capac mutat cell this relationship held true presenc multipl genotyp regardless development stage support notion stem cell dictat organ cancer risk use liver model system damageinduc activ stem cell function mark increas cancer risk therefor propos combin stem cell mutagenesi extrins factor enhanc prolifer cell popul creat perfect storm ultim determin organ cancer risk video abstract',\n",
       "  'ArticleTitle': 'Multi-organ Mapping of Cancer Risk.',\n",
       "  'Author': 'Zhu Liqin'},\n",
       " {'Abstract': ' missens mutat p53 tumor suppressor inactiv antiprolif properti promot metastasi gainoffunct activ we sustain express mutant p53 requir maintain prometastat phenotyp murin model pancreat cancer high metastat diseas frequent display p53 mutat transcript profil function screen identifi plateletderiv growth factor receptor b pdgfrb necessari suffici mediat effect mutant p53 induc pdgfrb cellautonom mechan involv inhibit p73nfi complex repress pdgfrb express p53defici noninvas cell block pdgfrb signal rna interfer small molecul inhibitor prevent pancreat cancer cell invas vitro metastasi format vivo final high pdgfrb express correl poor diseasefre surviv pancreat colon ovarian cancer patient implic pdgfrb prognost marker possibl target attenu metastasi p53 mutant tumor',\n",
       "  'ArticleTitle': u'Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor \\u03b2 signaling.',\n",
       "  'Author': 'Weissmueller Susann'},\n",
       " {'Abstract': ' we dna methyltransferas inhibitor dnmtis upregul immun signal cancer viral defens pathway in ovarian cancer oc dnmtis trigger cytosol sens doublestrand rna dsrna caus i interferon respons apoptosi knock dsrna sensor tlr3 mav reduc respons 2fold block interferon beta receptor abrog upregul hypermethyl endogen retrovirus erv gene accompani respons erv overexpress activ respons basal level erv viral defens gene express correl primari oc signatur separ primari sampl multipl tumor type the cancer genom atlas low versus high express group in melanoma patient treat immun checkpoint therapi high viral defens signatur express tumor associ durabl clinic respons dnmti treatment sensit antictla4 therapi preclin melanoma model',\n",
       "  'ArticleTitle': 'Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.',\n",
       "  'Author': 'Chiappinelli Katherine B'},\n",
       " {'Abstract': ' the monomer ralgtpas rala ralb recogn compon regulatori framework support tumorigen transform specif ralb requir suppress apoptot checkpoint activ mechanist basi unknown report effector protein ralb includ sec5 compon exocyst octamer protein complex implic tether vesicl membran surpris ralbsec5 effector complex direct recruit activ atyp ikappab kinas famili member tbk1 in cancer cell constitut engag pathway chronic ralb activ restrict initi apoptot program typic engag context oncogen stress although dispens surviv nontumorigen context pathway help mount innat immun respons virus exposur these observ defin mechanist contribut ralgtpas cancer cell surviv reveal ralbsec5 effector complex compon tbk1depend innat immun signal',\n",
       "  'ArticleTitle': 'RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.',\n",
       "  'Author': 'Chien Yuchen'},\n",
       " {'Abstract': ' colorect cancer lead caus cancerrel death mutat innat immun sensor aim2 frequent identifi patient colorect cancer aim2 modul colon tumorigenesi unknown here aim2defici mice hypersuscept colon tumor develop product inflammasomeassoci cytokin inflammatori mediat larg intact aim2defici mice intestin stem cell prone uncontrol prolifer aberr wnt signal expand popul tumoriniti stem cell absenc aim2 suscept aim2defici mice colorect tumorigenesi enhanc dysbiot gut microbiota reduc reciproc exchang gut microbiota healthi wildtyp mice these find uncov synergi specif host genet factor gut microbiota determin suscept colorect cancer therapeut modul aim2 express microbiota potenti prevent colorect cancer',\n",
       "  'ArticleTitle': 'Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.',\n",
       "  'Author': 'Man Si Ming'},\n",
       " {'Abstract': ' here subset breast cancer express high level 2 phosphatidylinositol5phosph 4kinas  andor  pi5p4k  provid evid kinas essenti growth absenc p53 knock pi5p4k  breast cancer cell line bear amplif gene encod pi5p4k  defici p53 impair growth plastic xenograft this growth phenotyp accompani enhanc level reactiv oxygen speci ros lead senesc mice homozyg delet tp53 pip4k2b viabl indic synthet lethal loss two gene import pip4k2a pip4k2b tp53 mice viabl dramat reduct tumor format compar tp53 litterm these result indic inhibitor pi5p4k effect prevent treat cancer mutat tp53',\n",
       "  'ArticleTitle': 'Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.',\n",
       "  'Author': 'Emerling Brooke M'},\n",
       " {'Abstract': ' in two companion report tracerx consortium investig tumor heterogen evolut earlystag nonsmal cell lung cancer the studi highlight prognost valu copynumb heterogen assess tumor biopsi circul tumor dna detect plasma suggest track evolut lung cancer aid clinic practic',\n",
       "  'ArticleTitle': 'Lung Cancer: A Wily Genetic Opponent.',\n",
       "  'Author': 'Hsu Peggy P'},\n",
       " {'Abstract': ' here demonstr proteincod rna transcript crosstalk compet common microrna microrna respons element foundat interact we term rna transcript compet endogen rnas cerna we test hypothesi context pten key tumor suppressor abund determin critic outcom tumorigenesi by combin comput experiment approach identifi valid endogen proteincod transcript regul pten antagon pi3kakt signal possess growth tumorsuppress properti notabl gene display concord express pattern pten copi number loss cancer our studi present road map predict valid cerna activ network impart transregulatori function proteincod mrnas',\n",
       "  'ArticleTitle': 'Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.',\n",
       "  'Author': 'Tay Yvonne'},\n",
       " {'Abstract': ' this year laskerdebakey prize clinic research dougla lowi john schiller celebr scienc behind one greatest advanc histori cancer research develop vaccin prevent infect prevent tumor induct pathogen strain human papilloma virus hpv',\n",
       "  'ArticleTitle': 'A Prize for Cancer Prevention.',\n",
       "  'Author': 'Varmus Harold'},\n",
       " {'Abstract': ' cell organ renew tissu perman withdraw cell cycl respons divers stress includ dysfunct telomer dna damag strong mitogen signal disrupt chromatin this respons term cellular senesc control p53 rb tumor suppressor protein constitut potent anticanc mechan nonetheless senesc cell acquir phenotyp chang contribut age certain agerel diseas includ latelif cancer thus senesc respons antagonist pleiotrop promot earlylif surviv curtail develop cancer eventu limit longev dysfunct senesc cell accumul',\n",
       "  'ArticleTitle': 'Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.',\n",
       "  'Author': 'Campisi Judith'},\n",
       " {'Abstract': ' how chanc discoveri tasmanian rainforest chang cours scientif career',\n",
       "  'ArticleTitle': 'Cancer in the Wilderness.',\n",
       "  'Author': 'Murchison Elizabeth P'},\n",
       " {'Abstract': ' ferroptosi form nonapoptot cell death key regul remain unknown we sought common mediat lethal 12 ferroptosisinduc small molecul we target metabolom profil deplet glutathion caus inactiv glutathion peroxidas gpxs respons one class compound chemoproteom strategi gpx4 direct inhibit second class compound gpx4 overexpress knockdown modul lethal 12 ferroptosi induc 11 compound lethal mechan in addit two repres ferroptosi induc prevent tumor growth xenograft mous tumor model sensit profil 177 cancer cell line reveal diffus larg b cell lymphoma renal cell carcinoma suscept gpx4regul ferroptosi thus gpx4 essenti regul ferroptot cancer cell death',\n",
       "  'ArticleTitle': 'Regulation of ferroptotic cancer cell death by GPX4.',\n",
       "  'Author': 'Yang Wan Seok'},\n",
       " {'Abstract': ' antivascular endotheli growth factor vegf cancer immunotherapi target angiogenesi develop resist patient common in issu cell croci al identifi complex set mechan galectin1 prolong cellsurfac retent vegf receptor 2 vegfr2 stimul vegfindepend tumor angiogenesi',\n",
       "  'ArticleTitle': 'Galectin-1 Pulls the Strings on VEGFR2.',\n",
       "  'Author': 'Stanley Pamela'},\n",
       " {'Abstract': ' brafv600 mutant colon cancer ccs characterist gene express signatur tumor lack mutat collect refer braflik tumor repres 20 ccs we shrnabas genet screen focus gene upregul brafv600 ccs identifi vulner tumor subtyp exploit therapeut here identifi ranbp2 known nup358 essenti surviv braflik nonbraflik cc cell suppress ranbp2 result mitot defect braflik cc cell lead cell death mechanist ranbp2 silenc reduc microtubul outgrowth kinetochor induc spindl perturb provid explan observ mitot defect we braflik ccs display far greater sensit microtubul poison vinorelbin vitro vivo suggest vinorelbin potenti tailor treatment braflik ccs',\n",
       "  'ArticleTitle': 'A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.',\n",
       "  'Author': 'Vecchione Loredana'},\n",
       " {'Abstract': ' metformin util cancer prevent treatment mechan effect remain elus through genet screen c elegan uncov two metformin respons element nuclear pore complex npc acylcoa dehydrogenas famili member10 acad10 we demonstr biguanid inhibit growth inhibit mitochondri respiratori capac restrain transit ragaragc gtpase heterodim npc nuclear exclus render ragc incap gain gdpbound state necessari stimul mtorc1 biguanideinduc inactiv mtorc1 subsequ inhibit growth transcript induct acad10 this ancient metformin respons pathway conserv worm human both restrict nuclear pore transit upregul acad10 requir biguanid reduc viabil melanoma pancreat cancer cell extend c elegan lifespan this pathway provid unifi mechan metformin kill cancer cell extend lifespan illumin potenti cancer target paperclip',\n",
       "  'ArticleTitle': u'An Ancient, Unified Mechanism for Metformin Growth Inhibition in C.\\xa0elegans and Cancer.',\n",
       "  'Author': 'Wu Lianfeng'},\n",
       " {'Abstract': ' line1 l1 retrotransposon mobil genet element compris 17 human genom new l1 insert profound alter gene function caus diseas signific cancer remain unclear here appli enhanc retrotransposon captur sequenc rcseq 19 hepatocellular carcinoma hcc genom elucid two archetyp l1mediat mechan enabl tumorigenesi in first exampl 419 211 donor present germlin retrotransposit event tumor suppressor mutat colorect cancer mcc mcc express ablat case enabl oncogen cateninwnt signal in second exampl suppress tumorigen 18 st18 activ tumorspecif l1 insert experiment assay confirm l1 interrupt negat feedback loop block st18 repress enhanc st18 frequent amplifi hcc nodul mdr2 mice support assign candid liver oncogen these proofofprincipl result substanti l1mediat retrotransposit etiolog factor hcc',\n",
       "  'ArticleTitle': 'Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.',\n",
       "  'Author': 'Shukla Ruchi'},\n",
       " {'Abstract': ' the myc oncogen contribut genesi human cancer recent insight express function led therapeut opportun myc activ bromodomain protein inhibit druglik molecul result tumor inhibit vivo tumor growth curb pharmacolog uncoupl bioenerget pathway involv glucos glutamin metabol mycinduc cellular biomass accumul other approach halt myc path cancer involv target mycmax dimer mycinduc microrna express here rich understand myc review highlight new biolog insight opportun cancer therapi',\n",
       "  'ArticleTitle': 'MYC on the path to cancer.',\n",
       "  'Author': 'Dang Chi V'},\n",
       " {'Abstract': ' monitor cancer age vivo remain experiment challeng here describ luciferas knockin mous p16luc faith report express p16ink4a tumor suppressor age biomark lifelong assess luminesc p16luc mice reveal exponenti increas age high variabl cohort contemporan hous syngen mice express p16ink4a age predict cancer develop suggest accumul senesc cell princip determin cancerrel death in 14 14 test tumor model express p16luc focal activ earli neoplast event enabl visual tumor sensit exceed imag modal activ p16ink4a emerg neoplasm surround stromal cell this work suggest p16ink4a activ characterist emerg cancer make p16luc allel sensit unbias report neoplast transform',\n",
       "  'ArticleTitle': 'Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.',\n",
       "  'Author': 'Burd Christin E'},\n",
       " {'Abstract': ' the serinethreonin protein phosphatas 2a pp2a heterotrimer enzym famili regul numer signal pathway biallel mutat structur pp2a abeta subunit occur type human tumor function consequ cancerassoci pp2a abeta mutat cell transform remain undefin here suppress pp2a abeta express permit immort human cell achiev tumorigen state cancerassoci abeta mutant fail revers tumorigen phenotyp induc pp2a abeta suppress indic mutant function null allel wildtyp pp2a abeta cancerderiv abeta mutant form complex small gtpase rala pp2a abetacontain complex dephosphoryl rala ser183 ser194 inactiv rala abolish transform function these observ identifi pp2a abeta tumor suppressor gene transform immort human cell regul function rala',\n",
       "  'ArticleTitle': 'The tumor suppressor PP2A Abeta regulates the RalA GTPase.',\n",
       "  'Author': 'Sablina Anna A'},\n",
       " {'Abstract': ' dna ligas iv respons seal doublestrand break dsbs nonhomolog endjoin nhej inhibit ligas iv result amass dsbs serv strategi treatment cancer here identifi molecul scr7 inhibit join dsbs cellfre repair system scr7 block ligas ivmedi join interf dna bind t4 dna ligas ligas i scr7 inhibit nhej ligas ivdepend manner cell activ intrins apoptot pathway more import scr7 imped tumor progress mous model coadminist dsbinduc therapeut modal enhanc sensit this inhibitor target nhej offer strategi treatment cancer improv exist regimen',\n",
       "  'ArticleTitle': 'An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.',\n",
       "  'Author': 'Srivastava Mrinal'},\n",
       " {'Abstract': ' kras hras share ident effector similar properti high degre tumortyp specif associ kras hras mutat suggest uniqu role oncogenesi here report oncogen kras hras suppress noncanon wntca2 signal effect contribut tumorigen properti kras bind calmodulin reduc camkii activ express fzd8 restor fzd8 kras mutant pancreat cell suppress malign deplet fzd8 hrasv12transform cell enhanc tumor initi capac interrupt krascalmodulin bind genet mean treatment oral activ protein kinas c pkcactiv prostratin repress tumorigenesi kras mutant pancreat cancer cell these find provid altern way select target undrugg protein',\n",
       "  'ArticleTitle': 'K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.',\n",
       "  'Author': 'Wang Man-Tzu'},\n",
       " {'Abstract': ' superenhanc larg cluster transcript enhanc drive express gene defin cell ident improv understand role superenhanc play biolog afford know constel factor constitut domain identifi superenhanc spectrum human cell type we describ popul transcript factor cofactor chromatin regul transcript apparatus occupi superenhanc embryon stem cell evid superenhanc high transcrib we produc catalog superenhanc broad rang human cell type superenhanc associ gene control defin biolog cell interest diseaseassoci variat enrich superenhanc diseaserelev cell type furthermor cancer cell generat superenhanc oncogen gene tumor pathogenesi thus superenhanc play key role human cell ident health diseas',\n",
       "  'ArticleTitle': 'Super-enhancers in the control of cell identity and disease.',\n",
       "  'Author': 'Hnisz Denes'},\n",
       " {'Abstract': ' celltyp plastic tumor suggest caus bidirect convers tumoriniti stem cell nonstem cell trigger inflammatori stroma nfb repres key transcript factor inflammatori tumor microenviron howev nfbs function tumoriniti cell examin use genet model intestin epitheli cell iecrestrict constitut wntactiv compris common event initi colon cancer demonstr nfb modul wnt signal iecspecif ablat relap65 retard crypt stem cell expans in contrast elev nfb signal enhanc wnt activ induc dedifferenti nonstem cell acquir tumoriniti capac thus data support concept bidirect convers highlight inflammatori signal dedifferenti generat tumoriniti cell vivo',\n",
       "  'ArticleTitle': 'Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.',\n",
       "  'Author': 'Schwitalla Sarah'},\n",
       " {'Abstract': ' although arf tumor suppressor p53 regul well establish numer studi indic arf suppress cell growth p53mdm2independ manner to understand mechan arfmedi tumor suppress identifi ubiquitin ligas arfbp1 key factor associ arf vivo arfbp1 harbor signatur hect motif ubiquitin ligas activ inhibit arf notabl inactiv arfbp1 mdm2 suppress growth p53 null cell manner reminisc arf induct surpris p53 wildtyp cell arfbp1 direct bind ubiquitin p53 inactiv endogen arfbp1 crucial arfmedi p53 stabil thus studi modifi current view arfmedi p53 activ reveal arfbp1 critic mediat p53independ p53depend tumor suppressor function arf as arfbp1 serv potenti target therapeut intervent tumor regardless p53 status',\n",
       "  'ArticleTitle': 'ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.',\n",
       "  'Author': 'Chen Delin'},\n",
       " {'Abstract': ' stromal communic cancer cell influenc treatment respons we stromal breast cancer brca cell util paracrin juxtacrin signal drive chemotherapi radiat resist upon heterotyp interact exosom transfer stromal brca cell rna exosom larg noncod transcript transpos element stimul pattern recognit receptor rigi activ stat1depend antivir signal in parallel stromal cell activ notch3 brca cell the paracrin antivir juxtacrin notch3 pathway converg stat1 facilit transcript respons notch3 expand therapyresist tumoriniti cell primari human andor mous brca analysi support role antiviralnotch3 pathway notch signal stromamedi resist abrog combin therapi gamma secretas inhibitor thus stromal cell orchestr intric crosstalk brca cell util exosom instig antivir signal this expand brca subpopul adept resist therapi reiniti tumor growth',\n",
       "  'ArticleTitle': 'Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.',\n",
       "  'Author': 'Boelens Mirjam C'},\n",
       " {'Abstract': ' heatshock factor 1 hsf1 master regul heatshock respons facilit malign transform cancer cell surviv prolifer model system the common assumpt effect mediat regul heatshock protein hsp express howev transcript network hsf1 coordin direct malign relationship heatshock respons defin by compar cell high low malign potenti alongsid nontransform counterpart identifi hsf1regul transcript program specif high malign cell distinct heat shock cancerspecif gene program support oncogen process cellcycl regul signal metabol adhes translat hsp gene integr program uniqu regul malign this hsf1 cancer program activ breast colon lung tumor isol direct human patient associ metastasi death thus hsf1 rewir transcriptom tumorigenesi prognost therapeut implic',\n",
       "  'ArticleTitle': 'HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.',\n",
       "  'Author': 'Mendillo Marc L'},\n",
       " {'Abstract': ' p53 p19arf tumor suppressor frequent mutat human tumor in highthroughput screen mice mutat collabor p53 p19arf defici identifi 10806 retrovir insert site implic 300 loci tumorigenesi this dataset reveal 20 gene mutat p19arfdefici p53defici wildtyp mice includ flt3 mmumir106a363 smg6 ccnd3 well network signific collabor mutual exclus interact cancer gene furthermor candid tumor suppressor gene well distinct cluster insert gene flt3 notch1 induc mutant differ spectra genet interact cross speci compar analysi acgh data human cancer cell line reveal known candid oncogen mmp13 slamf6 rreb1 tumor suppressor wwox arfrp2 this dataset prove rich resourc studi genet interact underli tumorigenesi',\n",
       "  'ArticleTitle': 'Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.',\n",
       "  'Author': 'Uren Anthony G'},\n",
       " {'Abstract': ' histon ubiquityl promin respons dna doublestrand break dsbs modif confin dna lesion understood here trip12 ubr5 two hect domain ubiquitin e3 ligas control accumul rnf168 ratelimit compon pathway ubiquityl histon dna breakag we rnf168 satur increas amount dsbs deplet trip12 ubr5 allow accumul rnf168 supraphysiolog level follow massiv spread ubiquitin conjug hyperaccumul ubiquitinregul genom caretak 53bp1 brca1 thus regulatori proteolyt ubiquityl wire selflimit circuit promot histon ubiquityl near dna lesion time counteract excess spread undamag chromosom we provid evid mechan vital homeostasi ubiquitincontrol event dna breakag subvert tumorigenesi',\n",
       "  'ArticleTitle': 'TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.',\n",
       "  'Author': 'Gudjonsson Thorkell'},\n",
       " {'Abstract': ' cancer aris genet alter invari lead dysregul transcript program these dysregul program caus cancer cell high depend certain regul gene express here discuss transcript control disrupt genet alter cancer cell transcript depend develop consequ dysregul program depend provid opportun novel therapeut intervent cancer',\n",
       "  'ArticleTitle': 'Transcriptional Addiction in Cancer.',\n",
       "  'Author': 'Bradner James E'},\n",
       " {'Abstract': ' reactiv oxygen speci ros implic pathophysiolog diseas includ cancer in studi jund member ap1 famili transcript factor reduc tumor angiogenesi limit rasmedi product ros use junddefici cell demonstr jund regul gene involv antioxid defens h2o2 product angiogenesi the accumul h2o2 jund cell decreas avail feii reduc activ hif prolyl hydroxylas phds target hypoxiainduc factorsalpha hifalpha degrad subsequ hifalpha protein accumul enhanc transcript vegfa potent proangiogen factor our studi uncov mechan jund protect cell oxid stress exert antiangiogen effect furthermor provid new insight regul phd activ allow immedi reactiv adapt chang o2 iron level cell',\n",
       "  'ArticleTitle': 'JunD reduces tumor angiogenesis by protecting cells from oxidative stress.',\n",
       "  'Author': 'Gerald Damien'},\n",
       " {'Abstract': ' here report phase 1b clinic trial test impact oncolyt virotherapi talimogen laherparepvec cytotox t cell infiltr therapeut efficaci antipd1 antibodi pembrolizumab twentyon patient advanc melanoma treat talimogen laherparepvec follow combin therapi pembrolizumab therapi general well toler fatigu fever chill common advers event no doselimit toxic occur confirm object respons rate 62 complet respons rate 33 immunerel respons criteria patient respond combin therapi increas cd8',\n",
       "  'ArticleTitle': 'Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.',\n",
       "  'Author': 'Ribas Antoni'},\n",
       " {'Abstract': ' although consid housekeep function multipl aspect protein synthesi regul differ somat cell includ stem cell modul celltypespecif manner these differ requir establish maintain differ cell ident cell function tissu homeostasi tumor suppress',\n",
       "  'ArticleTitle': 'Cellular differences in protein synthesis regulate tissue homeostasis.',\n",
       "  'Author': 'Buszczak Michael'},\n",
       " {'Abstract': ' the transcript factor nrf2 master regul cellular antioxid respons genet activ nonsmallcel lung cancer nsclcs instanc mutat negat regul keap1 while direct pharmacolog inhibit nrf2 proven challeng aberr activ rewir biochem network cancer cell creat special vulner here chemic proteom map druggabl protein select express keap1mut nsclc cell princip nr0b1 atyp orphan nuclear receptor engag multimer protein complex regul transcript output keap1mut nsclc cell we identifi small molecul coval target conserv cystein nr0b1 protein interact domain demonstr compound disrupt nr0b1 complex impair anchorageindepend growth keap1mut cancer cell our find design nr0b1 druggabl transcript regul support nrf2depend lung cancer',\n",
       "  'ArticleTitle': 'Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.',\n",
       "  'Author': 'Bar-Peled Liron'},\n",
       " {'Abstract': ' xbp1 part er stress respons activ cancer cell foster tumor growth in issu cell cubillosruiz al demonstr xbp1 tumorinfiltr dendrit cell blunt antitumor immun these find impli xbp1 relev target cancer therapi',\n",
       "  'ArticleTitle': 'ER Stress in Dendritic Cells Promotes Cancer.',\n",
       "  'Author': 'Garris Christopher S'},\n",
       " {'Abstract': ' pancreat ductal adenocarcinoma pda one lethal human malign part propens metastasi here organoid cultur system transcript enhanc landscap alter discret stage diseas progress pda mous model this approach reveal metastat transit accompani massiv recurr alter enhanc activ we implic pioneer factor foxa1 driver enhanc activ system mechan render pda cell invas less anchoragedepend growth vitro well metastat vivo in context foxa1depend enhanc reprogram activ transcript program embryon foregut endoderm collect studi implic enhanc reprogram foxa1 upregul retrograd development transit pda metastasi',\n",
       "  'ArticleTitle': 'Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.',\n",
       "  'Author': 'Roe Jae-Seok'},\n",
       " {'Abstract': ' in rspondinbas 3d cultur lgr5 stem cell multipl organ form everexpand epitheli organoid retain tissu ident we report establish tumor organoid cultur 20 consecut colorect carcinoma crc patient for organoid generat adjac normal tissu organoid close recapitul properti origin tumor the spectrum genet chang live biobank agre well previous largescal mutat analys crc gene express analysi indic major crc molecular subtyp repres tumor organoid amen highthroughput drug screen allow detect genedrug associ as exampl singl organoid cultur exquisit sensit wnt secret porcupin inhibitor carri mutat negat wnt feedback regul rnf43 apc organoid technolog fill gap cancer genet patient trial complement celllin xenograftbas drug studi allow person therapi design paperclip',\n",
       "  'ArticleTitle': 'Prospective derivation of a living organoid biobank of colorectal cancer patients.',\n",
       "  'Author': 'van de Wetering Marc'},\n",
       " {'Abstract': ' gut microbiota link chronic inflamm carcinogenesi chemotherapi failur major caus recurr poor prognosi colorect cancer patient here investig contribut gut microbiota chemoresist patient colorect cancer we fusobacterium f nucleatum abund colorect cancer tissu patient recurr post chemotherapi associ patient clinicopatholog characterisitc furthermor bioinformat function studi demonstr f nucleatum promot colorect cancer resist chemotherapi mechanist f nucleatum target tlr4 myd88 innat immun signal specif microrna activ autophagi pathway alter colorect cancer chemotherapeut respons thus f nucleatum orchestr molecular network tolllik receptor microrna autophagi clinic biolog mechanist control colorect cancer chemoresist measur target f nucleatum associ pathway yield valuabl insight clinic manag amelior colorect cancer patient outcom',\n",
       "  'ArticleTitle': 'Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.',\n",
       "  'Author': 'Yu TaChung'},\n",
       " {'Abstract': ' identif somat rearrang cancer genom acceler analysi highthroughput sequenc data howev character complex structur alter under mechan remain inadequ here appli algorithm predict structur variat short read report comprehens catalog somat structur variat mechan generat highcoverag wholegenom sequenc data 140 patient ten tumor type we character relat contribut differ type rearrang mutat mechan 20 somat delet complex delet form replic error describ differ mutat mechan somat germlin alter import provid detail reconstruct event respons loss cdkn2ab gain egfr glioblastoma reveal alter result multipl mechan even singl genom dna doublestrand break replic error drive somat rearrang',\n",
       "  'ArticleTitle': 'Diverse mechanisms of somatic structural variations in human cancer genomes.',\n",
       "  'Author': 'Yang Lixing'},\n",
       " {'Abstract': ' synonym mutat chang sequenc gene direct alter sequenc encod protein here evid silent mutat frequent contribut human cancer select synonym mutat oncogen cancertyp specif function consequ cancerassoci synonym mutat divers recurr alter exon motif regul splice associ chang oncogen splice tumor the p53 tumor suppressor tp53 recurr synonym mutat contrast oncogen adjac splice site inactiv we estim one two one five silent mutat oncogen select equat 6 8 select singlenucleotid chang gene in addit analys suggest dosagesensit oncogen select mutat 3 utr',\n",
       "  'ArticleTitle': 'Synonymous mutations frequently act as driver mutations in human cancers.',\n",
       "  'Author': 'Supek Fran'},\n",
       " {'Abstract': ' inflamm paramount pancreat oncogenesi we identifi uniqu activ t cell popul constitut 40 tumorinfiltr t cell human pancreat ductal adenocarcinoma pda recruit activ t cell conting divers chemokin signal delet deplet blockad t cell recruit protect pda result increas infiltr activ th1 polar t cell although t cell dispens outcom pda indispens mediat tumor protect t cell ablat pdainfiltr t cell express high level exhaust ligand negat adapt antitumor immun blockad pdl1 t cell enhanc cd4 cd8 t cell infiltr immunogen induc tumor protect suggest t cell critic sourc immunesuppress checkpoint ligand pda we describ t cell central regul effector t cell activ cancer novel crosstalk',\n",
       "  'ArticleTitle': u'\\u03b3\\u03b4 T Cells Support Pancreatic Oncogenesis by Restraining \\u03b1\\u03b2 T Cell Activation.',\n",
       "  'Author': 'Daley Donnele'},\n",
       " {'Abstract': ' the tumor microenviron play decis role chemotherapeut respons in issu cell yu al add find identifi bacterium fusobacterium nucleatum unrecogn chemoresist mediat colorect cancer establish microbiota potenti therapeut target',\n",
       "  'ArticleTitle': 'Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer.',\n",
       "  'Author': 'Ramos Azucena'},\n",
       " {'Abstract': ' global downregul microrna mirna common observ human cancer causat role tumorigenesi the mechan respons phenomenon remain poor understood here yap downstream target tumorsuppress hipposign pathway regul mirna biogenesi celldensitydepend manner at low cell densiti nuclear yap bind sequest p72 ddx17 regulatori compon mirnaprocess machineri at high cell densiti hippomedi cytoplasm retent yap facilit p72 associ microprocessor bind specif sequenc motif primirna inactiv hippo pathway express constitut activ yap caus widespread mirna suppress cell tumor correspond posttranscript induct myc express thus hippo pathway link contactinhibit regul mirna biogenesi respons widespread mirna repress observ cancer',\n",
       "  'ArticleTitle': 'Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.',\n",
       "  'Author': 'Mori Masaki'},\n",
       " {'Abstract': ' most cancer cell releas heterogen popul extracellular vesicl ev contain protein lipid nucleic acid in vitro experi ev uptak lead transfer function mrna alter cellular behavior howev similar vivo experi remain challeng cell ev discrimin nonevreceiv cell here creloxp system direct identifi tumor cell ev vivo we ev releas malign tumor cell taken less malign tumor cell locat distant tumor ev carri mrnas involv migrat metastasi by intravit imag less malign tumor cell ev display enhanc migratori behavior metastat capac we postul tumor cell local system share molecul carri ev vivo affect cellular behavior',\n",
       "  'ArticleTitle': u'In\\xa0Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior.',\n",
       "  'Author': 'Zomer Anoek'},\n",
       " {'Abstract': ' recent discoveri provid new hope relaps type cancer prevent induc ferroptosi',\n",
       "  'ArticleTitle': 'The Ferrous Awakens.',\n",
       "  'Author': 'Rennekamp Andrew J'},\n",
       " {'Abstract': ' colorect cancer metastas liver global kill 600000 peopl annual by function screen 661 microrna mirna parallel liver colon identifi mir551a mir483 robust endogen suppressor liver colon metastasi these mirna converg target creatin kinas braintyp ckb phosphoryl metabolit creatin generat phosphocreatin ckb releas extracellular space metastat cell encount hepat hypoxia catalyz product phosphocreatin import slc6a8 transport generat atpfuel metastat surviv combinatori therapeut viral deliveri mir551a mir4835p singledos adenoassoci viral aav deliveri suppress colon cancer metastasi ckb inhibit smallmolecul inhibitor import human liver metastas express higher ckb slc6a8 level reduc mir551amir483 level relat primari tumor we identifi extracellular space compart malign energet catalysi therapeut target',\n",
       "  'ArticleTitle': 'Extracellular metabolic energetics can promote cancer progression.',\n",
       "  'Author': 'Loo Jia Min'},\n",
       " {'Abstract': ' the tumor microenviron known play role tumorigenesi in issu yang al 2008 demonstr mast cell heterozyg nf1 gene promot growth neurofibroma mous model neurofibromatosi genet pharmacolog inhibit cell suffici block tumor growth',\n",
       "  'ArticleTitle': 'It takes a (dysfunctional) village to raise a tumor.',\n",
       "  'Author': 'Reilly Karlyne M'},\n",
       " {'Abstract': ' upon exposur stress trnas enzymat cleav yield distinct class trnaderiv fragment trfs yield distinct class trfs we identifi novel class trfs deriv trnaglu trnaasp trnag trnatyr induct suppress stabil multipl oncogen transcript breast cancer cell displac 3 untransl region utr rnabind protein ybx1 this mode posttranscript silenc sequenc specif fragment share common motif match ybx1 recognit sequenc lossoffunct gainoffunct studi antisens lockednucl acid lnas synthet rna mimet respect reveal fragment suppress growth serumstarv cancer cell invas metastasi breast cancer cell high metastat cell evad tumorsuppress pathway attenu induct trfs our find reveal tumorsuppress role specif trnaderiv fragment describ molecular mechan action this transcript displacementbas mechan general trna ribosomalrna snorna fragment',\n",
       "  'ArticleTitle': 'Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.',\n",
       "  'Author': 'Goodarzi Hani'},\n",
       " {'Abstract': ' the lack vitro prostat cancer model recapitul divers human prostat cancer hamper progress understand diseas pathogenesi therapi respons use 3d organoid system report success longterm cultur prostat cancer biopsi specimen circul tumor cell the first seven fulli character organoid line recapitul molecular divers prostat cancer subtyp includ tmprss2erg fusion spop mutat spink1 overexpress chd1 loss wholeexom sequenc low mutat burden consist genom studi mutat foxa1 pik3r1 well dna repair chromatin modifi pathway report advanc diseas loss p53 rb tumor suppressor pathway function common featur share organoid line the methodolog describ enabl generat larg repertoir patientderiv prostat cancer line amen genet pharmacolog studi',\n",
       "  'ArticleTitle': 'Organoid cultures derived from patients with advanced prostate cancer.',\n",
       "  'Author': 'Gao Dong'},\n",
       " {'Abstract': ' malign suppress immun system process term immunosurveil howev extent immunosurveil occur spontan cancer composit particip cell type remain obscur here cell transform trigger tissueresid lymphocyt respons oncogeneinduc murin cancer model noncircul cytotox lymphocyt deriv innat t cell receptor tcr tcr lineag expand earli tumor character high express nk11 cd49a cd103 cell share geneexpress signatur distinct convent nk cell t cell invari nkt cell generat lymphocyt depend cytokin il15 transcript factor nfil3 requir differenti tumorinfiltr nk cell il15 defici nfil3 defici result acceler tumor growth these find reveal tumorelicit immunosurveil mechan engag unconvent type1lik innat lymphoid cell 1 innatelik t cell',\n",
       "  'ArticleTitle': 'Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.',\n",
       "  'Author': u'Dadi Sa\\xefda'},\n",
       " {'Abstract': ' while preponder morbid mortal medulloblastoma patient metastat diseas research focus primari tumor dearth metastat tissu sampl model system medulloblastoma metastas exclus leptomening surfac brain spinal cord dissemin thought occur shed primari tumor cell cerebrospin fluid follow distal reimplant leptomening we evid medulloblastoma circul tumor cell ctcs therapyna patient demonstr vivo flank xenograft parabiosi medulloblastoma ctcs spread blood leptomening space form leptomening metastas medulloblastoma leptomening metastas express high level chemokin ccl2 express ccl2 medulloblastoma vivo suffici drive leptomening dissemin hematogen dissemin medulloblastoma offer new opportun diagnos treat lethal dissemin medulloblastoma',\n",
       "  'ArticleTitle': 'A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.',\n",
       "  'Author': 'Garzia Livia'},\n",
       " {'Abstract': ' by target surfac antigen express tumor cell monoclon antibodi demonstr efficaci cancer therapeut recent success antibodybas strategi focus enhanc antitumor immun respons target immun cell irrespect tumor antigen we discuss innov strategi propos impact futur antibodybas cancer therapi',\n",
       "  'ArticleTitle': 'Antibody-based immunotherapy of cancer.',\n",
       "  'Author': 'Weiner Louis M'},\n",
       " {'Abstract': ' we molecular dissect leptomening metastasi spread cancer cerebrospin fluid csf frequent fatal condit mediat unknown mechan we select lung breast cancer cell line abil infiltr grow csf remark acellular mitogenpoor metastasi microenviron complement compon 3 c3 upregul four leptomening metastat model prove necessari cancer growth leptomening space in human diseas cancer cell csf produc c3 correl clinic cours c3 express primari tumor predict leptomening relaps mechanist cancercellderiv c3 activ c3a receptor choroid plexus epithelium disrupt bloodcsf barrier this effect allow plasma compon includ amphiregulin mitogen enter csf promot cancer cell growth pharmacolog interfer c3 signal prove therapeut benefici suppress leptomening metastasi preclin model',\n",
       "  'ArticleTitle': 'Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.',\n",
       "  'Author': 'Boire Adrienne'},\n",
       " {'Abstract': ' brain metastasi omin complic cancer cancer cell infiltr brain die unknown caus here identifi plasmin reactiv brain stroma defens metastat invas plasminogen activ pa inhibitori serpin cancer cell shield defens plasmin suppress brain metastasi two way convert membranebound astrocyt fasl paracrin death signal cancer cell inactiv axon pathfind molecul l1cam metastat cell express spread brain capillari metastat outgrowth brain metastat cell lung cancer breast cancer express high level antipa serpin includ neuroserpin serpin b2 prevent plasmin generat metastasissuppress effect by protect cancer cell death signal foster vascular cooption antipa serpin provid unifi mechan initi brain metastasi lung breast cancer',\n",
       "  'ArticleTitle': 'Serpins promote cancer cell survival and vascular co-option in brain metastasis.',\n",
       "  'Author': 'Valiente Manuel'},\n",
       " {'Abstract': ' the mixedlineag leukemia mll protein histon methyltransferas mutat clinic biolog distinct subset acut leukemia mll associ cohort high conserv cofactor form macromolecular complex includ menin product men1 tumor suppressor gene mutat herit sporad endocrin tumor we demonstr oncogen mll fusion protein retain abil stabli associ menin highaffin aminotermin conserv bind motif interact requir initi mllmediat leukemogenesi furthermor menin essenti mainten mllassoci oncogen induc myeloid transform acut genet ablat menin revers aberr hox gene express mediat mllmenin promoterassoci complex abrog differenti arrest oncogen properti mlltransform leukem blast these result demonstr human oncoprotein critic depend direct physic interact tumor suppressor protein oncogen activ valid potenti target molecular therapi suggest central role menin alter epigenet function under pathogenesi hematopoiet cancer',\n",
       "  'ArticleTitle': 'The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.',\n",
       "  'Author': 'Yokoyama Akihiko'},\n",
       " {'Abstract': ' cancer invas cell tissuedriven process physic cellular molecular determin adapt react progress diseas cancer invas initi maintain signal pathway control cytoskelet dynam tumor cell turnov cellmatrix cellcel junction follow cell migrat adjac tissu here describ cellmatrix cellcel adhes proteas cytokin system underli tissu invas cancer cell we explain reciproc reprogram tumor cell surround tissu structur guid invas generat divers mode dissemin the result plastic contribut generat divers cancer invas rout program enhanc tumor heterogen ultim sustain metastat dissemin',\n",
       "  'ArticleTitle': 'Cancer invasion and the microenvironment: plasticity and reciprocity.',\n",
       "  'Author': 'Friedl Peter'},\n",
       " {'Abstract': ' the foxo transcript factor implic process includ tumor suppress cell death in issu two group report mice condit lack three predomin foxo transcript factor demonstr foxo critic longterm mainten hematopoiet stem cell foxo suppress format hemangioma lymphoma mice',\n",
       "  'ArticleTitle': 'FoxOs in tumor suppression and stem cell maintenance.',\n",
       "  'Author': 'Arden Karen C'},\n",
       " {'Abstract': ' activ phosphoinositid 3kinas pi3kakt signal appear oblig event develop cancer the high relat member mammalian foxo transcript factor famili foxo1 foxo3 foxo4 repres one effector arm pi3kakt signal prompt genet analysi role foxo neoplast phenotyp link pi3kakt activ while germlin somat delet five foxo allel produc remark modest neoplast phenotyp broad somat delet foxo engend progress cancerpron condit character thymic lymphoma hemangioma demonstr mammalian foxo bona fide tumor suppressor transcriptom promot analys differenti affect endothelium identifi direct foxo target reveal foxo regul target vivo high contextspecif even cell function studi valid sprouty2 pbx1 foxoregul mediat endotheli cell morphogenesi vascular homeostasi',\n",
       "  'ArticleTitle': 'FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.',\n",
       "  'Author': 'Paik Ji-Hye'},\n",
       " {'Abstract': ' to assess telomeras cancer therapeut target determin adapt mechan telomeras inhibit model telomeras reactiv subsequ extinct t cell lymphoma aris atm mice engin induc telomeras revers transcriptas allel telomeras reactiv set telomer dysfunct enabl full malign progress allevi telomer dysfunctioninduc checkpoint these cancer possess copi number alter target key loci human t cell lymphomagenesi upon telomeras extinct tumor growth eventu slow reinstat telomer dysfunctioninduc checkpoint growth subsequ resum tumor acquir altern lengthen telomer alt aberr transcript network center mitochondri biolog oxid defens alt tumor acquir amplificationoverexpress pgc1 master regul mitochondri biogenesi function mark sensit pgc1 sod2 knockdown genet model telomeras extinct reveal vulner motiv coincident inhibit mitochondri mainten oxid defens mechan enhanc antitelomeras cancer therapi',\n",
       "  'ArticleTitle': 'Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.',\n",
       "  'Author': 'Hu Jian'},\n",
       " {'Abstract': ' investig therapeut outlier except respons anticanc treatment uncov biomark drug sensit we perform preclin trial investig primari murin acut myeloid leukemia aml generat retrovir insert mutagenesi kras',\n",
       "  'ArticleTitle': 'KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.',\n",
       "  'Author': 'Burgess Michael R'},\n",
       " {'Abstract': ' effector t cell fibroblast major compon tumor microenviron the mean cellular interact affect chemoresist unclear here fibroblast diminish nuclear accumul platinum ovarian cancer cell result resist platinumbas chemotherapi we demonstr glutathion cystein releas fibroblast contribut resist cd8 t cell abolish resist alter glutathion cystin metabol fibroblast cd8 tcellderiv interferon ifn control fibroblast glutathion cystein upregul gammaglutamyltransferas transcript repress system xc cystin glutam antiport jakstat1 pathway the presenc stromal fibroblast cd8 t cell negat posit associ ovarian cancer patient surviv respect thus work uncov mode action effector t cell abrog stromalmedi chemoresist capit interplay chemotherapi immunotherapi hold high potenti cancer treatment',\n",
       "  'ArticleTitle': 'Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.',\n",
       "  'Author': 'Wang Weimin'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Tumor archaeology reveals that mutations love company.',\n",
       "  'Author': 'Setlur Sunita R'},\n",
       " {'Abstract': ' the high rate clinic respons proteinkinasetarget drug match cancer patient specif genom alter prompt effort cancer cell line ccl profil identifi addit biomark smallmolecul sensit we quantit measur sensit 242 genom character ccls inform set 354 small molecul target node cell circuitri uncov protein depend 1 associ specif cancergenom alter 2 target small molecul we creat cancer therapeut respons portal httpwwwbroadinstituteorgctrp enabl user correl genet featur sensit individu lineag control confound factor ccl profil we report candid depend associ activ mutat oncogen catenin sensit bcl2 famili antagonist navitoclax the resourc develop novel therapeut hypothes acceler discoveri drug match patient cancer genotyp lineag',\n",
       "  'ArticleTitle': 'An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.',\n",
       "  'Author': 'Basu Amrita'},\n",
       " {'Abstract': ' there lack effect predict biomark precis assign optim therapi cancer patient while effort direct infer drug respons phenotyp base genotyp focus use phenotyp inform gain direct perturb patient live cancer cell drug question to satisfi unmet need develop dynam bh3 profil techniqu measur earli chang net proapoptot signal mitochondrion prime induc chemotherapeut agent cancer cell requir prolong ex vivo cultur we cell line clinic experi earli druginduc death signal measur dynam bh3 profil predict chemotherapi respons cancer type agent includ combin chemotherapi we propos dynam bh3 profil broad predict biomark predict cytotox respons cancer chemotherapeut vivo',\n",
       "  'ArticleTitle': 'Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.',\n",
       "  'Author': 'Montero Joan'},\n",
       " {'Abstract': ' cell releas primari tumor seed metastas specif organ nonrandom process impli involv biolog select mechan base clinic function molecular evid cytokin tgfbeta breast tumor microenviron prime cancer cell metastasi lung central process induct angiopoietinlik 4 angptl4 tgfbeta smad signal pathway tgfbeta induct angptl4 cancer cell enter circul enhanc subsequ retent lung bone tumor cellderiv angptl4 disrupt vascular endotheli cellcel junction increas permeabl lung capillari facilit transendotheli passag tumor cell these result suggest mechan metastasi cytokin primari tumor microenviron induc express cytokin depart tumor cell empow cell disrupt lung capillari wall seed pulmonari metastas',\n",
       "  'ArticleTitle': 'TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.',\n",
       "  'Author': 'Padua David'},\n",
       " {'Abstract': ' phosphoinositid 3kinas pi3k activ stimul divers oncogen growth factor receptor elev pi3k signal consid hallmark cancer mani pi3k pathwaytarget therapi test oncolog trial result regulatori approv one isoformselect inhibitor idelalisib treatment certain blood cancer varieti agent differ stage develop in parallel pi3k research cancer biologist investig field uncov excit unpredict role pi3k catalyt regulatori subunit normal cell function diseas mani function imping oncolog influenc efficaci toxic pi3ktarget therapi here provid perspect role class i pi3k regul cellular metabol immun system function two topic close intertwin cancer biolog we discuss recent progress develop pi3ktarget therapi treatment cancer diseas',\n",
       "  'ArticleTitle': 'The PI3K Pathway in Human Disease.',\n",
       "  'Author': 'Fruman David A'},\n",
       " {'Abstract': ' genom rearrang thought occur progress tumor develop recent find suggest altern mechan involv massiv chromosom rearrang onestep catastroph event term chromothripsi we report wholegenom sequencingbas analysi sonichedgehog medulloblastoma shhmb brain tumor patient germlin tp53 mutat lifraumeni syndrom uncov massiv complex chromosom rearrang integr tp53 status microarray deep sequencingbas dna rearrang data addit patient reveal strike associ tp53 mutat chromothripsi shhmbs analysi addit tumor entiti substanti link tp53 mutat chromothripsi indic contextspecif role p53 catastroph dna rearrang among observ strong associ somat tp53 mutat chromothripsi acut myeloid leukemia these find connect p53 status chromothripsi specif tumor type provid genet basi understand aggress subtyp cancer',\n",
       "  'ArticleTitle': 'Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.',\n",
       "  'Author': 'Rausch Tobias'},\n",
       " {'Abstract': ' the risk specif cancer increas patient metabol dysfunct includ obes diabet here drosophila model explor effect diet tumor progress feed drosophila diet high carbohydr demonstr direct metabol dysfunct includ hyperglycemia hyperinsulinemia insulin resist we demonstr high dietari sugar convert rassrctransform tissu local growth aggress tumor emerg metastas wherea tissu display insulin resist rassrc tumor retain insulin pathway sensit increas abil import glucos resist apoptosi high dietari sugar increas canon winglesswnt pathway activ upregul insulin receptor gene express promot insulin sensit the result feedforward circuit amplifi dietmedi malign phenotyp rassrctransform tumor by target multipl step circuit ration appli drug combin demonstr potenti combinatori drug intervent treat dietenhanc malign tumor',\n",
       "  'ArticleTitle': 'Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling.',\n",
       "  'Author': 'Hirabayashi Susumu'},\n",
       " {'Abstract': ' littl known molecular machineri contribut sitespecif copi number variat cnvs fit chronolog tumor progress black al 2013 demonstr overexpress histon demethylas induc transient copi gain specif genom loci known harbor protooncogen',\n",
       "  'ArticleTitle': \"A histone modifier's ill-gotten copy gains.\",\n",
       "  'Author': 'Rickels Ryan'},\n",
       " {'Abstract': ' metastasi rare event doe rare variant high metastat cell primari tumor progress premalign state metastas stochast chang gene express argument evid adduc support posit a paper month cancer cell argument instead suggest model combin featur',\n",
       "  'ArticleTitle': 'Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?',\n",
       "  'Author': 'Hynes Richard O'},\n",
       " {'Abstract': ' this snapshot summar current knowledg key featur mutat landscap major pathway tumor evolut heterogen renal cell carcinoma well recent advanc therapeut develop to view snapshot open download pdf',\n",
       "  'ArticleTitle': 'SnapShot: Renal Cell Carcinoma.',\n",
       "  'Author': 'Turajlic Samra'},\n",
       " {'Abstract': ' among breast cancer tripleneg breast cancer tnbc poor understood refractori current target therapi use genet screen identifi ptpn12 tyrosin phosphatas tumor suppressor tnbc ptpn12 potent suppress mammari epitheli cell prolifer transform ptpn12 frequent compromis human tnbcs identifi upstream tumorsuppressor network posttranscript control ptpn12 ptpn12 suppress transform interact inhibit multipl oncogen tyrosin kinas includ her2 egfr the tumorigen metastat potenti ptpn12defici tnbc cell sever impair restor ptpn12 function combin inhibit ptpn12regul tyrosin kinas suggest tnbcs depend protooncogen tyrosin kinas constrain ptpn12 collect data identifi ptpn12 common inactiv tumor suppressor provid rational combinatori target protooncogen tyrosin kinas tnbc cancer base profil tyrosinephosphatas activ',\n",
       "  'ArticleTitle': 'Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.',\n",
       "  'Author': 'Sun Tingting'},\n",
       " {'Abstract': ' highgrad serous ovarian cancer hgsc exhibit extens malign clonal divers widespread nonrandom pattern diseas dissemin we investig local immun microenviron factor shape tumor progress properti interfac tumorinfiltr lymphocyt til cancer cell through multiregion studi 212 sampl 38 patient wholegenom sequenc immunohistochemistri histolog imag analysi gene express profil t b cell receptor sequenc identifi three immunolog subtyp sampl extens withinpati divers epitheli cd8 til negat associ malign divers reflect immunolog prune tumor clone infer neoantigen deplet hla i loss heterozygos spatial track t cell tumor clone in addit combinatori prognost effect mutat process immun properti observ illumin specif genom aberr type associ immun respons impact surviv we conclud withinpati spatial immun microenviron variat shape intraperiton malign spread provok new evolutionari perspect hgsc clonal dispers',\n",
       "  'ArticleTitle': 'Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.',\n",
       "  'Author': 'Zhang Allen W'},\n",
       " {'Abstract': ' cancer immunotherapi induc long last respons patient metastat cancer wide rang histolog broaden clinic applic treatment requir improv understand mechan limit cancer immunotherapi the interact immun system cancer cell continu dynam evolv initi establish cancer cell develop metastat diseas depend immun evas as molecular mechan resist immunotherapi elucid action strategi prevent treat deriv improv clinic outcom patient',\n",
       "  'ArticleTitle': 'Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.',\n",
       "  'Author': 'Sharma Padmanee'},\n",
       " {'Abstract': ' clinic trial key translat scientif advanc progress cancer research care confront develop basic scienc landscap clinic cancer research rapid evolv here review recent chang clinic trial design conduct forecast futur direct person global impact',\n",
       "  'ArticleTitle': 'Cancer Clinical Trials: The Rear-View Mirror and the Crystal Ball.',\n",
       "  'Author': 'Cescon Dave'},\n",
       " {'Abstract': ' studi biolog tumor caus germlin mutat led recent paradigmchang therapi drive precis prevent effort includ immun oncolog earli detect research here explor recent biolog advanc redefin spectrum cancer link hereditari predisposit syndrom leverag improv person risk assess develop novel intervent prevent intercept cancer',\n",
       "  'ArticleTitle': 'Translating Germline Cancer Risk into Precision Prevention.',\n",
       "  'Author': 'Yurgelun Matthew B'},\n",
       " {'Abstract': ' activ mutat kras frequent event divers human carcinoma promin human pancreat ductal adenocarcinoma pdac an induc krasg12ddriven mous model pdac establish critic role sustain krasg12d express tumor mainten provid model determin potenti under mechan krasg12dindepend pdac recurr here tumor undergo spontan relaps devoid krasg12d express downstream canon mapk signal instead acquir amplif overexpress transcript coactiv yap1 function studi establish role yap1 transcript factor tead2 drive krasg12dindepend tumor mainten the yap1tead2 complex act cooper e2f transcript factor activ cell cycl dna replic program our studi corrobor evid human pdac model portend novel mechan escap oncogen kras addict pdac',\n",
       "  'ArticleTitle': 'Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.',\n",
       "  'Author': 'Kapoor Avnish'},\n",
       " {'Abstract': ' limit access profus sequenc inform deriv cancer patient worldwid stymi basic research clinic decis effort underway streamlin safeguard data',\n",
       "  'ArticleTitle': 'Getting Data Sharing Right to Help Fulfill the Promise of Cancer Genomics.',\n",
       "  'Author': 'Savage Neil'},\n",
       " {'Abstract': ' metastas main caus cancer death mechan under metastat progress remain poor understood we isol pure popul cancer cell primari tumor metastas genet engin mous model human small cell lung cancer sclc mechan drive metastat spread lethal cancer genomewid character chromatin access reveal open larg number distal regulatori element genom metastat progress these chang correl copi number amplif nfib locus differenti access site high enrich nfib transcript factor bind site nfib necessari suffici increas chromatin access larg subset intergen region nfib promot prometastat neuron gene express program drive metastat abil sclc cell the identif widespread chromatin chang sclc progress reveal unexpect global reprogram metastat progress',\n",
       "  'ArticleTitle': 'Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.',\n",
       "  'Author': 'Denny Sarah K'},\n",
       " {'Abstract': ' muscl wast cachexia long postul key determin cancerrel death direct experiment evid substanti hypothesi here cancer cachexia model pharmacolog blockad actriib pathway prevent muscl wast complet revers prior loss skelet muscl cancerinduc cardiac atrophi this treatment dramat prolong surviv even anim tumor growth inhibit fat loss product proinflammatori cytokin reduc actriib pathway blockad abolish activ ubiquitinproteasom system induct atrophyspecif ubiquitin ligas muscl mark stimul muscl stem cell growth these find establish crucial link activ actriib pathway develop cancer cachexia thus actriib antagon promis new approach treat cancer cachexia inhibit se prolong surviv',\n",
       "  'ArticleTitle': 'Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.',\n",
       "  'Author': 'Zhou Xiaolan'},\n",
       " {'Abstract': ' dnademethyl agent clinic antitumor efficaci unknown mechan action use combin experiment bioinformat analys colorect cancer cell demonstr lowdos 5azacdr target colorect canceriniti cell cic induc viral mimicri this associ induct dsrnas deriv least part endogen retrovir element activ mda5mav rna recognit pathway downstream activ irf7 inde disrupt virus recognit pathway individu knock mda5 mav irf7 inhibit abil 5azacdr target colorect cic decreas 5azacdr longterm growth effect moreov transfect dsrna cic mimic effect 5azacdr togeth result repres major shift understand antitumor mechan dnademethyl agent highlight mda5mavsirf7 pathway potenti druggabl target cic',\n",
       "  'ArticleTitle': 'DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.',\n",
       "  'Author': 'Roulois David'},\n",
       " {'Abstract': ' medulloblastoma common pediatr malign brain tumor although current therapi improv surviv regimen high toxic associ signific morbid here report placent growth factor plgf express major medulloblastoma independ subtyp moreov high express plgf receptor neuropilin 1 nrp1 correl poor surviv patient we demonstr plgf nrp1 requir growth spread medulloblastoma plgfnrp1 blockad result direct antitumor effect vivo result medulloblastoma regress decreas metastasi increas mous surviv we reveal plgf produc cerebellar stroma tumorderiv sonic hedgehog shh plgf act nrp1and vascular endotheli growth factor receptor 1to promot tumor cell surviv this critic tumorstroma interactionmedi shh plgf nrp1 medulloblastoma subtypessupport develop therapi target plgfnrp1 pathway',\n",
       "  'ArticleTitle': 'Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.',\n",
       "  'Author': 'Snuderl Matija'},\n",
       " {'Abstract': ' genet screen identifi atyp tetraspanin tm4sf1 strong mediat metastat reactiv breast cancer intrigu tm4sf1 coupl collagen receptor tyrosin kinas ddr1 cortic adaptor syntenin 2 pkc the kinas phosphoryl activ jak2 lead activ stat3 this noncanon mechan signal induc express sox2 nanog sustain manifest cancer stem cell trait drive metastat reactiv lung bone brain bioinformat analys patholog studi corrobor clinic relev find we conclud noncanon ddr1 signal enabl breast cancer cell exploit ubiquit interstiti matrix compon collagen i undergo metastat reactiv multipl target organ',\n",
       "  'ArticleTitle': 'Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.',\n",
       "  'Author': 'Gao Hua'},\n",
       " {'Abstract': ' while numer cellintrins process known play decis role chemotherapeut respons relat littl known impact tumor microenviron therapeut outcom here wellestablish mous model burkitt lymphoma paracrin factor tumor microenviron modul lymphoma cell surviv follow administr genotox chemotherapi specif il6 timp1 releas thymus respons dna damag creat chemoresist nich promot surviv minim residu tumor burden serv reservoir eventu tumor relaps notabl il6 releas acut thymic endotheli cell p38depend manner follow genotox stress acut secretori respons preced gradual induct senesc tumorassoci stromal cell thus convent chemotherapi induc tumor regress simultan elicit stress respons protect subset tumor cell select anatom locat drug action',\n",
       "  'ArticleTitle': 'DNA damage-mediated induction of a chemoresistant niche.',\n",
       "  'Author': 'Gilbert Luke A'},\n",
       " {'Abstract': ' what chang need occur primari tumor metastat denni al address question small cell lung cancer sclc find chang genom access mediat singl transcript factor nfib compris least one mechan influenc metastasi',\n",
       "  'ArticleTitle': 'Opening a Chromatin Gate to Metastasis.',\n",
       "  'Author': 'Minna John D'},\n",
       " {'Abstract': ' the center medic technolog polici molecular evid develop consortium gather divers group 50 stakehold develop consensus core set data element valu essenti understand clinic util molecular target therapi oncolog',\n",
       "  'ArticleTitle': 'Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.',\n",
       "  'Author': 'Conley Robert B'},\n",
       " {'Abstract': ' carcinoma typic invad cohes multicellular unit process term collect invas it remain unclear differ subpopul cancer cell contribut process we develop threedimension 3d organoid assay identifi invas cancer cell primari breast tumor collect invas led special cancer cell defin express basal epitheli gene cytokeratin14 k14 p63 furthermor k14 cell led collect invas major human breast cancer subtyp import lumin cancer cell observ convert phenotyp invas leader follow induct basal epitheli gene although minor cell lumin tumor express basal epitheli gene knockdown k14 p63 suffici block collect invas our data reveal heterotyp interact epitheli subpopul critic collect invas we suggest target basal invas program limit metastat progress',\n",
       "  'ArticleTitle': 'Collective invasion in breast cancer requires a conserved basal epithelial program.',\n",
       "  'Author': 'Cheung Kevin J'},\n",
       " {'Abstract': ' the later ventricl lv preferenti locat brain tumor spread instruct cue respons uniqu tropism unknown in issu qin al elucid under mechan demonstr lvneural progenitor secret pleiotrophin ptncontain complex attract glioma cell rockrho activ',\n",
       "  'ArticleTitle': 'The Tropism of Pleiotrophin: Orchestrating Glioma Brain Invasion.',\n",
       "  'Author': 'Gutmann David H'},\n",
       " {'Abstract': ' allel loss essenti autophagi gene beclin1 occur human cancer render mice tumorpron suggest autophagi tumorsuppress mechan while tumor cell util autophagi surviv metabol stress autophagi mitig result cellular damag limit tumorigenesi in respons stress autophagydefect tumor cell preferenti accumul p62sqstm1 p62 endoplasm reticulum er chaperon damag mitochondria reactiv oxygen speci ros genom damag moreov suppress ros p62 accumul prevent damag result autophagi defect indic failur regul p62 caus oxid stress import sustain p62 express result autophagi defect suffici alter nfkappab regul gene express promot tumorigenesi thus defect autophagi mechan p62 upregul common observ human tumor contribut direct tumorigenesi like perturb signal transduct adaptor function p62control pathway critic oncogenesi',\n",
       "  'ArticleTitle': 'Autophagy suppresses tumorigenesis through elimination of p62.',\n",
       "  'Author': 'Mathew Robin'},\n",
       " {'Abstract': ' signal protein drive prolifer stem progenitor cell encod protooncogen ephb receptor repres rare except promot cell prolifer intestin epithelium function tumor suppressor control cell migrat inhibit invas growth we cell migrat prolifer control independ receptor ephb2 ephb2 regul cell posit kinaseindepend mediat phosphatidylinositol 3kinas ephb2 tyrosin kinas activ regul cell prolifer ablcyclin d1 pathway cyclin d1 regul uncoupl ephb signal progress adenoma colon carcinoma human allow continu prolifer invas growth the dissoci ephb2 signal pathway enabl select inhibit mitogen effect affect tumor suppressor function identifi pharmacolog strategi suppress adenoma growth',\n",
       "  'ArticleTitle': 'Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.',\n",
       "  'Author': 'Genander Maria'},\n",
       " {'Abstract': ' cancer believ accumul genet mutat although induc pluripot stem cell ipsc generat requir chang genom sequenc ipsc acquir unlimit growth potenti characterist share cancer cell here describ murin system reprogram factor express vivo control tempor doxycyclin dox notabl transient express reprogram factor vivo result tumor develop tissu consist undifferenti dysplast cell exhibit global chang dna methyl pattern the doxwithdrawn tumor aris kidney share number characterist wilm tumor common pediatr kidney cancer we demonstr ipsc deriv doxwithdrawn kidney tumor cell rise nonneoplast kidney cell mice prove undergon irrevers genet transform these find suggest epigenet regul associ ipsc deriv drive develop particular type cancer',\n",
       "  'ArticleTitle': 'Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation.',\n",
       "  'Author': 'Ohnishi Kotaro'},\n",
       " {'Abstract': ' most malign tumor disrupt p53 signal pathway order grow surviv although gene addit p53 mutat tumor recent studi ventura al 2007 xue al 2007 suggest restor p53 function suffici caus regress differ tumor type mice repres potent therapeut strategi treat certain human cancer martin al 2006 demonstr restor p53 activ result tumor regress add sober caveat tumor abl generat resist find way disrupt p53 pathway',\n",
       "  'ArticleTitle': \"Wild-type p53: tumors can't stand it.\",\n",
       "  'Author': 'Kastan Michael B'},\n",
       " {'Abstract': ' tissu stem cell contribut tissu regener wound repair cellular program hijack cancer cell here phenomenon skin homeostasi stem cell epidermi hair follicl fuel respect tissu we breakdown stem cell lineag confinementgr privileg associ fatesi hallmark function cancer develop we lineag plastic critic wound repair oper transient redirect fate investig mechan irrespect cellular origin lineag infidel occur wound stressrespons enhanc activ overrid homeostat enhanc govern lineag specif in cancer stressrespons transcript factor level rise caus lineag command reach excess when lineag stress factor collabor activ oncogen enhanc distinguish cancer wound',\n",
       "  'ArticleTitle': 'Stem Cell Lineage Infidelity Drives Wound Repair and Cancer.',\n",
       "  'Author': 'Ge Yejing'},\n",
       " {'Abstract': ' retinoblastoma result inactiv rb1 gene loss rb protein cell rb suppress retinoblastoma circuitri under need rb undefin here retinoblastoma cell express marker postmitot cone precursor marker retin cell type we demonstr human cone precursor promin express mdm2 nmyc retinoblastoma cell requir protein prolifer surviv mdm2 need suppress arfinduc apoptosi cultur retinoblastoma cell interest retinoblastoma cell mdm2 express regul conespecif rxrgamma transcript factor humanspecif rxrgamma consensus bind site prolifer requir rxrgamma well conespecif thyroid hormon receptorbeta2 these find provid support cone precursor origin retinoblastoma suggest human conespecif signal circuitri sensit oncogen effect rb1 mutat',\n",
       "  'ArticleTitle': 'Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.',\n",
       "  'Author': 'Xu Xiaoliang L'},\n",
       " {'Abstract': ' toward develop precis medicin framework metastat castrationresist prostat cancer mcrpc establish multiinstitut clinic sequenc infrastructur conduct prospect wholeexom transcriptom sequenc bone soft tissu tumor biopsi cohort 150 mcrpc affect individu aberr ar et gene tp53 pten frequent 4060 case tp53 ar alter enrich mcrpc compar primari prostat cancer we identifi new genom alter pik3cab rspondin brafraf1 apc catenin zbtb16plzf moreov aberr brca2 brca1 atm observ higher frequenc 193 compar primari prostat cancer 89 affect individu harbor clinic action aberr includ 627 aberr ar 65 cancerrel gene 8 action pathogen germlin alter this cohort studi provid clinic action inform impact treatment decis affect individu',\n",
       "  'ArticleTitle': 'Integrative clinical genomics of advanced prostate cancer.',\n",
       "  'Author': 'Robinson Dan'},\n",
       " {'Abstract': ' the pml gene involv t1517 chromosom transloc acut promyelocyt leukemia apl encod protein local pmlnuclear bodi subnuclear macromolecular structur pml control apoptosi cell prolifer senesc here review current understand role tumor suppress',\n",
       "  'ArticleTitle': 'The role of PML in tumor suppression.',\n",
       "  'Author': 'Salomoni Paolo'},\n",
       " {'Abstract': ' largescal genom studi identifi multipl somat aberr breast cancer includ copi number alter point mutat still identifi causal variant emerg vulner consequ genet alter remain major challeng we perform wholegenom small hairpin rna shrna dropout screen 77 breast cancer cell line use hierarch linear regress algorithm score screen result integr accompani detail genet proteom inform identifi vulner breast cancer includ candid driver reveal general function genom properti cancer cell comparison gene essenti drug sensit data suggest potenti resist mechan effect exist anticanc drug opportun combin therapi final demonstr util larg dataset identifi brd4 potenti target lumin breast cancer pik3ca mutat resist determin betinhibitor',\n",
       "  'ArticleTitle': 'Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.',\n",
       "  'Author': 'Marcotte Richard'},\n",
       " {'Abstract': ' the hallmark cancer compris six biolog capabl acquir multistep develop human tumor the hallmark constitut organ principl ration complex neoplast diseas they includ sustain prolif signal evad growth suppressor resist cell death enabl replic immort induc angiogenesi activ invas metastasi under hallmark genom instabl generat genet divers expedit acquisit inflamm foster multipl hallmark function conceptu progress decad ad two emerg hallmark potenti general listreprogram energi metabol evad immun destruct in addit cancer cell tumor exhibit dimens complex contain repertoir recruit ostens normal cell contribut acquisit hallmark trait creat tumor microenviron recognit widespread applic concept increas affect develop new mean treat human cancer',\n",
       "  'ArticleTitle': 'Hallmarks of cancer: the next generation.',\n",
       "  'Author': 'Hanahan Douglas'},\n",
       " {'Abstract': ' tgfbeta ligand act tumor suppressor earli stage tumor paradox divert potent prometastat factor advanc cancer the molecular natur switch remain enigmat here tgfbetadepend cell migrat invas metastasi empow mutantp53 oppos p63 mechanist tgfbeta act concert oncogen ras mutantp53 induc assembl mutantp53p63 protein complex smad serv essenti platform within ternari complex p63 function antagon downstream p63 identifi two candid metastasi suppressor gene associ metastasi risk larg cohort breast cancer patient thus two common oncogen lesion mutantp53 ras select earli neoplasm promot growth surviv prefigur cellular setup particular metastasi procliv tgfbetadepend inhibit p63 function',\n",
       "  'ArticleTitle': 'A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.',\n",
       "  'Author': 'Adorno Maddalena'},\n",
       " {'Abstract': ' cell celebr power reductionist molecular biolog major success four decad those particip cancer research period wit wild fluctuat time endless inexplic phenomenolog reign suprem period reductionist triumphal recent year move back confront endless complex diseas',\n",
       "  'ArticleTitle': 'Coming full circle-from endless complexity to simplicity and back again.',\n",
       "  'Author': 'Weinberg Robert A'},\n",
       " {'Abstract': ' a dichotom choic metazoan cell prolifer differenti measur trna pool cell type two distinct subset one induc prolifer cell repress opposit signatur correspond gene serv cellautonom function gene involv multicellular obey distinct codon usag proliferationinduc differentiationinduc trnas carri anticodon correspond codon enrich cellautonom multicellular gene respect becaus mrnas cellautonom gene induc prolifer cancer particular concomit induct codonenrich trnas suggest coordin transcript translat histon modif chang similar vicin cellautonom gene correspond trnas multicellular gene trnas suggest exist transcript program coordin trna suppli demand henc describ exist two distinct translat program oper prolifer differenti',\n",
       "  'ArticleTitle': 'A dual program for translation regulation in cellular proliferation and differentiation.',\n",
       "  'Author': 'Gingold Hila'},\n",
       " {'Abstract': ' the transcript factor hif1a key mediat cellular respons hypoxia despit hif1a homeostasi patholog littl known regul rna polymeras ii rnapii we report hif1a employ specif variant mediat complex stimul rnapii elong the mediatorassoci kinas cdk8 paralog cdk19 requir induct hif1a target gene hif1a induc bind cdk8mediat super elong complex sec contain aff4 cdk9 allevi rnapii paus cdk8 dispens hif1a chromatin bind histon acetyl essenti bind sec rnapii elong global analysi activ rnapii reveal hypoxiainduc gene paus activ prior induct our result provid mechanist link hif1a cdk8 two potent oncogen cellular respons hypoxia',\n",
       "  'ArticleTitle': 'HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.',\n",
       "  'Author': 'Galbraith Matthew D'},\n",
       " {'Abstract': ' accumul evid implic heterogen cancer cell popul respons stress exposur includ drug treatment while model acut respons anticanc agent drugsensit human tumor cell line consist detect small subpopul revers drugtoler cell these cell demonstr 100fold reduc drug sensit maintain viabil engag igf1 receptor signal alter chromatin state requir histon demethylas rbp2kdm5ajarid1a this drugtoler phenotyp transient acquir relinquish low frequenc individu cell popul implic dynam regul phenotyp heterogen drug toler the drugtoler subpopul select ablat treatment igf1 receptor inhibitor chromatinmodifi agent potenti yield therapeut opportun togeth find suggest cancer cell popul employ dynam surviv strategi individu cell transient revers drugtoler state protect popul erad potenti lethal exposur',\n",
       "  'ArticleTitle': 'A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.',\n",
       "  'Author': 'Sharma Sreenath V'},\n",
       " {'Abstract': ' contextspecif molecular vulner tumor evolut repres attract intervent target class howev frequenc divers somat lesion detect lung tumor confound effort identifi target to confront challeng appli parallel screen chemic genet perturb panel molecular annot nsclc line identifi intervent opportun tight link molecular respons indic predict target sensit anchor analysi match tumornorm cell model lung adenocarcinoma patient identifi three distinct targetresponseind pair repres signific frequenc 616 patient popul these includ nlrp3 mutationinflammasom activationdepend flip addict cooccur kras lkb1 mutationdriven copi addict select sensit synthet indolotriazin specifi sevengen express signatur target efficaci valid vivo mechanismofact studi inform generaliz principl underpin cancer cell biolog',\n",
       "  'ArticleTitle': 'Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.',\n",
       "  'Author': 'Kim Hyun Seok'},\n",
       " {'Abstract': ' molecular chaperon member heat shock protein 90 hsp90 famili thought promot tumor cell surviv function well understood here mitochondria tumor cell normal tissu contain hsp90 relat molecul trap1 these chaperon interact cyclophilin d immunophilin induc mitochondri cell death antagon function protein foldingrefold mechan disabl pathway novel hsp90 atpas antagonist direct mitochondria caus sudden collaps mitochondri function select tumor cell death therefor hsp90direct chaperon regul mitochondri integr organellespecif antagonist provid undescrib class potent anticanc agent',\n",
       "  'ArticleTitle': 'Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.',\n",
       "  'Author': 'Kang Byoung Heon'},\n",
       " {'Abstract': ' glioblastoma brain metastas high prolif brain tumor short surviv time previous 13cnmr analysi brain tumor resect patient infus 13cglucos demonstr robust oxid glucos citric acid cycl glucos contribut less 50 carbon acetylcoa pool here primari metastat mous orthotop brain tumor capac oxid 1213cacet simultan oxid 1613cglucos the tumor oxid u13cglutamin in vivo oxid 1213cacet valid brain tumor patient correl express acetylcoa synthetas enzym 2 acss2 togeth data demonstr strike common metabol phenotyp divers brain tumor includ abil oxid acet citric acid cycl this adapt meet high biosynthet bioenerget demand malign growth',\n",
       "  'ArticleTitle': 'Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.',\n",
       "  'Author': 'Mashimo Tomoyuki'},\n",
       " {'Abstract': ' tripleneg breast cancer aggress malign respond poor treatment now sun al 2011 activ protein tyrosin phosphatas ptpn12 lost larg percentag breast cancer subtyp offer molecular driver possibl therapeut target heterogen intract cancer',\n",
       "  'ArticleTitle': 'Uncovering a tumor suppressor for triple-negative breast cancers.',\n",
       "  'Author': 'Albeck John G'},\n",
       " {'Abstract': ' fibroblast constitut major stromal cell breast carcinoma function contribut cell tumorigenesi poor understood use coimplant tumor xenograft model demonstr carcinomaassoci fibroblast caf extract human breast carcinoma promot growth admix breast carcinoma cell normal mammari fibroblast deriv patient the caf exhibit trait myofibroblast play central role promot growth tumor cell abil secret stromal cellderiv factor 1 sdf1 caf promot angiogenesi recruit endotheli progenitor cell epc carcinoma effect mediat part sdf1 cafsecret sdf1 stimul tumor growth direct act cognat receptor cxcr4 express carcinoma cell our find indic fibroblast invas breast carcinoma contribut tumor promot larg part secret sdf1',\n",
       "  'ArticleTitle': 'Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.',\n",
       "  'Author': 'Orimo Akira'},\n",
       " {'Abstract': ' cell communic environ part cell surfac receptor engin receptor sens arbitrari input provid output orthogon endogen signal pathway challeng now lim colleagu report system base synthet notch receptor allow independ control input output divers cell type',\n",
       "  'ArticleTitle': 'A Receptor for All Occasions.',\n",
       "  'Author': 'Irvine Darrell J'},\n",
       " {'Abstract': ' stabil local p53 essenti tumor suppressor function ubiquitin e3 ubiquitin ligas mdm2 major regulatori mechan p53 induc p53 nuclear export degrad howev unclear ubiquitin cytoplasm p53 recycl here report usp10 cytoplasm ubiquitinspecif proteas deubiquitin p53 revers mdm2induc p53 nuclear export degrad after dna damag usp10 stabil fraction usp10 transloc nucleus activ p53 the transloc stabil usp10 regul atm mediat phosphoryl usp10 thr42 ser337 final usp10 suppress tumor cell growth cell wildtyp p53 usp10 express downregul high percentag clear cell carcinoma known p53 mutat these find reveal usp10 novel regul p53 provid altern mechan p53 inhibit cancer wildtyp p53',\n",
       "  'ArticleTitle': 'USP10 regulates p53 localization and stability by deubiquitinating p53.',\n",
       "  'Author': 'Yuan Jian'},\n",
       " {'Abstract': ' genom instabl defin higher normal rate mutat doubleedg sword as sourc genet divers natur select mutat benefici evolut on hand genom instabl catastroph consequ agerel diseas cancer mutat inactiv dna repair pathway repaircompet background genotox stress celluar process transcript replic overwhelm highfidel dna repair here review recent studi shed light endogen sourc mutat epigenom featur promot genom instabl cancer evolut',\n",
       "  'ArticleTitle': 'Endogenous DNA Damage as a Source of Genomic Instability in Cancer.',\n",
       "  'Author': 'Tubbs Anthony'},\n",
       " {'Abstract': ' the spiral cost new drug mandat fundament differ approach lifesav therapi afford cancer patient we call format new relationship academ drug discoveri center commerci partner acceler develop truli transform drug sustain price',\n",
       "  'ArticleTitle': 'How Much Longer Will We Put Up With $100,000 Cancer Drugs?',\n",
       "  'Author': 'Workman Paul'},\n",
       " {'Abstract': ' understand tumor cell invad tissu key develop drug block metastasi in issu muller al 2009 report mutant form tumor suppressor p53 cancer cell boost endocyt recycl adhes molecul integrin alpha5beta1 epiderm growth factor receptor promot invas metastasi',\n",
       "  'ArticleTitle': 'Integrins and mutant p53 on the road to metastasis.',\n",
       "  'Author': 'Selivanova Galina'},\n",
       " {'Abstract': ' cell migrat confin 3d tissu microenviron critic normal physiolog function dissemin tumor cell we discov cytoskelet structur prevent damag nucleus migrat confin microenviron the forminfamili actin filament nucleat fmn2 associ generat perinuclear actinfoc adhes fa system distinct character actinfa structur this system control nuclear shape posit cell migrat 2d surfac in confin 3d microenviron fmn2 promot cell surviv limit nuclear envelop damag dna doublestrand break we fmn2 upregul human melanoma disrupt fmn2 mous melanoma cell inhibit extravas metastasi lung our result indic critic role fmn2 generat perinuclear actinfa system protect nucleus dna damag promot cell surviv confin migrat promot cancer metastasi',\n",
       "  'ArticleTitle': 'FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis.',\n",
       "  'Author': 'Skau Colleen T'},\n",
       " {'Abstract': ' mutat process constant shape somat genom lead immun age cancer diseas when cancer outcom afford glimps process clonal expans malign cell here character less explor layer mutat landscap cancer mutat asymmetri two dna strand analyz wholegenom sequenc 590 tumor 14 differ cancer type reveal widespread asymmetri mutagen process transcript tclass asymmetri domin uv smoke livercancerassoci mutat replic rclass asymmetri domin pole apobec msiassoci mutat we report strike phenomenon transcriptioncoupl damag tcd nontranscrib dna strand provid evid apobec mutagenesi occur laggingstrand templat dna replic as genom sequenc studi classifi asymmetri illumin under biolog mechan dna damag repair',\n",
       "  'ArticleTitle': 'Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.',\n",
       "  'Author': 'Haradhvala Nicholas J'},\n",
       " {'Abstract': ' the wnt signal transduct cascad main regul develop anim kingdom wnts key driver type tissu stem cell adult mammal unsurpris mutat wnt pathway compon causat multipl growthrel patholog cancer here describ core wntcatenin signal pathway control stem cell contribut diseas final discuss strategi wntbase therapi',\n",
       "  'ArticleTitle': u'Wnt/\\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.',\n",
       "  'Author': 'Nusse Roel'},\n",
       " {'Abstract': ' glioblastoma stem cell gscs implic tumor neovascular invas therapeut resist to illumin mechan govern hallmark featur develop novo glioblastoma multiform gbm model deriv immort human neural stemprogenitor cell hnscs enabl precis systemlevel comparison premalign oncogeneinduc malign state nscs integr transcriptom epigenom analys uncov pax6dlx5 transcript program drive wnt5amedi gsc differenti endotheliallik cell gdec gdec recruit exist endotheli cell promot peritumor satellit lesion serv nich support growth invas glioma cell away primari tumor clinic data reveal higher wnt5a gdec express peritumor recurr gbms relat match intratumor primari gbms respect support wnt5amedi gsc differenti invas growth diseas recurr thus pax6dlx5wnt5a axi govern diffus spread glioma cell brain parenchyma contribut lethal gbm',\n",
       "  'ArticleTitle': 'Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.',\n",
       "  'Author': 'Hu Baoli'},\n",
       " {'Abstract': ' kras one frequent mutat oncogen human cancer despit substanti effort clinic strategi develop effect treat krasmut tumor here perform celllinebas screen identifi strong synergist interact cellcycl checkpointabrog chk1 mk2 inhibitor kras brafdriven cell mechanist krasmut cancer display intrins genotox stress lead tonic chk1 mk2 activ we demonstr simultan chk1 mk2 inhibit lead mitot catastroph krasmut cell this action synergist interact valid xenograft model well distinct kras brafdriven autochthon murin cancer model last combin checkpoint inhibit induc apoptot cell death kras brafmut tumor cell direct isol patient these result recommend simultan chk1 mk2 inhibit therapeut strategi treatment kras brafdriven cancer',\n",
       "  'ArticleTitle': 'A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.',\n",
       "  'Author': 'Dietlein Felix'},\n",
       " {'Abstract': ' drug deliveri schedul key factor efficaci cancer therapi mathemat model popul dynam treatment respons appli identifi better drug administr regim well provid mechanist insight to capit promis approach cancer field meet challeng move work clinic',\n",
       "  'ArticleTitle': 'Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort.',\n",
       "  'Author': 'Michor Franziska'},\n",
       " {'Abstract': ' cellular senesc limit prolif capac damag cell act intrins mechan tumor suppress in issu wajapeye al 2008 identifi insulin growth factor bind protein 7 igfbp7 secret factor mediat senesc induc oncogen braf normal melanocyt in addit igfbp7 trigger apoptosi cell progress melanoma suggest new approach melanoma treatment',\n",
       "  'ArticleTitle': 'Secreting tumor suppression.',\n",
       "  'Author': 'Chien Yuchen'},\n",
       " {'Abstract': ' it establish bcl11b specifi t cell fate here develop t cell bcl11b enhanc reposit lamina nuclear interior our search factor reloc bcl11b enhanc identifi noncod rna name thymod thymocyt differenti factor thymoddefici mice display block onset t cell develop develop lymphoid malign we thymod transcript promot demethyl ctcf bound site activ cohesindepend loop reposit bcl11b enhanc lamina nuclear interior juxtapos bcl11b enhanc promot singleloop domain these largescal chang nuclear architectur associ deposit activ epigenet mark loop domain plausibl facilit phase separ these data indic development progress tumor suppress noncod transcript orchestr chromatin fold compartment direct high precis enhancerpromot communic',\n",
       "  'ArticleTitle': 'Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.',\n",
       "  'Author': 'Isoda Takeshi'},\n",
       " {'Abstract': ' pancreat cancer one lethal malign late diagnosi limit respons treatment tractabl method identifi interrog pathway involv pancreat tumorigenesi urgent need we establish organoid model normal neoplast murin human pancrea tissu pancreat organoid rapid generat resect tumor biopsi surviv cryopreserv exhibit ductal diseasestagespecif characterist orthotop transplant neoplast organoid recapitul full spectrum tumor develop form earlygrad neoplasm progress local invas metastat carcinoma due abil genet manipul organoid platform probe genet cooper comprehens transcript proteom analys murin pancreat organoid reveal gene pathway alter diseas progress the confirm protein chang human tissu demonstr organoid facil model system characterist dead malign',\n",
       "  'ArticleTitle': 'Organoid models of human and mouse ductal pancreatic cancer.',\n",
       "  'Author': 'Boj Sylvia F'},\n",
       " {'Abstract': ' nivolumab pembrolizumab monoclon antibodi block program death1 receptor pd1 cd279 result disinhibit tumorspecif immun respons both approv treatment metastat melanoma nivolumab well nonsmal cell lung cancer',\n",
       "  'ArticleTitle': 'PD-1 Blockers.',\n",
       "  'Author': 'Wolchok Jedd D'},\n",
       " {'Abstract': ' transfer rnas trnas view static contributor gene express by develop highthroughput trna profil method specif trnas upregul human breast cancer cell gain metastat activ through lossoffunct gainoffunct clinicalassoci studi implic trnagluuuc trnaargccg promot breast cancer metastasi upregul trnas enhanc stabil ribosom occup transcript enrich cognat codon specif trnagluuuc promot metastat progress direct enhanc exosc2 express enhanc gripap1constitut induc pathway driven trna the cellular proteom shift prometastat state mirror global trna shift allow cellstat celltyp transgen express optim codon content quantif trna modul repres mechan cell achiev alter express specif transcript protein trnas dynam regul gene express trna codon landscap causal impact diseas progress',\n",
       "  'ArticleTitle': 'Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression.',\n",
       "  'Author': 'Goodarzi Hani'},\n",
       " {'Abstract': ' dure past decad cancer drug develop shift focus cytotox chemotherapi drug target specif molecular alter tumor although drug dramat shrink tumor respons temporari research focus overcom drug resist frequent caus treatment failur here reflect analog challeng face research infecti diseas we contrast resist mechan aris cancer infecti diseas discuss approach overcom viral bacteri infect hiv tuberculosi instruct develop ration approach cancer therapi in particular maxim effect initi treatment respons requir synergist combin therapi foremost approach a remain challeng field identifi drug elimin drugtoler persist cell infecti diseas tumorinitiatingstem cell cancer prevent late relaps shorten treatment durat',\n",
       "  'ArticleTitle': 'Converting cancer therapies into cures: lessons from infectious diseases.',\n",
       "  'Author': 'Glickman Michael S'},\n",
       " {'Abstract': ' this year laskerdebakey clinic research award goe jame allison discov antibodi blockad t cell molecul ctla4 unleash bodi immun respons malign tumor this led develop multipl immun checkpoint therapi prolong save live thousand cancer patient',\n",
       "  'ArticleTitle': 'Releasing the Brakes on Cancer Immunotherapy.',\n",
       "  'Author': 'Littman Dan R'},\n",
       " {'Abstract': '', 'ArticleTitle': 'Checkpoints.', 'Author': 'Allison James P'},\n",
       " {'Abstract': ' recent work xenopus embryo reveal unexpect development role tumor suppressor gene p53 this find implic evolut p53 interact smad tgfbeta depend mesoderm specif cooper p53 famili member',\n",
       "  'ArticleTitle': 'p53 and TGF-beta in development: prelude to tumor suppression?',\n",
       "  'Author': 'Whitman Malcolm'},\n",
       " {'Abstract': ' downregul mir143145 microrna mirna cluster repeat report colon cancer epitheli tumor in addit overexpress mirna inhibit tumorigenesi lead broad consensus function cellautonom epitheli tumor suppressor we generat mice delet mir143145 function mirna intestin physiolog diseas vivo although intestin develop proceed absenc mirna epitheli regener injuri dramat impair surpris mir143145 express function exclus mesenchym compart intestin defect epitheli regener mir143145defici mice result dysfunct smooth muscl myofibroblast associ derepress mir143 target igfbp5 impair igf signal epitheli injuri these result provid insight regul epitheli wound heal argu cellautonom tumor suppressor role mir143145 colon cancer',\n",
       "  'ArticleTitle': 'An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration.',\n",
       "  'Author': 'Chivukula Raghu R'},\n",
       " {'Abstract': ' dure cell divis cell form microtubulebas mitot spindl high special dynam structur mediat proper chromosom transmiss daughter cell cancer cell perturb mitot spindl approach cancer treatment trigger cell kill target microtubul dynam spindl assembl to identifi character protein necessari spindl assembl potenti antimitot target perform proteom genet analysi 592 mitot microtubul copurifi protein mmcps screen regul affect mitosi apoptosi report identif character stard9 kinesin3 famili member local centrosom stabil pericentriolar materi pcm stard9deplet cell fragment pcm form multipolar spindl activ spindl assembl checkpoint sac arrest mitosi undergo apoptosi interest stard9deplet synerg chemotherapeut agent taxol increas mitot death demonstr stard9 mitot kinesin potenti antimitot target',\n",
       "  'ArticleTitle': 'The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly.',\n",
       "  'Author': 'Torres Jorge Z'},\n",
       " {'Abstract': ' for major patient pancrea cancer high metastat procliv life limit some patient succumb local destruct diseas a molecular understand distinct diseas manifest critic inform patient manag use genet engin mous model heterozyg mutat dpc4smad4 attenu metastat potenti krasg12dtrp53r172h pancreat ductal adenocarcinoma increas prolifer subsequ loss heterozygos dpc4 restor metastat compet unleash prolifer creat high lethal combin express level runx3 respond combin dpc4 status coordin regul balanc cancer cell divis dissemin thus runx3 serv tumor suppressor promot slow prolifer orchestr metastat program stimul cell migrat invas secret protein favor distant colon these find suggest model anticip like diseas behavior patient tailor treatment strategi',\n",
       "  'ArticleTitle': 'RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.',\n",
       "  'Author': 'Whittle Martin C'},\n",
       " {'Abstract': ' hierarch cell state model stemlik tumorpropag cell repopul tumor therapi invok cancer suv al demonstr plastic development hierarchi glioma cell popul character epigenet state phenotyp distinct cell identifi four factor suffici reprogram differenti cell tumorigen stemlik state',\n",
       "  'ArticleTitle': 'Connect four with glioblastoma stem cell factors.',\n",
       "  'Author': 'Gronych Jan'},\n",
       " {'Abstract': ' cancer driven somat acquir point mutat chromosom rearrang convent thought accumul gradual time use nextgener sequenc character phenomenon term chromothripsi ten hundr genom rearrang occur oneoff cellular crisi rearrang involv one chromosom crisscross back forth involv region generat frequent oscil two copi number state these genom hallmark high improb rearrang accumul time instead impli occur singl cellular catastroph the stamp chromothripsi least 23 cancer subtyp 25 bone cancer we one one cancercaus lesion emerg genom crisi this phenomenon implic origin genom remodel tempor emerg cancer',\n",
       "  'ArticleTitle': 'Massive genomic rearrangement acquired in a single catastrophic event during cancer development.',\n",
       "  'Author': 'Stephens Philip J'},\n",
       " {'Abstract': ' cancer stem cell cscs propos drive tumor initi progress yet understand cellular molecular mechan underli csc properti limit here activ taz transduc hippo pathway requir sustain selfrenew tumoriniti capac breast cscs taz protein level activ elev prospect cscs poor differenti human tumor prognost valu gain taz endow selfrenew capac noncsc in epitheli cell taz form complex cellpolar determin scribbl loss scribbleor induct epithelialmesenchym transit emtdisrupt inhibitori associ taz core hippo kinas mst lat this studi link csc concept hippo pathway breast cancer reveal mechanist basi control hippo kinas cell polar',\n",
       "  'ArticleTitle': 'The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.',\n",
       "  'Author': 'Cordenonsi Michelangelo'},\n",
       " {'Abstract': ' atr activ replic stress protect replic fork local suppress origin fire global here function atr mechanist coupl although initi stabl stall fork atrdefici cell undergo nucleuswid breakag unschedul origin fire generat excess singlestrand dna exhaust nuclear pool rpa partial reduct rpa acceler fork breakag forc elev rpa suffici delay replic catastroph even absenc atr activ convers unschedul origin fire induc breakag stall fork even cell activ atr thus atrmedi suppress dormant origin shield activ fork irrevers breakag prevent exhaust nuclear rpa this studi elucid replic genom avoid destabil dna damag becaus cancer cell common featur intrins high replic stress studi provid molecular rational hypersensit atr inhibitor',\n",
       "  'ArticleTitle': 'ATR prohibits replication catastrophe by preventing global exhaustion of RPA.',\n",
       "  'Author': 'Toledo Luis Ignacio'},\n",
       " {'Abstract': ' colon cancer frequent harbor kras mutat subset kras mutant colon cancer cell line depend kras signal surviv in screen kinas promot surviv krasdepend colon cancer cell tak1 kinas map3k7 requir tumor cell viabil the induct apoptosi rnaimedi deplet pharmacolog inhibit tak1 link suppress hyperactiv wnt signal evid endogen genet reconstitut cell in apc mutantkrasdepend cell kras stimul bmp7 secret bmp signal lead tak1 activ enhanc wntdepend transcript an vitroderiv tak1 depend signatur enrich primari human colon cancer mutat apc kras suggest potenti clinic util stratifi patient popul togeth find identifi tak1 inhibit potenti therapeut strategi treatmentrefractori subset colon cancer exhibit aberr kras wnt pathway activ',\n",
       "  'ArticleTitle': 'TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.',\n",
       "  'Author': 'Singh Anurag'},\n",
       " {'Abstract': ' activ neuron exert mitogen effect normal neural precursor oligodendrogli precursor cell putat cellular origin highgrad glioma hgg by optogenet control cortic neuron activ patientderiv pediatr glioblastoma xenograft model demonstr activ neuron similar promot hgg prolifer growth vivo condit medium optogenet stimul cortic slice promot prolifer pediatr adult patientderiv hgg cultur indic secret activityregul mitogen the synapt protein neuroligin3 nlgn3 identifi lead candid mitogen solubl nlgn3 suffici necessari promot robust hgg cell prolifer nlgn3 induc pi3kmtor pathway activ feedforward express nlgn3 glioma cell nlgn3 express level human hgg negat correl patient surviv these find indic role activ neuron brain tumor microenviron identifi secret nlgn3 unexpect mechan promot neuron activityregul cancer growth',\n",
       "  'ArticleTitle': 'Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.',\n",
       "  'Author': 'Venkatesh Humsa S'},\n",
       " {'Abstract': ' the circadian clock control metabol physiolog process fine tune molecular mechan the clock remark plastic adapt exogen zeitgeb light nutrit how patholog condit given tissu influenc system circadian homeostasi tissu remain unansw question conceptu biomed here lung adenocarcinoma oper endogen reorgan circadian metabol highthroughput transcriptom metabolom reveal uniqu signatur transcript metabolit cycl exclus liver tumorbear mice remark lung cancer effect core clock reprogram hepat metabol alter proinflammatori respons stat3socs3 pathway this result disrupt akt ampk srebp signal lead alter insulin glucos lipid metabol thus lung adenocarcinoma function potent endogen circadian organ eco rewir pathophysiolog dimens distal tissu liver paperclip',\n",
       "  'ArticleTitle': 'Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.',\n",
       "  'Author': 'Masri Selma'},\n",
       " {'Abstract': ' small cell lung carcinoma sclc high lethal smokingassoci cancer known target genet alter use genom sequenc character somat evolut genet engin mous model gemm sclc initi loss trp53 rb1 we identifi alter dna copi number complex genom rearrang demonstr low somat point mutat frequenc absenc tobacco mutagen alter target tumor suppressor pten occur major murin sclc engin pten delet acceler murin sclc abrog loss chr19 trp53 rb1 pten compound mutant tumor final evid polyclon sequenti metastat spread murin sclc compar sequenc famili relat primari tumor metastas we propos tempor model sclc tumorigenesi implic human sclc therapeut natur cancergenom evolut gemm',\n",
       "  'ArticleTitle': 'Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.',\n",
       "  'Author': 'McFadden David G'},\n",
       " {'Abstract': ' stroma tumor microenviron play critic role cancer progress promot metastasi poor understood exosom small vesicl secret cell type enabl potent mode intercellular communic here report fibroblastsecret exosom promot breast cancer cell bcc protrus activ motil wntplanar cell polar pcp signal we exosomestimul bcc protrus display mutual exclus local core pcp complex fzddvl vanglpk in orthotop mous model breast cancer coinject bccs fibroblast dramat enhanc metastasi depend pcp signal bccs exosom compon cd81 fibroblast moreov demonstr traffick bccs promot tether autocrin wnt11 fibroblastderiv exosom this work reveal intercellular communic pathway fibroblast exosom mobil autocrin wntpcp signal drive bcc invas behavior',\n",
       "  'ArticleTitle': 'Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.',\n",
       "  'Author': 'Luga Valbona'},\n",
       " {'Abstract': ' melanoma metastasi devast outcom lack effect prevent therapeut we provid pharmacolog molecular genet evid establish liverx nuclear hormon receptor lxr therapeut target melanoma oral administr multipl lxr agonist suppress melanoma invas angiogenesi tumor progress metastasi molecular genet experi reveal effect mediat lxr elicit outcom transcript induct tumor stromal apolipoprotein apo lxr agon robust suppress tumor growth metastasi divers mutat spectrum melanoma line lxr target prolong anim surviv suppress progress establish metastas inhibit brain metastat colon import lxr activ display melanomasuppress cooper frontlin regimen dacarbazin braf inhibit antictla4 antibodi robust inhibit melanoma acquir resist braf inhibit dacarbazin we promis therapeut approach uniqu act transcript activ metastasi suppressor gene',\n",
       "  'ArticleTitle': 'Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.',\n",
       "  'Author': 'Pencheva Nora'},\n",
       " {'Abstract': ' the abil p53 regul transcript crucial tumor suppress impli inherit polymorph function p53bind site influenc cancer here identifi polymorph p53 respons element demonstr influenc cancer risk genomewid data set cancer suscept loci genet variat p53 occup p53bind site we uncov singlenucleotid polymorph snp function p53bind site establish influenc abil p53 bind regul transcript kitlg gene the snp resid kitlg associ one largest risk identifi cancer genomewid associ studi we establish snp undergon posit select evolut signifi select benefit similar snps rare genom negat select indic polymorph p53bind site detriment human',\n",
       "  'ArticleTitle': 'A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.',\n",
       "  'Author': 'Zeron-Medina Jorge'},\n",
       " {'Abstract': ' carcinomaassoci fibroblast caf abund heterogen stromal cell tumor microenviron critic involv cancer progress here demonstr two cellsurfac molecul cd10 gpr77 defin caf subset correl chemoresist poor surviv multipl cohort breast lung cancer patient cd10',\n",
       "  'ArticleTitle': 'CD10',\n",
       "  'Author': 'Su Shicheng'},\n",
       " {'Abstract': ' although cancer immunotherapi lead durabl outcom percentag patient respond disrupt approach remain modest date encourag nanotechnolog enhanc efficaci immunostimulatori small molecul biolog alter coloc biodistribut releas kinet',\n",
       "  'ArticleTitle': 'Immunoengineering: how nanotechnology can enhance cancer immunotherapy.',\n",
       "  'Author': 'Goldberg Michael S'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Immunotherapy: The path to win the war on cancer?',\n",
       "  'Author': 'Topalian Suzanne L'},\n",
       " {'Abstract': ' recent find gene fusion carcinoma recapitul discoveri chromosom abnorm leukemia sarcoma decad ago a recur featur carcinoma gene fusion contrast hematopoiet mesenchym malign result aberr cell signal this reflect differ differenti program tissu',\n",
       "  'ArticleTitle': 'Commonality but diversity in cancer gene fusions.',\n",
       "  'Author': 'Rabbitts Terence H'},\n",
       " {'Abstract': ' tgf long consid protean cytokin cancer chang role anti protumorigen contextdepend manner in issu cell david al mous model pancreat cancer shed light mechanist basi tgfinduc emt coupl apoptosi tumor progress',\n",
       "  'ArticleTitle': 'EMT: Matter of Life or Death?',\n",
       "  'Author': 'Gupta Sonal'},\n",
       " {'Abstract': ' polycomb pcg trithorax trxg group protein evolutionarili conserv chromatinmodifi factor origin identifi part epigenet cellular memori system maintain repress activ gene express state recent global control plethora cellular process this function divers achiev abil regul chromatin multipl level rang modifi local chromatin structur orchestr threedimension organ genom understand system fascin challeng critic relev biolog medicin misexpress mutat multipl pcg compon well trxg member compass famili swisnf complex implic cancer diseas',\n",
       "  'ArticleTitle': 'Genome Regulation by Polycomb and Trithorax: 70 Years and Counting.',\n",
       "  'Author': 'Schuettengruber Bernd'},\n",
       " {'Abstract': ' michael n hall year recipi lasker basic medic research award identif target rapamycin tor tor master regul cell growth metabol state dysregul contribut varieti diseas includ diabet obes neurodegen disord age cancer make tor pathway attract therapeut target',\n",
       "  'ArticleTitle': 'TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease.',\n",
       "  'Author': 'Blenis John'},\n",
       " {'Abstract': ' sever human papillomavirus 16 hpv16 oncoprotein contribut cellular transform vitro in issu cell mirabello colleagu highthroughput sequenc data assess divers hpv16 isol human patient these data suggest e7 oncoprotein fundament contributor vivo carcinogenesi',\n",
       "  'ArticleTitle': 'Crowd Control: E7 Conservation Is the Key to Cancer.',\n",
       "  'Author': 'White Elizabeth A'},\n",
       " {'Abstract': ' prostat apoptosi response4 par4 proapoptot protein intracellular function cytoplasm nucleus unexpect par4 protein spontan secret normal cancer cell cultur par4 transgen mice resist spontan tumor short exposur endoplasm reticulum er stressinduc agent increas cellular secret par4 brefeldin asensit pathway secret occur independ caspas activ apoptosi interest extracellular par4 induc apoptosi bind stress respons protein glucoseregul protein78 grp78 express surfac cancer cell the interact extracellular par4 cell surfac grp78 led apoptosi er stress activ faddcaspase8caspase3 pathway moreov apoptosi induc trail exert cancer cellspecif effect depend extracellular par4 signal cell surfac grp78 thus par4 activ extrins pathway involv cell surfac grp78 receptor induct apoptosi',\n",
       "  'ArticleTitle': 'The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.',\n",
       "  'Author': 'Burikhanov Ravshan'},\n",
       " {'Abstract': ' we report comprehens analysi 412 muscleinvas bladder cancer character multipl tcga analyt platform fiftyeight gene mutat mutat load associ apobecsignatur mutagenesi cluster mutat signatur identifi highmut subset 75 5year surviv mrna express cluster refin prior cluster analys identifi poorsurviv neuron subtyp major tumor lack small cell neuroendocrin histolog cluster mrna long noncod rna lncrna mirna express converg identifi subset differenti epithelialmesenchym transit status carcinoma situ score histolog featur surviv our analys identifi 5 express subtyp stratifi respons differ treatment',\n",
       "  'ArticleTitle': 'Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.',\n",
       "  'Author': 'Robertson A Gordon'},\n",
       " {'Abstract': ' individu lifraumeni syndrom carri inherit mutat p53 tumor suppressor gene predispos tumor develop to examin mechanist natur p53 missens mutat generat mice harbor gtoa substitut nucleotid 515 p53 p53515a correspond p53r175h hot spot mutat human cancer although p53515a mice display similar tumor spectrum surviv curv p53 mice tumor p53515a mice metastas high frequenc correspond embryon fibroblast p53515a515a mutant mice display enhanc cell prolifer dna synthesi transform potenti the disrupt p63 p73 p53 cell increas transform capac reiniti dna synthesi level observ p53515a515a cell addit p63 p73 function inactiv p53515a cell these result provid vivo valid gainoffunct properti certain p53 missens mutat suggest mechanist basi phenotyp',\n",
       "  'ArticleTitle': 'Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.',\n",
       "  'Author': 'Lang Gene A'},\n",
       " {'Abstract': ' cellular senesc provid intrins barrier tumor develop prevent prolifer cell risk malign transform in issu krizhanovski al 2008 report senesc player tumor suppress respons liver tissu injuri',\n",
       "  'ArticleTitle': 'Senescence: not just for tumor suppression.',\n",
       "  'Author': 'Green Michael R'},\n",
       " {'Abstract': ' microsatellitessimpl tandem repeat million site human genomecan shorten lengthen defect dna mismatch repair we comprehens genomewid analysi preval mutat spectrum function consequ microsatellit instabl msi cancer genom we analyz msi 277 colorect endometri cancer genom includ 57 microsatelliteunst one exom wholegenom sequenc data recurr msi event code sequenc tumor specif elev frameshifttoinfram ratio lower transcript level wildtyp allel moreov genomewid analysi reveal differ distribut msi versus point mutat includ overrepresent msi euchromat intron region compar heterochromat intergen region respect deplet msi nucleosomeoccupi sequenc our result provid panoram view msi cancer genom highlight tumor specif impact gene express role chromatin organ',\n",
       "  'ArticleTitle': 'The landscape of microsatellite instability in colorectal and endometrial cancer genomes.',\n",
       "  'Author': 'Kim Tae-Min'},\n",
       " {'Abstract': ' cellular senesc fundament cell fate physiolog pathophysiolog process this snapshot focus role cellular senesc health diseas age',\n",
       "  'ArticleTitle': 'SnapShot: Cellular Senescence in Pathophysiology.',\n",
       "  'Author': u'Mart\\xednez-Zamudio Ricardo Iv\\xe1n'},\n",
       " {'Abstract': ' cellular senesc fundament cell fate play physiolog pathophysiolog role this snapshot focus major signal pathway transcript control mechan consolid senesc phenotyp',\n",
       "  'ArticleTitle': 'SnapShot: Cellular Senescence Pathways.',\n",
       "  'Author': u'Mart\\xednez-Zamudio Ricardo Iv\\xe1n'},\n",
       " {'Abstract': ' the tumorsuppressor protein brca1 thought act preserv genom integr in issu cell joukov al demonstr brca1bard1 heterodim particip mitot spindl assembl process conduct gtpase ran loss mitot function contribut tumorigenesi',\n",
       "  'ArticleTitle': 'A mitotic role for BRCA1/BARD1 in tumor suppression?',\n",
       "  'Author': 'Clarke Paul R'},\n",
       " {'Abstract': ' until idea observ life deep tissu live mous resolut suffici pick cellular behavior molecular signal under remain muchcovet dream now new era intravit fluoresc microscopi dawn in primer review technolog revolut possibl demonstr intravit imag begin provid quantit dynam insight cell biolog immunolog tumor biolog neurobiolog',\n",
       "  'ArticleTitle': 'Intravital imaging.',\n",
       "  'Author': 'Pittet Mikael J'},\n",
       " {'Abstract': ' hepatocellular carcinoma hcc slowli develop malign postul evolv premalign lesion chronic damag liver howev establish premalign lesion actual contain tumor progenitor rise cancer here describ isol character hcc progenitor cell hcpcs differ mous hcc model unlik fulli malign hcc hcpcs rise cancer introduc liver undergo chronic damag compensatori prolifer although hcpcs exhibit similar transcriptom profil bipotenti hepatobiliari progenitor rise tumor cell resembl hcpcs resid dysplast lesion appear month hcc nodul unlik earli hepatocarcinogenesi depend paracrin il6 product inflammatori cell upregul lin28 express hcpcs acquir autocrin il6 signal stimul vivo growth malign progress this general mechan drive il6produc malign',\n",
       "  'ArticleTitle': 'Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.',\n",
       "  'Author': 'He Guobin'},\n",
       " {'Abstract': ' ras protein binari switch cycl on off state signal transduct these switch tight control rasrel diseas cancer rasopathi psychiatr disord mutat ras gene regul render ras protein persist activ the structur basi switch pathway ras control well known precis mechan ras protein function less clear all ras biolog occur membran precis understand ras interact membran essenti understand ras action interven rasdriven diseas',\n",
       "  'ArticleTitle': 'RAS Proteins and Their Regulators in Human Disease.',\n",
       "  'Author': 'Simanshu Dhirendra K'},\n",
       " {'Abstract': ' telomer crisi occur tumorigenesi deplet telomer reserv lead frequent telomer fusion the result dicentr chromosom propos drive genom instabl here examin fate dicentr human chromosom telomer crisi we observ dicentr chromosom invari persist mitosi develop 50200 m chromatin bridg connect daughter cell befor resolut 320 anaphas chromatin bridg induc nuclear envelop ruptur interphas accumul cytoplasm 3 nucleas trex1 develop rpacoat singl strand ss dna crispr knockout trex1 contribut generat ssdna resolut chromatin bridg postcrisi clone chromothripsi kataegi presum result dna repair apobec edit fragment chromatin bridg dna we propos chromothripsi human cancer trex1medi fragment dicentr chromosom form telomer crisi',\n",
       "  'ArticleTitle': 'Chromothripsis and Kataegis Induced by Telomere Crisis.',\n",
       "  'Author': 'Maciejowski John'},\n",
       " {'Abstract': ' glioblastoma gbms common malign primari brain tumor aggress treat surgeri chemotherapi radiotherapi despit treatment recurr inevit surviv improv minim 50 year recent studi suggest gbms exhibit heterogen instabl differenti state vari sensit state radiat here employ iter combin theoret experiment strategi take account tumor cellular heterogen dynam acquir radioresist predict effect differ radiat schedul use model identifi two deliveri schedul predict improv efficaci take advantag dynam instabl radioresist these schedul led superior surviv mice our interdisciplinari approach human cancer type treat radiotherapi lay foundat increas effect mainstay oncolog therapi paperclip',\n",
       "  'ArticleTitle': 'Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules.',\n",
       "  'Author': 'Leder Kevin'},\n",
       " {'Abstract': ' in issu cell murgia al 2006 confirm infecti agent canin transmiss vener tumor cancer cell tumor clonal origin their find implic understand relationship genom instabl transmiss cancer conserv biolog canin genom companion anim medicin',\n",
       "  'ArticleTitle': 'The singular history of a canine transmissible tumor.',\n",
       "  'Author': 'VonHoldt Bridgett M'},\n",
       " {'Abstract': ' two decad studi multipl model organ establish hippo pathway key regul organ size tissu homeostasi by inhibit yap taz transcript coactiv hippo pathway regul cell prolifer apoptosi stem respons wide rang extracellular intracellular signal includ cellcel contact cell polar mechan cue ligand gproteincoupl receptor cellular energi status dysregul hippo pathway exert signific impact cancer develop further investig function regulatori mechan pathway help uncov mysteri organ size control identifi new target cancer treatment',\n",
       "  'ArticleTitle': 'Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.',\n",
       "  'Author': 'Yu Fa-Xing'},\n",
       " {'Abstract': ' in order establish distal site metastat cancer cell need acquir organspecif trait zhang al provid evid breast cancer tumor cell acquisit properti success bone metastasi influenc signal stroma primari tumor',\n",
       "  'ArticleTitle': \"Breast cancer bone metastases: it's all about the neighborhood.\",\n",
       "  'Author': 'Guise Theresa A'},\n",
       " {'Abstract': ' cancer cell acquir patholog phenotyp accumul mutat perturb signal network howev global analysi event current limit here identifi six type networkattack mutat nam includ chang kinas sh2 modul network rewir genesi extinct phosphoryl site we develop comput platform rekinect identifi nam systemat interpret exom quantit phosphoproteom five ovarian cancer cell line global cancer genom repositori we identifi experiment valid nam includ pkc m501i pkd1 d665n encod specif switch analog appear kinas novo kinom we mutant molecular logic gate drift phosphothreonin signal weaken phosphoryl motif kinaseinactiv hotspot cancer our method pinpoint function nam scale complex cancer genom cell signal enhanc capabl therapeut target tumorspecif network',\n",
       "  'ArticleTitle': 'Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.',\n",
       "  'Author': 'Creixell Pau'},\n",
       " {'Abstract': ' the abil reliabl reproduc measur protein human proteom tissu cell transform understand systemslevel properti well specif pathway physiolog diseas here describ generat verif compendium high specif assay enabl quantif 997 20277 annot human protein wide access sensit robust target mass spectrometr method select reaction monitor srm this human srmatla provid definit coordin conclus identifi respect peptid biolog sampl we report data 166174 proteotyp peptid provid multipl independ assay quantifi human protein numer splice variant nonsynonym mutat posttransl modif the data freeli access resourc httpwwwsrmatlasorg demonstr util examin network respons inhibit cholesterol synthesi liver cell docetaxel prostat cancer line',\n",
       "  'ArticleTitle': 'Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome.',\n",
       "  'Author': 'Kusebauch Ulrike'},\n",
       " {'Abstract': ' tumor cell metastas distant organ genet epigenet alter includ chang microrna mir express here mir22 trigger epithelialmesenchym transit emt enhanc invas promot metastasi mous xenograft in condit mammari glandspecif transgen tg mous model mir22 enhanc mammari gland sidebranch expand stem cell compart promot tumor develop critic mir22 promot aggress metastat diseas mmtvmir22 tg mice well compound mmtvneu pyvtmir22 tg mice we demonstr mir22 exert metastat potenti silenc antimetastat mir200 direct target tet ten eleven transloc famili methylcytosin dioxygenas inhibit demethyl mir200 promot final mir22 overexpress correl poor clinic outcom silenc tetmir200 axi patient taken find implic mir22 crucial epigenet modifi promot emt breast cancer stem metastasi',\n",
       "  'ArticleTitle': 'MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.',\n",
       "  'Author': 'Song Su Jung'},\n",
       " {'Abstract': ' akt kinas play central role cell growth metabol tumorigenesi the traf6 e3 ligas orchestr igf1medi akt ubiquitin activ here akt ubiquitin induc activ erbb receptor unexpect contrast igf1 induc activ skp2 scf complex traf6 critic e3 ligas erbbreceptormedi akt ubiquitin membran recruit respons egf skp2 defici impair akt activ glut1 express glucos uptak glycolysi breast cancer progress tumor model moreov skp2 overexpress correl akt activ breast cancer metastasi serv marker poor prognosi her2posit patient final skp2 silenc sensit her2overexpress tumor herceptin treatment our studi suggest distinct e3 ligas util divers growth factor akt activ target glycolysi sensit her2posit tumor herceptin treatment',\n",
       "  'ArticleTitle': 'The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.',\n",
       "  'Author': 'Chan Chia-Hsin'},\n",
       " {'Abstract': ' heat shock factor 1 hsf1 master regul heat shock respons eukaryot high conserv protect mechan hsf1 function increas surviv great pathophysiolog condit how involv malign remain larg unexplor we report elimin hsf1 protect mice tumor induc mutat ras oncogen hot spot mutat tumor suppressor p53 in cell cultur hsf1 support malign transform orchestr network core cellular function includ prolifer surviv protein synthesi glucos metabol the strike effect hsf1 oncogen transform limit mous system tumor initi human cancer line divers origin greater depend hsf1 function maintain prolifer surviv nontransform counterpart while enhanc organism surviv longev circumst hsf1 opposit effect support lethal phenomenon cancer',\n",
       "  'ArticleTitle': 'Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.',\n",
       "  'Author': 'Dai Chengkai'},\n",
       " {'Abstract': ' identif driver mutat human diseas limit cohort size avail appropri statist model we propos framework systemat discoveri genet alter causal determin diseas priorit gene upstream function diseas driver regulatori network infer novo experiment data we test framework identifi genet determin mesenchym subtyp glioblastoma our analysi uncov klhl9 delet upstream activ two establish master regul subtyp cebp cebp rescu klhl9 express induc proteasom degrad cebp protein abrog mesenchym signatur reduc tumor viabil vitro vivo delet klhl9 confirm 50 mesenchym case independ cohort repres frequent genet determin subtyp the method general studi human diseas includ breast cancer alzheim diseas',\n",
       "  'ArticleTitle': 'Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.',\n",
       "  'Author': 'Chen James C'},\n",
       " {'Abstract': ' the mechanist target rapamycin mtor coordin eukaryot cell growth metabol environment input includ nutrient growth factor extens research past two decad establish central role mtor regul fundament cell process protein synthesi autophagi deregul mtor signal implic progress cancer diabet well age process here review recent advanc understand mtor function regul mammalian physiolog we highlight mtor signal network contribut human diseas discuss current futur prospect therapeut target mtor clinic',\n",
       "  'ArticleTitle': 'mTOR Signaling in Growth, Metabolism, and Disease.',\n",
       "  'Author': 'Saxton Robert A'},\n",
       " {'Abstract': ' superenhanc emerg subclass regulatori region control cell ident diseas gene howev biolog function impact mirna network unclear here report superenhanc drive biogenesi master mirna crucial cell ident enhanc transcript droshadgcr8medi primari mirna primirna process superenhanc broad h3k4me3 domain shape tissuespecif evolutionarili conserv atlas mirna express function crisprcas9 genom reveal superenhanc constitu act cooper facilit droshadgcr8 recruit primirna process boost cellspecif mirna product the betbromodomain inhibitor jq1 preferenti inhibit superenhancerdirect cotranscript primirna process furthermor superenhanc character pervas interact dgcr8drosha dgcr8drosharegul mrna stabil control suggest uniqu rna regul superenhanc final superenhanc mark multipl mirna associ cancer hallmark this studi present principl under mirna biolog health diseas unrecogn higherord properti superenhanc rna process transcript',\n",
       "  'ArticleTitle': 'Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.',\n",
       "  'Author': 'Suzuki Hiroshi I'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': u'Chris Marshall (1949\\u20132015).',\n",
       "  'Author': 'Rigby Peter W J'},\n",
       " {'Abstract': ' signific advanc develop novel therapeut cancer treatment target therapi revolution treatment cancer despit promis five percent new cancer drug approv fail lack efficaci the indic current preclin method limit predict success outcom such failur exact enorm cost financi qualiti human life this primer explor current status promis challeng preclin evalu advanc mous cancer model briefli address emerg model earlystag preclin develop',\n",
       "  'ArticleTitle': 'Preclinical mouse cancer models: a maze of opportunities and challenges.',\n",
       "  'Author': 'Day Chi-Ping'},\n",
       " {'Abstract': ' nonsmal cell lung cancer nsclc frequent caus cancer death worldwid half contain mutat receptor tyrosin kinasera pathway here raspathway mutant nsclc cell transcript factor gata2 loss gata2 reduc viabil nsclc cell raspathway mutat wildtyp cell unaffect integr gene express genom occup analys reveal gata2 regul proteasom il1sign rhosign pathway these pathway function signific reactiv rescu viabil gata2 deplet in krasdriven nsclc mous model gata2 loss dramat reduc tumor develop furthermor gata2 delet establish kras mutant tumor induc strike regress although gata2 like undrugg combin suppress gata2regul pathway clinic approv inhibitor caus mark tumor clearanc discoveri nononcogen addict kras mutant lung cancer gata2 present network druggabl pathway therapeut exploit',\n",
       "  'ArticleTitle': 'The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.',\n",
       "  'Author': 'Kumar Madhu S'},\n",
       " {'Abstract': ' nonapoptot form cell death facilit select elimin tumor cell activ specif patholog state the oncogen rasselect lethal small molecul erastin trigger uniqu irondepend form nonapoptot cell death term ferroptosi ferroptosi depend intracellular iron metal morpholog biochem genet distinct apoptosi necrosi autophagi we identifi small molecul ferrostatin1 potent inhibitor ferroptosi cancer cell glutamateinduc cell death organotyp rat brain slice suggest similar two process inde erastin glutam inhibit cystin uptak cystineglutam antiport system xc creat void antioxid defens cell ultim lead irondepend oxid death thus activ ferroptosi result nonapoptot destruct certain cancer cell inhibit process protect organ neurodegener',\n",
       "  'ArticleTitle': 'Ferroptosis: an iron-dependent form of nonapoptotic cell death.',\n",
       "  'Author': 'Dixon Scott J'},\n",
       " {'Abstract': ' skp2 e3 ligas overexpress numer human cancer play critic role cellcycl progress senesc metabol cancer progress metastasi in studi identifi specif skp2 inhibitor highthroughput silico screen larg divers chemic librari this skp2 inhibitor select suppress skp2 e3 ligas activ activ scf complex it phenocopi effect observ genet skp2 defici suppress surviv aktmedi glycolysi trigger p53independ cellular senesc strike discov critic function skp2 posit regul cancer stem cell popul selfrenew abil genet pharmacolog approach notabl skp2 inhibitor exhibit potent antitumor activ multipl anim model cooper chemotherapeut agent reduc cancer cell surviv our studi provid pharmacolog evid skp2 promis target restrict cancer stem cell cancer progress',\n",
       "  'ArticleTitle': 'Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.',\n",
       "  'Author': 'Chan Chia-Hsin'},\n",
       " {'Abstract': ' largescal transcriptom sequenc effort vast expand catalog long noncod rnas lncrnas vari evolutionari conserv lineag express cancer specif here function character novel ultraconserv lncrna thor ensg00000226856 exhibit express exclus testi broad rang human cancer thor knockdown overexpress multipl cell line anim model alter cell tumor growth support oncogen role we discov conserv interact thor igf2bp1 thor contribut mrna stabil activ igf2bp1 notabl transgen thor knockout produc fertil defect zebrafish confer resist melanoma onset likewis ectop express human thor zebrafish acceler onset melanoma thor repres novel class function cancertesti lncrnas structur function undergon posit evolutionari select',\n",
       "  'ArticleTitle': 'Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.',\n",
       "  'Author': 'Hosono Yasuyuki'},\n",
       " {'Abstract': ' although dna damag agent revolution chemotherapi solid tumor narrow therapeut window combin sever side effect limit broader here rad001 everolimus rapamycin deriv dramat enhanc cisplatininduc apoptosi wildtyp p53 mutant p53 tumor cell the isogen tumor cell line express wildtyp mtor cdna mutant bind rad001 demonstr effect rad001 inhibit mtor function we rad001 sensit cell cisplatin inhibit p53induc p21 express unexpect effect attribut small signific inhibit p21 translat combin short halflif these find provid molecular rational combin dna damag agent rad001 show general effect major anabol process dramat enhanc efficaci establish drug protocol treatment cancer patient solid tumor',\n",
       "  'ArticleTitle': 'The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.',\n",
       "  'Author': 'Beuvink Iwan'},\n",
       " {'Abstract': ' the cancer genom atlas tcga catalyz systemat character divers genom alter under human cancer at histor junction mark complet genom character 11000 tumor 33 cancer type current understand molecular process govern oncogenesi we illustr insight cancer synthesi find tcga pancanc atlas project three facet oncogenesi 1 somat driver mutat germlin pathogen variant interact tumor 2 influenc tumor genom epigenom transcriptom proteom 3 relationship tumor microenviron includ implic drug target driver event immunotherapi these result anchor futur character rare common tumor type primari relaps tumor cancer ancestri group guid deploy clinic genom sequenc',\n",
       "  'ArticleTitle': 'Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.',\n",
       "  'Author': 'Ding Li'},\n",
       " {'Abstract': ' in mous intestin tumor induc inhibit apc restor apc function caus complet tumor regress normal differenti return stem cell function irrespect tumor carri mutat kras p53 these find dow al valid wnt pathway exquisit target intervent',\n",
       "  'ArticleTitle': 'Wnt Down, Tumors Wind Up?',\n",
       "  'Author': 'Krimpenfort Paul'},\n",
       " {'Abstract': ' the myc oncoprotein thought stimul tumor cell growth prolifer amplif gene transcript mechan thwart effort inhibit myc function potenti cancer therapi use coval inhibitor cyclindepend kinas 7 cdk7 disrupt transcript amplifi mycn neuroblastoma cell demonstr downregul oncoprotein consequ massiv suppress mycndriven global transcript amplif this respons translat signific tumor regress mous model highrisk neuroblastoma introduct system toxic the strike treatment select mycnoverexpress cell correl preferenti downregul superenhancerassoci gene includ mycn known oncogen driver neuroblastoma these result indic cdk7 inhibit select target mechan promot global transcript amplif tumor cell use therapi cancer driven myc famili oncoprotein',\n",
       "  'ArticleTitle': 'CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.',\n",
       "  'Author': 'Chipumuro Edmond'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: MicroRNAs in Cancer.',\n",
       "  'Author': 'Spizzo Riccardo'},\n",
       " {'Abstract': ' in perspect synthes past observ field epigenet propos model epigenom modul cellular plastic develop diseas regul effect nois in model epigenom facilit phase transit develop reprogram mediat canal abil produc consist phenotyp outcom despit challeng variabl condit cell fate commit after ground argument discuss stochast nois nongenet heterogen explor hypothesi distinct chromatin domain known dysregul diseas remodel develop underli cellular plastic general we modern portray waddington epigenet landscap mathemat formal we specul new framework impact approach diseas mechan in particular help explain observ variabl dna methyl gene express increas cancer contribut tumor cell heterogen',\n",
       "  'ArticleTitle': 'Regulated noise in the epigenetic landscape of development and disease.',\n",
       "  'Author': 'Pujadas Elisabet'},\n",
       " {'Abstract': ' in issu cell wu al employ c elegan human cell experi identifi pathway metformin increas lifespan inhibit growth a key transcript target acad10 activ metformin induc nuclear exclus gtpase ragc inhibit mtorc1 unexpect mechan',\n",
       "  'ArticleTitle': 'Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging.',\n",
       "  'Author': u'Castillo-Quan Jorge Iv\\xe1n'},\n",
       " {'Abstract': ' the immun system microbiota mutual interact maintain homeostasi intestin howev compon microbiota alter balanc promot chronic inflamm promot intestin tumor develop we review recent advanc understand complex interact microbiota innat adapt immun system discuss potenti lead new direct understand cancer biolog treatment',\n",
       "  'ArticleTitle': 'The fire within: microbes inflame tumors.',\n",
       "  'Author': 'Gagliani Nicola'},\n",
       " {'Abstract': ' inflammatori respons play decis role differ stage tumor develop includ initi promot malign convers invas metastasi inflamm affect immun surveil respons therapi immun cell infiltr tumor engag extens dynam crosstalk cancer cell molecular event mediat dialog reveal this review outlin princip mechan govern effect inflamm immun tumor develop discuss attract new target cancer therapi prevent',\n",
       "  'ArticleTitle': 'Immunity, inflammation, and cancer.',\n",
       "  'Author': 'Grivennikov Sergei I'},\n",
       " {'Abstract': ' attempt treat cancer drug target mutat protein met mix success by screen compound alter phenotyp glioblastoma cellsan aggress brain tumorkitambi al identifi potenti new treatment diseas shed light unusu cell death mechan',\n",
       "  'ArticleTitle': 'Driving glioblastoma to drink.',\n",
       "  'Author': 'Gilbertson Richard J'},\n",
       " {'Abstract': ' the period2 gene play key role control circadian rhythm mice we report mice defici mper2 gene cancer prone after gamma radiat mice mark increas tumor develop reduc apoptosi thymocyt the core circadian gene induc gamma radiat wildtyp mice mper2 mutant mice tempor express gene involv cell cycl regul tumor suppress cyclin d1 cyclin a mdm2 gadd45alpha deregul mper2 mutant mice in particular transcript cmyc control direct circadian regul deregul mper2 mutant our studi suggest mper2 gene function tumor suppress regul dna damagerespons pathway',\n",
       "  'ArticleTitle': 'The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.',\n",
       "  'Author': 'Fu Loning'},\n",
       " {'Abstract': ' regulatori t cell treg play pivot role inhibit antitumor immun respons understand mechan govern treg homeostasi develop effect tumor immunotherapi we demonstr key role canon nuclear factor b nfb subunit p65 crel treg ident function in report nfb crel ablat impair generat mainten activ treg atreg subset known enrich site tumor use mous model demonstr melanoma growth drastic reduc mice lack crel p65 treg moreov chemic inhibit crel function delay melanoma growth impair atregmedi immunosuppress potenti effect antipd1 immunotherapi our studi establish inhibit nfb crel viabl therapeut approach enhanc checkpointtarget immunotherapi protocol',\n",
       "  'ArticleTitle': u'NF-\\u03baB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer.',\n",
       "  'Author': 'Grinberg-Bleyer Yenkel'},\n",
       " {'Abstract': ' alter transcript regul orchestr oncogen gene express program cancer here brg1brmassoci factor baf chromatin remodel complex mutat 20 human tumor interact ewsr1 member famili protein prionlik domain prld frequent partner oncogen fusion transcript factor in ewe sarcoma baf complex recruit ewsfli1 fusion protein tumorspecif enhanc contribut target gene activ this process neomorph properti ewsfli1 compar wildtyp fli1 depend tyrosin residu necessari phase transit ewsr1 prionlik domain furthermor fusion short fragment ewsr1 fli1 suffici recapitul baf complex retarget ewsfli1 activ our studi demonstr physic properti prionlik domain retarget critic chromatin regulatori complex establish maintain oncogen gene express program',\n",
       "  'ArticleTitle': 'Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain.',\n",
       "  'Author': 'Boulay Gaylor'},\n",
       " {'Abstract': ' epidemiolog studi indic overweight obes associ increas cancer risk to studi obes augment cancer risk develop focus hepatocellular carcinoma hcc common form liver cancer occurr progress affect obes cancer we demonstr dietari genet obes potent bona fide liver tumor promot mice obesitypromot hcc develop depend enhanc product tumorpromot cytokin il6 tnf caus hepat inflamm activ oncogen transcript factor stat3 the chronic inflammatori respons caus obes enhanc product il6 tnf increas risk cancer',\n",
       "  'ArticleTitle': 'Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.',\n",
       "  'Author': 'Park Eek Joong'},\n",
       " {'Abstract': ' microrna mirna regul key biolog process aberr express lead cancer the primari transcript canon mirna sequenti cleav rnase iii enzym drosha dicer generat 5 monophosph end subsequ mirna function in particular recognit 5 monophosph premirna dicer precis effect biogenesi mirna here identifi rnamethyltransferas bcdin3d omethyl 5 monophosph negat regul mirna matur specif bcdin3d phosphodimethyl premir145 vitro vivo phosphodimethyl premir145 display reduc process dicer vitro consist bcdin3d deplet lead lower premir145 concomit increas matur mir145 level breast cancer cell suppress tumorigen phenotyp togeth result uncov mirna methyl pathway potenti involv cancer antagon dicerdepend process mir145 well mirna',\n",
       "  'ArticleTitle': 'Human RNA methyltransferase BCDIN3D regulates microRNA processing.',\n",
       "  'Author': 'Xhemalce Blerta'},\n",
       " {'Abstract': ' p18 first identifi factor associ macromolecular trna synthetas complex here describ mous p18 lossoffunct phenotyp role p18 dna damag respons inactiv p18 allel caus embryon lethal heterozyg mice high suscept spontan tumor p18 induc transloc nucleus respons dna damag express p18 result elev p53 level p18 deplet block p53 induct p18 direct interact atmatr respons dna damag the activ atm depend level p18 suggest requir p18 activ atm low p18 express frequent observ differ human cancer cell line tissu these result suggest p18 haploinsuffici tumor suppressor key factor atmatrmedi p53 activ',\n",
       "  'ArticleTitle': 'The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.',\n",
       "  'Author': 'Park Bum-Joon'},\n",
       " {'Abstract': ' the phosphoinositid 3kinas pi3k pathway regul multipl step glucos metabol cytoskelet function cell movement attach here pi3k direct coordin glycolysi cytoskelet dynam aktindepend manner growth factor insulin stimul pi3kdepend activ rac lead disrupt actin cytoskeleton releas filament actinbound aldolas a increas aldolas activ consist pi3k inhibitor akt sgk mtor inhibitor caus signific decreas glycolysi step catalyz aldolas activ pik3ca mutat opposit effect these result point master regulatori function pi3k integr epitheli cell metabol form shape function coordin glycolysi energyintens dynam actin remodel',\n",
       "  'ArticleTitle': 'Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.',\n",
       "  'Author': 'Hu Hai'},\n",
       " {'Abstract': ' microrna mirna regul gene express by modul oncogen tumor suppressor pathway principl contribut tumorigenesi consist hypothesi recurr genet epigenet alter individu mirna tumor function studi elucid mechan action putat oncogen tumor suppressor mirna',\n",
       "  'ArticleTitle': 'MicroRNAs and cancer: short RNAs go a long way.',\n",
       "  'Author': 'Ventura Andrea'},\n",
       " {'Abstract': ' this snapshot illustr main concept under biolog therapeut vaccin cancer dendrit cell dcs essenti compon vaccin capac captur process antigen t cell we long way understand need elicit therapeut immun cancer escap natur barrier protect immun this progress enabl develop novel vaccin',\n",
       "  'ArticleTitle': 'SnapShot: cancer vaccines.',\n",
       "  'Author': 'Palucka Karolina'},\n",
       " {'Abstract': ' identifi driver gene cancer remain crucial bottleneck therapeut develop basic understand diseas we develop helio algorithm integr genom data primari tumor data function rnai screen pinpoint driver gene larg recurr amplifi region dna appli helio breast cancer data identifi set candid driver high enrich known driver p 1014 nine ten topscor helio gene known driver breast cancer vitro valid 12 candid predict helio ten confer enhanc anchorageindepend growth demonstr helioss exquisit sensit specif we extens character rsf1 driver identifi helio amplif correl poor prognosi increas tumorigenesi metastasi mous model we demonstr power approach identifi driver gene yield insight cancer',\n",
       "  'ArticleTitle': 'Integration of genomic data enables selective discovery of breast cancer drivers.',\n",
       "  'Author': u'Sanchez-Garcia F\\xe9lix'},\n",
       " {'Abstract': ' systemat studi cancer genom explod recent year these studi reveal score new cancer gene includ process known causal target cancer the gene affect cell signal chromatin epigenom regul rna splice protein homeostasi metabol lineag matur still cancer genom infanc much work remain complet mutat catalog primari tumor natur histori cancer connect recurr genom alter alter pathway acquir cellular vulner inform guid develop applic therapi',\n",
       "  'ArticleTitle': 'Lessons from the cancer genome.',\n",
       "  'Author': 'Garraway Levi A'},\n",
       " {'Abstract': ' pancreat cancer lead caus cancerrel death larg metastat dissemin we investig pancreat cancer progress util mathemat framework metastasi format comprehens data 228 patient 101 autopsi we pancreat cancer growth initi exponenti after estim rate pancreat cancer growth dissemin determin patient like harbor metastas diagnosi predict number size distribut metastas well patient surviv these find valid independ databas final analyz effect differ treatment modal find therapi effici reduc growth rate cell earlier cours treatment appear superior upfront tumor resect these predict valid clinic our interdisciplinari approach provid insight dynam pancreat cancer metastasi identifi optimum therapeut intervent',\n",
       "  'ArticleTitle': 'Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.',\n",
       "  'Author': 'Haeno Hiroshi'},\n",
       " {'Abstract': ' nuclear receptor bind chromosom end altern lengthen telomer alt cancer cell maintain end homolog recombin instead telomeras marzec al demonstr alt cell nuclear receptor trigger distal chromatin associ mediat telomeretelomer recombin event drive chromosomeintern target telomer insert tti',\n",
       "  'ArticleTitle': 'ALT telomeres get together with nuclear receptors.',\n",
       "  'Author': 'Aeby Eric'},\n",
       " {'Abstract': ' ampactiv protein kinas ampk master sensor regul cellular energi status upon metabol stress ampk suppress anabol promot catabol process regain energi homeostasi cancer cell occasion suppress growthrestrict ampk pathway mutat upstream regulatori kinas here describ widespread mechan suppress ampk ubiquitin degrad cancerspecif magea36trim28 ubiquitin ligas magea3 magea6 high similar protein express male germlin frequent reactiv human cancer magea36 necessari cancer cell viabil suffici drive tumorigen properti noncancer cell screen target magea36trim28 reveal ubiquitin degrad ampk1 this lead inhibit autophagi activ mtor signal hypersensit ampk agonist metformin these find elucid germlin mechan common hijack cancer suppress ampk',\n",
       "  'ArticleTitle': 'Degradation of AMPK by a cancer-specific ubiquitin ligase.',\n",
       "  'Author': 'Pineda Carlos T'},\n",
       " {'Abstract': ' the breakagefusionbridg cycl classic mechan telomeredriven genom instabl dysfunct telomer fuse chromosom extrem creat dicentr chromosom eventu break mitosi here uncov distinct pathway telomeredriven genom instabl occur cell maintain telomer altern lengthen telomer mechan we cell telomer dna ad multipl discret site genom correspond region regul nr2cf transcript factor these protein drive local telomer dna addit recruit telomer chromatin this mechan name target telomer insert tti generat potenti common fragil site destabil genom we propos tti driven nr2cf protein contribut format complex karyotyp alt tumor',\n",
       "  'ArticleTitle': 'Nuclear-receptor-mediated telomere insertion leads to genome instability in ALT cancers.',\n",
       "  'Author': 'Marzec Paulina'},\n",
       " {'Abstract': ' tumorigenesi multistep process character myriad genet epigenet alter identifi causal perturb confer malign transform central goal cancer biolog here report rnaibas genet screen gene suppress transform human mammari epitheli cell we identifi gene implic prolif control epitheli cell function includ two establish tumor suppressor tgfbr2 pten in addit uncov unrecogn tumor suppressor role restnrsf transcript repressor neuron gene express arraycgh analysi identifi rest frequent target delet colorect cancer furthermor detect frameshift mutat rest gene colorect cancer cell encod domin act truncat capabl transform epitheli cell cell lack rest exhibit increas pi3k signal depend pathway transform phenotyp these result implic rest human tumor suppressor provid novel approach identifi candid gene suppress develop human cancer',\n",
       "  'ArticleTitle': 'A genetic screen for candidate tumor suppressors identifies REST.',\n",
       "  'Author': 'Westbrook Thomas F'},\n",
       " {'Abstract': ' the mechan molecular chaperon assist qualiti control cytosol protein poor understood analysi chaperon requir degrad misfold variant cytosol protein vhl tumor suppressor reveal distinct chaperon pathway mediat fold qualiti control while fold degrad vhl requir hsp70 chaperonin tric essenti fold dispens degrad convers chaperon hsp90 particip vhl fold requir maintain misfold vhl solubl essenti degrad the cochaperon hopsti1p particip vhl qualiti control direct triag decis bridg hsp70hsp90 interact our find distinct chaperon complex uniqu requir qualiti control provid evid activ specif chaperon particip triag decis suggest hierarchi chaperon interact control altern fate cytosol protein',\n",
       "  'ArticleTitle': 'Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways.',\n",
       "  'Author': 'McClellan Amie J'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': u'Alan Hall (1952\\u20132015).',\n",
       "  'Author': 'Ridley Anne'},\n",
       " {'Abstract': ' the pyruv kinas isoform pkm1 pkm2 altern splice product pkm2 gene pkm2 pkm1 alter glucos metabol cancer cell contribut tumorigenesi mechan explain known biochem activ we pkm2 gene transcript activ hypoxiainduc factor 1 hif1 pkm2 interact direct hif1 subunit promot transactiv hif1 target gene enhanc hif1 bind p300 recruit hypoxia respons element pkm1 fail regul hif1 activ interact pkm2 prolyl hydroxylas 3 phd3 enhanc pkm2 bind hif1 pkm2 coactiv function mass spectrometri antihydroxyprolin antibodi assay demonstr pkm2 hydroxyl proline403408 phd3 knockdown inhibit pkm2 coactiv function reduc glucos uptak lactat product increas o2 consumpt cancer cell thus pkm2 particip posit feedback loop promot hif1 transactiv reprogram glucos metabol cancer cell',\n",
       "  'ArticleTitle': 'Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.',\n",
       "  'Author': 'Luo Weibo'},\n",
       " {'Abstract': ' telomeras express repress somat cell observ stem cell high percentag human cancer hypothes contribut tumorigenesi mainten stem cell state to explor telomeras regul employ general genet screen identifi negat regul htert we discov three tumor suppressoroncogen pathway involv htert repress one mad1cmyc pathway implic htert regul the second sip1 transcript target tgfbeta pathway mediat tgfbeta regul repress htert the third tumor suppressor menin direct repressor htert deplet menin immort primari human fibroblast caus transform phenotyp coupl express sv40 larg small t antigen oncogen ras these studi suggest multipl tumor suppressoroncogen pathway coordin repress htert express impli telomeras reactiv human tumor oncogen mutat',\n",
       "  'ArticleTitle': 'Multiple tumor suppressor pathways negatively regulate telomerase.',\n",
       "  'Author': 'Lin Shiaw Yih'},\n",
       " {'Abstract': ' aberr skp2 signal implic drive event tumorigenesi although under molecular mechan remain elus cytoplasm skp2 correl aggress form breast prostat cancer here report skp2 acetyl p300 k68 k71 process antagon sirt3 deacetylas inactiv sirt3 lead elev skp2 acetyl lead increas skp2 stabil impair cdh1mediat proteolysi pathway as result skp2 oncogen function increas cell express acetylationmimet mutant display enhanc cellular prolifer tumorigenesi vivo moreov acetyl skp2 nuclear local signal nls promot cytoplasm retent cytoplasm skp2 enhanc cellular migrat ubiquitin destruct ecadherin thus studi identifi acetylationdepend regulatori mechan govern skp2 oncogen function provid insight cytoplasm skp2 control cellular migrat',\n",
       "  'ArticleTitle': 'Acetylation-dependent regulation of Skp2 function.',\n",
       "  'Author': 'Inuzuka Hiroyuki'},\n",
       " {'Abstract': ' cell sens respond properti microenviron affect cell morpholog protein level local gene express even nuclear integr tissu microstiff larg influenc extracellular matrix vari dramat organ use paramet clarifi organ wide rang cell molecular process genom chang cancer',\n",
       "  'ArticleTitle': 'SnapShot: Mechanosensing Matrix.',\n",
       "  'Author': 'Irianto Jerome'},\n",
       " {'Abstract': ' tripleneg breast cancer tnbc high aggress form breast cancer exhibit extrem high level genet complex relat uniform transcript program we postul tnbc high depend uninterrupt transcript key set gene gene express program except sensit inhibitor transcript util kinas inhibitor crisprcas9medi gene edit tripleneg hormon receptorposit breast cancer cell except depend cdk7 transcript cyclindepend kinas tnbc cell uniqu depend transcript cdk suffer apoptot cell death cdk7 inhibit an achill cluster tnbcspecif gene sensit cdk7 inhibit frequent associ superenhanc we conclud cdk7 mediat transcript addict vital cluster gene tnbc cdk7 inhibit use therapi challeng cancer',\n",
       "  'ArticleTitle': 'CDK7-dependent transcriptional addiction in triple-negative breast cancer.',\n",
       "  'Author': 'Wang Yubao'},\n",
       " {'Abstract': ' the pml protein induc senesc oncogen stress absenc promot cellular transform in issu cell scaglioni al 2006 phosphoryl pml ck2 kinas frequent activ human cancer promot pml degrad therefor pharmacolog inhibit ck2induc pml loss offset tumor establish',\n",
       "  'ArticleTitle': 'CK2 and PML: regulating the regulator.',\n",
       "  'Author': u'Lallemand-Breitenbach Val\\xe9rie'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'No positive selection for G allele in a p53 response element in Europeans.',\n",
       "  'Author': 'Kumar Sudhir'},\n",
       " {'Abstract': ' the occurr cognit disturb cns inflamm infect correl increas level cytokin tumor necrosi factor tnf to date specif mechan cytokin alter cognit circuit demonstr here local increas tnf hippocamp dentat gyrus activ astrocyt tnf receptor 1 tnfr1 turn trigger astrocyteneuron signal cascad result persist function modif hippocamp excitatori synaps astrocyt tnfr1 signal necessari hippocamp synapt alter contextu learningmemori impair observ experiment autoimmun enceph eae anim model multipl sclerosi ms this process contribut pathogenesi cognit disturb ms well cns condit accompani inflammatori state infect',\n",
       "  'ArticleTitle': u'Neuroinflammatory TNF\\u03b1 Impairs Memory via Astrocyte Signaling.',\n",
       "  'Author': 'Habbas Samia'},\n",
       " {'Abstract': ' cancer evolv dynam clonal expans supersed one driven shift select pressur mutat process disrupt cancer gene these process mark genom cancer life histori encrypt somat mutat we develop algorithm deciph narrat appli 21 breast cancer mutat process evolv cancer lifespan emerg late contribut extens genet variat subclon diversif promin mutat fraction tumor cell everi tumor domin subclon lineag repres 50 tumor cell minim expans subclon occur hundr thousand mutat accumul impli exist longliv quiescent cell lineag capabl substanti prolifer acquisit enabl genom chang expans domin subclon appreci mass repres final ratelimit step breast cancer develop trigger diagnosi',\n",
       "  'ArticleTitle': 'The life history of 21 breast cancers.',\n",
       "  'Author': 'Nik-Zainal Serena'},\n",
       " {'Abstract': ' mani cancer patient suffer metastat relaps year undergon radic surgeri earli cancer cell dissemin follow protract period dormanc potenti explain preval clinic behavior increas evid suggest metastasisiniti cell cancer stem cell revert function state infiltr target organ their entri dormanc subsequ reactiv govern intrins program contextu cue resembl regul selfrenew capabl adult stem cell in addit metastat cell undergo reactiv nurs special extracellular matrix nich support posit signal wnt notch attenu negat signal bmp in spite signific remain uncertainti find provid framework understand logic metastat dormanc reactiv open new avenu therapeut intervent',\n",
       "  'ArticleTitle': 'Mechanisms governing metastatic dormancy and reactivation.',\n",
       "  'Author': 'Giancotti Filippo G'},\n",
       " {'Abstract': ' we report result wholegenom transcriptom sequenc tumor adjac normal tissu sampl 17 patient nonsmal cell lung carcinoma nsclc we identifi 3726 point mutat 90 indel code sequenc averag mutat frequenc 10fold higher smoker neversmok novel alter gene involv chromatin modif dna repair pathway identifi dach1 cftr reln abcb5 hgf deep digit sequenc reveal divers clonal pattern neversmok smoker all valid efgr kras mutat founder clone suggest possibl role cancer initi analysi reveal 14 fusion includ ros1 alk well novel metabol enzym cellcycl jakstat pathway alter lung cancer perturb 54 gene potenti target current avail drug',\n",
       "  'ArticleTitle': 'Genomic landscape of non-small cell lung cancer in smokers and never-smokers.',\n",
       "  'Author': 'Govindan Ramaswamy'},\n",
       " {'Abstract': ' genotypedirect therapi hold great promis treatment cancer crosstalk signal pathway confound simpl genotypedrug respons relationship to deliv promis precis medicin coordin effort need comprehens inventori signal feedback circuit exist cancer cell',\n",
       "  'ArticleTitle': 'A missing link in genotype-directed cancer therapy.',\n",
       "  'Author': u'Bernards Ren\\xe9'},\n",
       " {'Abstract': ' while studi cultur cell led new insight biolog control greater understand human pathophysiolog requir develop experiment system permit analysi intercellular communic tissuetissu interact relev organ context human organsonchip offer potenti power new approach confront longstand problem',\n",
       "  'ArticleTitle': 'Reverse Engineering Human Pathophysiology with Organs-on-Chips.',\n",
       "  'Author': 'Ingber Donald E'},\n",
       " {'Abstract': ' tumor mainten reli continu activ driver oncogen ratelimit role high context depend oncogen kras mutat signatur event pancreat ductal adenocarcinoma pdac serv critic role tumor initi here induc krasg12ddriven pdac mous model establish advanc pdac remain strict depend krasg12d express transcriptom metabolom analys indic krasg12d serv vital role control tumor metabol stimul glucos uptak channel glucos intermedi hexosamin biosynthesi pentos phosphat pathway ppp these studi reveal oncogen kras promot ribos biogenesi unlik canon model demonstr krasg12d drive glycolysi intermedi nonoxid ppp decoupl ribos biogenesi nadpnadphmedi redox control togeth work provid vivo mechanist insight oncogen kras promot metabol reprogram nativ tumor illumin potenti metabol target exploit therapeut benefit pdac',\n",
       "  'ArticleTitle': 'Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.',\n",
       "  'Author': 'Ying Haoqiang'},\n",
       " {'Abstract': ' heatshock factor 1 hsf1 transcript factor activ proteotox stress coordin induct heatshock respons in issu dai al 2007 hsf1 potent modifi tumorigenesi requir tumor initi mainten varieti cancer model these find add hsf1 grow list nononcogen exploit cancer drug target',\n",
       "  'ArticleTitle': 'Non-oncogene addiction and the stress phenotype of cancer cells.',\n",
       "  'Author': 'Solimini Nicole L'},\n",
       " {'Abstract': ' p53 frequent target mutat human tumor mutant p53 protein activ contribut tumorigenesi we employ threedimension cultur model nonmalign breast epitheli cell form spheroid reminisc acinar structur vivo breast cancer cell display high disorgan morpholog we mutant p53 deplet suffici phenotyp revert breast cancer cell acinarlik morpholog genomewid express analysi identifi mevalon pathway upregul mutant p53 statin sterol biosynthesi intermedi reveal pathway necessari suffici phenotyp effect mutant p53 breast tissu architectur mutant p53 associ sterol gene promot least part srebp transcript factor final p53 mutat correl high express sterol biosynthesi gene human breast tumor these find implic mevalon pathway therapeut target tumor bear mutat p53',\n",
       "  'ArticleTitle': 'Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.',\n",
       "  'Author': 'Freed-Pastor William A'},\n",
       " {'Abstract': ' metastasi chemoresist cancer link phenomena molecular basi link unknown we uncov network paracrin signal carcinoma myeloid endotheli cell drive process breast cancer cancer cell overexpress cxcl1 2 transcript hyperactiv 4q21 amplif prime surviv metastat site cxcl12 attract cd11bgr1 myeloid cell tumor produc chemokin includ s100a89 enhanc cancer cell surviv although chemotherapeut agent kill cancer cell treatment trigger parallel stromal reaction lead tnf product endotheli stromal cell tnf nfkb heighten cxcl12 express cancer cell amplifi cxcl12s100a89 loop caus chemoresist cxcr2 blocker break cycl augment efficaci chemotherapi breast tumor metastasi this network endothelialcarcinomamyeloid signal interact provid mechan link chemoresist metastasi opportun intervent',\n",
       "  'ArticleTitle': 'A CXCL1 paracrine network links cancer chemoresistance and metastasis.',\n",
       "  'Author': 'Acharyya Swarnali'},\n",
       " {'Abstract': ' sixteen ovarian tumor otu famili deubiquitinas dub exist human member regul cellsign cascad sever otu dub report ubiquitin ub chain linkag specif comprehens analys miss under mechan linkag specif unclear use ub chain eight linkag type reveal human otu enzym linkag specif prefer one two defin subset linkag type includ unstudi atyp ub chain biochem analysi five crystal structur otu dub ub substrat reveal four mechan linkag specif addit ubbind domain ubiquitin sequenc substrat defin s1 s2 ubbind site otu domain enabl otu dub distinguish linkag type we introduc ub chain restrict analysi otu dub restrict enzym reveal linkag relat abund ub chain substrat',\n",
       "  'ArticleTitle': 'OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.',\n",
       "  'Author': 'Mevissen Tycho E T'},\n",
       " {'Abstract': ' retino acid ra induc prolifer arrest differenti apoptosi defect retino acid receptor rar signal implic cancer the human tumor antigen prame overexpress varieti cancer function remain unclear we identifi prame domin repressor rar signal prame bind rar presenc ra prevent ligandinduc receptor activ target gene transcript recruit polycomb protein prame rar target promot inhibit rainduc differenti growth arrest apoptosi convers knockdown prame express rna interfer raresist human melanoma restor rar signal reinstat sensit antiprolif effect ra vitro vivo our data suggest overexpress prame frequent observ human cancer confer growth surviv advantag antagon rar signal',\n",
       "  'ArticleTitle': 'The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.',\n",
       "  'Author': 'Epping Mirjam T'},\n",
       " {'Abstract': ' nucleosom posit vari cell type by deep sequenc cellfre dna cfdna isol circul blood plasma generat map genomewid vivo nucleosom occup short cfdna fragment harbor footprint transcript factor the cfdna nucleosom occup correl well nuclear architectur gene structur express observ cell suggest inform cell origin nucleosom space infer cfdna healthi individu correl epigenet featur lymphoid myeloid cell consist hematopoiet cell death normal sourc cfdna we build observ nucleosom footprint infer cell type contribut cfdna patholog state cancer sinc strategi reli genet differ distinguish contribut tissu enabl noninvas monitor broader set clinic condit current possibl',\n",
       "  'ArticleTitle': 'Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.',\n",
       "  'Author': 'Snyder Matthew W'},\n",
       " {'Abstract': ' acquir chromosom instabl copi number alter hallmark cancer enzym capabl promot sitespecif copi number chang identifi here demonstr h3k936me3 lysin demethylas kdm4ajmjd2a overexpress lead local copi gain 1q12 1q21 xq131 global chromosom instabl kdm4aamplifi tumor increas copi gain region 1q12h copi gain occur singl cell cycl requir s phase stabl regener cell divis site increas copi number rerepl increas kdm4a mcm dna polymeras occup suv39h1kmt1a hp1 overexpress suppress copi gain h3k9k36 methyl interfer promot gain our result demonstr overexpress chromatin modifi result sitespecif copi gain this begin establish copi number chang origin tumorigenesi demonstr transient overexpress specif chromatin modul promot event',\n",
       "  'ArticleTitle': 'KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.',\n",
       "  'Author': 'Black Joshua C'},\n",
       " {'Abstract': ' the epigenet regul dnatempl process intens 15 year dna methyl histon modif nucleosom remodel rnamedi target regul biolog process fundament genesi cancer here basic principl behind epigenet pathway highlight evid suggest misregul culmin cancer this inform promis clinic preclin result epigenet drug chromatin regul signifi time embrac central role epigenet cancer',\n",
       "  'ArticleTitle': 'Cancer epigenetics: from mechanism to therapy.',\n",
       "  'Author': 'Dawson Mark A'},\n",
       " {'Abstract': ' in vitro model human diseas feasibl induc pluripot stem cell ipsc technolog here establish patientderiv ipsc lifraumeni syndrom lfs famili investig role mutant p53 develop osteosarcoma os lfs ipscderiv osteoblast ob recapitul os featur includ defect osteoblast differenti well tumorigen abil systemat analys reveal express gene enrich lfsderiv ob correl decreas time tumor recurr poor patient surviv furthermor lfs ob exhibit impair upregul imprint gene h19 osteogenesi restor h19 express lfs ob facilit osteoblast differenti repress tumorigen potenti by integr human imprint gene network ign function genom analys h19 mediat suppress lfsassoci os ign compon decorin dcn in summari find demonstr feasibl studi inherit human cancer syndrom ipsc',\n",
       "  'ArticleTitle': 'Modeling familial cancer with induced pluripotent stem cells.',\n",
       "  'Author': 'Lee Dung-Fang'},\n",
       " {'Abstract': ' pseudogen transcript provid novel tier gene regul generat endogen sirna mirnabind site character pseudogen express remain confin anecdot observ analyt challeng pose extrem close sequenc similar counterpart code gene here describ systemat analysi pseudogen transcript rnaseq resourc 293 sampl repres 13 cancer normal tissu type observ surpris preval genomewid express pseudogen categor ubiquit express lineag andor cancer specif further explor diseas subtyp specif function select express pseudogen taken provid evid transcrib pseudogen signific contributor transcript landscap cell posit play signific role cellular differenti cancer progress light describ cerna network our work provid transcriptom resourc enabl highthroughput analys pseudogen express',\n",
       "  'ArticleTitle': 'Expressed pseudogenes in the transcriptional landscape of human cancers.',\n",
       "  'Author': 'Kalyana-Sundaram Shanker'},\n",
       " {'Abstract': ' cell run carbohydr glycan sequenc carbohydr conjug protein lipid arguabl abund structur divers class molecul natur recent advanc glycom reveal scope scale function role impact human diseas',\n",
       "  'ArticleTitle': 'Glycomics hits the big time.',\n",
       "  'Author': 'Hart Gerald W'},\n",
       " {'Abstract': ' fmrp fragil x mental retard protein rnabind protein mutat fmrp protein associ neurolog diseas number mrnabind target this snapshot present 40 bona fide fmrp target mrna bind protein regul robust report mammal diseas associ',\n",
       "  'ArticleTitle': 'SnapShot: FMRP mRNA targets and diseases.',\n",
       "  'Author': 'Pasciuto Emanuela'},\n",
       " {'Abstract': ' our find plgf cancer target antiplgf use anticanc treatment challeng bai al here advantag carcinogeninduc transgen tumor model well ocular neovascular report evid support origin find plgf promis target anticanc therapi we evid efficaci addit antiplgf antibodi abil phenocopi genet defici silenc plgf cancer ocular diseas antiplgf antibodi effect we provid addit evid specif antiplgf antibodi experi suggest antiplgf treatment effect tumor further plgf blockag inhibit vessel abnorm densiti certain tumor enhanc vegftarget inhibit ocular diseas our find warrant test antiplgf therapi',\n",
       "  'ArticleTitle': 'Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.',\n",
       "  'Author': 'Van de Veire Sara'},\n",
       " {'Abstract': ' car synthet receptor reprogram immun cell therapeut purpos they compris three canon domain antigen recognit t cell activ costimul the car cdna genet integr t cell genom autolog car t cell generat patient peripher blood t cell expand recipi elimin target tumor to view bench bedsid open download pdf',\n",
       "  'ArticleTitle': 'CD19 CAR T Cells.',\n",
       "  'Author': 'Sadelain Michel'},\n",
       " {'Abstract': ' the transform growth factor beta tgfbeta signal pathway key player metazoan biolog misregul result tumor develop the regulatori cytokin tgfbeta exert tumorsuppress effect cancer cell elud malign evolut yet paradox tgfbeta modul process cell invas immun regul microenviron modif cancer cell exploit advantag consequ output tgfbeta respons high contextu develop differ tissu cancer the mechanist basi clinic relev tgfbeta role cancer increas clear pave way better understand complex therapeut potenti pathway',\n",
       "  'ArticleTitle': 'TGFbeta in Cancer.',\n",
       "  'Author': u'Massagu\\xe9 Joan'},\n",
       " {'Abstract': ' germlin determin gene express tumor infrequ complex transcript regul caus somat acquir alter we perform express quantit trait locus eqtlbas analys multilevel inform provid the cancer genom atlas tcga of factor measur cisact eqtl account 12 total variat tumor gene express somat copynumb alter cpg methyl account 73 33 respect eqtl analys 15 report breast cancer risk loci result discoveri three variant associ transcript level fals discoveri rate fdr 01 our transbas analysi identifi addit three risk loci act esr1 myc klf4 these find provid comprehens pictur gene express determin breast cancer well insight under biolog breast cancer risk loci',\n",
       "  'ArticleTitle': 'Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.',\n",
       "  'Author': 'Li Qiyuan'},\n",
       " {'Abstract': ' tumor cell highenerget anabol need known adapt metabol abl surviv prolifer condit nutrient stress we pkc defici promot plastic necessari cancer cell reprogram metabol util glutamin serin biosynthet pathway absenc glucos pkc repress express two key enzym pathway phgdh psat1 phosphoryl phgdh key residu inhibit enzymat activ interest loss pkc mice result enhanc intestin tumorigenesi increas level two metabol enzym patient low level pkc poor prognosi furthermor pkc caspase3 activ correl phgdh level human intestin tumor taken demonstr pkc critic metabol tumor suppressor mous human cancer',\n",
       "  'ArticleTitle': u'Control of nutrient stress-induced metabolic reprogramming by PKC\\u03b6 in tumorigenesis.',\n",
       "  'Author': 'Ma Li'},\n",
       " {'Abstract': ' protein kinas control cellular respons environment cue swift accur signal process breakdown highfidel capabl drive forc cancer diseas thus limit understand amino acid kinas domain encod substrat specif socal determin specif dos constitut major obstacl cancer signal here systemat dos experiment valid three name c1 c3 ape7 residu we demonstr dos form spars network nonconserv residu span distant region our result reveal like role interresidu allosteri specif evolutionari decoupl kinas activ specif appear load independ group residu final uncov similar properti drive sh2 domain specif demonstr identif dos util elucid greater understand role signal network cancer creixel al 2015 issu cell',\n",
       "  'ArticleTitle': 'Unmasking determinants of specificity in the human kinome.',\n",
       "  'Author': 'Creixell Pau'},\n",
       " {'Abstract': ' synonym mutat alter amino acid general consid nonfunct cancer supek al compel analysi suggest silent mutat oncogen alter transcript splice affect protein function',\n",
       "  'ArticleTitle': 'Silent mutations make some noise.',\n",
       "  'Author': 'Zheng Siyuan'},\n",
       " {'Abstract': ' the extent threedimension organ genom contribut chromosom transloc question cancer genom we generat highresolut hic spatial organ map g1arrest mous prob cell genom highthroughput genomewid transloc sequenc map transloc target dna doublestrand break dsbs rag endonucleasecleav antigenreceptor loci domin transloc partner target dsbs regardless genom posit reflect highfrequ dsbs loci coloc fraction cell to direct assess spatial proxim contribut normal genom dsbs ioniz radiat under condit transloc high enrich cis singl chromosom contain target dsbs chromosom subchromosom domain manner direct relat preexist spatial proxim by combin two highthroughput genom method genet tractabl system provid new len view cancer genom',\n",
       "  'ArticleTitle': 'Spatial organization of the mouse genome and its role in recurrent chromosomal translocations.',\n",
       "  'Author': 'Zhang Yu'},\n",
       " {'Abstract': ' lncrnas known regul number differ development tumorigen process here report role lncrna bcar4 breast cancer metastasi mediat chemokineinduc bind bcar4 two transcript factor extend regulatori consequ bcar4 bind snip1 pnut respons ccl21 releas snip1 inhibit p300depend histon acetyl turn enabl bcar4recruit pnut bind h3k18ac reliev inhibit rna pol ii activ pp1 phosphatas this mechan activ noncanon hedgehoggli2 transcript program promot cell migrat bcar4 express correl advanc breast cancer therapeut deliveri lock nucleic acid lnas target bcar4 suppress breast cancer metastasi mous model the find reveal diseaserelev lncrna mechan consist direct coordin protein recruit indirect regul transcript factor',\n",
       "  'ArticleTitle': 'lncRNA directs cooperative epigenetic regulation downstream of chemokine signals.',\n",
       "  'Author': 'Xing Zhen'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Noncoding RNAs and cancer.',\n",
       "  'Author': 'Lieberman Judy'},\n",
       " {'Abstract': ' genomewid identif mechan action moa smallmolecul compound character target effector activ modul repres high relev elus goal critic implic assess compound efficaci toxic current approach labor intens limit elucid highaffin bind target protein we introduc regulatori networkbas approach elucid genomewid moa protein base assess global dysregul molecular interact follow compound perturb analysi cellular perturb profil identifi establish moa protein 70 test compound elucid novel protein experiment valid final unknownmoa compound analysi reveal altretamin anticanc drug inhibitor glutathion peroxidas 4 lipid repair activ experiment confirm reveal unexpect similar activ sulfasalazin this suggest regulatori network analysi provid valuabl mechanist insight elucid smallmolecul moa compound similar',\n",
       "  'ArticleTitle': 'Elucidating Compound Mechanism of Action by Network Perturbation Analysis.',\n",
       "  'Author': 'Woo Jung Hoon'},\n",
       " {'Abstract': ' the transcript factor atf2 elicit oncogen activ melanoma tumor suppressor activ nonmalign skin cancer here identifi atf2 tumor suppressor function determin abil local mitochondria alter membran permeabl follow genotox stress the abil atf2 reach mitochondria determin pkc direct atf2 nuclear local genotox stress attenu pkc effect atf2 enabl atf2 nuclear export local mitochondria perturb hk1vdac1 complex increas mitochondri permeabl promot apoptosi signific high level pkc melanoma cell block atf2 nuclear export function mitochondria attenu apoptosi follow exposur genotox stress in melanoma tumor sampl high pkc level associ poor prognosi overal find provid framework understand subcellular local enabl atf2 oncogen tumor suppressor function',\n",
       "  'ArticleTitle': u'PKC\\u03b5 promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.',\n",
       "  'Author': 'Lau Eric'},\n",
       " {'Abstract': ' crisprcas9 versatil genom edit technolog studi function genet element to broad enabl applic cas9 vivo establish credepend cas9 knockin mous we demonstr vivo well ex vivo genom edit adenoassoci virus aav lentivirus particlemedi deliveri guid rna neuron immun cell endotheli cell use mice simultan model dynam kras p53 lkb1 top three mutat gene lung adenocarcinoma deliveri singl aav vector lung generat lossoffunct mutat p53 lkb1 well homologydirect repairmedi krasg12d mutat lead macroscop tumor adenocarcinoma patholog togeth result suggest cas9 mice empow wide rang biolog diseas model applic',\n",
       "  'ArticleTitle': 'CRISPR-Cas9 knockin mice for genome editing and cancer modeling.',\n",
       "  'Author': 'Platt Randall J'},\n",
       " {'Abstract': ' brafv600 mutant melanoma treat inhibitor braf mek kinas invari develop resist frequent caus reactiv mitogen activ protein kinas mapk pathway to identifi novel treatment option patient search acquir vulner mapk inhibitorresist melanoma we resist brafmek inhibitor associ increas level reactiv oxygen speci ros subsequ treatment histon deacetylas inhibitor vorinostat suppress slc7a11 lead lethal increas alreadyelev level ros drugresist cell this caus select apoptot death drugresist tumor cell consist treatment braf inhibitorresist melanoma vorinostat mice result dramat tumor regress in studi patient advanc brafmek inhibitorresist melanoma vorinostat select ablat drugresist tumor cell provid clinic proof concept novel therapi identifi',\n",
       "  'ArticleTitle': 'An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.',\n",
       "  'Author': 'Wang Liqin'},\n",
       " {'Abstract': ' acquir molecular chang promot spread primari tumor cell distant tissu in issu cell roe al metastat progress pancreat cancer involv largescal enhanc reprogram foxa1 activ transcript program specifi earli endoderm stem cell',\n",
       "  'ArticleTitle': 'Reprogramming Enhancers to Drive Metastasis.',\n",
       "  'Author': 'Mostoslavsky Raul'},\n",
       " {'Abstract': ' cancer progress involv gradual loss differenti phenotyp acquisit progenitor stemcelllik featur here provid novel stem indic assess degre oncogen dedifferenti we innov oneclass logist regress oclr machinelearn algorithm extract transcriptom epigenet featur set deriv nontransform pluripot stem cell differenti progeni use oclr abl identifi undiscov biolog mechan associ dedifferenti oncogen state analys tumor microenviron reveal unanticip correl cancer stem immun checkpoint express infiltr immun cell we dedifferenti oncogen phenotyp general promin metastat tumor applic stem indic singlecel data reveal pattern intratumor molecular heterogen final indic allow identif novel target possibl target therapi aim tumor differenti',\n",
       "  'ArticleTitle': 'Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.',\n",
       "  'Author': 'Malta Tathiane M'},\n",
       " {'Abstract': ' raf link ras one potent human oncogen effector erk prolifer this role evolutionarili conserv simpler multicellular organ express one raf mammal three this minireview highlight common diverg featur raf paralog signal output role tumorigenesi',\n",
       "  'ArticleTitle': 'Alike but Different: RAF Paralogs and Their Signaling Outputs.',\n",
       "  'Author': 'Desideri Enrico'},\n",
       " {'Abstract': ' the mechanist underpin metastat dormanc reactiv poor understood a gainoffunct cdna screen reveal coco secret antagonist tgf ligand induc dormant breast cancer cell undergo reactiv lung mechanist studi indic coco exert effect block lungderiv bmp ligand wherea coco enhanc manifest trait associ cancer stem cell bmp signal suppress coco induc discret gene express signatur associ metastat relaps lung bone brain patient experi mous model suggest organ contain nich devoid bioactiv bmp these find reveal metastasisiniti cell need overcom organspecif antimetastat signal order undergo reactiv',\n",
       "  'ArticleTitle': 'The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.',\n",
       "  'Author': 'Gao Hua'},\n",
       " {'Abstract': ' key cellular decis prolifer growth arrest typic occur spatial defin locat tissu loss spatial control hallmark diseas includ cancer yet pattern establish incomplet understood here report physic architectur featur multicellular sheet inform cell prolif capac mechan regul yap taz known mediat hippo signal organ growth yaptaz activ confin cell expos mechan stress stretch locat edgescurvatur contour epitheli sheet stiff surround extracellular matrix we identifi factincappingsev protein cofilin capz gelsolin essenti gatekeep limit yaptaz activ cell experienc low mechan stress includ contact inhibit prolifer we propos mechan forc overarch regul yaptaz multicellular context set respons hippo wnt gpcr signal',\n",
       "  'ArticleTitle': 'A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.',\n",
       "  'Author': 'Aragona Mariaceleste'},\n",
       " {'Abstract': ' mammalian target rapamycin complex 1 mtorc1 control growth surviv respons metabol cue oxid stress affect mtorc1 inhibitori stimulatori input wherea downregul tsc1tsc2 activ mtorc1 oxid stress molecular mechan mtorc1 inhibit remain unknown here identifi astrin essenti negat mtorc1 regul cellular stress respons upon stress astrin inhibit mtorc1 associ recruit mtorc1 compon raptor stress granul sgs prevent mtorc1hyperactivationinduc apoptosi in turn balanc mtorc1 activ enabl express stress factor by identifi astrin direct molecular link mtorc1 sg assembl stress respons establish unifi model mtorc1 inhibit activ stress import cancer cell apoptosi suppress stress depend astrin be frequent upregul tumor astrin potenti clinic relev target sensit tumor apoptosi',\n",
       "  'ArticleTitle': 'Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells.',\n",
       "  'Author': 'Thedieck Kathrin'},\n",
       " {'Abstract': ' dure mitot exit missegreg chromosom recruit nuclear envelop ne form micronuclei mn mn reduc function compar primari nuclei cell two compart appear structur compar here 60 mn undergo irrevers loss compartment interphas ne collaps this disrupt mn induc defect nuclear lamina assembl drastic reduc nuclear function trigger massiv dna damag mn disrupt associ chromatin compact invas endoplasm reticulum er tubul chromatin we identifi disrupt mn major subtyp human nonsmallcel lung cancer suggest disrupt mn use object biomark genom instabl solid tumor our studi ne collaps key event under mn dysfunct establish link aberr ne organ aneuploidi',\n",
       "  'ArticleTitle': 'Catastrophic nuclear envelope collapse in cancer cell micronuclei.',\n",
       "  'Author': 'Hatch Emily M'},\n",
       " {'Abstract': ' inhibitor alk egf receptor tyrosin kinas provok dramat shortliv respons lung cancer harbor eml4alk transloc activ mutat egfr respect we largescal rnai screen identifi med12 compon transcript mediat complex mutat cancer determin respons alk egfr inhibitor med12 part cytoplasm negat regul tgfr2 physic interact med12 suppress result activ tgfr signal necessari suffici drug resist tgf signal caus mekerk activ consequ med12 suppress confer resist mek braf inhibitor cancer med12 loss induc emtlik phenotyp associ chemotherapi resist colon cancer patient gefitinib lung cancer inhibit tgfr signal restor drug respons med12kd cell suggest strategi treat drugresist tumor lost med12',\n",
       "  'ArticleTitle': u'MED12 controls the response to multiple cancer drugs through regulation of TGF-\\u03b2 receptor signaling.',\n",
       "  'Author': 'Huang Sidong'},\n",
       " {'Abstract': ' mutat fundament process tumorigenesi howev degre rate somat mutat vari human genom mechanist basi under variat remain fulli elucid here perform crosscanc comparison 402 whole genom compris divers set childhood adult tumor includ solid hematopoiet malign surpris inact x chromosom femal cancer genom accumul averag twice four time somat mutat megabas compar individu autosom wholegenom sequenc clonal expand hematopoiet stemprogenitor cell hspcs healthi individu premalign myelodysplast syndrom mds sampl reveal x chromosom hypermut our data suggest hypermut inact x chromosom earli frequent featur tumorigenesi result dna replic stress aberr prolifer cell',\n",
       "  'ArticleTitle': 'Hypermutation of the inactive X chromosome is a frequent event in cancer.',\n",
       "  'Author': u'J\\xe4ger Natalie'},\n",
       " {'Abstract': ' the serinethreonin phosphatas protein phosphatas 2a pp2a play essenti role aspect cellular function tumor suppressor the core enzym pp2a compris 65 kda scaffold subunit 36 kda catalyt subunit here report crystal structur pp2a core enzym bound two inhibitor tumorinduc agent okada acid microcystinlr 26 28 a resolut respect the catalyt subunit recogn one end elong scaffold subunit interact conserv ridg heat repeat 1115 format core enzym forc scaffold subunit undergo pronounc structur rearrang the scaffold subunit exhibit consider conform flexibl propos play essenti role pp2a function these structur biochem analys reveal signific insight pp2a function serv framework deciph divers role pp2a cellular physiolog',\n",
       "  'ArticleTitle': 'Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.',\n",
       "  'Author': 'Xing Yongna'},\n",
       " {'Abstract': ' lung adenocarcinoma common subtyp nonsmal cell lung cancer respons 500000 death year worldwid here report exom genom sequenc 183 lung adenocarcinoma tumornorm dna pair these analys reveal mean exon somat mutat rate 120 eventsmegabas identifi major gene report mutat lung adenocarcinoma in addit identifi statist recurr somat mutat splice factor gene u2af1 truncat mutat affect rbm10 arid1a analysi nucleotid contextspecif mutat signatur group sampl set distinct cluster correl smoke histori alter report lung adenocarcinoma gene wholegenom sequenc analysi reveal frequent structur rearrang includ infram exon alter egfr sik2 kinas the candid gene identifi studi attract target biolog character therapeut target lung adenocarcinoma',\n",
       "  'ArticleTitle': 'Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.',\n",
       "  'Author': 'Imielinski Marcin'},\n",
       " {'Abstract': ' ductal carcinoma situ dcis earlystag breast cancer infrequ progress invas ductal carcinoma idc genom evolut difficult delin invas intratumor heterogen low number tumor cell duct to overcom challeng develop topograph singl cell sequenc tscs measur genom copi number profil singl tumor cell preserv spatial context tissu section we appli tscs 1293 singl cell 10 synchron patient dcis idc region addit exom sequenc our data reveal direct genom lineag situ invas tumor subpopul mutat copi number aberr evolv duct prior invas these result support multiclon invas model one clone escap duct migrat adjac tissu establish invas carcinoma',\n",
       "  'ArticleTitle': 'Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.',\n",
       "  'Author': 'Casasent Anna K'},\n",
       " {'Abstract': ' centriol barrelshap structur essenti format centrosom cilia flagella here review recent advanc understand function biogenesi organell emphas connect human diseas deregul centrosom number long propos contribut genom instabl tumor format mutat centrosom protein genet link microcephali dwarfism final structur function centriol aberr contribut ciliopathi varieti complex diseas stem absenc dysfunct cilia',\n",
       "  'ArticleTitle': 'Centrioles, centrosomes, and cilia in health and disease.',\n",
       "  'Author': 'Nigg Erich A'},\n",
       " {'Abstract': ' p53 and akt critic player regul tumorigenesi opposit effect p53 transactiv target gene exert function tumor suppressor akt phosphoryl substrat transduc downstream surviv signal in addit p53 akt negat regul balanc surviv death signal cell we identifi phlda3 p53 target gene encod ph domainon protein we phlda3 compet ph domain akt bind membran lipid inhibit akt transloc cellular membran activ ablat endogen phlda3 result enhanc akt activ decreas p53depend apoptosi we demonstr suppress anchorageindepend cell growth phlda3 loss phlda3 genom locus frequent observ primari lung cancer suggest role phlda3 tumor suppress our result reveal new mode coordin p53 akt pathway',\n",
       "  'ArticleTitle': 'PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt.',\n",
       "  'Author': 'Kawase Tatsuya'},\n",
       " {'Abstract': ' telomeras confer limitless prolif potenti human cell abil elong telomer natur end chromosom undergo progress attrit eventu compromis cell viabil howev role telomeras organism age remain unaddress part cancerpromot activ telomeras to circumv problem constitut express telomeras revers transcriptas tert one compon telomeras mice engin cancer resist mean enhanc express tumor suppressor p53 p16 p19arf in context tert overexpress improv fit epitheli barrier skin intestin produc system delay age accompani extens median life span these result demonstr constitut express tert provid antiag activ context mammalian organ',\n",
       "  'ArticleTitle': 'Telomerase reverse transcriptase delays aging in cancer-resistant mice.',\n",
       "  'Author': u'Tom\\xe1s-Loba Antonia'},\n",
       " {'Abstract': ' crosstalk complex signal pathway perturb oncogen limit componentbycompon approach understand human diseas network analysi normal oncogen signal rewir drug provid opportun target tumor high specif efficaci use target inhibit oncogen signal pathway combin dnadamag chemotherapi report timestagg egfr inhibit simultan coadministr dramat sensit subset tripleneg breast cancer cell genotox drug systemslevel analysisus highdens timedepend measur signal network gene express profil cell phenotyp respons combin mathemat modelingrev approach alter intrins state cell dynam rewir oncogen signal pathway this process convert cell less tumorigen state suscept dna damageinduc cell death reactiv extrins apoptot pathway function suppress oncogeneaddict state',\n",
       "  'ArticleTitle': 'Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.',\n",
       "  'Author': 'Lee Michael J'},\n",
       " {'Abstract': ' angiogenin ang secret ribonucleas rnase celltyp contextspecif role growth surviv regener although function requir receptormedi endocytosi appropri subcellular local ident cell surfac receptor remain undefin here plexinb2 plxnb2 function receptor ang endotheli cancer neuron normal hematopoiet leukem stem progenitor cell mechanist plxnb2 mediat intracellular rna process contribut cell growth surviv regen capabl ang antibodi generat angbind site plxnb2 restrict ang activ vitro vivo result inhibit establish xenograft tumor anginduc neurogenesi neuroprotect level proselfrenew transcript hematopoiet patientderiv leukem stem progenitor cell reduc progress leukemia vivo plxnb2 requir physiolog patholog function ang signific therapeut potenti solid hematopoiet cancer neurodegen diseas',\n",
       "  'ArticleTitle': 'Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.',\n",
       "  'Author': 'Yu Wenhao'},\n",
       " {'Abstract': ' nuclear pore complex npcs regul nuclearcytoplasm transport transcript genom integr eukaryot cell howev function role cancer remain poor understood we interrog evolutionari transcriptom landscap npc compon nucleoporin nup primari advanc metastat human prostat cancer pc focus lossoffunct genet screen topupregul nup aggress pc model identifi pom121 key contributor pc aggress mechanist pom121 promot pc progress enhanc importindepend nuclear transport key oncogen e2f1 myc pcspecif argata2 transcript factor uncov pharmacolog target axi inhibit decreas tumor growth restor standard therapi efficaci improv surviv patientderiv preclin model our studi molecular establish role npcs pc progress rational npcregul nuclear import target therapeut strategi lethal pc these find implic understand npc deregul contribut pathogenesi tumor type',\n",
       "  'ArticleTitle': 'Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.',\n",
       "  'Author': 'Rodriguez-Bravo Veronica'},\n",
       " {'Abstract': ' an altern therapeut target oncogen perform synthet lethal screen gene essenti context specif cancercaus mutat we highthroughput rna interfer rnai identifi synthet lethal interact cancer cell harbor mutant kras common mutat human oncogen we cell depend mutant kras exhibit sensit suppress serinethreonin kinas stk33 irrespect tissu origin stk33 requir krasindepend cell stk33 promot cancer cell viabil kinas activitydepend manner regul suppress mitochondri apoptosi mediat s6k1induc inactiv death agonist bad select mutant krasdepend cell these observ identifi stk33 target treatment mutant krasdriven cancer demonstr potenti rnai screen discov function depend creat oncogen mutat enabl therapeut intervent cancer undrugg genet alter',\n",
       "  'ArticleTitle': 'Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.',\n",
       "  'Author': 'Scholl Claudia'},\n",
       " {'Abstract': ' tumor cell display progress chang metabol correl malign includ develop lipogen phenotyp how store fat liber remodel support cancer pathogenesi remain unknown here enzym monoacylglycerol lipas magl high express aggress human cancer cell primari tumor regul fatti acid network enrich oncogen signal lipid promot migrat invas surviv vivo tumor growth overexpress magl nonaggress cancer cell recapitul fatti acid network increas pathogenicityphenotyp revers magl inhibitor impair magldepend tumor growth rescu highfat diet indic exogen sourc fatti acid contribut malign cancer lack magl activ togeth find reveal cancer cell coopt lipolyt enzym translat lipogen state array protumorigen signal paperflick',\n",
       "  'ArticleTitle': 'Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.',\n",
       "  'Author': 'Nomura Daniel K'},\n",
       " {'Abstract': ' cancer influenc microenviron broader environment effect play role remain poor defin we report mice live enrich hous environ reduc tumor growth increas remiss we effect melanoma colon cancer model caus physic activ serum anim held enrich environ ee inhibit cancer prolifer vitro mark lower leptin hypothalam brainderiv neurotroph factor bdnf select upregul ee genet overexpress reduc tumor burden bdnf knockdown block effect ee mechanist hypothalam bdnf downregul leptin product adipocyt sympathoneur betaadrenerg signal these result suggest genet environment activ bdnfleptin axi therapeut signific cancer',\n",
       "  'ArticleTitle': 'Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.',\n",
       "  'Author': 'Cao Lei'},\n",
       " {'Abstract': ' clinic acquir resist mapk inhibitor mapki therapi melanoma fulli explain genom mechan accompani coevolut intratumor immun we sought nongenom mechan acquir resist dynam immun composit compar transcriptomicmethylom analysi patientmatch melanoma tumor biopsi therapi diseas progress transcriptom alter resist tumor high recurr contrast mutat frequent correl differenti methyl tumor cellintrins cpg site we identifi tumor cell compart supraphysiolog cmet upexpress infraphysiolog lef1 downexpress yap1 signatur enrich driver acquir resist import high intratumor cytolyt t cell inflamm prior mapki therapi preced cd8 t cell deficiencyexhaust loss antigen present half diseaseprogress melanoma suggest crossresist salvag antipd1pdl1 immunotherapi thus melanoma acquir mapki resist high dynam recurr nongenom alter coevolv intratumor immun',\n",
       "  'ArticleTitle': 'Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.',\n",
       "  'Author': 'Hugo Willy'},\n",
       " {'Abstract': ' mutat tsc2 tumor suppressor caus tuber sclerosi complex diseas character hamartoma format multipl tissu tsc2 inhibit cell growth act gtpaseactiv protein rheb inhibit mtor central control cell growth here wnt activ mtor inhibit gsk3 involv betacatenindepend transcript gsk3 inhibit mtor pathway phosphoryl tsc2 manner depend ampkprim phosphoryl inhibit mtor rapamycin block wntinduc cell growth tumor develop suggest potenti therapeut valu rapamycin cancer activ wnt signal our result addit transcript activ wnt stimul translat cell growth activ tscmtor pathway furthermor sequenti phosphoryl tsc2 ampk gsk3 reveal molecular mechan signal integr cell growth regul',\n",
       "  'ArticleTitle': 'TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.',\n",
       "  'Author': 'Inoki Ken'},\n",
       " {'Abstract': ' the p53 tumor suppressor protein act major defens cancer among distinct featur abil elicit apoptot death cell cycl arrest in issu cell das al 2007 tanaka al 2007 provid new insight mechan dictat life death decis p53',\n",
       "  'ArticleTitle': 'Living with p53, dying of p53.',\n",
       "  'Author': 'Aylon Yael'},\n",
       " {'Abstract': ' it current unclear tissu chang surround multifoc epitheli tumor caus consequ cancer here provid evid loss mesenchym notchcsl signal caus tissu alter includ stromal atrophi inflamm potent trigger epitheli tumor mice carri mesenchymalspecif delet cslrbpj key notch effector exhibit spontan multifoc keratinocyt tumor develop dermal atrophi inflamm csldefici dermal fibroblast promot increas tumor cell prolifer upregul cjun cfos express consequ higher level diffus growth factor inflammatori cytokin matrixremodel enzym in human skin sampl stromal field adjac multifoc premalign actin keratosi lesion exhibit decreas notchcsl signal associ molecular chang import chang gene express induc uva known environment caus cutan field cancer skin cancer',\n",
       "  'ArticleTitle': 'Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.',\n",
       "  'Author': 'Hu Bing'},\n",
       " {'Abstract': ' just refer genom sequenc revolution human genet refer map interactom network critic fulli understand genotypephenotyp relationship here describ systemat map 14000 highqual human binari proteinprotein interact at equal qualiti map 30 larger avail smallscal studi publish literatur decad while current avail inform high bias cover relat small portion proteom systemat map appear strike homogen reveal broader human interactom network current appreci the map uncov signific interconnect known candid cancer gene product provid unbias evid expand function cancer landscap demonstr highqual interactom model help connect dot genom revolut',\n",
       "  'ArticleTitle': 'A proteome-scale map of the human interactome network.',\n",
       "  'Author': 'Rolland Thomas'},\n",
       " {'Abstract': ' the later ventricl subventricular zone svz frequent consequenti site pediatr adult glioma spread cellular molecular mechan mediat poor understood we demonstr neural precursor cell npcglioma cell communic underpin propens glioma colon svz secret chemoattract signal glioma cell home biochem proteom function analys svz npcsecret factor reveal neurit outgrowthpromot factor pleiotrophin requir bind partner sparcsparcl1 hsp90b key mediat chemoattract effect pleiotrophin express enrich svz pleiotrophin knock stark reduc glioma invas svz murin brain pleiotrophin complex bind partner activ glioma rhorock signal rock inhibit decreas invas svz npcsecret factor these find demonstr pathogen role npcglioma interact potenti therapeut target limit glioma invas paperclip',\n",
       "  'ArticleTitle': 'Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma.',\n",
       "  'Author': 'Qin Elizabeth Y'},\n",
       " {'Abstract': ' our understand cancer larg analysi aberr tumor cell popul yet increas clear tumor microenviron influenc tumorigenesi for exampl mesenchym support growth tumorigen epithelium howev fibroblast subject geneticepigenet chang result select pressur confer oncogen stress epithelium experiment assess recent analys human carcinoma tumorsuppressor gene mutat stroma suggest interplay multipl cell type select aberr nonautonom tumor progress we demonstr occur mous model prostat cancer epitheli cell cycl disrupt cellspecif inhibit prb function induc paracrin p53 respons suppress fibroblast prolifer associ stroma this interact impos strong select pressur yield high prolif mesenchym undergon p53 loss',\n",
       "  'ArticleTitle': 'Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.',\n",
       "  'Author': 'Hill Reginald'},\n",
       " {'Abstract': ' the major newli diagnos prostat cancer slow grow long natur life histori yet subset metastas lethal consequ we reconstruct phylogeni 293 local prostat tumor link clinic outcom data multipl subclon detect 59 patient specif subclon architectur associ advers clinicopatholog featur earli tumor develop character point mutat delet follow later subclon amplif chang trinucleotid mutat signatur specif gene select mutat prior follow subclon diversif includ mtor nkx31 rb1 patient lowrisk monoclon tumor rare relaps primari therapi 7 highrisk polyclon tumor frequent 61 the presenc multipl subclon index biopsi necessari suffici relaps local prostat cancer suggest evolutionawar biomark prospect studi lowrisk tumor suitabl activ surveil',\n",
       "  'ArticleTitle': 'The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.',\n",
       "  'Author': 'Espiritu Shadrielle Melijah G'},\n",
       " {'Abstract': ' cancer complex collect distinct genet diseas unit common hallmark here expand classic hallmark includ stress phenotyp tumorigenesi we describ conceptu framework oncogen nononcogen addict contribut hallmark exploit stress sensit stress overload select kill cancer cell in particular evid larg class nononcogen essenti cancer cell surviv attract drug target final discuss path ahead therapeut discoveri provid theoret consider combin orthogon cancer therapi',\n",
       "  'ArticleTitle': 'Principles of cancer therapy: oncogene and non-oncogene addiction.',\n",
       "  'Author': 'Luo Ji'},\n",
       " {'Abstract': ' upon ligand bind ripk1 recruit tumor necrosi factor receptor superfamili tnfrsf tolllik receptor tlr complex promot prosurviv inflammatori signal ripk1 direct regul caspase8medi apoptosi caspase8 activ block ripk3mlkldepend necroptosi we c57bl6 ripk1 mice die birth system inflamm transfer hematopoiet compart howev ripk1 progenitor fail engraft lethal irradi host proper block tnf revers defect emerg hematopoiesi surpris tnfr1 defici prevent inflamm ripk1 neonat delet ripk3 mlkl casp8 prevent extracellular releas necroptot damp il33 reduc myd88depend inflamm reduc inflamm ripk1ripk3 ripk1mlkl ripk1myd88 mice prevent neonat lethal ripk1ripk3casp8 mice surviv past wean these result reveal key function ripk1 inhibit necroptosi role limit promot inflamm',\n",
       "  'ArticleTitle': 'RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.',\n",
       "  'Author': 'Rickard James A'},\n",
       " {'Abstract': ' although initi describ end state cell extend round divis cultur clear cellular senesc induc differ stimuli play role tumor suppress vivo three recent studi cell report secret protein play role enforc senesc respons acosta al 2008 kuilman al 2008 wajapeye al 2008 these new studi identifi unanticip contributor tumorsuppress cell state',\n",
       "  'ArticleTitle': 'Unexpected pieces to the senescence puzzle.',\n",
       "  'Author': 'Cichowski Karen'},\n",
       " {'Abstract': ' an adult anim consist cell vast differ size activ regul cell size remain poor understood recent studi uncov signal pathway sizegrowth control identif diseas result aberr pathway renew interest field this review discuss current understand cell set size adapt size chang environ process relev human diseas',\n",
       "  'ArticleTitle': 'The regulation of cell size.',\n",
       "  'Author': 'Lloyd Alison C'},\n",
       " {'Abstract': ' kinas inhibitor limit success cancer treatment tumor circumv action use quantit proteom approach assess kinom activ respons mek inhibit tripleneg breast cancer tnbc cell genet engin mice gemm mek inhibit caus acut erk activ loss result rapid cmyc degrad induc express activ receptor tyrosin kinas rtks rnai knockdown erk cmyc mimick rtk induct mek inhibitor prevent proteasom cmyc degrad block kinom reprogram mek inhibitorinduc rtk stimul overcam mek2 inhibit mek1 inhibit reactiv erk produc drug resist the c3tag gemm tnbc similar induc rtks respons mek inhibit the inhibitorinduc rtk profil suggest kinas inhibitor combin therapi produc gemm tumor apoptosi regress singl agent ineffect this approach defin mechan drug resist allow ration design combin therapi cancer',\n",
       "  'ArticleTitle': 'Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.',\n",
       "  'Author': 'Duncan James S'},\n",
       " {'Abstract': ' tuber sclerosi tsc tumor syndrom caus mutat tsc1 tsc2 gene tsc tumorigenesi accompani loss heterozygos loh recent extracellular signalregul kinas erk activ tsc lesion lack tsc1 tsc2 loh here erk play critic role tsc progress posttransl inactiv tsc2 erkdepend phosphoryl lead tsc1tsc2 dissoci mark impair tsc2 abil inhibit mtor signal cell prolifer oncogen transform import express erk nonphosphorylat tsc2 mutant tsc2 tumor cell erk constitut activ block tumorigenec vivo wildtyp tsc2 ineffect our find posit rasmapk pathway upstream tsc complex suggest erk modul mtor signal contribut diseas progress phosphoryl inactiv tsc2',\n",
       "  'ArticleTitle': 'Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.',\n",
       "  'Author': 'Ma Li'},\n",
       " {'Abstract': ' novel antiangiogen strategi complementari mechan need maxim efficaci minim resist current angiogenesi inhibitor we explor therapeut potenti mechan alphaplgf antibodi placent growth factor plgf vegf homolog regul angiogen switch diseas health alphaplgf inhibit growth metastasi tumor includ resist vegfr inhibitor vegfri enhanc efficaci chemotherapi vegfri alphaplgf inhibit angiogenesi lymphangiogenesi tumor cell motil distinct vegfri alphaplgf prevent infiltr angiogen macrophag sever tumor hypoxia switch angiogen rescu program respons resist vegfri moreov caus enhanc vegfrirel side effect the efficaci safeti alphaplgf pleiotrop complementari mechan vegfri neglig induct angiogen rescu program suggest alphaplgf constitut novel approach cancer treatment',\n",
       "  'ArticleTitle': 'Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.',\n",
       "  'Author': 'Fischer Christian'},\n",
       " {'Abstract': ' diffus larg b cell lymphoma dlbcl common form blood cancer character strike degre genet clinic heterogen this heterogen pose major barrier understand genet basi diseas respons therapi here perform integr analysi wholeexom sequenc transcriptom sequenc cohort 1001 dlbcl patient comprehens defin landscap 150 genet driver diseas we character function impact gene unbias crispr screen dlbcl cell line defin oncogen promot cell growth a prognost model compris genet alter outperform current establish method cell origin intern prognost index compris clinic variabl dual myc bcl2 express these result comprehens defin genet driver function role dlbcl identifi new therapeut opportun diseas',\n",
       "  'ArticleTitle': u'Genetic and Functional Drivers of Diffuse Large B\\xa0Cell Lymphoma.',\n",
       "  'Author': 'Reddy Anupama'},\n",
       " {'Abstract': ' therapi develop adult diffus glioma hinder incomplet knowledg somat glioma drive alter suboptim diseas classif we defin complet set gene associ 1122 diffus grade iiiiiiv glioma the cancer genom atlas molecular profil improv diseas classif identifi molecular correl provid insight progress low highgrad diseas wholegenom sequenc data analysi determin atrx tert promot mutat associ increas telomer length recent advanc glioma classif base idh mutat 1p19q codelet status recapitul analysi dna methyl profil identifi clinic relev molecular subset a subtyp idh mutant glioma associ dna demethyl poor outcom group idhwildtyp diffus glioma molecular similar pilocyt astrocytoma relat favor surviv understand cohes diseas group aid improv clinic outcom',\n",
       "  'ArticleTitle': 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.',\n",
       "  'Author': 'Ceccarelli Michele'},\n",
       " {'Abstract': ' wntcatenin signal play key role pathogenesi colon cancer emerg evid indic oncogen catenin regul biolog process essenti cancer initi progress to deciph role catenin transform classifi catenin activ 85 cancer cell line perform genomescal lossoffunct screen catenin activ cancer depend signal pathway involv transcript regul yap1 specif yap1 transcript factor tbx5 form complex catenin phosphoryl yap1 tyrosin kinas yes1 lead local complex promot antiapoptot gene includ bcl2l1 birc5 a smallmolecul inhibitor yes1 imped prolifer catenindepend cancer cell line anim model these observ defin cateninyap1tbx5 complex essenti transform surviv catenindriven cancer',\n",
       "  'ArticleTitle': u'\\u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.',\n",
       "  'Author': 'Rosenbluh Joseph'},\n",
       " {'Abstract': ' therapeut har adapt immun checkpoint inhibit transform treatment cancer despit unpreced longterm respons patient respond therapi immunotherapi nonrespond harbor high level circul myeloidderiv suppressor cell mdscsan immunosuppress innat cell popul through genet pharmacolog approach uncov pathway govern mdsc abund multipl cancer type therapeut liverx nuclear receptor lxr agon reduc mdsc abund murin model patient treat firstinhuman dose escal phase 1 trial mdsc deplet associ activ cytotox t lymphocyt ctl respons mice patient the lxr transcript target apo mediat effect mice lxrapo activ therapi elicit robust antitumor respons enhanc t cell activ immunebas therapi we implic lxrapo axi regul innat immun suppress target enhanc efficaci cancer immunotherapi patient',\n",
       "  'ArticleTitle': 'LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.',\n",
       "  'Author': 'Tavazoie Masoud F'},\n",
       " {'Abstract': ' in issu overacredelgoff al interferon gamma product subset regulatori t cell tumor microenviron trigger treg instabl local restor antitumor immun',\n",
       "  'ArticleTitle': \"Curbing Tregs' (Lack of) Enthusiasm.\",\n",
       "  'Author': 'Merghoub Taha'},\n",
       " {'Abstract': ' cancer aris consequ cumul disrupt cellular growth control darwinian select herit chang provid greatest clonal advantag these trait acquir stabli maintain genet epigenet mean here explor way alter genom epigenom influenc cooper promot oncogen transform disrupt epigenom control pervas malign classifi enabl characterist cancer cell akin genom instabl mutat',\n",
       "  'ArticleTitle': 'Interplay between the cancer genome and epigenome.',\n",
       "  'Author': 'Shen Hui'},\n",
       " {'Abstract': ' chromothripsi scar genom local chromosom shatter repair occur oneoff catastroph outcom process detect massiv dna rearrang affect one chromosom although recent find suggest crucial role chromothripsi cancer develop reproduc infer process remain challeng requir cataclysm oneoff rearrang distinguish local lesion occur progress we describ conceptu criteria infer chromothripsi base rule altern hypothesi stepwis rearrang occur robust mean infer facilit indepth studi impact mechan under chromothripsi',\n",
       "  'ArticleTitle': 'Criteria for inference of chromothripsis in cancer genomes.',\n",
       "  'Author': 'Korbel Jan O'},\n",
       " {'Abstract': ' chromosom instabl earli cancer stage caus stress dna replic the molecular basi replic perturb context current unknown we replic dynam cell regul s phase entri cell prolifer rbe2f pathway aberr activ aberr activ pathway hpv16 e6e7 cyclin e oncogen decreas cellular nucleotid level newli transform cell exogen suppli nucleosid rescu replic stress dna damag dramat decreas oncogeneinduc transform increas transcript nucleotid biosynthesi gene mediat express transcript factor cmyc increas nucleotid pool rescu replicationinduc dna damag our result suggest model earli oncogenesi uncoordin activ factor regul cell prolifer lead insuffici nucleotid fail support normal replic genom stabil',\n",
       "  'ArticleTitle': 'Nucleotide deficiency promotes genomic instability in early stages of cancer development.',\n",
       "  'Author': 'Bester Assaf C'},\n",
       " {'Abstract': ' lossoffunct mutat tet2 occur frequent patient clonal hematopoiesi myelodysplast syndrom mds acut myeloid leukemia aml associ dna hypermethyl phenotyp to determin role tet2 defici leukemia stem cell mainten generat revers transgen rnai mous model restor endogen tet2 express tet2 restor revers aberr hematopoiet stem progenitor cell hspc selfrenew vitro vivo treatment vitamin c cofactor fe2',\n",
       "  'ArticleTitle': 'Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.',\n",
       "  'Author': 'Cimmino Luisa'},\n",
       " {'Abstract': ' cancer compris bewild assort diseas kill 75 million peopl year poor understand cancer divers current thwart goal cure patient recent integr genom stem cell technolog promis rout impass',\n",
       "  'ArticleTitle': 'Mapping cancer origins.',\n",
       "  'Author': 'Gilbertson Richard J'},\n",
       " {'Abstract': ' the growth lymphat vessel lymphangiogenesi activ involv number patholog process includ tissu inflamm tumor dissemin insuffici patient suffer lymphedema debilit condit character chronic tissu edema impair immun the recent explos knowledg molecular mechan govern lymphangiogenesi provid new possibl treat diseas',\n",
       "  'ArticleTitle': 'Lymphangiogenesis: Molecular mechanisms and future promise.',\n",
       "  'Author': 'Tammela Tuomas'},\n",
       " {'Abstract': ' a connect genet event lead tumor format signal pathway innat immun respons establish in issu chien al 2006 ralb gtpase regul ikk famili member tbk1 provid unexpect link signal pathway promot inflamm cancer in tumor cell ralbtbk1 pathway inhibit apoptosi nontumorigen cell stimul innat immun respons',\n",
       "  'ArticleTitle': 'RalB signaling: a bridge between inflammation and cancer.',\n",
       "  'Author': 'Mantovani Alberto'},\n",
       " {'Abstract': ' hepatocyt nuclear factor 4 hnf4 essenti liver develop hepatocyt function here transient inhibit hnf4 initi hepatocellular transform micrornainflammatori feedback loop circuit consist mir124 il6r stat3 mir24 mir629 moreov circuit activ maintain suppress hnf4 sustain oncogenesi system administr mir124 modul inflammatori signal prevent suppress hepatocellular carcinogenesi induc tumorspecif apoptosi toxic side effect as hnf4 circuit perturb human hepatocellular carcinoma data rais possibl manipul microrna feedbackinflammatori loop therapeut potenti treat liver cancer',\n",
       "  'ArticleTitle': u'An HNF4\\u03b1-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.',\n",
       "  'Author': 'Hatziapostolou Maria'},\n",
       " {'Abstract': ' rucaparib inhibitor nuclear poli adpribos polymeras inhibit parp1 parp2 parp3 follow similar drug olaparib it disrupt dna repair replic pathway possibl transcript lead select kill cancer cell brca12 mutat rucaparib approv recurr ovarian cancer germlin somat mutat brca12',\n",
       "  'ArticleTitle': 'PARP Inhibitors for Cancer Therapy.',\n",
       "  'Author': 'Lin Ken Y'},\n",
       " {'Abstract': ' current model impli ferm domain protein merlin encod tumor suppressor nf2 inhibit mitogen signal near plasma membran here close growthinhibitori form merlin accumul nucleus bind e3 ubiquitin ligas crl4dcaf1 suppress activ deplet dcaf1 block promitogen effect inactiv merlin convers enforc express merlininsensit mutant dcaf1 counteract antimitogen effect merlin reexpress merlin silenc dcaf1 implement similar tumorsuppress program gene express tumorderiv mutat invari disrupt merlin abil interact inhibit crl4dcaf1 final deplet dcaf1 inhibit hyperprolifer schwannoma cell nf2 patient suppress oncogen potenti merlindefici tumor cell line we propos merlin suppress tumorigenesi transloc nucleus inhibit crl4dcaf1',\n",
       "  'ArticleTitle': 'Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.',\n",
       "  'Author': 'Li Wei'},\n",
       " {'Abstract': ' the triumph person cancer therapeut recent year prompt oncologist rethink clinic trial design research differ prioriti trial reform',\n",
       "  'ArticleTitle': 'Redefining clinical trials: the age of personalized medicine.',\n",
       "  'Author': 'Vaidyanathan Gayathri'},\n",
       " {'Abstract': ' screen agent kill epitheli cancer stem cell cscs possibl rariti cell tumor cell popul relat instabl cultur we describ approach screen agent epitheli cscspecif toxic we implement method chemic screen discov compound show select toxic breast cscs one compound salinomycin reduc proport cscs 100fold relat paclitaxel common breast cancer chemotherapeut drug treatment mice salinomycin inhibit mammari tumor growth vivo induc increas epitheli differenti tumor cell in addit global gene express analys salinomycin treatment result loss express breast csc gene identifi analys breast tissu isol direct patient this studi demonstr abil identifi agent specif toxic epitheli cscs',\n",
       "  'ArticleTitle': 'Identification of selective inhibitors of cancer stem cells by high-throughput screening.',\n",
       "  'Author': 'Gupta Piyush B'},\n",
       " {'Abstract': ' the etiolog colorect cancer crc link defici mismatch repair adenomat polyposi coli apc protein diet inflammatori process gut microbiota howev mechan microbiota synerg etiolog factor promot crc clear we report alter microbiota composit reduc crc apcminmsh2 mice diet reduc carbohydr phenocopi effect gut microb induc crc mice inflammatori respons product dna mutagen provid carbohydratederiv metabolit butyr fuel hyperprolifer msh2 colon epitheli cell further provid evid mismatch repair pathway role regul catenin activ modul differenti transitamplifi cell colon these data provid explan interact microbiota diet mismatch repair defici crc induct paperclip',\n",
       "  'ArticleTitle': 'Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.',\n",
       "  'Author': 'Belcheva Antoaneta'},\n",
       " {'Abstract': ' person cancer medicin base increas knowledg cancer mutat repertoir avail agent target alter gene pathway given advanc cancer genet technolog therapeut develop time right develop clinic trial research framework move futur clinic decis heurist evidencebas decis although challeng integr genom test cancer treatment decis make widerang complex scientif ethic imper realiz benefit person cancer medicin given overwhelm burden cancer unpreced opportun advanc outcom patient',\n",
       "  'ArticleTitle': 'The genetic basis for cancer treatment decisions.',\n",
       "  'Author': 'Dancey Janet E'},\n",
       " {'Abstract': ' telomer shorten impair prolifer transform cell lead cancer initi induc chromosom instabl here discuss recent develop understand role telomer replic stress telomeras express somat stem cell affect genom integr control carcinogenesi',\n",
       "  'ArticleTitle': 'The role of telomeres in stem cells and cancer.',\n",
       "  'Author': u'G\\xfcnes Cagatay'},\n",
       " {'Abstract': ' invas lobular carcinoma ilc second preval histolog subtyp invas breast cancer here comprehens profil 817 breast tumor includ 127 ilc 490 ductal idc 88 mix idcilc besid ecadherin loss best known ilc genet hallmark identifi mutat target pten tbx3 foxa1 ilc enrich featur pten loss associ increas akt phosphoryl highest ilc breast cancer subtyp spatial cluster foxa1 mutat correl increas foxa1 express activ convers gata3 mutat high express character lumin a idc suggest differenti modul er activ ilc idc prolifer immunerel signatur determin three ilc transcript subtyp associ surviv differ mix idcilc case molecular classifi ilclik idclik reveal true hybrid featur this multidimension molecular atlas shed new light genet base ilc provid potenti clinic option',\n",
       "  'ArticleTitle': 'Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.',\n",
       "  'Author': 'Ciriello Giovanni'},\n",
       " {'Abstract': ' p53 tumor suppressor protein function frequent lost cancer missens mutat tp53 gene this result express pointmut p53 protein lost wildtyp tumor suppressor activ gain function contribut transform metastasi here mutant p53 express promot invas loss direct migrat metastat behavior these activ p53 reflect enhanc integrin epiderm growth factor receptor egfr traffick depend rabcoupl protein rcp result constitut activ egfrintegrin signal we provid evid mutant p53 promot cell invas inhibit tap63 simultan loss p53 tap63 recapitul phenotyp mutant p53 cell these find open possibl block alpha5beta1integrin andor egf receptor therapeut benefit mutant p53express cancer',\n",
       "  'ArticleTitle': 'Mutant p53 drives invasion by promoting integrin recycling.',\n",
       "  'Author': 'Muller Patricia A J'},\n",
       " {'Abstract': ' cancer direct affect least onethird human popul inherit genet determin cancer risk remain larg unknown mous model human cancer help understand diseas complex genet trait identifi multipl genet variant allel involv pathway affect individu cancer suscept',\n",
       "  'ArticleTitle': 'Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models.',\n",
       "  'Author': 'Balmain Allan'},\n",
       " {'Abstract': ' microrna well suit regul tumor metastasi capac coordin repress numer target gene potenti enabl intervent multipl step invasionmetastasi cascad we identifi microrna exemplifi attribut mir31 express correl invers metastasi human breast cancer patient overexpress mir31 otherwiseaggress breast tumor cell suppress metastasi we deploy stabl microrna spong strategi inhibit mir31 vivo allow otherwisenonaggress breast cancer cell metastas these phenotyp involv confound influenc primari tumor develop attribut mir31medi inhibit step metastasi includ local invas extravas initi surviv distant site metastat colon such pleiotropi achiev coordin repress cohort metastasispromot gene includ rhoa inde rhoa reexpress partial revers mir31impos metastasi suppress these find indic mir31 use multipl mechan oppos metastasi',\n",
       "  'ArticleTitle': 'A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.',\n",
       "  'Author': 'Valastyan Scott'},\n",
       " {'Abstract': ' dysregul rrna synthesi rna polymeras i pol i associ uncontrol cell prolifer here report box haca small nucleolar rna snornaend long noncod rna lncrna enhanc prerrna transcript slert slert requir box haca snorna end biogenesi transloc nucleolus delet slert impair prerrna transcript rrna product lead decreas tumorigenesi mechanist slert interact deadbox rna helicas ddx21 143nt nonsnorna sequenc superresolut imag reveal ddx21 form ringshap structur surround multipl pol i complex suppress prerrna transcript bind slert alloster alter individu ddx21 molecul loosen ddx21 ring evict ddx21 suppress pol i transcript togeth result reveal control ribosom biogenesi slert lncrna regulatori role ddx21 ringshap arrang act pol i complex',\n",
       "  'ArticleTitle': 'SLERT Regulates DDX21 Rings Associated with Pol I Transcription.',\n",
       "  'Author': 'Xing Yu-Hang'},\n",
       " {'Abstract': ' an understand metabol pathway base sole biochemistri textbook underestim pervas role metabol essenti aspect biolog it evid recent work human diseas involv abnorm metabol statesoften genet programmedthat perturb normal physiolog lead sever tissu dysfunct understand metabol outlier crucial frontier diseaseori research this review discuss broad impact metabol cellular function modern concept metabol inform understand common diseas cancer consid prospect develop new metabol approach diseas treatment',\n",
       "  'ArticleTitle': 'Cellular metabolism and disease: what do metabolic outliers teach us?',\n",
       "  'Author': 'DeBerardinis Ralph J'},\n",
       " {'Abstract': ' region sever oxygen depriv hypoxia tumor rapid cell divis aberr blood vessel format the hypoxiainduc factor hif mediat transcript respons local hypoxia normal tissu cancer promot tumor progress alter cellular metabol stimul angiogenesi recent hif activ specif signal pathway notch express transcript factor oct4 control stem cell self renew multipot as cancer thought develop small number transform selfrenew multipot cancer stem cell result suggest new role hif tumor progress',\n",
       "  'ArticleTitle': 'Hypoxia-inducible factors, stem cells, and cancer.',\n",
       "  'Author': 'Keith Brian'},\n",
       " {'Abstract': ' no metazoan cell surviv absent signal support milieu for multicellular life special tissu persist organ defin associ posit cell state critic understand tissu function maintain repair this review focus place progenitor stem cell especi emphas hematopoiet cell balanc free movement stabl posit concept regulatori interrelationship precis it review classic emerg concept nich consid nich function particip neoplast diseas',\n",
       "  'ArticleTitle': 'Nice neighborhood: emerging concepts of the stem cell niche.',\n",
       "  'Author': 'Scadden David T'},\n",
       " {'Abstract': ' a complex interplay environment factor impact metabol human cell tradit cultur media mous plasma mimic metabolit composit human plasma here develop cultur medium polar metabolit concentr compar human plasma human plasmalik medium hplm cultur hplm relat tradit media widespread effect cellular metabol includ metabolom redox state glucos util among promin inhibit novo pyrimidin synthesisan effect trace uric acid 10fold higher blood human mice nonprim we uric acid direct inhibit uridin monophosph synthas ump consequ reduc sensit cancer cell chemotherapeut agent 5fluorouracil thus media better recapitul composit human plasma reveal unforeseen metabol wire regul suggest hplm broad util',\n",
       "  'ArticleTitle': 'Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase.',\n",
       "  'Author': 'Cantor Jason R'},\n",
       " {'Abstract': ' kinas inhibitor usher era target therapi util date limit cancer bear oncogen kinas mutat two paper issu luo al 2009 scholl al 2009 chang landscap uncov kinasespecif vulner tumor ras mutat',\n",
       "  'ArticleTitle': 'Finding and drugging the vulnerabilities of RAS-dependent cancers.',\n",
       "  'Author': 'Sawyers Charles L'},\n",
       " {'Abstract': ' wnt signal play critic role embryon develop genet aberr network broad implic colorect cancer we wnt receptor frizzled2 fzd2 ligand wnt5ab elev metastat liver lung colon breast cancer cell line highgrad tumor express correl marker epithelialmesenchym transit emt pharmacolog genet perturb reveal fzd2 drive emt cell migrat unrecogn noncanon pathway includ fyn stat3 a gene signatur regul pathway predict metastasi surviv patient we develop antibodi fzd2 reduc cell migrat invas inhibit tumor growth metastasi xenograft we propos target pathway provid benefit patient tumor express high level fzd2 wnt5ab',\n",
       "  'ArticleTitle': 'A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.',\n",
       "  'Author': 'Gujral Taranjit S'},\n",
       " {'Abstract': ' despit massiv amount knowledg accumul p53 learn role tumor suppress new paper provid evid level mdm2 human presenc mutant form p53 mice profound impact surviv tumorigenesi these find lead new diagnost therapeut approach treat cancer patient',\n",
       "  'ArticleTitle': 'P53 and prognosis: new insights and further complexity.',\n",
       "  'Author': 'Vousden Karen H'},\n",
       " {'Abstract': ' pd1 immun checkpoint blockad provid signific clinic benefit melanoma patient we analyz somat mutanom transcriptom pretreat melanoma biopsi identifi factor influenc innat sensit resist antipd1 therapi we high mutat load associ improv surviv tumor respond patient enrich mutat dna repair gene brca2 innat resist tumor display transcript signatur refer ipr innat antipd1 resist indic concurr upexpress gene involv regul mesenchym transit cell adhes extracellular matrix remodel angiogenesi wound heal notabl mitogenactiv protein kinas mapktarget therapi mapk inhibitor induc similar signatur melanoma suggest nongenom form mapk inhibitor resist mediat crossresist antipd1 therapi valid ipr independ tumor cohort defin transcriptom subset distinct type advanc cancer these find suggest attenu biolog process underli ipr improv antipd1 respons melanoma cancer type',\n",
       "  'ArticleTitle': 'Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.',\n",
       "  'Author': 'Hugo Willy'},\n",
       " {'Abstract': ' tumorspecif pyruv kinas m2 pkm2 essenti warburg effect in addit wellestablish role aerob glycolysi pkm2 direct regul gene transcript howev mechan under nonmetabol function pkm2 remain elus we pkm2 direct bind histon h3 phosphoryl histon h3 t11 egf receptor activ this phosphoryl requir dissoci hdac3 ccnd1 myc promot region subsequ acetyl histon h3 k9 pkm2depend histon h3 modif instrument egfinduc express cyclin d1 cmyc tumor cell prolifer cellcycl progress brain tumorigenesi in addit level histon h3 t11 phosphoryl correl nuclear pkm2 express level glioma malign grade prognosi these find highlight role pkm2 protein kinas nonmetabol function histon modif essenti epigenet regul gene express tumorigenesi',\n",
       "  'ArticleTitle': 'PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.',\n",
       "  'Author': 'Yang Weiwei'},\n",
       " {'Abstract': ' it great therapeut understand tumor relaps failur therapi target oncogen cancer cell addict in issu kapoor al shao al identifi transcript coactiv yap1 central driver compens loss kras signal krasdepend cancer',\n",
       "  'ArticleTitle': 'YAP1 takes over when oncogenic K-Ras slumbers.',\n",
       "  'Author': 'Greten Florian R'},\n",
       " {'Abstract': ' the genet depend human cancer wide vari here catalog heterogen identifi function gene interact genotypedepend liabil cancer by genomewid crisprbas screen generat gene essenti dataset 14 human acut myeloid leukemia aml cell line set gene correl pattern essenti line reveal new gene relationship essenti substrat enzym molecular function uncharacter protein comparison differenti essenti gene rasdepend independ line uncov synthet lethal partner oncogen ras screen human aml engin mous prob cell converg surpris small number gene ras process mapk pathway pinpoint prex1 amlspecif activ mapk signal our find suggest general strategi defin mammalian gene network synthet lethal interact exploit natur genet epigenet divers human cancer cell',\n",
       "  'ArticleTitle': 'Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.',\n",
       "  'Author': 'Wang Tim'},\n",
       " {'Abstract': ' inflammasom complex function key innat immun effector trigger inflamm respons pathogen dangerassoci signal here report germlin mutat inflammasom sensor nlrp1 caus two overlap skin disord multipl selfheal palmoplantar carcinoma mspc famili keratosi lichenoid chronica fklc we nlrp1 promin inflammasom sensor human skin pathogen nlrp1 mutat gainoffunct allel predispos inflammasom activ mechanist nlrp1 mutat lead increas selfoligomer disrupt pyd lrr domain essenti maintain nlrp1 inact monom primari keratinocyt patient experi spontan inflammasom activ paracrin il1 signal suffici caus skin inflamm epiderm hyperplasia our find establish group nonfev inflammasom disord uncov unexpect autoinhibitori function pyrin domain provid first genet evid link nlrp1 skin inflammatori syndrom skin cancer predisposit',\n",
       "  'ArticleTitle': 'Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation.',\n",
       "  'Author': 'Zhong Franklin L'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: p53 posttranslational modifications.',\n",
       "  'Author': 'Kruse Jan-Philipp'},\n",
       " {'Abstract': ' in era nextgener sequenc signific challeng har cancer genom inform develop novel therapi key research thrust academia industri speed transit lesson learn cancer broad shape process genet contribut therapi diseas broad',\n",
       "  'ArticleTitle': 'A blueprint for advancing genetics-based cancer therapy.',\n",
       "  'Author': 'Sellers William R'},\n",
       " {'Abstract': ' receptorinteract protein kinas ripk1 involv ripk3depend independ signal pathway lead cell death andor inflamm genet ablat ripk1 caus postnat lethal prevent delet ripk3 caspase8 fadd howev anim lack ripk1 ripk3 caspase8 fadd surviv wean matur ripk1 function vitro limit caspase8depend tnfrinduc apoptosi anim lack ripk1 ripk3 tnfr1 surviv adulthood the role ripk3 promot lethal ripk1 mice suggest ripk3 activ inhibit ripk1 postbirth wherea tnfrinduc ripk3depend necroptosi requir ripk1 cell lack ripk1 sensit necroptosi trigger poli ic interferon disrupt tlr trif i interferon ifnar signal delay lethal ripk1tnfr1 mice these result clarifi complex role ripk1 postnat life provid insight regul faddcaspase8 ripk3mlkl signal ripk1',\n",
       "  'ArticleTitle': 'RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.',\n",
       "  'Author': 'Dillon Christopher P'},\n",
       " {'Abstract': ' the xlink foxp3 member forkheadwing helix transcript factor famili germlin mutat caus lethal autoimmun diseas male serendipit observ femal mice heterozyg scurfin mutat foxp3 gene foxp3sf develop cancer high rate the major cancer mammari carcinoma wildtyp foxp3 allel inactiv her2erbb2 overexpress foxp3 bound repress her2erbb2 promot delet function signific somat mutat downregul foxp3 gene common human breast cancer sampl correl her2erbb2 overexpress regardless status her2 amplif our data demonstr foxp3 xlink breast cancer suppressor gene regul her2erbb2 oncogen',\n",
       "  'ArticleTitle': 'FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.',\n",
       "  'Author': 'Zuo Tao'},\n",
       " {'Abstract': ' choic consequ immun cell survey migrat bodi resid nich environ distinct communiti cell extracellular matrix nutrient differ matur imbed immun cell physiolog metabol pathway metabolit provid energi substrat growth surviv instruct effector function differenti gene express this review immunometabol refer recent literatur cover choic environ impos metabol function immun cell highlight consequ homeostasi diseas',\n",
       "  'ArticleTitle': 'Metabolic Instruction of Immunity.',\n",
       "  'Author': 'Buck Michael D'},\n",
       " {'Abstract': ' the epiderm growth factor receptor egfr upregul numer human cancer inhibit egfr signal induc autophagi tumor cell here report unanticip role inact egfr autophagi initi inact egfr interact oncoprotein laptm4b requir endosom accumul egfr serum starvat inact egfr laptm4b stabil endosom recruit exocyst subcomplex contain sec5 we inact egfr laptm4b sec5 subcomplex requir basal starvationinduc autophagi laptm4b sec5 promot egfr associ autophagi inhibitor rubicon turn disassoci beclin 1 rubicon initi autophagi thus oncoprotein laptm4b facilit role inact egfr autophagi initi this pathway posit control tumor metabol promot tumor cell surviv serum depriv metabol stress',\n",
       "  'ArticleTitle': 'A kinase-independent role for EGF receptor in autophagy initiation.',\n",
       "  'Author': 'Tan Xiaojun'},\n",
       " {'Abstract': ' we clinic tissu lethal metastat castrationresist prostat cancer crpc patient rapid autopsi evalu divers genom transcriptom phosphoproteom dataset pathway analysi use tie diffus interact event tiedi integr differenti express master transcript regul function mutat gene differenti activ kinas crpc tissu synthes robust signal network consist druggabl kinas pathway use msigdb hallmark gene set six major signal pathway phosphoryl key residu enrich crpc tumor incorpor phosphoproteom data individu autopsi profil develop hallmark reveal clinic relev pathway inform potenti suitabl patient stratif target therapi late stage prostat cancer here describ phosphorylationbas cancer hallmark integr person signatur pchip shed light divers activ signal pathway metastat crpc provid integr pathwaybas refer drug priorit individu patient',\n",
       "  'ArticleTitle': 'Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.',\n",
       "  'Author': 'Drake Justin M'},\n",
       " {'Abstract': ' to provid detail analysi molecular compon under mechan associ ovarian cancer perform comprehens massspectrometrybas proteom character 174 ovarian tumor analyz the cancer genom atlas tcga 169 highgrad serous carcinoma hgscs integr proteom measur genom data yield number insight diseas differ copynumb altern influenc proteom protein associ chromosom instabl set signal pathway divers genom rearrang converg one associ short surviv specif protein acetyl associ homolog recombin defici suggest potenti mean stratifi patient therapi in addit provid valuabl resourc find provid view somat genom drive cancer proteom associ protein posttransl modif level clinic outcom hgsc video abstract',\n",
       "  'ArticleTitle': 'Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.',\n",
       "  'Author': 'Zhang Hui'},\n",
       " {'Abstract': ' the epithelialmesenchym transit emt associ acquisit motil invas selfrenew trait dure normal develop tumor pathogenesi chang cell phenotyp induc contextu signal epitheli cell receiv microenviron the signal respons induc emt maintain result cellular state unclear we describ three signal pathway involv transform growth factor tgf canon noncanon wnt signal collabor induc activ emt program function autocrin fashion maintain result mesenchym state downregul endogen synthes inhibitor autocrin signal epitheli cell enabl induct emt program convers disrupt autocrin signal ad inhibitor pathway inhibit migrat selfrenew primari mammari epitheli cell reduc tumorigen metastasi transform deriv',\n",
       "  'ArticleTitle': 'Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.',\n",
       "  'Author': 'Scheel Christina'},\n",
       " {'Abstract': ' this snapshot provid list tumor type character the cancer genom atlas tcga program key find relev discoveri describ marker paper tumor',\n",
       "  'ArticleTitle': 'SnapShot: TCGA-Analyzed Tumors.',\n",
       "  'Author': 'Blum Amy'},\n",
       " {'Abstract': ' the role enhanc key class noncod regulatori dna element cancer develop increas appreci here detect character larg number express enhanc genomewid analysi 8928 tumor sampl 33 cancer type tcga rnaseq data compar match normal tissu global enhanc activ observ cancer across cancer type global enhanc activ posit associ aneuploidi mutat load suggest hypothesi center chromatinst explain interplay integr eqtl mrna coexpress hic data analysi develop comput method infer causal enhancergen interact reveal enhanc clinic action gene have identifi enhanc 140 kb downstream pdl1 major immunotherapi target valid experiment this studi provid systemat view enhanc activ divers tumor context suggest clinic implic enhanc',\n",
       "  'ArticleTitle': 'A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.',\n",
       "  'Author': 'Chen Han'},\n",
       " {'Abstract': ' although cervic human papillomavirus 16 hpv16 infect undetect 12 year persist hpv16 caus half cervic cancer we novel hpv wholegenom sequenc techniqu evalu except larg collect 5570 hpv16infect casecontrol sampl determin viral genet variat influenc risk cervic precanc cancer we observ thousand uniqu hpv16 genom women share ident hpv16 sequenc stimul care reevalu clinic implic hpv mutat rate transmiss clearanc persist in casecontrol analys hpv16 control amino acid chang variant genom strike e7 devoid variant precancerscanc compar higher level control confirm cancer world strict conserv 98 amino acid e7 disrupt rb function critic hpv16 carcinogenesi present high specif target etiolog therapeut research',\n",
       "  'ArticleTitle': 'HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.',\n",
       "  'Author': 'Mirabello Lisa'},\n",
       " {'Abstract': ' the hif transcript factor promot adapt hypoxia stimul growth certain cancer includ tripleneg breast cancer tnbc the hif subunit prolylhydroxyl egln famili member normox condit caus rapid degrad we confirm tnbc cell secret glutam necessari suffici paracrin induct hif1 cell normox condit glutam inhibit xct glutamatecystin antiport lead intracellular cystein deplet egln1 main hif prolylhydroxylas undergo oxid selfinactiv absenc cystein biochem assay cell result hif1 accumul therefor egln1 sens oxygen cystein',\n",
       "  'ArticleTitle': 'Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.',\n",
       "  'Author': 'Briggs Kimberly J'},\n",
       " {'Abstract': ' the mutat overexpress epiderm growth factor receptor egfr associ develop varieti cancer make prototyp dimerizationactiv receptor tyrosin kinas promin target cancer drug use longtimescal molecular dynam simul n lobe dimer interfac wildtyp egfr kinas domain intrins disord order dimer our simul suggest cancerlink mutat distal dimer interfac widespread l834r mutat refer l858r facilit egfr dimer suppress local disord corrobor find biophys experi kinas enzymat assay indic l834r mutat caus abnorm high activ promot egfr dimer allow activ dimer we phosphoryl egfr kinas domain tyr845 suppress intrins disord suggest molecular mechan autonom egfr signal',\n",
       "  'ArticleTitle': 'Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization.',\n",
       "  'Author': 'Shan Yibing'},\n",
       " {'Abstract': ' tumor necrosi factor tnf constitut critic host defens tuberculosi excess implic tuberculosi pathogenesi zebrafish human use zebrafish elucid pathway tnf mediat tuberculosi pathogenesi tnf excess induc mitochondri reactiv oxygen speci ros infect macrophag rip1rip3depend pathway while initi increas macrophag microbicid activ ros rapid induc program necrosi necroptosi releas mycobacteria growthpermiss extracellular milieu tnfinduc necroptosi occur two pathway modul mitochondri cyclophilin d implic mitochondri permeabl transit pore format acid sphingomyelinasemedi ceramid product combin genet blockad cyclophilin d acid sphingomyelinas render high tnf state hyperresist prevent macrophag necrosi preserv increas microbicid activ similar cyclophilin dinhibit drug alisporivir acid sphingomyelinaseinactiv drug desipramin synerg revers suscept suggest therapeut potenti oral activ drug tuberculosi possibl tnfmediat diseas',\n",
       "  'ArticleTitle': 'TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species.',\n",
       "  'Author': 'Roca Francisco J'},\n",
       " {'Abstract': ' the develop solid tumor regul dynam interact evolv neoplast cell microenviron luo al 2007 demonstr tumorinfiltr immun cell express rankl induc activ nuclear local ikkalpha prostat epitheli tumor cell this lead repress maspin critic suppressor metastasi commit malign prostat epitheli cell metastat fate',\n",
       "  'ArticleTitle': 'IKKalpha at the crossroads of inflammation and metastasis.',\n",
       "  'Author': 'Affara Nesrine I'},\n",
       " {'Abstract': ' rna interfer power tool studi gene function reproduc generat rnai transgen mice remain signific limit by combin optim fluorescencecoupl mir30bas shrnas high effici es cell target develop fast scalabl pipelin product shrna transgen mice use system generat eight tetregul shrna transgen line target firefli renilla luciferas oct4 tumor suppressor p53 p16ink4a p19arf apc demonstr potent gene silenc gfptrack knockdown broad rang tissu vivo further shrna target apc illustr approach identifi predict phenotyp unknown function wellstudi gene in addit regul gene silenc valid apcwnt p19arf potenti therapeut target t cell acut lymphoblast leukemialymphoma lung adenocarcinoma respect this system provid costeffect scalabl platform product rnai transgen mice target mammalian gene paperclip',\n",
       "  'ArticleTitle': 'A rapid and scalable system for studying gene function in mice using conditional RNA interference.',\n",
       "  'Author': 'Premsrirut Prem K'},\n",
       " {'Abstract': ' breast cancer bc compris multipl distinct subtyp differ genet patholog clinic here describ robust protocol longterm cultur human mammari epitheli organoid use protocol 100 primari metastat bc organoid line generat broad recapitul divers diseas bc organoid morpholog typic match histopatholog hormon receptor status her2 status origin tumor dna copi number variat well sequenc chang consist tumororganoid pair larg retain even extend passag bc organoid furthermor popul major geneexpressionbas classif group allow vitro drug screen consist vivo xenotransplant patient respons this studi describ repres collect wellcharacter bc organoid avail cancer research drug develop well strategi assess vitro drug respons person fashion',\n",
       "  'ArticleTitle': 'A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.',\n",
       "  'Author': 'Sachs Norman'},\n",
       " {'Abstract': ' chromosom transloc hallmark leukemialymphoma appear solid tumor under mechan remain elus by establish cellular model mimic relat frequenc authent transloc event prolifer select report mechan nuclear receptordepend tumor transloc intron bind ligand androgen receptor ar first juxtapos transloc loci trigger intra interchromosom interact ar promot sitespecif dna doublestrand break dsbs transloc loci recruit two type enzymat activ induc genotox stress ligand ar includ activationinduc cytidin deaminas line1 repeatencod orf2 endonucleas these enzym synergist generat siteselect dsbs juxtapos transloc loci ligat nonhomolog end join pathway specif transloc our data suggest confluenc two parallel pathway initi ligand nuclear receptor genotox stress under nonrandom tumor transloc function type tumor patholog process',\n",
       "  'ArticleTitle': 'Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.',\n",
       "  'Author': 'Lin Chunru'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Snapshot: genetic mouse models of cancer.',\n",
       "  'Author': 'Zender Lars'},\n",
       " {'Abstract': ' human inherit heterozyg brca2 mutat increas risk develop cancer trigger carcinogenesi individu unclear tan al environment metabol aldehyd pose threat individu promot degrad wildtyp brca2 protein predispos genom instabl cancer',\n",
       "  'ArticleTitle': 'Aldehydes Pose a Threat to BRCA2 Mutation Carriers.',\n",
       "  'Author': 'Parmar Kalindi'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Translating research into therapies.',\n",
       "  'Author': 'Glimcher Laurie H'},\n",
       " {'Abstract': ' in colorect cancer patient high densiti cytotox cd8',\n",
       "  'ArticleTitle': 'Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.',\n",
       "  'Author': 'Ziegler Paul K'},\n",
       " {'Abstract': ' as cancer cell genom unveil breathtak pace genet principl play cancer emerg complex prompt assess classic genet interact model here discuss implic find cancer progress heterogen develop new therapeut approach',\n",
       "  'ArticleTitle': 'Genetic interactions in cancer progression and treatment.',\n",
       "  'Author': 'Ashworth Alan'},\n",
       " {'Abstract': ' build year basic scientif discoveri recent advanc field cancer genet medicin chemistri converg revolution treatment cancer start serendipit observ rare subset cancer paradigm shift clinic research pois ensur new molecular insight rapid appli shape emerg cancer therapi could mark turn point war cancer',\n",
       "  'ArticleTitle': 'The evolving war on cancer.',\n",
       "  'Author': 'Haber Daniel A'},\n",
       " {'Abstract': ' tumor long suspect hijack stem cell mechan tissu mainten repair ge al skin tumor exhibit merg chromatin profil distinct stem cell lineag this lineag infidel recreat state akin transient wound repair persist maintain uncontrol growth',\n",
       "  'ArticleTitle': \"Don't Stop Re-healin'! Cancer as an Ongoing Stem Cell Affair.\",\n",
       "  'Author': 'Rowbotham Samuel P'},\n",
       " {'Abstract': ' pediatr central nervous system primit neuroectoderm brain tumor cnspnet rare tumor illdefin biolog featur in issu cell sturm al stateoftheart method interrog tumor biolog their integr molecular analys led propos new molecular classif four new entiti identifi oncologist attent',\n",
       "  'ArticleTitle': 'Revisiting Management of Pediatric Brain Tumors with New Molecular Insights.',\n",
       "  'Author': 'Zaky Wafik'},\n",
       " {'Abstract': ' to stem spiral cost cancer treatment concert effort urgent need develop molecular diagnost better identifi patient respond expens target therapi opportun obstacl develop drug respons biomark discuss',\n",
       "  'ArticleTitle': \"It's diagnostics, stupid.\",\n",
       "  'Author': u'Bernards Ren\\xe9'},\n",
       " {'Abstract': ' the p53 tumor suppressor belong famili protein sens multipl cellular input regul cell prolifer apoptosi differenti whether function p53 intersect activ extracellular growth factor understood here report key cellular respons tgfbeta signal reli p53 famili member dure xenopus embryon develop p53 promot activ multipl tgfbeta target gene moreov mesoderm differenti inhibit p53deplet embryo in mammalian cell full transcript activ cdk inhibitor p21waf1 tgfbeta requir p53 p53defici cell display impair cytostat respons tgfbeta signal smad p53 protein complex converg separ cis bind element target promot synergist activ tgfbeta induc transcript p53 physic interact vivo smad2 tgfbetadepend fashion the result unveil unrecogn link two primari tumor suppressor pathway vertebr',\n",
       "  'ArticleTitle': 'Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.',\n",
       "  'Author': 'Cordenonsi Michelangelo'},\n",
       " {'Abstract': ' tripleneg breast cancer tnbc aggress subtyp frequent develop resist chemotherapi an unresolv question resist caus select rare preexist clone altern acquisit new genom aberr to question appli singlecel dna rna sequenc addit bulk exom sequenc profil longitudin sampl 20 tnbc patient neoadjuv chemotherapi nac deepexom sequenc identifi 10 patient nac led clonal extinct 10 patient clone persist treatment in 8 patient perform detail studi singlecel dna sequenc 900 cell singlecel rna sequenc 6862 cell our data resist genotyp preexist adapt select nac transcript profil acquir reprogram respons chemotherapi tnbc patient',\n",
       "  'ArticleTitle': 'Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.',\n",
       "  'Author': 'Kim Charissa'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'The multiple roles of PTEN in tumor suppression.',\n",
       "  'Author': 'Di Cristofano A'},\n",
       " {'Abstract': ' the human microbiota great affect physiolog diseas contribut bacteria respons chemotherapeut drug remain poor understood caenorhabd elegan bacteri diet provid power system studi hostbacteria interact here system studi bacteria affect c elegan respons chemotherapeut we differ bacteri speci increas respons one drug decreas effect we perform genet screen two bacteri speci three chemotherapeut drug 5fluorouracil 5fu 5fluoro2deoxyuridin fudr camptothecin cpt we numer bacteri nucleotid metabol gene affect drug efficaci c elegan surpris 5fu fudr act bacteri ribonucleotid metabol elicit cytotox effect c elegan thymineless death dna damag our studi provid blueprint character role bacteria host respons chemotherapeut',\n",
       "  'ArticleTitle': u'Bacterial Metabolism Affects the C.\\xa0elegans Response to Cancer Chemotherapeutics.',\n",
       "  'Author': u'Garc\\xeda-Gonz\\xe1lez Aurian P'},\n",
       " {'Abstract': ' fluoropyrimidin firstlin treatment colorect cancer efficaci high variabl patient we queri gut microb known sourc interindividu variabl impact drug efficaci combin two tractabl genet model bacterium e coli nematod c elegan perform threeway highthroughput screen unravel complex under hostmicrobedrug interact we report microb bolster suppress effect fluoropyrimidin metabol drug interconvers involv bacteri vitamin b',\n",
       "  'ArticleTitle': u'Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C.\\xa0elegans.',\n",
       "  'Author': 'Scott Timothy A'},\n",
       " {'Abstract': ' epigenet mechan propos play crucial role mammalian develop precis function partial understood to epigenet regul embryon develop differenti human embryon stem cell mesendoderm neural progenitor cell trophoblastlik cell mesenchym stem cell systemat character dna methyl chromatin modif transcriptom lineag we promot activ earli development stage tend cg rich engag h3k27me3 silenc nonexpress lineag by contrast promot gene express preferenti later stage cg poor employ dna methyl repress interest earli development regulatori gene locat larg genom domain general devoid dna methyl lineag term dna methyl valley dmvs our result suggest distinct epigenet mechan regul earli late stage es cell differenti',\n",
       "  'ArticleTitle': 'Epigenomic analysis of multilineage differentiation of human embryonic stem cells.',\n",
       "  'Author': 'Xie Wei'},\n",
       " {'Abstract': ' inhibitor apoptosi protein iap xiap ciap1 ciap2 upregul cancer cell it thought smallmolecul mimet smac endogen iap antagonist potenti apoptosi cancer cell promot caspas activ howev three recent paper two cell vinc al 2007 varfolomeev al 2007 one cancer cell petersen al 2007 report smac mimet kill cancer cell differ mechan induct autoubiquitin degrad ciap culmin tnfalphamedi cell death',\n",
       "  'ArticleTitle': 'Smac mimetics and TNFalpha: a dangerous liaison?',\n",
       "  'Author': 'Wu Hao'},\n",
       " {'Abstract': ' rna interfer promot ideal tool function genom date success stori princip model organ two paper issu cell chang rna interfer librari target larg proport human genom uncov two novel tumor suppressor gene rest transcript repressor silenc neuronspecif gene express pitx1 homeodomain transcript factor promot express negat regul ras',\n",
       "  'ArticleTitle': 'RNA interference libraries prove their worth in hunt for tumor suppressor genes.',\n",
       "  'Author': 'Downward Julian'},\n",
       " {'Abstract': ' the unpreced resolut highthroughput genom enabl recent discoveri phenomenon specif region genom shatter stitch singl devast event refer chromothripsi potenti mechan govern process emerg implic understand role genom rearrang develop diseas',\n",
       "  'ArticleTitle': 'Chromothripsis and human disease: piecing together the shattering process.',\n",
       "  'Author': 'Maher Christopher A'},\n",
       " {'Abstract': ' aneuploidi incorrect chromosom number hallmark cancer compound caus lethal aneuploid euploid cell provid new cancer therapi we identifi energi stressinduc agent aicar protein fold inhibitor 17aag autophagi inhibitor chloroquin exhibit properti aicar induc p53mediat apoptosi primari mous embryon fibroblast mef trisom chromosom 1 13 16 19 aicar 17aag combin efficaci aneuploid human cancer cell line our result suggest compound interfer pathway essenti surviv aneuploid cell serv new treatment strategi broad spectrum human tumor',\n",
       "  'ArticleTitle': 'Identification of aneuploidy-selective antiproliferation compounds.',\n",
       "  'Author': 'Tang Yun-Chi'},\n",
       " {'Abstract': ' a critic unresolv issu genotox stress respons result activ p53 tumor suppressor lead cellcycl arrest dna repair apoptosi we hematopoiet zinc finger hzf zincfingercontain p53 target gene modul p53 transactiv function autoregulatori feedback loop hzf induc p53 bind dnabind domain result preferenti transactiv proarrest p53 target gene proapoptot target gene thus p53 activ result cellcycl arrest hzf wildtyp mef hzf mef apoptosi induc exposur hzf null mice ioniz radiat result enhanc apoptosi organ compar wildtyp mice these find provid novel insight regul p53 transactiv function suggest hzf function key player regul cell fate decis respons genotox stress',\n",
       "  'ArticleTitle': 'Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.',\n",
       "  'Author': 'Das Sanjeev'},\n",
       " {'Abstract': ' the p53 tumor suppressor protein regul gene determin differ cellular outcom growth arrest cell death promoterselect transactiv p53 critic differ cellular outcom well understood we report human cellular apoptosi suscept protein hcascse1l associ subset p53 target promot includ pig3 p53autonom manner downregul hcascse1l decreas transcript p53 target promot preferenti bind reduc apoptosi in addit hcascse1l silenc lead increas methyl histon h3 lysin 27 pig3 gene hcascse1l function nucleocytoplasm transport factor close relat yeast homologu cse1 associ chromatin serv barrier protein prevent spread heterochromatin thus human cascse1l bind select gene signific function consequ p53mediat transcript determin cellular outcom',\n",
       "  'ArticleTitle': 'hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.',\n",
       "  'Author': 'Tanaka Tomoaki'},\n",
       " {'Abstract': ' ranbp2 nucleoporin sumo e3 ligas activ function nucleocytoplasm transport mitosi howev biolog relev ranbp2 vivo target e3 ligas activ unknown here anim low amount ranbp2 develop sever aneuploidi absenc overt transport defect the main chromosom segreg defect cell mice anaphasebridg format topoisomeras iialpha topo iialpha decaten sister centromer prior anaphas onset prevent bridg fail accumul inner centromer ranbp2 level low we ranbp2 sumoyl topo iialpha mitosi modif requir proper local inner centromer furthermor mice low amount ranbp2 high sensit tumor format togeth data identifi ranbp2 chromosom instabl gene regul topo iialpha sumoyl suppress tumorigenesi',\n",
       "  'ArticleTitle': 'Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.',\n",
       "  'Author': 'Dawlaty Meelad M'},\n",
       " {'Abstract': ' malat1 long noncod rna known misregul human cancer we identifi high conserv small rna 61 nucleotid origin malat1 locus broad express human tissu although long malat1 transcript local nuclear speckl small rna exclus cytoplasm rnase p cleav nascent malat1 transcript downstream genom encod polyarich tract simultan generat 3 end matur malat1 transcript 5 end small rna enzym involv trna biogenesi process small rna consist adopt trnalik structur our find reveal 3 end process mechan singl gene locus yield stabl nuclearretain noncod rna short polya taillik moieti small trnalik cytoplasm rna',\n",
       "  'ArticleTitle': \"3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.\",\n",
       "  'Author': 'Wilusz Jeremy E'},\n",
       " {'Abstract': ' neuroinflamm increas recogn potenti mediat cognit impair neurolog condit habba al demonstr proinflammatori cytokin tumor necrosi factor alpha signal astrocyt alter synapt transmiss impair cognit mous model multipl sclerosi',\n",
       "  'ArticleTitle': 'Astrocytes Underlie Neuroinflammatory Memory Impairment.',\n",
       "  'Author': 'Osso Lindsay A'},\n",
       " {'Abstract': ' myc oncoprotein direct regul transcript bind target gene explain fraction gene affect myc mrna turnov control aubind protein aubp recogn aurich element are transcript analys precancer malign mycexpress b cell reveal myc regul hundr arecontain are gene select aubp notabl myc direct suppress transcript tristetraprolin ttpzfp36 mrnadestabil aubp circuit oper b lymphopoiesi il7 signal import ttp suppress hallmark cancer myc involv restor ttp impair mycinduc lymphomagenesi abolish mainten malign state further select ttp loss malign ttp function tumor suppressor final mycttpdirect control select cancerassoci are gene disabl lymphomagenesi thus myc target aubp regul are gene control tumorigenesi',\n",
       "  'ArticleTitle': 'Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.',\n",
       "  'Author': 'Rounbehler Robert J'},\n",
       " {'Abstract': ' while function heterogen fibroblast cell popul tumor microenviron increas recogn lack definit marker complic elucid role ostens distinct fibroblast state in issu cell su al character new protumorigen cancerassoci fibroblast subset mediat chemoresist defin driven novel signal pathway',\n",
       "  'ArticleTitle': 'A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance.',\n",
       "  'Author': 'Huelsken Joerg'},\n",
       " {'Abstract': ' the gene express program establish maintain specif cell state human control thousand transcript factor cofactor chromatin regul misregul gene express program caus broad rang diseas here review recent advanc understand transcript regul discuss provid new insight transcript misregul diseas',\n",
       "  'ArticleTitle': 'Transcriptional regulation and its misregulation in disease.',\n",
       "  'Author': 'Lee Tong Ihn'},\n",
       " {'Abstract': ' dna doublestrand break dsbs multipl sourc includ exposur ioniz radiat the repair dsbs involv posttransl modif nucleosom concentr dnarepair protein site damag consequ nucleosom pack chromatin architectur surround dsb limit abil dnadamag respons access repair break here review earli chromatinbas event promot format open relax chromatin structur dsbs allow dnarepair machineri access spatial confin region surround dsb facilit mammalian dsb repair',\n",
       "  'ArticleTitle': 'Chromatin remodeling at DNA double-strand breaks.',\n",
       "  'Author': 'Price Brendan D'},\n",
       " {'Abstract': ' although genomewid hypomethyl hallmark cancer role activ dna demethyl tumorigenesi unknown here loss apc tumor suppressor gene caus upregul dna demethylas system concomit hypomethyl key intestin cell fate gene notabl hypomethyl maintain zebrafish intestin cell undifferenti state releas knockdown demethylas compon mechanist demethylas gene direct activ pou5f1 cebp indirect repress retino acid antagon pou5f1 cebp apc mutant lack retino acid result transcript repress retinol dehydrogenas l1 complex includ lef1 groucho2 ctbp1 lsd1 corest our find impli model apc control intestin cell fate switch dna methyl dynam wildtyp apc retino acid downregul demethylas compon promot dna methyl key gene help progenitor commit differenti',\n",
       "  'ArticleTitle': 'DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC.',\n",
       "  'Author': 'Rai Kunal'},\n",
       " {'Abstract': ' program cell death pcd play fundament role anim develop tissu homeostasi abnorm regul process associ wide varieti human diseas includ immunolog development disord neurodegener cancer here provid brief histor overview field reflect regul role mode pcd anim develop we discuss function regul apoptot protein includ caspas key execution apoptosi review nonleth function protein divers development process cell differenti tissu remodel final explor grow bodi work connect apoptosi stem cell cancer focus apoptot cell releas varieti signal communic cellular environ includ factor promot cell divis tissu regener wound heal',\n",
       "  'ArticleTitle': 'Programmed cell death in animal development and disease.',\n",
       "  'Author': 'Fuchs Yaron'},\n",
       " {'Abstract': ' dysregul splice altern splice under genet acquir diseas we overview recent strategi success modul splice therapeut clinic preclin context effect approach includ restor open read frame influenc altern splice induc exon inclus generat benefici protein remov deleteri one',\n",
       "  'ArticleTitle': 'Splice modulating therapies for human disease.',\n",
       "  'Author': 'Spitali Pietro'},\n",
       " {'Abstract': ' growth prostat cancer cell depend androgen stimul androgen receptor ar dihydrotestosteron dht potent androgen synthes prostat testosteron secret testi follow chemic surgic castrat prostat cancer shrink testosteron depriv howev tumor recur form castrationresist prostat cancer crpc here crpc express gainofst mutat lead gainoffunct 3hydroxysteroid dehydrogenas 1 3hsd1 catalyz initi ratelimit step convers adrenalderiv steroid dehydroepiandrosteron dht the mutat n367t affect catalyt function render enzym resist ubiquitin degrad lead profound accumul wherea dehydroepiandrosteron convers dht limit express 367t acceler convers provid dht necessari activ ar we suggest 3hsd1 valid target treatment crpc',\n",
       "  'ArticleTitle': 'A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.',\n",
       "  'Author': 'Chang Kai-Hsiung'},\n",
       " {'Abstract': ' degrad cytosol catenin apcaxin1 destruct complex repres key regul step wnt pathway it incomplet understood axin1 complex exert wntregul function here examin mechan wnt signal endogen level axin1 complex our result demonstr catenin phosphoryl insid axin1 complex ubiquin degrad proteasom intact axin1 complex in disagr current view disassembl complex inhibit phosphoryl axin1bound catenin wnt signal similar observ primari intestin epithelium colorect cancer cell line carri activ wnt pathway mutat wnt signal suppress catenin ubiquitin occur complex lead complex satur accumul phosphocatenin subsequ newli synthes catenin accumul free cytosol form engag nuclear tcf transcript factor',\n",
       "  'ArticleTitle': u'Wnt signaling through inhibition of \\u03b2-catenin degradation in an intact Axin1 complex.',\n",
       "  'Author': 'Li Vivian S W'},\n",
       " {'Abstract': ' inhibitor apoptosi iap protein antiapoptot regul block cell death respons divers stimuli they express elev level human malign attract target develop novel cancer therapeut herein demonstr smallmolecul iap antagonist bind select baculovirus iap repeat bir domain result dramat induct autoubiquitin activ rapid proteasom degrad ciap the iap antagonist induc cell death depend tnf signal novo protein biosynthesi addit ciap protein function regul nfkappab signal through ubiquitin e3 ligas activ ciap1 ciap2 promot proteasom degrad nik central serthr kinas noncanon nfkappab pathway',\n",
       "  'ArticleTitle': 'IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.',\n",
       "  'Author': 'Varfolomeev Eugene'},\n",
       " {'Abstract': ' chang dna copi number confin specif gene affect whole chromosom identifi caus diseas development abnorm sourc adapt potenti here discuss cost benefit dna copynumb alter chang dna copi number larg detriment amplif delet specif gene elicit discret defect largescal chang dna copi number caus detriment phenotyp cumul effect copynumb alter gene simultan on hand studi microorgan dna copynumb alter benefici increas surviv select pressur as dna copynumb alter underli human diseas end discuss gene copynumb chang therapeut target',\n",
       "  'ArticleTitle': 'Gene copy-number alterations: a cost-benefit analysis.',\n",
       "  'Author': 'Tang Yun-Chi'},\n",
       " {'Abstract': ' histon h2ax phosphoryl chromatin domain flank site dna doublestrand breakag associ gammairradi meiotic recombin dna replic antigen receptor rearrang here loss singl h2ax allel compromis genom integr enhanc suscept cancer absenc p53 in comparison heterozygot tumor earlier h2ax homozyg null background h2ax p53 lymphoma harbor increas frequenc clonal nonreciproc transloc amplif these includ complex rearrang juxtapos cmyc oncogen antigen receptor loci restor h2ax null allel wildtyp h2ax restor genom stabil radiat resist effect abolish substitut conserv serin phosphoryl site h2ax alanin glutam acid residu our result establish h2ax genom caretak requir function gene allel optim protect tumorigenesi',\n",
       "  'ArticleTitle': 'H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.',\n",
       "  'Author': 'Celeste Arkady'},\n",
       " {'Abstract': ' complex genom rearrang cgrs consist two breakpoint junction observ genom disord recent chromosom catastroph phenomenon term chromothripsi numer genom rearrang appar acquir one singl catastroph event describ multipl cancer here constitut acquir cgrs share similar cancer chromothripsi in 17 cgr case investig observ local multipl copi number chang includ delet duplic andor triplic well extens transloc invers genom rearrang involv vari size complex one case array compar genom hybrid reveal 18 copi number chang breakpoint sequenc identifi characterist featur includ small templat insert breakpoint microhomolog breakpoint junction attribut replic process the resembl cgr chromothripsi suggest similar mechanist underpin such chromosom catastroph event appear reflect basic dna metabol oper organ life cycl',\n",
       "  'ArticleTitle': 'Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements.',\n",
       "  'Author': 'Liu Pengfei'},\n",
       " {'Abstract': ' dna demethyl agent approv blood malign activ investig solid tumor drug work remain unclear in issu cell two group agent activ toxic cellular antivir program transcript activ endogen retrovir sequenc',\n",
       "  'ArticleTitle': 'DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.',\n",
       "  'Author': 'Licht Jonathan D'},\n",
       " {'Abstract': ' the tumor suppressor pten critic regul multipl cellular process mutat delet frequent human cancer subtl reduct pten express level profound impact carcinogenesi here pten level regul ubiquitinmedi proteasom degrad purifi ubiquitin ligas hectdomain protein nedd41 in cell nedd41 negat regul pten stabil catalyz pten polyubiquitin consist tumorsuppress role pten overexpress nedd41 potenti cellular transform strike mous cancer model multipl human cancer sampl genet background pten normal protein level low nedd41 high express suggest aberr upregul nedd41 posttransl suppress pten cancer elimin nedd41 express inhibit xenotranspl tumor growth ptendepend manner therefor nedd41 potenti protooncogen negat regul pten ubiquitin paradigm analog mdm2 p53',\n",
       "  'ArticleTitle': 'NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.',\n",
       "  'Author': 'Wang Xinjiang'},\n",
       " {'Abstract': ' threedimension 3d vitro model span gap twodimension cell cultur wholeanim system by mimick featur vivo environ take advantag tool studi cell tradit cell cultur 3d model provid uniqu perspect behavior stem cell develop tissu organ tumor these model help acceler translat research cancer biolog tissu engin',\n",
       "  'ArticleTitle': 'Modeling tissue morphogenesis and cancer in 3D.',\n",
       "  'Author': 'Yamada Kenneth M'},\n",
       " {'Abstract': ' find compon cellular circuit determin function systemat remain major challeng mammalian cell here introduc genomewid pool crisprcas9 librari dendrit cell dcs identifi gene control induct tumor necrosi factor tnf bacteri lipopolysaccharid lps key process host respons pathogen mediat tlr4 pathway we known regul tlr4 signal well dozen unknown candid valid by measur protein marker mrna profil dcs defici known candid gene classifi gene three function modul distinct effect canon respons lps highlight function paf complex oligosaccharyltransferas ost complex our find uncov new facet innat immun circuit primari cell provid genet approach dissect mammalian cell circuit',\n",
       "  'ArticleTitle': 'A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks.',\n",
       "  'Author': 'Parnas Oren'},\n",
       " {'Abstract': ' induct senesc perman restrict cellular prolifer oncogen stimul act potent barrier tumor develop the relev effector protein fundament cancer develop a recent studi identifi igfbp7 secret factor mediat melanocyt senesc induc oncogen braf common cutan nevi in contrast previous report demonstr braf signal induc igfbp7 express express igfbp7 target bnip3l smarcb1 pea15 human melanocyt fibroblast we correl braf mutat status igfbp7 protein express level 22 melanoma cell line 90 melanoma 46 benign nevi furthermor lentivir silenc strategi braf induc senesc melanocyt fibroblast irrespect presenc igfbp7 therefor conclud secret protein igfbp7 dispens brafv600einduc senesc human melanocyt',\n",
       "  'ArticleTitle': 'IGFBP7 is not required for B-RAF-induced melanocyte senescence.',\n",
       "  'Author': 'Scurr Lyndee L'},\n",
       " {'Abstract': ' the identif character cancer stem cell lead effect treatment cancer focus therapi malign cell to achiev goal necessari determin cancer follow cancer stem cell model address technic issu relat tumorigenesi assay test extent cancer cell heterogen aris genet versus epigenet differ',\n",
       "  'ArticleTitle': 'Heterogeneity in cancer: cancer stem cells versus clonal evolution.',\n",
       "  'Author': 'Shackleton Mark'},\n",
       " {'Abstract': ' metastasi occur genet unstabl cancer cell adapt tissu microenviron distant primari tumor this process involv select trait advantag cancer cell concomit recruit trait tumor stroma accommod invas metastat cell recent conceptu technolog advanc promot understand origin natur cancer metastasi',\n",
       "  'ArticleTitle': 'Cancer metastasis: building a framework.',\n",
       "  'Author': 'Gupta Gaorav P'},\n",
       " {'Abstract': ' diabet obes cancer affect upward 15 world popul interest three diseas juxtapos dysregul intracellular signal alter metabol state exact genet factor defin stabl metabol set point vivo remain poor understood here hedgehog signal rewir cellular metabol we identifi ciliumdepend smoca2ampk axi trigger rapid warburglik metabol reprogram minut activ requir proper metabol select flexibl we smo modul uncoupl smoampk axi canon signal identifi cyclopamin one new class select partial agonist capabl concomit inhibit canon activ noncanon hedgehog signal intrigu activ smoampk axi vivo drive robust insulinindepend glucos uptak muscl brown adipos tissu these data identifi multipl noncanon endpoint pivot ration design hedgehog modul provid new therapeut avenu obes diabet',\n",
       "  'ArticleTitle': 'Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.',\n",
       "  'Author': 'Teperino Raffaele'},\n",
       " {'Abstract': ' we employ gene target studi h2ax histon variant phosphoryl chromatin surround dna doublestrand break mice defici h2ax p53 hdeltadeltap rapid develop immatur t b lymphoma solid tumor moreov h2ax haploinsuffici caus genom instabl normal cell p53defici background earli onset tumor includ matur b lymphoma most h2axdeltadeltap53 h2axdeltap53 b lineag lymphoma harbor chromosom 12 igh15 cmyc transloc hallmark aberr vdj class switch recombin in contrast h2axdeltadeltap53 thymic lymphoma clonal transloc involv antigen receptor loci like occur cellular expans thus h2ax help prevent aberr repair program general dna breakag function dosagedepend suppressor genom instabl tumor mice notabl h2ax map cytogenet region frequent alter human cancer possibl implic similar function man',\n",
       "  'ArticleTitle': 'Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.',\n",
       "  'Author': 'Bassing Craig H'},\n",
       " {'Abstract': ' two studi one issu cell development cell cellfat determin brain tumor brat suppress selfrenew one daughter cell asymmetr divis neural stem cell this work suggest mechan loss polar stem cell lead tumorigenesi',\n",
       "  'ArticleTitle': 'Connecting cancer to the asymmetric division of stem cells.',\n",
       "  'Author': 'Wodarz Andreas'},\n",
       " {'Abstract': ' the tsc12 tumorsuppressor complex control protein synthesi regul mtor in issu cell inoki al 2006 report kinas gsk3 ampk cooper activ tsc2 inhibit mtor activ surpris phosphoryl tsc2 gsk3 mark suppress wnt signal this suggest compon mtor pathway therapeut target diseas link hyperact wnt signal',\n",
       "  'ArticleTitle': 'Mind the GAP: Wnt steps onto the mTORC1 train.',\n",
       "  'Author': 'Choo Andrew Y'},\n",
       " {'Abstract': ' the urea cycl uc main pathway mammal dispos wast nitrogen we specif alter express uc enzym occur tumor lead general metabol hallmark term uc dysregul ucd ucd elicit nitrogen divers carbamoylphosph synthetase2 aspart transcarbamylas dihydrooratas cad activ enhanc pyrimidin synthesi result detect chang nitrogen metabolit patient tumor biofluid the accompani excess pyrimidin versus purin nucleotid result genom signatur consist transvers mutat dna rna protein level this mutat bias associ increas number hydrophob tumor antigen better respons immun checkpoint inhibitor independ mutat load taken find demonstr ucd common featur tumor profound affect carcinogenesi mutagenesi immunotherapi respons',\n",
       "  'ArticleTitle': 'Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures.',\n",
       "  'Author': 'Lee Joo Sang'},\n",
       " {'Abstract': ' the analysi exon dna prostat cancer identifi recurr mutat gene spectrum genomewid alter profil extens diseas we sequenc genom 57 prostat tumor match normal tissu character somat alter studi accumul oncogenesi progress by model genesi genom rearrang identifi abund dna transloc delet high interdepend manner this phenomenon term chromoplexi frequent account dysregul prostat cancer gene appear disrupt multipl cancer gene coordin our model suggest chromoplexi induc consider genom derang relat event prostat cancer neoplasm support model punctuat cancer evolut by character clonal hierarchi genom lesion prostat tumor chart path oncogen event chromoplexi drive prostat carcinogenesi',\n",
       "  'ArticleTitle': 'Punctuated evolution of prostate cancer genomes.',\n",
       "  'Author': 'Baca Sylvan C'},\n",
       " {'Abstract': ' mani chemotherapeut drug kill fraction cancer cell limit efficaci we livecel imag role p53 dynam fraction kill colon cancer cell respons chemotherapi we surviv die cell reach similar level p53 indic cell death determin fix p53 threshold instead cell probabl death depend time level p53 cell reach threshold level p53 execut apoptosi threshold increas time the increas p53 apoptot threshold drugdepend induct antiapoptot gene inhibitor apoptosi iap famili our studi underlin measur dynam key player respons chemotherapi determin mechan resist optim time combin therapi',\n",
       "  'ArticleTitle': 'Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.',\n",
       "  'Author': 'Paek Andrew L'},\n",
       " {'Abstract': ' the hippo pathway crucial organ size control dysregul contribut tumorigenesi howev upstream signal regul mammalian hippo pathway remain elus here report hippo pathway regul gproteincoupl receptor gpcr signal serumborn lysophosphatid acid lpa sphingosin 1phosphoph s1p act g1213coupl receptor inhibit hippo pathway kinas lats12 activ yap taz transcript coactiv oncoprotein repress lats12 yap taz involv lpainduc gene express cell migrat prolifer in contrast stimul gscoupl receptor glucagon epinephrin activ lats12 kinas activ inhibit yap function thus gpcr signal activ inhibit hippoyap pathway depend coupl g protein our studi identifi extracellular diffus signal modul hippo pathway establish hippoyap pathway critic signal branch downstream gpcr',\n",
       "  'ArticleTitle': 'Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.',\n",
       "  'Author': 'Yu Fa-Xing'},\n",
       " {'Abstract': ' while mutat affect proteincod region examin cancer structur variant genomewid level poor defin through integr deep wholegenom transcriptom analysi 101 castrationresist prostat cancer metastas 109x tumor38x normal coverag identifi structur variant alter critic regul tumorigenesi progress detect exom approach notabl observ amplif intergen enhanc region 624 kb upstream androgen receptor ar 81 patient correl increas ar express tandem duplic hotspot occur near myc lncrnas associ posttransl myc regul class structur variat link distinct dna repair defici suggest etiolog includ associ cdk12 mutat tandem duplic tp53 inactiv invert rearrang chromothripsi brca2 inactiv delet togeth observ provid comprehens view structur variat affect critic regul metastat prostat cancer',\n",
       "  'ArticleTitle': 'Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.',\n",
       "  'Author': 'Quigley David A'},\n",
       " {'Abstract': ' the prostat cancer pca riskassoci snp rs11672691 posit associ aggress diseas diagnosi we rs11672691 map promot short isoform long noncod rna pcat19 pcat19short third intron long isoform pcat19long the risk variant associ decreas increas level pcat19short pcat19long respect mechanist risk snp region bifunct promot enhanc activ the risk variant rs11672691 ld snp rs887391 decreas bind transcript factor nkx31 yy1 promot pcat19short result weaker promot stronger enhanc activ subsequ activ pcat19long pcat19long interact hnrnpab activ subset cellcycl gene associ pca progress promot pca tumor growth metastasi taken find reveal risk snpmediat promoterenhanc switch mechan under initi progress aggress pca',\n",
       "  'ArticleTitle': 'Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.',\n",
       "  'Author': 'Hua Junjie Tony'},\n",
       " {'Abstract': ' genomewid associ studi gwas identifi rs11672691 19q13 associ aggress prostat cancer pca here independ confirm find cohort 2738 pca patient discov biolog mechan under associ we associ aggress pcaassoci allel g rs11672691 elev transcript level two biolog plausibl candid gene pcat19 ceacam21 implic pca cell growth tumor progress mechanist rs11672691 resid enhanc element alter bind site hoxa2 novel oncogen transcript factor prognost potenti pca remark crisprcas9medi singlenucleotid edit direct effect rs11672691 pcat19 ceacam21 express pca cellular aggress phenotyp clinic data demonstr synergist effect rs11672691 genotyp pcat19ceacam21 gene express pca prognosi these result provid plausibl mechan rs11672691 associ aggress pca lay ground work translat find clinic',\n",
       "  'ArticleTitle': 'Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.',\n",
       "  'Author': 'Gao Ping'},\n",
       " {'Abstract': ' tnfs main function stimul inflamm turn gene transcript ikknfkappab jnkap1 signal cascad tnf trigger apoptosi caspase8 role under mechan activ fulli understood here review recent data role jnk regul tnfdepend apoptosi discuss known far cell decid live die respons tnf',\n",
       "  'ArticleTitle': 'Tumor necrosis factor: an apoptosis JuNKie?',\n",
       "  'Author': 'Varfolomeev Eugene E'},\n",
       " {'Abstract': ' here unifi hypothesi messeng rnas transcrib pseudogen long noncod rnas talk microrna respons element mres letter new languag we propos compet endogen rna cerna activ form largescal regulatori network transcriptom great expand function genet inform human genom play role patholog condit cancer',\n",
       "  'ArticleTitle': 'A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?',\n",
       "  'Author': 'Salmena Leonardo'},\n",
       " {'Abstract': ' it wide believ inflamm associ obes role develop 2 diabet ib kinas beta ikk crucial kinas respond inflammatori stimuli tumor necrosi factor  tnf initi varieti intracellular signal cascad consid key element inflammationmedi develop insulin resist we contrari expect ikkmedi inflamm posit regul hepat glucos homeostasi ikk phosphoryl splice form xbox bind protein 1 xbp1s increas activ xbp1s we three experiment approach enhanc ikk activ liver obes mice observ increas xbp1s activ reduc er stress signific improv insulin sensit consequ glucos homeostasi our result reveal benefici role ikkmedi hepat inflamm glucos homeostasi',\n",
       "  'ArticleTitle': u'Inflammation Improves Glucose Homeostasis through IKK\\u03b2-XBP1s Interaction.',\n",
       "  'Author': 'Liu Junli'},\n",
       " {'Abstract': ' recent report indic hypoxia influenc circadian clock transcript activ hypoxiainduc factor hif clock gene unexpect uncov profound disrupt circadian clock diurnal transcriptom hypox cell permit acidifi recapitul tumor microenviron buffer acidif inhibit lactic acid product fulli rescu circadian oscil acidif human murin cell line well primari murin t cell suppress mechanist target rapamycin complex 1 mtorc1 signal key regul translat respons metabol status we acid drive peripher redistribut perinuclear lysosom away perinuclear rheb inhibit activ lysosomebound mtor restor mtorc1 signal translat govern rescu clock oscil our find reveal model acid produc cellular metabol respons hypoxia suppress circadian clock diminish translat clock constitu',\n",
       "  'ArticleTitle': 'Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR.',\n",
       "  'Author': 'Walton Zandra E'},\n",
       " {'Abstract': ' aberr wntbetacatenin signal follow loss tumor suppressor adenomat polyposi coli apc thought initi colon adenoma format use zebrafish human cell homozyg loss apc caus fail intestin cell differenti occur absenc nuclear betacatenin increas intestin cell prolifer therefor loss apc insuffici caus betacatenin nuclear local apc mutationinduc intestin differenti defect instead transcript corepressor ctermin bind protein1 ctbp1 prolifer defect nuclear accumul betacatenin requir addit activ kras these find suggest follow apc loss ctbp1 contribut adenoma initi first step kras activ betacatenin nuclear local promot adenoma progress carcinoma second step consist model human fap adenoma robust upregul ctbp1 absenc detect nuclear betacatenin nuclear betacatenin detect carcinoma',\n",
       "  'ArticleTitle': 'A two-step model for colon adenoma initiation and progression caused by APC loss.',\n",
       "  'Author': 'Phelps Reid A'},\n",
       " {'Abstract': ' use integr genom analysi 360 metastat castrationresist prostat cancer mcrpc sampl identifi novel subtyp prostat cancer typifi biallel loss cdk12 mutual exclus tumor driven dna repair defici et fusion spop mutat cdk12 loss enrich mcrpc relat clinic local diseas character focal tandem duplic ftds lead increas gene fusion mark differenti gene express ftds associ cdk12 loss result high recurr gain loci gene involv cell cycl dna replic cdk12 mutant case baselin diploid exhibit dna mutat signatur link defect homolog recombin cdk12 mutant case associ elev neoantigen burden ensu fusioninduc chimer open read frame increas tumor t cell infiltrationclon expans cdk12 inactiv defin distinct class mcrpc benefit immun checkpoint immunotherapi',\n",
       "  'ArticleTitle': 'Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.',\n",
       "  'Author': 'Wu Yi-Mi'},\n",
       " {'Abstract': ' oncogen activ ras gene point mutat occur 2030 human cancer the develop effect ras inhibitor challeng necessit new approach inhibit oncogen protein function studi switch region ras interact larg number effector protein contain common rasbind domain rbd becaus rbdmediat interact essenti ras signal block rbd associ small molecul constitut attract therapeut approach here evid rigosertib styrylbenzyl sulfon act rasmimet interact rbds raf kinas result inabl bind ras disrupt raf activ inhibit rasrafmek pathway we ribosertib bind rbds ralgd pi3k these result suggest target rbds multipl signal pathway rigosertib repres effect strategi inactiv ras signal',\n",
       "  'ArticleTitle': 'A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.',\n",
       "  'Author': 'Athuluri-Divakar Sai Krishna'},\n",
       " {'Abstract': ' transcript activ nuclear receptor rar retino acid ra lead inhibit cell growth howev tissu ra promot cell surviv hyperplasia activ unlik mediat rar here addit function rar ra activ orphan nuclear receptor pparbetadelta turn induc express prosurviv gene partit ra two receptor regul intracellular lipid bind protein crabpii fabp5 these protein deliv ra cytosol nuclear rar pparbetadelta respect select enhanc transcript activ cognat receptor consequ ra function rar proapoptot agent cell high crabpiifabp5 ratio signal pparbetadelta promot surviv cell high express fabp5 oppos effect ra cell growth eman altern activ two differ nuclear receptor',\n",
       "  'ArticleTitle': 'Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.',\n",
       "  'Author': 'Schug Thaddeus T'},\n",
       " {'Abstract': ' loss cell polar protein scribbl induc neoplasia drosophila promot uncontrol prolifer in mammal role polar protein play tumorigenesi well understood here demonstr deplet scribbl mammari epithelia disrupt cell polar block threedimension morphogenesi inhibit apoptosi induc dysplasia vivo progress tumor long latenc loss scribbl cooper oncogen cmyc transform epitheli cell induc tumor vivo block activ apoptosi pathway like deplet misloc scribbl cellcel junction suffici promot cell transform interest spontan mammari tumor mice human possess downregul misloc scribbl thus demonstr scribbl inhibit breast cancer format deregul polar pathway promot dysplast neoplast growth mammal disrupt morphogenesi inhibit cell death',\n",
       "  'ArticleTitle': 'Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.',\n",
       "  'Author': 'Zhan Lixing'},\n",
       " {'Abstract': ' dure develop sensori axon compet limit neurotroph support local neurotrophin insuffici trigger caspasedepend axon degener the signal drive axon degener local depriv propos resid axon our result instead support model despit apoptot machineri axon cell bodi activ particip gate axon caspas activ axon degener loss trophic support axon initi retrograd activ somat proapoptot pathway turn requir distal axon degener anterograd prodegen factor at molecular level cell bodi converg point two signal pathway integr action drive upregul proapoptot puma unexpect confin cell bodi puma overcom inhibit prosurviv bclxl bclw initi anterograd prodegen program highlight role cell bodi arbit largescal axon remov',\n",
       "  'ArticleTitle': 'Axon Degeneration Gated by Retrograde Activation of Somatic Pro-apoptotic Signaling.',\n",
       "  'Author': 'Simon David J'},\n",
       " {'Abstract': ' the flood genomewid data generat highthroughput technolog current provid biologist unpreced opportun manipul queri reconstruct function molecular network cell here outlin three under principl six strategi infer network model genom data then cancer exampl describ experiment comput approach infer differenti network identifi gene process drive diseas phenotyp in conclus discuss networklevel understand cancer predict drug respons guid therapeut',\n",
       "  'ArticleTitle': 'Principles and strategies for developing network models in cancer.',\n",
       "  'Author': \"Pe'er Dana\"},\n",
       " {'Abstract': ' the absenc cancerrestrict surfac marker major impedi antigenspecif immunotherapi chimer antigen receptor car t cell for exampl target canon myeloid marker cd33 acut myeloid leukemia aml result toxic destruct normal myeloid cell we hypothes leukemiaspecif antigen creat delet cd33 normal hematopoiet stem progenitor cell hspcs generat hematopoiet system resist cd33target therapi enabl specif target aml car t cell we generat cd33defici human hspcs demonstr normal engraft differenti immunodefici mice autolog cd33 ko hspc transplant rhesus macaqu demonstr longterm multilineag engraft geneedit cell normal myeloid function cd33defici cell impervi cd33target car t cell allow effici elimin leukemia myelotox these studi illumin novel approach antigenspecif immunotherapi genet engin host avoid ontarget offtumor toxic',\n",
       "  'ArticleTitle': 'Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.',\n",
       "  'Author': 'Kim Miriam Y'},\n",
       " {'Abstract': ' cohesin extrus thought play central role establish architectur mammalian genom howev extrus visual vivo function impact energet unknown use ultradeep hic loop domain form process requir cohesin atpas onc form loop compart maintain hour energi input strike atp observ emerg hundr ctcfindepend loop link regulatori dna we identifi architectur stripe loop anchor interact entir domain high frequenc stripe tether superenhanc cognat promot b cell facilit igh transcript recombin stripe anchor repres major hotspot topoisomerasemedi lesion promot chromosom transloc cancer in plasmacytoma stripe deregul ightransloc oncogen we propos higher organ coopt cohesin extrus enhanc transcript recombin implic tumor develop',\n",
       "  'ArticleTitle': 'The Energetics and Physiological Impact of Cohesin Extrusion.',\n",
       "  'Author': 'Vian Laura'},\n",
       " {'Abstract': ' t cell express chimer antigen receptor car promis cancer therapeut agent prospect ultim smart cancer therapeut to expand capabl car t cell split univers programm supra car system simultan encompass multipl critic upgrad abil switch target reengin t cell fine tune t cell activ strength sens logic respond multipl antigen these featur use combat relaps mitig overactiv enhanc specif we test supra system two differ tumor model demonstr broad util human compon minim potenti immunogen concern furthermor extend orthogon supra car system regul differ t cell subset independ demonstr dualli induc car system togeth supra car illustr multipl advanc logic control featur implement singl integr system',\n",
       "  'ArticleTitle': 'Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses.',\n",
       "  'Author': 'Cho Jang Hwan'},\n",
       " {'Abstract': ' to colon liver colon cancer metastas overcom hypoxia metabol stress loo al metastat cell achiev decreas mir483 mir551a express derepress creatin kinas express allow energi captur extracellular atp generat import phosphocreatin',\n",
       "  'ArticleTitle': 'The metabolic milieu of metastases.',\n",
       "  'Author': 'Sullivan William J'},\n",
       " {'Abstract': ' becaus apoptosi infect cell limit virus product spread virus coopt prosurviv gene host this includ epsteinbarr virus ebv gene bhrf1 homolog human bcl2 protein block apoptosi associ cancer comput design experiment optim generat novel protein call bindi bind bhrf1 picomolar affin bindi recogn hydrophob cleft bhrf1 manner similar bcl2 protein interact make addit contact achiev except affin specif bindi induc apoptosi ebvinfect cancer line deliv antibodytarget intracellular deliveri carrier bindi suppress tumor growth extend surviv xenograft diseas model ebvposit human lymphoma highspecificitydesign protein select kill target cell provid advantag toxic compound current generat antibodydrug conjug',\n",
       "  'ArticleTitle': 'A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells.',\n",
       "  'Author': 'Procko Erik'},\n",
       " {'Abstract': ' identifi molecular cancer driver critic precis oncolog multipl advanc algorithm identifi driver exist systemat attempt combin optim larg dataset we report pancanc pansoftwar analysi span 9423 tumor exom compris 33 the cancer genom atlas project 26 comput tool catalog driver gene mutat we identifi 299 driver gene implic anatom site cancercel type sequenc structurebas analys identifi 3400 putat missens driver mutat support multipl line evid experiment valid confirm 6085 predict mutat like driver we 300 msi tumor associ high pd1pdl1 57 tumor analyz harbor putat clinic action event our studi repres comprehens discoveri cancer gene mutat date serv blueprint futur biolog clinic endeavor',\n",
       "  'ArticleTitle': 'Comprehensive Characterization of Cancer Driver Genes and Mutations.',\n",
       "  'Author': 'Bailey Matthew H'},\n",
       " {'Abstract': ' b cell activ normal immun respons oncogen transform impos increas metabol demand b cell abil retain redox homeostasi while serinethreonineprotein phosphatas 2a pp2a identifi tumor suppressor multipl type cancer genet studi reveal essenti role pp2a b cell tumor therebi pp2a redirect glucos carbon util glycolysi pentos phosphat pathway ppp salvag oxid stress this uniqu vulner reflect constitut low ppp activ b cell transcript repress g6pd key ppp enzym b cell transcript factor pax5 ikzf1 reflect bcellspecif transcript ppprepress glucos carbon util b cell heavili skew favor glycolysi result lack pppdepend antioxid protect these find reveal gatekeep function ppp broad rang b cell malign effici target small molecul inhibit pp2a g6pd',\n",
       "  'ArticleTitle': 'B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.',\n",
       "  'Author': 'Xiao Gang'},\n",
       " {'Abstract': ' extens multiregion wholegenom exom sequenc perform tumor patient local well metastat clear cell renal cell carcinoma provid comprehens descript tumor origin intratumor heterogen evolut rout metastasi lay foundat develop precis clinic manag',\n",
       "  'ArticleTitle': 'Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.',\n",
       "  'Author': 'Ricketts Christopher J'},\n",
       " {'Abstract': ' clearcel renal cell carcinoma ccrcc exhibit broad rang metastat phenotyp systemat date here analyz 575 primari 335 metastat biopsi 100 patient metastat ccrcc includ two case sampledat postmortem metastat compet afford chromosom complex identifi 9p loss high select event drive metastasi ccrccrelat mortal p 00014 distinct pattern metastat dissemin observ includ rapid progress multipl tissu site seed primari tumor monoclon structur by contrast observ attenu progress case character high primari tumor heterogen metastat compet acquir gradual initi progress solitari metastasi final observ earli diverg primit ancestr clone protract latenc two decad featur pancreat metastas',\n",
       "  'ArticleTitle': 'Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.',\n",
       "  'Author': 'Turajlic Samra'},\n",
       " {'Abstract': ' clear cell renal cell carcinoma ccrcc character nearunivers loss short arm chromosom 3 delet tumor suppressor gene we analyz whole genom 95 biopsi 33 patient clear cell renal cell carcinoma we hotspot point mutat 5 utr tert target mycmaxmad1 repressor associ telomer lengthen the common structur abnorm generat simultan 3p loss 5q gain 36 patient typic chromothripsi this event occur childhood adolesc general initi event preced emerg tumor recent common ancestor year decad similar genom chang drive inherit ccrcc model differ age incid inherit sporad cancer suggest number cell 3p loss capabl initi sporad tumor hundr earli develop ccrcc follow welldefin evolutionari trajectori offer opportun earli intervent',\n",
       "  'ArticleTitle': 'Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.',\n",
       "  'Author': 'Mitchell Thomas J'},\n",
       " {'Abstract': ' we conduct largest investig predisposit variant cancer date discov 853 pathogen like pathogen variant 8 10389 case 33 cancer type twentyon gene singl crosscanc associ includ novel associ sdha melanoma palb2 stomach adenocarcinoma the 659 predisposit variant 18 addit larg delet tumor suppressor includ atm brca1 nf1 low gene express frequent 43 loss heterozygos biallel twohit event we discov 33 variant oncogen includ missens met ret ptpn11 associ high gene express we nomin 47 addit predisposit variant priorit vuss support multipl evid involv casecontrol frequenc loss heterozygos express effect coloc mutat modifi residu our integr approach link rare predisposit variant function consequ inform futur guidelin variant classif germlin genet test cancer',\n",
       "  'ArticleTitle': 'Pathogenic Germline Variants in 10,389 Adult Cancers.',\n",
       "  'Author': 'Huang Kuan-Lin'},\n",
       " {'Abstract': ' genet alter signal pathway control cellcycl progress apoptosi cell growth common hallmark cancer extent mechan cooccurr alter pathway differ individu tumor tumor type use mutat copynumb chang mrna express gene fusion dna methyl 9125 tumor profil the cancer genom atlas tcga analyz mechan pattern somat alter ten canon pathway cell cycl hippo myc notch nrf2 pi3kinaseakt rtkras tgf signal p53 cateninwnt we chart detail landscap pathway alter 33 cancer type stratifi 64 subtyp identifi pattern cooccurr mutual exclus eightynin percent tumor least one driver alter pathway 57 percent tumor least one alter potenti target current avail drug thirti percent tumor multipl target alter indic opportun combin therapi',\n",
       "  'ArticleTitle': 'Oncogenic Signaling Pathways in The Cancer Genome Atlas.',\n",
       "  'Author': 'Sanchez-Vega Francisco'},\n",
       " {'Abstract': ' the hedgehog hh signal pathway aberr activ major basal cell carcinoma bcc vismodegib sonidegib target inhibitor smoothen smo both drug approv local advanc bcc labcc vismodegib approv metastat bcc mbcc',\n",
       "  'ArticleTitle': 'Hedgehog Pathway Inhibition.',\n",
       "  'Author': 'Sekulic Aleksandar'},\n",
       " {'Abstract': ' the mechanist target rapamycin mtor signal pathway sens integr varieti environment cue regul organism growth homeostasi the pathway regul major cellular process implic increas number patholog condit includ cancer obes 2 diabet neurodegener here review recent advanc understand mtor pathway role health diseas age we discuss pharmacolog approach treat human patholog link mtor deregul',\n",
       "  'ArticleTitle': 'mTOR signaling in growth control and disease.',\n",
       "  'Author': 'Laplante Mathieu'},\n",
       " {'Abstract': ' the mechan wildtyp kras allel impart growth inhibitori effect oncogen kras cancer includ lung adenocarcinoma luad poor understood here genet induc model kras loss heterozygos loh kras dimer mediat wildtyp krasdepend fit human murin kras mutant luad tumor cell under resist mek inhibit these effect abrog wildtyp kras replac kras',\n",
       "  'ArticleTitle': 'KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.',\n",
       "  'Author': 'Ambrogio Chiara'},\n",
       " {'Abstract': ' endogen small rnas mirna regul gene express mechan conserv metazoan while number verifi human mirna expand function annot to perform genet screen novel function mirna develop librari vector express major clone human mirna creat correspond dna barcod array in screen mirna cooper oncogen cellular transform identifi mir372 mir373 permit prolifer tumorigenesi primari human cell harbor oncogen ras activ wildtyp p53 these mirna neutral p53mediat cdk inhibit possibl direct inhibit express tumorsuppressor lats2 we provid evid mirna potenti novel oncogen particip develop human testicular germ cell tumor numb p53 pathway allow tumorigen growth presenc wildtyp p53',\n",
       "  'ArticleTitle': 'A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.',\n",
       "  'Author': 'Voorhoeve P Mathijs'},\n",
       " {'Abstract': ' ras interact downstream effector regul complex cytoplasm signal network in issu gupta al 2007 mous model rasmedi tumorigenesi interact ras singl isoform phosphatidylinositol 3kinas pi3k call p110alpha pik3ca critic tumor format this result stimul reevalu pharmacolog approach target ras cancer treatment',\n",
       "  'ArticleTitle': 'Stopping ras in its tracks.',\n",
       "  'Author': 'Der Channing J'},\n",
       " {'Abstract': ' aneuploid genom character unbalanc chromosom stoichiometri karyotyp associ cancer malign drug resist pathogen fungi the phenotyp divers result karyotyp divers endow cell popul superior adapt we combin experiment data general stochast model degre phenotyp variat evolv escal degre growth suppress such scale like explain challeng treat aneuploidi diseas singl stressinduc agent instead propos design evolutionari trap et target karyotyp divers fit this strategi entail select condit channel karyotyp diverg popul one predomin predict drugabl karyotyp featur we provid proofofprincipl case bud yeast demonstr potenti efficaci strategi aneuploidybas azol resist candida albican by analyz exist pharmacogenom data propos potenti design et glioblastoma',\n",
       "  'ArticleTitle': 'Targeting the adaptability of heterogeneous aneuploids.',\n",
       "  'Author': 'Chen Guangbo'},\n",
       " {'Abstract': ' kras',\n",
       "  'ArticleTitle': 'Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.',\n",
       "  'Author': 'Janes Matthew R'},\n",
       " {'Abstract': ' the tumor suppressor p53 activ stress lead cellular outcom apoptosi cellcycl arrest it activ high sensit ensur cell react appropri damag howev prolifer cell encount transient damag normal growth cellcycl arrest apoptosi unfavor how p53 pathway achiev right balanc high sensit toler intrins damag use quantit timelaps microscopi individu human cell prolifer cell spontan puls p53 trigger excit mechan cellcycl phase associ intrins dna damag howev absenc sustain damag posttransl modif p53 inact prevent induc p21 express cellcycl arrest our approach quantifi basal dynam individu cell studi pathway human cell achiev sensit noisi environ',\n",
       "  'ArticleTitle': 'Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.',\n",
       "  'Author': 'Loewer Alexander'},\n",
       " {'Abstract': ' we describ landscap somat genom alter base multidimension comprehens character 500 glioblastoma tumor gbms we identifi novel mutat gene well complex rearrang signatur receptor includ egfr pdgfra tert promot mutat correl elev mrna express support role telomeras reactiv correl analys confirm surviv advantag proneur subtyp confer gcimp phenotyp mgmt dna methyl predict biomark treatment respons classic subtyp gbm integr analysi genom proteom profil challeng notion therapeut inhibit pathway altern inhibit target these data facilit discoveri therapeut diagnost target candid valid research clinic observ generat unanticip hypothes advanc molecular understand lethal cancer',\n",
       "  'ArticleTitle': 'The somatic genomic landscape of glioblastoma.',\n",
       "  'Author': 'Brennan Cameron W'},\n",
       " {'Abstract': ' specif primordi germ cell pgcs mark begin totipot state howev tractabl experiment model mechan human pgc hpgc specif remain unclear here demonstr specif hpgclike cell hpgclcs germlin compet pluripot stem cell the characterist hpgclcs consist embryon hpgcs germlin seminoma share cd38 cellsurfac marker collect defin like progress earli human germlin remark sox17 key regul hpgclike fate blimp1 repress endoderm somat gene specif hpgclcs notabl mechanist differ mous human pgc specif attribut diverg embryon develop pluripot state affect earli cellfat decis we establish foundat futur studi reset epigenom hpgclcs hpgcs totipot transmiss genet epigenet inform',\n",
       "  'ArticleTitle': 'SOX17 is a critical specifier of human primordial germ cell fate.',\n",
       "  'Author': 'Irie Naoko'},\n",
       " {'Abstract': ' cancer rare selfrenew tumoriniti cell tic howev tic self renew multipot differenti tumorigen maintain remain obscur becaus mirna regul cellfat decis compar mirna express selfrenew differenti cell breast cancer line breast tic btic nonbtic 1 degre breast cancer let7 mirna mark reduc btic increas differenti infect btic let7lentivirus reduc prolifer mammospher format proport undifferenti cell vitro tumor format metastasi nodscid mice antagon let7 antisens oligonucleotid enhanc vitro self renew nontic increas let7 parallel reduc hras hmga2 known let7 target silenc hras bticenrich cell line reduc self renew effect differenti silenc hmga2 enhanc differenti affect self renew therefor let7 regul multipl btic stem celllik properti silenc one target',\n",
       "  'ArticleTitle': 'let-7 regulates self renewal and tumorigenicity of breast cancer cells.',\n",
       "  'Author': 'Yu Fengyan'},\n",
       " {'Abstract': ' eighti percent malign tumor develop central nervous system malign glioma essenti incur here discuss recent sequenc studi identifi unexpect driver gliomagenesi includ mutat isocitr dehydrogenas 1 nfb pathway genomewid analys reshap classif scheme tumor enhanc prognost valu molecular marker we discuss controversi surround glioma stem cell explor integr new molecular data allow generat inform anim model advanc knowledg glioma origin progress treatment',\n",
       "  'ArticleTitle': 'Malignant glioma: lessons from genomics, mouse models, and stem cells.',\n",
       "  'Author': 'Chen Jian'},\n",
       " {'Abstract': ' immun checkpoint blockad revolution cancer treatment in issu cell insight longitudin multiom analysi largest yetreport cohort melanoma patient reveal tumor immun coevolv antipd1 therapi',\n",
       "  'ArticleTitle': 'Cancer Evolution during Immunotherapy.',\n",
       "  'Author': 'Andrews M C'},\n",
       " {'Abstract': ' cmyc myc transcript regul embryon stem es cell somat cell reprogram cancer here identifi myccent regulatori network es cell combin proteinprotein proteindna interact studi myc interact nua4 complex regul es cell ident in combin regulatori network inform defin three es cell modul core polycomb myc modul function separ illustr es cell transcript program compos distinct unit with modul analyt tool reassess hypothesi link es cell signatur cancer cancer stem cell we myc modul independ core modul activ cancer predict cancer outcom the appar similar cancer es cell signatur reflect larg part pervas natur myc regulatori network',\n",
       "  'ArticleTitle': 'A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.',\n",
       "  'Author': 'Kim Jonghwan'},\n",
       " {'Abstract': ' in issu cell martincorena al campbel al interrog select dynam tumor evolut largescal genom dataset they somat mutat cancer larg neutral highlight nearcomplet absenc negat select neutral evolut enabl toler hypermut defin surpris larg fraction adult cancer',\n",
       "  'ArticleTitle': 'Cancer Evolution: No Room for Negative Selection.',\n",
       "  'Author': 'Bakhoum Samuel F'},\n",
       " {'Abstract': ' the tasmanian devil sarcophilus harrisii largest marsupi carnivor endang transmiss facial cancer spread direct transfer live cancer cell bite here describ sequenc assembl annot tasmanian devil genom wholegenom sequenc two geograph distant subclon cancer genom analysi suggest cancer first aros femal tasmanian devil clone subsequ genet diverg spread tasmania the devil cancer genom contain 17000 somat base substitut mutat bear imprint distinct mutat process genotyp somat mutat 104 geograph tempor distribut tasmanian devil tumor reveal pattern evolut spread parasit clonal lineag evid select sweep one geograph area persist parallel lineag popul',\n",
       "  'ArticleTitle': 'Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.',\n",
       "  'Author': 'Murchison Elizabeth P'},\n",
       " {'Abstract': ' we report immedi effect estrogen signal transcriptom breast cancer cell global runon sequenc groseq the data analyz new bioinformat approach allow identifi transcript direct groseq data we estrogen signal direct regul strike larg fraction transcriptom rapid robust unexpect transient manner in addit proteincod gene estrogen regul distribut activ three rna polymeras virtual class noncod rna describ date we identifi larg number undetect estrogenregul intergen transcript proxim estrogen receptor bind site collect result provid comprehens measur primari immedi estrogen effect date resourc understand rapid signaldepend transcript system',\n",
       "  'ArticleTitle': 'A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.',\n",
       "  'Author': 'Hah Nasun'},\n",
       " {'Abstract': ' in respons dna damag g2 mammalian cell avoid entri mitosi instead initi dna repair here respons genotox stress g2 phosphatas cdc14b transloc nucleolus nucleoplasm induc activ ubiquitin ligas apcccdh1 consequ degrad plk1 promin mitot kinas this process induc stabil claspin activ dnadamag checkpoint wee1 inhibitor cellcycl progress allow effici g2 checkpoint as byproduct apcccdh1 reactiv dnadamag g2 cell claspin apcccdh1 substrat g1 target degrad howev process counteract deubiquityl enzym usp28 permit claspinmedi activ chk1 respons dna damag these find defin novel pathway crucial g2 dnadamagerespons checkpoint',\n",
       "  'ArticleTitle': 'The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.',\n",
       "  'Author': 'Bassermann Florian'},\n",
       " {'Abstract': ' exploit depend cancer cell transcript effect strategi target aggress therapeut recalcitr tumor wang al inhibit transcript thz1 smallmolecul inhibitor cyclindepend kinas cdk7 induc apoptot cell death tripleneg breast cancer',\n",
       "  'ArticleTitle': 'No driver behind the wheel? Targeting transcription in cancer.',\n",
       "  'Author': 'Franco Hector L'},\n",
       " {'Abstract': ' human breast tumor contain breast cancer stem cell bcsc popul properti reminisc normal stem cell we 37 microrna differenti express human bcscs nontumorigen cancer cell three cluster mir200c141 mir200b200a429 mir18396182 downregul human bcscs normal human murin mammari stemprogenitor cell embryon carcinoma cell express bmi1 known regul stem cell selfrenew modul mir200c mir200c inhibit clonal expans breast cancer cell suppress growth embryon carcinoma cell vitro most import mir200c suppress abil normal mammari stem cell form mammari duct tumor format driven human bcscs vivo the coordin downregul three microrna cluster similar function regul clonal expans mir200c provid molecular link connect bcscs normal stem cell',\n",
       "  'ArticleTitle': 'Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.',\n",
       "  'Author': 'Shimono Yohei'},\n",
       " {'Abstract': ' in issu cell hill al 2005 demonstr mous model prostat cancer tumor cell initi promot expans stromal fibroblast lack tumorsuppressor protein p53 paracrin mechan this result select high prolif fibroblast associ carcinoma promot tumor progress',\n",
       "  'ArticleTitle': 'Under pressure: stromal fibroblasts change their ways.',\n",
       "  'Author': 'Bierie Brian'},\n",
       " {'Abstract': ' ferroptosi form regul cell death character irondepend accumul lipid hydroperoxid lethal level emerg evid suggest ferroptosi repres ancient vulner caus incorpor polyunsatur fatti acid cellular membran cell develop complex system exploit defend vulner differ context the sensit ferroptosi tight link numer biolog process includ amino acid iron polyunsatur fatti acid metabol biosynthesi glutathion phospholipid nadph coenzym q',\n",
       "  'ArticleTitle': 'Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.',\n",
       "  'Author': 'Stockwell Brent R'},\n",
       " {'Abstract': ' although specif microrna mirna upregul cancer global mirna downregul common trait human malign the mechan phenomenon advantag afford remain poor understood here identifi microrna famili mir103107 attenu mirna biosynthesi target dicer key compon mirna process machineri in human breast cancer high level mir103107 associ metastasi poor outcom function mir103107 confer migratori capac vitro empow metastat dissemin nonaggress cell vivo inhibit mir103107 oppos migrat metastasi malign cell at cellular level key event foster mir103107 induct epithelialtomesenchym transit emt attain downregul mir200 level these find suggest new pathway dicer inhibit drift epitheli cancer lessdifferenti mesenchym fate foster metastasi',\n",
       "  'ArticleTitle': 'A MicroRNA targeting dicer for metastasis control.',\n",
       "  'Author': 'Martello Graziano'},\n",
       " {'Abstract': ' the p53 tumor suppressor gene common alter human tumor missens mutat result accumul mutant p53 protein these mutat confer dominantneg gainoffunct properti p53 to ascertain physiolog effect p53 point mutat structur mutant p53r172h contact mutant p53r270h codon 175 273 human engin endogen p53 locus mice p53r270h p53r172h mice model lifraumeni syndrom develop allelespecif tumor spectra distinct p53 mice in addit p53r270h p53r172h mice develop novel tumor compar p53 mice includ varieti carcinoma frequent endotheli tumor domin effect vari allel function observ primari cell deriv p53r270h p53r172h mice these result demonstr point mutant p53 allel express physiolog control enhanc oncogen potenti simpl loss p53 function',\n",
       "  'ArticleTitle': 'Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.',\n",
       "  'Author': 'Olive Kenneth P'},\n",
       " {'Abstract': ' compensatori prolifer trigger hepatocyt loss requir liver regener mainten promot develop hepatocellular carcinoma hcc despit extens investig cell respons hepatocyt restor hcc develop remain poor character we genet lineag trace identifi cell respons hepatocyt replenish follow chronic liver injuri queri role three distinct hcc model we preexist popul periport hepatocyt locat portal triad healthi liver express low amount sox9 bileductenrich gene undergo extens prolifer replenish liver mass chronic hepatocytedeplet injuri despit high regen potenti socal hybrid hepatocyt rise hcc chronic injur liver repres uniqu way restor tissu function avoid tumorigenesi this special set preexist differenti cell high suitabl cellbas therapi chronic hepatocytedeplet disord',\n",
       "  'ArticleTitle': 'Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.',\n",
       "  'Author': 'Font-Burgada Joan'},\n",
       " {'Abstract': ' in issu cell baar al foxo4 protect senesc cell viabil keep p53 sequest nuclear bodi prevent induc apoptosi disrupt interact alld amino acid peptid foxo4dri restor p53s apoptot role amelior consequ senescenceassoci loss tissu homeostasi',\n",
       "  'ArticleTitle': 'Rejuvenation by Therapeutic Elimination of Senescent Cells.',\n",
       "  'Author': 'Krimpenfort Paul'},\n",
       " {'Abstract': ' the accumul irrepar cellular damag restrict healthspan acut stress natur age senesc cell thought impair tissu function genet clearanc delay featur age identifi senesc cell avoid apoptosi allow prospect design antisenesc compound address homeostasi restor here identifi foxo4 pivot senesc cell viabil we design foxo4 peptid perturb foxo4 interact p53 in senesc cell select caus p53 nuclear exclus cellintrins apoptosi under condit well toler vivo foxo4 peptid neutral doxorubicininduc chemotox moreov restor fit fur densiti renal function fast age xpd',\n",
       "  'ArticleTitle': 'Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.',\n",
       "  'Author': 'Baar Marjolein P'},\n",
       " {'Abstract': ' metastasi lung adenocarcinoma occur swift multipl organ month diagnosi the mechan confer rapid metastat capac lung tumor unknown activ canon wnttcf pathway identifi determin metastasi brain bone lung adenocarcinoma progress gene express signatur denot wnttcf activ associ relaps multipl organ primari lung adenocarcinoma metastat subpopul isol independ lymph nodederiv lung adenocarcinoma cell line harbor hyperact wnttcf pathway reduct tcf activ cell attenu abil form brain bone metastas mice independ effect tumor growth lung the wnttcf target gene hoxb9 lef1 identifi mediat chemotact invas coloni outgrowth thus distinct wnttcf signal program lef1 hoxb9 enhanc compet lung adenocarcinoma cell colon bone brain for video summari articl see paperflick file avail onlin supplement data',\n",
       "  'ArticleTitle': 'WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.',\n",
       "  'Author': 'Nguyen Don X'},\n",
       " {'Abstract': ' sequenc effort led identif somat mutat affect selfrenew differenti canceriniti cell one recurr mutat target bind pocket ubiquitin ligas fbxw7 missens fbxw7 mutat preval tumor includ t cell acut lymphoblast leukemia tall to studi effect lesion generat anim carri regulat fbxw7 mutant allel here mutat bolster canceriniti cell activ collabor notch1 oncogen spare normal hematopoiet stem cell function we abl fbxw7 mutat affect ubiquityl halflif cmyc protein key tall oncogen use anim carri cmyc fusion allel connect fbxw7 function cmyc abund correl cmyc express leukemiainiti activ final demonstr smallmoleculemedi suppress myc activ lead tall remiss suggest effect therapeut strategi',\n",
       "  'ArticleTitle': 'The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.',\n",
       "  'Author': 'King Bryan'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Extrinsic apoptosis pathways.',\n",
       "  'Author': 'Verbrugge Inge'},\n",
       " {'Abstract': ' the dysregul relationship gut microbiota innat immun homeostasi lead rang complex diseas in issu man al reveal intracellular innat sensor aim2 regul microbi stem cell homeostasi gut protect colorect cancer',\n",
       "  'ArticleTitle': 'AIMing 2 Curtail Cancer.',\n",
       "  'Author': 'Rommereim Leah M'},\n",
       " {'Abstract': ' retino acid ra trigger antiprolif effect tumor cell ra synthet analog great potenti anticarcinogen agent retino acid receptor rar mediat ra effect direct regul gene express to defin genet network regul rar breast cancer identifi rar genom target chromatin immunoprecipit express analysi we rar bind genom high coincid estrogen receptor alpha eralpha bind result widespread crosstalk ra estrogen signal antagonist regul breast cancerassoci gene eralpha rarbind site appear coevolv larg scale human genom result competit bind activ nearbi overlap cisregulatori element the high coordin intersect two critic nuclear hormon receptor signal pathway provid global mechan balanc gene express output local regulatori interact dispers genom',\n",
       "  'ArticleTitle': 'Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.',\n",
       "  'Author': 'Hua Sujun'},\n",
       " {'Abstract': ' interact tumorigen cell surround microenviron critic tumor progress remain incomplet understood germlin mutat nf1 tumor suppressor gene caus neurofibromatosi 1 nf1 common genet disord character complex tumor call neurofibroma genet studi indic biallel loss nf1 requir tumorigen cell origin embryon schwann cell lineag howev physiolog state schwann cell loss heterozygos suffici neurofibroma format nf1 haploinsuffici least one addit nonneoplast lineag requir tumor progress here establish nf1 heterozygos bone marrowderiv cell tumor microenviron suffici allow neurofibroma progress context schwann cell nf1 defici further genet pharmacolog attenu ckit signal nf1 hematopoiet cell diminish neurofibroma initi progress final studi implic mast cell critic mediat tumor initi',\n",
       "  'ArticleTitle': 'Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.',\n",
       "  'Author': 'Yang Feng-Chun'},\n",
       " {'Abstract': ' lin28a lin28b select block express let7 microrna function oncogen varieti human cancer lin28a recruit tutas zcchc11tut4 let7 precursor block process dicer cell cytoplasm here unlik lin28a lin28b repress let7 process zcchc11independ mechan lin28b function nucleus sequest primari let7 transcript inhibit process microprocessor the inhibitori effect zcchc11 deplet tumorigen capac metastat potenti human cancer cell xenograft restrict lin28aexpress tumor furthermor major human colon breast tumor analyz exclus express lin28a lin28b lin28a express her2overexpress breast tumor lin28b express character tripleneg breast tumor overal result illumin distinct mechan lin28a lin28b function implic develop new strategi cancer therapi',\n",
       "  'ArticleTitle': 'Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.',\n",
       "  'Author': 'Piskounova Elena'},\n",
       " {'Abstract': ' dpc4smad4 mutat associ aggress pancreat cancer in issu cell whittl al demonstr runx3 express combin dpc4smad4 status predict metastat propens pancreat tumor provid valuabl guidanc person therapi patient pancreat cancer',\n",
       "  'ArticleTitle': \"It's a SMAD/SMAD World.\",\n",
       "  'Author': 'Taniguchi Cullen'},\n",
       " {'Abstract': ' glioblastoma multiform gbm aggress form brain cancer margin life expect base assumpt gbm cell gain function involv cancer process patientderiv glioblastoma cell gcs screen identifi cellular process amen develop target treatment the quininederiv nsc13316 reliabl select compromis viabil synthet chemic expans reveal delic structureact relationship analog increas potenc term vacquinol vacquinol stimul death membran ruffl cell round massiv macropinocyt vacuol accumul atp deplet cytoplasm membran ruptur gcs the map kinas mkk4 identifi shrna screen repres critic signal node vacquinol1 display excel vivo pharmacokinet brain exposur attenu diseas progress prolong surviv gbm anim model these result identifi vulner massiv vacuol target small molecul point possibl exploit process design anticanc therapi',\n",
       "  'ArticleTitle': 'RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.',\n",
       "  'Author': 'Kitambi Satish Srinivas'},\n",
       " {'Abstract': ' it increas appreci oncogen transform alter cellular metabol facilit cell prolifer less known metabol chang promot cancer cell aggress here analyz metabol gene express cancer cell line set highgrad carcinoma line express mesenchym marker share uniqu 44 gene signatur design mesenchym metabol signatur mms a facsbas shrna screen identifi mms gene essenti epithelialmesenchym transit emt cell prolifer dihydropyrimidin dehydrogenas dpyd pyrimidinedegrad enzym high express emt induct necessari cell acquir mesenchym characterist vitro tumorigen cell extravas mous lung this role dpyd mediat catalyt activ enzymat product dihydropyrimidin thus identifi metabol process essenti emt program associ acquisit metastat aggress cancer cell trait',\n",
       "  'ArticleTitle': 'Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.',\n",
       "  'Author': 'Shaul Yoav D'},\n",
       " {'Abstract': ' homeostasi gut microbiota critic influenc host health age develop genet engin probiot hold great promis new therapeut paradigm promot healthi age here screen 3983 escherichia coli mutant discov 29 bacteri gene delet increas longev host caenorhabd elegan a dozen bacteri mutant protect host agerel progress tumor growth amyloidbeta accumul mechanist discov five bacteri mutant promot longev increas secret polysaccharid colan acid ca regul mitochondri dynam unfold protein respons upr',\n",
       "  'ArticleTitle': 'Microbial Genetic Composition Tunes Host Longevity.',\n",
       "  'Author': 'Han Bing'},\n",
       " {'Abstract': ' mutat truncat singl copi tumor suppressor brca2 caus cancer suscept in cell bear heterozyg mutat cellular metabolit ubiquit environment toxin formaldehyd stall destabil dna replic fork engend structur chromosom aberr formaldehyd select deplet brca2 proteasom degrad mechan toxic affect addit cellular protein heterozyg brca2 truncat lower preexist brca2 express sensit brca2 haploinsuffici induc transient exposur natur concentr formaldehyd acetaldehyd alcohol catabolit detoxifi aldh2 precipit similar effect ribonucleas h1 amelior replic fork instabl chromosom aberr provok aldehydeinduc brca2 haploinsuffici suggest brca2 inactiv trigger spontan mutagenesi dna replic aberr rnadna hybrid rloop these find suggest model carcinogenesi brca2 mutat carrier incit compound pervas environ generat endogen certain tissu implic public health',\n",
       "  'ArticleTitle': 'A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.',\n",
       "  'Author': 'Tan Shawn Lu Wen'},\n",
       " {'Abstract': ' wherea chromosom transloc common pathogenet event cancer mechan promot poor understood to elucid transloc mechan mammalian cell develop highthroughput genomewid transloc sequenc htgts we employ htgts identifi ten thousand independ transloc junction involv fix iscei meganucleasegener dna doublestrand break dsbs cmyc oncogen igh locus b lymphocyt induc activationinduc cytidin deaminas aiddepend igh class switch dsbs transloc wide genom preferenti target transcrib chromosom region addit numer aiddepend aidindepend hot spot target compris cryptic iscei target comparison transloc junction genomewid nuclear runon reveal mark associ transcript start site transloc target the major transloc junction form endjoin short microhomolog our find implic divers field includ gene therapi cancer genom',\n",
       "  'ArticleTitle': 'Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells.',\n",
       "  'Author': 'Chiarle Roberto'},\n",
       " {'Abstract': ' proteintyrosin phosphatas ptps proteintyrosin kinas play key role cellular signal all class i ptps contain essenti activ site cysteinyl residu execut nucleophil attack substrat phosphotyrosyl residu the high reactiv catalyt cystein predispos ptps oxid reactiv oxygen speci h2o2 revers ptp oxid emerg cellular regulatori mechan contribut diseas cancer we exploit uniqu featur ptp enzymolog develop proteom method broad cell tissu sampl enabl comprehens identif quantif express classic ptps ptpome oxid subset ptpome oxptpom we mous human cell tissu includ cancer cell display distinct ptpome oxptpom reveal addit level complex regul proteintyrosin phosphoryl normal malign cell',\n",
       "  'ArticleTitle': 'Global proteomic assessment of the classical protein-tyrosine phosphatome and \"Redoxome\".',\n",
       "  'Author': 'Karisch Robert'},\n",
       " {'Abstract': ' cancer known opportunist util resourc surround growth surviv in issu cell venkatesh al demonstr occur brain identifi neuron activityinduc secret neuroligin3 novel mechan promot glioma prolifer',\n",
       "  'ArticleTitle': 'Shedding light on glioma growth.',\n",
       "  'Author': 'Lehrman Emily K'},\n",
       " {'Abstract': ' tumor suppressor block develop cancer lost tumor develop papa al partial loss normal pten tumor suppressor function compound addit disrupt caus express inact mutant pten protein this signific implic patient pten gene mutat',\n",
       "  'ArticleTitle': 'Mutant PTEN in Cancer: Worse Than Nothing.',\n",
       "  'Author': 'Leslie Nick R'},\n",
       " {'Abstract': ' chromosom rearrang includ transloc requir format join dna doubl strand break dsbs these event disrupt integr genom frequent involv produc leukemia lymphoma sarcoma despit event current understand genesi limit to examin origin chromosom rearrang develop transloc captur sequenc tcseq method document chromosom rearrang genomewid primari cell we examin 180000 rearrang 400 million b lymphocyt reveal proxim dsbs transcript activ chromosom territori key determin genom rearrang specif rearrang tend occur cis transcrib gene final activationinduc cytidin deaminas aid induc rearrang gene transloc partner matur b cell lymphoma',\n",
       "  'ArticleTitle': 'Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes.',\n",
       "  'Author': 'Klein Isaac A'},\n",
       " {'Abstract': ' therapeut strategi base modul microrna mirna activ hold great promis abil small rnas potent influenc cellular behavior in studi investig efficaci mirna replac therapi liver cancer we demonstr hepatocellular carcinoma hcc cell exhibit reduc express mir26a mirna express high level divers tissu express mirna liver cancer cell vitro induc cellcycl arrest associ direct target cyclin d2 e2 system administr mirna mous model hcc adenoassoci virus aav result inhibit cancer cell prolifer induct tumorspecif apoptosi dramat protect diseas progress toxic these find suggest deliveri mirna high express toler normal tissu lost diseas cell provid general strategi mirna replac therapi',\n",
       "  'ArticleTitle': 'Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.',\n",
       "  'Author': 'Kota Janaiah'},\n",
       " {'Abstract': ' mtorc1 promot cell growth respons nutrient growth factor insulin activ mtorc1 pi3kakt pathway inhibit tsc1tsc2tbc1d7 complex tsc complex turn rheb essenti activ mtorc1 howev mechanist basi pathway integr nutrientsens pathway unknown we demonstr insulin stimul acut dissoci tsc complex lysosom surfac subpopul rheb mtorc1 resid the tsc complex associ lysosom rhebdepend manner dissoci respons insulin requir aktmedi tsc2 phosphoryl loss pten tumor suppressor result constitut activ mtorc1 aktdepend dissoci tsc complex lysosom these find provid unifi mechan independ pathway affect spatial recruit mtorc1 tsc complex rheb lysosom surfac serv integr divers growth signal',\n",
       "  'ArticleTitle': 'Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.',\n",
       "  'Author': 'Menon Suchithra'},\n",
       " {'Abstract': ' mtorc1 activ lysosom menon al demetriad al mtorc1 deactiv lysosom determin recruit negat regul tumor suppressor complex tsc1tsc2 these report highlight subcellular local regul mtorc1',\n",
       "  'ArticleTitle': 'mTORC1: turning off is just as important as turning on.',\n",
       "  'Author': 'Benjamin Don'},\n",
       " {'Abstract': ' tetraploid propos intermedi step aneuploidi human cancer general mechan induct tetraploidi tumorigenesi lack we report tetraploid occur p53defici cell experienc prolong dna damag signal persist telomer dysfunct livecel imag reveal cell extend g2 atmatr chk1chk2mediat inhibit cdk1cyclinb eventu bypass mitosi despit lack mitosi cell apccdh1depend degrad replic inhibitor geminin follow accumul cdt1 requir origin licens cell enter second s phase result wholegenom redupl tetraploidi upon restor telomer protect tetraploid cell resum cell divis cycl prolifer these observ suggest general mechan induct tetraploid earli stage tumorigenesi telomer dysfunct result excess telomer shorten',\n",
       "  'ArticleTitle': 'Persistent telomere damage induces bypass of mitosis and tetraploidy.',\n",
       "  'Author': 'Davoli Teresa'},\n",
       " {'Abstract': ' cancer cell integr multipl biosynthet demand drive indefinit prolifer how key cellular process metabol protein synthesi crosstalk fuel cancer cell growth unknown here uncov mechan myc oncogen coordin product two abund class cellular macromolecul protein nucleic acid cancer cell we singl ratelimit enzym phosphoribosylpyrophosph synthetas 2 prps2 promot increas nucleotid biosynthesi myctransform cell remark prps2 coupl protein nucleotid biosynthesi special cisregulatori element prps2 5 utr control oncogen translat initi factor eif4 downstream myc activ we demonstr prps2 knockout mous nexus protein nucleotid biosynthesi control prps2 crucial mycdriven tumorigenesi togeth studi identifi translate anchor anabol circuit critic cancer cell surviv unexpect vulner undrugg oncogen myc paperflick',\n",
       "  'ArticleTitle': 'Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.',\n",
       "  'Author': 'Cunningham John T'},\n",
       " {'Abstract': ' the larg tumor antigen ltag simian virus 40 aaa protein hexamer helicas essenti viral dna replic eukaryot cell ltag function effici molecular machin power atp bind hydrolysi origin dna melt replic fork unwind to understand atp bind hydrolysi coupl conform chang determin highresolut structur approxim 19 a ltag hexam distinct nucleotid bind state the structur differ ltag nucleotid state detail molecular mechan conform chang trigger atp bindinghydrolysi reveal potenti mechan concert nucleotid bind hydrolysi dure conform chang angl orient domain monom alter creat irislik motion hexam addit six uniqu beta hairpin channel surfac move longitudin central channel possibl serv motor pull dna ltag doubl hexam unwind',\n",
       "  'ArticleTitle': 'Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen.',\n",
       "  'Author': 'Gai Dahai'},\n",
       " {'Abstract': ' we establish line transgen mice express a victoria green fluoresc protein gfp control promot vascular endotheli growth factor vegf mice bear transgen green cellular fluoresc heal margin granul tissu superfici ulcer wound implant solid tumor transgen mice lead accumul green fluoresc result tumor induct host vegf promot activ with time fluoresc cell invad tumor tumor mass spontan mammari tumor induc oncogen express vegfgfp mous strong stromal tumor express gfp in wound tumor model predomin gfpposit cell fibroblast the find vegf promot nontransform cell activ tumor microenviron point need understand stromal cell collabor tumor angiogenesi',\n",
       "  'ArticleTitle': 'Tumor induction of VEGF promoter activity in stromal cells.',\n",
       "  'Author': 'Fukumura D'},\n",
       " {'Abstract': ' inhibit protein phosphatas 2a pp2a activ identifi prerequisit transform human cell howev molecular mechan pp2a activ inhibit human cancer current unclear in studi describ cellular inhibitor pp2a oncogen activ the protein design cancer inhibitor pp2a cip2a interact direct oncogen transcript factor cmyc inhibit pp2a activ cmyc serin 62 s62 prevent cmyc proteolyt degrad in addit function cmyc stabil cip2a promot anchorageindepend cell growth vivo tumor format the oncogen activ cip2a demonstr transform human cell overexpress cip2a import cip2a overexpress two common human malign head neck squamous cell carcinoma hnscc colon cancer thus data cip2a human oncoprotein inhibit pp2a stabil cmyc human malign',\n",
       "  'ArticleTitle': 'CIP2A inhibits PP2A in human malignancies.',\n",
       "  'Author': 'Junttila Melissa R'},\n",
       " {'Abstract': ' chromosom rearrang gene fusion implic leukemogenesi caus deregul protooncogen reloc cryptic regulatori dna element aml inv3t33 associ aberr express stemcel regul evi1 appli function genom genomeengin demonstr 3q rearrang reposit distal gata2 enhanc ectop activ evi1 simultan confer gata2 function haploinsuffici identifi caus sporad famili amlmd monomacemberg syndrom genom excis ectop enhanc restor evi1 silenc led growth inhibit differenti aml cell replic pharmacolog bet inhibit our data structur rearrang involv chromosom reposit singl enhanc caus deregul two unrel distal gene cancer outcom',\n",
       "  'ArticleTitle': 'A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.',\n",
       "  'Author': u'Gr\\xf6schel Stefan'},\n",
       " {'Abstract': ' methionine1 m1link ubiquitin chain regul activ nfb immun homeostasi respons infect the negat regul m1link chain vivo remain poor understood here m1specif deubiquitinas otulin essenti prevent tnfassoci system inflamm human mice a homozyg hypomorph mutat human otulin caus potenti fatal autoinflammatori condit term otulinrel autoinflammatori syndrom ora four independ otulin mous model reveal otulin defici immun cell result celltypespecif effect rang overproduct inflammatori cytokin autoimmun accumul m1link polyubiquitin spontan nfb activ myeloid cell downregul m1polyubiquitin signal degrad lubac b t cell remark treatment antitnf neutral antibodi amelior inflamm ora patient rescu mous phenotyp henc otulin critic restrain lifethreaten spontan inflamm maintain immun homeostasi',\n",
       "  'ArticleTitle': 'The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.',\n",
       "  'Author': 'Damgaard Rune Busk'},\n",
       " {'Abstract': ' the transit prolifer precursor cell postmitot differenti cell crucial develop tissu homeostasi tumor suppress to studi cellcycl exit differenti vivo develop condit knockout lineagetrac system caenorhabd elegan combin lineagespecif gene inactiv genet screen reveal extens redund identifi cellcycl inhibitor swisnf chromatinremodel complex muscl precursor cell miss swisnf g1s inhibitor function arrest cell divis simultan inactiv regul caus continu prolifer c elegan tumor phenotyp further genet analys support swisnf act concert hlh1 myod antagon polycombmedi transcript repress suppress cye1 cyclin e transcript arrest cell divis muscl precursor thus swisnf g1s inhibitor provid altern mechan arrest cellcycl progress termin differenti offer insight frequent mutat swisnf gene human cancer',\n",
       "  'ArticleTitle': 'G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation.',\n",
       "  'Author': 'Ruijtenberg Suzan'},\n",
       " {'Abstract': ' the remov unwant damag mitochondria autophagi process call mitophagi essenti key event develop cellular homeostasi tumor suppress prevent neurodegener age howev precis mechan mitophagi remain uncertain here identifi inner mitochondri membran protein prohibitin 2 phb2 crucial mitophagi receptor involv target mitochondria autophag degrad phb2 bind autophagosom membraneassoci protein lc3 lc3interact region lir domain mitochondri depolar proteasomedepend outer membran ruptur phb2 requir parkininduc mitophagi mammalian cell clearanc patern mitochondria embryon fertil c elegan our find pinpoint conserv mechan eukaryot mitophagi demonstr function prohibitin 2 underli role physiolog age diseas',\n",
       "  'ArticleTitle': 'Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor.',\n",
       "  'Author': 'Wei Yongjie'},\n",
       " {'Abstract': ' the everdecreas cost sequenc usher new era genom medicin laura bonetta report new studi provid glimps opportun ahead',\n",
       "  'ArticleTitle': 'Whole-genome sequencing breaks the cost barrier.',\n",
       "  'Author': 'Bonetta Laura'},\n",
       " {'Abstract': ' recent structur studi receptor tyrosin kinas rtks reveal unexpect divers mechan activ growth factor ligand strategi induc dimer ligand bind surpris divers mechan coupl event activ intracellular tyrosin kinas domain as understand detail increas sophist provid context therapeut counter effect pathogen rtk mutat cancer diseas much remain learn complex signal network downstream rtks alter network translat cellular respons',\n",
       "  'ArticleTitle': 'Cell signaling by receptor tyrosine kinases.',\n",
       "  'Author': 'Lemmon Mark A'},\n",
       " {'Abstract': ' stemcel differenti desir lineag requir navig altern development path lead unwant cell type henc comprehens development roadmap crucial channel stemcel differenti desir fate to end map bifurc lineag choic lead pluripot 12 human mesoderm lineag includ bone muscl heart we defin extrins signal control binari lineag decis enabl logic block differenti unwant fate rapid steer pluripot stem cell 8099 pure human mesoderm lineag branchpoint this strategi enabl generat human bone heart progenitor engraft respect vivo model map stepwis chromatin singlecel gene express chang mesoderm develop uncov somit segment unobserv human embryon event transient mark hopx express collect roadmap enabl navig mesoderm develop produc transplant human tissu progenitor uncov development process video abstract',\n",
       "  'ArticleTitle': 'Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types.',\n",
       "  'Author': 'Loh Kyle M'},\n",
       " {'Abstract': ' recent exon sequenc studi reveal 20 human tumor mutat subunit mswisnf baf complex to under mechan human synovi sarcoma ss transform result transloc exact 78 amino acid ssx ss18 subunit baf complex we demonstr ss18ssx fusion protein compet assembl wildtyp ss18 form alter complex lack tumor suppressor baf47 hsnf5 the alter complex bind sox2 locus revers polycombmedi repress result sox2 activ sox2 uniform express ss tumor essenti prolifer increas concentr wildtyp ss18 lead reassembl wildtyp complex retarget away sox2 locus polycombmedi repress sox2 cessat prolifer this mechan transform depend two amino acid ssx provid potenti foundat therapeut intervent',\n",
       "  'ArticleTitle': 'Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.',\n",
       "  'Author': 'Kadoch Cigall'},\n",
       " {'Abstract': ' despit decad success cytotox chemotherapi acut myelogen leukemia aml biolog basi differenti success individu exist therapeut index remain obscur rather take genet approach favor took function approach ask differenti mitochondri readi apoptosi prime explain individu variat clinic behavior we mitochondri prime measur bh3 profil determin initi respons induct chemotherapi relaps remiss requir allogen bone marrow transplant differenti prime malign myeloblast normal hematopoiet stem cell support mitochondri basi therapeut index chemotherapi bh3 profil identifi bcl2 inhibit target strategi like use therapeut index bh3 profil refin predict inform provid convent biomark current util clinic predict biomark paperclip',\n",
       "  'ArticleTitle': 'Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.',\n",
       "  'Author': 'Vo Thanh-Trang'},\n",
       " {'Abstract': ' of myriad alter gene copi number cancer cell alter critic cancer phenotyp in issu cell zender al 2008 describ integr genom approach identifi new tumor suppressor gene involv hepatocellular carcinoma',\n",
       "  'ArticleTitle': 'RNAi Delivers Insights into Liver Cancer.',\n",
       "  'Author': u'Bernards Ren\\xe9'},\n",
       " {'Abstract': ' revers epigenet chang alter gene express characterist cancer diseas biotech compani take note start develop new drug revers pathogen epimut',\n",
       "  'ArticleTitle': 'Switching on epigenetic therapy.',\n",
       "  'Author': 'Karberg Sascha'},\n",
       " {'Abstract': ' cell enter senesc state stabl prolif arrest respons varieti cellular stress includ telomer eros dna damag oncogen signal act barrier malign transform vivo to identifi gene control senesc conduct unbias screen small hairpin rnas extend life span primari human fibroblast here report knock chemokin receptor cxcr2 il8rb allevi replic oncogeneinduc senesc oi diminish dnadamag respons convers ectop express cxcr2 result prematur senesc p53depend mechan cell undergo oi secret multipl cxcr2bind chemokin program regul nfkappab cebpbeta transcript factor coordin induc cxcr2 express cxcr2 upregul observ preneoplast lesion vivo these result suggest senesc cell activ selfamplifi secretori network cxcr2bind chemokin reinforc growth arrest',\n",
       "  'ArticleTitle': 'Chemokine signaling via the CXCR2 receptor reinforces senescence.',\n",
       "  'Author': 'Acosta Juan C'},\n",
       " {'Abstract': ' increas antibiot resist bacteri pathogen render infect untreat avail antibiot klebsiella pneumonia bacteri pathogen acquir highlevel antibiot resist common caus pulmonari infect optim clearanc k pneumonia host lung requir tnf il17a herein demonstr inflammatori monocyt rapid recruit lung k pneumoniaeinfect mice produc tnf mark increas frequenc il17produc innat lymphoid cell while pulmonari clearanc k pneumonia preserv neutrophildeplet mice monocyt deplet tnf defici impair il17adepend resolut pneumonia monocytemedi bacteri uptak kill enhanc ilc product il17a indic innat lymphocyt engag positivefeedback loop monocyt promot clearanc pneumonia innat immun defens high antibioticresist bacteri pathogen depend crosstalk inflammatori monocyt innat lymphocyt mediat tnf il17a',\n",
       "  'ArticleTitle': 'Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance.',\n",
       "  'Author': 'Xiong Huizhong'},\n",
       " {'Abstract': ' yap mechanosensit transcript activ critic role cancer regener organ size control here forc appli nucleus direct drive yap nuclear transloc decreas mechan restrict nuclear pore molecular transport exposur stiff environ lead cell establish mechan connect nucleus cytoskeleton allow forc exert focal adhes reach nucleus forc transmiss lead nuclear flatten stretch nuclear pore reduc mechan resist molecular transport increas yap nuclear import the restrict transport regul mechan stabil transport protein determin activ nuclear transport yap passiv transport small protein our result unveil mechanosens mechan mediat direct nuclear pore demonstr yap potenti general applic transcript regul',\n",
       "  'ArticleTitle': 'Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores.',\n",
       "  'Author': 'Elosegui-Artola Alberto'},\n",
       " {'Abstract': ' by analyz gene express data glioblastoma combin match microrna profil uncov posttranscript regul layer surpris magnitud compris 248000 microrna mirmedi interact these includ 7000 gene transcript act mir spong 148 gene act altern nonspong interact biochem analys cell line confirm network regul establish driver tumor initi subtyp implement includ pten pdgfra rb1 vegfa stat3 runx1 suggest interact mediat crosstalk canon oncogen pathway sirna silenc 13 mirmedi pten regul locus delet predict pten express variabl suffici downregul pten 3utrdepend manner increas tumor cell growth rate thus mirmedi interact provid mechanist experiment valid rational loss pten express larg number glioma sampl intact pten locus',\n",
       "  'ArticleTitle': 'An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.',\n",
       "  'Author': 'Sumazin Pavel'},\n",
       " {'Abstract': ' the epitheli mesenchym transit emt play crucial role format bodi plan differenti multipl tissu organ emt contribut tissu repair advers caus organ fibrosi promot carcinoma progress varieti mechan emt endow cell migratori invas properti induc stem cell properti prevent apoptosi senesc contribut immunosuppress thus mesenchym state associ capac cell migrat distant organ maintain stem allow subsequ differenti multipl cell type develop initi metastasi',\n",
       "  'ArticleTitle': 'Epithelial-mesenchymal transitions in development and disease.',\n",
       "  'Author': 'Thiery Jean Paul'},\n",
       " {'Abstract': ' the recent discoveri normal neoplast epitheli cell reenter stem cell state rais intrigu possibl aggress carcinoma deriv exist content cancer stem cell cscs procliv generat new cscs noncsc popul here demonstr noncsc human basal breast cancer plastic cell popul switch noncsc csc state the observ cell plastic depend zeb1 key regul epithelialmesenchym transit we plastic noncsc maintain zeb1 promot bival chromatin configur enabl respond microenvironment signal tgf in respons zeb1 promot convert bival activ chromatin configur zeb1 transcript increas noncsc subsequ enter csc state our find support dynam model interconvers low high tumorigen state occur frequent increas tumorigen malign potenti',\n",
       "  'ArticleTitle': 'Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.',\n",
       "  'Author': 'Chaffer Christine L'},\n",
       " {'Abstract': ' the mtorc1 kinas master growth regul sens environment cue includ amino acid activ mtorc1 arginin requir slc38a9 poor understood lysosom membran protein homolog amino acid transport here valid slc38a9 arginin sensor mtorc1 pathway uncov unexpect central role slc38a9 amino acid homeostasi slc38a9 mediat transport arginineregul fashion essenti amino acid lysosom includ leucin mtorc1 sens cytosol sestrin protein slc38a9 necessari leucin generat lysosom proteolysi exit lysosom activ mtorc1 pancreat cancer cell macropinocytos protein nutrient sourc requir slc38a9 form tumor thus slc38a9 arginin serv lysosom messeng coupl mtorc1 activ releas lysosom essenti amino acid need drive cell growth',\n",
       "  'ArticleTitle': 'mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient.',\n",
       "  'Author': 'Wyant Gregory A'},\n",
       " {'Abstract': ' the human genom fold creat thousand interv call contact domain exhibit enhanc contact frequenc loop domain form tether two locialmost bound ctcf cohesin chromosom compart domain form genom interv similar histon mark cosegreg here explor effect degrad cohesin all loop domain elimin compart domain histon mark affect loss loop domain lead widespread ectop gene activ affect signific minor activ gene in particular cohesin loss caus superenhanc coloc form hundr link chromosom affect regul nearbi gene we restor cohesin monitor reform loop although reform rate vari great megabases loop recov hour consist model loop extrus rapid',\n",
       "  'ArticleTitle': 'Cohesin Loss Eliminates All Loop Domains.',\n",
       "  'Author': 'Rao Suhas S P'},\n",
       " {'Abstract': ' akt activ associ malign akt act part inhibit foxo tumor suppressor we convers role aktfoxo acut myeloid leukemia aml rather decreas foxo activ observ foxo activ 40 aml patient sampl regardless genet subtyp we observ activ human mllaf9 leukemia alleleinduc aml mice activ akt compound delet foxo134 reduc leukem cell growth mark diminish leukemiainiti cell lic function vivo improv anim surviv foxo inhibit result myeloid matur subsequ aml cell death foxo activ invers correl jnkcjun signal leukem cell resist foxo inhibit respond jnk inhibit these data reveal molecular role aktfoxo jnkcjun maintain differenti blockad target inhibit leukemia rang genet lesion',\n",
       "  'ArticleTitle': 'AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.',\n",
       "  'Author': 'Sykes Stephen M'},\n",
       " {'Abstract': ' the evolut prostat cancer androgendepend state one androgenindepend mark lethal progress the androgen receptor ar essenti function androgenindepend cancer poor understood we defin direct ardepend target gene androgendepend independ cancer cell generat ardepend gene express profil ar cistrom in contrast androgendepend cell ar select upregul mphase cellcycl gene androgenindepend cell includ ube2c gene inactiv mphase checkpoint we epigenet mark ube2c enhanc notabl histon h3k4 methyl foxa1 transcript factor bind androgenindepend cell direct arenhanc bind ube2c activ thus role ar androgenindepend cancer cell direct androgendepend gene express program androgen execut distinct program result androgenindepend growth',\n",
       "  'ArticleTitle': 'Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.',\n",
       "  'Author': 'Wang Qianben'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Lung cancer models.',\n",
       "  'Author': 'Farago Anna F'},\n",
       " {'Abstract': ' a new studi shimono al 2009 demonstr certain microrna regul selfrenew factor bmi1 downregul purifi popul normal mammari epitheli stem cell breast tumoriniti cell these find implic regul selfrenew differenti microrna suggest new way target cancer stem cell',\n",
       "  'ArticleTitle': 'MicroRNAs and parallel stem cell lives.',\n",
       "  'Author': 'Dirks Peter B'},\n",
       " {'Abstract': ' the loss express particular microrna contribut tumorigenesi kota al 2009 explor mous model promis new approach treatment liver cancerreestablish express mirna viral vector',\n",
       "  'ArticleTitle': 'New hope for a microRNA therapy for liver cancer.',\n",
       "  'Author': 'Rossi John J'},\n",
       " {'Abstract': ' tumor necrosi factor tnf potent proinflammatori cytokin mammal the degrad tnf mrna critic restrict tnf synthesi involv constitut decay element cde 3 utr mrna here demonstr cde fold rna stemloop motif recogn roquin roquin2 bind roquin initi degrad tnf mrna limit tnf product macrophag roquin protein promot mrna degrad recruit ccr4caf1not deadenylas complex cde sequenc high conserv 50 vertebr mrnas encod regul develop inflamm in macrophag cdecontain mrnas identifi primari target roquin transcriptomewid scale thus roquin protein act broad mediat mrna deadenyl recogn conserv class stemloop rna degrad motif',\n",
       "  'ArticleTitle': 'Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs.',\n",
       "  'Author': 'Leppek Kathrin'},\n",
       " {'Abstract': ' interferon ifn signal essenti antivir respons induct ifnstimul gene isg through nonbias highthroughput rnai screen 711 known epigenet modifi cellular model ifnmedi inhibit hbv replic identifi methyltransferas setd2 critic amplifi ifnmedi antivir immun condit knockout mice hepatocytespecif delet setd2 exhibit enhanc hbv infect mechanist setd2 direct mediat stat1 methyl lysin 525 methyltransferas activ reinforc ifnactiv stat1 phosphoryl antivir cellular respons in addit setd2 select catalyz trimethyl h3k36 promot isg isg15 lead gene activ our studi identifi stat1 methyl k525 catalyz methyltransferas setd2 essenti signal event ifndepend antivir immun indic potenti setd2 control viral infect',\n",
       "  'ArticleTitle': 'Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.',\n",
       "  'Author': 'Chen Kun'},\n",
       " {'Abstract': ' aberr fusion heterolog chromosom preval cytogenet abnorm cancer cell oncogen chromosom transloc provid cell prolif surviv advantag they initi transform acquir secondarili result genom instabl here highlight recent advanc understand origin chromosom transloc incipi lymphoid cancer tumorsuppress pathway limit frequenc aberr recombin event deciph mechan mediat chromosom fusion open new avenu develop therapeut strategi aim elimin lesion lead initi mainten progress cancer',\n",
       "  'ArticleTitle': 'Origin of chromosomal translocations in lymphoid cancer.',\n",
       "  'Author': u'Nussenzweig Andr\\xe9'},\n",
       " {'Abstract': ' although restor p53 function attract tumorspecif therapeut strategi remain unclear p53 loss requir transit earli bottleneck tumorigenesi mainten establish tumor to explor efficaci p53 reinstat tumor therapi revers switchabl p53 knockin ki mous model permit modul p53 status wildtyp knockout use wellcharacter emumyc lymphoma model p53 spontan activ restor establish emumyc lymphoma vivo trigger rapid apoptosi confer signific increas surviv nonetheless reimposit p53 function potent select emerg p53resist tumor inactiv p19arf p53 our studi provid insight natur time p53activ signal establish tumor resist p53 evolv aid optim p53base tumor therapi',\n",
       "  'ArticleTitle': 'Modeling the therapeutic efficacy of p53 restoration in tumors.',\n",
       "  'Author': 'Martins Carla P'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Lack of Evidence that CYTH2/ARNO Functions as a Direct Intracellular EGFR Activator.',\n",
       "  'Author': 'Anastasi Sergio'},\n",
       " {'Abstract': ' fanconi anemia fa pathway gene tumor suppressor bestcharacter function repair damag nuclear dna here describ essenti role fa gene two form select autophagi genet delet fancc block autophag clearanc virus virophagi increas suscept lethal viral enceph fanconi anemia complement group c fancc protein interact parkin requir vitro vivo clearanc damag mitochondria decreas mitochondri reactiv oxygen speci ros product inflammasom activ the mitophagi function fancc genet distinct role genom dna damag repair moreov addit gene fa pathway includ fanca fancf fancl fancd2 brca1 brca2 requir mitophagi thus member fa pathway repres undescrib class select autophagi gene function immun organellar homeostasi these find implic understand pathogenesi fa cancer associ mutat fa gene',\n",
       "  'ArticleTitle': 'Fanconi Anemia Proteins Function in Mitophagy and Immunity.',\n",
       "  'Author': 'Sumpter Rhea'},\n",
       " {'Abstract': ' dna methyl 5 posit cytosin 5mc key epigenet mark critic biolog patholog process 5mc convert 5hydroxymethylcytosin 5hmc teneleven transloc tet famili dna hydroxylas here report loss 5hmc epigenet hallmark melanoma diagnost prognost implic genomewid map 5hmc reveal loss 5hmc landscap melanoma epigenom we downregul isocitr dehydrogenas 2 idh2 tet famili enzym like one mechan under 5hmc loss melanoma rebuild 5hmc landscap melanoma cell reintroduc activ tet2 idh2 suppress melanoma growth increas tumorfre surviv anim model thus studi reveal critic function 5hmc melanoma develop direct link idh tet activitydepend epigenet pathway 5hmcmediat suppress melanoma progress suggest new strategi epigenet cancer therapi',\n",
       "  'ArticleTitle': 'Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.',\n",
       "  'Author': 'Lian Christine Guo'},\n",
       " {'Abstract': ' this year lasker debakey clinic research award goe napoleon ferrara discoveri vascular endotheli growth factor vegf major mediat angiogenesi develop effect antivegf therapi wet macular degener lead caus blind elder',\n",
       "  'ArticleTitle': 'Clinical application of therapies targeting VEGF.',\n",
       "  'Author': 'Yancopoulos George D'},\n",
       " {'Abstract': ' alter estrogenmedi cellular signal play essenti role pathogenesi endometriosi in addit higher estrogen receptor er  level enhanc er activ detect endometriot tissu inhibit enhanc er activ erselect antagonist suppress mous ectop lesion growth notabl gain er function stimul progress endometriosi as mechan evad endogen immun surveil cell surviv er interact cellular apoptot machineri cytoplasm inhibit tnfinduc apoptosi er interact compon cytoplasm inflammasom increas interleukin1 enhanc cellular adhes prolifer properti furthermor gain er function enhanc epithelialmesenchym transit signal increas invas activ endometriot tissu establish ectop lesion collect reveal endometri tissu generat retrograd menstruat escap immun surveil develop sustain ectop lesion gain er function',\n",
       "  'ArticleTitle': u'Estrogen Receptor \\u03b2 Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis.',\n",
       "  'Author': 'Han Sang Jun'},\n",
       " {'Abstract': ' increas mobil chromatin surround doublestrand break dsbs yeast mammalian cell under mechan contribut dsb repair remain unclear here telomerebas system track dna damag foci high resolut live cell we greater mobil damag chromatin requir 53bp1 sun12 linker nucleoskeleton cytoskeleton linc complex dynam microtubul the data demonstr excurs promot nonhomolog end join dysfunct telomer implic nesprin4 kinesin telomer fusion 53bp1lincmicrotubuledepend mobil evid irradiationinduc dsbs contribut misrejoin druginduc dsbs brca1defici cell show dsb mobil detriment cell numer dsbs in contrast physiolog condit cell one lesion dsb mobil propos prevent error dna repair',\n",
       "  'ArticleTitle': '53BP1 and the LINC Complex Promote Microtubule-Dependent DSB Mobility and DNA Repair.',\n",
       "  'Author': 'Lottersberger Francisca'},\n",
       " {'Abstract': ' aneuploidi caus prolif disadvantag normal cell analyz date condit associ diseas character unab prolif potenti cancer the mechan allow cancer cell toler advers effect aneuploidi known to probe question identifi aneuploid yeast strain improv prolif abil their molecular character reveal strainspecif genet alter well mutat share differ aneuploid strain among lossoffunct mutat gene encod deubiquitin enzym ubp6 improv growth rate four differ aneuploid yeast strain attenu chang intracellular protein composit caus aneuploidi our result demonstr exist aneuploidytoler mutat improv fit multipl differ aneuploidi highlight ubiquitinproteasom degrad suppress advers effect aneuploidi',\n",
       "  'ArticleTitle': 'Identification of aneuploidy-tolerating mutations.',\n",
       "  'Author': 'Torres Eduardo M'},\n",
       " {'Abstract': ' hepatocellular carcinoma hcc sexual dimorph rodent human higher incid male effect depend sex hormon the molecular mechan estrogen prevent androgen promot liver cancer remain unclear here sexual dimorph hcc complet revers foxa1 foxa2defici mice diethylnitrosamineinduc hepatocarcinogenesi coregul target gene foxa1a2 estrogen receptor er androgen receptor ar increas hepatocarcinogenesi normal femal male mice respect lost foxa12defici mice thus estrogendepend resist androgenmedi facilit hcc foxa12 strike singl nucleotid polymorph foxa2 bind site reduc bind foxa2 er target human liver correl hcc develop women thus foxa factor target central sexual dimorph hcc',\n",
       "  'ArticleTitle': 'Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.',\n",
       "  'Author': 'Li Zhaoyu'},\n",
       " {'Abstract': ' increas express epiderm growth factor receptor her2erbb2 frequent observ breast cancer target anticanc drug herceptin now zuo al 2007 reveal xlink gene encod transcript factor foxp3 breast cancer tumor suppressor repress express her2erbb2',\n",
       "  'ArticleTitle': 'The X factor: skewing X inactivation towards cancer.',\n",
       "  'Author': u'Medema Ren\\xe9 H'},\n",
       " {'Abstract': ' malign peripher nerv sheath tumor mpnsts soft tissu sarcoma connect tissu surround peripher nerv they occur sporad subset patient neurofibromatosi 1 nf1 mpnsts high aggress therapeut resist typic fatal use compar transcriptom analysi identifi cxcr4 gproteincoupl receptor high express mous model nf1defici mpnsts nontransform precursor cell the chemokin receptor cxcr4 ligand cxcl12 promot mpnst growth stimul cyclin d1 express cellcycl progress pi3kinas pi3k catenin signal suppress cxcr4 activ shrna pharmacolog inhibit decreas mpnst cell growth cultur inhibit tumorigenesi allograft spontan genet mous model mpnst we demonstr conserv activ molecular pathway human mpnsts our find indic role cxcr4 nf1associ mpnst develop identifi therapeut target',\n",
       "  'ArticleTitle': 'CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.',\n",
       "  'Author': 'Mo Wei'},\n",
       " {'Abstract': ' autophagi intracellular catabol mechan mediat degrad cytoplasm protein organell we report potent small molecul inhibitor autophagi name spautin1 specif potent autophagi inhibitor1 spautin1 promot degrad vps34 pi3 kinas complex inhibit two ubiquitinspecif peptidas usp10 usp13 target beclin1 subunit vps34 complex beclin1 tumor suppressor frequent monoallel lost human cancer interest beclin1 control protein stabil usp10 usp13 regul deubiquitin activ sinc usp10 mediat deubiquitin p53 regul deubiquitin activ usp10 usp13 beclin1 provid mechan beclin1 control level p53 our studi provid molecular mechan involv protein deubiquitin connect two tumor suppressor p53 beclin1 potent small molecul inhibitor autophagi possibl lead compound develop anticanc drug',\n",
       "  'ArticleTitle': 'Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.',\n",
       "  'Author': 'Liu Junli'},\n",
       " {'Abstract': ' fat ft cadherin enorm cell adhes molecul function cell surfac regul tumorsuppress hippo signal pathway planar cell polar pcp tissu organ mutat ft cadherin varieti tumor presum defect hippo signal pcp here drosophila ft function mitochondria direct regul mitochondri electron transport chain integr promot oxid phosphoryl proteolyt cleavag releas solubl 68 kda fragment ftmito import mitochondria ftmito bind direct nadh dehydrogenas ubiquinon flavoprotein 2 ndufv2 core compon complex i stabil holoenzym loss ft lead loss complex i activ increas reactiv oxygen speci switch aerob glycolysi defect mitochondri activ ft mutant independ hippo pcp signal reminisc warburg effect',\n",
       "  'ArticleTitle': 'The atypical cadherin fat directly regulates mitochondrial function and metabolic state.',\n",
       "  'Author': 'Sing Anson'},\n",
       " {'Abstract': ' the signal adaptor p62 multidomain protein implic activ transcript factor nfkappab recent find link p62 activ extrins apoptosi pathway mathew al 2009 modul p62 autophagi key factor tumorigenesi these find place p62 critic decis point control cell death surviv',\n",
       "  'ArticleTitle': 'p62 at the crossroads of autophagy, apoptosis, and cancer.',\n",
       "  'Author': 'Moscat Jorge'},\n",
       " {'Abstract': ' repair dna doublestrand break dsbs nonhomolog end join critic neural develop brain cell frequent contain somat genom variat involv dsb intermedi we unbias highthroughput approach identifi genom region harbor recurr dsbs primari neural stemprogenitor cell nspcs we identifi 27 recurr dsb cluster rdcs remark occur gene bodi most nspc rdcs detect mild aphidicolininduc replic stress provid nucleotideresolut view replicationassoci genom fragil site the vast major rdcs occur long transcrib laterepl gene moreov 90 identifi rdccontain gene involv synaps function andor neural cell adhes substanti fraction implic tumor suppress andor mental disord our character nspc rdcs reveal basi gene fragil suggest potenti impact dna break neurodevelop neural function',\n",
       "  'ArticleTitle': 'Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells.',\n",
       "  'Author': 'Wei Pei-Chi'},\n",
       " {'Abstract': ' uvinduc pigment suntan requir induct alphamelanocytestimul hormon alphamsh secret keratinocyt alphamsh bioactiv peptid cleavag product proopiomelanocortin pomc here provid biochem genet evid demonstr uv induct pomcmsh skin direct control p53 wherea p53 potent stimul pomc promot respons uv absenc p53 knockout mice associ absenc uvtan respons the pathway produc betaendorphin pomc deriv potenti contribut sunseek behavior furthermor instanc uvindepend patholog pigment involv p53 mimick tan respons p53 function sensoreffector uv pigment constant environment exposur moreov pathway activ numer condit patholog pigment mimic tan respons',\n",
       "  'ArticleTitle': 'Central role of p53 in the suntan response and pathologic hyperpigmentation.',\n",
       "  'Author': 'Cui Rutao'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: forkhead transcription factors I.',\n",
       "  'Author': 'Tuteja Geetu'},\n",
       " {'Abstract': ' the egf receptor egfr requir skin develop implic epitheli tumor format transgen mice express domin form son sevenless sosf basal keratinocyt develop skin papilloma 100 penetr howev tumor format inhibit hypomorph wa2 null egfr background similar egfrdefici fibroblast resist transform sosf rasv12 tumorigen restor express antiapoptot bcl2 gene the k5sosf papilloma primari keratinocytesfrom wa2 mice display increas apoptosi reduc akt phosphoryl graft experi impli cellautonom requir egfr keratinocyt therefor egfr function surviv factor oncogen transform provid valuabl target therapeut intervent broader rang tumor anticip',\n",
       "  'ArticleTitle': 'The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development.',\n",
       "  'Author': 'Sibilia M'},\n",
       " {'Abstract': ' the hippo signal pathway function yorki control tissu growth homeostasi how pathway regul nondevelopment process remain larg unexplor here report essenti role hippo signal innat immun yorki direct regul transcript drosophila ib homolog cactus toll receptormedi antimicrobi respons loss hippo pathway tumor suppressor activ yorki fat bodi drosophila immun organ lead elev cactus mrna level decreas express antimicrobi peptid vulner infect gramposit bacteria furthermor gramposit bacteria acut activ hippoyorki signal fat bodi tollmyd88pell cascad pellemedi phosphoryl degrad cka subunit hippoinhibitori stripak pp2a complex our studi elucid tollmedi hippo signal pathway antimicrobi respons highlight regul ibcactus transcript innat immun identifi gramposit bacteria extracellular stimuli hippo signal physiolog set',\n",
       "  'ArticleTitle': 'Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila.',\n",
       "  'Author': 'Liu Bo'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'NF1 tumor suppressor gene function: narrowing the GAP.',\n",
       "  'Author': 'Cichowski K'},\n",
       " {'Abstract': ' dure differenti human embryon stem cell hesc shut regulatori network confer pluripot process design pluripot state dissolut psd in highthroughput rnai screen inclus set differenti condit identifi central contextdepend process regul psd hesc includ histon acetyl chromatin remodel rna splice signal pathway strike detect strong specif enrich cellcycl gene involv dna replic g2 phase progress genet chemic perturb studi demonstr s g2 phase attenu psd possess intrins propens pluripot state independ g1 phase our data function establish pluripot control hardwir cellcycl machineri s g2 phasespecif pathway determinist restrict psd absenc pathway g1 phase potenti permit initi differenti',\n",
       "  'ArticleTitle': 'Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways.',\n",
       "  'Author': 'Gonzales Kevin Andrew Uy'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'P53 is a tumor suppressor gene.',\n",
       "  'Author': 'Levine Arnold J'},\n",
       " {'Abstract': ' nuclear exclus forkhead transcript factor foxo3a protein kinas akt contribut cell surviv we investig patholog relationship phosphoylatedakt aktp foxo3a primari tumor surpris foxo3a exclud nuclei tumor lack aktp suggest aktindepend mechan regul foxo3a local we provid evid mechan show ikappab kinas ikk physic interact phosphoryl inhibit foxo3a independ akt caus proteolysi foxo3a ubdepend proteasom pathway cytoplasm foxo3a correl express ikkbeta aktp tumor associ poor surviv breast cancer further constitut express ikkbeta promot cell prolifer tumorigenesi overridden foxo3a these result suggest negat regul foxo factor ikk key mechan promot cell growth tumorigenesi',\n",
       "  'ArticleTitle': 'IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.',\n",
       "  'Author': 'Hu Mickey C-T'},\n",
       " {'Abstract': ' the proinflammatori cytokin tumor necrosi factor tnf alpha signal cell surviv death the biolog outcom tnfalpha treatment determin balanc nfkappab jun kinas jnk signal nfkappab promot surviv jnk enhanc cell death critic ident jnk substrat promot tnfalphainduc apoptosi outstand here tnfalphamedi jnk activ acceler turnov nfkappabinduc antiapoptot protein cflip inhibitor caspase8 this direct cflip phosphoryl depend jnkmediat phosphoryl activ e3 ubiquitin ligas itch ubiquitin cflip induc proteasom degrad jnk1 itch defici treatment jnk inhibitor render mice resist three distinct model tnfalphainduc acut liver failur cell mice display induc cflipl ubiquitin degrad thus jnk antagon nfkappab tnfalpha signal promot proteasom elimin cflipl',\n",
       "  'ArticleTitle': 'The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.',\n",
       "  'Author': 'Chang Lufen'},\n",
       " {'Abstract': ' hematopoiet stem cell hscs resid hypox nich bone marrow cord blood yet essenti hsc studi perform cell isol process nonphysiolog ambient air by collect manipul bone marrow cord blood nativ condit hypoxia demonstr brief exposur ambient oxygen decreas recoveri longterm repopul hscs increas progenitor cell phenomenon term extraphysiolog oxygen shockstress ephoss thus true number hscs bone marrow cord blood routin underestim we link ros product induct mitochondri permeabl transit pore mptp cyclophilin d p53 mechan ephoss the mptp inhibitor cyclosporin a protect mous bone marrow human cord blood hscs ephoss collect air result increas recoveri transplant hscs mitig ephoss cell collect process pharmacolog mean clinic advantag transplant',\n",
       "  'ArticleTitle': 'Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.',\n",
       "  'Author': 'Mantel Charlie R'},\n",
       " {'Abstract': ' skin largest organ bodi plagu cancer exposur ultraviolet radiat sun a report cui al 2007 issu cell explain tumor suppressor p53 protect skin stimul suntan respons',\n",
       "  'ArticleTitle': 'The sunny side of p53.',\n",
       "  'Author': 'Oren Moshe'},\n",
       " {'Abstract': ' the treatment advanc prostat cancer transform novel antiandrogen therapi enzalutamid here identifi induct glucocorticoid receptor gr express common featur drugresist tumor credenti preclin model find confirm patient sampl gr substitut androgen receptor ar activ similar distinguish set target gene necessari mainten resist phenotyp the gr agonist dexamethason suffici confer enzalutamid resist gr antagonist restor sensit acut ar inhibit result gr upregul subset prostat cancer cell relief armedi feedback repress gr express these find establish mechan escap ar blockad expans cell prime drive ar target gene altern nuclear receptor drug exposur',\n",
       "  'ArticleTitle': 'Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.',\n",
       "  'Author': 'Arora Vivek K'},\n",
       " {'Abstract': ' amplif erbb2 locus encod receptor tyrosin kinas common aggress breast tumor correl poor prognosi the mechan under erbb2medi breast carcinoma progress remain incomplet defin to examin role signal celladhes receptor beta 4 integrin erbb2medi tumorigenesi introduc target delet beta 4 signal domain mous model erbb2induc mammari carcinoma loss beta 4 signal suppress mammari tumor onset invas growth ex vivo studi indic beta 4 form complex erbb2 enhanc activ transcript factor stat3 cjun stat3 contribut disrupt epitheli adhes polar cjun requir hyperprolifer final delet beta 4 signal domain enhanc efficaci erbb2target therapi these result indic beta 4 integrin promot tumor progress amplifi erbb2 signal identifi beta 4 potenti target molecular therapi breast cancer',\n",
       "  'ArticleTitle': 'Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.',\n",
       "  'Author': 'Guo Wenjun'},\n",
       " {'Abstract': ' extens genet alter epitheli malign use three complementari genet approach boehm al 2007 identifi ikbkewhich encod ikkepsilon compon nfkappab pathwaya breast cancer oncogen',\n",
       "  'ArticleTitle': 'All roads lead to IKKepsilon.',\n",
       "  'Author': 'Agami Reuven'},\n",
       " {'Abstract': ' although known gene promot metastasi suppressor metastasi adorno al 2009 identifi p63 potent suppressor metastasi uncov intric mechan inactiv metastasi cancer cell respons transform growth factor beta',\n",
       "  'ArticleTitle': 'beta-tting on p63 as a metastatic suppressor.',\n",
       "  'Author': 'Clohessy John G'},\n",
       " {'Abstract': ' inactiv cell death major step tumor develop p53 tumor suppressor frequent mutat cancer critic mediat cell death while role p53 apoptosi well establish direct link pathway control cell death unknown here describ dram damageregul autophagi modul p53 target gene encod lysosom protein induc macroautophagi effector p53mediat death we p53 induc autophagi dramdepend manner overexpress dram caus minim cell death dram essenti p53mediat apoptosi moreov analysi dram primari tumor reveal frequent decreas express accompani retent wildtyp p53 collect studi report stressinduc regul autophagi highlight relationship dram autophagi p53 function damageinduc program cell death',\n",
       "  'ArticleTitle': 'DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.',\n",
       "  'Author': 'Crighton Diane'},\n",
       " {'Abstract': ' the p53 tumor suppressor pathway coordin dna repair cellcycl arrest apoptosi senesc preserv genom stabil prevent tumor format the discoveri three new target gene p53 reveal unexpect function tumor suppressor regul glucos metabol autophagi',\n",
       "  'ArticleTitle': 'p53 and metabolism: Inside the TIGAR.',\n",
       "  'Author': 'Green Douglas R'},\n",
       " {'Abstract': ' xiap prevent apoptosi bind inhibit caspas inhibit reliev iap antagonist smacdiablo iap antagonist compound iac design inhibit xiap kill tumor cell becaus xiap inhibit postmitochondri caspas caspas 8 inhibitor block kill iac instead apoptosi caus iac block caspas 8 inhibitor crma iap antagonist activ nfkappab signal inhibt ciap1 in sensit tumor line iap antagonist induc nfkappabstimul product tnfalpha kill cell autocrin fashion inhibit nfkappab reduc tnfalpha product block nfkappab activ tnfalpha allow tumor cell surviv iacinduc apoptosi cell treat iac ciap1 delet sensit apoptosi induc exogen tnfalpha suggest novel use compound treat cancer',\n",
       "  'ArticleTitle': 'IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.',\n",
       "  'Author': 'Vince James E'},\n",
       " {'Abstract': ' granzym a gzma induc caspaseindepend cell death pathway character singlestrand dna nick featur apoptosi a gzmaactiv dnase gaad er associ complex contain pp32 gzma substrat set hmg2 ape1 we gaad nm23h1 nucleosid diphosph kinas implic suppress tumor metastasi specif inhibitor igaad set nm23h1 bind set releas inhibit gzma cleavag set after gzma load ctl attack set nm23h1 transloc nucleus set degrad allow nm23h1 nick chromosom dna gzmatreat cell silenc nm23h1 express resist gzmamedi dna damag cytolysi cell overexpress nm23h1 sensit',\n",
       "  'ArticleTitle': 'Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.',\n",
       "  'Author': 'Fan Zusen'},\n",
       " {'Abstract': ' the epiderm growth factor receptor egfr repres one common target protein anticanc therapi to direct examin structur dynam properti egfr activ epiderm growth factor egf nativ membran develop solidst nuclear magnet reson ssnmrbase approach support dynam nuclear polar dnp in contrast previous crystallograph result experi ligandfre state extracellular domain ecd high dynam intracellular kinas domain kd rigid ligand bind restrict local motion egfr domain includ ecd ctermin region we propos reduct conform entropi ecd ligand bind favor cooper bind requir receptor dimer caus alloster activ intracellular tyrosin kinas',\n",
       "  'ArticleTitle': 'EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMR.',\n",
       "  'Author': 'Kaplan Mohammed'},\n",
       " {'Abstract': ' a link inflamm cancer long suspect molecular natur remain ill defin a key player inflamm transcript factor nfkappab activ trigger respons infecti agent proinflammatori cytokin ikappab kinas ikk complex use colitisassoci cancer model delet ikkbeta intestin epitheli cell decreas inflamm lead dramat decreas tumor incid affect tumor size this link increas epitheli apoptosi tumor promot delet ikkbeta myeloid cell result signific decreas tumor size this delet diminish express proinflammatori cytokin serv tumor growth factor affect apoptosi thus specif inactiv ikknfkappab pathway two differ cell type attenu format inflammationassoci tumor in addit suppress apoptosi advanc tumor ikkbeta link inflamm cancer',\n",
       "  'ArticleTitle': 'IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.',\n",
       "  'Author': 'Greten Florian R'},\n",
       " {'Abstract': ' coordin organ behavior crucial effect respons environment stimuli by studi regener hair follicl respons pattern hair pluck demonstr organlevel quorum sens allow coordin respons skin injuri pluck hair differ densiti lead regener five time neighbor unpluck rest hair indic activ collect decisionmak process through data model rang quorum signal estim order 1 greater expect diffus molecular cue molecular genet analysi uncov twostep mechan releas ccl2 injur hair lead recruit tnfsecret macrophag accumul signal pluck unpluck follicl by coupl immun respons regener mechan allow skin respond predict distress disregard mild injuri meet stronger injuri fullscal cooper activ stem cell',\n",
       "  'ArticleTitle': 'Organ-level quorum sensing directs regeneration in hair stem cell populations.',\n",
       "  'Author': 'Chen Chih-Chiang'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: DNA polymerases II mammals.',\n",
       "  'Author': 'Foti James J'},\n",
       " {'Abstract': ' the myriad chang occur malign progress cancer cell challeng clinician basic scientist two new studi natur underscor central role genom instabl tumor biolog edward al 2008 sakai al 2008 these report describ secondari chang brca2 locus restor wildtyp read frame contribut develop resist chemotherapeut agent',\n",
       "  'ArticleTitle': 'The Yin and Yang of treating BRCA-deficient tumors.',\n",
       "  'Author': 'Martin Richard W'},\n",
       " {'Abstract': ' systemat character cancer genom reveal stagger number divers aberr differ individu function physiolog impact tumor genet alter remain poor defin we develop comput framework integr chromosom copi number gene express data detect aberr promot cancer progress we demonstr util framework melanoma data set our analysi correct identifi known driver melanoma predict multipl tumor depend two depend tbc1d16 rab27a confirm empir suggest abnorm regul protein traffick contribut prolifer melanoma togeth result demonstr abil integr bayesian approach identifi candid driver biolog possibl therapeut cancer',\n",
       "  'ArticleTitle': 'An integrated approach to uncover drivers of cancer.',\n",
       "  'Author': 'Akavia Uri David'},\n",
       " {'Abstract': ' spot fever group sfg rickettsia human pathogen infect cell vasculatur they dissemin host tissu process celltocel spread involv protrus format engulf vacuolar escap other bacteri pathogen reli actinbas motil provid physic forc spread here sfg speci rickettsia parkeri typic lack actin tail spread instead manipul host intercellular tension mechanotransduct promot spread use transposon mutagenesi identifi surfac cell antigen 4 sca4 secret effector spread promot protrus engulf sca4 interact celladhes protein vinculin block associ vinculin bind partner catenin use traction monolay stress microscopi sca4 reduc vinculindepend mechanotransduct cellcel junction our result suggest sca4 reliev intercellular tension promot protrus engulf repres distinct strategi manipul cytoskelet forc generat enabl spread',\n",
       "  'ArticleTitle': 'Rickettsia Sca4 Reduces Vinculin-Mediated Intercellular Tension to Promote Spread.',\n",
       "  'Author': 'Lamason Rebecca L'},\n",
       " {'Abstract': ' mitochondri ribosom translat membran integr core subunit oxid phosphoryl system encod mtdna these translat product associ nuclearencod import protein form enzym complex produc atp here human mitochondri ribosom display translat plastic cope suppli import nuclearencod subunit ribosom express mitochondrialencod cox1 mrna select engag cytochrom c oxidas assembl factor inner membran assembl defect cytochrom c oxidas arrest mitochondri translat ribosom nascent chain complex partial membraneinsert cox1 translat product this complex repres prime state translat product retriev assembl these find establish mammalian translat plastic pathway mitochondria enabl adapt mitochondri protein synthesi influx nuclearencod subunit',\n",
       "  'ArticleTitle': 'Mitochondrial Protein Synthesis Adapts to Influx of Nuclear-Encoded Protein.',\n",
       "  'Author': 'Richter-Dennerlein Ricarda'},\n",
       " {'Abstract': ' member swisnf chromatinremodel complex frequent mutat gene human cancer suppress tumorigenesi current unclear here drosophila neuroblast demonstr swisnf compon osa arid1 prevent tumorigenesi ensur correct lineag progress stem cell lineag we osa induc transcript program transitamplifi popul initi tempor pattern limit selfrenew prevent dedifferenti we identifi prdm protein hamlet key compon program hamlet direct induc osa regul progress progenitor distinct transcript state limit number transitamplifi divis our data provid mechanist explan widespread tumor suppressor activ swisnf becaus hamlet homolog evi1 prdm16 frequent mutat cancer mechan well conserv human stem cell lineag paperclip',\n",
       "  'ArticleTitle': 'SWI/SNF complex prevents lineage reversion and induces temporal patterning in neural stem cells.',\n",
       "  'Author': 'Eroglu Elif'},\n",
       " {'Abstract': ' lysinespecif demethylas 1 lsd1 exert pathwayspecif activ anim develop link highrisk cancer here report lsd1 integr compon mi2nucleosom remodel deacetylas nurd complex transcript target analysi reveal lsd1nurd complex regul cellular signal pathway includ tgfbeta1 signal pathway critic involv cell prolifer surviv epithelialtomesenchym transit we demonstr lsd1 inhibit invas breast cancer cell vitro suppress breast cancer metastat potenti vivo we lsd1 downregul breast carcinoma level express negat correl tgfbeta1 our data provid molecular basi interplay histon demethyl deacetyl chromatin remodel by enlist lsd1 nurd complex expand chromatin remodel capac includ atpas histon deacetylas histon demethylas',\n",
       "  'ArticleTitle': 'LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.',\n",
       "  'Author': 'Wang Yan'},\n",
       " {'Abstract': ' the mrna polyadenyl factor cstf interact brca1associ protein bard1 interact repress nuclear mrna polyadenyl machineri vitro given suspect role brca1bard1 dna repair test inhibit mrna process link dna damag strike 3 cleavag extract cell treat hydroxyurea ultraviolet light transient inhibit although chang detect cstf bard1 brca1 protein level increas amount cstfbard1brca1 complex detect support physiolog signific result identifi tumorassoci germlin mutat bard1 gln564his reduc bind cstf abrog inhibit polyadenyl togeth result indic link mrna 3 process dna repair tumor suppress',\n",
       "  'ArticleTitle': \"The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.\",\n",
       "  'Author': 'Kleiman F E'},\n",
       " {'Abstract': ' the exosom regul process degrad surveil plethora rna speci howev littl known exosom recogn recruit divers substrat we report identif adaptor protein recruit exosomeassoci helicas mtr4 uniqu rna substrat nop53 yeast homolog tumor suppressor pict1 target mtr4 preribosom particl exosomemedi process second adaptor utp18 recruit mtr4 cleav rrna fragment destin degrad exosom both nop53 utp18 contain consensus motif dock arch domain mtr4 target specif substrat these find exosom employ general mechan recruit defin substrat process regul adaptor protein',\n",
       "  'ArticleTitle': 'The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins.',\n",
       "  'Author': 'Thoms Matthias'},\n",
       " {'Abstract': ' brca1 breast ovarian cancersuppressor gene exert tumorsuppress function appear associ least part dna repair checkpoint mitot regulatori activ earlier work laboratori suggest abil brca1 communic inact x chromosom xi femal somat cell ganesan al 2002 xiao al 2007 issu cell challeng conclus here discuss publish data laboratori new result provid support role brca1 regul xist concentr xi somat cell',\n",
       "  'ArticleTitle': 'Further evidence for BRCA1 communication with the inactive X chromosome.',\n",
       "  'Author': 'Silver Daniel P'},\n",
       " {'Abstract': ' through vivo select human cancer cell popul uncov converg cooper mirna network drive melanoma metastasi we identifi mir1908 mir199a5p mir199a3p endogen promot metastat invas angiogenesi colon melanoma these mirna converg target apolipoprotein e apo heat shock factor dnaja4 cancersecret apo suppress invas metastat endotheli recruit mer engag melanoma cell lrp1 endotheli cell lrp8 receptor respect dnaja4 promot apo express express level mirna apo correl human metastat progress outcom treatment cell lock nucleic acid lnas target mirna inhibit metastasi multipl organ therapeut deliveri lnas suppress melanoma metastasi we identifi mirna dual cellintrinsiccellextrins role cancer reveal converg cooper metastat mirna network identifi apo antiangiogen metastasissuppress factor uncov multipl prognost mirna synergist combinatori therapeut potenti melanoma',\n",
       "  'ArticleTitle': 'Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.',\n",
       "  'Author': 'Pencheva Nora'},\n",
       " {'Abstract': ' the tumor suppressor p53 activ genotox oxid stress turn inhibit cell prolifer growth induct specif target gene cell growth posit regul mtor activ inhibit tsc1tsc2 complex although genotox stress suggest inhibit mtor p53mediat activ mtor inhibitor precis mechan link unknown we demonstr product two p53 target gene sestrin1 sestrin2 activ amprespons protein kinas ampk target phosphoryl tsc2 stimul gap activ inhibit mtor correspond sestrin2defici mice fail inhibit mtor signal genotox challeng sestrin1 sestrin2 provid link genotox stress p53 mtor signal pathway',\n",
       "  'ArticleTitle': 'p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.',\n",
       "  'Author': 'Budanov Andrei V'},\n",
       " {'Abstract': ' shallow gradient chemoattract sens g proteinlink signal pathway elicit local bind ph domain specif pi345p3 site membran rearrang cytoskeleton pseudopod extens occur disrupt pi 3phosphatas pten dictyostelium discoideum dramat prolong broaden ph domain reloc actin polymer respons caus cell lack pten follow circuit rout attract exogen express ptengfp local surfac membran rear cell membran local requir putat pi45p2 bind motif requir chemotaxi these result suggest specif phosphoinositid direct actin polymer cell lead edg regul pten feedback loop play critic role gradient sens direct migrat',\n",
       "  'ArticleTitle': 'Tumor suppressor PTEN mediates sensing of chemoattractant gradients.',\n",
       "  'Author': 'Iijima Miho'},\n",
       " {'Abstract': ' lin28 high conserv rnabind protein emerg modul process let7 microrna this role lin28 implic mechanist understand pluripot time develop oncogenesi',\n",
       "  'ArticleTitle': 'Lin28: A microRNA regulator with a macro role.',\n",
       "  'Author': 'Viswanathan Srinivas R'},\n",
       " {'Abstract': ' repair dna doubl strand break homolog recombin hr initi rad51 filament nucleat singlestrand dna ssdna catalyz strand exchang homolog duplex dna brca2 rad51 paralog tumor suppressor critic mediat rad51 to gain insight rad51 paralog function investig heterodimer rad51 paralog complex rfs1rip1 uncov molecular basi rad51 paralog promot hr unlik brca2 nucleat rad51ssdna filament rfs1rip1 bind remodel presynapt filament stabil open flexibl conform ssdna access nucleas digest rad51 dissoci rate reduc walker box mutat rfs1 abolish filament remodel fail stimul rad51 strand exchang activ demonstr remodel essenti rfs1rip1 function we propos rad51 paralog stimul hr remodel rad51 filament prime strand exchang templat duplex',\n",
       "  'ArticleTitle': 'Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination.',\n",
       "  'Author': 'Taylor Martin R G'},\n",
       " {'Abstract': ' posttransl modif ptms tubulin specifi microtubul special cellular function compris term tubulin code ptms histon compris analog histon code reader writer eras cytoskeleton epigenom heretofor distinct we methyl ptm dynam microtubul histon methyltransferas setdomaincontain 2 setd2 respons h3 lysin 36 trimethyl h3k36me3 histon methyl tubulin lysin 40 lysin mark acetyl microtubul methyl microtubul occur mitosi cytokinesi ablat setd2 delet caus mitot spindl cytokinesi defect micronuclei polyploidi these data identifi setd2 dualfunct methyltransferas chromatin cytoskeleton requir methyl mainten genom stabil integr tubulin histon code',\n",
       "  'ArticleTitle': 'Dual Chromatin and Cytoskeletal Remodeling by SETD2.',\n",
       "  'Author': 'Park In Young'},\n",
       " {'Abstract': ' epitheli cell requir attach extracellular matrix ecm suppress apoptot cell death program term anoiki here describ nonapoptot cell death program matrixdetach cell initi unrecogn unusu process involv invas one cell lead transient state live cell contain neighbor host cell live intern cell degrad lysosom enzym releas we term cell intern process entosi evid entosi mechan under common observ cellincel cytolog featur human cancer further propos entosi driven compact forc associ adheren junction format absenc integrin engag repres intrins tumor suppress mechan cell detach ecm',\n",
       "  'ArticleTitle': 'A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.',\n",
       "  'Author': 'Overholtzer Michael'},\n",
       " {'Abstract': ' cell respond sensit timevari input complex signal environ to understand signal network process dynam input gene express output role nois cellular inform process immun pathway nfb period cytokin input microfluid singlecel measur stochast model we nfb dynam fibroblast synchron oscil tnf signal entrain lead increas nfb oscil amplitud mrna output compar nonentrain respons simul intrins biochem nois individu cell improv nfb oscil entrain celltocel variabl nfb natur frequenc creat popul robust enabl entrain wider rang dynam input this wide rang confirm experi entrain cell measur input period these result indic synergi oscil nois allow cell achiev effici gene express dynam chang signal environ',\n",
       "  'ArticleTitle': 'Noise facilitates transcriptional control under dynamic inputs.',\n",
       "  'Author': 'Kellogg Ryan A'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'DNA methylation of transcriptional enhancers and cancer predisposition.',\n",
       "  'Author': 'Aran Dvir'},\n",
       " {'Abstract': ' laboratori mice paramount understand basic biolog phenomena limit model complex diseas human freeliv mammal becaus microbiom major factor mammalian physiolog aim identifi natur evolv refer microbiom better recapitul physiolog phenomena relev natur world outsid laboratori among 21 distinct mous popul worldwid identifi close relat wild relat standard laboratori mous strain it bacteri gut microbiom differ laboratori mous counterpart transfer maintain laboratori mice generat laboratori mice reconstitut natur microbiota exhibit reduc inflamm increas surviv follow influenza virus infect improv resist mutageninflammationinduc colorect tumorigenesi by demonstr host fitnesspromot trait natur microbiota find enabl discoveri protect mechan relev natur world improv model complex diseas freeliv mammal video abstract',\n",
       "  'ArticleTitle': 'Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance.',\n",
       "  'Author': 'Rosshart Stephan P'},\n",
       " {'Abstract': ' through network progress matur vesicl endosom system connect cell interior extracellular space intrigu network exhibit bilater architectur compris relat immobil perinuclear vesicl cloud high dynam peripher conting how spatiotempor organ achiev function curat unclear here reveal endoplasm reticulum erloc ubiquitin ligas ring finger protein 26 rnf26 global architect entir endosom system includ transgolgi network tgn to specifi perinuclear vesicl coordin catalyt compet rnf26 recruit ubiquitin scaffold p62sequestosom 1 p62sqstm1 turn attract ubiquitinbind domain ubd vesicl adaptor consequ rnf26 restrain fast transport divers vesicl common molecular mechan oper er membran deubiquitin enzym usp15 oppos rnf26 activ allow vesicl releas cell peripheri by draw endosom system architectur rnf26 orchestr endosom matur traffick cargo includ signal receptor space time',\n",
       "  'ArticleTitle': 'An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport.',\n",
       "  'Author': 'Jongsma Marlieke L M'},\n",
       " {'Abstract': ' defect circadian rhythm influenc physiolog behavior implic treatment sleep disord metabol diseas cancer although core regulatori compon clock rhythmic defin insight mechan underpin amplitud limit here reverb core inhibitori compon clock transcript target ubiquitin subsequ degrad fbox protein fbxw7 by reliev reverbdepend repress fbxw7 provid unrecogn mechan enhanc amplitud clock gene transcript cyclindepend kinas 1 cdk1mediat phosphoryl reverb necessari fbxw7 recognit moreov target hepat disrupt fbxw7 alter circadian express core clock gene perturb wholebodi lipid glucos level this cdk1fbxw7 pathway control reverb repress defin unexpect molecular mechan reengag posit transcript arm clock well potenti rout manipul clock amplitud small molecul cdk1 inhibit',\n",
       "  'ArticleTitle': u'Circadian Amplitude Regulation via FBXW7-Targeted REV-ERB\\u03b1 Degradation.',\n",
       "  'Author': 'Zhao Xuan'},\n",
       " {'Abstract': ' activ mutat flt3 occur 30 acut myeloid leukemia aml case associ relaps poor prognosi midostaurin first drug approv aml 2000 first multikinas inhibitor approv flt3mutant subtyp to view bench bedsid open download pdf',\n",
       "  'ArticleTitle': 'First Approved Kinase Inhibitor for AML.',\n",
       "  'Author': 'Rasko John E J'},\n",
       " {'Abstract': ' prolifer cell cross point return replic dna divid this commit decis play fundament role cancer degen diseas propos mediat phosphoryl retinoblastoma rb protein here inactiv anaphasepromot complexcyclosom apccdh1 necessari characterist point return cellcycl entri our studi apccdh1 inactiv rapid bistabl switch initi short start dna replic cyclin ecdk2 irrevers emi1 exposur stress rb phosphoryl apccdh1 inactiv apccdh1 inactiv revert cell mitogensensit quiescent state later reenter cell cycl thus apccdh1 inactiv commit point cell lose abil return quiescenc decid progress cell cycl',\n",
       "  'ArticleTitle': 'Irreversible APC(Cdh1) Inactivation Underlies the Point of No Return for Cell-Cycle Entry.',\n",
       "  'Author': 'Cappell Steven D'},\n",
       " {'Abstract': ' secretas famili intramembranecleav proteas involv signal pathway diseas includ alzheim diseas ad cell coexpress differ secretas complex includ two homolog presenilin psen we examin signific heterogen identifi uniqu motif psen2 direct secretas late endosomeslysosom phosphorylationdepend interact ap1 adaptor complex accord psen2 select cleav late endosomallysosom local substrat generat promin pool intracellular a contain longer a famili ad fadassoci mutat psen2 increas level longer a moreov subset fad mutant psen1 broad distribut cell phenocopi psen2 shift local late endosomeslysosom thus local secretas determin substrat specif fadcaus mutat enhanc accumul aggregationpron a42 intracellular acid compart the find reveal potenti role specif intracellular local reaction contribut ad pathogenesi',\n",
       "  'ArticleTitle': u'Restricted Location of PSEN2/\\u03b3-Secretase Determines Substrate Specificity and Generates an Intracellular A\\u03b2 Pool.',\n",
       "  'Author': 'Sannerud Ragna'},\n",
       " {'Abstract': ' oncogen mutat small gtpase ras high preval cancer understand vulner cancer lack we undertook genomewid rnai screen identifi synthet lethal interact kras oncogen we discov divers set protein deplet select impair viabil ras mutant cell among observ strong enrich gene mitot function we describ pathway involv mitot kinas plk1 anaphasepromot complexcyclosom proteasom inhibit result prometaphas accumul subsequ death ras mutant cell gene express analysi indic reduc express gene pathway correl increas surviv patient bear tumor ras transcript signatur our result suggest underappreci role ras mitot progress demonstr pharmacolog tractabl pathway potenti treatment cancer harbor ras mutat',\n",
       "  'ArticleTitle': 'A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.',\n",
       "  'Author': 'Luo Ji'},\n",
       " {'Abstract': ' hematopoiet stem cell hscs underli product blood immun cell lifetim organ in vertebr embryo hscs uniqu transdifferenti hemogen endothelium compris floor dorsal aorta brief development window to date process replic vitro pluripot precursor part full complement requir signal input remain determin here tnfr2 tnf activ notch nfb signal pathway establish hsc fate indic requir inflammatori signal hsc generat we determin primit neutrophil major sourc tnf assign role transient innat immun cell establish hsc program these result demonstr proinflammatori signal absenc infect util develop embryo generat lineal precursor adult hematopoiet system',\n",
       "  'ArticleTitle': 'Proinflammatory signaling regulates hematopoietic stem cell emergence.',\n",
       "  'Author': u'Esp\\xedn-Palaz\\xf3n Raquel'},\n",
       " {'Abstract': ' while tumor suppressor function p53 long recogn contribut p53 numer aspect diseas normal life appreci this burgeon rang respons p53 reflect increas varieti mechan p53 function abil activ transcript remain key p53s modus operandi control p53s transcript activ crucial determin p53 respons activ decis understand exploit effici generat drug select activ inhibit p53',\n",
       "  'ArticleTitle': 'Blinded by the Light: The Growing Complexity of p53.',\n",
       "  'Author': 'Vousden Karen H'},\n",
       " {'Abstract': ' in issu cell reddi al report integr genet character diffus larg b cell lymphoma dlbcl includ largescal exom captur transcriptom crispr screen integr clinic biomark studi this provid first comprehens overview dlbcl biolog basi futur precis medicin approach diseas',\n",
       "  'ArticleTitle': 'Untangling the Web of Lymphoma Somatic Mutations.',\n",
       "  'Author': 'Teater Matt'},\n",
       " {'Abstract': ' describ decad ago warburg effect aerob glycolysi key metabol hallmark cancer signific remain unclear in essay reexamin warburg effect establish framework understand contribut alter metabol cancer cell',\n",
       "  'ArticleTitle': 'Cancer cell metabolism: Warburg and beyond.',\n",
       "  'Author': 'Hsu Peggy P'},\n",
       " {'Abstract': ' the activ tumor suppressor p53 facilit cellular respons genotox stress p53 respons execut interact inhibitor mdm2 abolish there conflict report question p53 posttransl modif phosphoryl acetyl essenti play subtl finetun role p53 respons thus remain unclear p53 modif absolut requir activ we identifi major acetyl site p53 although unacetyl p53 retain abil induc p53mdm2 feedback loop loss acetyl complet abolish p53depend growth arrest apoptosi notabl acetyl p53 abrog mdm2mediat repress block recruit mdm2 p53respons promot lead p53 activ independ phosphoryl status our studi identifi p53 acetyl indispens event destabil p53mdm2 interact enabl p53mediat stress respons',\n",
       "  'ArticleTitle': 'Acetylation is indispensable for p53 activation.',\n",
       "  'Author': 'Tang Yi'},\n",
       " {'Abstract': ' prionlik domain emerg driver neurodegen diseas now boulay al establish transloc prionlik domain oncogen ewsfli1 fusion protein enabl phasesepar event inappropri recruit chromatinremodel factor elicit aberr transcript program under ewe sarcoma',\n",
       "  'ArticleTitle': \"Prion-like Domains Program Ewing's Sarcoma.\",\n",
       "  'Author': 'Shorter James'},\n",
       " {'Abstract': ' gene duplic major evolutionari forc drive adapt speciat allow acquisit new function augment diversifi exist function here report gene duplic event yield outcometh generat antagonist function one product duplic eventupf3bi critic nonsensemedi rna decay nmd pathway autosom counterpartupf3aencod enigmat protein trace nmd activ use lossoffunct approach vitro vivo discov upf3a act potent nmd inhibitor stabil hundr transcript evid suggest upf3a acquir repressor activ simpl impair critic domain rapid mechan wide evolut mice condit lack upf3a exhibit hyper nmd display defect embryogenesi gametogenesi our result support model upf3a serv molecular rheostat direct development event',\n",
       "  'ArticleTitle': 'The Antagonistic Gene Paralogs Upf3a and Upf3b Govern Nonsense-Mediated RNA Decay.',\n",
       "  'Author': 'Shum Eleen Y'},\n",
       " {'Abstract': ' in small phase ib studi issu cell riba al report combin intralesion inject modifi human herp simplex virus system antipd1 treatment result 62 respons rate patient metastat melanoma accompani enhanc t cell infiltr virusinject lesion',\n",
       "  'ArticleTitle': 'Converting Cold into Hot Tumors by Combining Immunotherapies.',\n",
       "  'Author': 'Haanen John B A G'},\n",
       " {'Abstract': ' histon modif regul chromatindepend process mechan contribut specif outcom remain unclear h3k4me3 promin histon mark associ activ gene promot transcript interact effector protein includ initi factor tfiid we demonstr h3k4me3taf3 interact direct global tfiid recruit activ gene p53 target further analys 1 h3k4me3 enhanc p53depend transcript stimul preiniti complex pic format 2 h3k4me3 taf3 interact act independ cooper tata box direct pic format transcript 3 h3k4me3taf3tfiid interact regul geneselect function p53 respons genotox stress our find indic mechan h3k4me3 direct pic assembl rapid induct specif p53 target gene',\n",
       "  'ArticleTitle': 'H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation.',\n",
       "  'Author': 'Lauberth Shannon M'},\n",
       " {'Abstract': ' mechanist target rapamycin complex 1 mtorc1 integr divers environment signal control cellular growth organism homeostasi in respons nutrient rag gtpase recruit mtorc1 lysosom activ rag regul remain incomplet understood here sestrin bind heterodimer ragabragcd gtpase function guanin nucleotid dissoci inhibitor gdis ragab sestrin overexpress inhibit aminoacidinduc rag guanin nucleotid exchang mtorc1 transloc lysosom mutat conserv gdi motif creat dominantneg form sestrin render mtorc1 activ insensit amino acid depriv cellperm peptid contain gdi motif inhibit mtorc1 signal mice defici sestrin exhibit reduc postnat surviv associ defect mtorc1 inactiv multipl organ neonat fast these find reveal nonredund mechan sestrin famili gdis regul nutrientsens rag gtpase control mtorc1 signal',\n",
       "  'ArticleTitle': 'Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.',\n",
       "  'Author': 'Peng Min'},\n",
       " {'Abstract': ' have correct number centrosom crucial proper chromosom segreg cell divis prevent aneuploidi hallmark cancer cell sever recent studi basto al 2008 kwon al 2008 yang al 2008 reveal mechan protect consequ harbor centrosom',\n",
       "  'ArticleTitle': 'A tale of too many centrosomes.',\n",
       "  'Author': 'Acilan Ceyda'},\n",
       " {'Abstract': ' the immunolog synaps form cytotox t lymphocyt ctl infect transform target cell physic activ structur capabl exert mechan forc here investig synapt forc promot destruct target cell ctls kill secret toxic proteas pore form protein perforin synaps biophys experi reveal strike correl magnitud forc exert synaps speed perforin pore format target cell impli forc potenti cytotox enhanc perforin activ consist interpret increas target cell tension augment pore format perforin kill ctls our data indic ctls coordin perforin releas forc exert space time these result reveal unappreci physic dimens lymphocyt function demonstr cell mechan forc control activ outgo chemic signal',\n",
       "  'ArticleTitle': 'Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing.',\n",
       "  'Author': 'Basu Roshni'},\n",
       " {'Abstract': ' migrat cell exhibit distinct motil mode switch mode base chemic physic cue liu al ruprecht al describ confin contractil influenc motil mode plastic instig mode term stabl bleb migrat embryon tumor cell',\n",
       "  'ArticleTitle': 'Cell migration, freshly squeezed.',\n",
       "  'Author': 'Welch Matthew D'},\n",
       " {'Abstract': ' here describ pattern gene express human tumor deconvolut reveal mechan action cyclin d1 oncogen comput analysi express pattern thousand gene hundr tumor specimen suggest transcript factor cebpbetanfil6 particip consequ cyclin d1 overexpress function analys confirm involv cebpbeta regul gene affect cyclin d1 establish protein indispens effector potenti facet cyclin d1 biolog this work demonstr tumor gene express databas studi function human oncogen situ',\n",
       "  'ArticleTitle': 'A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.',\n",
       "  'Author': 'Lamb Justin'},\n",
       " {'Abstract': ' myelin sheath provid critic function trophic support axon white matter tract brain oligodendrocyt precursor cell opc extraordinari metabol requir develop differenti produc multipl myelin segment impli first secur adequ access blood suppli howev mechan coordin myelin angiogenesi unclear here oxygen tension mediat opcencod hypoxiainduc factor hif function essenti regul postnat myelin constitut hif12 stabil result opc matur arrest autocrin activ canon wnt7a7b surpris opc paracrin activ induc excess postnat white matter angiogenesi vivo direct stimul endotheli cell prolifer vitro convers opcspecif hif12 loss function lead insuffici angiogenesi corpus callosum catastroph axon loss these find indic opcintrins hif signal coupl postnat white matter angiogenesi axon integr onset myelin mammalian forebrain',\n",
       "  'ArticleTitle': 'Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis.',\n",
       "  'Author': 'Yuen Tracy J'},\n",
       " {'Abstract': ' innat immun first line defens infect protect host develop adapt immun critic affect natur adapt respons we contrast tumor necrosi factor alpha tnfalpha relat protein tweak attenu transit innat adapt mechan tweak mice overabund natur killer nk cell display hypersensit bacteri endotoxin innat immun cell produc excess interferon ifngamma interleukin il12 tweak inhibit stimul transcript activ stat1 induc p65 nuclear factor nfkappab associ histon deacetylas 1 repress cytokin product tweak mice develop overs spleen expand memori t helper 1 th1 subtyp cell age mount stronger innat adapt th1base respons tumor challeng thus tweak suppress product ifngamma il12 curtail innat respons transit adapt th1 immun',\n",
       "  'ArticleTitle': 'TWEAK attenuates the transition from innate to adaptive immunity.',\n",
       "  'Author': 'Maecker Heather'},\n",
       " {'Abstract': ' stress granul mrnaprotein granul form translat initi limit relat patholog granul neurodegen diseas superresolut microscopi reveal stabl substructur refer core stress granul purifi proteom analysi stress granul core reveal dens network proteinprotein interact link stress granul human diseas identifi atpdepend helicas protein remodel conserv stress granul compon atp requir stress granul assembl dynam moreov multipl atpdriven machin affect stress granul differ cct complex inhibit stress granul assembl mcm rvb complex promot stress granul persist our observ suggest stress granul contain stabl core structur surround dynam shell assembl disassembl transit core shell modul numer protein rna remodel complex',\n",
       "  'ArticleTitle': 'ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.',\n",
       "  'Author': 'Jain Saumya'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Ras Signaling.',\n",
       "  'Author': 'Cully Megan'},\n",
       " {'Abstract': ' cellular lipid requir achiev combin biosynthesi import program use isotop tracer analysi i interferon ifn signal shift balanc program decreas synthesi increas import cholesterol long chain fatti acid genet enforc metabol shift macrophag suffici render mice resist viral challeng demonstr reprogram balanc two metabol pathway vivo unexpect mechanist studi reveal limit flux cholesterol biosynthet pathway spontan engag i ifn respons stingdepend manner the upregul i ifn trace decreas pool size synthes cholesterol inhibit replenish cell free cholesterol taken studi delin metabolicinflammatori circuit link perturb cholesterol biosynthesi activ innat immun',\n",
       "  'ArticleTitle': 'Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.',\n",
       "  'Author': 'York Autumn G'},\n",
       " {'Abstract': ' the abil perturb gene human cell crucial elucid gene function hold great potenti find therapeut target diseas cancer to extend catalog human core contextdepend fit gene develop highcomplex secondgener genomescal crisprcas9 grna librari appli fit screen five human cell line use improv bayesian analyt approach consist 5fold fit gene observ we list 1580 human core fit gene describ general properti moreov demonstr contextdepend fit gene accur recapitul pathwayspecif genet vulner induc known oncogen reveal celltypespecif depend specif receptor tyrosin kinas even oncogen kras background thus rigor identif human cell line fit gene highcomplex crisprcas9 librari afford highresolut view genet vulner cell',\n",
       "  'ArticleTitle': 'High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.',\n",
       "  'Author': 'Hart Traver'},\n",
       " {'Abstract': ' in respons dna damag p53 tumor suppressor elicit apoptosi cellcycl arrest repair critic decis specif cell type remain larg undefin we investig mechan transcript repressor slug rescu hematopoiet progenitor cell lethal dose gamma radiat we slug transcript induc p53 irradi protect damag cell apoptosi direct repress p53mediat transcript puma key bh3on antagonist antiapoptot bcl2 protein we establish physiolog signific slugmedi repress puma demonstr mice defici gene surviv dose totalbodi irradi lethal deplet hematopoiet progenitor popul mice lack slug thus slug function downstream p53 develop blood cell critic switch prevent apoptosi antagon transactiv puma p53',\n",
       "  'ArticleTitle': 'Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.',\n",
       "  'Author': 'Wu Wen-Shu'},\n",
       " {'Abstract': ' whi gene harm overexpress by test possibl caus overexpress phenotyp yeast identifi intrins protein disord determin dosag sensit disord region prone promiscu molecular interact concentr increas demonstr like caus patholog gene overexpress we valid find two anim drosophila melanogast caenorhabd elegan in mice human properti associ dosagesensit oncogen massactiondriven molecular interact frequent caus cancer dosagesensit gene tight regul transcript rna protein level serv prevent harm increas protein concentr physiolog condit massactiondriven interact promiscu singl theoret framework understand predict possibl treat effect increas gene express evolut diseas',\n",
       "  'ArticleTitle': 'Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity.',\n",
       "  'Author': 'Vavouri Tanya'},\n",
       " {'Abstract': ' upon dna damag ataxia telangiectasia mutat atm kinas trigger multipl event promot cell surviv facilit repair if damag excess atm stimul cytokin secret alert neighbor cell apoptosi elimin afflict cell atm augment cell surviv activ nuclear factor nfb atm induc cytokin product apoptosi remain elus here uncov p53independ mechan transmit atmdriven cytokin caspas signal strong genotox damag extens dna lesion stimul two sequenti nfb activ phase requir atm nemoikk the first phase induc tnftnfr1 feedforward signal promot second phase drive rip1 phosphoryl in turn rip1 kinas trigger jnk3mapk10depend interleukin8 secret faddmedi proapoptot caspase8 activ thus context excess dna damag atm employ nemo rip1 kinas autocrin tnf signal switch cytokin product caspas activ these result shed light cellfat regul atm',\n",
       "  'ArticleTitle': u'NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-\\u03b1 feedforward signaling.',\n",
       "  'Author': 'Biton Sharon'},\n",
       " {'Abstract': ' while catalog mammalian transcript express level differ cell type diseas state rapid expand understand transcript function lag behind we robust technolog enabl systemat investig cellular consequ repress induc individu transcript we identifi rule specif target transcript repressor crispri typic achiev 9099 knockdown minim offtarget effect activ crispra endogen gene endonucleasedefici cas9 togeth enabl modul gene express 1000fold rang use rule construct genomescal crispri crispra librari valid two pool screen growthbas screen identifi essenti gene tumor suppressor regul differenti screen sensit choleradiphtheria toxin provid broad insight mechan pathogen entri retrotransloc toxic our result establish crispri crispra power tool provid rich complementari inform map complex pathway',\n",
       "  'ArticleTitle': 'Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.',\n",
       "  'Author': 'Gilbert Luke A'},\n",
       " {'Abstract': ' genom instabl alter gene express hallmark eukaryot age the yeast histon deacetylas sir2 silenc transcript stabil repetit dna age respons dna break sir complex reloc site genom instabl result desilenc gene caus steril characterist yeast age use embryon stem cell mammalian sir2 sirt1 repress repetit dna function divers set gene mous genom in respons dna damag sirt1 dissoci loci reloc dna break promot repair result transcript chang parallel age mous brain increas sirt1 express promot surviv mous model genom instabl suppress agedepend transcript chang thus dna damageinduc redistribut sirt1 chromatinmodifi protein conserv mechan age eukaryot',\n",
       "  'ArticleTitle': 'SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.',\n",
       "  'Author': 'Oberdoerffer Philipp'},\n",
       " {'Abstract': ' the protocadherin fat known tumor suppressor regul growth drosophila conserv function planar cell polar establish mcneill colleagu identifi unsuspect role ctermin proteolyt product fat mitochondria regul electron transport machineri metabol',\n",
       "  'ArticleTitle': 'Metabolism and the other fat: a protocadherin in mitochondria.',\n",
       "  'Author': 'Baker Nicholas E'},\n",
       " {'Abstract': ' target ras pathway long critic therapeut challeng oncolog burgess al examin relat express mutant wildtyp kras modul clonal fit sensit mek inhibitor model kras',\n",
       "  'ArticleTitle': 'Doubling Down on Mutant RAS Can MEK or Break Leukemia.',\n",
       "  'Author': 'Tothova Zuzana'},\n",
       " {'Abstract': ' dnmt3a mutat occur 25 acut myeloid leukemia aml patient the common mutat dnmt3a',\n",
       "  'ArticleTitle': 'CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.',\n",
       "  'Author': 'Spencer David H'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Poisoning the Devil.',\n",
       "  'Author': 'Chen Zhu'},\n",
       " {'Abstract': ' cellular senesc stabl state prolif arrest provid barrier malign transform contribut antitumor activ certain chemotherapi senesc cell accumul senescenceassoci heterochromat foci sahf provid chromatin buffer prevent activ proliferationassoci gene mitogen transcript factor surpris highmobl group a hmga protein promot tumorigenesi accumul chromatin senesc fibroblast essenti structur compon sahf hmga protein cooper p16ink4a tumor suppressor promot sahf format prolif arrest stabil senesc contribut repress proliferationassoci gene these antiprolif activ cancel coexpress hdm2 cdk4 oncogen coamplifi hmga2 human cancer our result identifi compon senesc machineri contribut heterochromatin format impli hmga protein act tumor suppressor network',\n",
       "  'ArticleTitle': 'A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.',\n",
       "  'Author': 'Narita Masashi'},\n",
       " {'Abstract': ' mammalian interphas chromosom interact nuclear lamina nl hundr larg laminaassoci domain lad we report method map nl contact genomewid singl human cell analysi 400 map reveal core architectur consist genepoor lad contact nl high celltocel consist interspers lad variabl nl interact the variabl contact tend celltyp specif sensit chang genom ploidi consist contact singlecel map indic nl contact involv multival interact hundr kilobas moreov observ extens intrachromosom coordin nl contact even ten megabas such coordin loci exhibit preferenti interact detect hic final consist nl contact invers link gene activ singl cell correl posit heterochromat histon modif h3k9me3 these result highlight fundament principl singlecel chromatin organ video abstract',\n",
       "  'ArticleTitle': 'Genome-wide maps of nuclear lamina interactions in single human cells.',\n",
       "  'Author': 'Kind Jop'},\n",
       " {'Abstract': ' stress granul membraneless organell compos rnabind protein rbps rna function impair stress granul implic amyotroph later sclerosi frontotempor dementia multisystem proteinopathydiseas character fibrillar inclus rbps genet evid suggest link persist stress granul accumul patholog inclus here demonstr diseaserel rbp hnrnpa1 undergo liquidliquid phase separ llps proteinrich droplet mediat low complex sequenc domain lcd while lcd hnrnpa1 suffici mediat llps rna recognit motif contribut llps presenc rna give rise mechan regul assembl import requir llps fibril enhanc proteinrich droplet we suggest lcdmediat llps contribut assembl stress granul liquid properti provid mechanist link persist stress granul fibrillar protein patholog diseas',\n",
       "  'ArticleTitle': 'Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization.',\n",
       "  'Author': 'Molliex Amandine'},\n",
       " {'Abstract': ' n6methyladenosin m6a abund intern modif messeng rna while presenc m6a transcript impact nuclear rna fate reader mark mediat process nuclear transcript identifi we rnabind protein hnrnpa2b1 bind m6abear rnas vivo vitro biochem footprint match m6a consensus motif hnrnpa2b1 direct bind set nuclear transcript elicit similar altern splice effect m6a writer mettl3 moreov hnrnpa2b1 bind m6a mark subset primari mirna transcript interact microrna microprocessor complex protein dgcr8 promot primari mirna process also hnrnpa2b1 loss mettl3 deplet caus similar process defect primirna precursor we propos hnrnpa2b1 nuclear reader m6a mark mediat part mark effect primari microrna process altern splice paperclip',\n",
       "  'ArticleTitle': 'HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.',\n",
       "  'Author': u'Alarc\\xf3n Claudio R'},\n",
       " {'Abstract': ' stem cell high abund earli develop rare popul adult organ the molecular mechan caus stem cell exit prolifer specif time well understood here chang energi metabol induc steroid hormon ecdyson mediat initi irrevers cascad event lead cellcycl exit drosophila neural stem cell we time induct oxid phosphoryl mitochondri respiratori chain requir neuroblast uncoupl cell cycl cell growth this result progress reduct neuroblast cell size ultim termin differenti brain tumor mutant neuroblast fail undergo shrinkag process continu prolifer adulthood our find cell size control modifi system hormon signal reveal uniqu connect metabol prolifer stem cell',\n",
       "  'ArticleTitle': 'Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells.',\n",
       "  'Author': 'Homem Catarina C F'},\n",
       " {'Abstract': ' despit success tyrosin kinasebas cancer therapeut solid tumor tyrosin kinas drive diseas remain unknown limit abil identifi drug target predict respons here first largescal survey tyrosin kinas activ lung cancer use phosphoproteom approach character tyrosin kinas signal 41 nonsmal cell lung cancer nsclc cell line 150 nsclc tumor profil phosphotyrosin signal generat analyz identifi known oncogen kinas egfr cmet well novel alk ros fusion protein other activ tyrosin kinas pdgfralpha ddr1 implic genesi nsclc identifi by focus activ cell circuitri approach outlin provid insight cancer biolog avail chromosom transcript level appli broad human cancer',\n",
       "  'ArticleTitle': 'Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.',\n",
       "  'Author': 'Rikova Klarisa'},\n",
       " {'Abstract': ' chromosom transloc mixedlineag leukemia mll gene partner gene result aggress leukemia dismal outcom despit similar express mrna level wildtyp chimer mll allel chimer protein stabl we report ube2o function regul stabil wildtyp mll respons interleukin1 signal target wildtyp mll degrad imped mll leukemia cell prolifer downregul specif group target gene mll chimera oncogen cofactor super elong complex pharmacolog inhibit pathway delay progress improv surviv murin leukemia stabil wildtyp mll protein displac mll chimera target gene reliev cellular oncogen addict mll chimera stabil mll provid paradigm develop therapi aggress mll leukemia cancer caus transloc',\n",
       "  'ArticleTitle': 'Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.',\n",
       "  'Author': 'Liang Kaiwei'},\n",
       " {'Abstract': ' tor complex 1 torc1 potent anabol regul cellular growth metabol when cell suffici amino acid torc1 activ lysosom local mediat rag gtpase upon amino acid remov rag gtpase releas torc1 caus cytoplasm inact we amino acid remov rag gtpase recruit tsc2 lysosom act rheb onli rag gtpase rheb inact torc1 fulli releas lysosom upon amino acid withdraw cell lack tsc2 fail complet releas torc1 lysosom fail complet inactiv torc1 fail adjust physiolog amino acid starvat these data suggest regul tsc2 subcellular local general mechan control activ place tsc2 aminoacidsens pathway torc1',\n",
       "  'ArticleTitle': 'Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.',\n",
       "  'Author': 'Demetriades Constantinos'},\n",
       " {'Abstract': ' in respons cellular genom break mre11rad50nbs1 mrn activ global atm dna damag respons ddr prevent cellular replic here mrnatm critic function defend cell dna virus we reveal tempor distinct respons adenovirus genom critic mrnatm ddr inactiv e1b55ke4orf3 viral oncoprotein global mrnindepend atm ddr viral nuclear domain impact viral replic we mrn bind adenovirus genom activ local atm respons prevent viral dna replic in contrast chromosom break atm activ amplifi h2ax megabas chromatin induc global signal replic arrest thus h2ax foci discrimin self nonself genom determin local antivir global atm respons appropri this provid eleg mechan neutral viral genom jeopard cellular viabil',\n",
       "  'ArticleTitle': 'Viral and Cellular Genomes Activate Distinct DNA Damage Responses.',\n",
       "  'Author': 'Shah Govind A'},\n",
       " {'Abstract': ' malt b cell lymphoma t114p22q32 recurr breakpoint upstream promot novel gene bcl10 bcl10 cellular homolog equin herpesvirus2 e10 gene contain aminotermin caspas recruit domain card homolog apoptot molecul bcl10 e10 activ nfkappab caus apoptosi 293 cell bcl10 express malt lymphoma exhibit frameshift mutat result truncat distal card truncat bcl10 activ nfkappab induc apoptosi wildtyp bcl10 suppress transform mutant form lost activ display gainoffunct transform activ similar mutat detect tumor type indic bcl10 common involv pathogenesi human malign',\n",
       "  'ArticleTitle': 'Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.',\n",
       "  'Author': 'Willis T G'},\n",
       " {'Abstract': ' the p53 tumorsuppressor protein prevent cancer develop mechan includ induct cellcycl arrest apoptosi mainten genom stabil we identifi p53induc gene name tigar tp53induc glycolysi apoptosi regul tigar express lower fructose26bisphosph level cell result inhibit glycolysi decreas intracellular reactiv oxygen speci ros level these function tigar correl abil protect cell rosassoci apoptosi consequ knockdown endogen tigar express sensit cell p53induc death express tigar modul apoptot respons p53 allow surviv face mild transient stress signal revers repair the decreas intracellular ros level respons tigar play role abil p53 protect accumul genom damag',\n",
       "  'ArticleTitle': 'TIGAR, a p53-inducible regulator of glycolysis and apoptosis.',\n",
       "  'Author': 'Bensaad Karim'},\n",
       " {'Abstract': ' adapt endoplasm reticulum er pathway mhc class i mhci present dendrit cell enabl crosspresent peptid deriv phagocytos microb infect cell tumor cell cd8 t cell how peptid intersect mhci molecul remain poor understood here mhci select accumul phagosom carri microbi compon engag tolllik receptor tlr signal although crosspresent requir sec22bmedi phagosom recruit peptid load complex ergolgi intermedi compart ergic step independ tlr signal deliv mhci instead mhci recruit endosom recycl compart erc mark rab11a vamp3cellubrevin vamp8endobrevin hold larg reserv mhci while rab11a activ stock erc store mhci myd88depend tlr signal drive ibkinas ikk2medi phosphoryl phagosomeassoci snap23 phosphosnap23 stabil snare complex orchestr ercphagosom fusion enrich phagosom ercderiv mhci subsequ crosspresent infect',\n",
       "  'ArticleTitle': 'TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.',\n",
       "  'Author': 'Nair-Gupta Priyanka'},\n",
       " {'Abstract': ' the hippo transduc yaptaz play posit well negat role wnt signal under mechan remain unclear here provid biochem function genet evid yap taz integr compon catenin destruct complex serv cytoplasm sink yaptaz in wnton cell yaptaz physic dislodg destruct complex allow nuclear accumul activ wntyaptazdepend biolog effect yaptaz requir intestin crypt overgrowth induc apc defici crypt regener ex vivo in wntoff cell yaptaz essenti trcp recruit complex catenin inactiv in wnton cell releas yaptaz complex instrument wntcatenin signal in line catenindepend mainten es cell undifferenti state sustain loss yaptaz this work reveal unpreced signal framework relev organ size control regener tumor suppress',\n",
       "  'ArticleTitle': u'YAP/TAZ incorporation in the \\u03b2-catenin destruction complex orchestrates the Wnt response.',\n",
       "  'Author': 'Azzolin Luca'},\n",
       " {'Abstract': ' the kinas inhibitor p27kip1 regul g1 cell cycl phase here data indic oncogen kinas src regul p27 stabil phosphoryl p27 tyrosin 74 tyrosin 88 src inhibitor increas cellular p27 stabil src overexpress acceler p27 proteolysi srcphosphoryl p27 inhibit cyclin ecdk2 poor vitro src transfect reduc p27cyclin ecdk2 complex our data indic phosphoryl src impair cdk2 inhibitori action p27 reduc steadyst bind cyclin ecdk2 facilit cyclin ecdk2depend p27 proteolysi furthermor srcactiv breast cancer line reduc p27 observ correl src activ reduc nuclear p27 482 primari human breast cancer import report tamoxifenresist breast cancer cell line src inhibit increas p27 level restor tamoxifen sensit these data provid new rational src inhibitor cancer therapi',\n",
       "  'ArticleTitle': 'p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.',\n",
       "  'Author': 'Chu Isabel'},\n",
       " {'Abstract': ' sirtuin focus intens scrutini discoveri sir2 yeast longev factor function deacetylas adp ribosylas sirtuin regul cofactor nad serv sensor metabol state cell organ here examin role sirtuin divers eukaryot speci special emphasi link age agerel diseas includ cancer diabet neurodegen disord',\n",
       "  'ArticleTitle': 'Sirtuins in aging and age-related disease.',\n",
       "  'Author': 'Longo Valter D'},\n",
       " {'Abstract': ' the age tissuespecif stem cell progenitor cell compart believ central declin tissu organ integr function elder here examin evid link stem cell dysfunct pathophysiolog condit accompani age focus mechan under stem cell declin contribut diseas pathogenesi',\n",
       "  'ArticleTitle': 'Stems cells and the pathways to aging and cancer.',\n",
       "  'Author': 'Rossi Derrick J'},\n",
       " {'Abstract': ' the phagocyt innat immun system macrophag neutrophil contribut antibacteri defens function special cooper unclear here report three distinct phagocyt subset play high coordin role bacteri urinari tract infect ly6c macrophag act tissueresid sentinel attract circul neutrophil ly6c macrophag such ly6c macrophag play undescrib helper role recruit site infect produc cytokin tnf caus ly6c macrophag secret cxcl2 this chemokin activ matrix metalloproteinase9 neutrophil allow entri uroepithelium combat bacteria in summari sentinel macrophag elicit power antibacteri function neutrophil confirm helper macrophag reminisc licens role helper t cell antivir adapt immun these find identifi helper macrophag tnf critic regul innat immun bacteri infect epithelia',\n",
       "  'ArticleTitle': 'Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.',\n",
       "  'Author': 'Schiwon Marzena'},\n",
       " {'Abstract': ' ischemiaassoci oxid damag lead necrosi major caus catastroph tissu loss elucid signal mechan paramount p53 central stress sensor respond multipl insult includ oxid stress orchestr apoptot autophag cell death whether p53 activ oxid stressinduc necrosi unknown here uncov role p53 activ necrosi in respons oxid stress p53 accumul mitochondri matrix trigger mitochondri permeabl transit pore ptp open necrosi physic interact ptp regul cyclophilin d cypd intrigu robust p53cypd complex form brain ischemiareperfus injuri in contrast reduct p53 level cyclosporin a pretreat mice prevent complex associ effect stroke protect our studi identifi mitochondri p53cypd axi contributor oxid stressinduc necrosi implic axi stroke patholog',\n",
       "  'ArticleTitle': 'p53 opens the mitochondrial permeability transition pore to trigger necrosis.',\n",
       "  'Author': 'Vaseva Angelina V'},\n",
       " {'Abstract': ' mitochondri respir cell prolifer specif metabol requir fulfil respir support prolifer defin here major role respir prolifer cell provid electron acceptor aspart synthesi this find consist observ cell lack function respiratori chain auxotroph pyruv serv exogen electron acceptor further pyruv requir fulfil altern electron acceptor alphaketobutyr provid cell carbon atp alphaketobutyr restor prolifer respir inhibit suggest altern electron acceptor substitut respir support prolifer we electron acceptor limit produc aspart suppli aspart enabl prolifer respir defici cell absenc exogen electron acceptor togeth data argu major function respir prolifer cell support aspart synthesi',\n",
       "  'ArticleTitle': 'Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells.',\n",
       "  'Author': 'Sullivan Lucas B'},\n",
       " {'Abstract': ' small molecul interfer microtubul dynam taxol vinca alkaloid wide cell biolog research clinic anticanc drug howev activ restrict specif target cell caus sever side effect chemotherapi here introduc photostatin inhibitor switch vivo visibl light optic control microtubul dynam photostatin modul microtubul dynam subsecond respons time control mitosi live organ singlecel spatial precis in longerterm applic cell cultur photostatin 250 time cytotox switch blue light dark therefor photostatin valuabl tool cell biolog promis new class precis chemotherapeut toxic spatiotempor constrain light',\n",
       "  'ArticleTitle': 'Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death.',\n",
       "  'Author': 'Borowiak Malgorzata'},\n",
       " {'Abstract': ' the tumor suppressor protein p53 crucial player dna damag respons regul way notabl ubiquitin in issu yuan al 2010 identifi deubiquitin proteas usp10 new regul p53 dna damag respons tumor develop',\n",
       "  'ArticleTitle': 'USP10: friend and foe.',\n",
       "  'Author': 'Jochemsen Aart G'},\n",
       " {'Abstract': ' lipid play central role physiolog diseas structur metabol signal function interact protein here describ set lipidbas chemic proteom probe global interact map mammalian cell these interact involv hundr protein divers function class frequent occur site drug action we determin target profil drug lipidinteract proteom reveal ligand content extend far tradit defin categori druggabl protein in support find describ select ligand lipidbind protein nucleobindin1 nucb1 compound perturb hydrolyt oxid metabol endocannabinoid cell the describ chemic proteom platform provid integr path pharmacolog character wide rang protein particip lipid pathway cell',\n",
       "  'ArticleTitle': 'A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells.',\n",
       "  'Author': 'Niphakis Micah J'},\n",
       " {'Abstract': ' the presenc ribonucleotid genom dna undesir given increas suscept hydrolysi ribonucleas rnase h enzym recogn process embed ribonucleotid domain life howev unicellular organ bud yeast requir viabil even effici cellular prolifer human rnase h2 hypomorph mutat caus neuroinflammatori disord aicardigoutir syndrom here report rnase h2 essenti enzym mice requir embryon growth gastrul onward rnase h2 null embryo accumul larg number singl di ribonucleotid embed genom dna 1000000 cell result genom instabl p53depend dnadamag respons our find establish rnase h2 key mammalian genom surveil enzym requir ribonucleotid remov demonstr ribonucleotid common occur endogen nucleotid base lesion replic cell',\n",
       "  'ArticleTitle': 'Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development.',\n",
       "  'Author': 'Reijns Martin A M'},\n",
       " {'Abstract': ' the rewir metabol cancer thought result hyperactiv signal pathway instruct cell grow sebastian al loss tumor suppressor sirt6 transform cell activ tumor metabol this occur independ mutat canon growth signal pathway reveal tumorigen role cancer metabol',\n",
       "  'ArticleTitle': \"SIRT6 puts cancer metabolism in the driver's seat.\",\n",
       "  'Author': 'Lyssiotis Costas A'},\n",
       " {'Abstract': ' inhibitor dna bind id antagon basichelixloophelix bhlh transcript factor inhibit differenti maintain stem cell fate id ubiquitin proteasom degrad occur differenti tissu id neoplasm appear escap degrad we deubiquitin enzym usp1 promot id protein stabil stem celllik characterist osteosarcoma usp1 bound deubiquitin stabil id1 id2 id3 a subset primari human osteosarcoma coordin overexpress usp1 id protein usp1 knockdown osteosarcoma cell precipit id protein destabil cellcycl arrest osteogen differenti convers ectop usp1 express mesenchym stem cell stabil id protein inhibit osteoblast differenti enhanc prolifer consist usp1 function normal mesenchym stem cell usp1defici mice osteopen our observ implic usp1 preserv stem cell state character osteosarcoma identifi usp1 target differenti therapi',\n",
       "  'ArticleTitle': 'USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.',\n",
       "  'Author': 'Williams Samuel A'},\n",
       " {'Abstract': ' myc contribut pathogenesi major human cancer strategi modul function cmyc oncoprotein exist toward object target myc transcript interf chromatindepend signal transduct rna polymeras inhibit acetyllysin recognit domain bromodomain putat coactiv protein implic transcript initi elong use select smallmolecul bromodomain inhibitor jq1 identifi bet bromodomain protein regulatori factor cmyc bet inhibit jq1 downregul myc transcript follow genomewid downregul mycdepend target gene in experiment model multipl myeloma mycdepend hematolog malign jq1 produc potent antiprolif effect associ cellcycl arrest cellular senesc efficaci jq1 three murin model multipl myeloma establish therapeut rational bet bromodomain inhibit diseas malign character patholog activ cmyc',\n",
       "  'ArticleTitle': 'BET bromodomain inhibition as a therapeutic strategy to target c-Myc.',\n",
       "  'Author': 'Delmore Jake E'},\n",
       " {'Abstract': ' effect differenti therapi acut myeloid leukemia aml restrict small subset patient one defin genet abnorm use unbias small molecul screen syke al identifi mechan derepress differenti model aml driven distinct genet driver',\n",
       "  'ArticleTitle': 'Lifting the Differentiation Embargo.',\n",
       "  'Author': 'Latif Anne-Louise'},\n",
       " {'Abstract': ' pten dysfunct play crucial role pathogenesi hereditari sporad cancer here pten homodimer activ conform exert lipid phosphatas activ ptdins345p3 we demonstr catalyt inact cancerassoci pten mutant heterodimer wildtyp pten constrain phosphatas activ dominantneg manner to studi consequ homo heterodimer wildtyp mutant pten vivo generat pten knockin mice harbor two cancerassoci pten mutat ptenc124 pteng129 heterozyg ptenc124 pteng129 cell tissu exhibit increas sensit pi3kakt activ compar wildtyp pten counterpart differ longer appar ptenc124 pten cell notabl pten ki mice tumor prone display featur reminisc complet pten loss our find reveal pten loss pten mutat synonym defin work model function regul pten',\n",
       "  'ArticleTitle': 'Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.',\n",
       "  'Author': 'Papa Antonella'},\n",
       " {'Abstract': ' while acut myeloid leukemia aml compris dispar genet subtyp one share hallmark arrest leukem myeloblast immatur selfrenew stage develop therapi overcom differenti arrest repres power treatment strategi we leverag observ major aml despit genet heterogen share express hoxa9 gene downregul myeloid differenti use condit hoxa9 model system perform highthroughput phenotyp screen defin compound overcam differenti blockad target identif led unanticip discoveri inhibit enzym dihydroorot dehydrogenas dhodh enabl myeloid differenti human mous aml model in vivo dhodh inhibitor reduc leukem cell burden decreas level leukemiainiti cell improv surviv these data demonstr role dhodh metabol regul differenti point inhibit strategi overcom differenti blockad aml',\n",
       "  'ArticleTitle': 'Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.',\n",
       "  'Author': 'Sykes David B'},\n",
       " {'Abstract': ' all cancer carri somat mutat the pattern mutat cancer genom reflect dna damag repair process cancer cell precursor expos to explor mechan generat catalog somat mutat 21 breast cancer appli mathemat method extract mutat signatur under process multipl distinct singl doublenucleotid substitut signatur discern cancer brca1 brca2 mutat exhibit characterist combin substitut mutat signatur distinct profil delet complex relationship somat mutat preval transcript detect a remark phenomenon local hypermut term kataegi observ region kataegi differ cancer coloc somat rearrang base substitut region exclus cytosin tpc dinucleotid the mechan under mutat signatur unknown howev role apobec famili cytidin deaminas propos',\n",
       "  'ArticleTitle': 'Mutational processes molding the genomes of 21 breast cancers.',\n",
       "  'Author': 'Nik-Zainal Serena'},\n",
       " {'Abstract': ' prolifer selfrenew epithelium gastric corpus occur exclus isthmus gland cell migrat bidirect pit base the isthmus general view stem cell zone we stem cell marker troy express gland base small subpopul fulli differenti chief cell by lineag trace troyegfpirescreert2 allel singl mark chief cell generat entir label gastric unit period month this phenomenon acceler tissu damag troy chief cell cultur generat longliv gastric organoid troy mark specif subset chief cell display plastic capabl replenish entir gastric unit essenti serv quiescent reserv stem cell these observ challeng notion stem cell hierarchi repres oneway street',\n",
       "  'ArticleTitle': 'Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium.',\n",
       "  'Author': 'Stange Daniel E'},\n",
       " {'Abstract': ' transcript coregul gene occur context longrang chromosom contact form multigen complex such contact transcript lost knockout studi transcript factor structur chromatin protein to ask chromosom contact requir cotranscript multigen complex devis strategi talen cleav disrupt gene loop wellcharacter multigen complex monitor disrupt rna fish immunofluoresc microscopi reveal perturb site contact direct effect transcript interact gene unexpect effect cotranscript hierarch domin subordin member multigen complex engag intra interchromosom contact this observ reveal profound influenc chromosom contact transcript coregul gene multigen complex',\n",
       "  'ArticleTitle': 'Chromosomal contact permits transcription between coregulated genes.',\n",
       "  'Author': 'Fanucchi Stephanie'},\n",
       " {'Abstract': ' burkholderia pseudomallei b mallei bacteri pathogen caus melioidosi glander close relat b thailandensi nonpathogen all trimer autotransport bima facilit actinbas motil host cell fusion dissemin here bima ortholog mimic differ host actinpolymer protein b thailandensi bima activ host arp23 complex in contrast b pseudomallei b mallei bima mimic host enavasp actin polymeras abil nucleat elong bundl filament associ barb end well wh2 motif oligomer activ mechanist differ bima ortholog result distinct actin filament organ motil paramet affect effici cell fusion infect our result identifi bacteri enavasp mimic reveal pathogen imit full spectrum host actinpolymer pathway suggest mimicri differ polymer mechan influenc key paramet infect',\n",
       "  'ArticleTitle': 'Virulent Burkholderia species mimic host actin polymerases to drive actin-based motility.',\n",
       "  'Author': 'Benanti Erin L'},\n",
       " {'Abstract': ' hepat c virus hcv uniqu requir liverspecif microrna122 replic global effect endogen mirna target infect unexplor here highthroughput sequenc crosslink immunoprecipit hitsclip experi human argonaut ago hcv infect robust ago bind hcv 5utr known predict mir122 site on human transcriptom observ reduc ago bind function mrna derepress mir122 target virus infect this mir122 spong effect reliev redirect mir15 target swap mirna tropism virus singlecel express data report contain mir122 site signific derepress hcv infect depend express level site number we describ quantit mathemat model hcvinduc mir122 sequestr propos mir122 inhibit hcv rna result global derepress host mir122 target provid environ fertil longterm oncogen potenti hcv',\n",
       "  'ArticleTitle': 'Hepatitis C virus RNA functionally sequesters miR-122.',\n",
       "  'Author': 'Luna Joseph M'},\n",
       " {'Abstract': ' mitochondria bioenerget biosynthet signal organell integr stress sens allow cellular adapt environ therefor surpris mitochondria mediat tumorigenesi process requir flexibl adapt cellular environment alter addit cancer treatment multipl aspect mitochondri biolog bioenerget support transform includ mitochondri biogenesi turnov fission fusion dynam cell death suscept oxid stress regul metabol signal thus understand mechan mitochondri function tumorigenesi critic generat cancer therapeut',\n",
       "  'ArticleTitle': 'Mitochondria and Cancer.',\n",
       "  'Author': 'Vyas Sejal'},\n",
       " {'Abstract': ' regulatori network orchestr key transcript factor tfs propos play central role determin stem cell state howev master transcript regul adult stem cell poor understood we identifi two tfs slug sox9 act cooper determin mammari stem cell masc state inhibit slug sox9 block masc activ primari mammari epitheli cell convers transient coexpress exogen slug sox9 suffic convert differenti lumin cell masc longterm mammari glandreconstitut abil slug sox9 induc masc activ distinct autoregulatori gene express program we coexpress slug sox9 promot tumorigen metastasisseed abil human breast cancer cell associ poor patient surviv provid direct evid human breast cancer stem cell control key regul similar oper normal murin masc',\n",
       "  'ArticleTitle': 'Slug and Sox9 cooperatively determine the mammary stem cell state.',\n",
       "  'Author': 'Guo Wenjun'},\n",
       " {'Abstract': ' the mesenchymalamoeboid transit mat propos mechan cancer cell adapt migrat mode environ while molecular pathway involv transit well document role microenviron mat poor understood here investig confin adhes affect transit we report absenc focal adhes condit confin mesenchym cell spontan switch fast amoeboid migrat phenotyp we identifi two main type fast migrationon involv local protrus second involv myosiniidepend mechan instabl cell cortex lead global cortic flow interest transform cell prone adopt fast migrat mode final propos generic model explain migrat transit predict phase diagram migrat phenotyp base three main control paramet confin adhes contractil',\n",
       "  'ArticleTitle': 'Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells.',\n",
       "  'Author': 'Liu Yan-Jun'},\n",
       " {'Abstract': ' recent evid suggest subset cancer cell tumor socal cancer stem cell drive growth metastasi tumor understand pathway regul prolifer selfrenew surviv differenti malign normal stem cell shed light mechan lead cancer suggest better mode treatment',\n",
       "  'ArticleTitle': 'Stem cells and cancer: two faces of eve.',\n",
       "  'Author': 'Clarke Michael F'},\n",
       " {'Abstract': ' venetoclax bh3 mimet approv treat chronic lymphocyt leukemia cancer cell resist apoptosi prime death elev bcl2 bind proapoptot protein hold check venetoclax releas antagon first approv drug target proteinprotein interact',\n",
       "  'ArticleTitle': 'A BH3 Mimetic for Killing Cancer Cells.',\n",
       "  'Author': 'Green Douglas R'},\n",
       " {'Abstract': ' the ink4a tumor suppressor locus encod p16ink4a inhibitor cyclin ddepend kinas p19arf altern read frame protein block cell prolifer surpris mice lack p19arf express function p16ink4a develop tumor earli life their embryo fibroblast mef senesc transform oncogen hara convers arf arf mef strain continu prolifer cell line involv loss p19arf p53 p53mediat checkpoint control unperturb arfnul fibroblast strain p53negat cell line resist p19arfinduc growth arrest therefor ink4a encod growth inhibitori protein act upstream retinoblastoma protein p53 mutat delet target locus cancer cell unlik function equival',\n",
       "  'ArticleTitle': 'Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.',\n",
       "  'Author': 'Kamijo T'},\n",
       " {'Abstract': ' the discoveri enhanc regul transcript unit encod erna rais new question mechan activ here report unexpect molecular mechan under liganddepend enhanc activ base dna nick reliev torsion stress erna synthesi use dihydrotestosteron dhtinduc bind androgen receptor ar prostat cancer cell enhanc model rapid recruit minut dna topoisomeras i top1 larg cohort arregul enhanc furthermor dna nick activ top1 prerequisit robust erna synthesi enhanc activ kinet accompani recruit atr mrn complex follow addit compon dna damag repair machineri arregul enhanc togeth studi reveal linkag erna synthesi liganddepend top1medi nickinga strategi exert quantit effect erna express regul arbound enhancerdepend transcript program',\n",
       "  'ArticleTitle': 'Ligand-dependent enhancer activation regulated by topoisomerase-I activity.',\n",
       "  'Author': 'Puc Janusz'},\n",
       " {'Abstract': ' the h3k4me3 mark chromatin close correl activ transcrib gene mechan involv generat function fulli understood in vitro studi recombin chromatin purifi human factor demonstr robust set1 complex set1cmedi h3k4 trimethyl depend p53 p300mediat h3 acetyl correspond set1cmedi enhanc p53 p300depend transcript reflect primari effect set1c h3k4 trimethyl direct set1cp53 set1cp300 interact indic target recruit mechan complementari cellbas assay demonstr dnadamageinduc p53set1c interact correspond enrich set1c h3k4me3 p53 target gene p21waf1 correspond codepend h3k4 trimethyl transcript p300 set1c these result establish mechan set1c p300 act cooper direct interact coupl histon modif facilit function p53',\n",
       "  'ArticleTitle': 'SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.',\n",
       "  'Author': 'Tang Zhanyun'},\n",
       " {'Abstract': ' identif bona fide tumor suppressor challeng larg number genet alter human cancer to evalu candid gene chromosom region recurr delet human cancer coupl highresolut genom analysi twostag genet studi rna interfer rnai we cyfip1 subunit wave complex regul cytoskelet dynam common delet human epitheli cancer reduc express cyfip1 common observ invas epitheli tumor associ poor prognosi set silenc cyfip1 disturb normal epitheli morphogenesi vitro cooper oncogen ras produc invas carcinoma vivo mechanist link alter waveregul actin dynam impair cellcel adhes cellecm interact thus propos cyfip1 invas suppressor gene',\n",
       "  'ArticleTitle': 'Cyfip1 is a putative invasion suppressor in epithelial cancers.',\n",
       "  'Author': 'Silva Jose M'},\n",
       " {'Abstract': ' tap63 homolog p53 tumor suppressor qualiti control factor femal germlin remark undamag oocyt express high level protein suggest tap63 activ tight control inhibitori mechan biochem studi propos inhibit requir ctermin transactiv inhibitori domain howev structur mechan tap63 inhibit remain unknown here tap63 inact dimer state we reveal relief inhibit lead tetram format 20fold higher dna affin in vivo phosphorylationtrigg tetramer tap63 revers dephosphoryl furthermor helix oligomer domain p63 crucial tetram stabil compet transactiv domain bind site our result demonstr tap63 inhibit complex domaindomain interact provid basi regul qualiti control oocyt',\n",
       "  'ArticleTitle': u'DNA damage in oocytes induces a switch of the quality control factor TAp63\\u03b1 from dimer to tetramer.',\n",
       "  'Author': 'Deutsch Gregor B'},\n",
       " {'Abstract': ' identifi new regul stem cell state offer potenti futur gain biomedicin evid tumor suppressor p53 key regul stem cell state cicales al 2009 suggest broad role protein pathway control normal tissu homeostasi tumor format',\n",
       "  'ArticleTitle': 'p53: a new kingpin in the stem cell arena.',\n",
       "  'Author': 'Aparicio Samuel'},\n",
       " {'Abstract': ' glycosyl process high natur select pressur presum modul resist infect here ask inactiv udpgalactosegalactoside13galactosyltransferas 13gt gene ablat express gal13gal14glcnacr gal glycan allow product antig antibodi ab human confer protect plasmodium spp infect causat agent malaria major drive forc human evolut we demonstr plasmodium spp human gut pathobiont e coli o86b7 express gal antig ab associ protect malaria transmiss human well 13gtdefici mice produc protect antig ab colon e coli o86b7 antig ab target plasmodium sporozoit complementmedi cytotox skin inocul anophel mosquito vaccin gal confer steril protect malaria mice suggest similar approach reduc malaria transmiss human',\n",
       "  'ArticleTitle': 'Gut microbiota elicits a protective immune response against malaria transmission.',\n",
       "  'Author': 'Yilmaz Bahtiyar'},\n",
       " {'Abstract': ' the dna damag respons ddr protein 53bp1 protect dna end excess resect g1 favor repair nonhomolog endjoin nhej oppos homolog recombin hr dure s phase brca1 antagon 53bp1 promot hr the pronhej antirecombinas function 53bp1 mediat part rif1 known factor requir 53bp1 phosphoryl recruit doublestrand break dsbs here 53bp1 phosphomut 53bp18a compris alanin substitut eight ntermin stq phosphoryl site mimic 53bp1 defici restor genom stabil brca1defici cell behav wildtyp 53bp1 respect immunoglobulin class switch recombin csr 53bp18a recruit rif1 fail recruit ddr protein ptip dsbs disrupt ptip phenocopi 53bp18a we conclud 53bp1 promot product csr suppress mutagen dna repair distinct phosphodepend interact rif1 ptip',\n",
       "  'ArticleTitle': '53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions.',\n",
       "  'Author': 'Callen Elsa'},\n",
       " {'Abstract': ' alter circadian clock link cancer develop puram al issu uncov differenti requir healthi hematopoiet diseas leukem stem cell core circadian transcript factor leukem cell clock machineri surviv growth',\n",
       "  'ArticleTitle': 'A Time Bomb for Leukemia.',\n",
       "  'Author': 'Maryanovich Maria'},\n",
       " {'Abstract': ' regul enhanc activ control gene express program here report biochem complex contain potenti chromatin reader rack7 histon lysin 4 trimethyl h3k4me3specif demethylas kdm5c occupi activ enhanc includ superenhanc loss rack7 kdm5c result overactiv enhanc character deposit h3k4me3 h3k27ac increas transcript erna nearbi gene furthermor loss rack7 kdm5c lead derepress s100a oncogen cancerrel phenotyp our find reveal rack7kdm5cregul dynam interchang histon h3k4me1 h3k4me3 activ enhanc repres addit layer regul enhanc activ we propos rack7kdm5c function enhanc brake ensur appropri enhanc activ compromis contribut tumorigenesi',\n",
       "  'ArticleTitle': 'Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.',\n",
       "  'Author': 'Shen Hongjie'},\n",
       " {'Abstract': ' leukemia stem cell lscs capac selfrenew propag diseas serial transplant anim model elimin cell popul requir curat therapi here describ seri pool vivo rnai screen identifi essenti transcript factor tfs murin model acut myeloid leukemia aml genet phenotyp defin lscs these screen reveal heterodimer circadian rhythm tfs clock bmal1 gene requir growth aml cell vitro vivo disrupt canon circadian pathway compon produc antileukem effect includ impair prolifer enhanc myeloid differenti deplet lscs we normal malign hematopoiet cell harbor intact clock robust circadian oscil genet knockout model reveal leukemiaspecif depend pathway our find establish role core circadian clock gene aml',\n",
       "  'ArticleTitle': 'Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.',\n",
       "  'Author': 'Puram Rishi V'},\n",
       " {'Abstract': ' the chk2p53puma pathway major regul dnadamageinduc apoptosi respons doublestrand break vivo through analysi 53bp1 complex discov new ubiquitin proteas usp28 regul pathway use human cell line faith recapitul chk2p53puma pathway usp28 requir stabil chk2 53bp1 respons dna damag in cell line usp28 chk2 requir dnadamageinduc apoptosi accomplish part regul p53 induct proapoptot gene puma our studi implic dnadamageinduc ubiquitin deubiquitin major regul dnadamag respons chk2 53bp1 number protein dnadamag checkpoint pathway includ mediat mdc1 claspin topbp1',\n",
       "  'ArticleTitle': 'A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.',\n",
       "  'Author': 'Zhang Dong'},\n",
       " {'Abstract': ' cellular senesc implic patholog respons adult repercuss tumor suppress wound heal age two studi muozespn al storer al reveal senesc contribut embryon develop suggest primordi role normal physiolog',\n",
       "  'ArticleTitle': 'A new development in senescence.',\n",
       "  'Author': 'Banito Ana'},\n",
       " {'Abstract': ' senesc form cellcycl arrest link tumor suppress age howev remain controversi document nonpatholog state here describ senesc normal development mechan embryo includ apic ectoderm ridg aer neural roof plate two signal center embryon pattern embryon senesc cell nonprolif share featur oncogeneinduc senesc oi includ express p21 p15 mediat senescenceassoci secretori phenotyp sasp interest mice defici p21 defect embryon senesc aer mainten pattern surpris under mesenchym identifi sourc senesc instruct aer ultim fate senesc cell apoptosi macrophagemedi clearanc we propos senesc normal program mechan play instruct role develop oi evolutionarili adapt reactiv development process',\n",
       "  'ArticleTitle': 'Senescence is a developmental mechanism that contributes to embryonic growth and patterning.',\n",
       "  'Author': 'Storer Mekayla'},\n",
       " {'Abstract': ' the p53 carcinogenesi stem central role induc cell cycl arrest apoptosi respons cellular stress we identifi drosophila homolog p53 dmp53 like mammalian p53 dmp53 bind human p53 bind site overexpress dmp53 induc apoptosi import inhibit dmp53 function render cell resist x rayinduc apoptosi suggest dmp53 requir apoptot respons dna damag unlik mammalian p53 dmp53 appear unabl induc g1 cell cycl block overexpress inhibit dmp53 activ affect x rayinduc cell cycl arrest these data reveal ancestr proapoptot function p53 identifi drosophila ideal model system elucid p53 apoptot pathway induc dna damag',\n",
       "  'ArticleTitle': 'Drosophila p53 is a structural and functional homolog of the tumor suppressor p53.',\n",
       "  'Author': 'Ollmann M'},\n",
       " {'Abstract': ' evas dna damageinduc cell death mutat p53 tumor suppressor overexpress prosurviv bcl2 famili protein key step malign transform therapeut resist we report deplet acut inhibit checkpoint kinas 1 chk1 suffici restor gammaradiationinduc apoptosi p53 mutant zebrafish embryo surpris caspase3 activ prior dna fragment contrast classic intrins extrins apoptosi rather altern apoptot program engag cell autonom requir atm ataxia telangiectasia mutat atr atm rad3rel caspase2 affect p53 loss overexpress bcl2xl similar chk1 inhibitortr human tumor cell hyperactiv atm atr caspase2 gammaradi trigger caspase2depend apoptot program bypass p53 defici excess bcl2 the evolutionarili conserv chk1suppress pathway defin novel apoptot process respons chk1 inhibitor insensit p53 bcl2 alter implic cancer therapi',\n",
       "  'ArticleTitle': 'Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.',\n",
       "  'Author': 'Sidi Samuel'},\n",
       " {'Abstract': ' dure neurogenesi progress progenitor cell differenti neuron believ unidirect irrevers the rb famili protein rb p107 p130 regul cellcycl exit differenti retinogenesi rb p130 redund express neuron inner nuclear layer inl retina we adult rbp130defici retina p107 compens prevent ectop prolifer inl neuron howev p107 haploinsuffici process differenti rbp107p130 horizont interneuron reenter cell cycl clonal expand form metastat retinoblastoma horizont cell affect rbp107p130 rbp107p130 retina suggest one copi rb p130 suffici prevent horizont prolifer we report differenti neuron prolifer form cancer maintain differenti state includ neurit synapt connect',\n",
       "  'ArticleTitle': 'Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice.',\n",
       "  'Author': 'Ajioka Itsuki'},\n",
       " {'Abstract': ' mutat keratinocyt melanocyt precursor caus extens sun exposur wellestablish contributor skin cancer now hu al provid evid sun harm ray caus tumorpromot epigenet modif dermal fibroblast highlight tumorstroma interact cancer',\n",
       "  'ArticleTitle': 'Field cancerization: something new under the sun.',\n",
       "  'Author': 'Vanharanta Sakari'},\n",
       " {'Abstract': ' fight viral infect hamper scarciti viral target variabl result develop resist virus cellular moleculeswhich attract altern targetsfor life cycl provid dispens normal cell function use model organ drosophila melanogast identifi ribosom protein rack1 cellular factor requir infect intern ribosom entri site irescontain virus we rack1 essenti determin hepat c virus translat infect indic function conserv distant relat human fli virus inhibit rack1 affect drosophila human cell viabil prolifer rack1silenc adult fli viabl indic protein essenti general translat our find demonstr specif function rack1 select mrna translat uncov target develop broad antivir intervent',\n",
       "  'ArticleTitle': 'RACK1 controls IRES-mediated translation of viruses.',\n",
       "  'Author': 'Majzoub Karim'},\n",
       " {'Abstract': ' regnase1 known zc3h12a mcpip1 rnase destabil set mrnas includ il6 il12b cleavag 3 utr although regnase1 inactiv lead develop autoimmun diseas character t cell activ hyperimmunoglobulinemia mice mechan regnase1medi immun regul remain unclear we regnase1 essenti prevent aberr effector cd4 t cell generat cell autonom moreov t cell regnase1 regul mrnas set gene includ crel ox40 il2 cleavag 3 utr interest t cell receptor tcr stimul lead cleavag regnase1 r111 malt1paracaspas free t cell regnase1medi suppress furthermor malt1 proteas activ critic control mrna stabil t cell effector gene collect result indic dynam control regnase1 express t cell critic control t cell activ',\n",
       "  'ArticleTitle': 'Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation.',\n",
       "  'Author': 'Uehata Takuya'},\n",
       " {'Abstract': ' the induct cellular senesc activ oncogen act barrier cell transform now identifi key compon senesc pathway prevent tumorigenesi mous model skin cancer they p38regulatedactiv protein kinas prak induc senesc downstream oncogen ras direct phosphoryl activ tumorsuppressor protein p53',\n",
       "  'ArticleTitle': 'Oncogene-induced senescence pathways weave an intricate tapestry.',\n",
       "  'Author': 'Yaswen Paul'},\n",
       " {'Abstract': ' cellular senesc state irrevers growth arrest trigger multipl mechan includ telomer shorten epigenet derepress ink4aarf locus dna damag togeth mechan limit excess aberr cellular prolifer state senesc protect develop cancer recent evid suggest cellular senesc involv age',\n",
       "  'ArticleTitle': 'Cellular senescence in cancer and aging.',\n",
       "  'Author': 'Collado Manuel'},\n",
       " {'Abstract': ' pi3k pten lipid phosphatas control level cellular phosphatidylinositol 345trisphosph activ akt kinas promot cell growth surviv mutat activ akt common observ human cancer we report entpd5 endoplasm reticulum er enzym upregul cell line primari human tumor sampl activ akt entpd5 hydrolyz udp ump promot protein nglycosyl fold er knockdown entpd5 pten null cell caus er stress loss growth factor receptor entpd5 cytidin monophosph kinase1 adenyl kinase1 constitut atp hydrolysi cycl convert atp amp result compensatori increas aerob glycolysi known warburg effect the growth pten null cell inhibit vitro mous xenograft tumor model entpd5 integr part pi3kpten regulatori loop potenti target anticanc therapi',\n",
       "  'ArticleTitle': 'The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.',\n",
       "  'Author': 'Fang Min'},\n",
       " {'Abstract': ' telomer length mainten requisit featur cellular immort hallmark human cancer while human cancer express telomeras activ 1015 employ recombinationdepend telomer mainten pathway known altern lengthen telomer alt character multitelomer cluster associ promyelocyt leukemia protein bodi here dna doublestrand break dsb respons alt telomer trigger longrang movement cluster chromosom termini result homologydirect telomer synthesi damag telomer initi increas random surveil nuclear space display rapid direct movement associ recipi telomer micronrang distanc this phenomenon requir rad51 hop2mnd1 heterodim essenti homolog chromosom synapsi meiosi these find implic special homolog search mechan altdepend telomer mainten provid molecular basi under prefer recombin nonsist telomer alt',\n",
       "  'ArticleTitle': 'Interchromosomal homology searches drive directional ALT telomere movement and synapsis.',\n",
       "  'Author': 'Cho Nam Woo'},\n",
       " {'Abstract': ' signal erbb receptor requir activ cytoplasm kinas domain initi ligand bind receptor ectodomain cytoplasm factor contribut activ unknown here identifi member cytohesin protein famili factor cytohesin inhibit decreas erbb receptor autophosphoryl signal cytohesin overexpress stimul receptor activ monitor epiderm growth factor receptor egfr conform anisotropi microscopi cellfre reconstitut cytohesindepend receptor autophosphoryl indic cytohesin facilit conform rearrang intracellular domain dimer receptor consist cytohesin play promin role erbb receptor signal cytohesin overexpress correl egf signal pathway activ human lung adenocarcinoma chemic inhibit cytohesin result reduc prolifer egfrdepend lung cancer cell vitro vivo our result establish cytohesin cytoplasm conform activ erbb receptor pathophysiolog relev',\n",
       "  'ArticleTitle': 'Cytohesins are cytoplasmic ErbB receptor activators.',\n",
       "  'Author': 'Bill Anke'},\n",
       " {'Abstract': ' the p7c3 class aminopropyl carbazol chemic foster surviv neuron varieti rodent model neurodegener nerv cell injuri to uncov mechan action activ deriv p7c3 modifi contain benzophenon photocrosslink alkyn click chemistri this deriv bind nicotinamid phosphoribosyltransferas nampt ratelimit enzym involv convers nicotinamid nicotinamid adenin dinucleotid nad administr activ p7c3 chemic cell treat doxorubicin induc nad deplet led rebound intracellular level nad concomit protect doxorubicinmedi toxic activ p7c3 variant likewis enhanc activ purifi nampt enzym provid evid act increas nad level namptmedi salvag',\n",
       "  'ArticleTitle': 'P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.',\n",
       "  'Author': 'Wang Gelin'},\n",
       " {'Abstract': ' ca2 essenti ubiquit second messeng chang cytosol ca2 trigger event critic tumorigenesi cellular motil prolifer apoptosi we isoform secretori pathway ca2atpas spca2 upregul breast cancerderiv cell human breast tumor suppress spca2 attenu basal ca2 level tumorigen contrari convent role golgi ca2 sequestr express spca2 increas ca2 influx mechan depend storeoper ca2 channel orai1 unexpect spca2orai1 signal independ er ca2 store stim1 stim2 sensor uncoupl ca2atpas activ spca2 bind spca2 amino terminus orai1 enabl access carboxyl terminus orai1 activ ca2 influx our find reveal signal pathway orai1spca2 complex elicit constitut storeindepend ca2 signal promot tumorigenesi',\n",
       "  'ArticleTitle': 'Store-independent activation of Orai1 by SPCA2 in mammary tumors.',\n",
       "  'Author': 'Feng Mingye'},\n",
       " {'Abstract': ' femal germlin mutat brca1 predispos develop breast ovarian cancer a previous report indic brca1 coloc necessari correct local xist noncod rna coat inact x chromosom xi mediat format facult heterochromatin a model emerg studi suggest loss brca1 femal cell reactiv gene xi loss xist rna howev independ studi brca1 xist rna reveal littl evid support model we report brca1 enrich xist rnacoat chromatin xi neither mutat deplet brca1 caus signific chang xist rna local xlink gene express togeth result support role brca1 promot xist rna local xi regul xistdepend function maintain stabil facult heterochromatin',\n",
       "  'ArticleTitle': 'The XIST noncoding RNA functions independently of BRCA1 in X inactivation.',\n",
       "  'Author': 'Xiao Cuiying'},\n",
       " {'Abstract': ' tumor heterogen present challeng infer clonal evolut driver gene identif here describ method analyz cancer genom singlecel nucleotid level to perform analys first devis valid highthroughput wholegenom singlecel sequenc method two lymphoblastoid cell line singl cell we carri wholeexom singlecel sequenc 90 cell jak2neg myeloprolif neoplasm patient the sequenc data 58 cell pass qualiti control criteria data indic neoplasm repres monoclon evolut we identifi essenti thrombocythemia etrel candid mutat sesn2 ntrk1 involv neoplasm progress this pilot studi allow initi character diseaserel genet architectur singlecel nucleotid level further establish singlecel sequenc method open way detail analys varieti tumor type includ high genet complex patient',\n",
       "  'ArticleTitle': 'Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm.',\n",
       "  'Author': 'Hou Yong'},\n",
       " {'Abstract': ' deadbox helicas play essenti role rna metabol speci emerg data suggest addit function immun through rnai screen identifi evolutionarili conserv interferonindepend role deadbox helicas ddx17 restrict rift valley fever virus rvfv mosquitotransmit virus bunyavirus famili caus sever morbid mortal human livestock loss drosophila ddx17 rm62 cell fli enhanc rvfv infect similar deplet ddx17 relat helicas ddx5 increas rvfv replic human cell use crosslink immunoprecipit highthroughput sequenc clipseq ddx17 bind stem loop host primirna facilit process essenti stem loop bunyavir rna restrict infect thus ddx17 dual role recognit stem loop nucleus endogen microrna mirna biogenesi cytoplasm surveil structur nonselfel',\n",
       "  'ArticleTitle': 'Stem-loop recognition by DDX17 facilitates miRNA processing and antiviral defense.',\n",
       "  'Author': 'Moy Ryan H'},\n",
       " {'Abstract': ' a grow number studi reveal cell send receiv inform control tempor behavior dynam signal molecul in review discuss known dynam signal network role control cellular respons we identifi general principl emerg field focus ident quantiti stimulus encod tempor pattern signal dynam influenc cellular outcom specif dynam pattern shape interpret structur molecular network we conclud discuss potenti function role transmit cellular inform dynam signal molecul possibl applic treatment diseas',\n",
       "  'ArticleTitle': 'Encoding and decoding cellular information through signaling dynamics.',\n",
       "  'Author': 'Purvis Jeremy E'},\n",
       " {'Abstract': ' studi model plant arabidopsi thaliana littl impact advanc medic research survey scientif literatur misconcept mani discoveri direct relev human health diseas elabor arabidopsi process human biolog easili versatil model plant',\n",
       "  'ArticleTitle': 'The impact of Arabidopsis on human health: diversifying our portfolio.',\n",
       "  'Author': 'Jones Alan M'},\n",
       " {'Abstract': ' rag initi antibodi vdj recombin develop lymphocyt generat ontarget dna break match pair bona fide recombin signal sequenc rsss we employ bait raggener break endogen ectop insert rss pair identifi huge number rag offtarget break such break occur simpl cac motif defin rss cleavag site larg confin converg ctcfbind element cbeflank loop domain contain bait rss pair mark orient depend rag offtarget activ loop span 2 megabas impli involv linear track in regard major rag offtarget chromosom transloc occur converg rss pair enhanc loop final delet cbebas igh locus element disrupt vdj recombin domain correspond alter rag offtarget distribut igh our find reveal rag activ development focus implic mechan chromatin domain har biolog process',\n",
       "  'ArticleTitle': 'Chromosomal Loop Domains Direct the Recombination of Antigen Receptor Genes.',\n",
       "  'Author': 'Hu Jiazhi'},\n",
       " {'Abstract': ' dna transcript replic repair regul histon acetyl process requir generat acetylcoenzym a coa here subunit mitochondri pyruv dehydrogenas complex pdc function nucleus mammalian cell we knockdown nuclear pdc isol function nuclei decreas novo synthesi acetylcoa acetyl core histon nuclear pdc level increas cellcycledepend manner respons serum epiderm growth factor mitochondri stress accompani correspond decreas mitochondri pdc level suggest transloc mitochondria nucleus inhibit nuclear pdc decreas acetyl specif lysin residu histon g1s phase progress express s phase marker dynam transloc mitochondri pdc nucleus provid pathway nuclear acetylcoa synthesi requir histon acetyl epigenet regul',\n",
       "  'ArticleTitle': 'A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation.',\n",
       "  'Author': 'Sutendra Gopinath'},\n",
       " {'Abstract': ' atr control chromosom integr chromatin dynam we yeast mec1atr promot chromatin detach nuclear envelop counteract aberr topolog transit dna replic here provid evid atr activ nuclear envelop respond mechan stress human atr associ nuclear envelop s phase prophas osmot stress mechan stretch reloc atr nuclear membran cell cycl the atrmedi mechan respons occur rang physiolog forc revers independ dna damag signal atrdefect cell exhibit aberr chromatin condens nuclear envelop breakdown we propos mechan forc deriv chromosom dynam torsion stress nuclear membran activ atr modul nuclear envelop plastic chromatin associ nuclear envelop enabl cell cope mechan strain impos molecular process',\n",
       "  'ArticleTitle': 'ATR mediates a checkpoint at the nuclear envelope in response to mechanical stress.',\n",
       "  'Author': 'Kumar Amit'},\n",
       " {'Abstract': ' in issu hughesdavi al describ novel gene product emsi suppress transactiv activ brca2 emsi locat amplicon sporad breast ovarian cancer suggest overexpress mimic effect brca2 inactiv the implic brca2 function discuss',\n",
       "  'ArticleTitle': 'The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.',\n",
       "  'Author': 'Haber Daniel A'},\n",
       " {'Abstract': ' the ib kinas complex ikk key regul immun respons inflamm cell surviv tumorigenesi the prosurviv function ikk center activ transcript factor nfb target gene product inhibit caspas prevent prolong jnk activ here report inactiv bh3on protein bad ikk independ nfb activ suppress tnfinduc apoptosi tnftreat ikk mous embryon fibroblast mef undergo apoptosi faster mef defici rela crel lack inhibit bad ikk ikk phosphoryl bad serine26 ser26 prime inactiv elimin ser26 phosphoryl promot bad proapoptot activ acceler tnfinduc apoptosi cultur cell increas mortal anim our result reveal ikk inhibit tnfinduc apoptosi two distinct cooper mechan activ surviv factor nfb inactiv proapoptot bh3on bad protein',\n",
       "  'ArticleTitle': u'Inactivation of BAD by IKK inhibits TNF\\u03b1-induced apoptosis independently of NF-\\u03baB activation.',\n",
       "  'Author': 'Yan Jie'},\n",
       " {'Abstract': ' cancer cell individu tumor exist distinct phenotyp state differ function attribut while cancer cell popul typic display distinct equilibria proport cell state mechan occur poor understood here studi dynam phenotyp proport human breast cancer cell line we subpopul cell purifi given phenotyp state return equilibrium proport time these observ explain markov model cell transit stochast state a predict model given certain condit subpopul cell return equilibrium phenotyp proport time a second predict breast cancer stemlik cell novo nonstemlik cell these find contribut understand cancer heterogen reveal stochast singlecel behavior promot phenotyp equilibrium popul cancer cell',\n",
       "  'ArticleTitle': 'Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.',\n",
       "  'Author': 'Gupta Piyush B'},\n",
       " {'Abstract': ' regul pyruv fate determin anabol versus catabol metabol a new report journal natur kaplon al suggest drive pyruv oxid thwart tumor growth brafdriven melanoma induc oncogeneinduc senesc find exploit therapeut',\n",
       "  'ArticleTitle': 'Pyruvate as a pivot point for oncogene-induced senescence.',\n",
       "  'Author': 'Olenchock Benjamin A'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: PTEN signaling pathways.',\n",
       "  'Author': 'Carracedo Arkaitz'},\n",
       " {'Abstract': ' receptor tyrosin kinas eph famili bind cell surfaceassoci ephrin ligand neighbor cell the ensu bidirect signal emerg major form contactdepend communic cell new find reveal eph receptor ephrin coordin development process normal physiolog homeostasi adult organ imbal ephephrin function contribut varieti diseas the challeng better understand complex seem paradox signal mechan eph receptor ephrin enabl effect strategi target protein treatment diseas diabet cancer',\n",
       "  'ArticleTitle': 'Eph-ephrin bidirectional signaling in physiology and disease.',\n",
       "  'Author': 'Pasquale Elena B'},\n",
       " {'Abstract': ' two abund class mobil element alu l1 element continu generat new retrotransposon insert human genom estim suggest element generat million new germlin insert individu human genom worldwid unfortun current technolog capabl detect young insert true extent germlin mutagenesi endogen human retrotransposon difficult examin here describ technolog detect young retrotransposon insert demonstr insert abund human popul we new somat l1 insert occur high frequenc human lung cancer genom genomewid analysi suggest alter dna methyl respons high level l1 mobil observ tumor our data indic transposonmedi mutagenesi extens human genom like major impact human biolog diseas',\n",
       "  'ArticleTitle': 'Natural mutagenesis of human genomes by endogenous retrotransposons.',\n",
       "  'Author': 'Iskow Rebecca C'},\n",
       " {'Abstract': ' factor sustain selfrenew mous embryon stem cell esc well describ in contrast machineri regul exit pluripot ill defin in largescal small interf rna sirna screen knockdown tumor suppressor folliculin flcn tsc2 prevent esc commit tsc2 lie upstream mammalian target rapamycin mtor flcn act downstream parallel flcn interact partner fnip1 fnip2 drive differenti restrict nuclear local activ bhlh transcript factor tfe3 convers enforc nuclear tfe3 enabl esc withstand differenti condit genomewid locat function analys tfe3 direct integr pluripot circuitri transcript regul esrrb these find identifi cellintrins rheostat destabil groundstat pluripot allow lineag commit congruent stagespecif subcellular reloc tfe3 suggest flcnfnip12 contribut development progress pluripot epiblast vivo',\n",
       "  'ArticleTitle': 'Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3.',\n",
       "  'Author': 'Betschinger Joerg'},\n",
       " {'Abstract': ' chronic infect plasmodium falciparum epidemiolog associ endem burkitt lymphoma matur b cell cancer character chromosom transloc cmyc oncogen igh 50 year ago whether infect promot b cell lymphoma mechan remain unknown to relationship parasit diseas lymphomagenesi plasmodium chabaudi pc produc chronic malaria infect mice pc induc prolong expans germin center gcs uniqu compart b cell undergo rapid clonal expans express activationinduc cytidin deaminas aid dna mutat gc b cell elicit pc infect suffer widespread dna damag lead chromosom transloc although infect chang rate modifi lymphomagenesi favor matur b cell lymphoma aid depend chromosom transloc thus malaria infect favor matur b cell cancer elicit protract aid express gc b cell paperclip',\n",
       "  'ArticleTitle': 'Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma.',\n",
       "  'Author': 'Robbiani Davide F'},\n",
       " {'Abstract': ' nussenzweig colleagu evalu genom instabl germin center deriv lymphomagenesi mice infect plasmodium recreat hallmark characterist burkitt lymphoma form cancer common part africa malaria endem',\n",
       "  'ArticleTitle': 'Malaria-Induced B Cell Genomic Instability.',\n",
       "  'Author': 'Rothschild Gerson'},\n",
       " {'Abstract': ' aberr gene function alter pattern gene express key featur cancer grow evid acquir epigenet abnorm particip genet alter caus dysregul here review recent advanc understand epigenet alter particip earliest stage neoplasia includ stemprecursor cell contribut discuss grow implic advanc strategi control cancer',\n",
       "  'ArticleTitle': 'The epigenomics of cancer.',\n",
       "  'Author': 'Jones Peter A'},\n",
       " {'Abstract': ' monoclon antibodi standard therapeut cancer includ anticd20 antibodi rituximab b cell nonhodgkin lymphoma nhl rituximab antibodi curat combin cytotox chemotherapi clinic benefit here report erad human nhl sole monoclon antibodi therapi combin rituximab block anticd47 antibodi we identifi increas express cd47 human nhl cell determin higher cd47 express independ predict advers clinic outcom multipl nhl subtyp block anticd47 antibodi preferenti enabl phagocytosi nhl cell synerg rituximab treatment human nhlengraft mice anticd47 antibodi reduc lymphoma burden improv surviv combin treatment rituximab led elimin lymphoma cure these antibodi synerg mechan combin fc receptor fcrdepend fcrindepend stimul phagocytosi cancer',\n",
       "  'ArticleTitle': 'Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.',\n",
       "  'Author': 'Chao Mark P'},\n",
       " {'Abstract': ' cd95 quintessenti death receptor bound ligand cell undergo apoptosi recent evid suggest cd95 mediat apoptosi divers nonapoptot function depend tissu condit',\n",
       "  'ArticleTitle': 'The CD95 receptor: apoptosis revisited.',\n",
       "  'Author': 'Peter Marcus E'},\n",
       " {'Abstract': ' acut myeloid leukemia aml manifest phenotyp function divers cell patient intratumor phenotyp function heterogen link physic sort experi function distinct subpopul prospect isol surfac phenotyp this assumpt proven problemat develop datadriven approach use mass cytometri profil surfac intracellular signal protein simultan million healthi leukem cell we develop phenograph algorithm defin phenotyp highdimension singlecel data phenograph reveal surfac phenotyp leukem blast reflect intracellular state use hematopoiet progenitor defin signalingbas measur cellular phenotyp led isol gene express signatur predict surviv independ cohort this studi present new method largescal analysi singlecel heterogen demonstr util yield insight aml pathophysiolog',\n",
       "  'ArticleTitle': 'Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.',\n",
       "  'Author': 'Levine Jacob H'},\n",
       " {'Abstract': ' eif4 major capbind protein long consid limit translat mammalian genom howev eif4 dose requir organism level remain unexplor by generat eif4 haploinsuffici mous 50 reduct eif4 express compat normal develop global protein synthesi imped cellular transform genomewid translat profil uncov translat program induc oncogen transform reveal critic role dose eif4 translat network mrnas enrich uniqu 5 utr signatur in particular demonstr dose eif4 essenti translat mrnas regul reactiv oxygen speci fuel transform cancer cell surviv vivo our find indic eif4 maintain level excess normal develop hijack cancer cell drive translat program support tumorigenesi',\n",
       "  'ArticleTitle': 'Differential Requirements for eIF4E Dose in Normal Development and Cancer.',\n",
       "  'Author': 'Truitt Morgan L'},\n",
       " {'Abstract': ' nich local tissu microenviron maintain regul stem cell longpredict mammalian studi structur character invertebr tissu method reliabl identifi individu stem cell function requir although similar singlecel resolut achiev mammalian tissu principl like govern behavior nich divers organ emerg consider progress elucid microenviron promot stem cell mainten mechan stem cell mainten key regul homeostasi like contribut age tumorigenesi alter adulthood',\n",
       "  'ArticleTitle': 'Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.',\n",
       "  'Author': 'Morrison Sean J'},\n",
       " {'Abstract': ' regul movement stem cell critic organogenesi develop homeostasi repair adulthood here biolog signific molecular mechan under stem cell traffick generat germlin generat regener blood muscl comparison organ lineag reveal remark conserv well special home migrat mechan matur leukocyt adult fetal stem cell cancer stem cell in vivo traffick underpin success therapeut applic hematopoiet stem cell bonemarrow transplant elucid home migrat pathway system enabl broader applic stem cell target cell therapi drug deliveri',\n",
       "  'ArticleTitle': 'Stem cell trafficking in tissue development, growth, and disease.',\n",
       "  'Author': 'Laird Diana J'},\n",
       " {'Abstract': ' the cellcycl transit g1 s phase difficult visual we har antiphas oscil protein mark cellcycl transit order develop genet encod fluoresc probe purpos these probe effect label individu g1 phase nuclei red sg2m phase green we abl generat cultur cell transgen mice constitut express cellcycl probe cell nucleus exhibit red green fluoresc we perform timelaps imag explor spatiotempor pattern cellcycl dynam epithelialmesenchym transit cultur cell migrat differenti neural progenitor brain slice develop tumor blood vessel live mice these mice cell line serv model system permit unpreced spatial tempor resolut help better understand cell cycl coordin biolog event',\n",
       "  'ArticleTitle': 'Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.',\n",
       "  'Author': 'Sakaue-Sawano Asako'},\n",
       " {'Abstract': ' the pten tumor suppressor mutat divers human cancer hereditari cancer predisposit syndrom pten phosphatas act polypeptid phosphoinositid substrat vitro the pten structur reveal phosphatas domain similar protein phosphatas enlarg activ site accommod phosphoinositid substrat the structur reveal pten c2 domain the pten c2 domain bind phospholipid membran vitro mutat basic residu mediat reduc pten membran affin abil suppress growth glioblastoma tumor cell the phosphatas c2 domain associ extens interfac suggest c2 domain serv product posit catalyt domain membran',\n",
       "  'ArticleTitle': 'Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.',\n",
       "  'Author': 'Lee J O'},\n",
       " {'Abstract': ' runx3pebp2alphac null mous gastric mucosa exhibit hyperplasia stimul prolifer suppress apoptosi epitheli cell cell resist growthinhibitori apoptosisinduc action tgfbeta indic runx3 major growth regul gastric epitheli cell between 45 60 human gastric cancer cell express runx3 hemizyg delet hypermethyl runx3 promot region tumorigen human gastric cancer cell line nude mice invers relat level runx3 express mutat r122c occur conserv runt domain abolish tumorsuppress effect runx3 suggest lack runx3 function causal relat genesi progress human gastric cancer',\n",
       "  'ArticleTitle': 'Causal relationship between the loss of RUNX3 expression and gastric cancer.',\n",
       "  'Author': 'Li Qing Lin'},\n",
       " {'Abstract': ' outbreak fatal leukemialik cancer marin bivalv world led massiv popul loss the caus diseas unknown we identifi retrotransposon steamer high express amplifi high copi number neoplast cell softshel clam mya arenaria through analysi steamer integr site mitochondri dna singlenucleotid polymorph snps polymorph microsatellit allel genotyp neoplast cell match host anim instead neoplast cell dispers locat new york main princ edward island pei canada ident genotyp differ host these result indic cancer spread anim marin environ clonal transmiss cell deriv singl origin clam our find suggest horizont transmiss cancer cell widespread natur suppos',\n",
       "  'ArticleTitle': 'Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams.',\n",
       "  'Author': 'Metzger Michael J'},\n",
       " {'Abstract': ' research past decad suggest role pseudogen physiolog diseas in vitro experi demonstr pseudogen contribut cell transform mechan howev vivo evid causal role pseudogen cancer develop lack here report mice engin overexpress fulllength murin braf pseudogen brafrs1 pseudo cds 3 utr develop aggress malign resembl human diffus larg b cell lymphoma we brafrs1 human ortholog brafp1 elicit oncogen activ least part competit endogen rnas cerna elev braf express mapk activ vitro vivo notabl transcript genom aberr brafp1 occur frequent multipl human cancer includ b cell lymphoma our engin mous model demonstr oncogen potenti pseudogen indic cernamedi microrna sequestr contribut develop cancer',\n",
       "  'ArticleTitle': 'The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.',\n",
       "  'Author': 'Karreth Florian A'},\n",
       " {'Abstract': ' express oncogen primari cell paradox block prolifer induc senesc apoptosi pathway remain elucid here perform genomewid rnainterfer screen identifi 17 gene requir activ braf oncogen brafv600 block prolifer human primari fibroblast melanocyt surpris secret protein igfbp7 central role brafv600emedi senesc apoptosi express brafv600 primari cell lead synthesi secret igfbp7 act autocrineparacrin pathway inhibit brafmekerk signal induc senesc apoptosi apoptosi result igfbp7medi upregul bnip3l proapoptot bcl2 famili protein recombin igfbp7 rigfbp7 induc apoptosi brafv600eposit human melanoma cell line system administ rigfbp7 mark suppress growth brafv600eposit tumor xenograft mice immunohistochem analysi human skin nevi melanoma sampl implic loss igfbp7 express critic step melanoma genesi',\n",
       "  'ArticleTitle': 'Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.',\n",
       "  'Author': 'Wajapeyee Narendra'},\n",
       " {'Abstract': ' clinic epidemiolog studi suggest associ infecti agent chronic inflammatori disord cancer better understand microbi patternrecognit receptor innat immun signal pathway host help elucid connect microbi infect chronic diseas we propos key aspect pathogenesi aberr epitheli barrier instig microbi toxin environment insult genet predisposit host loss epitheli integr result activ resid inflammatori cell microbi invad endogen ligand when coupl failur normal control mechan limit leukocyt activ cascad establish induc chronic inflamm consequ here outlin mechanist framework briefli review alter innat immun respons gene murin model provid insight potenti microbi origin divers condit includ crohn diseas psoriasi atherosclerosi diabet liver cancer',\n",
       "  'ArticleTitle': 'Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.',\n",
       "  'Author': 'Karin Michael'},\n",
       " {'Abstract': ' the eukaryot biolog clock involv negat transcriptiontransl feedback loop clock gene regul transcript output gene metabol signific while 10 liver transcriptom rhythmic fifth driven novo transcript indic mrna process major circadian compon here report inhibit transmethyl reaction elong circadian period rna sequenc reveal methyl inhibit caus widespread chang transcript rna process machineri associ m6arna methyl we identifi m6a site clock gene transcript specif inhibit m6a methyl silenc m6a methylas mettl3 suffici elicit circadian period elong rna process delay analysi circadian nucleocytoplasm distribut clock gene per2 arntl reveal uncoupl steadyst premrna cytoplasm mrna rhythm m6a methyl inhibit',\n",
       "  'ArticleTitle': 'RNA-methylation-dependent RNA processing controls the speed of the circadian clock.',\n",
       "  'Author': 'Fustin Jean-Michel'},\n",
       " {'Abstract': ' defin precis molecular strategi coordin pattern transcript respons specif signal central understand normal develop homeostasi well pathogenesi hormonedepend cancer here report specif prostat cancer cellmacrophag interact mediat switch function select androgen receptor antagonistsmodul sarm repress activ vivo this base evolutionarili conserv receptor ntermin lhx7ll motif select sex steroid receptor caus recruit tab2 compon ncor corepressor complex tab2 act sensor inflammatori signal serv molecular beacon recruit mekk1 turn mediat dismiss ncorhdac complex permit derepress androgen estrogen receptor target gene surpris conserv sensor strategi arisen mediat revers sex steroiddepend repress limit cohort target gene respons inflammatori signal link inflammatori nuclear receptor ligand respons essenti reproduct function',\n",
       "  'ArticleTitle': 'Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.',\n",
       "  'Author': 'Zhu Ping'},\n",
       " {'Abstract': ' proteaseactiv receptor par uniqu class g proteincoupl receptor play critic role thrombosi inflamm vascular biolog par1 propos involv invas metastat process cancer howev proteas respons activ proinvas function par1 remain identifi here express par1 requir suffici promot growth invas breast carcinoma cell xenograft model further matrix metalloproteas mmp1 function proteas agonist par1 cleav receptor proper site generat par1depend ca2 signal migrat mmp1 activ deriv fibroblast absent breast cancer cell these result demonstr mmp1 stromaltumor microenviron alter behavior cancer cell par1 promot cell migrat invas',\n",
       "  'ArticleTitle': 'PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.',\n",
       "  'Author': 'Boire Adrienne'},\n",
       " {'Abstract': ' program necrosi form caspaseindepend cell death molecular regul poor understood the kinas rip1 crucial program necrosi mediat activ prosurviv transcript factor nfkappab we postul addit molecul requir activ program necrosi use rna interfer screen identifi kinas rip3 crucial activ program necrosi induc tnf virus infect rip3 regul necrosisspecif rip1 phosphoryl the phosphoryl rip1 rip3 stabil associ pronecrot complex activ pronecrot kinas activ trigger downstream reactiv oxygen speci product the pronecrot rip1rip3 complex induc vaccinia virus infect consequ rip3 mice exhibit sever impair virusinduc tissu necrosi inflamm control viral replic our find suggest rip3 control program necrosi initi pronecrot kinas cascad necessari inflammatori respons virus infect',\n",
       "  'ArticleTitle': 'Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.',\n",
       "  'Author': 'Cho Young Sik'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Forkhead transcription factors II.',\n",
       "  'Author': 'Tuteja Geetu'},\n",
       " {'Abstract': ' myc high pleiotrop transcript factor deregul promot cancer in contrast myc haploinsuffici myc mice exhibit increas lifespan they resist ageassoci patholog includ osteoporosi cardiac fibrosi immunosenesc they appear activ higher metabol rate healthier lipid metabol transcriptom analysi reveal gene express signatur enrich metabol immun process the ancestr role myc regul ribosom biogenesi reflect reduc protein translat invers correl longev we observ chang nutrient energi sens pathway includ reduc serum igf1 increas ampk activ decreas akt tor s6k activ in contrast observ longev model myc mice improv stress manag pathway our find indic myc activ signific impact longev multipl aspect mammalian healthspan',\n",
       "  'ArticleTitle': 'Reduced expression of MYC increases longevity and enhances healthspan.',\n",
       "  'Author': 'Hofmann Jeffrey W'},\n",
       " {'Abstract': ' apoptosi play key role develop cancer respons tumor cell therapeut intervent recent work threedimension cell cultur model underscor interact epitheli cellsboth normal malignantand extracellular matrix surround inform life death decis research area begin defin oncogen pathway interfer process biochem pathway transmit signal proper cellmatrix interact promot cell surviv',\n",
       "  'ArticleTitle': 'Taking the study of cancer cell survival to a new dimension.',\n",
       "  'Author': 'Jacks Tyler'},\n",
       " {'Abstract': ' understand recov fulli function transcript activ chromatin integr challeng genotox stress critic issu here investig chromatin dynam regul transcript activ respons dna damag human cell identifi pathway involv histon chaperon histon regul a hira promot transcript restart uvc damag our mechanist studi reveal hira accumul site uvc irradi detect dna damag prior repair deposit newli synthes h33 histon this local action hira depend ubiquityl event associ damag recognit furthermor demonstr earli transient function hira respons dna damag prime chromatin later reactiv transcript we propos hiradepend histon deposit serv chromatin bookmark system facilit transcript recoveri genotox stress',\n",
       "  'ArticleTitle': 'Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA.',\n",
       "  'Author': u'Adam Salom\\xe9'},\n",
       " {'Abstract': ' microrna heterogen ribonucleoprotein hnrnps posttranscript gene regul bind mrna sequencespecif manner here report loss mir328 occur blast crisi chronic myelogen leukemia cmlbc bcrabl dose kinasedepend manner mapkhnrnp e2 pathway restor mir328 express rescu differenti impair surviv leukem blast simultan interact translat regul polyrcbind protein hnrnp e2 mrna encod surviv factor pim1 respect the interact hnrnp e2 independ microrna seed sequenc lead releas cebpa mrna hnrnp e2medi translat inhibit altogeth data reveal dual abil microrna control cell fate base pair mrna target decoy activ interfer function regulatori protein',\n",
       "  'ArticleTitle': 'miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.',\n",
       "  'Author': 'Eiring Anna M'},\n",
       " {'Abstract': ' the antibodi gene mutat activationinduc cytidin deaminas aid promiscu damag oncogen lead chromosom transloc tumorigenesi whi nonimmunoglobulin loci suscept aid activ unknown here studi aidmedi lesion context nuclear architectur b cell regulom we aid target random distribut genom group superenhanc regulatori cluster unexpect domain aid deamin activ promot erna enhanc interconnect instanc megabas linear chromatin use genom edit demonstr 3dlink target cooper recruit aidmedi break furthermor comparison hypermut mous b cell aidinduc kataegi human lymphoma transloc mef reveal aid damag differ gene differ cell type yet case target associ topolog complex high transcrib superenhanc demonstr compart key mediat aid recruit',\n",
       "  'ArticleTitle': 'B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.',\n",
       "  'Author': 'Qian Jason'},\n",
       " {'Abstract': ' osteoblast compon hematopoiet microenviron bone howev mechan osteoblast control hematopoiesi remain unknown we augment hif signal osteoprogenitor result hsc nich expans associ select expans erythroid lineag increas red blood cell product occur epodepend manner increas epo express bone suppress epo express kidney in contrast inactiv hif osteoprogenitor reduc epo express bone import augment hif activ osteoprogenitor protect mice stressinduc anemia pharmacolog genet inhibit prolyl hydroxylases123 osteoprogenitor elev epo express bone increas hematocrit these data reveal unexpect role osteoblast product epo modul erythropoiesi furthermor studi demonstr molecular role osteoblast phdvhlhif signal target elev hscs erythroid progenitor local hematopoiet microenviron',\n",
       "  'ArticleTitle': 'The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO.',\n",
       "  'Author': 'Rankin Erinn B'},\n",
       " {'Abstract': ' dure cell divis transcript factor tfs remov chromatin twice dna synthesi condens chromosom how tfs effici site follow stage unclear here analyz bind pattern express tfs human colorect cancer cell we bind tfs high cluster cluster enrich bind motif major tf class strike cluster form cohesin loss cohesin decreas dna access bind tfs cluster we cohesin remain bound s phase hold nascent sister chromatid tf cluster site furthermor cohesin remain bound cluster site tfs evict earli m phase these result suggest cohesinbind function cellular memori promot reestablish tf cluster dna replic chromatin condens',\n",
       "  'ArticleTitle': 'Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites.',\n",
       "  'Author': 'Yan Jian'},\n",
       " {'Abstract': ' characterist transform tumor cell includ increas level protein synthesi elev express rna polymeras pol iii product trnas 5s rrna howev deregul pol iii transcript contribut transform unclear generat cell line express induc pol iiispecif transcript factor brf1 allow rais trna 5s rrna level brf1 induct caus increas cell prolifer oncogen transform deplet brf1 imped transform among gene product induc brf1 trnaimet initi polypeptid synthesi overexpress trnaimet suffici stimul cell prolifer allow immort fibroblast form foci cultur tumor mice the data indic elev trna synthesi promot cellular transform',\n",
       "  'ArticleTitle': 'Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation.',\n",
       "  'Author': 'Marshall Lynne'},\n",
       " {'Abstract': ' vessel sprout migrat tip prolifer stalk endotheli cell ec control genet signal notch unknown metabol regul process here ec reli glycolysi oxid phosphoryl atp product loss glycolyt activ pfkfb3 ec impair vessel format mechanist pfkfb3 regul ec prolifer control format filopodialamellipodia direct migrat part compartment factin motil protrus mosaic vitro vivo sprout assay reveal pfkfb3 overexpress overrul prostalk activ notch pfkfb3 defici impair tip cell format notch blockad impli glycolysi regul vessel branch',\n",
       "  'ArticleTitle': 'Role of PFKFB3-driven glycolysis in vessel sprouting.',\n",
       "  'Author': 'De Bock Katrien'},\n",
       " {'Abstract': ' nikolaev al issu cell report identif parkinlik protein parc role anchor tumor suppressor protein p53 cytoplasm reveal level control p53 function regul subcellular local p53 parc serv novel target treatment certain type tumor',\n",
       "  'ArticleTitle': 'Parc-ing p53 in the cytoplasm.',\n",
       "  'Author': 'Kastan Michael B'},\n",
       " {'Abstract': ' coordin cell prolifer cell death essenti attain proper organ size develop maintain tissu homeostasi postnat life in drosophila two process orchestr hippo kinas cascad growthsuppress pathway ultim antagon transcript coactiv yorki yki here demonstr singl phosphoryl site yki mediat growthsuppress output hippo pathway hippomedi phosphoryl inactiv yki exclud nucleus loss hippo signal lead nuclear accumul increas yki activ we delin mammalian hippo signal pathway culmin phosphoryl yap mammalian homolog yki use condit yap transgen mous model demonstr mammalian hippo pathway potent regul organ size dysregul lead tumorigenesi these result uncov univers sizecontrol mechan metazoan',\n",
       "  'ArticleTitle': 'Elucidation of a universal size-control mechanism in Drosophila and mammals.',\n",
       "  'Author': 'Dong Jixin'},\n",
       " {'Abstract': ' the complex genom aberr human tumor hamper delin gene drive tumorigen process in issu cell demonstr cognat mous tumor model recapitul genet alter unexpect fidel these result indic crossspeci genom analysi power strategi identifi respons gene assess oncogen capac appropri genet context',\n",
       "  'ArticleTitle': 'Cross-species oncogenomics in cancer gene identification.',\n",
       "  'Author': 'Peeper Daniel'},\n",
       " {'Abstract': ' suscept tuberculosi histor ascrib inadequ immun respons fail control infect mycobacteria in zebrafish suscept mycobacterium marinum result inadequ excess acut inflamm modul leukotrien a4 hydrolas lta4h locus control balanc pro antiinflammatori eicosanoid reveal two distinct molecular rout mycobacteri suscept converg dysregul tnf level inadequ inflamm caus excess lipoxin hyperinflamm driven excess leukotrien b4 we identifi therapi target extrem in human identifi singl nucleotid polymorph lta4h promot regul transcript activ in tubercul mening polymorph associ inflammatori cell recruit patient surviv respons adjunct antiinflammatori therapi togeth find suggest hostdirect therapi tailor patient lta4h genotyp counter detriment effect extrem inflamm',\n",
       "  'ArticleTitle': 'Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.',\n",
       "  'Author': 'Tobin David M'},\n",
       " {'Abstract': ' for decad the cancer genom atlas tcga program collect clinicopatholog annot data multiplatform molecular profil 11000 human tumor 33 differ cancer type tcga clinic data contain key featur repres democrat natur data collect process to ensur proper larg clinic dataset associ genom featur develop standard dataset name tcga pancanc clinic data resourc tcgacdr includ four major clinic outcom endpoint in addit detail major challeng statist limit encount effort integr acquir clinic data summari includ endpoint usag recommend cancer these tcgacdr find appear consist cancer genom studi independ tcga effort provid opportun investig cancer biolog clinic correl unpreced scale',\n",
       "  'ArticleTitle': 'An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.',\n",
       "  'Author': 'Liu Jianfang'},\n",
       " {'Abstract': ' the cacna1a gene encod voltageg calcium channel subunit 1a involv pre postsynapt ca2 signal gene express genet neurolog disord we cacna1a coordin gene express bicistron mrna bear cryptic intern ribosom entri site ire the first cistron encod wellcharacter 1a subunit the second express transcript factor 1act coordin express program gene involv neural purkinj cell develop 1act contain polyglutamin polyq tract expand caus spinocerebellar ataxia 6 sca6 when express independ polypeptid 1actbear expand polyq tractlack transcript factor function neurit outgrowth properti caus cell death cultur lead ataxia cerebellar atrophi transgen mice suppress cacna1a ire function sca6 potenti therapeut strategi',\n",
       "  'ArticleTitle': 'Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.',\n",
       "  'Author': 'Du Xiaofei'},\n",
       " {'Abstract': ' knock express diseaserel gene small interf rnas sirna potenti treat varieti ill this essay examin opportun har rna interfer rnai therapi well obstacl possibl way circumv',\n",
       "  'ArticleTitle': 'Knocking down disease with siRNAs.',\n",
       "  'Author': 'Dykxhoorn Derek M'},\n",
       " {'Abstract': ' in respons dna damag mammalian cell trigger p53depend transcript induct factor regul dna repair cellcycl progress cell surviv through differenti proteom identifi heterogen nuclear ribonucleoprotein k hnrnp k rapid induc dna damag manner requir dnadamag signal kinas atm atr induct hnrnp k ensu inhibit ubiquitindepend proteasom degrad mediat ubiquitin e3 ligas hdm2mdm2 strike hnrnp k deplet abrog transcript induct p53 target gene caus defect dnadamageinduc cellcyclecheckpoint arrest furthermor respons dna damag p53 hnrnp k recruit promot p53respons gene mutual depend manner these find establish hnrnp k new hdm2 target serv cofactor p53 hnrnp k play key role coordin transcript respons dna damag',\n",
       "  'ArticleTitle': 'hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.',\n",
       "  'Author': 'Moumen Abdeladim'},\n",
       " {'Abstract': ' target molecular therapi cancer treatment promis limit in issu heidorn al 2010 class target molecular therapi clinic effect one melanoma subtyp advers clinic effect',\n",
       "  'ArticleTitle': 'The brothers RAF.',\n",
       "  'Author': 'Kwong Lawrence N'},\n",
       " {'Abstract': '', 'ArticleTitle': 'Drug rehab.', 'Author': 'Kvajo Mirna'},\n",
       " {'Abstract': ' the number cell organ determin regul cell prolifer cell death relat mechan identifi modul process in screen drosophila mutat result tissu overgrowth identifi salvador sav gene promot cell cycl exit cell death elev cyclin e diap1 level mutant cell result delay cell cycl exit impair apoptosi salvador contain two ww domain bind wart lat protein kinas the human ortholog salvador hww45 mutat three cancer cell line thus salvador restrict cell number vivo function dual regul cell prolifer apoptosi',\n",
       "  'ArticleTitle': 'salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.',\n",
       "  'Author': 'Tapon Nicolas'},\n",
       " {'Abstract': ' we represent differ analysi identifi homozyg genom delet select tumor progress mous nf2 tp53 tumor model we describ delet target dock4 member cdm gene famili encod regul small gtpase dock4 activ rap gtpase enhanc format adheren junction dock4 mutat subset human cancer cell line recurr missens mutant identifi human prostat ovarian cancer encod protein defect rap1 activ the engulf defect c elegan mutant lack cdm gene ced5 rescu wildtyp dock4 mutant allel express wildtyp mutant dock4 mous osteosarcoma cell delet endogen gene suppress growth soft agar tumor invas vivo dock4 encod cdm famili member regul intercellular junction disrupt tumorigenesi',\n",
       "  'ArticleTitle': 'DOCK4, a GTPase activator, is disrupted during tumorigenesis.',\n",
       "  'Author': 'Yajnik Vijay'},\n",
       " {'Abstract': ' most avail inform endoplasm reticulum erplasma membran pm contact cell higher eukaryot concern protein implic regul ca2 entri howev grow evid suggest contact play general role cell physiolog point exist addit ubiquit express erpm tether here three extend synaptotagmin esyt er protein particip tether function c2 domaindepend interact pm requir pi45p2 case esyt2 esyt3 elev cytosol ca2 case esyt1 as form heteromer complex esyt confer cytosol ca2 regul erpm contact format esytsdepend contact requir storeoper ca2 entri thus erpm tether function esyt tricalbin yeast mediat format erpm contact site function distinct mediat stim1 orai1',\n",
       "  'ArticleTitle': 'PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions mediated by the extended synaptotagmins.',\n",
       "  'Author': 'Giordano Francesca'},\n",
       " {'Abstract': ' the balanc oxid nonoxid glucos metabol essenti number pathophysiolog process by delet enzym affect aerob glycolysi differ potenc examin modul glucos metabol affect hematopoiet leukem cell popul we defici m2 pyruv kinas isoform pkm2 reduc level metabol intermedi biosynthesi impair progenitor function perturb hematopoiet stem cell hscs lactat dehydrogenas a ldha delet inhibit function hscs progenitor hematopoiesi in contrast leukemia initi transform allel putat affect hscs progenitor inhibit absenc pkm2 ldha indic cellstatespecif respons metabol manipul hematopoiesi set leukemia this find suggest finetun level glycolysi explor therapeut treat leukemia preserv hsc function',\n",
       "  'ArticleTitle': 'Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis.',\n",
       "  'Author': 'Wang Ying-Hua'},\n",
       " {'Abstract': ' lymphocyt activ initi global increas messeng rna synthesi howev mechan drive transcriptom amplif immun respons unknown by monitor singlestrand dna genom wide genom naiv cell pois rapid activ in g0 90 promot gene express cycl lymphocyt polymeras load unmelt support basal transcript furthermor transit abort product elong kinet limit caus polymeras accumul nearer transcript start site rest lymphocyt limit express transcript factor iih complex includ xpb xpd helicas involv promot melt open complex extens to date two ratelimit step control global gene express eukaryot preiniti complex assembl polymeras paus our studi identifi promot melt third key regulatori step propos mechan ensur prompt lymphocyt respons invad pathogen',\n",
       "  'ArticleTitle': 'Global regulation of promoter melting in naive lymphocytes.',\n",
       "  'Author': 'Kouzine Fedor'},\n",
       " {'Abstract': ' cherub autosomaldomin syndrom character inflammatori destruct boni lesion result symmetr deform facial bone cherub caus mutat sh3bp2 gene encod adaptor protein 3bp2 most identifi mutat 3bp2 lie peptid sequenc rsppdg a mous model cherub develop hyperact boneremodel osteoclast system inflamm character expans myelomonocyt lineag the mechan cherub mutat alter 3bp2 function remain obscur here tankyras member polyadpribosepolymeras parp famili regul 3bp2 stabil adpribosyl subsequ ubiquityl e3ubiquitin ligas rnf146 osteoclast cherub mutat uncoupl 3bp2 tankyrasemedi protein destruct result stabil subsequ hyperactiv src syk vav signal pathway',\n",
       "  'ArticleTitle': 'Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.',\n",
       "  'Author': 'Levaot Noam'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'SnapShot: Rho family GTPases.',\n",
       "  'Author': 'Vega Francisco M'},\n",
       " {'Abstract': ' guanin nucleotid exchang factor gef gtpaseactiv protein gap regul activ small guanin nucleotidebind g protein control cellular function in general gef turn signal catalyz exchang gproteinbound gdp gtp gap termin signal induc gtp hydrolysi gef gap multidomain protein regul extracellular signal local cue control cellular event time space recent evid suggest protein potenti therapeut target develop drug treat diseas includ cancer',\n",
       "  'ArticleTitle': 'GEFs and GAPs: critical elements in the control of small G proteins.',\n",
       "  'Author': 'Bos Johannes L'},\n",
       " {'Abstract': ' microglia embryon seed macrophag contribut brain develop homeostasi patholog it essenti deciph microgli properti tempor regul intrins extrins factor sexual ident microbiom here microglia undergo differenti phase discern transcriptom signatur chromatin access landscap diverg adult male femal remark absenc microbiom germfre mice time sexual dimorph impact prenat postnat microglia profound perturb male embryo femal adult antibiot treatment adult mice trigger sexual bias microgli respons reveal acut longterm effect microbiota deplet final human fetal microglia exhibit signific overlap murin transcriptom signatur our studi microglia respond environment challeng sex timedepend manner prenat stage major implic understand microgli contribut health diseas',\n",
       "  'ArticleTitle': 'Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner.',\n",
       "  'Author': 'Thion Morgane Sonia'},\n",
       " {'Abstract': ' dna doublestrand break dsbs initi extens local global alter chromatin structur atm kinas histon h2a ubiquityl uh2a chromatin surround dsbs one exampl thought recruit repair protein uh2a implic transcript repress intrigu untest hypothesi function conserv context dsbs use novel report allow visual repair protein recruit local transcript singl cell describ atmdepend transcript silenc program cis dsbs atm prevent rna polymeras ii elongationdepend chromatin decondens region distal dsbs silenc partial depend e3 ubiquitin ligas rnf8 rnf168 revers silenc reli uh2a deubiquityl enzym usp16 these find insight role posttransl modif mediat crosstalk divers process occur chromatin',\n",
       "  'ArticleTitle': 'ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks.',\n",
       "  'Author': 'Shanbhag Niraj M'},\n",
       " {'Abstract': ' notch signal key development pathway subject frequent genet epigenet perturb differ human tumor here long noncod rna lncrna gene addit mrnas key downstream target oncogen notch1 human t cell acut lymphoblast leukemia tall by integr transcriptom profil chromatin state map uncov unreport tallspecif lncrna gene fraction direct control notch1rpbj activ complex final one specif notchregul lncrna lunar1 requir effici tall growth vitro vivo abil enhanc igf1r mrna express sustain igf1 signal these result confirm lncrnas downstream target notch signal pathway addit key regul oncogen state tall',\n",
       "  'ArticleTitle': 'Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.',\n",
       "  'Author': 'Trimarchi Thomas'},\n",
       " {'Abstract': ' the holobiont concept defin collect contribut eukaryot prokaryot counterpart multicellular organ introduc complex definit individu enabl new comprehens view human evolut person characterist here provid snapshot evolv microbialhost associ relat distinct mileston lifespan human we discuss current knowledg biolog symbiosi microbiom host portray challeng understand interact potenti effect human physiolog includ microbiomenerv system interrelationship relev human variat individu',\n",
       "  'ArticleTitle': 'Our Gut Microbiome: The Evolving Inner Self.',\n",
       "  'Author': 'Kundu Parag'},\n",
       " {'Abstract': ' extracellular signal regul protein translat cell function a key advantag control translat level opportun regul protein synthesi specif cellular subregion howev littl known mechan link extracellular cue translat spatial precis here transmembran receptor dcc form bind complex contain multipl translat compon includ eukaryot initi factor ribosom larg small subunit monosom in neuron axon dendrit dcc coloc particl translat machineri newli synthes protein the extracellular ligand netrin promot dccmediat translat disassoci translat compon the function physic associ cell surfac receptor translat machineri lead generaliz model local extracellular regul protein synthesi base transmembran translat regul complex',\n",
       "  'ArticleTitle': 'Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation.',\n",
       "  'Author': 'Tcherkezian Joseph'},\n",
       " {'Abstract': ' altern splice wt1 result insert omiss three amino acid kts zinc finger 3 4 in vitro experi suggest distinct molecular function kts isoform we generat mous strain specif isoform remov heterozyg mice reduct kts level develop glomerulosclerosi repres model frasier syndrom homozyg mutant strain die birth kidney defect strike mice lack kts isoform complet xy sex revers dramat reduct sri express level our data demonstr distinct function two splice variant place kts variant regul sri sex determin pathway',\n",
       "  'ArticleTitle': \"Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation.\",\n",
       "  'Author': 'Hammes A'},\n",
       " {'Abstract': ' the nuclear lamina nl interact hundr larg genom region term lamina associ domain lad the dynam interact relat epigenet modif poor understood we visual fate lad singl cell molecular contact memori approach in nucleus 30 lad posit peripheri lad intermitt molecular contact nl remain constrain peripheri upon mitosi lad posit detect inherit instead stochast reshuffl contact individu lad nl link transcript repress h3k9 dimethyl singl cell furthermor identifi h3k9 methyltransferas g9a regul nl contact collect result highlight principl dynam spatial architectur chromosom relat gene regul',\n",
       "  'ArticleTitle': 'Single-cell dynamics of genome-nuclear lamina interactions.',\n",
       "  'Author': 'Kind Jop'},\n",
       " {'Abstract': ' constitut cellautonom immun metazoan predat interferoninduc immun compris primordi innat defens phagocyt mobil interferoninduc respons engag wellcharacter signal pathway pathogenassoci molecular pattern pamp the signal control deploy constitut cellautonom respons infect remain elus vitapamp denot microbi viabil signal danger cellular exploit intracellular pathogen we cyclicdiadenosin monophosph live gramposit bacteria vitapamp engag innat sensor stimul interferon gene sting mediat endoplasm reticulum er stress subsequ inactiv mechanist target rapamycin mobil autophagi sequest stress er membran resolv er stress curtail phagocyt death this vitapampinduc erphagi addit orchestr interferon respons local erresid sting autophagosom our find identifi stressmedi erphagi cellautonom respons mobil stingdepend sens specif vitapamp elucid innat receptor engag multilay homeostat mechan promot immun surviv infect',\n",
       "  'ArticleTitle': 'STING Senses Microbial Viability to Orchestrate Stress-Mediated Autophagy of the Endoplasmic Reticulum.',\n",
       "  'Author': 'Moretti Julien'},\n",
       " {'Abstract': ' stem cell believ crucial player tumor develop there interest identifi compart harbor stem cell involv lung cancer given high incid recurr rate diseas in issu cell kim colleagu describ nich bronchioalveolar duct junction adult mous lung harbor stem cell adenocarcinoma like they enrich propag differenti stem cell vitro activ oncogen protein kras this studi provid excit insight stem cell compart oper normal lungtissu homeostasi develop lung cancer the new work offer perspect possibl therapeut intervent combat lung cancer',\n",
       "  'ArticleTitle': 'Stem cells for lung cancer?',\n",
       "  'Author': 'Berns Anton'},\n",
       " {'Abstract': ' microrna mirna known regul express gene involv control develop prolifer apoptosi stress respons as cluster recent natur paper alter express specif mirna gene contribut initi progress cancer',\n",
       "  'ArticleTitle': 'miRNAs, cancer, and stem cell division.',\n",
       "  'Author': 'Croce Carlo M'},\n",
       " {'Abstract': ' x chromosom aneuploidi long associ human cancer causal establish in mammal x chromosom inactiv xci trigger xist rna equal gene express sex here delet xist blood compart mice demonstr mutant femal develop high aggress myeloprolif neoplasm myelodysplast syndrom mix mpnmds 100 penetr signific diseas compon includ primari myelofibrosi leukemia histiocyt sarcoma vascul xistdefici hematopoiet stem cell hscs aberr matur agedepend loss reconstitut experi indic mpnmds myelofibrosi hematopoiet stromal origin we propos xist loss result x reactiv consequ genomewid chang lead cancer causal link x chromosom cancer mice thus xist rna requir maintain xci suppress cancer vivo',\n",
       "  'ArticleTitle': 'Xist RNA is a potent suppressor of hematologic cancer in mice.',\n",
       "  'Author': 'Yildirim Eda'},\n",
       " {'Abstract': ' genet interact gi map compris pairwis measur function one gene depend presenc second enabl systemat explor gene function microorgan here twostag strategi construct highdens gi map mammalian cell first ultracomplex pool shrna librari 25 shrnasgen identifi highconfid hit gene given phenotyp effect shrnas we construct doubleshrna librari systemat measur gis hit a gi map focus ricin suscept broad recapitul known pathway provid unexpect insight these includ noncanon role copi uncharacter protein complex affect toxin clearanc special role ribosom protein rps25 function distinct mammalian trapp complex the abil rapid generat mammalian gi map provid potenti transform tool defin gene function design combin therapi base synergist pair',\n",
       "  'ArticleTitle': 'A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility.',\n",
       "  'Author': 'Bassik Michael C'},\n",
       " {'Abstract': ' histon modif key regul chromatin function howev littl known extent histon modif direct impact chromatin here address modif globular domain histon regul chromatin function we demonstr h3k122ac suffici stimul transcript mutat h3k122 impair transcript activ attribut direct effect h3k122ac histonedna bind in line h3k122ac defin genomewid genet element chromatin featur associ activ transcript furthermor h3k122ac catalyz coactiv p300cbp induc nuclear hormon receptor signal collect suggest transcript regul elicit effect signal histon tail direct structur perturb nucleosom direct acetyl later surfac',\n",
       "  'ArticleTitle': 'Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.',\n",
       "  'Author': 'Tropberger Philipp'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Role for IGFBP7 in senescence induction by BRAF.',\n",
       "  'Author': 'Wajapeyee Narendra'},\n",
       " {'Abstract': ' mitochondri dysfunct common featur neurodegener age we identifi mitochondri dysfunct xeroderma pigmentosum group a xpa nucleotid excis dna repair disord sever neurodegener silico vivo xpadefici cell defect mitophagi excess cleavag pink1 increas mitochondri membran potenti the mitochondri abnorm appear caus decreas activ nadsirt1pgc1 axi trigger hyperactiv dna damag sensor parp1 this phenotyp rescu parp1 inhibit supplement nad precursor rescu lifespan defect xpa1 nematod import pathogenesi appear common ataxiatelangiectasia cockayn syndrom two dna repair disord neurodegener absent xpc dna repair disord neurodegener our find reveal nuclearmitochondri crosstalk critic mainten mitochondri health',\n",
       "  'ArticleTitle': 'Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction.',\n",
       "  'Author': 'Fang Evandro Fei'},\n",
       " {'Abstract': ' in cancer cell genet alter activ protooncogen contribut tumorigenesi howev protein product oncogen overexpress alter protooncogen help explain phenomenon compar similar prolifer nontransform cell line cancer cell line express substanti amount mrna isoform shorter 3 untransl region utr these shorter isoform result altern cleavag polyadenyl apa the apa function consequ shorter mrna isoform exhibit increas stabil typic produc tenfold protein part loss micrornamedi repress moreov express shorter mrna isoform protooncogen igf2bp1imp1 led far oncogen transform express fulllength annot mrna the high incid apa cancer cell consequ loss 3utr repress element suggest pervas role apa oncogen activ genet alter',\n",
       "  'ArticleTitle': \"Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.\",\n",
       "  'Author': 'Mayr Christine'},\n",
       " {'Abstract': ' the glucocorticoid receptor gr eukaryot transcript factor regul gene express interact chromatin dna respons element photobleach experi live cell indic receptor transient interact dna time scale second predict respons element spars occupi averag here bind one receptor glucocorticoid respons element gre reduc steadyst bind receptor variant gre mathemat simul reproduc noncompetit state short grgre resid time relat long time dna bind event at genom site gr bind caus increas chromatin access concurr steadyst bind level variant receptor actual increas phenomenon term assist load tempor spars transcript factordna interact induc local chromatin reorgan result transient access bind secondari regulatori factor',\n",
       "  'ArticleTitle': 'Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.',\n",
       "  'Author': 'Voss Ty C'},\n",
       " {'Abstract': ' the heterodimer tumorsuppressor complex brca1bard1 exhibit e3 ubiquitin ligas activ particip cell prolifer chromosom stabil control incomplet defin mechan here mammalian cell xenopus egg extract brca1bard1 requir mitot spindlepol assembl accumul tpx2 major spindl organ ran target spindl pole this function centrosom independ oper downstream ran gtpase depend brca1bard1 e3 ubiquitin ligas activ xenopus brca1bard1 form endogen complex three spindlepol protein tpx2 numa xrhamma known tpx2 partnerand attenu xrhamm function these observ reveal unrecogn function brca1bard1 mitot spindl assembl like contribut role chromosom stabil control tumor suppress',\n",
       "  'ArticleTitle': 'The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.',\n",
       "  'Author': 'Joukov Vladimir'},\n",
       " {'Abstract': ' optic imag dynam live specimen involv tradeoff spatial resolut tempor resolut phototox difficult three dimens here report rapid threedimension 3d dynam diffract limit thick dens fluoresc live specimen time point combin ultrathin planar illumin produc scan bessel beam superresolut structur illumin microscopi we demonstr vivo karyotyp chromosom mitosi identifi differ dynam actin cytoskeleton dorsal ventral surfac fibroblast compar spin disk confoc microscopi demonstr reduc photodamag imag rapid morpholog chang d discoideum cell well improv contrast resolut depth develop c elegan embryo bessel beam structur plane illumin promis new insight complex biolog phenomena requir 4d subcellular spatiotempor detail singl multicellular context',\n",
       "  'ArticleTitle': 'Noninvasive imaging beyond the diffraction limit of 3D dynamics in thickly fluorescent specimens.',\n",
       "  'Author': 'Gao Liang'},\n",
       " {'Abstract': ' wnt growth factor fundament regul cell fate wnt signal translat biolog respons incomplet understood here report taz biolog potent transcript coactiv serv downstream element wntcatenin cascad this function taz independ wellestablish role mediat hippo signal in absenc wnt activ compon catenin destruct complexapc axin gsk3are requir taz low level taz degrad depend phosphoryl catenin bridg taz ubiquitin ligas trcp upon wnt signal escap catenin destruct complex impair taz degrad lead concomit accumul catenin taz at genomewid level substanti portion wnt transcript respons mediat taz taz activ general featur wnt signal function relev mediat wnt biolog effect',\n",
       "  'ArticleTitle': 'Role of TAZ as mediator of Wnt signaling.',\n",
       "  'Author': 'Azzolin Luca'},\n",
       " {'Abstract': ' tgfbeta signal essenti develop prolif homeostasi dure embryogenesi matern determin act concert tgfbeta signal form mesoderm endoderm in contrast ectoderm specif requir tgfbeta respons attenu mechan achiev remain unknown in function screen ectoderm determin identifi ectodermin ecto in xenopus embryo ecto essenti specif ectoderm act restrict mesoderminduc activ tgfbeta signal mesoderm favor neural induct ecto ringtyp ubiquitin ligas smad4 tgfbeta signal transduc deplet ecto human cell enforc tgfbetainduc cytostasi play causal role limit antimitogen effect smad4 tumor cell we propos ectodermin key switch control tgfbeta gene respons earli embryon develop cell prolifer',\n",
       "  'ArticleTitle': 'Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase.',\n",
       "  'Author': 'Dupont Sirio'},\n",
       " {'Abstract': ' antigen ag crosspresent dendrit cell dcs involv present intern ag mhc class i molecul initi cd8 t cellmedi immun respons certain pathogen tumor cell here identifi snare sec22b specif regul ag crosspresent sec22b local ergolgi intermedi compart ergic pair plasma membran snare syntaxin 4 phagosom phgs deplet sec22b inhibit recruit erresid protein phgs vacuol contain toxoplasma gondii parasit in sec22bdefici dcs crosspresent compromis ag phagocytosi endocytosi invas t gondii sec22b silenc inhibit ag export cytosol increas phagosom degrad acceler lysosom recruit our find provid insight intracellular traffic pathway requir crosspresent sec22bdepend recruit er protein phgs critic influenc phagosom function dcs',\n",
       "  'ArticleTitle': 'Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells.',\n",
       "  'Author': 'Cebrian Ignacio'},\n",
       " {'Abstract': ' protein kinas control cellular decis process phosphoryl specif substrat thousand vivo phosphoryl site identifi proteomewid map howev systemat match site specif kinas infeas limit specif consensus motif influenc contextu factor protein scaffold local express cellular substrat specif we develop approach networkin augment motifbas predict network context kinas phosphoprotein the provid 6080 comput capabl assign vivo substrat specif networkin pinpoint kinas respons specif phosphoryl yield 25fold improv accuraci phosphoryl network construct appli approach dna damag signal 53bp1 rad50 phosphoryl cdk1 atm respect we describ scalabl strategi evalu predict suggest bclaf1 gsk3 substrat',\n",
       "  'ArticleTitle': 'Systematic discovery of in vivo phosphorylation networks.',\n",
       "  'Author': 'Linding Rune'},\n",
       " {'Abstract': ' the transmiss agent caus canin transmiss vener tumor ctvt thought tumor cell to test hypothesi analyz genet marker includ major histocompat mhc gene microsatellit mitochondri dna mtdna natur occur tumor match blood sampl in case tumor genet distinct host moreov tumor collect 40 dog 5 contin deriv singl neoplast clone diverg two subclad phylogenet analys indic ctvt like origin wolf east asian breed dog 200 2500 year ago although ctvt high aneuploid remark stabl genotyp dure progress growth ctvt downmodul mhc antigen express our find implic understand genom instabl cancer natur transplant allograft capac somat cell evolv transmiss parasit',\n",
       "  'ArticleTitle': 'Clonal origin and evolution of a transmissible cancer.',\n",
       "  'Author': 'Murgia Claudio'},\n",
       " {'Abstract': ' telomeras activ critic normal transform human cell escap crisi implic oncogenesi here describ novel pin2trf1 bind protein pinx1 inhibit telomeras activ affect tumorigen pinx1 small tid domain bind telomeras catalyt subunit htert potent inhibit activ overexpress pinx1 tid domain inhibit telomeras activ shorten telomer induc crisi deplet endogen pinx1 increas telomeras activ elong telomer deplet pinx1 increas tumorigen nude mice consist chromosom local 8p23 region frequent loss heterozygos number human cancer thus pinx1 potent telomeras inhibitor putat tumor suppressor',\n",
       "  'ArticleTitle': 'The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor.',\n",
       "  'Author': 'Zhou X Z'},\n",
       " {'Abstract': ' ciliogenesi preced lineagedetermin signal skin develop to understand perform shrnamedi knockdown seven intraflagellar transport protein ift condit ablat ift88 kif3a embryogenesi in cultur keratinocyt embryon epidermi elimin cilia kif3a caus hyperprolifer surpris independ prolifer ciliari mutant display defect notch signal commit progenitor differenti notch receptor notchprocess enzym coloc cilia wildtyp epiderm cell moreov differenti defect ciliari mutant cell autonom rescu activ notch nicd by contrast shh signal oper requir epiderm ciliogenesi notch signal differenti rather shh signal defect ciliari mutant occur later arrest hair follicl morphogenesi skin these find unveil tempor spatial distinct function primari cilia nexus signal prolifer differenti',\n",
       "  'ArticleTitle': 'A role for the primary cilium in Notch signaling and epidermal differentiation during skin development.',\n",
       "  'Author': 'Ezratty Ellen J'},\n",
       " {'Abstract': ' in contrast animalbas mutant phenotyp assay recent biochem quantit genet studi identifi hundr potenti regul known signal pathway we discuss discrep previous model new data put forward differ signal conceptu framework incorpor timedepend quantit contribut suggest new framework impact studi human diseas',\n",
       "  'ArticleTitle': 'Genetic screening for signal transduction in the era of network biology.',\n",
       "  'Author': 'Friedman Adam'},\n",
       " {'Abstract': ' nih prepar announc plan pilot phase propos human cancer genom project this initi seek provid complet list mutat rise cancer',\n",
       "  'ArticleTitle': 'Going on a cancer gene hunt.',\n",
       "  'Author': 'Bonetta Laura'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Obituary: Janet Davison Rowley 1925-2013.',\n",
       "  'Author': 'Olopade Olufunmilayo I'},\n",
       " {'Abstract': ' pathway govern stem cell sc function subvert cancer here report isol near puriti human normal mammari scs hnmscs cultur mammospher basi abil retain lipophil dye pkh26 consequ quiescent natur pkh26posit cell possess characterist hnmscs the transcript profil pkh26posit cell hnmsc signatur abl predict biolog molecular featur breast cancer by marker hnmsc signatur prospect isol scs normal gland breast tumor poor differenti g3 cancer display higher content prospect isol cancer scs cscs welldifferenti g1 cancer by compar g3 g1 tumor xenotransplant experi direct demonstr g3s enrich cscs our data support notion heterogen phenotyp molecular trait human breast cancer function csc content',\n",
       "  'ArticleTitle': 'Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.',\n",
       "  'Author': 'Pece Salvatore'},\n",
       " {'Abstract': ' the poudomain transcript factor oct4 express pluripot cell mammalian embryo in addit germcel tumor somat tumor detect express oct4 while oct4 role preimplant develop maintain embryon cell pluripot state littl known potenti oncogen properti here effect ectop oct4 express somat tissu adult mice doxycyclinedepend express system activ oct4 result dysplast growth epitheli tissu depend continu oct4 express dysplast lesion expans progenitor cell increas betacatenin transcript activ in intestin oct4 express caus dysplasia inhibit cellular differenti manner similar embryon cell these data certain adult progenitor remain compet interpret key embryon signal support notion progenitor cell drive forc tumorigenesi',\n",
       "  'ArticleTitle': 'Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.',\n",
       "  'Author': 'Hochedlinger Konrad'},\n",
       " {'Abstract': ' the let7 tumor suppressor microrna known regul oncogen rnabind protein lin28ab promot malign inhibit let7 biogenesi we uncov unexpect role lin28let7 pathway regul metabol when overexpress mice lin28a lin28b promot insulinsensit state resist highfatdiet induc diabet convers musclespecif loss lin28a overexpress let7 result insulin resist impair glucos toler these phenomena occur part let7medi repress multipl compon insulinpi3kmtor pathway includ igf1r insr irs2 in addit mtor inhibitor rapamycin abrog lin28amedi insulin sensit enhanc glucos uptak moreov let7 target enrich gene contain snps associ 2 diabet control fast glucos human genomewid associ studi these data establish lin28let7 pathway central regul mammalian glucos metabol',\n",
       "  'ArticleTitle': 'The Lin28/let-7 axis regulates glucose metabolism.',\n",
       "  'Author': 'Zhu Hao'},\n",
       " {'Abstract': ' in cancer foxo famili transcript factor function tumor suppressor direct inactiv oncogen signal pi3kakt pathway now skyke al 2011 identifi paradox requir foxo mainten leukemiainiti cell',\n",
       "  'ArticleTitle': 'A new FOXO pathway required for leukemogenesis.',\n",
       "  'Author': 'Downing James R'},\n",
       " {'Abstract': ' foxo forkhead transcript factor act signal transduc confluenc smad pi3k foxg1 pathway smad protein activ tgfbeta form complex foxo protein turn growth inhibitori gene p21cip1 this process negat control pi3k pathway known inhibitor foxo local nucleus telencephal develop factor foxg1 bind foxosmad complex block p21cip1 express we suggest activ network confer resist tgfbetamedi cytostasi develop telencephal neuroepithelium glioblastoma brain tumor cell',\n",
       "  'ArticleTitle': 'Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.',\n",
       "  'Author': 'Seoane Joan'},\n",
       " {'Abstract': ' the cjun nh2termin kinas jnk signal pathway implic develop tumor necrosi factor tnfdepend hepat jnk play critic role hepatocyt tnfstimul cell death vivo to test hypothesi examin phenotyp mice compound disrupt jnk1 jnk2 gene mice loss jnk12 express hepatocyt exhibit defect develop hepat compar control mice mice loss jnk12 hematopoiet compart exhibit profound defect hepat associ mark reduc express tnfalpha these data indic jnk requir tnfalpha express tnfalphastimul death hepatocyt inde tnfalpha induc similar hepat damag mice hepatocytespecif jnk12 defici control mice these observ confirm role jnk develop hepat identifi hematopoiet cell site essenti function jnk',\n",
       "  'ArticleTitle': 'Induction of hepatitis by JNK-mediated expression of TNF-alpha.',\n",
       "  'Author': 'Das Madhumita'},\n",
       " {'Abstract': ' caveolin play essenti role format characterist surfac pit caveola cover surfac anim cell the fundament principl caveola format slowli emerg here caveolin express prokaryot host lack intracellular membran system drive format cytoplasm vesicl contain polymer caveolin vesicl format induc express wildtyp caveolin caveolin mutant defect caveola format mammalian system in addit cryoelectron tomographi induc membran domain equival size caveolin densiti nativ caveola reveal possibl polyhedr arrang caveolin oligom the caveolininduc vesicl heterolog caveola hcaveola form bud cytoplasm membran generat membran domain distinct lipid composit periplasm solut encapsul bud hcaveola purifi hcaveola tailor target specif cell interest',\n",
       "  'ArticleTitle': 'Constitutive formation of caveolae in a bacterium.',\n",
       "  'Author': 'Walser Piers J'},\n",
       " {'Abstract': ' telomer synthesi cancer cell stem cell involv traffick telomeras cajal bodi telomeras thought recruit telomer interact telomerebind protein here obfold domain telomerebind protein tpp1 recruit telomeras telomer associ telomeras revers transcriptas tert when tether away telomer telomerebind protein tpp1 obfold domain suffici recruit telomeras heterolog chromatin locus express minim tpp1 obfold inhibit telomer mainten block access telomeras cognat bind site telomer we identifi amino acid requir tpp1telomeras interact includ specif loop residu tpp1 obfold domain individu residu tert mutat subset pulmonari fibrosi patient these data defin potenti interfac telomerasetpp1 interact requir telomer mainten implic defect telomeras recruit telomeraserel diseas',\n",
       "  'ArticleTitle': 'TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends.',\n",
       "  'Author': 'Zhong Franklin L'},\n",
       " {'Abstract': ' the archetyp human tumor suppressor p53 consid uniqu transactiv properti the assumpt base fact addit identifi human p53 isoform lack transcript activ howev provid evid exist altern splice p53 isoform deltap53 exert transcript activ independ p53 in contrast p53 deltap53 transactiv endogen p21 1433sigma mdm2 bax pig3 promot cell cycl studi deltap53 display differenti transcript activ damag s phase cell upon activ atrintra phase checkpoint deltap53 p53 transactiv cdk inhibitor p21 induct p21 result downregul cyclin acdk activ attenu s phase progress data demonstr deltap53p21cyclin acdk pathway crucial facilit uncoupl repair replic event indic deltap53 essenti element atrintra phase checkpoint',\n",
       "  'ArticleTitle': 'A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.',\n",
       "  'Author': 'Rohaly Gabor'},\n",
       " {'Abstract': ' activ p53 transcript factor respons varieti cellular stress includ dna damag oncogen activ initi program gene express block prolif expans damag cell while benefici impact anticanc function p53 well establish recent paper suggest p53 activ circumst act manner detriment longterm homeostasi organ here discuss signific particip p53 three nonmutu exclus theori human age involv dna damag telomer shorten oxid stress these good copbad cop function p53 appear place nexus two oppos forc cancer age by extens relationship impli therapi aim reduc cancer postpon age increas longev work upstream downstream level p53',\n",
       "  'ArticleTitle': 'p53: good cop/bad cop.',\n",
       "  'Author': 'Sharpless Norman E'},\n",
       " {'Abstract': ' dure gastrul amphibian embryo specif three germ layer endo ecto mesoderm regul matern zygot mechan although known mesoderm specif requir cooper tgfbeta signal p53 activ requir matern factor essenti zygot factor elus here report znfinger protein xfdl156 ectoderm zygot factor suppress mesoderm differenti xfdl156 overexpress suppress mesoderm marker deplet induc aberr mesoderm differenti presumpt ectoderm furthermor xfdl156 mammalian homolog interact ctermin regulatori region p53 inhibit p53 target gene induct mesoderm differenti thus xfdl156 activ restrict mesoderm differenti presumpt ectoderm control spatiotempor respons p53',\n",
       "  'ArticleTitle': 'Ectodermal factor restricts mesoderm differentiation by inhibiting p53.',\n",
       "  'Author': 'Sasai Noriaki'},\n",
       " {'Abstract': ' investig famili tree tumor identifi cellular origin daunt task liu al 2011 eleg lineag trace techniqu madm visual glioma earliest stage they mutat origin induc neural stem cell lie dormant trigger malign transform follow differenti oligodendrocyt precursor cell',\n",
       "  'ArticleTitle': 'Glioma development: where did it all go wrong?',\n",
       "  'Author': 'Sukhdeo Kumar'},\n",
       " {'Abstract': ' mani lipidteth protein glycolipid exist monom nanoclust surfac live cell the spatial distribut dynam format breakup nanoclust reflect thermal chemic equilibrium control activ remodel under cortic actin we propos model nanoclust base activ hydrodynam cell surfac molecul bound dynam actin activ driven form transient cluster this consist explain experiment observ use fcs tirf microscopi provid evid exist short dynam polymer actin filament cortex key assumpt theoret framework our theori predict lipidanchor protein interact dynam actin exhibit anomal concentr fluctuat cell membran protein capabl bind direct actin form nanoclust these confirm experiment provid activ mechan molecular organ spatiotempor regul plasma membran',\n",
       "  'ArticleTitle': 'Active remodeling of cortical actin regulates spatiotemporal organization of cell surface molecules.',\n",
       "  'Author': 'Gowrishankar Kripa'},\n",
       " {'Abstract': ' we identifi angiogenesi inhibitor angiostatin use similar strategi identifi endostatin angiogenesi inhibitor produc hemangioendothelioma endostatin 20 kda ctermin fragment collagen xviii endostatin inhibit endotheli prolifer potent inhibit angiogenesi tumor growth by novel method sustain releas e colideriv endostatin administ nonrefold suspens primari tumor regress dormant microscop lesion immunohistochemistri reveal block angiogenesi accompani high prolifer balanc apoptosi tumor cell there toxic togeth angiostatin data find valid strategi identifi endogen angiogenesi inhibitor suggest theme fragment protein angiogenesi inhibitor demonstr dormanc therapi',\n",
       "  'ArticleTitle': 'Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.',\n",
       "  'Author': \"O'Reilly M S\"},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Nanotechnologists seek biological niches.',\n",
       "  'Author': 'Amato Ivan'},\n",
       " {'Abstract': ' the alzheim diseaselink gene presenilin requir intramembran proteolysi amyloid precursor protein contribut pathogenesi neurodegener character loss neuron connect role presenilin establish neuron connect less clear through forward genet screen mice recess gene affect motor neuron identifi columbus allel disrupt motor axon project spinal cord we map mutat presenilin1 gene motor neuron commissur interneuron columbus mutant lack presenilin1 acquir inappropri attract netrin produc floor plate accumul dcc receptor fragment membran insensit slitrobo silenc our find reveal presenilindepend dcc receptor process coordin interplay netrindcc slitrobo signal thus presenilin key neural circuit builder gate spatiotempor pattern guidanc signal ensur neural project occur high fidel',\n",
       "  'ArticleTitle': 'Presenilin-dependent receptor processing is required for axon guidance.',\n",
       "  'Author': 'Bai Ge'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Tumor suppressing pathways.',\n",
       "  'Author': 'White R L'},\n",
       " {'Abstract': ' autism spectrum disord asd group genet disord overlap neurolog condit we describ abnorm branchedchain amino acid bcaa catabol pathway caus asd here solut carrier transport 7a5 slc7a5 larg neutral amino acid transport local blood brain barrier bbb essenti role maintain normal level brain bcaa in mice delet slc7a5 endotheli cell bbb lead atyp brain amino acid profil abnorm mrna translat sever neurolog abnorm furthermor identifi patient autist trait motor delay carri deleteri homozyg mutat slc7a5 gene final demonstr bcaa intracerebroventricular administr amelior abnorm behavior adult mutant mice our data elucid neurolog syndrom defin slc7a5 mutat support essenti role bcaa human brain function',\n",
       "  'ArticleTitle': 'Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.',\n",
       "  'Author': u'T\\u0103rlungeanu Dora C'},\n",
       " {'Abstract': ' cellularst inform generat develop cell propag regulatori region we report consist pattern gain loss dnase ihypersensit site dhss cell progress embryon stem cell esc termin fate dhs pattern convey rich inform cell fate lineag relationship distinct inform convey gene express develop cell share proport dhs landscap esc proport decreas continu cell differenti progress provid quantit benchmark development matur development stabl dhss dens encod bind site transcript factor involv autoregulatori feedback circuit in contrast normal cell cancer cell extens reactiv silenc esc dhss development program extern cell lineag malign deriv our result point chang regulatori dna landscap quantit indic cellfat transit lineag relationship dysfunct',\n",
       "  'ArticleTitle': 'Developmental fate and cellular maturity encoded in human regulatory DNA landscapes.',\n",
       "  'Author': 'Stergachis Andrew B'},\n",
       " {'Abstract': ' overexpress brf1 transcript factor rna polymeras iii apparatus transform cell vitro caus tumor format vivo marshal al 2008 one transcript product rna polymeras iii initi trnamet mediat effect reveal unexpect role trna tumorigenesi',\n",
       "  'ArticleTitle': 'A tRNA with oncogenic capacity.',\n",
       "  'Author': 'Berns Anton'},\n",
       " {'Abstract': ' fbox protein substrat bind subunit scf skp1cul1fbox protein ubiquitin ligas complex use affin purif mass spectrometri identifi rrm2 ribonucleotid reductas famili member 2 interactor fbox protein cyclin f ribonucleotid reductas rnr catalyz convers ribonucleotid deoxyribonucleotid dntps necessari replic repair dna synthesi we g2 follow cdkmediat phosphoryl thr33 rrm2 degrad scfcyclin f maintain balanc dntp pool genom stabil after dna damag cyclin f downregul atrdepend manner allow accumul rrm2 defect elimin cyclin f delay dna repair sensit cell dna damag phenotyp revert express nondegrad rrm2 mutant in summari identifi biochem pathway control abund dntps ensur effici dna repair respons genotox stress',\n",
       "  'ArticleTitle': 'Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.',\n",
       "  'Author': \"D'Angiolella Vincenzo\"},\n",
       " {'Abstract': ' dure metastasi migrat breast cancer stem cell undergo loss polar lead epithelialtomesenchym transit emt gupta al 2009 attribut cancer stem cell develop highthroughput screen success identifi small molecul inhibit cancer stem cell prolifer induct differenti',\n",
       "  'ArticleTitle': 'Breast cancer stem cells: eradication by differentiation therapy?',\n",
       "  'Author': 'Beug Hartmut'},\n",
       " {'Abstract': ' pten tumor suppressor sequenc homolog protein tyrosin phosphatas cytoskelet protein tensin mptenmut mous embryo display region increas prolifer in contrast mptendefici immort mous embryon fibroblast exhibit decreas sensit cell death respons number apoptot stimuli accompani constitut elev activ phosphoryl protein kinas bakt crucial regul cell surviv express exogen pten mutant cell restor sensit agonistinduc apoptosi normal pattern pkbakt phosphoryl furthermor pten negat regul intracellular level phosphatidylinositol 345 trisphosph cell dephosphoryl vitro our result pten exert role tumor suppressor negat regul pi3kpkbakt signal pathway',\n",
       "  'ArticleTitle': 'Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.',\n",
       "  'Author': 'Stambolic V'},\n",
       " {'Abstract': ' the wnt pathway control cell fate tissu homeostasi cancer it activ entail associ betacatenin nuclear tcflef protein result transcript activ target gene the mechan nuclear betacatenin control transcript larg unknown here genet identifi novel wntwg pathway compon mediat transcript output betacateninarmadillo we drosophila hyrax human ortholog parafibromin compon polymeraseassoci factor 1 paf1 complex requir nuclear transduct wntwg signal bind direct ctermin region betacateninarmadillo moreov transactiv potenti parafibrominhyrax depend recruit pygopus betacateninarmadillo our result assign tumor suppressor parafibromin unexpect role wnt signal provid molecular mechan wnt target gene control nuclear wnt signal complex direct engag paf1 complex control transcript initi elong rna polymeras ii',\n",
       "  'ArticleTitle': 'Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.',\n",
       "  'Author': 'Mosimann Christian'},\n",
       " {'Abstract': ' wt1 encod zinc finger transcript factor implic kidney differenti tumorigenesi in report assay wt1 repress transcript gc tcrich promot physiolog target remain uncertain we hybrid highdens oligonucleotid array search nativ gene express alter follow induc express wt1 the major target wt1 amphiregulin member epiderm growth factor famili the wt1kts isoform bind direct amphiregulin promot result potent transcript activ the vivo express profil amphiregulin fetal kidney develop mirror high specif pattern wt1 recombin amphiregulin stimul epitheli branch organ cultur embryon mous kidney these observ suggest model wt1 transcript regul kidney differenti',\n",
       "  'ArticleTitle': 'The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.',\n",
       "  'Author': 'Lee S B'},\n",
       " {'Abstract': ' smac mimet induc apoptosi synergist tnfalpha trigger format caspase8activ complex contain receptor interact protein kinase1 ripk1 caspas inhibitor block form apoptosi type cell howev cell line caspas inhibitor switch apoptot respons necrosi a genom wide sirna screen reveal member rip kinas famili rip3 requir necrosi the express rip3 differ cell line correl respons necrosi induct the kinas activ rip3 essenti necrosi execut upon induct necrosi rip3 recruit ripk1 form necrosisinduc complex embryon fibroblast rip3 knockout mice resist necrosi rip3 knockout anim devoid inflamm inflict tissu damag acut pancreat model these data indic rip3 determin cellular necrosi respons tnfalpha famili deathinduc cytokin',\n",
       "  'ArticleTitle': 'Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.',\n",
       "  'Author': 'He Sudan'},\n",
       " {'Abstract': ' dure develop regener prolifer tissuespecif stem cell tight control produc organ predetermin size the molecular determin process remain poor understood here function yap1 transcript effector hippo signal pathway skin biolog use gain lossoffunct studi yap1 critic modul epiderm stem cell prolifer tissu expans yap1 mediat effect interact tead transcript factor addit studi reveal catenin molecul implic tumor suppress cell densiti sens skin upstream negat regul yap1 catenin control yap1 activ phosphoryl modul interact 1433 pp2a phosphatas togeth data identifi yap1 determin prolif capac epiderm stem cell effector crowd control molecular circuitri mammalian skin',\n",
       "  'ArticleTitle': u'Yap1 acts downstream of \\u03b1-catenin to control epidermal proliferation.',\n",
       "  'Author': 'Schlegelmilch Karin'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Lonely no more: p53 finds its kin in a tumor suppressor haven.',\n",
       "  'Author': 'Oren M'},\n",
       " {'Abstract': ' the tradit view p53 activ includ three stepsp53 stabil dna bind transcript activ howev recent studi indic step p53 activ complex origin anticip moreov genet studi mice vitro studi purifi compon suggest classic model suffici explain aspect p53 activ vivo to reconcil differ propos antirepress releas p53 repress factor mdm2 mdmx key step physiolog activ p53',\n",
       "  'ArticleTitle': 'Modes of p53 regulation.',\n",
       "  'Author': 'Kruse Jan-Philipp'},\n",
       " {'Abstract': ' dna palindrom coloc cancer cell chromosom region predispos gene amplif the molecular mechan palindrom caus gene amplif larg unknown use yeast model system hairpincap doublestrand break dsbs occur locat human aluquasipalindrom lead format intrachromosom amplicon larg invert repeat equival homogen stain region mammalian chromosom extrachromosom palindrom molecul equival doubl minut dm mammalian cell we demonstr specif outcom gene amplif appli select natur break chromosom locat amplifi gene relat site hairpincap dsb the rule palindromedepend pathway gene amplif defin yeast oper format amplicon human tumor',\n",
       "  'ArticleTitle': 'The pattern of gene amplification is determined by the chromosomal location of hairpin-capped breaks.',\n",
       "  'Author': 'Narayanan Vidhya'},\n",
       " {'Abstract': ' assembl eif4eeif4g complex central role regul gene express level translat initi this complex regul 4ebp compet eif4g bind eif4 tumorsuppressor activ to pharmacolog mimic 4ebp function develop highthroughput screen assay identifi smallmolecul inhibitor eif4eeif4g interact the potent compound identifi 4egi1 bind eif4 disrupt eif4eeif4g associ inhibit capdepend translat initi factorindepend translat while 4egi1 displac eif4g eif4 effect enhanc 4ebp1 associ vitro cell 4egi1 inhibit cellular express oncogen protein encod weak mrnas exhibit activ multipl cancer cell line appear preferenti effect transform versus nontransform cell the identif compound provid new tool studi translat control establish possibl new strategi cancer therapi',\n",
       "  'ArticleTitle': 'Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.',\n",
       "  'Author': 'Moerke Nathan J'},\n",
       " {'Abstract': ' tumor cell frequent display abnorm number chromosom phenomenon known aneuploidi tang al 2011 aneuploid cell sensit compound induc proteotox energi stress could vulner lead new cancer therapi',\n",
       "  'ArticleTitle': 'Targeting aneuploidy for cancer therapy.',\n",
       "  'Author': 'Manchado Eusebio'},\n",
       " {'Abstract': ' littl known neutrophil cell establish singl zone actin assembl migrat a widespread assumpt lead edg prevent format addit front generat longrang diffus inhibitor sequest essenti polar compon we morpholog perturb cellsev experi comput simul diffusionbas mechan suffici longrang inhibit pseudopod instead plasma membran tension serv longrang inhibitor neutrophil we membran tension doubl leadingedg protrus increas tension suffici longrang inhibit actin assembl rac activ furthermor reduc membran tension caus uniform actin assembl we suggest tension diffus molecul generat sequest lead edg domin sourc longrang inhibit constrain spread exist front prevent format secondari front',\n",
       "  'ArticleTitle': 'Membrane tension maintains cell polarity by confining signals to the leading edge during neutrophil migration.',\n",
       "  'Author': 'Houk Andrew R'},\n",
       " {'Abstract': ' higherord chromosom organ transcript regul poor understood eukaryot use genomewid chromatin interact analysi pairedendtag sequenc chiapet map longrang chromatin interact associ rna polymeras ii human cell uncov widespread promotercent intragen extragen intergen interact these interact aggreg higherord cluster proxim distal gene engag promoterpromot interact most gene promoterpromot interact activ transcrib cooper interact promot influenc impli combinatori complex transcript control compar analys differ cell line cellspecif chromatin interact provid structur framework cellspecif transcript suggest signific enrich enhancerpromot interact cellspecif function furthermor geneticallyidentifi diseaseassoci noncod element spatial engag correspond gene longrang interact overal studi provid insight transcript regul threedimension chromatin interact housekeep cellspecif gene human cell',\n",
       "  'ArticleTitle': 'Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation.',\n",
       "  'Author': 'Li Guoliang'},\n",
       " {'Abstract': ' the receptorinteract serinethreonin kinas 3 rip3 key signal molecul program necrosi necroptosi pathway this pathway play role varieti physiolog patholog condit includ develop tissu damag respons antivir immun here report identif small molecul call en4n3methoxypyrazin2ylsulfamoylphenyl35nitrothiophene2ylacrylamidehereaft refer necrosulfonamidethat block necrosi downstream rip3 activ an affin probe deriv necrosulfonamid coimmunoprecipit antirip3 antibodi identifi mix lineag kinas domainlik protein mlkl interact target mlkl phosphoryl rip3 threonin 357 serin 358 residu phosphoryl event critic necrosi treat cell necrosulfonamid knock mlkl express arrest necrosi specif step rip3 form discret puncta cell these find implic mlkl key mediat necrosi signal downstream kinas rip3',\n",
       "  'ArticleTitle': 'Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.',\n",
       "  'Author': 'Sun Liming'},\n",
       " {'Abstract': ' the heterogen instabl human tumor hamper straightforward identif cancercaus mutat genom approach herein describ mous model liver cancer initi progenitor cell harbor defin cancerpredispos lesion genomewid analys tumor mous model human hepatocellular carcinoma reveal recurr amplif mous chromosom 9qa1 synten region human chromosom 11q22 geneexpress analys delin ciap1 known inhibitor apoptosi yap transcript factor candid oncogen amplicon in genet context amplif ciap1 yap acceler tumorigenesi requir sustain rapid growth ampliconcontain tumor furthermor ciap1 yap cooper promot tumorigenesi our result establish tractabl model liver cancer identifi two oncogen cooper virtu coamplif genom locus suggest effici strategi annot human cancer gene',\n",
       "  'ArticleTitle': 'Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.',\n",
       "  'Author': 'Zender Lars'},\n",
       " {'Abstract': ' microrna mirna govern expand number biolog diseas process understand mechan mirna pathway regul repres area investig we determin human mirnagener complex compris dicer phosphotrbp isoform phosphoryl trbp mediat mitogenactiv protein kinas mapk erk express phosphomim trbp trbp phosphoryl enhanc mirna product increas stabil mirnagener complex mitogen signal respons serum tumor promot pma depend trbp phosphoryl these effect accompani coordin increas level growthpromot mirna reduc express let7 tumor suppressor mirna convers pharmacolog inhibit mapkerk result antigrowth mirna profil taken studi indic mapkerk pathway regul mirna machineri suggest general principl signal system target mirna pathway achiev biolog respons',\n",
       "  'ArticleTitle': 'Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling.',\n",
       "  'Author': 'Paroo Zain'},\n",
       " {'Abstract': ' the ink4a gene encod two distinct growth inhibitorsth cyclindepend kinas inhibitor p16ink4a compon rb pathway tumor suppressor p19arf function link p53 here p19arf potent suppress oncogen transform primari cell function abrog p53 neutral viral oncoprotein dominantneg mutant p53 antagonist mdm2 this find coupl observ p19arf mdm2 physic interact p19rrf block mdm2induc p53 degrad transactiv silenc suggest p19arf function mechanist prevent mdm2s neutral p53 togeth find ascrib ink4a potent tumor suppressor activ cooper action two protein product relat two central growth control pathway rb p53',\n",
       "  'ArticleTitle': \"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.\",\n",
       "  'Author': 'Pomerantz J'},\n",
       " {'Abstract': ' recent 1000 larg intergen noncod rnas lincrna report these rnas evolutionarili conserv mammalian genom presum function divers biolog process here report identif lincrna regul p53 one lincrna lincrnap21 serv repressor p53depend transcript respons inhibit lincrnap21 affect express hundr gene target enrich gene repress p53 the observ transcript repress lincrnap21 mediat physic associ hnrnpk this interact requir proper genom local hnrnpk repress gene regul p53 mediat apoptosi we propos model transcript factor activ lincrna serv key repressor physic associ repress complex modul local set activ gene',\n",
       "  'ArticleTitle': 'A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.',\n",
       "  'Author': 'Huarte Maite'},\n",
       " {'Abstract': ' the ink4aarf locus encod two unrel protein function tumor suppress p16ink4 bind inhibit activ cdk4 cdk6 arf arrest cell cycl p53depend manner we arf bind mdm2 promot rapid degrad mdm2 this interact mediat exon 1betaencod ntermin domain arf ctermin region mdm2 arfpromot mdm2 degrad associ mdm2 modif concurr p53 stabil accumul the function consequ arfregul p53 level mdm2 proteolysi evidenc abil ectop express arf restor p53impos g1 cell cycl arrest abrog mdm2 thus delet arfink4a locus simultan impair ink4acyclin dcdk4rb arfmdm2p53 pathway',\n",
       "  'ArticleTitle': 'ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.',\n",
       "  'Author': 'Zhang Y'},\n",
       " {'Abstract': '',\n",
       "  'ArticleTitle': 'Parsing Ink4a/Arf: \"pure\" p16-null mice.',\n",
       "  'Author': 'Sherr C J'}]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ablist"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#https://stackoverflow.com/questions/42002859/creating-a-tf-idf-matrix-python-3-6\n",
    "\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "corpus = [ab['Abstract'] for ab in ablist]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "def get_similarity_matrix(content_as_str):\n",
    "    tfidf_vectorizer = TfidfVectorizer()\n",
    "    tfidf_matrix = tfidf_vectorizer.fit_transform(content_as_str) #fit the vectorizer to synopses\n",
    "    similarity_matrix = cosine_similarity(tfidf_matrix)\n",
    "    return (similarity_matrix, tfidf_matrix)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "(similarity_matrix, tfidf_matrix) = get_similarity_matrix(corpus)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 8.19 s, sys: 186 ms, total: 8.38 s\n",
      "Wall time: 4.49 s\n"
     ]
    }
   ],
   "source": [
    "\n",
    "from sklearn.cluster import KMeans\n",
    "\n",
    "num_clusters = 5\n",
    "\n",
    "km = KMeans(n_clusters=num_clusters)\n",
    "\n",
    "%time km.fit(tfidf_matrix)\n",
    "\n",
    "clusters = km.labels_.tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from sklearn.externals import joblib\n",
    "\n",
    "#uncomment the below to save your model \n",
    "#since I've already run my model I am loading from the pickle\n",
    "\n",
    "joblib.dump(km,  'doc_cluster.pkl')\n",
    "\n",
    "km = joblib.load('doc_cluster.pkl')\n",
    "clusters = km.labels_.tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "cluster_list=[]\n",
    "for a in range(len(clusters)):\n",
    "    papers={}\n",
    "    papers['title']=ablist[a]['ArticleTitle']\n",
    "    papers['author']=ablist[a]['Author']\n",
    "    papers['cluster']=clusters[a]\n",
    "    cluster_list.append(papers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'author': 'McGranahan Nicholas',\n",
       "  'cluster': 0,\n",
       "  'title': 'Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.'},\n",
       " {'author': 'Chang Chih-Hao',\n",
       "  'cluster': 4,\n",
       "  'title': 'Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.'},\n",
       " {'author': 'Sturm Dominik',\n",
       "  'cluster': 4,\n",
       "  'title': 'New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.'},\n",
       " {'author': 'DiLillo David J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect.'},\n",
       " {'author': 'Overacre-Delgoffe Abigail E',\n",
       "  'cluster': 4,\n",
       "  'title': u'Interferon-\\u03b3 Drives T'},\n",
       " {'author': 'Zelenay Santiago',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.'},\n",
       " {'author': 'Grabocka Elda',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules.'},\n",
       " {'author': 'Boice Michael',\n",
       "  'cluster': 1,\n",
       "  'title': 'Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.'},\n",
       " {'author': 'Nirschl Christopher J',\n",
       "  'cluster': 4,\n",
       "  'title': u'IFN\\u03b3-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.'},\n",
       " {'author': 'Ganem Neil J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cytokinesis failure triggers hippo tumor suppressor pathway activation.'},\n",
       " {'author': 'Bruna Alejandra',\n",
       "  'cluster': 0,\n",
       "  'title': 'A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.'},\n",
       " {'author': 'Matei Irina',\n",
       "  'cluster': 4,\n",
       "  'title': 'Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis.'},\n",
       " {'author': 'Sukumar Madhusudhanan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Nutrient Competition: A New Axis of Tumor Immunosuppression.'},\n",
       " {'author': 'Antal Corina E',\n",
       "  'cluster': 1,\n",
       "  'title': \"Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.\"},\n",
       " {'author': 'Tang Zijian',\n",
       "  'cluster': 1,\n",
       "  'title': 'MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1.'},\n",
       " {'author': 'Roybal Kole T',\n",
       "  'cluster': 4,\n",
       "  'title': 'Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.'},\n",
       " {'author': 'Cubillos-Ruiz Juan R',\n",
       "  'cluster': 4,\n",
       "  'title': 'ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.'},\n",
       " {'author': 'Israelsen William J',\n",
       "  'cluster': 1,\n",
       "  'title': 'PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.'},\n",
       " {'author': 'Tape Christopher J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.'},\n",
       " {'author': 'Dive Caroline',\n",
       "  'cluster': 4,\n",
       "  'title': 'SnapShot: Circulating Tumor Cells.'},\n",
       " {'author': 'Aravanis Alexander M',\n",
       "  'cluster': 0,\n",
       "  'title': 'Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.'},\n",
       " {'author': u'Sebasti\\xe1n Carlos',\n",
       "  'cluster': 1,\n",
       "  'title': 'The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.'},\n",
       " {'author': u'Jim\\xe9nez-S\\xe1nchez Alejandro',\n",
       "  'cluster': 4,\n",
       "  'title': 'Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.'},\n",
       " {'author': 'Riaz Nadeem',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.'},\n",
       " {'author': 'Aceto Nicola',\n",
       "  'cluster': 4,\n",
       "  'title': 'Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.'},\n",
       " {'author': 'Guo Jessie Yanxiang',\n",
       "  'cluster': 3,\n",
       "  'title': 'Autophagy-mediated tumor promotion.'},\n",
       " {'author': 'Kravtsova-Ivantsiv Yelena',\n",
       "  'cluster': 1,\n",
       "  'title': u'KPC1-mediated ubiquitination and proteasomal processing of NF-\\u03baB1 p105 to p50 restricts tumor growth.'},\n",
       " {'author': 'Gao Jianjun',\n",
       "  'cluster': 0,\n",
       "  'title': u'Loss of IFN-\\u03b3 Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.'},\n",
       " {'author': 'Serrels Alan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity.'},\n",
       " {'author': 'Li Tongyuan',\n",
       "  'cluster': 3,\n",
       "  'title': 'Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.'},\n",
       " {'author': 'Puram Sidharth V',\n",
       "  'cluster': 4,\n",
       "  'title': 'Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.'},\n",
       " {'author': u'Lov\\xe9n Jakob',\n",
       "  'cluster': 1,\n",
       "  'title': 'Selective inhibition of tumor oncogenes by disruption of super-enhancers.'},\n",
       " {'author': 'Lin Charles Y',\n",
       "  'cluster': 1,\n",
       "  'title': 'Transcriptional amplification in tumor cells with elevated c-Myc.'},\n",
       " {'author': 'Kim Mi-Young',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor self-seeding by circulating cancer cells.'},\n",
       " {'author': 'Spitzer Matthew H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Systemic Immunity Is Required for Effective Cancer Immunotherapy.'},\n",
       " {'author': 'Dijkstra Krijn K',\n",
       "  'cluster': 4,\n",
       "  'title': 'Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.'},\n",
       " {'author': 'Azizi Elham',\n",
       "  'cluster': 4,\n",
       "  'title': 'Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.'},\n",
       " {'author': 'Ho Ping-Chih',\n",
       "  'cluster': 4,\n",
       "  'title': 'Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.'},\n",
       " {'author': 'Singer Meromit',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.'},\n",
       " {'author': 'Brady Colleen A',\n",
       "  'cluster': 3,\n",
       "  'title': 'Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.'},\n",
       " {'author': 'Han Yanmei',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.'},\n",
       " {'author': 'Sheng Wanqiang',\n",
       "  'cluster': 4,\n",
       "  'title': 'LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.'},\n",
       " {'author': 'Lujambio Amaia',\n",
       "  'cluster': 3,\n",
       "  'title': 'Non-cell-autonomous tumor suppression by p53.'},\n",
       " {'author': 'Johnston Amelia J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival.'},\n",
       " {'author': 'Wei Yongjie',\n",
       "  'cluster': 1,\n",
       "  'title': 'EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.'},\n",
       " {'author': 'Li Leanne',\n",
       "  'cluster': 1,\n",
       "  'title': 'Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion.'},\n",
       " {'author': 'Kleffel Sonja',\n",
       "  'cluster': 4,\n",
       "  'title': 'Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.'},\n",
       " {'author': 'Tschaharganeh Darjus F',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.'},\n",
       " {'author': u'B\\xf6ttcher Jan P',\n",
       "  'cluster': 4,\n",
       "  'title': 'NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.'},\n",
       " {'author': 'Chen Sidi',\n",
       "  'cluster': 4,\n",
       "  'title': 'Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.'},\n",
       " {'author': 'David Charles J',\n",
       "  'cluster': 1,\n",
       "  'title': u'TGF-\\u03b2 Tumor Suppression through a Lethal EMT.'},\n",
       " {'author': 'Geiger Roger',\n",
       "  'cluster': 1,\n",
       "  'title': 'L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.'},\n",
       " {'author': u'Suv\\xe0 Mario L',\n",
       "  'cluster': 4,\n",
       "  'title': 'Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.'},\n",
       " {'author': 'Lee Suk Hyung',\n",
       "  'cluster': 0,\n",
       "  'title': 'Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.'},\n",
       " {'author': 'Zhang Xiang H-F',\n",
       "  'cluster': 4,\n",
       "  'title': 'Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.'},\n",
       " {'author': 'Barrow Alexander D',\n",
       "  'cluster': 4,\n",
       "  'title': 'Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.'},\n",
       " {'author': 'Moroishi Toshiro',\n",
       "  'cluster': 4,\n",
       "  'title': 'The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.'},\n",
       " {'author': 'Shao Diane D',\n",
       "  'cluster': 1,\n",
       "  'title': 'KRAS and YAP1 converge to regulate EMT and tumor survival.'},\n",
       " {'author': 'Benci Joseph L',\n",
       "  'cluster': 0,\n",
       "  'title': 'Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.'},\n",
       " {'author': 'Chio Iok In Christine',\n",
       "  'cluster': 1,\n",
       "  'title': 'NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.'},\n",
       " {'author': 'Bais Carlos',\n",
       "  'cluster': 0,\n",
       "  'title': 'PlGF blockade does not inhibit angiogenesis during primary tumor growth.'},\n",
       " {'author': 'Xu Xun',\n",
       "  'cluster': 4,\n",
       "  'title': 'Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.'},\n",
       " {'author': 'Zhang Wen Cai',\n",
       "  'cluster': 4,\n",
       "  'title': 'Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.'},\n",
       " {'author': 'Qian Bin-Zhi',\n",
       "  'cluster': 4,\n",
       "  'title': 'Macrophage diversity enhances tumor progression and metastasis.'},\n",
       " {'author': 'Scherz-Shouval Ruth',\n",
       "  'cluster': 4,\n",
       "  'title': 'The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.'},\n",
       " {'author': 'Valastyan Scott',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor metastasis: molecular insights and evolving paradigms.'},\n",
       " {'author': 'Turajlic Samra',\n",
       "  'cluster': 2,\n",
       "  'title': 'Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.'},\n",
       " {'author': 'Leung Cheuk T',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor self-seeding: bidirectional flow of tumor cells.'},\n",
       " {'author': 'Cheng Lin',\n",
       "  'cluster': 4,\n",
       "  'title': 'Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.'},\n",
       " {'author': 'Cubillos-Ruiz Juan R',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.'},\n",
       " {'author': 'Pallasch Christian P',\n",
       "  'cluster': 4,\n",
       "  'title': 'Sensitizing protective tumor microenvironments to antibody-mediated therapy.'},\n",
       " {'author': 'Jain Rakesh K',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: Tumor angiogenesis.'},\n",
       " {'author': 'Goetz Jacky G',\n",
       "  'cluster': 4,\n",
       "  'title': 'Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.'},\n",
       " {'author': 'Lichtenberger Beate M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.'},\n",
       " {'author': 'Campbell Brittany B',\n",
       "  'cluster': 2,\n",
       "  'title': 'Comprehensive Analysis of Hypermutation in Human Cancer.'},\n",
       " {'author': 'Zhong Zhenyu',\n",
       "  'cluster': 4,\n",
       "  'title': 'Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment.'},\n",
       " {'author': 'Song Min Sup',\n",
       "  'cluster': 1,\n",
       "  'title': 'Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.'},\n",
       " {'author': 'Cho Seung Woo',\n",
       "  'cluster': 2,\n",
       "  'title': 'Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.'},\n",
       " {'author': 'Zhao Boyang',\n",
       "  'cluster': 0,\n",
       "  'title': 'Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution.'},\n",
       " {'author': 'Kessenbrock Kai',\n",
       "  'cluster': 4,\n",
       "  'title': 'Matrix metalloproteinases: regulators of the tumor microenvironment.'},\n",
       " {'author': 'Palmer Adam C',\n",
       "  'cluster': 0,\n",
       "  'title': 'Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy.'},\n",
       " {'author': 'Kastenhuber Edward R',\n",
       "  'cluster': 3,\n",
       "  'title': 'Putting p53 in Context.'},\n",
       " {'author': u'Martincorena I\\xf1igo',\n",
       "  'cluster': 2,\n",
       "  'title': 'Universal Patterns of Selection in Cancer and Somatic Tissues.'},\n",
       " {'author': 'Bautch Victoria L',\n",
       "  'cluster': 4,\n",
       "  'title': 'Endothelial cells form a phalanx to block tumor metastasis.'},\n",
       " {'author': 'Mazzone Massimiliano',\n",
       "  'cluster': 4,\n",
       "  'title': 'Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.'},\n",
       " {'author': 'Gee Marvin H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes.'},\n",
       " {'author': 'Su Rui',\n",
       "  'cluster': 1,\n",
       "  'title': 'R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m'},\n",
       " {'author': 'Lavin Yonit',\n",
       "  'cluster': 4,\n",
       "  'title': 'Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.'},\n",
       " {'author': 'Vokes Natalie I',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor Evolution: A Problem of Histocompatibility.'},\n",
       " {'author': 'Jerby-Arnon Livnat',\n",
       "  'cluster': 0,\n",
       "  'title': 'Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.'},\n",
       " {'author': 'Oricchio Elisa',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.'},\n",
       " {'author': 'Chen Jonathan H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Heavy Metal Enlightens Tumor Immunity.'},\n",
       " {'author': 'Liu Chong',\n",
       "  'cluster': 4,\n",
       "  'title': 'Mosaic analysis with double markers reveals tumor cell of origin in glioma.'},\n",
       " {'author': 'Kortlever Roderik M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.'},\n",
       " {'author': 'Marchese Francesco P',\n",
       "  'cluster': 2,\n",
       "  'title': 'A \"Counter-Enhancer\" in Tumor Suppression.'},\n",
       " {'author': 'Cicalese Angelo',\n",
       "  'cluster': 3,\n",
       "  'title': 'The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.'},\n",
       " {'author': 'Rooney Michael S',\n",
       "  'cluster': 4,\n",
       "  'title': 'Molecular and genetic properties of tumors associated with local immune cytolytic activity.'},\n",
       " {'author': 'McDonald E Robert',\n",
       "  'cluster': 0,\n",
       "  'title': 'Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.'},\n",
       " {'author': 'Yecies Jessica L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Chewing the fat on tumor cell metabolism.'},\n",
       " {'author': 'Topper Michael J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.'},\n",
       " {'author': 'Sun Peiqing',\n",
       "  'cluster': 3,\n",
       "  'title': 'PRAK is essential for ras-induced senescence and tumor suppression.'},\n",
       " {'author': 'Palucka A Karolina',\n",
       "  'cluster': 0,\n",
       "  'title': 'The Basis of Oncoimmunology.'},\n",
       " {'author': 'Sowell Ryan T',\n",
       "  'cluster': 4,\n",
       "  'title': u'Probing the Diversity of T\\xa0Cell Dysfunction in Cancer.'},\n",
       " {'author': 'Marty Rachel',\n",
       "  'cluster': 0,\n",
       "  'title': 'MHC-I Genotype Restricts the Oncogenic Mutational Landscape.'},\n",
       " {'author': 'Zitvogel Laurence',\n",
       "  'cluster': 4,\n",
       "  'title': 'Microbiome and Anticancer Immunosurveillance.'},\n",
       " {'author': 'Dewson Grant',\n",
       "  'cluster': 4,\n",
       "  'title': 'The Walrus and the Carpenter: Complex Regulation of Tumor Immunity in Colorectal Cancer.'},\n",
       " {'author': 'Wei Spencer C',\n",
       "  'cluster': 4,\n",
       "  'title': 'Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.'},\n",
       " {'author': 'Moscat Jorge',\n",
       "  'cluster': 1,\n",
       "  'title': 'p62 in Cancer: Signaling Adaptor Beyond Autophagy.'},\n",
       " {'author': 'Comerford Sarah A',\n",
       "  'cluster': 4,\n",
       "  'title': 'Acetate dependence of tumors.'},\n",
       " {'author': 'Powell Anne E',\n",
       "  'cluster': 4,\n",
       "  'title': 'The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor.'},\n",
       " {'author': 'Oshimori Naoki',\n",
       "  'cluster': 4,\n",
       "  'title': u'TGF-\\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma.'},\n",
       " {'author': 'Ou Horng D',\n",
       "  'cluster': 1,\n",
       "  'title': 'A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.'},\n",
       " {'author': 'Zheng Chunhong',\n",
       "  'cluster': 4,\n",
       "  'title': 'Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.'},\n",
       " {'author': 'Scaglioni Pier Paolo',\n",
       "  'cluster': 1,\n",
       "  'title': 'A CK2-dependent mechanism for degradation of the PML tumor suppressor.'},\n",
       " {'author': 'Tsherniak Aviad',\n",
       "  'cluster': 4,\n",
       "  'title': 'Defining a Cancer Dependency Map.'},\n",
       " {'author': 'Singer Meromit',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.'},\n",
       " {'author': 'Supek Fran',\n",
       "  'cluster': 2,\n",
       "  'title': 'Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes.'},\n",
       " {'author': 'Rhim Andrew D',\n",
       "  'cluster': 4,\n",
       "  'title': 'EMT and dissemination precede pancreatic tumor formation.'},\n",
       " {'author': 'Lai Zhi-Chun',\n",
       "  'cluster': 1,\n",
       "  'title': 'Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.'},\n",
       " {'author': 'Bagchi Anindya',\n",
       "  'cluster': 2,\n",
       "  'title': 'CHD5 is a tumor suppressor at human 1p36.'},\n",
       " {'author': 'Clever David',\n",
       "  'cluster': 4,\n",
       "  'title': 'Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.'},\n",
       " {'author': 'Hyman David M',\n",
       "  'cluster': 0,\n",
       "  'title': 'Implementing Genome-Driven Oncology.'},\n",
       " {'author': 'Vander Heiden Matthew G',\n",
       "  'cluster': 4,\n",
       "  'title': 'Understanding the Intersections between Metabolism and Cancer Biology.'},\n",
       " {'author': 'Roybal Kole T',\n",
       "  'cluster': 4,\n",
       "  'title': 'Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.'},\n",
       " {'author': 'Sherr Charles J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Principles of tumor suppression.'},\n",
       " {'author': 'Salmena Leonardo',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tenets of PTEN tumor suppression.'},\n",
       " {'author': u'Chevrier St\\xe9phane',\n",
       "  'cluster': 4,\n",
       "  'title': 'An Immune Atlas of Clear Cell Renal Cell Carcinoma.'},\n",
       " {'author': 'Ikeda Fumiyo',\n",
       "  'cluster': 1,\n",
       "  'title': 'CYLD in ubiquitin signaling and tumor pathogenesis.'},\n",
       " {'author': 'Dive Caroline',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: Circulating Tumor Cells.'},\n",
       " {'author': 'Bond Gareth L',\n",
       "  'cluster': 3,\n",
       "  'title': 'A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.'},\n",
       " {'author': 'McAllister Sandra S',\n",
       "  'cluster': 4,\n",
       "  'title': 'Systemic endocrine instigation of indolent tumor growth requires osteopontin.'},\n",
       " {'author': 'McGranahan Nicholas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer Evolution Constrained by the Immune Microenvironment.'},\n",
       " {'author': 'Zender Lars',\n",
       "  'cluster': 2,\n",
       "  'title': 'An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.'},\n",
       " {'author': 'Welm Alana L',\n",
       "  'cluster': 4,\n",
       "  'title': 'TGFbeta primes breast tumor cells for metastasis.'},\n",
       " {'author': 'Malladi Srinivas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.'},\n",
       " {'author': 'Condeelis John',\n",
       "  'cluster': 4,\n",
       "  'title': 'Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.'},\n",
       " {'author': 'Lim Wendell A',\n",
       "  'cluster': 4,\n",
       "  'title': 'The Principles of Engineering Immune Cells to Treat Cancer.'},\n",
       " {'author': 'Cohen Robert L',\n",
       "  'cluster': 0,\n",
       "  'title': \"From cancer genomics to precision oncology--tissue's still an issue.\"},\n",
       " {'author': 'Minn Andy J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling.'},\n",
       " {'author': 'Anderson Alexander R A',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment.'},\n",
       " {'author': 'Tkach Mercedes',\n",
       "  'cluster': 4,\n",
       "  'title': 'Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.'},\n",
       " {'author': 'Mumby Marc',\n",
       "  'cluster': 1,\n",
       "  'title': 'PP2A: unveiling a reluctant tumor suppressor.'},\n",
       " {'author': 'Roesch Alexander',\n",
       "  'cluster': 4,\n",
       "  'title': 'A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.'},\n",
       " {'author': 'Tape Christopher J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.'},\n",
       " {'author': 'Tschaharganeh Darjus F',\n",
       "  'cluster': 1,\n",
       "  'title': 'p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer.'},\n",
       " {'author': 'He Shenghui',\n",
       "  'cluster': 1,\n",
       "  'title': 'Senescence in Health and Disease.'},\n",
       " {'author': 'Nissim Lior',\n",
       "  'cluster': 4,\n",
       "  'title': 'Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.'},\n",
       " {'author': 'Stroka Kimberly M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Water permeation drives tumor cell migration in confined microenvironments.'},\n",
       " {'author': 'Imielinski Marcin',\n",
       "  'cluster': 2,\n",
       "  'title': 'Insertions and Deletions Target Lineage-Defining Genes in Human Cancers.'},\n",
       " {'author': 'Hajitou Amin',\n",
       "  'cluster': 1,\n",
       "  'title': 'A hybrid vector for ligand-directed tumor targeting and molecular imaging.'},\n",
       " {'author': 'Dow Lukas E',\n",
       "  'cluster': 4,\n",
       "  'title': 'Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.'},\n",
       " {'author': 'McGranahan Nicholas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.'},\n",
       " {'author': 'Csibi Alfred',\n",
       "  'cluster': 1,\n",
       "  'title': 'The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.'},\n",
       " {'author': 'Fantin Valeria R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Self-eating limits EGFR-dependent tumor growth.'},\n",
       " {'author': 'Liu X Shirley',\n",
       "  'cluster': 4,\n",
       "  'title': 'Applications of Immunogenomics to Cancer.'},\n",
       " {'author': 'Davoli Teresa',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.'},\n",
       " {'author': 'Guarnerio Jlenia',\n",
       "  'cluster': 2,\n",
       "  'title': 'Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.'},\n",
       " {'author': 'Sharma Padmanee',\n",
       "  'cluster': 0,\n",
       "  'title': 'Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.'},\n",
       " {'author': 'Klug Lillian R',\n",
       "  'cluster': 1,\n",
       "  'title': 'PDGFRA Antibody for Soft Tissue Sarcoma.'},\n",
       " {'author': 'Nabet Barzin Y',\n",
       "  'cluster': 4,\n",
       "  'title': 'Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.'},\n",
       " {'author': 'Lambert Arthur W',\n",
       "  'cluster': 4,\n",
       "  'title': 'Emerging Biological Principles of Metastasis.'},\n",
       " {'author': 'Kugel Sita',\n",
       "  'cluster': 1,\n",
       "  'title': 'SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.'},\n",
       " {'author': 'Trotman Lloyd C',\n",
       "  'cluster': 1,\n",
       "  'title': 'Ubiquitination regulates PTEN nuclear import and tumor suppression.'},\n",
       " {'author': 'Levental Kandice R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Matrix crosslinking forces tumor progression by enhancing integrin signaling.'},\n",
       " {'author': 'Huang Yu-Han',\n",
       "  'cluster': 0,\n",
       "  'title': 'A Biomarker Harvest from One Thousand Cancer Cell Lines.'},\n",
       " {'author': 'Adhikary Sovana',\n",
       "  'cluster': 1,\n",
       "  'title': 'The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.'},\n",
       " {'author': 'Welsch Matthew E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Multivalent Small-Molecule Pan-RAS Inhibitors.'},\n",
       " {'author': 'Canela Andres',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genome Organization Drives Chromosome Fragility.'},\n",
       " {'author': 'Godar Samuel',\n",
       "  'cluster': 3,\n",
       "  'title': 'Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.'},\n",
       " {'author': 'Massoumi Ramin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.'},\n",
       " {'author': 'Iorio Francesco',\n",
       "  'cluster': 0,\n",
       "  'title': 'A Landscape of Pharmacogenomic Interactions in Cancer.'},\n",
       " {'author': 'Hotary Kevin B',\n",
       "  'cluster': 4,\n",
       "  'title': 'Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.'},\n",
       " {'author': 'Chen Wen Yong',\n",
       "  'cluster': 3,\n",
       "  'title': 'Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.'},\n",
       " {'author': 'Karreth Florian A',\n",
       "  'cluster': 1,\n",
       "  'title': 'In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.'},\n",
       " {'author': 'Yang Jing',\n",
       "  'cluster': 4,\n",
       "  'title': 'Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.'},\n",
       " {'author': 'Ding Zhihu',\n",
       "  'cluster': 2,\n",
       "  'title': 'Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.'},\n",
       " {'author': 'Hoadley Katherine A',\n",
       "  'cluster': 0,\n",
       "  'title': 'Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.'},\n",
       " {'author': 'Nieto M Angela', 'cluster': 4, 'title': 'EMT: 2016.'},\n",
       " {'author': 'Leprivier Gabriel',\n",
       "  'cluster': 1,\n",
       "  'title': 'The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.'},\n",
       " {'author': 'Eyler Christine E',\n",
       "  'cluster': 4,\n",
       "  'title': 'Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.'},\n",
       " {'author': 'Yin Feng',\n",
       "  'cluster': 1,\n",
       "  'title': 'Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.'},\n",
       " {'author': 'Eferl Robert',\n",
       "  'cluster': 3,\n",
       "  'title': 'Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53.'},\n",
       " {'author': 'Betschinger Joerg',\n",
       "  'cluster': 1,\n",
       "  'title': 'Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells.'},\n",
       " {'author': 'Bonavita Eduardo',\n",
       "  'cluster': 1,\n",
       "  'title': 'PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.'},\n",
       " {'author': u'H\\xf6lzel Michael',\n",
       "  'cluster': 1,\n",
       "  'title': 'NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.'},\n",
       " {'author': 'Sherman Mara H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.'},\n",
       " {'author': 'Ghoneim Hazem E',\n",
       "  'cluster': 4,\n",
       "  'title': 'De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.'},\n",
       " {'author': 'Sanz-Moreno Victoria',\n",
       "  'cluster': 1,\n",
       "  'title': 'Rac activation and inactivation control plasticity of tumor cell movement.'},\n",
       " {'author': 'Hensley Christopher T',\n",
       "  'cluster': 4,\n",
       "  'title': 'Metabolic Heterogeneity in Human Lung Tumors.'},\n",
       " {'author': 'Croci Diego O',\n",
       "  'cluster': 1,\n",
       "  'title': 'Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.'},\n",
       " {'author': 'Hock Andreas K',\n",
       "  'cluster': 3,\n",
       "  'title': 'Tumor suppression by p53: fall of the triumvirate?'},\n",
       " {'author': 'Subramanian Aravind',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.'},\n",
       " {'author': 'Garcia-Cao Isabel',\n",
       "  'cluster': 1,\n",
       "  'title': 'Systemic elevation of PTEN induces a tumor-suppressive metabolic state.'},\n",
       " {'author': 'Faubert Brandon',\n",
       "  'cluster': 4,\n",
       "  'title': 'Lactate Metabolism in Human Lung Tumors.'},\n",
       " {'author': 'Ell Brian', 'cluster': 1, 'title': 'SnapShot: Bone Metastasis.'},\n",
       " {'author': 'Heidorn Sonja J',\n",
       "  'cluster': 0,\n",
       "  'title': 'Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.'},\n",
       " {'author': 'Lee Dung-Fang',\n",
       "  'cluster': 1,\n",
       "  'title': 'IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.'},\n",
       " {'author': 'Klebanoff Christopher A',\n",
       "  'cluster': 0,\n",
       "  'title': 'Customizing Functionality and Payload Delivery for Receptor-Engineered T Cells.'},\n",
       " {'author': 'Nijhawan Deepak',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cancer vulnerabilities unveiled by genomic loss.'},\n",
       " {'author': 'Zhu Liqin',\n",
       "  'cluster': 4,\n",
       "  'title': 'Multi-organ Mapping of Cancer Risk.'},\n",
       " {'author': 'Weissmueller Susann',\n",
       "  'cluster': 3,\n",
       "  'title': u'Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor \\u03b2 signaling.'},\n",
       " {'author': 'Chiappinelli Katherine B',\n",
       "  'cluster': 0,\n",
       "  'title': 'Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.'},\n",
       " {'author': 'Chien Yuchen',\n",
       "  'cluster': 1,\n",
       "  'title': 'RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.'},\n",
       " {'author': 'Man Si Ming',\n",
       "  'cluster': 4,\n",
       "  'title': 'Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.'},\n",
       " {'author': 'Emerling Brooke M',\n",
       "  'cluster': 3,\n",
       "  'title': 'Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.'},\n",
       " {'author': 'Hsu Peggy P',\n",
       "  'cluster': 4,\n",
       "  'title': 'Lung Cancer: A Wily Genetic Opponent.'},\n",
       " {'author': 'Tay Yvonne',\n",
       "  'cluster': 1,\n",
       "  'title': 'Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.'},\n",
       " {'author': 'Varmus Harold',\n",
       "  'cluster': 0,\n",
       "  'title': 'A Prize for Cancer Prevention.'},\n",
       " {'author': 'Campisi Judith',\n",
       "  'cluster': 3,\n",
       "  'title': 'Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.'},\n",
       " {'author': 'Murchison Elizabeth P',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cancer in the Wilderness.'},\n",
       " {'author': 'Yang Wan Seok',\n",
       "  'cluster': 4,\n",
       "  'title': 'Regulation of ferroptotic cancer cell death by GPX4.'},\n",
       " {'author': 'Stanley Pamela',\n",
       "  'cluster': 0,\n",
       "  'title': 'Galectin-1 Pulls the Strings on VEGFR2.'},\n",
       " {'author': 'Vecchione Loredana',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.'},\n",
       " {'author': 'Wu Lianfeng',\n",
       "  'cluster': 1,\n",
       "  'title': u'An Ancient, Unified Mechanism for Metformin Growth Inhibition in C.\\xa0elegans and Cancer.'},\n",
       " {'author': 'Shukla Ruchi',\n",
       "  'cluster': 2,\n",
       "  'title': 'Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.'},\n",
       " {'author': 'Dang Chi V', 'cluster': 1, 'title': 'MYC on the path to cancer.'},\n",
       " {'author': 'Burd Christin E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.'},\n",
       " {'author': 'Sablina Anna A',\n",
       "  'cluster': 1,\n",
       "  'title': 'The tumor suppressor PP2A Abeta regulates the RalA GTPase.'},\n",
       " {'author': 'Srivastava Mrinal',\n",
       "  'cluster': 1,\n",
       "  'title': 'An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.'},\n",
       " {'author': 'Wang Man-Tzu',\n",
       "  'cluster': 1,\n",
       "  'title': 'K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.'},\n",
       " {'author': 'Hnisz Denes',\n",
       "  'cluster': 4,\n",
       "  'title': 'Super-enhancers in the control of cell identity and disease.'},\n",
       " {'author': 'Schwitalla Sarah',\n",
       "  'cluster': 4,\n",
       "  'title': 'Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.'},\n",
       " {'author': 'Chen Delin',\n",
       "  'cluster': 3,\n",
       "  'title': 'ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.'},\n",
       " {'author': 'Boelens Mirjam C',\n",
       "  'cluster': 4,\n",
       "  'title': 'Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.'},\n",
       " {'author': 'Mendillo Marc L',\n",
       "  'cluster': 4,\n",
       "  'title': 'HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.'},\n",
       " {'author': 'Uren Anthony G',\n",
       "  'cluster': 3,\n",
       "  'title': 'Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.'},\n",
       " {'author': 'Gudjonsson Thorkell',\n",
       "  'cluster': 2,\n",
       "  'title': 'TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.'},\n",
       " {'author': 'Bradner James E',\n",
       "  'cluster': 4,\n",
       "  'title': 'Transcriptional Addiction in Cancer.'},\n",
       " {'author': 'Gerald Damien',\n",
       "  'cluster': 1,\n",
       "  'title': 'JunD reduces tumor angiogenesis by protecting cells from oxidative stress.'},\n",
       " {'author': 'Ribas Antoni',\n",
       "  'cluster': 0,\n",
       "  'title': 'Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.'},\n",
       " {'author': 'Buszczak Michael',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cellular differences in protein synthesis regulate tissue homeostasis.'},\n",
       " {'author': 'Bar-Peled Liron',\n",
       "  'cluster': 1,\n",
       "  'title': 'Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.'},\n",
       " {'author': 'Garris Christopher S',\n",
       "  'cluster': 4,\n",
       "  'title': 'ER Stress in Dendritic Cells Promotes Cancer.'},\n",
       " {'author': 'Roe Jae-Seok',\n",
       "  'cluster': 4,\n",
       "  'title': 'Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.'},\n",
       " {'author': 'van de Wetering Marc',\n",
       "  'cluster': 0,\n",
       "  'title': 'Prospective derivation of a living organoid biobank of colorectal cancer patients.'},\n",
       " {'author': 'Yu TaChung',\n",
       "  'cluster': 0,\n",
       "  'title': 'Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.'},\n",
       " {'author': 'Yang Lixing',\n",
       "  'cluster': 2,\n",
       "  'title': 'Diverse mechanisms of somatic structural variations in human cancer genomes.'},\n",
       " {'author': 'Supek Fran',\n",
       "  'cluster': 2,\n",
       "  'title': 'Synonymous mutations frequently act as driver mutations in human cancers.'},\n",
       " {'author': 'Daley Donnele',\n",
       "  'cluster': 4,\n",
       "  'title': u'\\u03b3\\u03b4 T Cells Support Pancreatic Oncogenesis by Restraining \\u03b1\\u03b2 T Cell Activation.'},\n",
       " {'author': 'Ramos Azucena',\n",
       "  'cluster': 4,\n",
       "  'title': 'Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer.'},\n",
       " {'author': 'Mori Masaki',\n",
       "  'cluster': 1,\n",
       "  'title': 'Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.'},\n",
       " {'author': 'Zomer Anoek',\n",
       "  'cluster': 4,\n",
       "  'title': u'In\\xa0Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior.'},\n",
       " {'author': 'Rennekamp Andrew J',\n",
       "  'cluster': 2,\n",
       "  'title': 'The Ferrous Awakens.'},\n",
       " {'author': 'Loo Jia Min',\n",
       "  'cluster': 1,\n",
       "  'title': 'Extracellular metabolic energetics can promote cancer progression.'},\n",
       " {'author': 'Reilly Karlyne M',\n",
       "  'cluster': 4,\n",
       "  'title': 'It takes a (dysfunctional) village to raise a tumor.'},\n",
       " {'author': 'Goodarzi Hani',\n",
       "  'cluster': 4,\n",
       "  'title': 'Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement.'},\n",
       " {'author': 'Gao Dong',\n",
       "  'cluster': 0,\n",
       "  'title': 'Organoid cultures derived from patients with advanced prostate cancer.'},\n",
       " {'author': u'Dadi Sa\\xefda',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.'},\n",
       " {'author': 'Garzia Livia',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.'},\n",
       " {'author': 'Weiner Louis M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Antibody-based immunotherapy of cancer.'},\n",
       " {'author': 'Boire Adrienne',\n",
       "  'cluster': 4,\n",
       "  'title': 'Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.'},\n",
       " {'author': 'Valiente Manuel',\n",
       "  'cluster': 4,\n",
       "  'title': 'Serpins promote cancer cell survival and vascular co-option in brain metastasis.'},\n",
       " {'author': 'Yokoyama Akihiko',\n",
       "  'cluster': 1,\n",
       "  'title': 'The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.'},\n",
       " {'author': 'Friedl Peter',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer invasion and the microenvironment: plasticity and reciprocity.'},\n",
       " {'author': 'Arden Karen C',\n",
       "  'cluster': 1,\n",
       "  'title': 'FoxOs in tumor suppression and stem cell maintenance.'},\n",
       " {'author': 'Paik Ji-Hye',\n",
       "  'cluster': 1,\n",
       "  'title': 'FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.'},\n",
       " {'author': 'Hu Jian',\n",
       "  'cluster': 2,\n",
       "  'title': 'Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.'},\n",
       " {'author': 'Burgess Michael R',\n",
       "  'cluster': 0,\n",
       "  'title': 'KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.'},\n",
       " {'author': 'Wang Weimin',\n",
       "  'cluster': 4,\n",
       "  'title': 'Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.'},\n",
       " {'author': 'Setlur Sunita R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tumor archaeology reveals that mutations love company.'},\n",
       " {'author': 'Basu Amrita',\n",
       "  'cluster': 0,\n",
       "  'title': 'An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.'},\n",
       " {'author': 'Montero Joan',\n",
       "  'cluster': 0,\n",
       "  'title': 'Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.'},\n",
       " {'author': 'Padua David',\n",
       "  'cluster': 4,\n",
       "  'title': 'TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.'},\n",
       " {'author': 'Fruman David A',\n",
       "  'cluster': 0,\n",
       "  'title': 'The PI3K Pathway in Human Disease.'},\n",
       " {'author': 'Rausch Tobias',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.'},\n",
       " {'author': 'Hirabayashi Susumu',\n",
       "  'cluster': 0,\n",
       "  'title': 'Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling.'},\n",
       " {'author': 'Rickels Ryan',\n",
       "  'cluster': 2,\n",
       "  'title': \"A histone modifier's ill-gotten copy gains.\"},\n",
       " {'author': 'Hynes Richard O',\n",
       "  'cluster': 4,\n",
       "  'title': 'Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?'},\n",
       " {'author': 'Turajlic Samra',\n",
       "  'cluster': 4,\n",
       "  'title': 'SnapShot: Renal Cell Carcinoma.'},\n",
       " {'author': 'Sun Tingting',\n",
       "  'cluster': 1,\n",
       "  'title': 'Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.'},\n",
       " {'author': 'Zhang Allen W',\n",
       "  'cluster': 4,\n",
       "  'title': 'Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.'},\n",
       " {'author': 'Sharma Padmanee',\n",
       "  'cluster': 0,\n",
       "  'title': 'Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.'},\n",
       " {'author': 'Cescon Dave',\n",
       "  'cluster': 0,\n",
       "  'title': 'Cancer Clinical Trials: The Rear-View Mirror and the Crystal Ball.'},\n",
       " {'author': 'Yurgelun Matthew B',\n",
       "  'cluster': 0,\n",
       "  'title': 'Translating Germline Cancer Risk into Precision Prevention.'},\n",
       " {'author': 'Kapoor Avnish',\n",
       "  'cluster': 1,\n",
       "  'title': 'Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.'},\n",
       " {'author': 'Savage Neil',\n",
       "  'cluster': 0,\n",
       "  'title': 'Getting Data Sharing Right to Help Fulfill the Promise of Cancer Genomics.'},\n",
       " {'author': 'Denny Sarah K',\n",
       "  'cluster': 4,\n",
       "  'title': 'Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.'},\n",
       " {'author': 'Zhou Xiaolan',\n",
       "  'cluster': 1,\n",
       "  'title': 'Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.'},\n",
       " {'author': 'Roulois David',\n",
       "  'cluster': 1,\n",
       "  'title': 'DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.'},\n",
       " {'author': 'Snuderl Matija',\n",
       "  'cluster': 0,\n",
       "  'title': 'Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.'},\n",
       " {'author': 'Gao Hua',\n",
       "  'cluster': 4,\n",
       "  'title': 'Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.'},\n",
       " {'author': 'Gilbert Luke A',\n",
       "  'cluster': 4,\n",
       "  'title': 'DNA damage-mediated induction of a chemoresistant niche.'},\n",
       " {'author': 'Minna John D',\n",
       "  'cluster': 2,\n",
       "  'title': 'Opening a Chromatin Gate to Metastasis.'},\n",
       " {'author': 'Conley Robert B',\n",
       "  'cluster': 0,\n",
       "  'title': 'Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.'},\n",
       " {'author': 'Cheung Kevin J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Collective invasion in breast cancer requires a conserved basal epithelial program.'},\n",
       " {'author': 'Gutmann David H',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Tropism of Pleiotrophin: Orchestrating Glioma Brain Invasion.'},\n",
       " {'author': 'Mathew Robin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Autophagy suppresses tumorigenesis through elimination of p62.'},\n",
       " {'author': 'Genander Maria',\n",
       "  'cluster': 1,\n",
       "  'title': 'Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.'},\n",
       " {'author': 'Ohnishi Kotaro',\n",
       "  'cluster': 4,\n",
       "  'title': 'Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation.'},\n",
       " {'author': 'Kastan Michael B',\n",
       "  'cluster': 3,\n",
       "  'title': \"Wild-type p53: tumors can't stand it.\"},\n",
       " {'author': 'Ge Yejing',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stem Cell Lineage Infidelity Drives Wound Repair and Cancer.'},\n",
       " {'author': 'Xu Xiaoliang L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.'},\n",
       " {'author': 'Robinson Dan',\n",
       "  'cluster': 0,\n",
       "  'title': 'Integrative clinical genomics of advanced prostate cancer.'},\n",
       " {'author': 'Salomoni Paolo',\n",
       "  'cluster': 1,\n",
       "  'title': 'The role of PML in tumor suppression.'},\n",
       " {'author': 'Marcotte Richard',\n",
       "  'cluster': 0,\n",
       "  'title': 'Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.'},\n",
       " {'author': 'Hanahan Douglas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Hallmarks of cancer: the next generation.'},\n",
       " {'author': 'Adorno Maddalena',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.'},\n",
       " {'author': 'Weinberg Robert A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Coming full circle-from endless complexity to simplicity and back again.'},\n",
       " {'author': 'Gingold Hila',\n",
       "  'cluster': 1,\n",
       "  'title': 'A dual program for translation regulation in cellular proliferation and differentiation.'},\n",
       " {'author': 'Galbraith Matthew D',\n",
       "  'cluster': 1,\n",
       "  'title': 'HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.'},\n",
       " {'author': 'Sharma Sreenath V',\n",
       "  'cluster': 4,\n",
       "  'title': 'A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.'},\n",
       " {'author': 'Kim Hyun Seok',\n",
       "  'cluster': 0,\n",
       "  'title': 'Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.'},\n",
       " {'author': 'Kang Byoung Heon',\n",
       "  'cluster': 1,\n",
       "  'title': 'Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.'},\n",
       " {'author': 'Mashimo Tomoyuki',\n",
       "  'cluster': 4,\n",
       "  'title': 'Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.'},\n",
       " {'author': 'Albeck John G',\n",
       "  'cluster': 0,\n",
       "  'title': 'Uncovering a tumor suppressor for triple-negative breast cancers.'},\n",
       " {'author': 'Orimo Akira',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.'},\n",
       " {'author': 'Irvine Darrell J',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Receptor for All Occasions.'},\n",
       " {'author': 'Yuan Jian',\n",
       "  'cluster': 3,\n",
       "  'title': 'USP10 regulates p53 localization and stability by deubiquitinating p53.'},\n",
       " {'author': 'Tubbs Anthony',\n",
       "  'cluster': 2,\n",
       "  'title': 'Endogenous DNA Damage as a Source of Genomic Instability in Cancer.'},\n",
       " {'author': 'Workman Paul',\n",
       "  'cluster': 0,\n",
       "  'title': 'How Much Longer Will We Put Up With $100,000 Cancer Drugs?'},\n",
       " {'author': 'Selivanova Galina',\n",
       "  'cluster': 4,\n",
       "  'title': 'Integrins and mutant p53 on the road to metastasis.'},\n",
       " {'author': 'Skau Colleen T',\n",
       "  'cluster': 4,\n",
       "  'title': 'FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis.'},\n",
       " {'author': 'Haradhvala Nicholas J',\n",
       "  'cluster': 2,\n",
       "  'title': 'Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.'},\n",
       " {'author': 'Nusse Roel',\n",
       "  'cluster': 1,\n",
       "  'title': u'Wnt/\\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.'},\n",
       " {'author': 'Hu Baoli',\n",
       "  'cluster': 4,\n",
       "  'title': 'Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.'},\n",
       " {'author': 'Dietlein Felix',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.'},\n",
       " {'author': 'Michor Franziska',\n",
       "  'cluster': 0,\n",
       "  'title': 'Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort.'},\n",
       " {'author': 'Chien Yuchen',\n",
       "  'cluster': 1,\n",
       "  'title': 'Secreting tumor suppression.'},\n",
       " {'author': 'Isoda Takeshi',\n",
       "  'cluster': 1,\n",
       "  'title': 'Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.'},\n",
       " {'author': 'Boj Sylvia F',\n",
       "  'cluster': 4,\n",
       "  'title': 'Organoid models of human and mouse ductal pancreatic cancer.'},\n",
       " {'author': 'Wolchok Jedd D', 'cluster': 4, 'title': 'PD-1 Blockers.'},\n",
       " {'author': 'Goodarzi Hani',\n",
       "  'cluster': 1,\n",
       "  'title': 'Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression.'},\n",
       " {'author': 'Glickman Michael S',\n",
       "  'cluster': 0,\n",
       "  'title': 'Converting cancer therapies into cures: lessons from infectious diseases.'},\n",
       " {'author': 'Littman Dan R',\n",
       "  'cluster': 0,\n",
       "  'title': 'Releasing the Brakes on Cancer Immunotherapy.'},\n",
       " {'author': 'Allison James P', 'cluster': 1, 'title': 'Checkpoints.'},\n",
       " {'author': 'Whitman Malcolm',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53 and TGF-beta in development: prelude to tumor suppression?'},\n",
       " {'author': 'Chivukula Raghu R',\n",
       "  'cluster': 1,\n",
       "  'title': 'An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration.'},\n",
       " {'author': 'Torres Jorge Z',\n",
       "  'cluster': 1,\n",
       "  'title': 'The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly.'},\n",
       " {'author': 'Whittle Martin C',\n",
       "  'cluster': 4,\n",
       "  'title': 'RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.'},\n",
       " {'author': 'Gronych Jan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Connect four with glioblastoma stem cell factors.'},\n",
       " {'author': 'Stephens Philip J',\n",
       "  'cluster': 2,\n",
       "  'title': 'Massive genomic rearrangement acquired in a single catastrophic event during cancer development.'},\n",
       " {'author': 'Cordenonsi Michelangelo',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.'},\n",
       " {'author': 'Toledo Luis Ignacio',\n",
       "  'cluster': 1,\n",
       "  'title': 'ATR prohibits replication catastrophe by preventing global exhaustion of RPA.'},\n",
       " {'author': 'Singh Anurag',\n",
       "  'cluster': 1,\n",
       "  'title': 'TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.'},\n",
       " {'author': 'Venkatesh Humsa S',\n",
       "  'cluster': 1,\n",
       "  'title': 'Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.'},\n",
       " {'author': 'Masri Selma',\n",
       "  'cluster': 1,\n",
       "  'title': 'Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.'},\n",
       " {'author': 'McFadden David G',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.'},\n",
       " {'author': 'Luga Valbona',\n",
       "  'cluster': 4,\n",
       "  'title': 'Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.'},\n",
       " {'author': 'Pencheva Nora',\n",
       "  'cluster': 0,\n",
       "  'title': 'Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.'},\n",
       " {'author': 'Zeron-Medina Jorge',\n",
       "  'cluster': 3,\n",
       "  'title': 'A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.'},\n",
       " {'author': 'Su Shicheng', 'cluster': 4, 'title': 'CD10'},\n",
       " {'author': 'Goldberg Michael S',\n",
       "  'cluster': 0,\n",
       "  'title': 'Immunoengineering: how nanotechnology can enhance cancer immunotherapy.'},\n",
       " {'author': 'Topalian Suzanne L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Immunotherapy: The path to win the war on cancer?'},\n",
       " {'author': 'Rabbitts Terence H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Commonality but diversity in cancer gene fusions.'},\n",
       " {'author': 'Gupta Sonal',\n",
       "  'cluster': 4,\n",
       "  'title': 'EMT: Matter of Life or Death?'},\n",
       " {'author': 'Schuettengruber Bernd',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genome Regulation by Polycomb and Trithorax: 70 Years and Counting.'},\n",
       " {'author': 'Blenis John',\n",
       "  'cluster': 1,\n",
       "  'title': 'TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease.'},\n",
       " {'author': 'White Elizabeth A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Crowd Control: E7 Conservation Is the Key to Cancer.'},\n",
       " {'author': 'Burikhanov Ravshan',\n",
       "  'cluster': 1,\n",
       "  'title': 'The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.'},\n",
       " {'author': 'Robertson A Gordon',\n",
       "  'cluster': 1,\n",
       "  'title': 'Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.'},\n",
       " {'author': 'Lang Gene A',\n",
       "  'cluster': 3,\n",
       "  'title': 'Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.'},\n",
       " {'author': 'Green Michael R',\n",
       "  'cluster': 4,\n",
       "  'title': 'Senescence: not just for tumor suppression.'},\n",
       " {'author': 'Kim Tae-Min',\n",
       "  'cluster': 2,\n",
       "  'title': 'The landscape of microsatellite instability in colorectal and endometrial cancer genomes.'},\n",
       " {'author': u'Mart\\xednez-Zamudio Ricardo Iv\\xe1n',\n",
       "  'cluster': 3,\n",
       "  'title': 'SnapShot: Cellular Senescence in Pathophysiology.'},\n",
       " {'author': u'Mart\\xednez-Zamudio Ricardo Iv\\xe1n',\n",
       "  'cluster': 3,\n",
       "  'title': 'SnapShot: Cellular Senescence Pathways.'},\n",
       " {'author': 'Clarke Paul R',\n",
       "  'cluster': 2,\n",
       "  'title': 'A mitotic role for BRCA1/BARD1 in tumor suppression?'},\n",
       " {'author': 'Pittet Mikael J', 'cluster': 1, 'title': 'Intravital imaging.'},\n",
       " {'author': 'He Guobin',\n",
       "  'cluster': 4,\n",
       "  'title': 'Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.'},\n",
       " {'author': 'Simanshu Dhirendra K',\n",
       "  'cluster': 1,\n",
       "  'title': 'RAS Proteins and Their Regulators in Human Disease.'},\n",
       " {'author': 'Maciejowski John',\n",
       "  'cluster': 2,\n",
       "  'title': 'Chromothripsis and Kataegis Induced by Telomere Crisis.'},\n",
       " {'author': 'Leder Kevin',\n",
       "  'cluster': 0,\n",
       "  'title': 'Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules.'},\n",
       " {'author': 'VonHoldt Bridgett M',\n",
       "  'cluster': 2,\n",
       "  'title': 'The singular history of a canine transmissible tumor.'},\n",
       " {'author': 'Yu Fa-Xing',\n",
       "  'cluster': 1,\n",
       "  'title': 'Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.'},\n",
       " {'author': 'Guise Theresa A',\n",
       "  'cluster': 4,\n",
       "  'title': \"Breast cancer bone metastases: it's all about the neighborhood.\"},\n",
       " {'author': 'Creixell Pau',\n",
       "  'cluster': 1,\n",
       "  'title': 'Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.'},\n",
       " {'author': 'Kusebauch Ulrike',\n",
       "  'cluster': 1,\n",
       "  'title': 'Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome.'},\n",
       " {'author': 'Song Su Jung',\n",
       "  'cluster': 4,\n",
       "  'title': 'MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.'},\n",
       " {'author': 'Chan Chia-Hsin',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.'},\n",
       " {'author': 'Dai Chengkai',\n",
       "  'cluster': 1,\n",
       "  'title': 'Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.'},\n",
       " {'author': 'Chen James C',\n",
       "  'cluster': 1,\n",
       "  'title': 'Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.'},\n",
       " {'author': 'Saxton Robert A',\n",
       "  'cluster': 1,\n",
       "  'title': 'mTOR Signaling in Growth, Metabolism, and Disease.'},\n",
       " {'author': 'Suzuki Hiroshi I',\n",
       "  'cluster': 1,\n",
       "  'title': 'Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.'},\n",
       " {'author': 'Rigby Peter W J',\n",
       "  'cluster': 1,\n",
       "  'title': u'Chris Marshall (1949\\u20132015).'},\n",
       " {'author': 'Day Chi-Ping',\n",
       "  'cluster': 0,\n",
       "  'title': 'Preclinical mouse cancer models: a maze of opportunities and challenges.'},\n",
       " {'author': 'Kumar Madhu S',\n",
       "  'cluster': 1,\n",
       "  'title': 'The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.'},\n",
       " {'author': 'Dixon Scott J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Ferroptosis: an iron-dependent form of nonapoptotic cell death.'},\n",
       " {'author': 'Chan Chia-Hsin',\n",
       "  'cluster': 4,\n",
       "  'title': 'Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.'},\n",
       " {'author': 'Hosono Yasuyuki',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.'},\n",
       " {'author': 'Beuvink Iwan',\n",
       "  'cluster': 3,\n",
       "  'title': 'The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.'},\n",
       " {'author': 'Ding Li',\n",
       "  'cluster': 2,\n",
       "  'title': 'Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.'},\n",
       " {'author': 'Krimpenfort Paul',\n",
       "  'cluster': 3,\n",
       "  'title': 'Wnt Down, Tumors Wind Up?'},\n",
       " {'author': 'Chipumuro Edmond',\n",
       "  'cluster': 1,\n",
       "  'title': 'CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.'},\n",
       " {'author': 'Spizzo Riccardo',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: MicroRNAs in Cancer.'},\n",
       " {'author': 'Pujadas Elisabet',\n",
       "  'cluster': 4,\n",
       "  'title': 'Regulated noise in the epigenetic landscape of development and disease.'},\n",
       " {'author': u'Castillo-Quan Jorge Iv\\xe1n',\n",
       "  'cluster': 1,\n",
       "  'title': 'Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging.'},\n",
       " {'author': 'Gagliani Nicola',\n",
       "  'cluster': 4,\n",
       "  'title': 'The fire within: microbes inflame tumors.'},\n",
       " {'author': 'Grivennikov Sergei I',\n",
       "  'cluster': 4,\n",
       "  'title': 'Immunity, inflammation, and cancer.'},\n",
       " {'author': 'Gilbertson Richard J',\n",
       "  'cluster': 0,\n",
       "  'title': 'Driving glioblastoma to drink.'},\n",
       " {'author': 'Fu Loning',\n",
       "  'cluster': 1,\n",
       "  'title': 'The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.'},\n",
       " {'author': 'Grinberg-Bleyer Yenkel',\n",
       "  'cluster': 4,\n",
       "  'title': u'NF-\\u03baB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer.'},\n",
       " {'author': 'Boulay Gaylor',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain.'},\n",
       " {'author': 'Park Eek Joong',\n",
       "  'cluster': 4,\n",
       "  'title': 'Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.'},\n",
       " {'author': 'Xhemalce Blerta',\n",
       "  'cluster': 1,\n",
       "  'title': 'Human RNA methyltransferase BCDIN3D regulates microRNA processing.'},\n",
       " {'author': 'Park Bum-Joon',\n",
       "  'cluster': 3,\n",
       "  'title': 'The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.'},\n",
       " {'author': 'Hu Hai',\n",
       "  'cluster': 1,\n",
       "  'title': 'Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.'},\n",
       " {'author': 'Ventura Andrea',\n",
       "  'cluster': 1,\n",
       "  'title': 'MicroRNAs and cancer: short RNAs go a long way.'},\n",
       " {'author': 'Palucka Karolina',\n",
       "  'cluster': 4,\n",
       "  'title': 'SnapShot: cancer vaccines.'},\n",
       " {'author': u'Sanchez-Garcia F\\xe9lix',\n",
       "  'cluster': 2,\n",
       "  'title': 'Integration of genomic data enables selective discovery of breast cancer drivers.'},\n",
       " {'author': 'Garraway Levi A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Lessons from the cancer genome.'},\n",
       " {'author': 'Haeno Hiroshi',\n",
       "  'cluster': 4,\n",
       "  'title': 'Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.'},\n",
       " {'author': 'Aeby Eric',\n",
       "  'cluster': 2,\n",
       "  'title': 'ALT telomeres get together with nuclear receptors.'},\n",
       " {'author': 'Pineda Carlos T',\n",
       "  'cluster': 1,\n",
       "  'title': 'Degradation of AMPK by a cancer-specific ubiquitin ligase.'},\n",
       " {'author': 'Marzec Paulina',\n",
       "  'cluster': 2,\n",
       "  'title': 'Nuclear-receptor-mediated telomere insertion leads to genome instability in ALT cancers.'},\n",
       " {'author': 'Westbrook Thomas F',\n",
       "  'cluster': 4,\n",
       "  'title': 'A genetic screen for candidate tumor suppressors identifies REST.'},\n",
       " {'author': 'McClellan Amie J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways.'},\n",
       " {'author': 'Ridley Anne',\n",
       "  'cluster': 1,\n",
       "  'title': u'Alan Hall (1952\\u20132015).'},\n",
       " {'author': 'Luo Weibo',\n",
       "  'cluster': 1,\n",
       "  'title': 'Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.'},\n",
       " {'author': 'Lin Shiaw Yih',\n",
       "  'cluster': 1,\n",
       "  'title': 'Multiple tumor suppressor pathways negatively regulate telomerase.'},\n",
       " {'author': 'Inuzuka Hiroyuki',\n",
       "  'cluster': 1,\n",
       "  'title': 'Acetylation-dependent regulation of Skp2 function.'},\n",
       " {'author': 'Irianto Jerome',\n",
       "  'cluster': 4,\n",
       "  'title': 'SnapShot: Mechanosensing Matrix.'},\n",
       " {'author': 'Wang Yubao',\n",
       "  'cluster': 1,\n",
       "  'title': 'CDK7-dependent transcriptional addiction in triple-negative breast cancer.'},\n",
       " {'author': u'Lallemand-Breitenbach Val\\xe9rie',\n",
       "  'cluster': 1,\n",
       "  'title': 'CK2 and PML: regulating the regulator.'},\n",
       " {'author': 'Kumar Sudhir',\n",
       "  'cluster': 1,\n",
       "  'title': 'No positive selection for G allele in a p53 response element in Europeans.'},\n",
       " {'author': 'Habbas Samia',\n",
       "  'cluster': 1,\n",
       "  'title': u'Neuroinflammatory TNF\\u03b1 Impairs Memory via Astrocyte Signaling.'},\n",
       " {'author': 'Nik-Zainal Serena',\n",
       "  'cluster': 2,\n",
       "  'title': 'The life history of 21 breast cancers.'},\n",
       " {'author': 'Giancotti Filippo G',\n",
       "  'cluster': 4,\n",
       "  'title': 'Mechanisms governing metastatic dormancy and reactivation.'},\n",
       " {'author': 'Govindan Ramaswamy',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genomic landscape of non-small cell lung cancer in smokers and never-smokers.'},\n",
       " {'author': u'Bernards Ren\\xe9',\n",
       "  'cluster': 0,\n",
       "  'title': 'A missing link in genotype-directed cancer therapy.'},\n",
       " {'author': 'Ingber Donald E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Reverse Engineering Human Pathophysiology with Organs-on-Chips.'},\n",
       " {'author': 'Ying Haoqiang',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.'},\n",
       " {'author': 'Solimini Nicole L',\n",
       "  'cluster': 0,\n",
       "  'title': 'Non-oncogene addiction and the stress phenotype of cancer cells.'},\n",
       " {'author': 'Freed-Pastor William A',\n",
       "  'cluster': 3,\n",
       "  'title': 'Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.'},\n",
       " {'author': 'Acharyya Swarnali',\n",
       "  'cluster': 4,\n",
       "  'title': 'A CXCL1 paracrine network links cancer chemoresistance and metastasis.'},\n",
       " {'author': 'Mevissen Tycho E T',\n",
       "  'cluster': 1,\n",
       "  'title': 'OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.'},\n",
       " {'author': 'Epping Mirjam T',\n",
       "  'cluster': 1,\n",
       "  'title': 'The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.'},\n",
       " {'author': 'Snyder Matthew W',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.'},\n",
       " {'author': 'Black Joshua C',\n",
       "  'cluster': 2,\n",
       "  'title': 'KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.'},\n",
       " {'author': 'Dawson Mark A',\n",
       "  'cluster': 0,\n",
       "  'title': 'Cancer epigenetics: from mechanism to therapy.'},\n",
       " {'author': 'Lee Dung-Fang',\n",
       "  'cluster': 1,\n",
       "  'title': 'Modeling familial cancer with induced pluripotent stem cells.'},\n",
       " {'author': 'Kalyana-Sundaram Shanker',\n",
       "  'cluster': 1,\n",
       "  'title': 'Expressed pseudogenes in the transcriptional landscape of human cancers.'},\n",
       " {'author': 'Hart Gerald W',\n",
       "  'cluster': 1,\n",
       "  'title': 'Glycomics hits the big time.'},\n",
       " {'author': 'Pasciuto Emanuela',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: FMRP mRNA targets and diseases.'},\n",
       " {'author': 'Van de Veire Sara',\n",
       "  'cluster': 0,\n",
       "  'title': 'Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.'},\n",
       " {'author': 'Sadelain Michel', 'cluster': 4, 'title': 'CD19 CAR T Cells.'},\n",
       " {'author': u'Massagu\\xe9 Joan', 'cluster': 4, 'title': 'TGFbeta in Cancer.'},\n",
       " {'author': 'Li Qiyuan',\n",
       "  'cluster': 2,\n",
       "  'title': 'Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.'},\n",
       " {'author': 'Ma Li',\n",
       "  'cluster': 1,\n",
       "  'title': u'Control of nutrient stress-induced metabolic reprogramming by PKC\\u03b6 in tumorigenesis.'},\n",
       " {'author': 'Creixell Pau',\n",
       "  'cluster': 1,\n",
       "  'title': 'Unmasking determinants of specificity in the human kinome.'},\n",
       " {'author': 'Zheng Siyuan',\n",
       "  'cluster': 2,\n",
       "  'title': 'Silent mutations make some noise.'},\n",
       " {'author': 'Zhang Yu',\n",
       "  'cluster': 2,\n",
       "  'title': 'Spatial organization of the mouse genome and its role in recurrent chromosomal translocations.'},\n",
       " {'author': 'Xing Zhen',\n",
       "  'cluster': 1,\n",
       "  'title': 'lncRNA directs cooperative epigenetic regulation downstream of chemokine signals.'},\n",
       " {'author': 'Lieberman Judy',\n",
       "  'cluster': 1,\n",
       "  'title': 'Noncoding RNAs and cancer.'},\n",
       " {'author': 'Woo Jung Hoon',\n",
       "  'cluster': 1,\n",
       "  'title': 'Elucidating Compound Mechanism of Action by Network Perturbation Analysis.'},\n",
       " {'author': 'Lau Eric',\n",
       "  'cluster': 1,\n",
       "  'title': u'PKC\\u03b5 promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.'},\n",
       " {'author': 'Platt Randall J',\n",
       "  'cluster': 4,\n",
       "  'title': 'CRISPR-Cas9 knockin mice for genome editing and cancer modeling.'},\n",
       " {'author': 'Wang Liqin',\n",
       "  'cluster': 0,\n",
       "  'title': 'An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.'},\n",
       " {'author': 'Mostoslavsky Raul',\n",
       "  'cluster': 4,\n",
       "  'title': 'Reprogramming Enhancers to Drive Metastasis.'},\n",
       " {'author': 'Malta Tathiane M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.'},\n",
       " {'author': 'Desideri Enrico',\n",
       "  'cluster': 1,\n",
       "  'title': 'Alike but Different: RAF Paralogs and Their Signaling Outputs.'},\n",
       " {'author': 'Gao Hua',\n",
       "  'cluster': 4,\n",
       "  'title': 'The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.'},\n",
       " {'author': 'Aragona Mariaceleste',\n",
       "  'cluster': 1,\n",
       "  'title': 'A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.'},\n",
       " {'author': 'Thedieck Kathrin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells.'},\n",
       " {'author': 'Hatch Emily M',\n",
       "  'cluster': 2,\n",
       "  'title': 'Catastrophic nuclear envelope collapse in cancer cell micronuclei.'},\n",
       " {'author': 'Huang Sidong',\n",
       "  'cluster': 0,\n",
       "  'title': u'MED12 controls the response to multiple cancer drugs through regulation of TGF-\\u03b2 receptor signaling.'},\n",
       " {'author': u'J\\xe4ger Natalie',\n",
       "  'cluster': 2,\n",
       "  'title': 'Hypermutation of the inactive X chromosome is a frequent event in cancer.'},\n",
       " {'author': 'Xing Yongna',\n",
       "  'cluster': 1,\n",
       "  'title': 'Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.'},\n",
       " {'author': 'Imielinski Marcin',\n",
       "  'cluster': 2,\n",
       "  'title': 'Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.'},\n",
       " {'author': 'Casasent Anna K',\n",
       "  'cluster': 4,\n",
       "  'title': 'Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.'},\n",
       " {'author': 'Nigg Erich A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Centrioles, centrosomes, and cilia in health and disease.'},\n",
       " {'author': 'Kawase Tatsuya',\n",
       "  'cluster': 3,\n",
       "  'title': 'PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt.'},\n",
       " {'author': u'Tom\\xe1s-Loba Antonia',\n",
       "  'cluster': 1,\n",
       "  'title': 'Telomerase reverse transcriptase delays aging in cancer-resistant mice.'},\n",
       " {'author': 'Lee Michael J',\n",
       "  'cluster': 0,\n",
       "  'title': 'Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.'},\n",
       " {'author': 'Yu Wenhao',\n",
       "  'cluster': 4,\n",
       "  'title': 'Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.'},\n",
       " {'author': 'Rodriguez-Bravo Veronica',\n",
       "  'cluster': 0,\n",
       "  'title': 'Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.'},\n",
       " {'author': 'Scholl Claudia',\n",
       "  'cluster': 1,\n",
       "  'title': 'Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.'},\n",
       " {'author': 'Nomura Daniel K',\n",
       "  'cluster': 4,\n",
       "  'title': 'Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.'},\n",
       " {'author': 'Cao Lei',\n",
       "  'cluster': 1,\n",
       "  'title': 'Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.'},\n",
       " {'author': 'Hugo Willy',\n",
       "  'cluster': 4,\n",
       "  'title': 'Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.'},\n",
       " {'author': 'Inoki Ken',\n",
       "  'cluster': 1,\n",
       "  'title': 'TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.'},\n",
       " {'author': 'Aylon Yael',\n",
       "  'cluster': 3,\n",
       "  'title': 'Living with p53, dying of p53.'},\n",
       " {'author': 'Hu Bing',\n",
       "  'cluster': 4,\n",
       "  'title': 'Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.'},\n",
       " {'author': 'Rolland Thomas',\n",
       "  'cluster': 2,\n",
       "  'title': 'A proteome-scale map of the human interactome network.'},\n",
       " {'author': 'Qin Elizabeth Y',\n",
       "  'cluster': 1,\n",
       "  'title': 'Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma.'},\n",
       " {'author': 'Hill Reginald',\n",
       "  'cluster': 4,\n",
       "  'title': 'Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.'},\n",
       " {'author': 'Espiritu Shadrielle Melijah G',\n",
       "  'cluster': 0,\n",
       "  'title': 'The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.'},\n",
       " {'author': 'Luo Ji',\n",
       "  'cluster': 0,\n",
       "  'title': 'Principles of cancer therapy: oncogene and non-oncogene addiction.'},\n",
       " {'author': 'Rickard James A',\n",
       "  'cluster': 1,\n",
       "  'title': 'RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.'},\n",
       " {'author': 'Cichowski Karen',\n",
       "  'cluster': 4,\n",
       "  'title': 'Unexpected pieces to the senescence puzzle.'},\n",
       " {'author': 'Lloyd Alison C',\n",
       "  'cluster': 1,\n",
       "  'title': 'The regulation of cell size.'},\n",
       " {'author': 'Duncan James S',\n",
       "  'cluster': 0,\n",
       "  'title': 'Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.'},\n",
       " {'author': 'Ma Li',\n",
       "  'cluster': 1,\n",
       "  'title': 'Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.'},\n",
       " {'author': 'Fischer Christian',\n",
       "  'cluster': 0,\n",
       "  'title': 'Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.'},\n",
       " {'author': 'Reddy Anupama',\n",
       "  'cluster': 0,\n",
       "  'title': u'Genetic and Functional Drivers of Diffuse Large B\\xa0Cell Lymphoma.'},\n",
       " {'author': 'Ceccarelli Michele',\n",
       "  'cluster': 2,\n",
       "  'title': 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.'},\n",
       " {'author': 'Rosenbluh Joseph',\n",
       "  'cluster': 1,\n",
       "  'title': u'\\u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.'},\n",
       " {'author': 'Tavazoie Masoud F',\n",
       "  'cluster': 0,\n",
       "  'title': 'LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.'},\n",
       " {'author': 'Merghoub Taha',\n",
       "  'cluster': 4,\n",
       "  'title': \"Curbing Tregs' (Lack of) Enthusiasm.\"},\n",
       " {'author': 'Shen Hui',\n",
       "  'cluster': 2,\n",
       "  'title': 'Interplay between the cancer genome and epigenome.'},\n",
       " {'author': 'Korbel Jan O',\n",
       "  'cluster': 2,\n",
       "  'title': 'Criteria for inference of chromothripsis in cancer genomes.'},\n",
       " {'author': 'Bester Assaf C',\n",
       "  'cluster': 1,\n",
       "  'title': 'Nucleotide deficiency promotes genomic instability in early stages of cancer development.'},\n",
       " {'author': 'Cimmino Luisa',\n",
       "  'cluster': 1,\n",
       "  'title': 'Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.'},\n",
       " {'author': 'Gilbertson Richard J',\n",
       "  'cluster': 0,\n",
       "  'title': 'Mapping cancer origins.'},\n",
       " {'author': 'Tammela Tuomas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Lymphangiogenesis: Molecular mechanisms and future promise.'},\n",
       " {'author': 'Mantovani Alberto',\n",
       "  'cluster': 4,\n",
       "  'title': 'RalB signaling: a bridge between inflammation and cancer.'},\n",
       " {'author': 'Hatziapostolou Maria',\n",
       "  'cluster': 1,\n",
       "  'title': u'An HNF4\\u03b1-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.'},\n",
       " {'author': 'Lin Ken Y',\n",
       "  'cluster': 2,\n",
       "  'title': 'PARP Inhibitors for Cancer Therapy.'},\n",
       " {'author': 'Li Wei',\n",
       "  'cluster': 1,\n",
       "  'title': 'Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.'},\n",
       " {'author': 'Vaidyanathan Gayathri',\n",
       "  'cluster': 0,\n",
       "  'title': 'Redefining clinical trials: the age of personalized medicine.'},\n",
       " {'author': 'Gupta Piyush B',\n",
       "  'cluster': 4,\n",
       "  'title': 'Identification of selective inhibitors of cancer stem cells by high-throughput screening.'},\n",
       " {'author': 'Belcheva Antoaneta',\n",
       "  'cluster': 1,\n",
       "  'title': 'Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.'},\n",
       " {'author': 'Dancey Janet E',\n",
       "  'cluster': 0,\n",
       "  'title': 'The genetic basis for cancer treatment decisions.'},\n",
       " {'author': u'G\\xfcnes Cagatay',\n",
       "  'cluster': 2,\n",
       "  'title': 'The role of telomeres in stem cells and cancer.'},\n",
       " {'author': 'Ciriello Giovanni',\n",
       "  'cluster': 1,\n",
       "  'title': 'Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.'},\n",
       " {'author': 'Muller Patricia A J',\n",
       "  'cluster': 3,\n",
       "  'title': 'Mutant p53 drives invasion by promoting integrin recycling.'},\n",
       " {'author': 'Balmain Allan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models.'},\n",
       " {'author': 'Valastyan Scott',\n",
       "  'cluster': 4,\n",
       "  'title': 'A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.'},\n",
       " {'author': 'Xing Yu-Hang',\n",
       "  'cluster': 1,\n",
       "  'title': 'SLERT Regulates DDX21 Rings Associated with Pol I Transcription.'},\n",
       " {'author': 'DeBerardinis Ralph J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cellular metabolism and disease: what do metabolic outliers teach us?'},\n",
       " {'author': 'Keith Brian',\n",
       "  'cluster': 4,\n",
       "  'title': 'Hypoxia-inducible factors, stem cells, and cancer.'},\n",
       " {'author': 'Scadden David T',\n",
       "  'cluster': 4,\n",
       "  'title': 'Nice neighborhood: emerging concepts of the stem cell niche.'},\n",
       " {'author': 'Cantor Jason R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase.'},\n",
       " {'author': 'Sawyers Charles L',\n",
       "  'cluster': 2,\n",
       "  'title': 'Finding and drugging the vulnerabilities of RAS-dependent cancers.'},\n",
       " {'author': 'Gujral Taranjit S',\n",
       "  'cluster': 4,\n",
       "  'title': 'A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.'},\n",
       " {'author': 'Vousden Karen H',\n",
       "  'cluster': 3,\n",
       "  'title': 'P53 and prognosis: new insights and further complexity.'},\n",
       " {'author': 'Hugo Willy',\n",
       "  'cluster': 0,\n",
       "  'title': 'Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.'},\n",
       " {'author': 'Yang Weiwei',\n",
       "  'cluster': 1,\n",
       "  'title': 'PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.'},\n",
       " {'author': 'Greten Florian R',\n",
       "  'cluster': 2,\n",
       "  'title': 'YAP1 takes over when oncogenic K-Ras slumbers.'},\n",
       " {'author': 'Wang Tim',\n",
       "  'cluster': 1,\n",
       "  'title': 'Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.'},\n",
       " {'author': 'Zhong Franklin L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation.'},\n",
       " {'author': 'Kruse Jan-Philipp',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: p53 posttranslational modifications.'},\n",
       " {'author': 'Sellers William R',\n",
       "  'cluster': 0,\n",
       "  'title': 'A blueprint for advancing genetics-based cancer therapy.'},\n",
       " {'author': 'Dillon Christopher P',\n",
       "  'cluster': 1,\n",
       "  'title': 'RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.'},\n",
       " {'author': 'Zuo Tao',\n",
       "  'cluster': 2,\n",
       "  'title': 'FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.'},\n",
       " {'author': 'Buck Michael D',\n",
       "  'cluster': 4,\n",
       "  'title': 'Metabolic Instruction of Immunity.'},\n",
       " {'author': 'Tan Xiaojun',\n",
       "  'cluster': 1,\n",
       "  'title': 'A kinase-independent role for EGF receptor in autophagy initiation.'},\n",
       " {'author': 'Drake Justin M',\n",
       "  'cluster': 0,\n",
       "  'title': 'Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.'},\n",
       " {'author': 'Zhang Hui',\n",
       "  'cluster': 2,\n",
       "  'title': 'Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.'},\n",
       " {'author': 'Scheel Christina',\n",
       "  'cluster': 4,\n",
       "  'title': 'Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.'},\n",
       " {'author': 'Blum Amy',\n",
       "  'cluster': 2,\n",
       "  'title': 'SnapShot: TCGA-Analyzed Tumors.'},\n",
       " {'author': 'Chen Han',\n",
       "  'cluster': 2,\n",
       "  'title': 'A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.'},\n",
       " {'author': 'Mirabello Lisa',\n",
       "  'cluster': 2,\n",
       "  'title': 'HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.'},\n",
       " {'author': 'Briggs Kimberly J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.'},\n",
       " {'author': 'Shan Yibing',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization.'},\n",
       " {'author': 'Roca Francisco J',\n",
       "  'cluster': 1,\n",
       "  'title': 'TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species.'},\n",
       " {'author': 'Affara Nesrine I',\n",
       "  'cluster': 4,\n",
       "  'title': 'IKKalpha at the crossroads of inflammation and metastasis.'},\n",
       " {'author': 'Premsrirut Prem K',\n",
       "  'cluster': 1,\n",
       "  'title': 'A rapid and scalable system for studying gene function in mice using conditional RNA interference.'},\n",
       " {'author': 'Sachs Norman',\n",
       "  'cluster': 0,\n",
       "  'title': 'A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.'},\n",
       " {'author': 'Lin Chunru',\n",
       "  'cluster': 2,\n",
       "  'title': 'Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.'},\n",
       " {'author': 'Zender Lars',\n",
       "  'cluster': 1,\n",
       "  'title': 'Snapshot: genetic mouse models of cancer.'},\n",
       " {'author': 'Parmar Kalindi',\n",
       "  'cluster': 2,\n",
       "  'title': 'Aldehydes Pose a Threat to BRCA2 Mutation Carriers.'},\n",
       " {'author': 'Glimcher Laurie H',\n",
       "  'cluster': 1,\n",
       "  'title': 'Translating research into therapies.'},\n",
       " {'author': 'Ziegler Paul K',\n",
       "  'cluster': 0,\n",
       "  'title': 'Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.'},\n",
       " {'author': 'Ashworth Alan',\n",
       "  'cluster': 0,\n",
       "  'title': 'Genetic interactions in cancer progression and treatment.'},\n",
       " {'author': 'Haber Daniel A',\n",
       "  'cluster': 0,\n",
       "  'title': 'The evolving war on cancer.'},\n",
       " {'author': 'Rowbotham Samuel P',\n",
       "  'cluster': 4,\n",
       "  'title': \"Don't Stop Re-healin'! Cancer as an Ongoing Stem Cell Affair.\"},\n",
       " {'author': 'Zaky Wafik',\n",
       "  'cluster': 4,\n",
       "  'title': 'Revisiting Management of Pediatric Brain Tumors with New Molecular Insights.'},\n",
       " {'author': u'Bernards Ren\\xe9',\n",
       "  'cluster': 0,\n",
       "  'title': \"It's diagnostics, stupid.\"},\n",
       " {'author': 'Cordenonsi Michelangelo',\n",
       "  'cluster': 3,\n",
       "  'title': 'Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.'},\n",
       " {'author': 'Kim Charissa',\n",
       "  'cluster': 0,\n",
       "  'title': 'Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.'},\n",
       " {'author': 'Di Cristofano A',\n",
       "  'cluster': 1,\n",
       "  'title': 'The multiple roles of PTEN in tumor suppression.'},\n",
       " {'author': u'Garc\\xeda-Gonz\\xe1lez Aurian P',\n",
       "  'cluster': 0,\n",
       "  'title': u'Bacterial Metabolism Affects the C.\\xa0elegans Response to Cancer Chemotherapeutics.'},\n",
       " {'author': 'Scott Timothy A',\n",
       "  'cluster': 0,\n",
       "  'title': u'Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C.\\xa0elegans.'},\n",
       " {'author': 'Xie Wei',\n",
       "  'cluster': 4,\n",
       "  'title': 'Epigenomic analysis of multilineage differentiation of human embryonic stem cells.'},\n",
       " {'author': 'Wu Hao',\n",
       "  'cluster': 4,\n",
       "  'title': 'Smac mimetics and TNFalpha: a dangerous liaison?'},\n",
       " {'author': 'Downward Julian',\n",
       "  'cluster': 1,\n",
       "  'title': 'RNA interference libraries prove their worth in hunt for tumor suppressor genes.'},\n",
       " {'author': 'Maher Christopher A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Chromothripsis and human disease: piecing together the shattering process.'},\n",
       " {'author': 'Tang Yun-Chi',\n",
       "  'cluster': 1,\n",
       "  'title': 'Identification of aneuploidy-selective antiproliferation compounds.'},\n",
       " {'author': 'Das Sanjeev',\n",
       "  'cluster': 3,\n",
       "  'title': 'Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.'},\n",
       " {'author': 'Tanaka Tomoaki',\n",
       "  'cluster': 3,\n",
       "  'title': 'hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.'},\n",
       " {'author': 'Dawlaty Meelad M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.'},\n",
       " {'author': 'Wilusz Jeremy E',\n",
       "  'cluster': 1,\n",
       "  'title': \"3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.\"},\n",
       " {'author': 'Osso Lindsay A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Astrocytes Underlie Neuroinflammatory Memory Impairment.'},\n",
       " {'author': 'Rounbehler Robert J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.'},\n",
       " {'author': 'Huelsken Joerg',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance.'},\n",
       " {'author': 'Lee Tong Ihn',\n",
       "  'cluster': 1,\n",
       "  'title': 'Transcriptional regulation and its misregulation in disease.'},\n",
       " {'author': 'Price Brendan D',\n",
       "  'cluster': 2,\n",
       "  'title': 'Chromatin remodeling at DNA double-strand breaks.'},\n",
       " {'author': 'Rai Kunal',\n",
       "  'cluster': 1,\n",
       "  'title': 'DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC.'},\n",
       " {'author': 'Fuchs Yaron',\n",
       "  'cluster': 4,\n",
       "  'title': 'Programmed cell death in animal development and disease.'},\n",
       " {'author': 'Spitali Pietro',\n",
       "  'cluster': 0,\n",
       "  'title': 'Splice modulating therapies for human disease.'},\n",
       " {'author': 'Chang Kai-Hsiung',\n",
       "  'cluster': 0,\n",
       "  'title': 'A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.'},\n",
       " {'author': 'Li Vivian S W',\n",
       "  'cluster': 1,\n",
       "  'title': u'Wnt signaling through inhibition of \\u03b2-catenin degradation in an intact Axin1 complex.'},\n",
       " {'author': 'Varfolomeev Eugene',\n",
       "  'cluster': 1,\n",
       "  'title': 'IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.'},\n",
       " {'author': 'Tang Yun-Chi',\n",
       "  'cluster': 2,\n",
       "  'title': 'Gene copy-number alterations: a cost-benefit analysis.'},\n",
       " {'author': 'Celeste Arkady',\n",
       "  'cluster': 2,\n",
       "  'title': 'H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.'},\n",
       " {'author': 'Liu Pengfei',\n",
       "  'cluster': 2,\n",
       "  'title': 'Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements.'},\n",
       " {'author': 'Licht Jonathan D',\n",
       "  'cluster': 4,\n",
       "  'title': 'DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.'},\n",
       " {'author': 'Wang Xinjiang',\n",
       "  'cluster': 1,\n",
       "  'title': 'NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.'},\n",
       " {'author': 'Yamada Kenneth M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Modeling tissue morphogenesis and cancer in 3D.'},\n",
       " {'author': 'Parnas Oren',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks.'},\n",
       " {'author': 'Scurr Lyndee L',\n",
       "  'cluster': 1,\n",
       "  'title': 'IGFBP7 is not required for B-RAF-induced melanocyte senescence.'},\n",
       " {'author': 'Shackleton Mark',\n",
       "  'cluster': 4,\n",
       "  'title': 'Heterogeneity in cancer: cancer stem cells versus clonal evolution.'},\n",
       " {'author': 'Gupta Gaorav P',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer metastasis: building a framework.'},\n",
       " {'author': 'Teperino Raffaele',\n",
       "  'cluster': 1,\n",
       "  'title': 'Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.'},\n",
       " {'author': 'Bassing Craig H',\n",
       "  'cluster': 2,\n",
       "  'title': 'Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.'},\n",
       " {'author': 'Wodarz Andreas',\n",
       "  'cluster': 4,\n",
       "  'title': 'Connecting cancer to the asymmetric division of stem cells.'},\n",
       " {'author': 'Choo Andrew Y',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mind the GAP: Wnt steps onto the mTORC1 train.'},\n",
       " {'author': 'Lee Joo Sang',\n",
       "  'cluster': 4,\n",
       "  'title': 'Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures.'},\n",
       " {'author': 'Baca Sylvan C',\n",
       "  'cluster': 2,\n",
       "  'title': 'Punctuated evolution of prostate cancer genomes.'},\n",
       " {'author': 'Paek Andrew L',\n",
       "  'cluster': 3,\n",
       "  'title': 'Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.'},\n",
       " {'author': 'Yu Fa-Xing',\n",
       "  'cluster': 1,\n",
       "  'title': 'Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.'},\n",
       " {'author': 'Quigley David A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.'},\n",
       " {'author': 'Hua Junjie Tony',\n",
       "  'cluster': 1,\n",
       "  'title': 'Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.'},\n",
       " {'author': 'Gao Ping',\n",
       "  'cluster': 0,\n",
       "  'title': 'Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.'},\n",
       " {'author': 'Varfolomeev Eugene E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tumor necrosis factor: an apoptosis JuNKie?'},\n",
       " {'author': 'Salmena Leonardo',\n",
       "  'cluster': 1,\n",
       "  'title': 'A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?'},\n",
       " {'author': 'Liu Junli',\n",
       "  'cluster': 1,\n",
       "  'title': u'Inflammation Improves Glucose Homeostasis through IKK\\u03b2-XBP1s Interaction.'},\n",
       " {'author': 'Walton Zandra E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR.'},\n",
       " {'author': 'Phelps Reid A',\n",
       "  'cluster': 1,\n",
       "  'title': 'A two-step model for colon adenoma initiation and progression caused by APC loss.'},\n",
       " {'author': 'Wu Yi-Mi',\n",
       "  'cluster': 2,\n",
       "  'title': 'Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.'},\n",
       " {'author': 'Athuluri-Divakar Sai Krishna',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.'},\n",
       " {'author': 'Schug Thaddeus T',\n",
       "  'cluster': 1,\n",
       "  'title': 'Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.'},\n",
       " {'author': 'Zhan Lixing',\n",
       "  'cluster': 1,\n",
       "  'title': 'Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.'},\n",
       " {'author': 'Simon David J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Axon Degeneration Gated by Retrograde Activation of Somatic Pro-apoptotic Signaling.'},\n",
       " {'author': \"Pe'er Dana\",\n",
       "  'cluster': 0,\n",
       "  'title': 'Principles and strategies for developing network models in cancer.'},\n",
       " {'author': 'Kim Miriam Y',\n",
       "  'cluster': 4,\n",
       "  'title': 'Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.'},\n",
       " {'author': 'Vian Laura',\n",
       "  'cluster': 2,\n",
       "  'title': 'The Energetics and Physiological Impact of Cohesin Extrusion.'},\n",
       " {'author': 'Cho Jang Hwan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses.'},\n",
       " {'author': 'Sullivan William J',\n",
       "  'cluster': 1,\n",
       "  'title': 'The metabolic milieu of metastases.'},\n",
       " {'author': 'Procko Erik',\n",
       "  'cluster': 1,\n",
       "  'title': 'A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells.'},\n",
       " {'author': 'Bailey Matthew H',\n",
       "  'cluster': 2,\n",
       "  'title': 'Comprehensive Characterization of Cancer Driver Genes and Mutations.'},\n",
       " {'author': 'Xiao Gang',\n",
       "  'cluster': 4,\n",
       "  'title': 'B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.'},\n",
       " {'author': 'Ricketts Christopher J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.'},\n",
       " {'author': 'Turajlic Samra',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.'},\n",
       " {'author': 'Mitchell Thomas J',\n",
       "  'cluster': 2,\n",
       "  'title': 'Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.'},\n",
       " {'author': 'Huang Kuan-Lin',\n",
       "  'cluster': 2,\n",
       "  'title': 'Pathogenic Germline Variants in 10,389 Adult Cancers.'},\n",
       " {'author': 'Sanchez-Vega Francisco',\n",
       "  'cluster': 2,\n",
       "  'title': 'Oncogenic Signaling Pathways in The Cancer Genome Atlas.'},\n",
       " {'author': 'Sekulic Aleksandar',\n",
       "  'cluster': 0,\n",
       "  'title': 'Hedgehog Pathway Inhibition.'},\n",
       " {'author': 'Laplante Mathieu',\n",
       "  'cluster': 1,\n",
       "  'title': 'mTOR signaling in growth control and disease.'},\n",
       " {'author': 'Ambrogio Chiara',\n",
       "  'cluster': 1,\n",
       "  'title': 'KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.'},\n",
       " {'author': 'Voorhoeve P Mathijs',\n",
       "  'cluster': 3,\n",
       "  'title': 'A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.'},\n",
       " {'author': 'Der Channing J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Stopping ras in its tracks.'},\n",
       " {'author': 'Chen Guangbo',\n",
       "  'cluster': 0,\n",
       "  'title': 'Targeting the adaptability of heterogeneous aneuploids.'},\n",
       " {'author': 'Janes Matthew R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.'},\n",
       " {'author': 'Loewer Alexander',\n",
       "  'cluster': 3,\n",
       "  'title': 'Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.'},\n",
       " {'author': 'Brennan Cameron W',\n",
       "  'cluster': 0,\n",
       "  'title': 'The somatic genomic landscape of glioblastoma.'},\n",
       " {'author': 'Irie Naoko',\n",
       "  'cluster': 4,\n",
       "  'title': 'SOX17 is a critical specifier of human primordial germ cell fate.'},\n",
       " {'author': 'Yu Fengyan',\n",
       "  'cluster': 4,\n",
       "  'title': 'let-7 regulates self renewal and tumorigenicity of breast cancer cells.'},\n",
       " {'author': 'Chen Jian',\n",
       "  'cluster': 4,\n",
       "  'title': 'Malignant glioma: lessons from genomics, mouse models, and stem cells.'},\n",
       " {'author': 'Andrews M C',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer Evolution during Immunotherapy.'},\n",
       " {'author': 'Kim Jonghwan',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.'},\n",
       " {'author': 'Bakhoum Samuel F',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cancer Evolution: No Room for Negative Selection.'},\n",
       " {'author': 'Murchison Elizabeth P',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.'},\n",
       " {'author': 'Hah Nasun',\n",
       "  'cluster': 1,\n",
       "  'title': 'A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.'},\n",
       " {'author': 'Bassermann Florian',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.'},\n",
       " {'author': 'Franco Hector L',\n",
       "  'cluster': 4,\n",
       "  'title': 'No driver behind the wheel? Targeting transcription in cancer.'},\n",
       " {'author': 'Shimono Yohei',\n",
       "  'cluster': 4,\n",
       "  'title': 'Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.'},\n",
       " {'author': 'Bierie Brian',\n",
       "  'cluster': 4,\n",
       "  'title': 'Under pressure: stromal fibroblasts change their ways.'},\n",
       " {'author': 'Stockwell Brent R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.'},\n",
       " {'author': 'Martello Graziano',\n",
       "  'cluster': 4,\n",
       "  'title': 'A MicroRNA targeting dicer for metastasis control.'},\n",
       " {'author': 'Olive Kenneth P',\n",
       "  'cluster': 3,\n",
       "  'title': 'Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.'},\n",
       " {'author': 'Font-Burgada Joan',\n",
       "  'cluster': 4,\n",
       "  'title': 'Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.'},\n",
       " {'author': 'Krimpenfort Paul',\n",
       "  'cluster': 3,\n",
       "  'title': 'Rejuvenation by Therapeutic Elimination of Senescent Cells.'},\n",
       " {'author': 'Baar Marjolein P',\n",
       "  'cluster': 3,\n",
       "  'title': 'Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.'},\n",
       " {'author': 'Nguyen Don X',\n",
       "  'cluster': 4,\n",
       "  'title': 'WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.'},\n",
       " {'author': 'King Bryan',\n",
       "  'cluster': 1,\n",
       "  'title': 'The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.'},\n",
       " {'author': 'Verbrugge Inge',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: Extrinsic apoptosis pathways.'},\n",
       " {'author': 'Rommereim Leah M',\n",
       "  'cluster': 4,\n",
       "  'title': 'AIMing 2 Curtail Cancer.'},\n",
       " {'author': 'Hua Sujun',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.'},\n",
       " {'author': 'Yang Feng-Chun',\n",
       "  'cluster': 4,\n",
       "  'title': 'Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.'},\n",
       " {'author': 'Piskounova Elena',\n",
       "  'cluster': 1,\n",
       "  'title': 'Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.'},\n",
       " {'author': 'Taniguchi Cullen',\n",
       "  'cluster': 4,\n",
       "  'title': \"It's a SMAD/SMAD World.\"},\n",
       " {'author': 'Kitambi Satish Srinivas',\n",
       "  'cluster': 1,\n",
       "  'title': 'RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.'},\n",
       " {'author': 'Shaul Yoav D',\n",
       "  'cluster': 4,\n",
       "  'title': 'Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.'},\n",
       " {'author': 'Han Bing',\n",
       "  'cluster': 1,\n",
       "  'title': 'Microbial Genetic Composition Tunes Host Longevity.'},\n",
       " {'author': 'Tan Shawn Lu Wen',\n",
       "  'cluster': 2,\n",
       "  'title': 'A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.'},\n",
       " {'author': 'Chiarle Roberto',\n",
       "  'cluster': 2,\n",
       "  'title': 'Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells.'},\n",
       " {'author': 'Karisch Robert',\n",
       "  'cluster': 1,\n",
       "  'title': 'Global proteomic assessment of the classical protein-tyrosine phosphatome and \"Redoxome\".'},\n",
       " {'author': 'Lehrman Emily K',\n",
       "  'cluster': 4,\n",
       "  'title': 'Shedding light on glioma growth.'},\n",
       " {'author': 'Leslie Nick R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mutant PTEN in Cancer: Worse Than Nothing.'},\n",
       " {'author': 'Klein Isaac A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes.'},\n",
       " {'author': 'Kota Janaiah',\n",
       "  'cluster': 4,\n",
       "  'title': 'Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.'},\n",
       " {'author': 'Menon Suchithra',\n",
       "  'cluster': 1,\n",
       "  'title': 'Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.'},\n",
       " {'author': 'Benjamin Don',\n",
       "  'cluster': 1,\n",
       "  'title': 'mTORC1: turning off is just as important as turning on.'},\n",
       " {'author': 'Davoli Teresa',\n",
       "  'cluster': 2,\n",
       "  'title': 'Persistent telomere damage induces bypass of mitosis and tetraploidy.'},\n",
       " {'author': 'Cunningham John T',\n",
       "  'cluster': 1,\n",
       "  'title': 'Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.'},\n",
       " {'author': 'Gai Dahai',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen.'},\n",
       " {'author': 'Fukumura D',\n",
       "  'cluster': 4,\n",
       "  'title': 'Tumor induction of VEGF promoter activity in stromal cells.'},\n",
       " {'author': 'Junttila Melissa R',\n",
       "  'cluster': 1,\n",
       "  'title': 'CIP2A inhibits PP2A in human malignancies.'},\n",
       " {'author': u'Gr\\xf6schel Stefan',\n",
       "  'cluster': 2,\n",
       "  'title': 'A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.'},\n",
       " {'author': 'Damgaard Rune Busk',\n",
       "  'cluster': 4,\n",
       "  'title': 'The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.'},\n",
       " {'author': 'Ruijtenberg Suzan',\n",
       "  'cluster': 4,\n",
       "  'title': 'G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation.'},\n",
       " {'author': 'Wei Yongjie',\n",
       "  'cluster': 1,\n",
       "  'title': 'Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor.'},\n",
       " {'author': 'Bonetta Laura',\n",
       "  'cluster': 2,\n",
       "  'title': 'Whole-genome sequencing breaks the cost barrier.'},\n",
       " {'author': 'Lemmon Mark A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cell signaling by receptor tyrosine kinases.'},\n",
       " {'author': 'Loh Kyle M',\n",
       "  'cluster': 4,\n",
       "  'title': 'Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types.'},\n",
       " {'author': 'Kadoch Cigall',\n",
       "  'cluster': 1,\n",
       "  'title': 'Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.'},\n",
       " {'author': 'Vo Thanh-Trang',\n",
       "  'cluster': 0,\n",
       "  'title': 'Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.'},\n",
       " {'author': u'Bernards Ren\\xe9',\n",
       "  'cluster': 2,\n",
       "  'title': 'RNAi Delivers Insights into Liver Cancer.'},\n",
       " {'author': 'Karberg Sascha',\n",
       "  'cluster': 0,\n",
       "  'title': 'Switching on epigenetic therapy.'},\n",
       " {'author': 'Acosta Juan C',\n",
       "  'cluster': 3,\n",
       "  'title': 'Chemokine signaling via the CXCR2 receptor reinforces senescence.'},\n",
       " {'author': 'Xiong Huizhong',\n",
       "  'cluster': 1,\n",
       "  'title': 'Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance.'},\n",
       " {'author': 'Elosegui-Artola Alberto',\n",
       "  'cluster': 1,\n",
       "  'title': 'Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores.'},\n",
       " {'author': 'Sumazin Pavel',\n",
       "  'cluster': 1,\n",
       "  'title': 'An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.'},\n",
       " {'author': 'Thiery Jean Paul',\n",
       "  'cluster': 4,\n",
       "  'title': 'Epithelial-mesenchymal transitions in development and disease.'},\n",
       " {'author': 'Chaffer Christine L',\n",
       "  'cluster': 4,\n",
       "  'title': 'Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.'},\n",
       " {'author': 'Wyant Gregory A',\n",
       "  'cluster': 1,\n",
       "  'title': 'mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient.'},\n",
       " {'author': 'Rao Suhas S P',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cohesin Loss Eliminates All Loop Domains.'},\n",
       " {'author': 'Sykes Stephen M',\n",
       "  'cluster': 1,\n",
       "  'title': 'AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.'},\n",
       " {'author': 'Wang Qianben',\n",
       "  'cluster': 1,\n",
       "  'title': 'Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.'},\n",
       " {'author': 'Farago Anna F',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: Lung cancer models.'},\n",
       " {'author': 'Dirks Peter B',\n",
       "  'cluster': 4,\n",
       "  'title': 'MicroRNAs and parallel stem cell lives.'},\n",
       " {'author': 'Rossi John J',\n",
       "  'cluster': 1,\n",
       "  'title': 'New hope for a microRNA therapy for liver cancer.'},\n",
       " {'author': 'Leppek Kathrin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs.'},\n",
       " {'author': 'Chen Kun',\n",
       "  'cluster': 1,\n",
       "  'title': 'Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.'},\n",
       " {'author': u'Nussenzweig Andr\\xe9',\n",
       "  'cluster': 2,\n",
       "  'title': 'Origin of chromosomal translocations in lymphoid cancer.'},\n",
       " {'author': 'Martins Carla P',\n",
       "  'cluster': 3,\n",
       "  'title': 'Modeling the therapeutic efficacy of p53 restoration in tumors.'},\n",
       " {'author': 'Anastasi Sergio',\n",
       "  'cluster': 1,\n",
       "  'title': 'Lack of Evidence that CYTH2/ARNO Functions as a Direct Intracellular EGFR Activator.'},\n",
       " {'author': 'Sumpter Rhea',\n",
       "  'cluster': 2,\n",
       "  'title': 'Fanconi Anemia Proteins Function in Mitophagy and Immunity.'},\n",
       " {'author': 'Lian Christine Guo',\n",
       "  'cluster': 1,\n",
       "  'title': 'Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.'},\n",
       " {'author': 'Yancopoulos George D',\n",
       "  'cluster': 0,\n",
       "  'title': 'Clinical application of therapies targeting VEGF.'},\n",
       " {'author': 'Han Sang Jun',\n",
       "  'cluster': 1,\n",
       "  'title': u'Estrogen Receptor \\u03b2 Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis.'},\n",
       " {'author': 'Lottersberger Francisca',\n",
       "  'cluster': 2,\n",
       "  'title': '53BP1 and the LINC Complex Promote Microtubule-Dependent DSB Mobility and DNA Repair.'},\n",
       " {'author': 'Torres Eduardo M',\n",
       "  'cluster': 2,\n",
       "  'title': 'Identification of aneuploidy-tolerating mutations.'},\n",
       " {'author': 'Li Zhaoyu',\n",
       "  'cluster': 1,\n",
       "  'title': 'Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.'},\n",
       " {'author': u'Medema Ren\\xe9 H',\n",
       "  'cluster': 2,\n",
       "  'title': 'The X factor: skewing X inactivation towards cancer.'},\n",
       " {'author': 'Mo Wei',\n",
       "  'cluster': 1,\n",
       "  'title': 'CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.'},\n",
       " {'author': 'Liu Junli',\n",
       "  'cluster': 3,\n",
       "  'title': 'Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.'},\n",
       " {'author': 'Sing Anson',\n",
       "  'cluster': 1,\n",
       "  'title': 'The atypical cadherin fat directly regulates mitochondrial function and metabolic state.'},\n",
       " {'author': 'Moscat Jorge',\n",
       "  'cluster': 1,\n",
       "  'title': 'p62 at the crossroads of autophagy, apoptosis, and cancer.'},\n",
       " {'author': 'Wei Pei-Chi',\n",
       "  'cluster': 2,\n",
       "  'title': 'Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells.'},\n",
       " {'author': 'Cui Rutao',\n",
       "  'cluster': 3,\n",
       "  'title': 'Central role of p53 in the suntan response and pathologic hyperpigmentation.'},\n",
       " {'author': 'Tuteja Geetu',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: forkhead transcription factors I.'},\n",
       " {'author': 'Sibilia M',\n",
       "  'cluster': 1,\n",
       "  'title': 'The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development.'},\n",
       " {'author': 'Liu Bo',\n",
       "  'cluster': 1,\n",
       "  'title': 'Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila.'},\n",
       " {'author': 'Cichowski K',\n",
       "  'cluster': 1,\n",
       "  'title': 'NF1 tumor suppressor gene function: narrowing the GAP.'},\n",
       " {'author': 'Gonzales Kevin Andrew Uy',\n",
       "  'cluster': 1,\n",
       "  'title': 'Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways.'},\n",
       " {'author': 'Levine Arnold J',\n",
       "  'cluster': 1,\n",
       "  'title': 'P53 is a tumor suppressor gene.'},\n",
       " {'author': 'Hu Mickey C-T',\n",
       "  'cluster': 1,\n",
       "  'title': 'IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.'},\n",
       " {'author': 'Chang Lufen',\n",
       "  'cluster': 1,\n",
       "  'title': 'The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.'},\n",
       " {'author': 'Mantel Charlie R',\n",
       "  'cluster': 4,\n",
       "  'title': 'Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.'},\n",
       " {'author': 'Oren Moshe', 'cluster': 3, 'title': 'The sunny side of p53.'},\n",
       " {'author': 'Arora Vivek K',\n",
       "  'cluster': 0,\n",
       "  'title': 'Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.'},\n",
       " {'author': 'Guo Wenjun',\n",
       "  'cluster': 4,\n",
       "  'title': 'Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.'},\n",
       " {'author': 'Agami Reuven',\n",
       "  'cluster': 2,\n",
       "  'title': 'All roads lead to IKKepsilon.'},\n",
       " {'author': 'Clohessy John G',\n",
       "  'cluster': 4,\n",
       "  'title': 'beta-tting on p63 as a metastatic suppressor.'},\n",
       " {'author': 'Crighton Diane',\n",
       "  'cluster': 3,\n",
       "  'title': 'DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.'},\n",
       " {'author': 'Green Douglas R',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53 and metabolism: Inside the TIGAR.'},\n",
       " {'author': 'Vince James E',\n",
       "  'cluster': 1,\n",
       "  'title': 'IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.'},\n",
       " {'author': 'Fan Zusen',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.'},\n",
       " {'author': 'Kaplan Mohammed',\n",
       "  'cluster': 1,\n",
       "  'title': 'EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMR.'},\n",
       " {'author': 'Greten Florian R',\n",
       "  'cluster': 4,\n",
       "  'title': 'IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.'},\n",
       " {'author': 'Chen Chih-Chiang',\n",
       "  'cluster': 1,\n",
       "  'title': 'Organ-level quorum sensing directs regeneration in hair stem cell populations.'},\n",
       " {'author': 'Foti James J',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: DNA polymerases II mammals.'},\n",
       " {'author': 'Martin Richard W',\n",
       "  'cluster': 2,\n",
       "  'title': 'The Yin and Yang of treating BRCA-deficient tumors.'},\n",
       " {'author': 'Akavia Uri David',\n",
       "  'cluster': 2,\n",
       "  'title': 'An integrated approach to uncover drivers of cancer.'},\n",
       " {'author': 'Lamason Rebecca L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Rickettsia Sca4 Reduces Vinculin-Mediated Intercellular Tension to Promote Spread.'},\n",
       " {'author': 'Richter-Dennerlein Ricarda',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mitochondrial Protein Synthesis Adapts to Influx of Nuclear-Encoded Protein.'},\n",
       " {'author': 'Eroglu Elif',\n",
       "  'cluster': 1,\n",
       "  'title': 'SWI/SNF complex prevents lineage reversion and induces temporal patterning in neural stem cells.'},\n",
       " {'author': 'Wang Yan',\n",
       "  'cluster': 1,\n",
       "  'title': 'LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.'},\n",
       " {'author': 'Kleiman F E',\n",
       "  'cluster': 1,\n",
       "  'title': \"The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.\"},\n",
       " {'author': 'Thoms Matthias',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins.'},\n",
       " {'author': 'Silver Daniel P',\n",
       "  'cluster': 2,\n",
       "  'title': 'Further evidence for BRCA1 communication with the inactive X chromosome.'},\n",
       " {'author': 'Pencheva Nora',\n",
       "  'cluster': 4,\n",
       "  'title': 'Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.'},\n",
       " {'author': 'Budanov Andrei V',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.'},\n",
       " {'author': 'Iijima Miho',\n",
       "  'cluster': 1,\n",
       "  'title': 'Tumor suppressor PTEN mediates sensing of chemoattractant gradients.'},\n",
       " {'author': 'Viswanathan Srinivas R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Lin28: A microRNA regulator with a macro role.'},\n",
       " {'author': 'Taylor Martin R G',\n",
       "  'cluster': 1,\n",
       "  'title': 'Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination.'},\n",
       " {'author': 'Park In Young',\n",
       "  'cluster': 1,\n",
       "  'title': 'Dual Chromatin and Cytoskeletal Remodeling by SETD2.'},\n",
       " {'author': 'Overholtzer Michael',\n",
       "  'cluster': 4,\n",
       "  'title': 'A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.'},\n",
       " {'author': 'Kellogg Ryan A',\n",
       "  'cluster': 4,\n",
       "  'title': 'Noise facilitates transcriptional control under dynamic inputs.'},\n",
       " {'author': 'Aran Dvir',\n",
       "  'cluster': 1,\n",
       "  'title': 'DNA methylation of transcriptional enhancers and cancer predisposition.'},\n",
       " {'author': 'Rosshart Stephan P',\n",
       "  'cluster': 1,\n",
       "  'title': 'Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance.'},\n",
       " {'author': 'Jongsma Marlieke L M',\n",
       "  'cluster': 1,\n",
       "  'title': 'An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport.'},\n",
       " {'author': 'Zhao Xuan',\n",
       "  'cluster': 1,\n",
       "  'title': u'Circadian Amplitude Regulation via FBXW7-Targeted REV-ERB\\u03b1 Degradation.'},\n",
       " {'author': 'Rasko John E J',\n",
       "  'cluster': 0,\n",
       "  'title': 'First Approved Kinase Inhibitor for AML.'},\n",
       " {'author': 'Cappell Steven D',\n",
       "  'cluster': 1,\n",
       "  'title': 'Irreversible APC(Cdh1) Inactivation Underlies the Point of No Return for Cell-Cycle Entry.'},\n",
       " {'author': 'Sannerud Ragna',\n",
       "  'cluster': 1,\n",
       "  'title': u'Restricted Location of PSEN2/\\u03b3-Secretase Determines Substrate Specificity and Generates an Intracellular A\\u03b2 Pool.'},\n",
       " {'author': 'Luo Ji',\n",
       "  'cluster': 1,\n",
       "  'title': 'A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.'},\n",
       " {'author': u'Esp\\xedn-Palaz\\xf3n Raquel',\n",
       "  'cluster': 4,\n",
       "  'title': 'Proinflammatory signaling regulates hematopoietic stem cell emergence.'},\n",
       " {'author': 'Vousden Karen H',\n",
       "  'cluster': 3,\n",
       "  'title': 'Blinded by the Light: The Growing Complexity of p53.'},\n",
       " {'author': 'Teater Matt',\n",
       "  'cluster': 0,\n",
       "  'title': 'Untangling the Web of Lymphoma Somatic Mutations.'},\n",
       " {'author': 'Hsu Peggy P',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cancer cell metabolism: Warburg and beyond.'},\n",
       " {'author': 'Tang Yi',\n",
       "  'cluster': 3,\n",
       "  'title': 'Acetylation is indispensable for p53 activation.'},\n",
       " {'author': 'Shorter James',\n",
       "  'cluster': 2,\n",
       "  'title': \"Prion-like Domains Program Ewing's Sarcoma.\"},\n",
       " {'author': 'Shum Eleen Y',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Antagonistic Gene Paralogs Upf3a and Upf3b Govern Nonsense-Mediated RNA Decay.'},\n",
       " {'author': 'Haanen John B A G',\n",
       "  'cluster': 4,\n",
       "  'title': 'Converting Cold into Hot Tumors by Combining Immunotherapies.'},\n",
       " {'author': 'Lauberth Shannon M',\n",
       "  'cluster': 3,\n",
       "  'title': 'H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation.'},\n",
       " {'author': 'Peng Min',\n",
       "  'cluster': 1,\n",
       "  'title': 'Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.'},\n",
       " {'author': 'Acilan Ceyda',\n",
       "  'cluster': 2,\n",
       "  'title': 'A tale of too many centrosomes.'},\n",
       " {'author': 'Basu Roshni',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing.'},\n",
       " {'author': 'Welch Matthew D',\n",
       "  'cluster': 4,\n",
       "  'title': 'Cell migration, freshly squeezed.'},\n",
       " {'author': 'Lamb Justin',\n",
       "  'cluster': 1,\n",
       "  'title': 'A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.'},\n",
       " {'author': 'Yuen Tracy J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis.'},\n",
       " {'author': 'Maecker Heather',\n",
       "  'cluster': 4,\n",
       "  'title': 'TWEAK attenuates the transition from innate to adaptive immunity.'},\n",
       " {'author': 'Jain Saumya',\n",
       "  'cluster': 1,\n",
       "  'title': 'ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.'},\n",
       " {'author': 'Cully Megan', 'cluster': 1, 'title': 'SnapShot: Ras Signaling.'},\n",
       " {'author': 'York Autumn G',\n",
       "  'cluster': 1,\n",
       "  'title': 'Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.'},\n",
       " {'author': 'Hart Traver',\n",
       "  'cluster': 1,\n",
       "  'title': 'High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.'},\n",
       " {'author': 'Wu Wen-Shu',\n",
       "  'cluster': 3,\n",
       "  'title': 'Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.'},\n",
       " {'author': 'Vavouri Tanya',\n",
       "  'cluster': 1,\n",
       "  'title': 'Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity.'},\n",
       " {'author': 'Biton Sharon',\n",
       "  'cluster': 1,\n",
       "  'title': u'NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-\\u03b1 feedforward signaling.'},\n",
       " {'author': 'Gilbert Luke A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.'},\n",
       " {'author': 'Oberdoerffer Philipp',\n",
       "  'cluster': 2,\n",
       "  'title': 'SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.'},\n",
       " {'author': 'Baker Nicholas E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Metabolism and the other fat: a protocadherin in mitochondria.'},\n",
       " {'author': 'Tothova Zuzana',\n",
       "  'cluster': 1,\n",
       "  'title': 'Doubling Down on Mutant RAS Can MEK or Break Leukemia.'},\n",
       " {'author': 'Spencer David H',\n",
       "  'cluster': 0,\n",
       "  'title': 'CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.'},\n",
       " {'author': 'Chen Zhu', 'cluster': 1, 'title': 'Poisoning the Devil.'},\n",
       " {'author': 'Narita Masashi',\n",
       "  'cluster': 3,\n",
       "  'title': 'A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.'},\n",
       " {'author': 'Kind Jop',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genome-wide maps of nuclear lamina interactions in single human cells.'},\n",
       " {'author': 'Molliex Amandine',\n",
       "  'cluster': 1,\n",
       "  'title': 'Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization.'},\n",
       " {'author': u'Alarc\\xf3n Claudio R',\n",
       "  'cluster': 1,\n",
       "  'title': 'HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.'},\n",
       " {'author': 'Homem Catarina C F',\n",
       "  'cluster': 4,\n",
       "  'title': 'Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells.'},\n",
       " {'author': 'Rikova Klarisa',\n",
       "  'cluster': 1,\n",
       "  'title': 'Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.'},\n",
       " {'author': 'Liang Kaiwei',\n",
       "  'cluster': 1,\n",
       "  'title': 'Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.'},\n",
       " {'author': 'Demetriades Constantinos',\n",
       "  'cluster': 1,\n",
       "  'title': 'Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.'},\n",
       " {'author': 'Shah Govind A',\n",
       "  'cluster': 2,\n",
       "  'title': 'Viral and Cellular Genomes Activate Distinct DNA Damage Responses.'},\n",
       " {'author': 'Willis T G',\n",
       "  'cluster': 1,\n",
       "  'title': 'Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.'},\n",
       " {'author': 'Bensaad Karim',\n",
       "  'cluster': 3,\n",
       "  'title': 'TIGAR, a p53-inducible regulator of glycolysis and apoptosis.'},\n",
       " {'author': 'Nair-Gupta Priyanka',\n",
       "  'cluster': 1,\n",
       "  'title': 'TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.'},\n",
       " {'author': 'Azzolin Luca',\n",
       "  'cluster': 1,\n",
       "  'title': u'YAP/TAZ incorporation in the \\u03b2-catenin destruction complex orchestrates the Wnt response.'},\n",
       " {'author': 'Chu Isabel',\n",
       "  'cluster': 1,\n",
       "  'title': 'p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.'},\n",
       " {'author': 'Longo Valter D',\n",
       "  'cluster': 1,\n",
       "  'title': 'Sirtuins in aging and age-related disease.'},\n",
       " {'author': 'Rossi Derrick J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stems cells and the pathways to aging and cancer.'},\n",
       " {'author': 'Schiwon Marzena',\n",
       "  'cluster': 4,\n",
       "  'title': 'Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.'},\n",
       " {'author': 'Vaseva Angelina V',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53 opens the mitochondrial permeability transition pore to trigger necrosis.'},\n",
       " {'author': 'Sullivan Lucas B',\n",
       "  'cluster': 1,\n",
       "  'title': 'Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells.'},\n",
       " {'author': 'Borowiak Malgorzata',\n",
       "  'cluster': 1,\n",
       "  'title': 'Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death.'},\n",
       " {'author': 'Jochemsen Aart G',\n",
       "  'cluster': 3,\n",
       "  'title': 'USP10: friend and foe.'},\n",
       " {'author': 'Niphakis Micah J',\n",
       "  'cluster': 1,\n",
       "  'title': 'A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells.'},\n",
       " {'author': 'Reijns Martin A M',\n",
       "  'cluster': 2,\n",
       "  'title': 'Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development.'},\n",
       " {'author': 'Lyssiotis Costas A',\n",
       "  'cluster': 4,\n",
       "  'title': \"SIRT6 puts cancer metabolism in the driver's seat.\"},\n",
       " {'author': 'Williams Samuel A',\n",
       "  'cluster': 1,\n",
       "  'title': 'USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.'},\n",
       " {'author': 'Delmore Jake E',\n",
       "  'cluster': 1,\n",
       "  'title': 'BET bromodomain inhibition as a therapeutic strategy to target c-Myc.'},\n",
       " {'author': 'Latif Anne-Louise',\n",
       "  'cluster': 0,\n",
       "  'title': 'Lifting the Differentiation Embargo.'},\n",
       " {'author': 'Papa Antonella',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.'},\n",
       " {'author': 'Sykes David B',\n",
       "  'cluster': 4,\n",
       "  'title': 'Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.'},\n",
       " {'author': 'Nik-Zainal Serena',\n",
       "  'cluster': 2,\n",
       "  'title': 'Mutational processes molding the genomes of 21 breast cancers.'},\n",
       " {'author': 'Stange Daniel E',\n",
       "  'cluster': 4,\n",
       "  'title': 'Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium.'},\n",
       " {'author': 'Fanucchi Stephanie',\n",
       "  'cluster': 1,\n",
       "  'title': 'Chromosomal contact permits transcription between coregulated genes.'},\n",
       " {'author': 'Benanti Erin L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Virulent Burkholderia species mimic host actin polymerases to drive actin-based motility.'},\n",
       " {'author': 'Luna Joseph M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Hepatitis C virus RNA functionally sequesters miR-122.'},\n",
       " {'author': 'Vyas Sejal', 'cluster': 1, 'title': 'Mitochondria and Cancer.'},\n",
       " {'author': 'Guo Wenjun',\n",
       "  'cluster': 4,\n",
       "  'title': 'Slug and Sox9 cooperatively determine the mammary stem cell state.'},\n",
       " {'author': 'Liu Yan-Jun',\n",
       "  'cluster': 4,\n",
       "  'title': 'Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells.'},\n",
       " {'author': 'Clarke Michael F',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stem cells and cancer: two faces of eve.'},\n",
       " {'author': 'Green Douglas R',\n",
       "  'cluster': 1,\n",
       "  'title': 'A BH3 Mimetic for Killing Cancer Cells.'},\n",
       " {'author': 'Kamijo T',\n",
       "  'cluster': 3,\n",
       "  'title': 'Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.'},\n",
       " {'author': 'Puc Janusz',\n",
       "  'cluster': 1,\n",
       "  'title': 'Ligand-dependent enhancer activation regulated by topoisomerase-I activity.'},\n",
       " {'author': 'Tang Zhanyun',\n",
       "  'cluster': 3,\n",
       "  'title': 'SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.'},\n",
       " {'author': 'Silva Jose M',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cyfip1 is a putative invasion suppressor in epithelial cancers.'},\n",
       " {'author': 'Deutsch Gregor B',\n",
       "  'cluster': 1,\n",
       "  'title': u'DNA damage in oocytes induces a switch of the quality control factor TAp63\\u03b1 from dimer to tetramer.'},\n",
       " {'author': 'Aparicio Samuel',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53: a new kingpin in the stem cell arena.'},\n",
       " {'author': 'Yilmaz Bahtiyar',\n",
       "  'cluster': 1,\n",
       "  'title': 'Gut microbiota elicits a protective immune response against malaria transmission.'},\n",
       " {'author': 'Callen Elsa',\n",
       "  'cluster': 2,\n",
       "  'title': '53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions.'},\n",
       " {'author': 'Maryanovich Maria',\n",
       "  'cluster': 4,\n",
       "  'title': 'A Time Bomb for Leukemia.'},\n",
       " {'author': 'Shen Hongjie',\n",
       "  'cluster': 1,\n",
       "  'title': 'Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.'},\n",
       " {'author': 'Puram Rishi V',\n",
       "  'cluster': 4,\n",
       "  'title': 'Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.'},\n",
       " {'author': 'Zhang Dong',\n",
       "  'cluster': 1,\n",
       "  'title': 'A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.'},\n",
       " {'author': 'Banito Ana',\n",
       "  'cluster': 1,\n",
       "  'title': 'A new development in senescence.'},\n",
       " {'author': 'Storer Mekayla',\n",
       "  'cluster': 3,\n",
       "  'title': 'Senescence is a developmental mechanism that contributes to embryonic growth and patterning.'},\n",
       " {'author': 'Ollmann M',\n",
       "  'cluster': 3,\n",
       "  'title': 'Drosophila p53 is a structural and functional homolog of the tumor suppressor p53.'},\n",
       " {'author': 'Sidi Samuel',\n",
       "  'cluster': 3,\n",
       "  'title': 'Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.'},\n",
       " {'author': 'Ajioka Itsuki',\n",
       "  'cluster': 1,\n",
       "  'title': 'Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice.'},\n",
       " {'author': 'Vanharanta Sakari',\n",
       "  'cluster': 2,\n",
       "  'title': 'Field cancerization: something new under the sun.'},\n",
       " {'author': 'Majzoub Karim',\n",
       "  'cluster': 1,\n",
       "  'title': 'RACK1 controls IRES-mediated translation of viruses.'},\n",
       " {'author': 'Uehata Takuya',\n",
       "  'cluster': 4,\n",
       "  'title': 'Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation.'},\n",
       " {'author': 'Yaswen Paul',\n",
       "  'cluster': 3,\n",
       "  'title': 'Oncogene-induced senescence pathways weave an intricate tapestry.'},\n",
       " {'author': 'Collado Manuel',\n",
       "  'cluster': 3,\n",
       "  'title': 'Cellular senescence in cancer and aging.'},\n",
       " {'author': 'Fang Min',\n",
       "  'cluster': 1,\n",
       "  'title': 'The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.'},\n",
       " {'author': 'Cho Nam Woo',\n",
       "  'cluster': 2,\n",
       "  'title': 'Interchromosomal homology searches drive directional ALT telomere movement and synapsis.'},\n",
       " {'author': 'Bill Anke',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cytohesins are cytoplasmic ErbB receptor activators.'},\n",
       " {'author': 'Wang Gelin',\n",
       "  'cluster': 1,\n",
       "  'title': 'P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.'},\n",
       " {'author': 'Feng Mingye',\n",
       "  'cluster': 1,\n",
       "  'title': 'Store-independent activation of Orai1 by SPCA2 in mammary tumors.'},\n",
       " {'author': 'Xiao Cuiying',\n",
       "  'cluster': 2,\n",
       "  'title': 'The XIST noncoding RNA functions independently of BRCA1 in X inactivation.'},\n",
       " {'author': 'Hou Yong',\n",
       "  'cluster': 4,\n",
       "  'title': 'Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm.'},\n",
       " {'author': 'Moy Ryan H',\n",
       "  'cluster': 1,\n",
       "  'title': 'Stem-loop recognition by DDX17 facilitates miRNA processing and antiviral defense.'},\n",
       " {'author': 'Purvis Jeremy E',\n",
       "  'cluster': 1,\n",
       "  'title': 'Encoding and decoding cellular information through signaling dynamics.'},\n",
       " {'author': 'Jones Alan M',\n",
       "  'cluster': 1,\n",
       "  'title': 'The impact of Arabidopsis on human health: diversifying our portfolio.'},\n",
       " {'author': 'Hu Jiazhi',\n",
       "  'cluster': 1,\n",
       "  'title': 'Chromosomal Loop Domains Direct the Recombination of Antigen Receptor Genes.'},\n",
       " {'author': 'Sutendra Gopinath',\n",
       "  'cluster': 1,\n",
       "  'title': 'A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation.'},\n",
       " {'author': 'Kumar Amit',\n",
       "  'cluster': 1,\n",
       "  'title': 'ATR mediates a checkpoint at the nuclear envelope in response to mechanical stress.'},\n",
       " {'author': 'Haber Daniel A',\n",
       "  'cluster': 2,\n",
       "  'title': 'The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.'},\n",
       " {'author': 'Yan Jie',\n",
       "  'cluster': 1,\n",
       "  'title': u'Inactivation of BAD by IKK inhibits TNF\\u03b1-induced apoptosis independently of NF-\\u03baB activation.'},\n",
       " {'author': 'Gupta Piyush B',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.'},\n",
       " {'author': 'Olenchock Benjamin A',\n",
       "  'cluster': 1,\n",
       "  'title': 'Pyruvate as a pivot point for oncogene-induced senescence.'},\n",
       " {'author': 'Carracedo Arkaitz',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: PTEN signaling pathways.'},\n",
       " {'author': 'Pasquale Elena B',\n",
       "  'cluster': 1,\n",
       "  'title': 'Eph-ephrin bidirectional signaling in physiology and disease.'},\n",
       " {'author': 'Iskow Rebecca C',\n",
       "  'cluster': 2,\n",
       "  'title': 'Natural mutagenesis of human genomes by endogenous retrotransposons.'},\n",
       " {'author': 'Betschinger Joerg',\n",
       "  'cluster': 1,\n",
       "  'title': 'Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3.'},\n",
       " {'author': 'Robbiani Davide F',\n",
       "  'cluster': 2,\n",
       "  'title': 'Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma.'},\n",
       " {'author': 'Rothschild Gerson',\n",
       "  'cluster': 2,\n",
       "  'title': 'Malaria-Induced B Cell Genomic Instability.'},\n",
       " {'author': 'Jones Peter A',\n",
       "  'cluster': 0,\n",
       "  'title': 'The epigenomics of cancer.'},\n",
       " {'author': 'Chao Mark P',\n",
       "  'cluster': 0,\n",
       "  'title': 'Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.'},\n",
       " {'author': 'Peter Marcus E',\n",
       "  'cluster': 1,\n",
       "  'title': 'The CD95 receptor: apoptosis revisited.'},\n",
       " {'author': 'Levine Jacob H',\n",
       "  'cluster': 4,\n",
       "  'title': 'Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.'},\n",
       " {'author': 'Truitt Morgan L',\n",
       "  'cluster': 1,\n",
       "  'title': 'Differential Requirements for eIF4E Dose in Normal Development and Cancer.'},\n",
       " {'author': 'Morrison Sean J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.'},\n",
       " {'author': 'Laird Diana J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stem cell trafficking in tissue development, growth, and disease.'},\n",
       " {'author': 'Sakaue-Sawano Asako',\n",
       "  'cluster': 4,\n",
       "  'title': 'Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.'},\n",
       " {'author': 'Lee J O',\n",
       "  'cluster': 1,\n",
       "  'title': 'Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.'},\n",
       " {'author': 'Li Qing Lin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Causal relationship between the loss of RUNX3 expression and gastric cancer.'},\n",
       " {'author': 'Metzger Michael J',\n",
       "  'cluster': 4,\n",
       "  'title': 'Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams.'},\n",
       " {'author': 'Karreth Florian A',\n",
       "  'cluster': 1,\n",
       "  'title': 'The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.'},\n",
       " {'author': 'Wajapeyee Narendra',\n",
       "  'cluster': 1,\n",
       "  'title': 'Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.'},\n",
       " {'author': 'Karin Michael',\n",
       "  'cluster': 4,\n",
       "  'title': 'Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.'},\n",
       " {'author': 'Fustin Jean-Michel',\n",
       "  'cluster': 1,\n",
       "  'title': 'RNA-methylation-dependent RNA processing controls the speed of the circadian clock.'},\n",
       " {'author': 'Zhu Ping',\n",
       "  'cluster': 1,\n",
       "  'title': 'Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.'},\n",
       " {'author': 'Boire Adrienne',\n",
       "  'cluster': 4,\n",
       "  'title': 'PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.'},\n",
       " {'author': 'Cho Young Sik',\n",
       "  'cluster': 1,\n",
       "  'title': 'Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.'},\n",
       " {'author': 'Tuteja Geetu',\n",
       "  'cluster': 1,\n",
       "  'title': 'Forkhead transcription factors II.'},\n",
       " {'author': 'Hofmann Jeffrey W',\n",
       "  'cluster': 1,\n",
       "  'title': 'Reduced expression of MYC increases longevity and enhances healthspan.'},\n",
       " {'author': 'Jacks Tyler',\n",
       "  'cluster': 4,\n",
       "  'title': 'Taking the study of cancer cell survival to a new dimension.'},\n",
       " {'author': u'Adam Salom\\xe9',\n",
       "  'cluster': 1,\n",
       "  'title': 'Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA.'},\n",
       " {'author': 'Eiring Anna M',\n",
       "  'cluster': 1,\n",
       "  'title': 'miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.'},\n",
       " {'author': 'Qian Jason',\n",
       "  'cluster': 2,\n",
       "  'title': 'B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.'},\n",
       " {'author': 'Rankin Erinn B',\n",
       "  'cluster': 1,\n",
       "  'title': 'The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO.'},\n",
       " {'author': 'Yan Jian',\n",
       "  'cluster': 1,\n",
       "  'title': 'Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites.'},\n",
       " {'author': 'Marshall Lynne',\n",
       "  'cluster': 1,\n",
       "  'title': 'Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation.'},\n",
       " {'author': 'De Bock Katrien',\n",
       "  'cluster': 1,\n",
       "  'title': 'Role of PFKFB3-driven glycolysis in vessel sprouting.'},\n",
       " {'author': 'Kastan Michael B',\n",
       "  'cluster': 3,\n",
       "  'title': 'Parc-ing p53 in the cytoplasm.'},\n",
       " {'author': 'Dong Jixin',\n",
       "  'cluster': 1,\n",
       "  'title': 'Elucidation of a universal size-control mechanism in Drosophila and mammals.'},\n",
       " {'author': 'Peeper Daniel',\n",
       "  'cluster': 2,\n",
       "  'title': 'Cross-species oncogenomics in cancer gene identification.'},\n",
       " {'author': 'Tobin David M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.'},\n",
       " {'author': 'Liu Jianfang',\n",
       "  'cluster': 0,\n",
       "  'title': 'An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.'},\n",
       " {'author': 'Du Xiaofei',\n",
       "  'cluster': 1,\n",
       "  'title': 'Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.'},\n",
       " {'author': 'Dykxhoorn Derek M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Knocking down disease with siRNAs.'},\n",
       " {'author': 'Moumen Abdeladim',\n",
       "  'cluster': 3,\n",
       "  'title': 'hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.'},\n",
       " {'author': 'Kwong Lawrence N', 'cluster': 0, 'title': 'The brothers RAF.'},\n",
       " {'author': 'Kvajo Mirna', 'cluster': 1, 'title': 'Drug rehab.'},\n",
       " {'author': 'Tapon Nicolas',\n",
       "  'cluster': 1,\n",
       "  'title': 'salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.'},\n",
       " {'author': 'Yajnik Vijay',\n",
       "  'cluster': 1,\n",
       "  'title': 'DOCK4, a GTPase activator, is disrupted during tumorigenesis.'},\n",
       " {'author': 'Giordano Francesca',\n",
       "  'cluster': 1,\n",
       "  'title': 'PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions mediated by the extended synaptotagmins.'},\n",
       " {'author': 'Wang Ying-Hua',\n",
       "  'cluster': 1,\n",
       "  'title': 'Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis.'},\n",
       " {'author': 'Kouzine Fedor',\n",
       "  'cluster': 1,\n",
       "  'title': 'Global regulation of promoter melting in naive lymphocytes.'},\n",
       " {'author': 'Levaot Noam',\n",
       "  'cluster': 1,\n",
       "  'title': 'Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.'},\n",
       " {'author': 'Vega Francisco M',\n",
       "  'cluster': 1,\n",
       "  'title': 'SnapShot: Rho family GTPases.'},\n",
       " {'author': 'Bos Johannes L',\n",
       "  'cluster': 1,\n",
       "  'title': 'GEFs and GAPs: critical elements in the control of small G proteins.'},\n",
       " {'author': 'Thion Morgane Sonia',\n",
       "  'cluster': 1,\n",
       "  'title': 'Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner.'},\n",
       " {'author': 'Shanbhag Niraj M',\n",
       "  'cluster': 2,\n",
       "  'title': 'ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks.'},\n",
       " {'author': 'Trimarchi Thomas',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.'},\n",
       " {'author': 'Kundu Parag',\n",
       "  'cluster': 1,\n",
       "  'title': 'Our Gut Microbiome: The Evolving Inner Self.'},\n",
       " {'author': 'Tcherkezian Joseph',\n",
       "  'cluster': 1,\n",
       "  'title': 'Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation.'},\n",
       " {'author': 'Hammes A',\n",
       "  'cluster': 1,\n",
       "  'title': \"Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation.\"},\n",
       " {'author': 'Kind Jop',\n",
       "  'cluster': 1,\n",
       "  'title': 'Single-cell dynamics of genome-nuclear lamina interactions.'},\n",
       " {'author': 'Moretti Julien',\n",
       "  'cluster': 1,\n",
       "  'title': 'STING Senses Microbial Viability to Orchestrate Stress-Mediated Autophagy of the Endoplasmic Reticulum.'},\n",
       " {'author': 'Berns Anton',\n",
       "  'cluster': 4,\n",
       "  'title': 'Stem cells for lung cancer?'},\n",
       " {'author': 'Croce Carlo M',\n",
       "  'cluster': 1,\n",
       "  'title': 'miRNAs, cancer, and stem cell division.'},\n",
       " {'author': 'Yildirim Eda',\n",
       "  'cluster': 2,\n",
       "  'title': 'Xist RNA is a potent suppressor of hematologic cancer in mice.'},\n",
       " {'author': 'Bassik Michael C',\n",
       "  'cluster': 1,\n",
       "  'title': 'A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility.'},\n",
       " {'author': 'Tropberger Philipp',\n",
       "  'cluster': 1,\n",
       "  'title': 'Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.'},\n",
       " {'author': 'Wajapeyee Narendra',\n",
       "  'cluster': 1,\n",
       "  'title': 'Role for IGFBP7 in senescence induction by BRAF.'},\n",
       " {'author': 'Fang Evandro Fei',\n",
       "  'cluster': 1,\n",
       "  'title': 'Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction.'},\n",
       " {'author': 'Mayr Christine',\n",
       "  'cluster': 1,\n",
       "  'title': \"Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.\"},\n",
       " {'author': 'Voss Ty C',\n",
       "  'cluster': 1,\n",
       "  'title': 'Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.'},\n",
       " {'author': 'Joukov Vladimir',\n",
       "  'cluster': 1,\n",
       "  'title': 'The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.'},\n",
       " {'author': 'Gao Liang',\n",
       "  'cluster': 1,\n",
       "  'title': 'Noninvasive imaging beyond the diffraction limit of 3D dynamics in thickly fluorescent specimens.'},\n",
       " {'author': 'Azzolin Luca',\n",
       "  'cluster': 1,\n",
       "  'title': 'Role of TAZ as mediator of Wnt signaling.'},\n",
       " {'author': 'Dupont Sirio',\n",
       "  'cluster': 1,\n",
       "  'title': 'Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase.'},\n",
       " {'author': 'Cebrian Ignacio',\n",
       "  'cluster': 1,\n",
       "  'title': 'Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells.'},\n",
       " {'author': 'Linding Rune',\n",
       "  'cluster': 1,\n",
       "  'title': 'Systematic discovery of in vivo phosphorylation networks.'},\n",
       " {'author': 'Murgia Claudio',\n",
       "  'cluster': 4,\n",
       "  'title': 'Clonal origin and evolution of a transmissible cancer.'},\n",
       " {'author': 'Zhou X Z',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor.'},\n",
       " {'author': 'Ezratty Ellen J',\n",
       "  'cluster': 1,\n",
       "  'title': 'A role for the primary cilium in Notch signaling and epidermal differentiation during skin development.'},\n",
       " {'author': 'Friedman Adam',\n",
       "  'cluster': 1,\n",
       "  'title': 'Genetic screening for signal transduction in the era of network biology.'},\n",
       " {'author': 'Bonetta Laura',\n",
       "  'cluster': 2,\n",
       "  'title': 'Going on a cancer gene hunt.'},\n",
       " {'author': 'Olopade Olufunmilayo I',\n",
       "  'cluster': 1,\n",
       "  'title': 'Obituary: Janet Davison Rowley 1925-2013.'},\n",
       " {'author': 'Pece Salvatore',\n",
       "  'cluster': 4,\n",
       "  'title': 'Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.'},\n",
       " {'author': 'Hochedlinger Konrad',\n",
       "  'cluster': 4,\n",
       "  'title': 'Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.'},\n",
       " {'author': 'Zhu Hao',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Lin28/let-7 axis regulates glucose metabolism.'},\n",
       " {'author': 'Downing James R',\n",
       "  'cluster': 1,\n",
       "  'title': 'A new FOXO pathway required for leukemogenesis.'},\n",
       " {'author': 'Seoane Joan',\n",
       "  'cluster': 1,\n",
       "  'title': 'Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.'},\n",
       " {'author': 'Das Madhumita',\n",
       "  'cluster': 1,\n",
       "  'title': 'Induction of hepatitis by JNK-mediated expression of TNF-alpha.'},\n",
       " {'author': 'Walser Piers J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Constitutive formation of caveolae in a bacterium.'},\n",
       " {'author': 'Zhong Franklin L',\n",
       "  'cluster': 1,\n",
       "  'title': 'TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends.'},\n",
       " {'author': 'Rohaly Gabor',\n",
       "  'cluster': 3,\n",
       "  'title': 'A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.'},\n",
       " {'author': 'Sharpless Norman E',\n",
       "  'cluster': 3,\n",
       "  'title': 'p53: good cop/bad cop.'},\n",
       " {'author': 'Sasai Noriaki',\n",
       "  'cluster': 3,\n",
       "  'title': 'Ectodermal factor restricts mesoderm differentiation by inhibiting p53.'},\n",
       " {'author': 'Sukhdeo Kumar',\n",
       "  'cluster': 4,\n",
       "  'title': 'Glioma development: where did it all go wrong?'},\n",
       " {'author': 'Gowrishankar Kripa',\n",
       "  'cluster': 1,\n",
       "  'title': 'Active remodeling of cortical actin regulates spatiotemporal organization of cell surface molecules.'},\n",
       " {'author': \"O'Reilly M S\",\n",
       "  'cluster': 1,\n",
       "  'title': 'Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.'},\n",
       " {'author': 'Amato Ivan',\n",
       "  'cluster': 1,\n",
       "  'title': 'Nanotechnologists seek biological niches.'},\n",
       " {'author': 'Bai Ge',\n",
       "  'cluster': 1,\n",
       "  'title': 'Presenilin-dependent receptor processing is required for axon guidance.'},\n",
       " {'author': 'White R L', 'cluster': 1, 'title': 'Tumor suppressing pathways.'},\n",
       " {'author': u'T\\u0103rlungeanu Dora C',\n",
       "  'cluster': 1,\n",
       "  'title': 'Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.'},\n",
       " {'author': 'Stergachis Andrew B',\n",
       "  'cluster': 4,\n",
       "  'title': 'Developmental fate and cellular maturity encoded in human regulatory DNA landscapes.'},\n",
       " {'author': 'Berns Anton',\n",
       "  'cluster': 1,\n",
       "  'title': 'A tRNA with oncogenic capacity.'},\n",
       " {'author': \"D'Angiolella Vincenzo\",\n",
       "  'cluster': 1,\n",
       "  'title': 'Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.'},\n",
       " {'author': 'Beug Hartmut',\n",
       "  'cluster': 4,\n",
       "  'title': 'Breast cancer stem cells: eradication by differentiation therapy?'},\n",
       " {'author': 'Stambolic V',\n",
       "  'cluster': 1,\n",
       "  'title': 'Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.'},\n",
       " {'author': 'Mosimann Christian',\n",
       "  'cluster': 1,\n",
       "  'title': 'Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.'},\n",
       " {'author': 'Lee S B',\n",
       "  'cluster': 1,\n",
       "  'title': 'The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.'},\n",
       " {'author': 'He Sudan',\n",
       "  'cluster': 1,\n",
       "  'title': 'Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.'},\n",
       " {'author': 'Schlegelmilch Karin',\n",
       "  'cluster': 1,\n",
       "  'title': u'Yap1 acts downstream of \\u03b1-catenin to control epidermal proliferation.'},\n",
       " {'author': 'Oren M',\n",
       "  'cluster': 1,\n",
       "  'title': 'Lonely no more: p53 finds its kin in a tumor suppressor haven.'},\n",
       " {'author': 'Kruse Jan-Philipp',\n",
       "  'cluster': 3,\n",
       "  'title': 'Modes of p53 regulation.'},\n",
       " {'author': 'Narayanan Vidhya',\n",
       "  'cluster': 2,\n",
       "  'title': 'The pattern of gene amplification is determined by the chromosomal location of hairpin-capped breaks.'},\n",
       " {'author': 'Moerke Nathan J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.'},\n",
       " {'author': 'Manchado Eusebio',\n",
       "  'cluster': 2,\n",
       "  'title': 'Targeting aneuploidy for cancer therapy.'},\n",
       " {'author': 'Houk Andrew R',\n",
       "  'cluster': 1,\n",
       "  'title': 'Membrane tension maintains cell polarity by confining signals to the leading edge during neutrophil migration.'},\n",
       " {'author': 'Li Guoliang',\n",
       "  'cluster': 1,\n",
       "  'title': 'Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation.'},\n",
       " {'author': 'Sun Liming',\n",
       "  'cluster': 1,\n",
       "  'title': 'Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.'},\n",
       " {'author': 'Zender Lars',\n",
       "  'cluster': 2,\n",
       "  'title': 'Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.'},\n",
       " {'author': 'Paroo Zain',\n",
       "  'cluster': 1,\n",
       "  'title': 'Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling.'},\n",
       " {'author': 'Pomerantz J',\n",
       "  'cluster': 3,\n",
       "  'title': \"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.\"},\n",
       " {'author': 'Huarte Maite',\n",
       "  'cluster': 3,\n",
       "  'title': 'A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.'},\n",
       " {'author': 'Zhang Y',\n",
       "  'cluster': 3,\n",
       "  'title': 'ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.'},\n",
       " {'author': 'Sherr C J',\n",
       "  'cluster': 1,\n",
       "  'title': 'Parsing Ink4a/Arf: \"pure\" p16-null mice.'}]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "frame=pd.DataFrame(cluster_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1    426\n",
       "4    269\n",
       "2    118\n",
       "0     99\n",
       "3     75\n",
       "Name: cluster, dtype: int64"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "frame['cluster'].value_counts() "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Top terms per cluster:\n",
      "Cluster 0 words:"
     ]
    },
    {
     "ename": "NameError",
     "evalue": "name 'vocab_frame' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-66-3d23cafde5a8>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     11\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     12\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mind\u001b[0m \u001b[0;32min\u001b[0m \u001b[0morder_centroids\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m:\u001b[0m\u001b[0;36m6\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0;31m#replace 6 with n words per cluster\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 13\u001b[0;31m         \u001b[0;32mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m' %s'\u001b[0m \u001b[0;34m%\u001b[0m \u001b[0mvocab_frame\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mix\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mterms\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mind\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m' '\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mvalues\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtolist\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mencode\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'utf-8'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'ignore'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mend\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m','\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     14\u001b[0m     \u001b[0;32mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;31m#add whitespace\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     15\u001b[0m     \u001b[0;32mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;31m#add whitespace\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'vocab_frame' is not defined"
     ]
    }
   ],
   "source": [
    "from __future__ import print_function\n",
    "\n",
    "print(\"Top terms per cluster:\")\n",
    "\n",
    "#sort cluster centers by proximity to centroid\n",
    "order_centroids = km.cluster_centers_.argsort()[:, ::-1] \n",
    "\n",
    "\n",
    "for i in range(num_clusters):\n",
    "    print(\"Cluster %d words:\" % i, end='')\n",
    "    \n",
    "    for ind in order_centroids[i, :6]: #replace 6 with n words per cluster\n",
    "        print(' %s' % vocab_frame.ix[terms[ind].split(' ')].values.tolist()[0][0].encode('utf-8', 'ignore'), end=',')\n",
    "    print() #add whitespace\n",
    "    print() #add whitespace\n",
    "    \n",
    "    print(\"Cluster %d titles:\" % i, end='')\n",
    "    for title in frame.ix[i]['title'].values.tolist():\n",
    "        print(' %s,' % title, end='')\n",
    "    print() #add whitespace\n",
    "    print() #add whitespace\n",
    "    \n",
    "print()\n",
    "print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "987"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(ablist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "987"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(clusters)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "from sklearn.manifold import MDS\n",
    "from sklearn.cluster import KMeans\n",
    "from sklearn.decomposition import PCA\n",
    "from sklearn.manifold import TSNE\n",
    "from sklearn.cluster import DBSCAN\n",
    "import numpy as np\n",
    "\n",
    "\n",
    "def get_cluster_kmeans(tfidf_matrix, num_clusters):\n",
    "    km = KMeans(n_clusters = num_clusters)\n",
    "    km.fit(tfidf_matrix)\n",
    "    cluster_list = km.labels_.tolist()\n",
    "    return cluster_list\n",
    "\n",
    "def pca_reduction(similarity_matrix, n_components):\n",
    "    one_min_sim = 1 - similarity_matrix\n",
    "    pca = PCA(n_components=10)\n",
    "    pos = pca.fit_transform(one_min_sim)\n",
    "    x_pos, y_pos = pos[:, 0], pos[:, 1]\n",
    "    return (x_pos, y_pos)\n",
    "km_clusters = get_cluster_kmeans(tfidf_matrix, 5)  # KMeans\n",
    "x_pos, y_pos = pca_reduction(similarity_matrix, 10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[3,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 0,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 0,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 0,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 1,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 0,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 0,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 0,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 0,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 0,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 1,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 0,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 0,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 0,\n",
       " 3,\n",
       " 0,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 0,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 1,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 0,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 1,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 0,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 0,\n",
       " 1,\n",
       " 0,\n",
       " 3,\n",
       " 0,\n",
       " 1,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 1,\n",
       " 4,\n",
       " 0,\n",
       " 0,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 1,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 0,\n",
       " 4,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 1,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 0,\n",
       " 3,\n",
       " 2,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 0,\n",
       " 0,\n",
       " 1,\n",
       " 1,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 0,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 4,\n",
       " 3,\n",
       " 0,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 1,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 3,\n",
       " 3,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 4,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 1,\n",
       " 1,\n",
       " 1,\n",
       " 4,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 4,\n",
       " 2,\n",
       " 1,\n",
       " 3,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 2,\n",
       " 2,\n",
       " 3,\n",
       " 2,\n",
       " 1,\n",
       " 1,\n",
       " 1,\n",
       " 2]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "km_clusters"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import matplotlib as mpl\n",
    "import pandas as pd\n",
    "from scipy.cluster.hierarchy import ward, dendrogram\n",
    "\n",
    "\n",
    "def scatter_clusters(x_pos, y_pos, clusters, titles):\n",
    "    cluster_colors = {0: '#cc0000',\n",
    "                      1: '#006600',\n",
    "                      2: '#002699',\n",
    "                      3: '#ffff33',\n",
    "                      4: '#ffa64d',\n",
    "                      5: '#000000'}\n",
    "    # As many as items\n",
    "    cluster_names = {0: '',\n",
    "                 1: '',  \n",
    "                 2: '', \n",
    "                 3: '',\n",
    "                 4: '',\n",
    "                 5: ''}\n",
    "                 \n",
    "    df = pd.DataFrame(dict(x= x_pos, y= y_pos, label= clusters, title= titles)) \n",
    "    groups = df.groupby('label')\n",
    "    fig, ax = plt.subplots(figsize=(17, 9))  # Set size\n",
    "    ax.set_axis_bgcolor('#e6f7ff')\n",
    "    # Iterate through groups to layer the plot\n",
    "    for name, group in groups:\n",
    "        ax.plot(group.x, group.y, marker='D', linestyle='solid', ms=15, \n",
    "                label=cluster_names[name], color=cluster_colors[name], mec='black')\n",
    "        ax.set_aspect('auto')\n",
    "        ax.tick_params(axis= 'x', which='both', labelbottom='off')\n",
    "        ax.tick_params(axis= 'y', which='both', labelleft='off')\n",
    "    ax.legend(numpoints=1)\n",
    "\n",
    "    for i in range(len(df)):\n",
    "        ax.text(df.ix[i]['x'], df.ix[i]['y'], df.ix[i]['title'], size= 15)  \n",
    "    plt.show() # Show the plot\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'authors' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-27-2cf5cea28935>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mscatter_clusters\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mx_pos\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0my_pos\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mkm_clusters\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mauthors\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;31m# Scatter K-means with PCA\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m: name 'authors' is not defined"
     ]
    }
   ],
   "source": [
    "scatter_clusters(x_pos, y_pos, km_clusters, authors) # Scatter K-means with PCA"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
